<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />


<meta name="author" content="Godefroy Chery" />


<title>BMIN503/EPID600 Project Template</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<script>/*! jQuery v3.6.0 | (c) OpenJS Foundation and other contributors | jquery.org/license */
!function(e,t){"use strict";"object"==typeof module&&"object"==typeof module.exports?module.exports=e.document?t(e,!0):function(e){if(!e.document)throw new Error("jQuery requires a window with a document");return t(e)}:t(e)}("undefined"!=typeof window?window:this,function(C,e){"use strict";var t=[],r=Object.getPrototypeOf,s=t.slice,g=t.flat?function(e){return t.flat.call(e)}:function(e){return t.concat.apply([],e)},u=t.push,i=t.indexOf,n={},o=n.toString,v=n.hasOwnProperty,a=v.toString,l=a.call(Object),y={},m=function(e){return"function"==typeof e&&"number"!=typeof e.nodeType&&"function"!=typeof e.item},x=function(e){return null!=e&&e===e.window},E=C.document,c={type:!0,src:!0,nonce:!0,noModule:!0};function b(e,t,n){var r,i,o=(n=n||E).createElement("script");if(o.text=e,t)for(r in c)(i=t[r]||t.getAttribute&&t.getAttribute(r))&&o.setAttribute(r,i);n.head.appendChild(o).parentNode.removeChild(o)}function w(e){return null==e?e+"":"object"==typeof e||"function"==typeof e?n[o.call(e)]||"object":typeof e}var f="3.6.0",S=function(e,t){return new S.fn.init(e,t)};function p(e){var t=!!e&&"length"in e&&e.length,n=w(e);return!m(e)&&!x(e)&&("array"===n||0===t||"number"==typeof t&&0<t&&t-1 in e)}S.fn=S.prototype={jquery:f,constructor:S,length:0,toArray:function(){return s.call(this)},get:function(e){return null==e?s.call(this):e<0?this[e+this.length]:this[e]},pushStack:function(e){var t=S.merge(this.constructor(),e);return t.prevObject=this,t},each:function(e){return S.each(this,e)},map:function(n){return this.pushStack(S.map(this,function(e,t){return n.call(e,t,e)}))},slice:function(){return this.pushStack(s.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},even:function(){return this.pushStack(S.grep(this,function(e,t){return(t+1)%2}))},odd:function(){return this.pushStack(S.grep(this,function(e,t){return t%2}))},eq:function(e){var t=this.length,n=+e+(e<0?t:0);return this.pushStack(0<=n&&n<t?[this[n]]:[])},end:function(){return this.prevObject||this.constructor()},push:u,sort:t.sort,splice:t.splice},S.extend=S.fn.extend=function(){var e,t,n,r,i,o,a=arguments[0]||{},s=1,u=arguments.length,l=!1;for("boolean"==typeof a&&(l=a,a=arguments[s]||{},s++),"object"==typeof a||m(a)||(a={}),s===u&&(a=this,s--);s<u;s++)if(null!=(e=arguments[s]))for(t in e)r=e[t],"__proto__"!==t&&a!==r&&(l&&r&&(S.isPlainObject(r)||(i=Array.isArray(r)))?(n=a[t],o=i&&!Array.isArray(n)?[]:i||S.isPlainObject(n)?n:{},i=!1,a[t]=S.extend(l,o,r)):void 0!==r&&(a[t]=r));return a},S.extend({expando:"jQuery"+(f+Math.random()).replace(/\D/g,""),isReady:!0,error:function(e){throw new Error(e)},noop:function(){},isPlainObject:function(e){var t,n;return!(!e||"[object Object]"!==o.call(e))&&(!(t=r(e))||"function"==typeof(n=v.call(t,"constructor")&&t.constructor)&&a.call(n)===l)},isEmptyObject:function(e){var t;for(t in e)return!1;return!0},globalEval:function(e,t,n){b(e,{nonce:t&&t.nonce},n)},each:function(e,t){var n,r=0;if(p(e)){for(n=e.length;r<n;r++)if(!1===t.call(e[r],r,e[r]))break}else for(r in e)if(!1===t.call(e[r],r,e[r]))break;return e},makeArray:function(e,t){var n=t||[];return null!=e&&(p(Object(e))?S.merge(n,"string"==typeof e?[e]:e):u.call(n,e)),n},inArray:function(e,t,n){return null==t?-1:i.call(t,e,n)},merge:function(e,t){for(var n=+t.length,r=0,i=e.length;r<n;r++)e[i++]=t[r];return e.length=i,e},grep:function(e,t,n){for(var r=[],i=0,o=e.length,a=!n;i<o;i++)!t(e[i],i)!==a&&r.push(e[i]);return r},map:function(e,t,n){var r,i,o=0,a=[];if(p(e))for(r=e.length;o<r;o++)null!=(i=t(e[o],o,n))&&a.push(i);else for(o in e)null!=(i=t(e[o],o,n))&&a.push(i);return g(a)},guid:1,support:y}),"function"==typeof Symbol&&(S.fn[Symbol.iterator]=t[Symbol.iterator]),S.each("Boolean Number String Function Array Date RegExp Object Error Symbol".split(" "),function(e,t){n["[object "+t+"]"]=t.toLowerCase()});var d=function(n){var e,d,b,o,i,h,f,g,w,u,l,T,C,a,E,v,s,c,y,S="sizzle"+1*new Date,p=n.document,k=0,r=0,m=ue(),x=ue(),A=ue(),N=ue(),j=function(e,t){return e===t&&(l=!0),0},D={}.hasOwnProperty,t=[],q=t.pop,L=t.push,H=t.push,O=t.slice,P=function(e,t){for(var n=0,r=e.length;n<r;n++)if(e[n]===t)return n;return-1},R="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",M="[\\x20\\t\\r\\n\\f]",I="(?:\\\\[\\da-fA-F]{1,6}"+M+"?|\\\\[^\\r\\n\\f]|[\\w-]|[^\0-\\x7f])+",W="\\["+M+"*("+I+")(?:"+M+"*([*^$|!~]?=)"+M+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+I+"))|)"+M+"*\\]",F=":("+I+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+W+")*)|.*)\\)|)",B=new RegExp(M+"+","g"),$=new RegExp("^"+M+"+|((?:^|[^\\\\])(?:\\\\.)*)"+M+"+$","g"),_=new RegExp("^"+M+"*,"+M+"*"),z=new RegExp("^"+M+"*([>+~]|"+M+")"+M+"*"),U=new RegExp(M+"|>"),X=new RegExp(F),V=new RegExp("^"+I+"$"),G={ID:new RegExp("^#("+I+")"),CLASS:new RegExp("^\\.("+I+")"),TAG:new RegExp("^("+I+"|[*])"),ATTR:new RegExp("^"+W),PSEUDO:new RegExp("^"+F),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+M+"*(even|odd|(([+-]|)(\\d*)n|)"+M+"*(?:([+-]|)"+M+"*(\\d+)|))"+M+"*\\)|)","i"),bool:new RegExp("^(?:"+R+")$","i"),needsContext:new RegExp("^"+M+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+M+"*((?:-\\d)?\\d*)"+M+"*\\)|)(?=[^-]|$)","i")},Y=/HTML$/i,Q=/^(?:input|select|textarea|button)$/i,J=/^h\d$/i,K=/^[^{]+\{\s*\[native \w/,Z=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,ee=/[+~]/,te=new RegExp("\\\\[\\da-fA-F]{1,6}"+M+"?|\\\\([^\\r\\n\\f])","g"),ne=function(e,t){var n="0x"+e.slice(1)-65536;return t||(n<0?String.fromCharCode(n+65536):String.fromCharCode(n>>10|55296,1023&n|56320))},re=/([\0-\x1f\x7f]|^-?\d)|^-$|[^\0-\x1f\x7f-\uFFFF\w-]/g,ie=function(e,t){return t?"\0"===e?"\ufffd":e.slice(0,-1)+"\\"+e.charCodeAt(e.length-1).toString(16)+" ":"\\"+e},oe=function(){T()},ae=be(function(e){return!0===e.disabled&&"fieldset"===e.nodeName.toLowerCase()},{dir:"parentNode",next:"legend"});try{H.apply(t=O.call(p.childNodes),p.childNodes),t[p.childNodes.length].nodeType}catch(e){H={apply:t.length?function(e,t){L.apply(e,O.call(t))}:function(e,t){var n=e.length,r=0;while(e[n++]=t[r++]);e.length=n-1}}}function se(t,e,n,r){var i,o,a,s,u,l,c,f=e&&e.ownerDocument,p=e?e.nodeType:9;if(n=n||[],"string"!=typeof t||!t||1!==p&&9!==p&&11!==p)return n;if(!r&&(T(e),e=e||C,E)){if(11!==p&&(u=Z.exec(t)))if(i=u[1]){if(9===p){if(!(a=e.getElementById(i)))return n;if(a.id===i)return n.push(a),n}else if(f&&(a=f.getElementById(i))&&y(e,a)&&a.id===i)return n.push(a),n}else{if(u[2])return H.apply(n,e.getElementsByTagName(t)),n;if((i=u[3])&&d.getElementsByClassName&&e.getElementsByClassName)return H.apply(n,e.getElementsByClassName(i)),n}if(d.qsa&&!N[t+" "]&&(!v||!v.test(t))&&(1!==p||"object"!==e.nodeName.toLowerCase())){if(c=t,f=e,1===p&&(U.test(t)||z.test(t))){(f=ee.test(t)&&ye(e.parentNode)||e)===e&&d.scope||((s=e.getAttribute("id"))?s=s.replace(re,ie):e.setAttribute("id",s=S)),o=(l=h(t)).length;while(o--)l[o]=(s?"#"+s:":scope")+" "+xe(l[o]);c=l.join(",")}try{return H.apply(n,f.querySelectorAll(c)),n}catch(e){N(t,!0)}finally{s===S&&e.removeAttribute("id")}}}return g(t.replace($,"$1"),e,n,r)}function ue(){var r=[];return function e(t,n){return r.push(t+" ")>b.cacheLength&&delete e[r.shift()],e[t+" "]=n}}function le(e){return e[S]=!0,e}function ce(e){var t=C.createElement("fieldset");try{return!!e(t)}catch(e){return!1}finally{t.parentNode&&t.parentNode.removeChild(t),t=null}}function fe(e,t){var n=e.split("|"),r=n.length;while(r--)b.attrHandle[n[r]]=t}function pe(e,t){var n=t&&e,r=n&&1===e.nodeType&&1===t.nodeType&&e.sourceIndex-t.sourceIndex;if(r)return r;if(n)while(n=n.nextSibling)if(n===t)return-1;return e?1:-1}function de(t){return function(e){return"input"===e.nodeName.toLowerCase()&&e.type===t}}function he(n){return function(e){var t=e.nodeName.toLowerCase();return("input"===t||"button"===t)&&e.type===n}}function ge(t){return function(e){return"form"in e?e.parentNode&&!1===e.disabled?"label"in e?"label"in e.parentNode?e.parentNode.disabled===t:e.disabled===t:e.isDisabled===t||e.isDisabled!==!t&&ae(e)===t:e.disabled===t:"label"in e&&e.disabled===t}}function ve(a){return le(function(o){return o=+o,le(function(e,t){var n,r=a([],e.length,o),i=r.length;while(i--)e[n=r[i]]&&(e[n]=!(t[n]=e[n]))})})}function ye(e){return e&&"undefined"!=typeof e.getElementsByTagName&&e}for(e in d=se.support={},i=se.isXML=function(e){var t=e&&e.namespaceURI,n=e&&(e.ownerDocument||e).documentElement;return!Y.test(t||n&&n.nodeName||"HTML")},T=se.setDocument=function(e){var t,n,r=e?e.ownerDocument||e:p;return r!=C&&9===r.nodeType&&r.documentElement&&(a=(C=r).documentElement,E=!i(C),p!=C&&(n=C.defaultView)&&n.top!==n&&(n.addEventListener?n.addEventListener("unload",oe,!1):n.attachEvent&&n.attachEvent("onunload",oe)),d.scope=ce(function(e){return a.appendChild(e).appendChild(C.createElement("div")),"undefined"!=typeof e.querySelectorAll&&!e.querySelectorAll(":scope fieldset div").length}),d.attributes=ce(function(e){return e.className="i",!e.getAttribute("className")}),d.getElementsByTagName=ce(function(e){return e.appendChild(C.createComment("")),!e.getElementsByTagName("*").length}),d.getElementsByClassName=K.test(C.getElementsByClassName),d.getById=ce(function(e){return a.appendChild(e).id=S,!C.getElementsByName||!C.getElementsByName(S).length}),d.getById?(b.filter.ID=function(e){var t=e.replace(te,ne);return function(e){return e.getAttribute("id")===t}},b.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&E){var n=t.getElementById(e);return n?[n]:[]}}):(b.filter.ID=function(e){var n=e.replace(te,ne);return function(e){var t="undefined"!=typeof e.getAttributeNode&&e.getAttributeNode("id");return t&&t.value===n}},b.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&E){var n,r,i,o=t.getElementById(e);if(o){if((n=o.getAttributeNode("id"))&&n.value===e)return[o];i=t.getElementsByName(e),r=0;while(o=i[r++])if((n=o.getAttributeNode("id"))&&n.value===e)return[o]}return[]}}),b.find.TAG=d.getElementsByTagName?function(e,t){return"undefined"!=typeof t.getElementsByTagName?t.getElementsByTagName(e):d.qsa?t.querySelectorAll(e):void 0}:function(e,t){var n,r=[],i=0,o=t.getElementsByTagName(e);if("*"===e){while(n=o[i++])1===n.nodeType&&r.push(n);return r}return o},b.find.CLASS=d.getElementsByClassName&&function(e,t){if("undefined"!=typeof t.getElementsByClassName&&E)return t.getElementsByClassName(e)},s=[],v=[],(d.qsa=K.test(C.querySelectorAll))&&(ce(function(e){var t;a.appendChild(e).innerHTML="<a id='"+S+"'></a><select id='"+S+"-\r\\' msallowcapture=''><option selected=''></option></select>",e.querySelectorAll("[msallowcapture^='']").length&&v.push("[*^$]="+M+"*(?:''|\"\")"),e.querySelectorAll("[selected]").length||v.push("\\["+M+"*(?:value|"+R+")"),e.querySelectorAll("[id~="+S+"-]").length||v.push("~="),(t=C.createElement("input")).setAttribute("name",""),e.appendChild(t),e.querySelectorAll("[name='']").length||v.push("\\["+M+"*name"+M+"*="+M+"*(?:''|\"\")"),e.querySelectorAll(":checked").length||v.push(":checked"),e.querySelectorAll("a#"+S+"+*").length||v.push(".#.+[+~]"),e.querySelectorAll("\\\f"),v.push("[\\r\\n\\f]")}),ce(function(e){e.innerHTML="<a href='' disabled='disabled'></a><select disabled='disabled'><option/></select>";var t=C.createElement("input");t.setAttribute("type","hidden"),e.appendChild(t).setAttribute("name","D"),e.querySelectorAll("[name=d]").length&&v.push("name"+M+"*[*^$|!~]?="),2!==e.querySelectorAll(":enabled").length&&v.push(":enabled",":disabled"),a.appendChild(e).disabled=!0,2!==e.querySelectorAll(":disabled").length&&v.push(":enabled",":disabled"),e.querySelectorAll("*,:x"),v.push(",.*:")})),(d.matchesSelector=K.test(c=a.matches||a.webkitMatchesSelector||a.mozMatchesSelector||a.oMatchesSelector||a.msMatchesSelector))&&ce(function(e){d.disconnectedMatch=c.call(e,"*"),c.call(e,"[s!='']:x"),s.push("!=",F)}),v=v.length&&new RegExp(v.join("|")),s=s.length&&new RegExp(s.join("|")),t=K.test(a.compareDocumentPosition),y=t||K.test(a.contains)?function(e,t){var n=9===e.nodeType?e.documentElement:e,r=t&&t.parentNode;return e===r||!(!r||1!==r.nodeType||!(n.contains?n.contains(r):e.compareDocumentPosition&&16&e.compareDocumentPosition(r)))}:function(e,t){if(t)while(t=t.parentNode)if(t===e)return!0;return!1},j=t?function(e,t){if(e===t)return l=!0,0;var n=!e.compareDocumentPosition-!t.compareDocumentPosition;return n||(1&(n=(e.ownerDocument||e)==(t.ownerDocument||t)?e.compareDocumentPosition(t):1)||!d.sortDetached&&t.compareDocumentPosition(e)===n?e==C||e.ownerDocument==p&&y(p,e)?-1:t==C||t.ownerDocument==p&&y(p,t)?1:u?P(u,e)-P(u,t):0:4&n?-1:1)}:function(e,t){if(e===t)return l=!0,0;var n,r=0,i=e.parentNode,o=t.parentNode,a=[e],s=[t];if(!i||!o)return e==C?-1:t==C?1:i?-1:o?1:u?P(u,e)-P(u,t):0;if(i===o)return pe(e,t);n=e;while(n=n.parentNode)a.unshift(n);n=t;while(n=n.parentNode)s.unshift(n);while(a[r]===s[r])r++;return r?pe(a[r],s[r]):a[r]==p?-1:s[r]==p?1:0}),C},se.matches=function(e,t){return se(e,null,null,t)},se.matchesSelector=function(e,t){if(T(e),d.matchesSelector&&E&&!N[t+" "]&&(!s||!s.test(t))&&(!v||!v.test(t)))try{var n=c.call(e,t);if(n||d.disconnectedMatch||e.document&&11!==e.document.nodeType)return n}catch(e){N(t,!0)}return 0<se(t,C,null,[e]).length},se.contains=function(e,t){return(e.ownerDocument||e)!=C&&T(e),y(e,t)},se.attr=function(e,t){(e.ownerDocument||e)!=C&&T(e);var n=b.attrHandle[t.toLowerCase()],r=n&&D.call(b.attrHandle,t.toLowerCase())?n(e,t,!E):void 0;return void 0!==r?r:d.attributes||!E?e.getAttribute(t):(r=e.getAttributeNode(t))&&r.specified?r.value:null},se.escape=function(e){return(e+"").replace(re,ie)},se.error=function(e){throw new Error("Syntax error, unrecognized expression: "+e)},se.uniqueSort=function(e){var t,n=[],r=0,i=0;if(l=!d.detectDuplicates,u=!d.sortStable&&e.slice(0),e.sort(j),l){while(t=e[i++])t===e[i]&&(r=n.push(i));while(r--)e.splice(n[r],1)}return u=null,e},o=se.getText=function(e){var t,n="",r=0,i=e.nodeType;if(i){if(1===i||9===i||11===i){if("string"==typeof e.textContent)return e.textContent;for(e=e.firstChild;e;e=e.nextSibling)n+=o(e)}else if(3===i||4===i)return e.nodeValue}else while(t=e[r++])n+=o(t);return n},(b=se.selectors={cacheLength:50,createPseudo:le,match:G,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(e){return e[1]=e[1].replace(te,ne),e[3]=(e[3]||e[4]||e[5]||"").replace(te,ne),"~="===e[2]&&(e[3]=" "+e[3]+" "),e.slice(0,4)},CHILD:function(e){return e[1]=e[1].toLowerCase(),"nth"===e[1].slice(0,3)?(e[3]||se.error(e[0]),e[4]=+(e[4]?e[5]+(e[6]||1):2*("even"===e[3]||"odd"===e[3])),e[5]=+(e[7]+e[8]||"odd"===e[3])):e[3]&&se.error(e[0]),e},PSEUDO:function(e){var t,n=!e[6]&&e[2];return G.CHILD.test(e[0])?null:(e[3]?e[2]=e[4]||e[5]||"":n&&X.test(n)&&(t=h(n,!0))&&(t=n.indexOf(")",n.length-t)-n.length)&&(e[0]=e[0].slice(0,t),e[2]=n.slice(0,t)),e.slice(0,3))}},filter:{TAG:function(e){var t=e.replace(te,ne).toLowerCase();return"*"===e?function(){return!0}:function(e){return e.nodeName&&e.nodeName.toLowerCase()===t}},CLASS:function(e){var t=m[e+" "];return t||(t=new RegExp("(^|"+M+")"+e+"("+M+"|$)"))&&m(e,function(e){return t.test("string"==typeof e.className&&e.className||"undefined"!=typeof e.getAttribute&&e.getAttribute("class")||"")})},ATTR:function(n,r,i){return function(e){var t=se.attr(e,n);return null==t?"!="===r:!r||(t+="","="===r?t===i:"!="===r?t!==i:"^="===r?i&&0===t.indexOf(i):"*="===r?i&&-1<t.indexOf(i):"$="===r?i&&t.slice(-i.length)===i:"~="===r?-1<(" "+t.replace(B," ")+" ").indexOf(i):"|="===r&&(t===i||t.slice(0,i.length+1)===i+"-"))}},CHILD:function(h,e,t,g,v){var y="nth"!==h.slice(0,3),m="last"!==h.slice(-4),x="of-type"===e;return 1===g&&0===v?function(e){return!!e.parentNode}:function(e,t,n){var r,i,o,a,s,u,l=y!==m?"nextSibling":"previousSibling",c=e.parentNode,f=x&&e.nodeName.toLowerCase(),p=!n&&!x,d=!1;if(c){if(y){while(l){a=e;while(a=a[l])if(x?a.nodeName.toLowerCase()===f:1===a.nodeType)return!1;u=l="only"===h&&!u&&"nextSibling"}return!0}if(u=[m?c.firstChild:c.lastChild],m&&p){d=(s=(r=(i=(o=(a=c)[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]||[])[0]===k&&r[1])&&r[2],a=s&&c.childNodes[s];while(a=++s&&a&&a[l]||(d=s=0)||u.pop())if(1===a.nodeType&&++d&&a===e){i[h]=[k,s,d];break}}else if(p&&(d=s=(r=(i=(o=(a=e)[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]||[])[0]===k&&r[1]),!1===d)while(a=++s&&a&&a[l]||(d=s=0)||u.pop())if((x?a.nodeName.toLowerCase()===f:1===a.nodeType)&&++d&&(p&&((i=(o=a[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]=[k,d]),a===e))break;return(d-=v)===g||d%g==0&&0<=d/g}}},PSEUDO:function(e,o){var t,a=b.pseudos[e]||b.setFilters[e.toLowerCase()]||se.error("unsupported pseudo: "+e);return a[S]?a(o):1<a.length?(t=[e,e,"",o],b.setFilters.hasOwnProperty(e.toLowerCase())?le(function(e,t){var n,r=a(e,o),i=r.length;while(i--)e[n=P(e,r[i])]=!(t[n]=r[i])}):function(e){return a(e,0,t)}):a}},pseudos:{not:le(function(e){var r=[],i=[],s=f(e.replace($,"$1"));return s[S]?le(function(e,t,n,r){var i,o=s(e,null,r,[]),a=e.length;while(a--)(i=o[a])&&(e[a]=!(t[a]=i))}):function(e,t,n){return r[0]=e,s(r,null,n,i),r[0]=null,!i.pop()}}),has:le(function(t){return function(e){return 0<se(t,e).length}}),contains:le(function(t){return t=t.replace(te,ne),function(e){return-1<(e.textContent||o(e)).indexOf(t)}}),lang:le(function(n){return V.test(n||"")||se.error("unsupported lang: "+n),n=n.replace(te,ne).toLowerCase(),function(e){var t;do{if(t=E?e.lang:e.getAttribute("xml:lang")||e.getAttribute("lang"))return(t=t.toLowerCase())===n||0===t.indexOf(n+"-")}while((e=e.parentNode)&&1===e.nodeType);return!1}}),target:function(e){var t=n.location&&n.location.hash;return t&&t.slice(1)===e.id},root:function(e){return e===a},focus:function(e){return e===C.activeElement&&(!C.hasFocus||C.hasFocus())&&!!(e.type||e.href||~e.tabIndex)},enabled:ge(!1),disabled:ge(!0),checked:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&!!e.checked||"option"===t&&!!e.selected},selected:function(e){return e.parentNode&&e.parentNode.selectedIndex,!0===e.selected},empty:function(e){for(e=e.firstChild;e;e=e.nextSibling)if(e.nodeType<6)return!1;return!0},parent:function(e){return!b.pseudos.empty(e)},header:function(e){return J.test(e.nodeName)},input:function(e){return Q.test(e.nodeName)},button:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&"button"===e.type||"button"===t},text:function(e){var t;return"input"===e.nodeName.toLowerCase()&&"text"===e.type&&(null==(t=e.getAttribute("type"))||"text"===t.toLowerCase())},first:ve(function(){return[0]}),last:ve(function(e,t){return[t-1]}),eq:ve(function(e,t,n){return[n<0?n+t:n]}),even:ve(function(e,t){for(var n=0;n<t;n+=2)e.push(n);return e}),odd:ve(function(e,t){for(var n=1;n<t;n+=2)e.push(n);return e}),lt:ve(function(e,t,n){for(var r=n<0?n+t:t<n?t:n;0<=--r;)e.push(r);return e}),gt:ve(function(e,t,n){for(var r=n<0?n+t:n;++r<t;)e.push(r);return e})}}).pseudos.nth=b.pseudos.eq,{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})b.pseudos[e]=de(e);for(e in{submit:!0,reset:!0})b.pseudos[e]=he(e);function me(){}function xe(e){for(var t=0,n=e.length,r="";t<n;t++)r+=e[t].value;return r}function be(s,e,t){var u=e.dir,l=e.next,c=l||u,f=t&&"parentNode"===c,p=r++;return e.first?function(e,t,n){while(e=e[u])if(1===e.nodeType||f)return s(e,t,n);return!1}:function(e,t,n){var r,i,o,a=[k,p];if(n){while(e=e[u])if((1===e.nodeType||f)&&s(e,t,n))return!0}else while(e=e[u])if(1===e.nodeType||f)if(i=(o=e[S]||(e[S]={}))[e.uniqueID]||(o[e.uniqueID]={}),l&&l===e.nodeName.toLowerCase())e=e[u]||e;else{if((r=i[c])&&r[0]===k&&r[1]===p)return a[2]=r[2];if((i[c]=a)[2]=s(e,t,n))return!0}return!1}}function we(i){return 1<i.length?function(e,t,n){var r=i.length;while(r--)if(!i[r](e,t,n))return!1;return!0}:i[0]}function Te(e,t,n,r,i){for(var o,a=[],s=0,u=e.length,l=null!=t;s<u;s++)(o=e[s])&&(n&&!n(o,r,i)||(a.push(o),l&&t.push(s)));return a}function Ce(d,h,g,v,y,e){return v&&!v[S]&&(v=Ce(v)),y&&!y[S]&&(y=Ce(y,e)),le(function(e,t,n,r){var i,o,a,s=[],u=[],l=t.length,c=e||function(e,t,n){for(var r=0,i=t.length;r<i;r++)se(e,t[r],n);return n}(h||"*",n.nodeType?[n]:n,[]),f=!d||!e&&h?c:Te(c,s,d,n,r),p=g?y||(e?d:l||v)?[]:t:f;if(g&&g(f,p,n,r),v){i=Te(p,u),v(i,[],n,r),o=i.length;while(o--)(a=i[o])&&(p[u[o]]=!(f[u[o]]=a))}if(e){if(y||d){if(y){i=[],o=p.length;while(o--)(a=p[o])&&i.push(f[o]=a);y(null,p=[],i,r)}o=p.length;while(o--)(a=p[o])&&-1<(i=y?P(e,a):s[o])&&(e[i]=!(t[i]=a))}}else p=Te(p===t?p.splice(l,p.length):p),y?y(null,t,p,r):H.apply(t,p)})}function Ee(e){for(var i,t,n,r=e.length,o=b.relative[e[0].type],a=o||b.relative[" "],s=o?1:0,u=be(function(e){return e===i},a,!0),l=be(function(e){return-1<P(i,e)},a,!0),c=[function(e,t,n){var r=!o&&(n||t!==w)||((i=t).nodeType?u(e,t,n):l(e,t,n));return i=null,r}];s<r;s++)if(t=b.relative[e[s].type])c=[be(we(c),t)];else{if((t=b.filter[e[s].type].apply(null,e[s].matches))[S]){for(n=++s;n<r;n++)if(b.relative[e[n].type])break;return Ce(1<s&&we(c),1<s&&xe(e.slice(0,s-1).concat({value:" "===e[s-2].type?"*":""})).replace($,"$1"),t,s<n&&Ee(e.slice(s,n)),n<r&&Ee(e=e.slice(n)),n<r&&xe(e))}c.push(t)}return we(c)}return me.prototype=b.filters=b.pseudos,b.setFilters=new me,h=se.tokenize=function(e,t){var n,r,i,o,a,s,u,l=x[e+" "];if(l)return t?0:l.slice(0);a=e,s=[],u=b.preFilter;while(a){for(o in n&&!(r=_.exec(a))||(r&&(a=a.slice(r[0].length)||a),s.push(i=[])),n=!1,(r=z.exec(a))&&(n=r.shift(),i.push({value:n,type:r[0].replace($," ")}),a=a.slice(n.length)),b.filter)!(r=G[o].exec(a))||u[o]&&!(r=u[o](r))||(n=r.shift(),i.push({value:n,type:o,matches:r}),a=a.slice(n.length));if(!n)break}return t?a.length:a?se.error(e):x(e,s).slice(0)},f=se.compile=function(e,t){var n,v,y,m,x,r,i=[],o=[],a=A[e+" "];if(!a){t||(t=h(e)),n=t.length;while(n--)(a=Ee(t[n]))[S]?i.push(a):o.push(a);(a=A(e,(v=o,m=0<(y=i).length,x=0<v.length,r=function(e,t,n,r,i){var o,a,s,u=0,l="0",c=e&&[],f=[],p=w,d=e||x&&b.find.TAG("*",i),h=k+=null==p?1:Math.random()||.1,g=d.length;for(i&&(w=t==C||t||i);l!==g&&null!=(o=d[l]);l++){if(x&&o){a=0,t||o.ownerDocument==C||(T(o),n=!E);while(s=v[a++])if(s(o,t||C,n)){r.push(o);break}i&&(k=h)}m&&((o=!s&&o)&&u--,e&&c.push(o))}if(u+=l,m&&l!==u){a=0;while(s=y[a++])s(c,f,t,n);if(e){if(0<u)while(l--)c[l]||f[l]||(f[l]=q.call(r));f=Te(f)}H.apply(r,f),i&&!e&&0<f.length&&1<u+y.length&&se.uniqueSort(r)}return i&&(k=h,w=p),c},m?le(r):r))).selector=e}return a},g=se.select=function(e,t,n,r){var i,o,a,s,u,l="function"==typeof e&&e,c=!r&&h(e=l.selector||e);if(n=n||[],1===c.length){if(2<(o=c[0]=c[0].slice(0)).length&&"ID"===(a=o[0]).type&&9===t.nodeType&&E&&b.relative[o[1].type]){if(!(t=(b.find.ID(a.matches[0].replace(te,ne),t)||[])[0]))return n;l&&(t=t.parentNode),e=e.slice(o.shift().value.length)}i=G.needsContext.test(e)?0:o.length;while(i--){if(a=o[i],b.relative[s=a.type])break;if((u=b.find[s])&&(r=u(a.matches[0].replace(te,ne),ee.test(o[0].type)&&ye(t.parentNode)||t))){if(o.splice(i,1),!(e=r.length&&xe(o)))return H.apply(n,r),n;break}}}return(l||f(e,c))(r,t,!E,n,!t||ee.test(e)&&ye(t.parentNode)||t),n},d.sortStable=S.split("").sort(j).join("")===S,d.detectDuplicates=!!l,T(),d.sortDetached=ce(function(e){return 1&e.compareDocumentPosition(C.createElement("fieldset"))}),ce(function(e){return e.innerHTML="<a href='#'></a>","#"===e.firstChild.getAttribute("href")})||fe("type|href|height|width",function(e,t,n){if(!n)return e.getAttribute(t,"type"===t.toLowerCase()?1:2)}),d.attributes&&ce(function(e){return e.innerHTML="<input/>",e.firstChild.setAttribute("value",""),""===e.firstChild.getAttribute("value")})||fe("value",function(e,t,n){if(!n&&"input"===e.nodeName.toLowerCase())return e.defaultValue}),ce(function(e){return null==e.getAttribute("disabled")})||fe(R,function(e,t,n){var r;if(!n)return!0===e[t]?t.toLowerCase():(r=e.getAttributeNode(t))&&r.specified?r.value:null}),se}(C);S.find=d,S.expr=d.selectors,S.expr[":"]=S.expr.pseudos,S.uniqueSort=S.unique=d.uniqueSort,S.text=d.getText,S.isXMLDoc=d.isXML,S.contains=d.contains,S.escapeSelector=d.escape;var h=function(e,t,n){var r=[],i=void 0!==n;while((e=e[t])&&9!==e.nodeType)if(1===e.nodeType){if(i&&S(e).is(n))break;r.push(e)}return r},T=function(e,t){for(var n=[];e;e=e.nextSibling)1===e.nodeType&&e!==t&&n.push(e);return n},k=S.expr.match.needsContext;function A(e,t){return e.nodeName&&e.nodeName.toLowerCase()===t.toLowerCase()}var N=/^<([a-z][^\/\0>:\x20\t\r\n\f]*)[\x20\t\r\n\f]*\/?>(?:<\/\1>|)$/i;function j(e,n,r){return m(n)?S.grep(e,function(e,t){return!!n.call(e,t,e)!==r}):n.nodeType?S.grep(e,function(e){return e===n!==r}):"string"!=typeof n?S.grep(e,function(e){return-1<i.call(n,e)!==r}):S.filter(n,e,r)}S.filter=function(e,t,n){var r=t[0];return n&&(e=":not("+e+")"),1===t.length&&1===r.nodeType?S.find.matchesSelector(r,e)?[r]:[]:S.find.matches(e,S.grep(t,function(e){return 1===e.nodeType}))},S.fn.extend({find:function(e){var t,n,r=this.length,i=this;if("string"!=typeof e)return this.pushStack(S(e).filter(function(){for(t=0;t<r;t++)if(S.contains(i[t],this))return!0}));for(n=this.pushStack([]),t=0;t<r;t++)S.find(e,i[t],n);return 1<r?S.uniqueSort(n):n},filter:function(e){return this.pushStack(j(this,e||[],!1))},not:function(e){return this.pushStack(j(this,e||[],!0))},is:function(e){return!!j(this,"string"==typeof e&&k.test(e)?S(e):e||[],!1).length}});var D,q=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]+))$/;(S.fn.init=function(e,t,n){var r,i;if(!e)return this;if(n=n||D,"string"==typeof e){if(!(r="<"===e[0]&&">"===e[e.length-1]&&3<=e.length?[null,e,null]:q.exec(e))||!r[1]&&t)return!t||t.jquery?(t||n).find(e):this.constructor(t).find(e);if(r[1]){if(t=t instanceof S?t[0]:t,S.merge(this,S.parseHTML(r[1],t&&t.nodeType?t.ownerDocument||t:E,!0)),N.test(r[1])&&S.isPlainObject(t))for(r in t)m(this[r])?this[r](t[r]):this.attr(r,t[r]);return this}return(i=E.getElementById(r[2]))&&(this[0]=i,this.length=1),this}return e.nodeType?(this[0]=e,this.length=1,this):m(e)?void 0!==n.ready?n.ready(e):e(S):S.makeArray(e,this)}).prototype=S.fn,D=S(E);var L=/^(?:parents|prev(?:Until|All))/,H={children:!0,contents:!0,next:!0,prev:!0};function O(e,t){while((e=e[t])&&1!==e.nodeType);return e}S.fn.extend({has:function(e){var t=S(e,this),n=t.length;return this.filter(function(){for(var e=0;e<n;e++)if(S.contains(this,t[e]))return!0})},closest:function(e,t){var n,r=0,i=this.length,o=[],a="string"!=typeof e&&S(e);if(!k.test(e))for(;r<i;r++)for(n=this[r];n&&n!==t;n=n.parentNode)if(n.nodeType<11&&(a?-1<a.index(n):1===n.nodeType&&S.find.matchesSelector(n,e))){o.push(n);break}return this.pushStack(1<o.length?S.uniqueSort(o):o)},index:function(e){return e?"string"==typeof e?i.call(S(e),this[0]):i.call(this,e.jquery?e[0]:e):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(e,t){return this.pushStack(S.uniqueSort(S.merge(this.get(),S(e,t))))},addBack:function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}}),S.each({parent:function(e){var t=e.parentNode;return t&&11!==t.nodeType?t:null},parents:function(e){return h(e,"parentNode")},parentsUntil:function(e,t,n){return h(e,"parentNode",n)},next:function(e){return O(e,"nextSibling")},prev:function(e){return O(e,"previousSibling")},nextAll:function(e){return h(e,"nextSibling")},prevAll:function(e){return h(e,"previousSibling")},nextUntil:function(e,t,n){return h(e,"nextSibling",n)},prevUntil:function(e,t,n){return h(e,"previousSibling",n)},siblings:function(e){return T((e.parentNode||{}).firstChild,e)},children:function(e){return T(e.firstChild)},contents:function(e){return null!=e.contentDocument&&r(e.contentDocument)?e.contentDocument:(A(e,"template")&&(e=e.content||e),S.merge([],e.childNodes))}},function(r,i){S.fn[r]=function(e,t){var n=S.map(this,i,e);return"Until"!==r.slice(-5)&&(t=e),t&&"string"==typeof t&&(n=S.filter(t,n)),1<this.length&&(H[r]||S.uniqueSort(n),L.test(r)&&n.reverse()),this.pushStack(n)}});var P=/[^\x20\t\r\n\f]+/g;function R(e){return e}function M(e){throw e}function I(e,t,n,r){var i;try{e&&m(i=e.promise)?i.call(e).done(t).fail(n):e&&m(i=e.then)?i.call(e,t,n):t.apply(void 0,[e].slice(r))}catch(e){n.apply(void 0,[e])}}S.Callbacks=function(r){var e,n;r="string"==typeof r?(e=r,n={},S.each(e.match(P)||[],function(e,t){n[t]=!0}),n):S.extend({},r);var i,t,o,a,s=[],u=[],l=-1,c=function(){for(a=a||r.once,o=i=!0;u.length;l=-1){t=u.shift();while(++l<s.length)!1===s[l].apply(t[0],t[1])&&r.stopOnFalse&&(l=s.length,t=!1)}r.memory||(t=!1),i=!1,a&&(s=t?[]:"")},f={add:function(){return s&&(t&&!i&&(l=s.length-1,u.push(t)),function n(e){S.each(e,function(e,t){m(t)?r.unique&&f.has(t)||s.push(t):t&&t.length&&"string"!==w(t)&&n(t)})}(arguments),t&&!i&&c()),this},remove:function(){return S.each(arguments,function(e,t){var n;while(-1<(n=S.inArray(t,s,n)))s.splice(n,1),n<=l&&l--}),this},has:function(e){return e?-1<S.inArray(e,s):0<s.length},empty:function(){return s&&(s=[]),this},disable:function(){return a=u=[],s=t="",this},disabled:function(){return!s},lock:function(){return a=u=[],t||i||(s=t=""),this},locked:function(){return!!a},fireWith:function(e,t){return a||(t=[e,(t=t||[]).slice?t.slice():t],u.push(t),i||c()),this},fire:function(){return f.fireWith(this,arguments),this},fired:function(){return!!o}};return f},S.extend({Deferred:function(e){var o=[["notify","progress",S.Callbacks("memory"),S.Callbacks("memory"),2],["resolve","done",S.Callbacks("once memory"),S.Callbacks("once memory"),0,"resolved"],["reject","fail",S.Callbacks("once memory"),S.Callbacks("once memory"),1,"rejected"]],i="pending",a={state:function(){return i},always:function(){return s.done(arguments).fail(arguments),this},"catch":function(e){return a.then(null,e)},pipe:function(){var i=arguments;return S.Deferred(function(r){S.each(o,function(e,t){var n=m(i[t[4]])&&i[t[4]];s[t[1]](function(){var e=n&&n.apply(this,arguments);e&&m(e.promise)?e.promise().progress(r.notify).done(r.resolve).fail(r.reject):r[t[0]+"With"](this,n?[e]:arguments)})}),i=null}).promise()},then:function(t,n,r){var u=0;function l(i,o,a,s){return function(){var n=this,r=arguments,e=function(){var e,t;if(!(i<u)){if((e=a.apply(n,r))===o.promise())throw new TypeError("Thenable self-resolution");t=e&&("object"==typeof e||"function"==typeof e)&&e.then,m(t)?s?t.call(e,l(u,o,R,s),l(u,o,M,s)):(u++,t.call(e,l(u,o,R,s),l(u,o,M,s),l(u,o,R,o.notifyWith))):(a!==R&&(n=void 0,r=[e]),(s||o.resolveWith)(n,r))}},t=s?e:function(){try{e()}catch(e){S.Deferred.exceptionHook&&S.Deferred.exceptionHook(e,t.stackTrace),u<=i+1&&(a!==M&&(n=void 0,r=[e]),o.rejectWith(n,r))}};i?t():(S.Deferred.getStackHook&&(t.stackTrace=S.Deferred.getStackHook()),C.setTimeout(t))}}return S.Deferred(function(e){o[0][3].add(l(0,e,m(r)?r:R,e.notifyWith)),o[1][3].add(l(0,e,m(t)?t:R)),o[2][3].add(l(0,e,m(n)?n:M))}).promise()},promise:function(e){return null!=e?S.extend(e,a):a}},s={};return S.each(o,function(e,t){var n=t[2],r=t[5];a[t[1]]=n.add,r&&n.add(function(){i=r},o[3-e][2].disable,o[3-e][3].disable,o[0][2].lock,o[0][3].lock),n.add(t[3].fire),s[t[0]]=function(){return s[t[0]+"With"](this===s?void 0:this,arguments),this},s[t[0]+"With"]=n.fireWith}),a.promise(s),e&&e.call(s,s),s},when:function(e){var n=arguments.length,t=n,r=Array(t),i=s.call(arguments),o=S.Deferred(),a=function(t){return function(e){r[t]=this,i[t]=1<arguments.length?s.call(arguments):e,--n||o.resolveWith(r,i)}};if(n<=1&&(I(e,o.done(a(t)).resolve,o.reject,!n),"pending"===o.state()||m(i[t]&&i[t].then)))return o.then();while(t--)I(i[t],a(t),o.reject);return o.promise()}});var W=/^(Eval|Internal|Range|Reference|Syntax|Type|URI)Error$/;S.Deferred.exceptionHook=function(e,t){C.console&&C.console.warn&&e&&W.test(e.name)&&C.console.warn("jQuery.Deferred exception: "+e.message,e.stack,t)},S.readyException=function(e){C.setTimeout(function(){throw e})};var F=S.Deferred();function B(){E.removeEventListener("DOMContentLoaded",B),C.removeEventListener("load",B),S.ready()}S.fn.ready=function(e){return F.then(e)["catch"](function(e){S.readyException(e)}),this},S.extend({isReady:!1,readyWait:1,ready:function(e){(!0===e?--S.readyWait:S.isReady)||(S.isReady=!0)!==e&&0<--S.readyWait||F.resolveWith(E,[S])}}),S.ready.then=F.then,"complete"===E.readyState||"loading"!==E.readyState&&!E.documentElement.doScroll?C.setTimeout(S.ready):(E.addEventListener("DOMContentLoaded",B),C.addEventListener("load",B));var $=function(e,t,n,r,i,o,a){var s=0,u=e.length,l=null==n;if("object"===w(n))for(s in i=!0,n)$(e,t,s,n[s],!0,o,a);else if(void 0!==r&&(i=!0,m(r)||(a=!0),l&&(a?(t.call(e,r),t=null):(l=t,t=function(e,t,n){return l.call(S(e),n)})),t))for(;s<u;s++)t(e[s],n,a?r:r.call(e[s],s,t(e[s],n)));return i?e:l?t.call(e):u?t(e[0],n):o},_=/^-ms-/,z=/-([a-z])/g;function U(e,t){return t.toUpperCase()}function X(e){return e.replace(_,"ms-").replace(z,U)}var V=function(e){return 1===e.nodeType||9===e.nodeType||!+e.nodeType};function G(){this.expando=S.expando+G.uid++}G.uid=1,G.prototype={cache:function(e){var t=e[this.expando];return t||(t={},V(e)&&(e.nodeType?e[this.expando]=t:Object.defineProperty(e,this.expando,{value:t,configurable:!0}))),t},set:function(e,t,n){var r,i=this.cache(e);if("string"==typeof t)i[X(t)]=n;else for(r in t)i[X(r)]=t[r];return i},get:function(e,t){return void 0===t?this.cache(e):e[this.expando]&&e[this.expando][X(t)]},access:function(e,t,n){return void 0===t||t&&"string"==typeof t&&void 0===n?this.get(e,t):(this.set(e,t,n),void 0!==n?n:t)},remove:function(e,t){var n,r=e[this.expando];if(void 0!==r){if(void 0!==t){n=(t=Array.isArray(t)?t.map(X):(t=X(t))in r?[t]:t.match(P)||[]).length;while(n--)delete r[t[n]]}(void 0===t||S.isEmptyObject(r))&&(e.nodeType?e[this.expando]=void 0:delete e[this.expando])}},hasData:function(e){var t=e[this.expando];return void 0!==t&&!S.isEmptyObject(t)}};var Y=new G,Q=new G,J=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,K=/[A-Z]/g;function Z(e,t,n){var r,i;if(void 0===n&&1===e.nodeType)if(r="data-"+t.replace(K,"-$&").toLowerCase(),"string"==typeof(n=e.getAttribute(r))){try{n="true"===(i=n)||"false"!==i&&("null"===i?null:i===+i+""?+i:J.test(i)?JSON.parse(i):i)}catch(e){}Q.set(e,t,n)}else n=void 0;return n}S.extend({hasData:function(e){return Q.hasData(e)||Y.hasData(e)},data:function(e,t,n){return Q.access(e,t,n)},removeData:function(e,t){Q.remove(e,t)},_data:function(e,t,n){return Y.access(e,t,n)},_removeData:function(e,t){Y.remove(e,t)}}),S.fn.extend({data:function(n,e){var t,r,i,o=this[0],a=o&&o.attributes;if(void 0===n){if(this.length&&(i=Q.get(o),1===o.nodeType&&!Y.get(o,"hasDataAttrs"))){t=a.length;while(t--)a[t]&&0===(r=a[t].name).indexOf("data-")&&(r=X(r.slice(5)),Z(o,r,i[r]));Y.set(o,"hasDataAttrs",!0)}return i}return"object"==typeof n?this.each(function(){Q.set(this,n)}):$(this,function(e){var t;if(o&&void 0===e)return void 0!==(t=Q.get(o,n))?t:void 0!==(t=Z(o,n))?t:void 0;this.each(function(){Q.set(this,n,e)})},null,e,1<arguments.length,null,!0)},removeData:function(e){return this.each(function(){Q.remove(this,e)})}}),S.extend({queue:function(e,t,n){var r;if(e)return t=(t||"fx")+"queue",r=Y.get(e,t),n&&(!r||Array.isArray(n)?r=Y.access(e,t,S.makeArray(n)):r.push(n)),r||[]},dequeue:function(e,t){t=t||"fx";var n=S.queue(e,t),r=n.length,i=n.shift(),o=S._queueHooks(e,t);"inprogress"===i&&(i=n.shift(),r--),i&&("fx"===t&&n.unshift("inprogress"),delete o.stop,i.call(e,function(){S.dequeue(e,t)},o)),!r&&o&&o.empty.fire()},_queueHooks:function(e,t){var n=t+"queueHooks";return Y.get(e,n)||Y.access(e,n,{empty:S.Callbacks("once memory").add(function(){Y.remove(e,[t+"queue",n])})})}}),S.fn.extend({queue:function(t,n){var e=2;return"string"!=typeof t&&(n=t,t="fx",e--),arguments.length<e?S.queue(this[0],t):void 0===n?this:this.each(function(){var e=S.queue(this,t,n);S._queueHooks(this,t),"fx"===t&&"inprogress"!==e[0]&&S.dequeue(this,t)})},dequeue:function(e){return this.each(function(){S.dequeue(this,e)})},clearQueue:function(e){return this.queue(e||"fx",[])},promise:function(e,t){var n,r=1,i=S.Deferred(),o=this,a=this.length,s=function(){--r||i.resolveWith(o,[o])};"string"!=typeof e&&(t=e,e=void 0),e=e||"fx";while(a--)(n=Y.get(o[a],e+"queueHooks"))&&n.empty&&(r++,n.empty.add(s));return s(),i.promise(t)}});var ee=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,te=new RegExp("^(?:([+-])=|)("+ee+")([a-z%]*)$","i"),ne=["Top","Right","Bottom","Left"],re=E.documentElement,ie=function(e){return S.contains(e.ownerDocument,e)},oe={composed:!0};re.getRootNode&&(ie=function(e){return S.contains(e.ownerDocument,e)||e.getRootNode(oe)===e.ownerDocument});var ae=function(e,t){return"none"===(e=t||e).style.display||""===e.style.display&&ie(e)&&"none"===S.css(e,"display")};function se(e,t,n,r){var i,o,a=20,s=r?function(){return r.cur()}:function(){return S.css(e,t,"")},u=s(),l=n&&n[3]||(S.cssNumber[t]?"":"px"),c=e.nodeType&&(S.cssNumber[t]||"px"!==l&&+u)&&te.exec(S.css(e,t));if(c&&c[3]!==l){u/=2,l=l||c[3],c=+u||1;while(a--)S.style(e,t,c+l),(1-o)*(1-(o=s()/u||.5))<=0&&(a=0),c/=o;c*=2,S.style(e,t,c+l),n=n||[]}return n&&(c=+c||+u||0,i=n[1]?c+(n[1]+1)*n[2]:+n[2],r&&(r.unit=l,r.start=c,r.end=i)),i}var ue={};function le(e,t){for(var n,r,i,o,a,s,u,l=[],c=0,f=e.length;c<f;c++)(r=e[c]).style&&(n=r.style.display,t?("none"===n&&(l[c]=Y.get(r,"display")||null,l[c]||(r.style.display="")),""===r.style.display&&ae(r)&&(l[c]=(u=a=o=void 0,a=(i=r).ownerDocument,s=i.nodeName,(u=ue[s])||(o=a.body.appendChild(a.createElement(s)),u=S.css(o,"display"),o.parentNode.removeChild(o),"none"===u&&(u="block"),ue[s]=u)))):"none"!==n&&(l[c]="none",Y.set(r,"display",n)));for(c=0;c<f;c++)null!=l[c]&&(e[c].style.display=l[c]);return e}S.fn.extend({show:function(){return le(this,!0)},hide:function(){return le(this)},toggle:function(e){return"boolean"==typeof e?e?this.show():this.hide():this.each(function(){ae(this)?S(this).show():S(this).hide()})}});var ce,fe,pe=/^(?:checkbox|radio)$/i,de=/<([a-z][^\/\0>\x20\t\r\n\f]*)/i,he=/^$|^module$|\/(?:java|ecma)script/i;ce=E.createDocumentFragment().appendChild(E.createElement("div")),(fe=E.createElement("input")).setAttribute("type","radio"),fe.setAttribute("checked","checked"),fe.setAttribute("name","t"),ce.appendChild(fe),y.checkClone=ce.cloneNode(!0).cloneNode(!0).lastChild.checked,ce.innerHTML="<textarea>x</textarea>",y.noCloneChecked=!!ce.cloneNode(!0).lastChild.defaultValue,ce.innerHTML="<option></option>",y.option=!!ce.lastChild;var ge={thead:[1,"<table>","</table>"],col:[2,"<table><colgroup>","</colgroup></table>"],tr:[2,"<table><tbody>","</tbody></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:[0,"",""]};function ve(e,t){var n;return n="undefined"!=typeof e.getElementsByTagName?e.getElementsByTagName(t||"*"):"undefined"!=typeof e.querySelectorAll?e.querySelectorAll(t||"*"):[],void 0===t||t&&A(e,t)?S.merge([e],n):n}function ye(e,t){for(var n=0,r=e.length;n<r;n++)Y.set(e[n],"globalEval",!t||Y.get(t[n],"globalEval"))}ge.tbody=ge.tfoot=ge.colgroup=ge.caption=ge.thead,ge.th=ge.td,y.option||(ge.optgroup=ge.option=[1,"<select multiple='multiple'>","</select>"]);var me=/<|&#?\w+;/;function xe(e,t,n,r,i){for(var o,a,s,u,l,c,f=t.createDocumentFragment(),p=[],d=0,h=e.length;d<h;d++)if((o=e[d])||0===o)if("object"===w(o))S.merge(p,o.nodeType?[o]:o);else if(me.test(o)){a=a||f.appendChild(t.createElement("div")),s=(de.exec(o)||["",""])[1].toLowerCase(),u=ge[s]||ge._default,a.innerHTML=u[1]+S.htmlPrefilter(o)+u[2],c=u[0];while(c--)a=a.lastChild;S.merge(p,a.childNodes),(a=f.firstChild).textContent=""}else p.push(t.createTextNode(o));f.textContent="",d=0;while(o=p[d++])if(r&&-1<S.inArray(o,r))i&&i.push(o);else if(l=ie(o),a=ve(f.appendChild(o),"script"),l&&ye(a),n){c=0;while(o=a[c++])he.test(o.type||"")&&n.push(o)}return f}var be=/^([^.]*)(?:\.(.+)|)/;function we(){return!0}function Te(){return!1}function Ce(e,t){return e===function(){try{return E.activeElement}catch(e){}}()==("focus"===t)}function Ee(e,t,n,r,i,o){var a,s;if("object"==typeof t){for(s in"string"!=typeof n&&(r=r||n,n=void 0),t)Ee(e,s,n,r,t[s],o);return e}if(null==r&&null==i?(i=n,r=n=void 0):null==i&&("string"==typeof n?(i=r,r=void 0):(i=r,r=n,n=void 0)),!1===i)i=Te;else if(!i)return e;return 1===o&&(a=i,(i=function(e){return S().off(e),a.apply(this,arguments)}).guid=a.guid||(a.guid=S.guid++)),e.each(function(){S.event.add(this,t,i,r,n)})}function Se(e,i,o){o?(Y.set(e,i,!1),S.event.add(e,i,{namespace:!1,handler:function(e){var t,n,r=Y.get(this,i);if(1&e.isTrigger&&this[i]){if(r.length)(S.event.special[i]||{}).delegateType&&e.stopPropagation();else if(r=s.call(arguments),Y.set(this,i,r),t=o(this,i),this[i](),r!==(n=Y.get(this,i))||t?Y.set(this,i,!1):n={},r!==n)return e.stopImmediatePropagation(),e.preventDefault(),n&&n.value}else r.length&&(Y.set(this,i,{value:S.event.trigger(S.extend(r[0],S.Event.prototype),r.slice(1),this)}),e.stopImmediatePropagation())}})):void 0===Y.get(e,i)&&S.event.add(e,i,we)}S.event={global:{},add:function(t,e,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,v=Y.get(t);if(V(t)){n.handler&&(n=(o=n).handler,i=o.selector),i&&S.find.matchesSelector(re,i),n.guid||(n.guid=S.guid++),(u=v.events)||(u=v.events=Object.create(null)),(a=v.handle)||(a=v.handle=function(e){return"undefined"!=typeof S&&S.event.triggered!==e.type?S.event.dispatch.apply(t,arguments):void 0}),l=(e=(e||"").match(P)||[""]).length;while(l--)d=g=(s=be.exec(e[l])||[])[1],h=(s[2]||"").split(".").sort(),d&&(f=S.event.special[d]||{},d=(i?f.delegateType:f.bindType)||d,f=S.event.special[d]||{},c=S.extend({type:d,origType:g,data:r,handler:n,guid:n.guid,selector:i,needsContext:i&&S.expr.match.needsContext.test(i),namespace:h.join(".")},o),(p=u[d])||((p=u[d]=[]).delegateCount=0,f.setup&&!1!==f.setup.call(t,r,h,a)||t.addEventListener&&t.addEventListener(d,a)),f.add&&(f.add.call(t,c),c.handler.guid||(c.handler.guid=n.guid)),i?p.splice(p.delegateCount++,0,c):p.push(c),S.event.global[d]=!0)}},remove:function(e,t,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,v=Y.hasData(e)&&Y.get(e);if(v&&(u=v.events)){l=(t=(t||"").match(P)||[""]).length;while(l--)if(d=g=(s=be.exec(t[l])||[])[1],h=(s[2]||"").split(".").sort(),d){f=S.event.special[d]||{},p=u[d=(r?f.delegateType:f.bindType)||d]||[],s=s[2]&&new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"),a=o=p.length;while(o--)c=p[o],!i&&g!==c.origType||n&&n.guid!==c.guid||s&&!s.test(c.namespace)||r&&r!==c.selector&&("**"!==r||!c.selector)||(p.splice(o,1),c.selector&&p.delegateCount--,f.remove&&f.remove.call(e,c));a&&!p.length&&(f.teardown&&!1!==f.teardown.call(e,h,v.handle)||S.removeEvent(e,d,v.handle),delete u[d])}else for(d in u)S.event.remove(e,d+t[l],n,r,!0);S.isEmptyObject(u)&&Y.remove(e,"handle events")}},dispatch:function(e){var t,n,r,i,o,a,s=new Array(arguments.length),u=S.event.fix(e),l=(Y.get(this,"events")||Object.create(null))[u.type]||[],c=S.event.special[u.type]||{};for(s[0]=u,t=1;t<arguments.length;t++)s[t]=arguments[t];if(u.delegateTarget=this,!c.preDispatch||!1!==c.preDispatch.call(this,u)){a=S.event.handlers.call(this,u,l),t=0;while((i=a[t++])&&!u.isPropagationStopped()){u.currentTarget=i.elem,n=0;while((o=i.handlers[n++])&&!u.isImmediatePropagationStopped())u.rnamespace&&!1!==o.namespace&&!u.rnamespace.test(o.namespace)||(u.handleObj=o,u.data=o.data,void 0!==(r=((S.event.special[o.origType]||{}).handle||o.handler).apply(i.elem,s))&&!1===(u.result=r)&&(u.preventDefault(),u.stopPropagation()))}return c.postDispatch&&c.postDispatch.call(this,u),u.result}},handlers:function(e,t){var n,r,i,o,a,s=[],u=t.delegateCount,l=e.target;if(u&&l.nodeType&&!("click"===e.type&&1<=e.button))for(;l!==this;l=l.parentNode||this)if(1===l.nodeType&&("click"!==e.type||!0!==l.disabled)){for(o=[],a={},n=0;n<u;n++)void 0===a[i=(r=t[n]).selector+" "]&&(a[i]=r.needsContext?-1<S(i,this).index(l):S.find(i,this,null,[l]).length),a[i]&&o.push(r);o.length&&s.push({elem:l,handlers:o})}return l=this,u<t.length&&s.push({elem:l,handlers:t.slice(u)}),s},addProp:function(t,e){Object.defineProperty(S.Event.prototype,t,{enumerable:!0,configurable:!0,get:m(e)?function(){if(this.originalEvent)return e(this.originalEvent)}:function(){if(this.originalEvent)return this.originalEvent[t]},set:function(e){Object.defineProperty(this,t,{enumerable:!0,configurable:!0,writable:!0,value:e})}})},fix:function(e){return e[S.expando]?e:new S.Event(e)},special:{load:{noBubble:!0},click:{setup:function(e){var t=this||e;return pe.test(t.type)&&t.click&&A(t,"input")&&Se(t,"click",we),!1},trigger:function(e){var t=this||e;return pe.test(t.type)&&t.click&&A(t,"input")&&Se(t,"click"),!0},_default:function(e){var t=e.target;return pe.test(t.type)&&t.click&&A(t,"input")&&Y.get(t,"click")||A(t,"a")}},beforeunload:{postDispatch:function(e){void 0!==e.result&&e.originalEvent&&(e.originalEvent.returnValue=e.result)}}}},S.removeEvent=function(e,t,n){e.removeEventListener&&e.removeEventListener(t,n)},S.Event=function(e,t){if(!(this instanceof S.Event))return new S.Event(e,t);e&&e.type?(this.originalEvent=e,this.type=e.type,this.isDefaultPrevented=e.defaultPrevented||void 0===e.defaultPrevented&&!1===e.returnValue?we:Te,this.target=e.target&&3===e.target.nodeType?e.target.parentNode:e.target,this.currentTarget=e.currentTarget,this.relatedTarget=e.relatedTarget):this.type=e,t&&S.extend(this,t),this.timeStamp=e&&e.timeStamp||Date.now(),this[S.expando]=!0},S.Event.prototype={constructor:S.Event,isDefaultPrevented:Te,isPropagationStopped:Te,isImmediatePropagationStopped:Te,isSimulated:!1,preventDefault:function(){var e=this.originalEvent;this.isDefaultPrevented=we,e&&!this.isSimulated&&e.preventDefault()},stopPropagation:function(){var e=this.originalEvent;this.isPropagationStopped=we,e&&!this.isSimulated&&e.stopPropagation()},stopImmediatePropagation:function(){var e=this.originalEvent;this.isImmediatePropagationStopped=we,e&&!this.isSimulated&&e.stopImmediatePropagation(),this.stopPropagation()}},S.each({altKey:!0,bubbles:!0,cancelable:!0,changedTouches:!0,ctrlKey:!0,detail:!0,eventPhase:!0,metaKey:!0,pageX:!0,pageY:!0,shiftKey:!0,view:!0,"char":!0,code:!0,charCode:!0,key:!0,keyCode:!0,button:!0,buttons:!0,clientX:!0,clientY:!0,offsetX:!0,offsetY:!0,pointerId:!0,pointerType:!0,screenX:!0,screenY:!0,targetTouches:!0,toElement:!0,touches:!0,which:!0},S.event.addProp),S.each({focus:"focusin",blur:"focusout"},function(e,t){S.event.special[e]={setup:function(){return Se(this,e,Ce),!1},trigger:function(){return Se(this,e),!0},_default:function(){return!0},delegateType:t}}),S.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(e,i){S.event.special[e]={delegateType:i,bindType:i,handle:function(e){var t,n=e.relatedTarget,r=e.handleObj;return n&&(n===this||S.contains(this,n))||(e.type=r.origType,t=r.handler.apply(this,arguments),e.type=i),t}}}),S.fn.extend({on:function(e,t,n,r){return Ee(this,e,t,n,r)},one:function(e,t,n,r){return Ee(this,e,t,n,r,1)},off:function(e,t,n){var r,i;if(e&&e.preventDefault&&e.handleObj)return r=e.handleObj,S(e.delegateTarget).off(r.namespace?r.origType+"."+r.namespace:r.origType,r.selector,r.handler),this;if("object"==typeof e){for(i in e)this.off(i,t,e[i]);return this}return!1!==t&&"function"!=typeof t||(n=t,t=void 0),!1===n&&(n=Te),this.each(function(){S.event.remove(this,e,n,t)})}});var ke=/<script|<style|<link/i,Ae=/checked\s*(?:[^=]|=\s*.checked.)/i,Ne=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g;function je(e,t){return A(e,"table")&&A(11!==t.nodeType?t:t.firstChild,"tr")&&S(e).children("tbody")[0]||e}function De(e){return e.type=(null!==e.getAttribute("type"))+"/"+e.type,e}function qe(e){return"true/"===(e.type||"").slice(0,5)?e.type=e.type.slice(5):e.removeAttribute("type"),e}function Le(e,t){var n,r,i,o,a,s;if(1===t.nodeType){if(Y.hasData(e)&&(s=Y.get(e).events))for(i in Y.remove(t,"handle events"),s)for(n=0,r=s[i].length;n<r;n++)S.event.add(t,i,s[i][n]);Q.hasData(e)&&(o=Q.access(e),a=S.extend({},o),Q.set(t,a))}}function He(n,r,i,o){r=g(r);var e,t,a,s,u,l,c=0,f=n.length,p=f-1,d=r[0],h=m(d);if(h||1<f&&"string"==typeof d&&!y.checkClone&&Ae.test(d))return n.each(function(e){var t=n.eq(e);h&&(r[0]=d.call(this,e,t.html())),He(t,r,i,o)});if(f&&(t=(e=xe(r,n[0].ownerDocument,!1,n,o)).firstChild,1===e.childNodes.length&&(e=t),t||o)){for(s=(a=S.map(ve(e,"script"),De)).length;c<f;c++)u=e,c!==p&&(u=S.clone(u,!0,!0),s&&S.merge(a,ve(u,"script"))),i.call(n[c],u,c);if(s)for(l=a[a.length-1].ownerDocument,S.map(a,qe),c=0;c<s;c++)u=a[c],he.test(u.type||"")&&!Y.access(u,"globalEval")&&S.contains(l,u)&&(u.src&&"module"!==(u.type||"").toLowerCase()?S._evalUrl&&!u.noModule&&S._evalUrl(u.src,{nonce:u.nonce||u.getAttribute("nonce")},l):b(u.textContent.replace(Ne,""),u,l))}return n}function Oe(e,t,n){for(var r,i=t?S.filter(t,e):e,o=0;null!=(r=i[o]);o++)n||1!==r.nodeType||S.cleanData(ve(r)),r.parentNode&&(n&&ie(r)&&ye(ve(r,"script")),r.parentNode.removeChild(r));return e}S.extend({htmlPrefilter:function(e){return e},clone:function(e,t,n){var r,i,o,a,s,u,l,c=e.cloneNode(!0),f=ie(e);if(!(y.noCloneChecked||1!==e.nodeType&&11!==e.nodeType||S.isXMLDoc(e)))for(a=ve(c),r=0,i=(o=ve(e)).length;r<i;r++)s=o[r],u=a[r],void 0,"input"===(l=u.nodeName.toLowerCase())&&pe.test(s.type)?u.checked=s.checked:"input"!==l&&"textarea"!==l||(u.defaultValue=s.defaultValue);if(t)if(n)for(o=o||ve(e),a=a||ve(c),r=0,i=o.length;r<i;r++)Le(o[r],a[r]);else Le(e,c);return 0<(a=ve(c,"script")).length&&ye(a,!f&&ve(e,"script")),c},cleanData:function(e){for(var t,n,r,i=S.event.special,o=0;void 0!==(n=e[o]);o++)if(V(n)){if(t=n[Y.expando]){if(t.events)for(r in t.events)i[r]?S.event.remove(n,r):S.removeEvent(n,r,t.handle);n[Y.expando]=void 0}n[Q.expando]&&(n[Q.expando]=void 0)}}}),S.fn.extend({detach:function(e){return Oe(this,e,!0)},remove:function(e){return Oe(this,e)},text:function(e){return $(this,function(e){return void 0===e?S.text(this):this.empty().each(function(){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||(this.textContent=e)})},null,e,arguments.length)},append:function(){return He(this,arguments,function(e){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||je(this,e).appendChild(e)})},prepend:function(){return He(this,arguments,function(e){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var t=je(this,e);t.insertBefore(e,t.firstChild)}})},before:function(){return He(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this)})},after:function(){return He(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this.nextSibling)})},empty:function(){for(var e,t=0;null!=(e=this[t]);t++)1===e.nodeType&&(S.cleanData(ve(e,!1)),e.textContent="");return this},clone:function(e,t){return e=null!=e&&e,t=null==t?e:t,this.map(function(){return S.clone(this,e,t)})},html:function(e){return $(this,function(e){var t=this[0]||{},n=0,r=this.length;if(void 0===e&&1===t.nodeType)return t.innerHTML;if("string"==typeof e&&!ke.test(e)&&!ge[(de.exec(e)||["",""])[1].toLowerCase()]){e=S.htmlPrefilter(e);try{for(;n<r;n++)1===(t=this[n]||{}).nodeType&&(S.cleanData(ve(t,!1)),t.innerHTML=e);t=0}catch(e){}}t&&this.empty().append(e)},null,e,arguments.length)},replaceWith:function(){var n=[];return He(this,arguments,function(e){var t=this.parentNode;S.inArray(this,n)<0&&(S.cleanData(ve(this)),t&&t.replaceChild(e,this))},n)}}),S.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(e,a){S.fn[e]=function(e){for(var t,n=[],r=S(e),i=r.length-1,o=0;o<=i;o++)t=o===i?this:this.clone(!0),S(r[o])[a](t),u.apply(n,t.get());return this.pushStack(n)}});var Pe=new RegExp("^("+ee+")(?!px)[a-z%]+$","i"),Re=function(e){var t=e.ownerDocument.defaultView;return t&&t.opener||(t=C),t.getComputedStyle(e)},Me=function(e,t,n){var r,i,o={};for(i in t)o[i]=e.style[i],e.style[i]=t[i];for(i in r=n.call(e),t)e.style[i]=o[i];return r},Ie=new RegExp(ne.join("|"),"i");function We(e,t,n){var r,i,o,a,s=e.style;return(n=n||Re(e))&&(""!==(a=n.getPropertyValue(t)||n[t])||ie(e)||(a=S.style(e,t)),!y.pixelBoxStyles()&&Pe.test(a)&&Ie.test(t)&&(r=s.width,i=s.minWidth,o=s.maxWidth,s.minWidth=s.maxWidth=s.width=a,a=n.width,s.width=r,s.minWidth=i,s.maxWidth=o)),void 0!==a?a+"":a}function Fe(e,t){return{get:function(){if(!e())return(this.get=t).apply(this,arguments);delete this.get}}}!function(){function e(){if(l){u.style.cssText="position:absolute;left:-11111px;width:60px;margin-top:1px;padding:0;border:0",l.style.cssText="position:relative;display:block;box-sizing:border-box;overflow:scroll;margin:auto;border:1px;padding:1px;width:60%;top:1%",re.appendChild(u).appendChild(l);var e=C.getComputedStyle(l);n="1%"!==e.top,s=12===t(e.marginLeft),l.style.right="60%",o=36===t(e.right),r=36===t(e.width),l.style.position="absolute",i=12===t(l.offsetWidth/3),re.removeChild(u),l=null}}function t(e){return Math.round(parseFloat(e))}var n,r,i,o,a,s,u=E.createElement("div"),l=E.createElement("div");l.style&&(l.style.backgroundClip="content-box",l.cloneNode(!0).style.backgroundClip="",y.clearCloneStyle="content-box"===l.style.backgroundClip,S.extend(y,{boxSizingReliable:function(){return e(),r},pixelBoxStyles:function(){return e(),o},pixelPosition:function(){return e(),n},reliableMarginLeft:function(){return e(),s},scrollboxSize:function(){return e(),i},reliableTrDimensions:function(){var e,t,n,r;return null==a&&(e=E.createElement("table"),t=E.createElement("tr"),n=E.createElement("div"),e.style.cssText="position:absolute;left:-11111px;border-collapse:separate",t.style.cssText="border:1px solid",t.style.height="1px",n.style.height="9px",n.style.display="block",re.appendChild(e).appendChild(t).appendChild(n),r=C.getComputedStyle(t),a=parseInt(r.height,10)+parseInt(r.borderTopWidth,10)+parseInt(r.borderBottomWidth,10)===t.offsetHeight,re.removeChild(e)),a}}))}();var Be=["Webkit","Moz","ms"],$e=E.createElement("div").style,_e={};function ze(e){var t=S.cssProps[e]||_e[e];return t||(e in $e?e:_e[e]=function(e){var t=e[0].toUpperCase()+e.slice(1),n=Be.length;while(n--)if((e=Be[n]+t)in $e)return e}(e)||e)}var Ue=/^(none|table(?!-c[ea]).+)/,Xe=/^--/,Ve={position:"absolute",visibility:"hidden",display:"block"},Ge={letterSpacing:"0",fontWeight:"400"};function Ye(e,t,n){var r=te.exec(t);return r?Math.max(0,r[2]-(n||0))+(r[3]||"px"):t}function Qe(e,t,n,r,i,o){var a="width"===t?1:0,s=0,u=0;if(n===(r?"border":"content"))return 0;for(;a<4;a+=2)"margin"===n&&(u+=S.css(e,n+ne[a],!0,i)),r?("content"===n&&(u-=S.css(e,"padding"+ne[a],!0,i)),"margin"!==n&&(u-=S.css(e,"border"+ne[a]+"Width",!0,i))):(u+=S.css(e,"padding"+ne[a],!0,i),"padding"!==n?u+=S.css(e,"border"+ne[a]+"Width",!0,i):s+=S.css(e,"border"+ne[a]+"Width",!0,i));return!r&&0<=o&&(u+=Math.max(0,Math.ceil(e["offset"+t[0].toUpperCase()+t.slice(1)]-o-u-s-.5))||0),u}function Je(e,t,n){var r=Re(e),i=(!y.boxSizingReliable()||n)&&"border-box"===S.css(e,"boxSizing",!1,r),o=i,a=We(e,t,r),s="offset"+t[0].toUpperCase()+t.slice(1);if(Pe.test(a)){if(!n)return a;a="auto"}return(!y.boxSizingReliable()&&i||!y.reliableTrDimensions()&&A(e,"tr")||"auto"===a||!parseFloat(a)&&"inline"===S.css(e,"display",!1,r))&&e.getClientRects().length&&(i="border-box"===S.css(e,"boxSizing",!1,r),(o=s in e)&&(a=e[s])),(a=parseFloat(a)||0)+Qe(e,t,n||(i?"border":"content"),o,r,a)+"px"}function Ke(e,t,n,r,i){return new Ke.prototype.init(e,t,n,r,i)}S.extend({cssHooks:{opacity:{get:function(e,t){if(t){var n=We(e,"opacity");return""===n?"1":n}}}},cssNumber:{animationIterationCount:!0,columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,gridArea:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnStart:!0,gridRow:!0,gridRowEnd:!0,gridRowStart:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{},style:function(e,t,n,r){if(e&&3!==e.nodeType&&8!==e.nodeType&&e.style){var i,o,a,s=X(t),u=Xe.test(t),l=e.style;if(u||(t=ze(s)),a=S.cssHooks[t]||S.cssHooks[s],void 0===n)return a&&"get"in a&&void 0!==(i=a.get(e,!1,r))?i:l[t];"string"===(o=typeof n)&&(i=te.exec(n))&&i[1]&&(n=se(e,t,i),o="number"),null!=n&&n==n&&("number"!==o||u||(n+=i&&i[3]||(S.cssNumber[s]?"":"px")),y.clearCloneStyle||""!==n||0!==t.indexOf("background")||(l[t]="inherit"),a&&"set"in a&&void 0===(n=a.set(e,n,r))||(u?l.setProperty(t,n):l[t]=n))}},css:function(e,t,n,r){var i,o,a,s=X(t);return Xe.test(t)||(t=ze(s)),(a=S.cssHooks[t]||S.cssHooks[s])&&"get"in a&&(i=a.get(e,!0,n)),void 0===i&&(i=We(e,t,r)),"normal"===i&&t in Ge&&(i=Ge[t]),""===n||n?(o=parseFloat(i),!0===n||isFinite(o)?o||0:i):i}}),S.each(["height","width"],function(e,u){S.cssHooks[u]={get:function(e,t,n){if(t)return!Ue.test(S.css(e,"display"))||e.getClientRects().length&&e.getBoundingClientRect().width?Je(e,u,n):Me(e,Ve,function(){return Je(e,u,n)})},set:function(e,t,n){var r,i=Re(e),o=!y.scrollboxSize()&&"absolute"===i.position,a=(o||n)&&"border-box"===S.css(e,"boxSizing",!1,i),s=n?Qe(e,u,n,a,i):0;return a&&o&&(s-=Math.ceil(e["offset"+u[0].toUpperCase()+u.slice(1)]-parseFloat(i[u])-Qe(e,u,"border",!1,i)-.5)),s&&(r=te.exec(t))&&"px"!==(r[3]||"px")&&(e.style[u]=t,t=S.css(e,u)),Ye(0,t,s)}}}),S.cssHooks.marginLeft=Fe(y.reliableMarginLeft,function(e,t){if(t)return(parseFloat(We(e,"marginLeft"))||e.getBoundingClientRect().left-Me(e,{marginLeft:0},function(){return e.getBoundingClientRect().left}))+"px"}),S.each({margin:"",padding:"",border:"Width"},function(i,o){S.cssHooks[i+o]={expand:function(e){for(var t=0,n={},r="string"==typeof e?e.split(" "):[e];t<4;t++)n[i+ne[t]+o]=r[t]||r[t-2]||r[0];return n}},"margin"!==i&&(S.cssHooks[i+o].set=Ye)}),S.fn.extend({css:function(e,t){return $(this,function(e,t,n){var r,i,o={},a=0;if(Array.isArray(t)){for(r=Re(e),i=t.length;a<i;a++)o[t[a]]=S.css(e,t[a],!1,r);return o}return void 0!==n?S.style(e,t,n):S.css(e,t)},e,t,1<arguments.length)}}),((S.Tween=Ke).prototype={constructor:Ke,init:function(e,t,n,r,i,o){this.elem=e,this.prop=n,this.easing=i||S.easing._default,this.options=t,this.start=this.now=this.cur(),this.end=r,this.unit=o||(S.cssNumber[n]?"":"px")},cur:function(){var e=Ke.propHooks[this.prop];return e&&e.get?e.get(this):Ke.propHooks._default.get(this)},run:function(e){var t,n=Ke.propHooks[this.prop];return this.options.duration?this.pos=t=S.easing[this.easing](e,this.options.duration*e,0,1,this.options.duration):this.pos=t=e,this.now=(this.end-this.start)*t+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),n&&n.set?n.set(this):Ke.propHooks._default.set(this),this}}).init.prototype=Ke.prototype,(Ke.propHooks={_default:{get:function(e){var t;return 1!==e.elem.nodeType||null!=e.elem[e.prop]&&null==e.elem.style[e.prop]?e.elem[e.prop]:(t=S.css(e.elem,e.prop,""))&&"auto"!==t?t:0},set:function(e){S.fx.step[e.prop]?S.fx.step[e.prop](e):1!==e.elem.nodeType||!S.cssHooks[e.prop]&&null==e.elem.style[ze(e.prop)]?e.elem[e.prop]=e.now:S.style(e.elem,e.prop,e.now+e.unit)}}}).scrollTop=Ke.propHooks.scrollLeft={set:function(e){e.elem.nodeType&&e.elem.parentNode&&(e.elem[e.prop]=e.now)}},S.easing={linear:function(e){return e},swing:function(e){return.5-Math.cos(e*Math.PI)/2},_default:"swing"},S.fx=Ke.prototype.init,S.fx.step={};var Ze,et,tt,nt,rt=/^(?:toggle|show|hide)$/,it=/queueHooks$/;function ot(){et&&(!1===E.hidden&&C.requestAnimationFrame?C.requestAnimationFrame(ot):C.setTimeout(ot,S.fx.interval),S.fx.tick())}function at(){return C.setTimeout(function(){Ze=void 0}),Ze=Date.now()}function st(e,t){var n,r=0,i={height:e};for(t=t?1:0;r<4;r+=2-t)i["margin"+(n=ne[r])]=i["padding"+n]=e;return t&&(i.opacity=i.width=e),i}function ut(e,t,n){for(var r,i=(lt.tweeners[t]||[]).concat(lt.tweeners["*"]),o=0,a=i.length;o<a;o++)if(r=i[o].call(n,t,e))return r}function lt(o,e,t){var n,a,r=0,i=lt.prefilters.length,s=S.Deferred().always(function(){delete u.elem}),u=function(){if(a)return!1;for(var e=Ze||at(),t=Math.max(0,l.startTime+l.duration-e),n=1-(t/l.duration||0),r=0,i=l.tweens.length;r<i;r++)l.tweens[r].run(n);return s.notifyWith(o,[l,n,t]),n<1&&i?t:(i||s.notifyWith(o,[l,1,0]),s.resolveWith(o,[l]),!1)},l=s.promise({elem:o,props:S.extend({},e),opts:S.extend(!0,{specialEasing:{},easing:S.easing._default},t),originalProperties:e,originalOptions:t,startTime:Ze||at(),duration:t.duration,tweens:[],createTween:function(e,t){var n=S.Tween(o,l.opts,e,t,l.opts.specialEasing[e]||l.opts.easing);return l.tweens.push(n),n},stop:function(e){var t=0,n=e?l.tweens.length:0;if(a)return this;for(a=!0;t<n;t++)l.tweens[t].run(1);return e?(s.notifyWith(o,[l,1,0]),s.resolveWith(o,[l,e])):s.rejectWith(o,[l,e]),this}}),c=l.props;for(!function(e,t){var n,r,i,o,a;for(n in e)if(i=t[r=X(n)],o=e[n],Array.isArray(o)&&(i=o[1],o=e[n]=o[0]),n!==r&&(e[r]=o,delete e[n]),(a=S.cssHooks[r])&&"expand"in a)for(n in o=a.expand(o),delete e[r],o)n in e||(e[n]=o[n],t[n]=i);else t[r]=i}(c,l.opts.specialEasing);r<i;r++)if(n=lt.prefilters[r].call(l,o,c,l.opts))return m(n.stop)&&(S._queueHooks(l.elem,l.opts.queue).stop=n.stop.bind(n)),n;return S.map(c,ut,l),m(l.opts.start)&&l.opts.start.call(o,l),l.progress(l.opts.progress).done(l.opts.done,l.opts.complete).fail(l.opts.fail).always(l.opts.always),S.fx.timer(S.extend(u,{elem:o,anim:l,queue:l.opts.queue})),l}S.Animation=S.extend(lt,{tweeners:{"*":[function(e,t){var n=this.createTween(e,t);return se(n.elem,e,te.exec(t),n),n}]},tweener:function(e,t){m(e)?(t=e,e=["*"]):e=e.match(P);for(var n,r=0,i=e.length;r<i;r++)n=e[r],lt.tweeners[n]=lt.tweeners[n]||[],lt.tweeners[n].unshift(t)},prefilters:[function(e,t,n){var r,i,o,a,s,u,l,c,f="width"in t||"height"in t,p=this,d={},h=e.style,g=e.nodeType&&ae(e),v=Y.get(e,"fxshow");for(r in n.queue||(null==(a=S._queueHooks(e,"fx")).unqueued&&(a.unqueued=0,s=a.empty.fire,a.empty.fire=function(){a.unqueued||s()}),a.unqueued++,p.always(function(){p.always(function(){a.unqueued--,S.queue(e,"fx").length||a.empty.fire()})})),t)if(i=t[r],rt.test(i)){if(delete t[r],o=o||"toggle"===i,i===(g?"hide":"show")){if("show"!==i||!v||void 0===v[r])continue;g=!0}d[r]=v&&v[r]||S.style(e,r)}if((u=!S.isEmptyObject(t))||!S.isEmptyObject(d))for(r in f&&1===e.nodeType&&(n.overflow=[h.overflow,h.overflowX,h.overflowY],null==(l=v&&v.display)&&(l=Y.get(e,"display")),"none"===(c=S.css(e,"display"))&&(l?c=l:(le([e],!0),l=e.style.display||l,c=S.css(e,"display"),le([e]))),("inline"===c||"inline-block"===c&&null!=l)&&"none"===S.css(e,"float")&&(u||(p.done(function(){h.display=l}),null==l&&(c=h.display,l="none"===c?"":c)),h.display="inline-block")),n.overflow&&(h.overflow="hidden",p.always(function(){h.overflow=n.overflow[0],h.overflowX=n.overflow[1],h.overflowY=n.overflow[2]})),u=!1,d)u||(v?"hidden"in v&&(g=v.hidden):v=Y.access(e,"fxshow",{display:l}),o&&(v.hidden=!g),g&&le([e],!0),p.done(function(){for(r in g||le([e]),Y.remove(e,"fxshow"),d)S.style(e,r,d[r])})),u=ut(g?v[r]:0,r,p),r in v||(v[r]=u.start,g&&(u.end=u.start,u.start=0))}],prefilter:function(e,t){t?lt.prefilters.unshift(e):lt.prefilters.push(e)}}),S.speed=function(e,t,n){var r=e&&"object"==typeof e?S.extend({},e):{complete:n||!n&&t||m(e)&&e,duration:e,easing:n&&t||t&&!m(t)&&t};return S.fx.off?r.duration=0:"number"!=typeof r.duration&&(r.duration in S.fx.speeds?r.duration=S.fx.speeds[r.duration]:r.duration=S.fx.speeds._default),null!=r.queue&&!0!==r.queue||(r.queue="fx"),r.old=r.complete,r.complete=function(){m(r.old)&&r.old.call(this),r.queue&&S.dequeue(this,r.queue)},r},S.fn.extend({fadeTo:function(e,t,n,r){return this.filter(ae).css("opacity",0).show().end().animate({opacity:t},e,n,r)},animate:function(t,e,n,r){var i=S.isEmptyObject(t),o=S.speed(e,n,r),a=function(){var e=lt(this,S.extend({},t),o);(i||Y.get(this,"finish"))&&e.stop(!0)};return a.finish=a,i||!1===o.queue?this.each(a):this.queue(o.queue,a)},stop:function(i,e,o){var a=function(e){var t=e.stop;delete e.stop,t(o)};return"string"!=typeof i&&(o=e,e=i,i=void 0),e&&this.queue(i||"fx",[]),this.each(function(){var e=!0,t=null!=i&&i+"queueHooks",n=S.timers,r=Y.get(this);if(t)r[t]&&r[t].stop&&a(r[t]);else for(t in r)r[t]&&r[t].stop&&it.test(t)&&a(r[t]);for(t=n.length;t--;)n[t].elem!==this||null!=i&&n[t].queue!==i||(n[t].anim.stop(o),e=!1,n.splice(t,1));!e&&o||S.dequeue(this,i)})},finish:function(a){return!1!==a&&(a=a||"fx"),this.each(function(){var e,t=Y.get(this),n=t[a+"queue"],r=t[a+"queueHooks"],i=S.timers,o=n?n.length:0;for(t.finish=!0,S.queue(this,a,[]),r&&r.stop&&r.stop.call(this,!0),e=i.length;e--;)i[e].elem===this&&i[e].queue===a&&(i[e].anim.stop(!0),i.splice(e,1));for(e=0;e<o;e++)n[e]&&n[e].finish&&n[e].finish.call(this);delete t.finish})}}),S.each(["toggle","show","hide"],function(e,r){var i=S.fn[r];S.fn[r]=function(e,t,n){return null==e||"boolean"==typeof e?i.apply(this,arguments):this.animate(st(r,!0),e,t,n)}}),S.each({slideDown:st("show"),slideUp:st("hide"),slideToggle:st("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(e,r){S.fn[e]=function(e,t,n){return this.animate(r,e,t,n)}}),S.timers=[],S.fx.tick=function(){var e,t=0,n=S.timers;for(Ze=Date.now();t<n.length;t++)(e=n[t])()||n[t]!==e||n.splice(t--,1);n.length||S.fx.stop(),Ze=void 0},S.fx.timer=function(e){S.timers.push(e),S.fx.start()},S.fx.interval=13,S.fx.start=function(){et||(et=!0,ot())},S.fx.stop=function(){et=null},S.fx.speeds={slow:600,fast:200,_default:400},S.fn.delay=function(r,e){return r=S.fx&&S.fx.speeds[r]||r,e=e||"fx",this.queue(e,function(e,t){var n=C.setTimeout(e,r);t.stop=function(){C.clearTimeout(n)}})},tt=E.createElement("input"),nt=E.createElement("select").appendChild(E.createElement("option")),tt.type="checkbox",y.checkOn=""!==tt.value,y.optSelected=nt.selected,(tt=E.createElement("input")).value="t",tt.type="radio",y.radioValue="t"===tt.value;var ct,ft=S.expr.attrHandle;S.fn.extend({attr:function(e,t){return $(this,S.attr,e,t,1<arguments.length)},removeAttr:function(e){return this.each(function(){S.removeAttr(this,e)})}}),S.extend({attr:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return"undefined"==typeof e.getAttribute?S.prop(e,t,n):(1===o&&S.isXMLDoc(e)||(i=S.attrHooks[t.toLowerCase()]||(S.expr.match.bool.test(t)?ct:void 0)),void 0!==n?null===n?void S.removeAttr(e,t):i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:(e.setAttribute(t,n+""),n):i&&"get"in i&&null!==(r=i.get(e,t))?r:null==(r=S.find.attr(e,t))?void 0:r)},attrHooks:{type:{set:function(e,t){if(!y.radioValue&&"radio"===t&&A(e,"input")){var n=e.value;return e.setAttribute("type",t),n&&(e.value=n),t}}}},removeAttr:function(e,t){var n,r=0,i=t&&t.match(P);if(i&&1===e.nodeType)while(n=i[r++])e.removeAttribute(n)}}),ct={set:function(e,t,n){return!1===t?S.removeAttr(e,n):e.setAttribute(n,n),n}},S.each(S.expr.match.bool.source.match(/\w+/g),function(e,t){var a=ft[t]||S.find.attr;ft[t]=function(e,t,n){var r,i,o=t.toLowerCase();return n||(i=ft[o],ft[o]=r,r=null!=a(e,t,n)?o:null,ft[o]=i),r}});var pt=/^(?:input|select|textarea|button)$/i,dt=/^(?:a|area)$/i;function ht(e){return(e.match(P)||[]).join(" ")}function gt(e){return e.getAttribute&&e.getAttribute("class")||""}function vt(e){return Array.isArray(e)?e:"string"==typeof e&&e.match(P)||[]}S.fn.extend({prop:function(e,t){return $(this,S.prop,e,t,1<arguments.length)},removeProp:function(e){return this.each(function(){delete this[S.propFix[e]||e]})}}),S.extend({prop:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return 1===o&&S.isXMLDoc(e)||(t=S.propFix[t]||t,i=S.propHooks[t]),void 0!==n?i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:e[t]=n:i&&"get"in i&&null!==(r=i.get(e,t))?r:e[t]},propHooks:{tabIndex:{get:function(e){var t=S.find.attr(e,"tabindex");return t?parseInt(t,10):pt.test(e.nodeName)||dt.test(e.nodeName)&&e.href?0:-1}}},propFix:{"for":"htmlFor","class":"className"}}),y.optSelected||(S.propHooks.selected={get:function(e){var t=e.parentNode;return t&&t.parentNode&&t.parentNode.selectedIndex,null},set:function(e){var t=e.parentNode;t&&(t.selectedIndex,t.parentNode&&t.parentNode.selectedIndex)}}),S.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){S.propFix[this.toLowerCase()]=this}),S.fn.extend({addClass:function(t){var e,n,r,i,o,a,s,u=0;if(m(t))return this.each(function(e){S(this).addClass(t.call(this,e,gt(this)))});if((e=vt(t)).length)while(n=this[u++])if(i=gt(n),r=1===n.nodeType&&" "+ht(i)+" "){a=0;while(o=e[a++])r.indexOf(" "+o+" ")<0&&(r+=o+" ");i!==(s=ht(r))&&n.setAttribute("class",s)}return this},removeClass:function(t){var e,n,r,i,o,a,s,u=0;if(m(t))return this.each(function(e){S(this).removeClass(t.call(this,e,gt(this)))});if(!arguments.length)return this.attr("class","");if((e=vt(t)).length)while(n=this[u++])if(i=gt(n),r=1===n.nodeType&&" "+ht(i)+" "){a=0;while(o=e[a++])while(-1<r.indexOf(" "+o+" "))r=r.replace(" "+o+" "," ");i!==(s=ht(r))&&n.setAttribute("class",s)}return this},toggleClass:function(i,t){var o=typeof i,a="string"===o||Array.isArray(i);return"boolean"==typeof t&&a?t?this.addClass(i):this.removeClass(i):m(i)?this.each(function(e){S(this).toggleClass(i.call(this,e,gt(this),t),t)}):this.each(function(){var e,t,n,r;if(a){t=0,n=S(this),r=vt(i);while(e=r[t++])n.hasClass(e)?n.removeClass(e):n.addClass(e)}else void 0!==i&&"boolean"!==o||((e=gt(this))&&Y.set(this,"__className__",e),this.setAttribute&&this.setAttribute("class",e||!1===i?"":Y.get(this,"__className__")||""))})},hasClass:function(e){var t,n,r=0;t=" "+e+" ";while(n=this[r++])if(1===n.nodeType&&-1<(" "+ht(gt(n))+" ").indexOf(t))return!0;return!1}});var yt=/\r/g;S.fn.extend({val:function(n){var r,e,i,t=this[0];return arguments.length?(i=m(n),this.each(function(e){var t;1===this.nodeType&&(null==(t=i?n.call(this,e,S(this).val()):n)?t="":"number"==typeof t?t+="":Array.isArray(t)&&(t=S.map(t,function(e){return null==e?"":e+""})),(r=S.valHooks[this.type]||S.valHooks[this.nodeName.toLowerCase()])&&"set"in r&&void 0!==r.set(this,t,"value")||(this.value=t))})):t?(r=S.valHooks[t.type]||S.valHooks[t.nodeName.toLowerCase()])&&"get"in r&&void 0!==(e=r.get(t,"value"))?e:"string"==typeof(e=t.value)?e.replace(yt,""):null==e?"":e:void 0}}),S.extend({valHooks:{option:{get:function(e){var t=S.find.attr(e,"value");return null!=t?t:ht(S.text(e))}},select:{get:function(e){var t,n,r,i=e.options,o=e.selectedIndex,a="select-one"===e.type,s=a?null:[],u=a?o+1:i.length;for(r=o<0?u:a?o:0;r<u;r++)if(((n=i[r]).selected||r===o)&&!n.disabled&&(!n.parentNode.disabled||!A(n.parentNode,"optgroup"))){if(t=S(n).val(),a)return t;s.push(t)}return s},set:function(e,t){var n,r,i=e.options,o=S.makeArray(t),a=i.length;while(a--)((r=i[a]).selected=-1<S.inArray(S.valHooks.option.get(r),o))&&(n=!0);return n||(e.selectedIndex=-1),o}}}}),S.each(["radio","checkbox"],function(){S.valHooks[this]={set:function(e,t){if(Array.isArray(t))return e.checked=-1<S.inArray(S(e).val(),t)}},y.checkOn||(S.valHooks[this].get=function(e){return null===e.getAttribute("value")?"on":e.value})}),y.focusin="onfocusin"in C;var mt=/^(?:focusinfocus|focusoutblur)$/,xt=function(e){e.stopPropagation()};S.extend(S.event,{trigger:function(e,t,n,r){var i,o,a,s,u,l,c,f,p=[n||E],d=v.call(e,"type")?e.type:e,h=v.call(e,"namespace")?e.namespace.split("."):[];if(o=f=a=n=n||E,3!==n.nodeType&&8!==n.nodeType&&!mt.test(d+S.event.triggered)&&(-1<d.indexOf(".")&&(d=(h=d.split(".")).shift(),h.sort()),u=d.indexOf(":")<0&&"on"+d,(e=e[S.expando]?e:new S.Event(d,"object"==typeof e&&e)).isTrigger=r?2:3,e.namespace=h.join("."),e.rnamespace=e.namespace?new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,e.result=void 0,e.target||(e.target=n),t=null==t?[e]:S.makeArray(t,[e]),c=S.event.special[d]||{},r||!c.trigger||!1!==c.trigger.apply(n,t))){if(!r&&!c.noBubble&&!x(n)){for(s=c.delegateType||d,mt.test(s+d)||(o=o.parentNode);o;o=o.parentNode)p.push(o),a=o;a===(n.ownerDocument||E)&&p.push(a.defaultView||a.parentWindow||C)}i=0;while((o=p[i++])&&!e.isPropagationStopped())f=o,e.type=1<i?s:c.bindType||d,(l=(Y.get(o,"events")||Object.create(null))[e.type]&&Y.get(o,"handle"))&&l.apply(o,t),(l=u&&o[u])&&l.apply&&V(o)&&(e.result=l.apply(o,t),!1===e.result&&e.preventDefault());return e.type=d,r||e.isDefaultPrevented()||c._default&&!1!==c._default.apply(p.pop(),t)||!V(n)||u&&m(n[d])&&!x(n)&&((a=n[u])&&(n[u]=null),S.event.triggered=d,e.isPropagationStopped()&&f.addEventListener(d,xt),n[d](),e.isPropagationStopped()&&f.removeEventListener(d,xt),S.event.triggered=void 0,a&&(n[u]=a)),e.result}},simulate:function(e,t,n){var r=S.extend(new S.Event,n,{type:e,isSimulated:!0});S.event.trigger(r,null,t)}}),S.fn.extend({trigger:function(e,t){return this.each(function(){S.event.trigger(e,t,this)})},triggerHandler:function(e,t){var n=this[0];if(n)return S.event.trigger(e,t,n,!0)}}),y.focusin||S.each({focus:"focusin",blur:"focusout"},function(n,r){var i=function(e){S.event.simulate(r,e.target,S.event.fix(e))};S.event.special[r]={setup:function(){var e=this.ownerDocument||this.document||this,t=Y.access(e,r);t||e.addEventListener(n,i,!0),Y.access(e,r,(t||0)+1)},teardown:function(){var e=this.ownerDocument||this.document||this,t=Y.access(e,r)-1;t?Y.access(e,r,t):(e.removeEventListener(n,i,!0),Y.remove(e,r))}}});var bt=C.location,wt={guid:Date.now()},Tt=/\?/;S.parseXML=function(e){var t,n;if(!e||"string"!=typeof e)return null;try{t=(new C.DOMParser).parseFromString(e,"text/xml")}catch(e){}return n=t&&t.getElementsByTagName("parsererror")[0],t&&!n||S.error("Invalid XML: "+(n?S.map(n.childNodes,function(e){return e.textContent}).join("\n"):e)),t};var Ct=/\[\]$/,Et=/\r?\n/g,St=/^(?:submit|button|image|reset|file)$/i,kt=/^(?:input|select|textarea|keygen)/i;function At(n,e,r,i){var t;if(Array.isArray(e))S.each(e,function(e,t){r||Ct.test(n)?i(n,t):At(n+"["+("object"==typeof t&&null!=t?e:"")+"]",t,r,i)});else if(r||"object"!==w(e))i(n,e);else for(t in e)At(n+"["+t+"]",e[t],r,i)}S.param=function(e,t){var n,r=[],i=function(e,t){var n=m(t)?t():t;r[r.length]=encodeURIComponent(e)+"="+encodeURIComponent(null==n?"":n)};if(null==e)return"";if(Array.isArray(e)||e.jquery&&!S.isPlainObject(e))S.each(e,function(){i(this.name,this.value)});else for(n in e)At(n,e[n],t,i);return r.join("&")},S.fn.extend({serialize:function(){return S.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var e=S.prop(this,"elements");return e?S.makeArray(e):this}).filter(function(){var e=this.type;return this.name&&!S(this).is(":disabled")&&kt.test(this.nodeName)&&!St.test(e)&&(this.checked||!pe.test(e))}).map(function(e,t){var n=S(this).val();return null==n?null:Array.isArray(n)?S.map(n,function(e){return{name:t.name,value:e.replace(Et,"\r\n")}}):{name:t.name,value:n.replace(Et,"\r\n")}}).get()}});var Nt=/%20/g,jt=/#.*$/,Dt=/([?&])_=[^&]*/,qt=/^(.*?):[ \t]*([^\r\n]*)$/gm,Lt=/^(?:GET|HEAD)$/,Ht=/^\/\//,Ot={},Pt={},Rt="*/".concat("*"),Mt=E.createElement("a");function It(o){return function(e,t){"string"!=typeof e&&(t=e,e="*");var n,r=0,i=e.toLowerCase().match(P)||[];if(m(t))while(n=i[r++])"+"===n[0]?(n=n.slice(1)||"*",(o[n]=o[n]||[]).unshift(t)):(o[n]=o[n]||[]).push(t)}}function Wt(t,i,o,a){var s={},u=t===Pt;function l(e){var r;return s[e]=!0,S.each(t[e]||[],function(e,t){var n=t(i,o,a);return"string"!=typeof n||u||s[n]?u?!(r=n):void 0:(i.dataTypes.unshift(n),l(n),!1)}),r}return l(i.dataTypes[0])||!s["*"]&&l("*")}function Ft(e,t){var n,r,i=S.ajaxSettings.flatOptions||{};for(n in t)void 0!==t[n]&&((i[n]?e:r||(r={}))[n]=t[n]);return r&&S.extend(!0,e,r),e}Mt.href=bt.href,S.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:bt.href,type:"GET",isLocal:/^(?:about|app|app-storage|.+-extension|file|res|widget):$/.test(bt.protocol),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Rt,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/\bxml\b/,html:/\bhtml/,json:/\bjson\b/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":JSON.parse,"text xml":S.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(e,t){return t?Ft(Ft(e,S.ajaxSettings),t):Ft(S.ajaxSettings,e)},ajaxPrefilter:It(Ot),ajaxTransport:It(Pt),ajax:function(e,t){"object"==typeof e&&(t=e,e=void 0),t=t||{};var c,f,p,n,d,r,h,g,i,o,v=S.ajaxSetup({},t),y=v.context||v,m=v.context&&(y.nodeType||y.jquery)?S(y):S.event,x=S.Deferred(),b=S.Callbacks("once memory"),w=v.statusCode||{},a={},s={},u="canceled",T={readyState:0,getResponseHeader:function(e){var t;if(h){if(!n){n={};while(t=qt.exec(p))n[t[1].toLowerCase()+" "]=(n[t[1].toLowerCase()+" "]||[]).concat(t[2])}t=n[e.toLowerCase()+" "]}return null==t?null:t.join(", ")},getAllResponseHeaders:function(){return h?p:null},setRequestHeader:function(e,t){return null==h&&(e=s[e.toLowerCase()]=s[e.toLowerCase()]||e,a[e]=t),this},overrideMimeType:function(e){return null==h&&(v.mimeType=e),this},statusCode:function(e){var t;if(e)if(h)T.always(e[T.status]);else for(t in e)w[t]=[w[t],e[t]];return this},abort:function(e){var t=e||u;return c&&c.abort(t),l(0,t),this}};if(x.promise(T),v.url=((e||v.url||bt.href)+"").replace(Ht,bt.protocol+"//"),v.type=t.method||t.type||v.method||v.type,v.dataTypes=(v.dataType||"*").toLowerCase().match(P)||[""],null==v.crossDomain){r=E.createElement("a");try{r.href=v.url,r.href=r.href,v.crossDomain=Mt.protocol+"//"+Mt.host!=r.protocol+"//"+r.host}catch(e){v.crossDomain=!0}}if(v.data&&v.processData&&"string"!=typeof v.data&&(v.data=S.param(v.data,v.traditional)),Wt(Ot,v,t,T),h)return T;for(i in(g=S.event&&v.global)&&0==S.active++&&S.event.trigger("ajaxStart"),v.type=v.type.toUpperCase(),v.hasContent=!Lt.test(v.type),f=v.url.replace(jt,""),v.hasContent?v.data&&v.processData&&0===(v.contentType||"").indexOf("application/x-www-form-urlencoded")&&(v.data=v.data.replace(Nt,"+")):(o=v.url.slice(f.length),v.data&&(v.processData||"string"==typeof v.data)&&(f+=(Tt.test(f)?"&":"?")+v.data,delete v.data),!1===v.cache&&(f=f.replace(Dt,"$1"),o=(Tt.test(f)?"&":"?")+"_="+wt.guid+++o),v.url=f+o),v.ifModified&&(S.lastModified[f]&&T.setRequestHeader("If-Modified-Since",S.lastModified[f]),S.etag[f]&&T.setRequestHeader("If-None-Match",S.etag[f])),(v.data&&v.hasContent&&!1!==v.contentType||t.contentType)&&T.setRequestHeader("Content-Type",v.contentType),T.setRequestHeader("Accept",v.dataTypes[0]&&v.accepts[v.dataTypes[0]]?v.accepts[v.dataTypes[0]]+("*"!==v.dataTypes[0]?", "+Rt+"; q=0.01":""):v.accepts["*"]),v.headers)T.setRequestHeader(i,v.headers[i]);if(v.beforeSend&&(!1===v.beforeSend.call(y,T,v)||h))return T.abort();if(u="abort",b.add(v.complete),T.done(v.success),T.fail(v.error),c=Wt(Pt,v,t,T)){if(T.readyState=1,g&&m.trigger("ajaxSend",[T,v]),h)return T;v.async&&0<v.timeout&&(d=C.setTimeout(function(){T.abort("timeout")},v.timeout));try{h=!1,c.send(a,l)}catch(e){if(h)throw e;l(-1,e)}}else l(-1,"No Transport");function l(e,t,n,r){var i,o,a,s,u,l=t;h||(h=!0,d&&C.clearTimeout(d),c=void 0,p=r||"",T.readyState=0<e?4:0,i=200<=e&&e<300||304===e,n&&(s=function(e,t,n){var r,i,o,a,s=e.contents,u=e.dataTypes;while("*"===u[0])u.shift(),void 0===r&&(r=e.mimeType||t.getResponseHeader("Content-Type"));if(r)for(i in s)if(s[i]&&s[i].test(r)){u.unshift(i);break}if(u[0]in n)o=u[0];else{for(i in n){if(!u[0]||e.converters[i+" "+u[0]]){o=i;break}a||(a=i)}o=o||a}if(o)return o!==u[0]&&u.unshift(o),n[o]}(v,T,n)),!i&&-1<S.inArray("script",v.dataTypes)&&S.inArray("json",v.dataTypes)<0&&(v.converters["text script"]=function(){}),s=function(e,t,n,r){var i,o,a,s,u,l={},c=e.dataTypes.slice();if(c[1])for(a in e.converters)l[a.toLowerCase()]=e.converters[a];o=c.shift();while(o)if(e.responseFields[o]&&(n[e.responseFields[o]]=t),!u&&r&&e.dataFilter&&(t=e.dataFilter(t,e.dataType)),u=o,o=c.shift())if("*"===o)o=u;else if("*"!==u&&u!==o){if(!(a=l[u+" "+o]||l["* "+o]))for(i in l)if((s=i.split(" "))[1]===o&&(a=l[u+" "+s[0]]||l["* "+s[0]])){!0===a?a=l[i]:!0!==l[i]&&(o=s[0],c.unshift(s[1]));break}if(!0!==a)if(a&&e["throws"])t=a(t);else try{t=a(t)}catch(e){return{state:"parsererror",error:a?e:"No conversion from "+u+" to "+o}}}return{state:"success",data:t}}(v,s,T,i),i?(v.ifModified&&((u=T.getResponseHeader("Last-Modified"))&&(S.lastModified[f]=u),(u=T.getResponseHeader("etag"))&&(S.etag[f]=u)),204===e||"HEAD"===v.type?l="nocontent":304===e?l="notmodified":(l=s.state,o=s.data,i=!(a=s.error))):(a=l,!e&&l||(l="error",e<0&&(e=0))),T.status=e,T.statusText=(t||l)+"",i?x.resolveWith(y,[o,l,T]):x.rejectWith(y,[T,l,a]),T.statusCode(w),w=void 0,g&&m.trigger(i?"ajaxSuccess":"ajaxError",[T,v,i?o:a]),b.fireWith(y,[T,l]),g&&(m.trigger("ajaxComplete",[T,v]),--S.active||S.event.trigger("ajaxStop")))}return T},getJSON:function(e,t,n){return S.get(e,t,n,"json")},getScript:function(e,t){return S.get(e,void 0,t,"script")}}),S.each(["get","post"],function(e,i){S[i]=function(e,t,n,r){return m(t)&&(r=r||n,n=t,t=void 0),S.ajax(S.extend({url:e,type:i,dataType:r,data:t,success:n},S.isPlainObject(e)&&e))}}),S.ajaxPrefilter(function(e){var t;for(t in e.headers)"content-type"===t.toLowerCase()&&(e.contentType=e.headers[t]||"")}),S._evalUrl=function(e,t,n){return S.ajax({url:e,type:"GET",dataType:"script",cache:!0,async:!1,global:!1,converters:{"text script":function(){}},dataFilter:function(e){S.globalEval(e,t,n)}})},S.fn.extend({wrapAll:function(e){var t;return this[0]&&(m(e)&&(e=e.call(this[0])),t=S(e,this[0].ownerDocument).eq(0).clone(!0),this[0].parentNode&&t.insertBefore(this[0]),t.map(function(){var e=this;while(e.firstElementChild)e=e.firstElementChild;return e}).append(this)),this},wrapInner:function(n){return m(n)?this.each(function(e){S(this).wrapInner(n.call(this,e))}):this.each(function(){var e=S(this),t=e.contents();t.length?t.wrapAll(n):e.append(n)})},wrap:function(t){var n=m(t);return this.each(function(e){S(this).wrapAll(n?t.call(this,e):t)})},unwrap:function(e){return this.parent(e).not("body").each(function(){S(this).replaceWith(this.childNodes)}),this}}),S.expr.pseudos.hidden=function(e){return!S.expr.pseudos.visible(e)},S.expr.pseudos.visible=function(e){return!!(e.offsetWidth||e.offsetHeight||e.getClientRects().length)},S.ajaxSettings.xhr=function(){try{return new C.XMLHttpRequest}catch(e){}};var Bt={0:200,1223:204},$t=S.ajaxSettings.xhr();y.cors=!!$t&&"withCredentials"in $t,y.ajax=$t=!!$t,S.ajaxTransport(function(i){var o,a;if(y.cors||$t&&!i.crossDomain)return{send:function(e,t){var n,r=i.xhr();if(r.open(i.type,i.url,i.async,i.username,i.password),i.xhrFields)for(n in i.xhrFields)r[n]=i.xhrFields[n];for(n in i.mimeType&&r.overrideMimeType&&r.overrideMimeType(i.mimeType),i.crossDomain||e["X-Requested-With"]||(e["X-Requested-With"]="XMLHttpRequest"),e)r.setRequestHeader(n,e[n]);o=function(e){return function(){o&&(o=a=r.onload=r.onerror=r.onabort=r.ontimeout=r.onreadystatechange=null,"abort"===e?r.abort():"error"===e?"number"!=typeof r.status?t(0,"error"):t(r.status,r.statusText):t(Bt[r.status]||r.status,r.statusText,"text"!==(r.responseType||"text")||"string"!=typeof r.responseText?{binary:r.response}:{text:r.responseText},r.getAllResponseHeaders()))}},r.onload=o(),a=r.onerror=r.ontimeout=o("error"),void 0!==r.onabort?r.onabort=a:r.onreadystatechange=function(){4===r.readyState&&C.setTimeout(function(){o&&a()})},o=o("abort");try{r.send(i.hasContent&&i.data||null)}catch(e){if(o)throw e}},abort:function(){o&&o()}}}),S.ajaxPrefilter(function(e){e.crossDomain&&(e.contents.script=!1)}),S.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/\b(?:java|ecma)script\b/},converters:{"text script":function(e){return S.globalEval(e),e}}}),S.ajaxPrefilter("script",function(e){void 0===e.cache&&(e.cache=!1),e.crossDomain&&(e.type="GET")}),S.ajaxTransport("script",function(n){var r,i;if(n.crossDomain||n.scriptAttrs)return{send:function(e,t){r=S("<script>").attr(n.scriptAttrs||{}).prop({charset:n.scriptCharset,src:n.url}).on("load error",i=function(e){r.remove(),i=null,e&&t("error"===e.type?404:200,e.type)}),E.head.appendChild(r[0])},abort:function(){i&&i()}}});var _t,zt=[],Ut=/(=)\?(?=&|$)|\?\?/;S.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var e=zt.pop()||S.expando+"_"+wt.guid++;return this[e]=!0,e}}),S.ajaxPrefilter("json jsonp",function(e,t,n){var r,i,o,a=!1!==e.jsonp&&(Ut.test(e.url)?"url":"string"==typeof e.data&&0===(e.contentType||"").indexOf("application/x-www-form-urlencoded")&&Ut.test(e.data)&&"data");if(a||"jsonp"===e.dataTypes[0])return r=e.jsonpCallback=m(e.jsonpCallback)?e.jsonpCallback():e.jsonpCallback,a?e[a]=e[a].replace(Ut,"$1"+r):!1!==e.jsonp&&(e.url+=(Tt.test(e.url)?"&":"?")+e.jsonp+"="+r),e.converters["script json"]=function(){return o||S.error(r+" was not called"),o[0]},e.dataTypes[0]="json",i=C[r],C[r]=function(){o=arguments},n.always(function(){void 0===i?S(C).removeProp(r):C[r]=i,e[r]&&(e.jsonpCallback=t.jsonpCallback,zt.push(r)),o&&m(i)&&i(o[0]),o=i=void 0}),"script"}),y.createHTMLDocument=((_t=E.implementation.createHTMLDocument("").body).innerHTML="<form></form><form></form>",2===_t.childNodes.length),S.parseHTML=function(e,t,n){return"string"!=typeof e?[]:("boolean"==typeof t&&(n=t,t=!1),t||(y.createHTMLDocument?((r=(t=E.implementation.createHTMLDocument("")).createElement("base")).href=E.location.href,t.head.appendChild(r)):t=E),o=!n&&[],(i=N.exec(e))?[t.createElement(i[1])]:(i=xe([e],t,o),o&&o.length&&S(o).remove(),S.merge([],i.childNodes)));var r,i,o},S.fn.load=function(e,t,n){var r,i,o,a=this,s=e.indexOf(" ");return-1<s&&(r=ht(e.slice(s)),e=e.slice(0,s)),m(t)?(n=t,t=void 0):t&&"object"==typeof t&&(i="POST"),0<a.length&&S.ajax({url:e,type:i||"GET",dataType:"html",data:t}).done(function(e){o=arguments,a.html(r?S("<div>").append(S.parseHTML(e)).find(r):e)}).always(n&&function(e,t){a.each(function(){n.apply(this,o||[e.responseText,t,e])})}),this},S.expr.pseudos.animated=function(t){return S.grep(S.timers,function(e){return t===e.elem}).length},S.offset={setOffset:function(e,t,n){var r,i,o,a,s,u,l=S.css(e,"position"),c=S(e),f={};"static"===l&&(e.style.position="relative"),s=c.offset(),o=S.css(e,"top"),u=S.css(e,"left"),("absolute"===l||"fixed"===l)&&-1<(o+u).indexOf("auto")?(a=(r=c.position()).top,i=r.left):(a=parseFloat(o)||0,i=parseFloat(u)||0),m(t)&&(t=t.call(e,n,S.extend({},s))),null!=t.top&&(f.top=t.top-s.top+a),null!=t.left&&(f.left=t.left-s.left+i),"using"in t?t.using.call(e,f):c.css(f)}},S.fn.extend({offset:function(t){if(arguments.length)return void 0===t?this:this.each(function(e){S.offset.setOffset(this,t,e)});var e,n,r=this[0];return r?r.getClientRects().length?(e=r.getBoundingClientRect(),n=r.ownerDocument.defaultView,{top:e.top+n.pageYOffset,left:e.left+n.pageXOffset}):{top:0,left:0}:void 0},position:function(){if(this[0]){var e,t,n,r=this[0],i={top:0,left:0};if("fixed"===S.css(r,"position"))t=r.getBoundingClientRect();else{t=this.offset(),n=r.ownerDocument,e=r.offsetParent||n.documentElement;while(e&&(e===n.body||e===n.documentElement)&&"static"===S.css(e,"position"))e=e.parentNode;e&&e!==r&&1===e.nodeType&&((i=S(e).offset()).top+=S.css(e,"borderTopWidth",!0),i.left+=S.css(e,"borderLeftWidth",!0))}return{top:t.top-i.top-S.css(r,"marginTop",!0),left:t.left-i.left-S.css(r,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var e=this.offsetParent;while(e&&"static"===S.css(e,"position"))e=e.offsetParent;return e||re})}}),S.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(t,i){var o="pageYOffset"===i;S.fn[t]=function(e){return $(this,function(e,t,n){var r;if(x(e)?r=e:9===e.nodeType&&(r=e.defaultView),void 0===n)return r?r[i]:e[t];r?r.scrollTo(o?r.pageXOffset:n,o?n:r.pageYOffset):e[t]=n},t,e,arguments.length)}}),S.each(["top","left"],function(e,n){S.cssHooks[n]=Fe(y.pixelPosition,function(e,t){if(t)return t=We(e,n),Pe.test(t)?S(e).position()[n]+"px":t})}),S.each({Height:"height",Width:"width"},function(a,s){S.each({padding:"inner"+a,content:s,"":"outer"+a},function(r,o){S.fn[o]=function(e,t){var n=arguments.length&&(r||"boolean"!=typeof e),i=r||(!0===e||!0===t?"margin":"border");return $(this,function(e,t,n){var r;return x(e)?0===o.indexOf("outer")?e["inner"+a]:e.document.documentElement["client"+a]:9===e.nodeType?(r=e.documentElement,Math.max(e.body["scroll"+a],r["scroll"+a],e.body["offset"+a],r["offset"+a],r["client"+a])):void 0===n?S.css(e,t,i):S.style(e,t,n,i)},s,n?e:void 0,n)}})}),S.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(e,t){S.fn[t]=function(e){return this.on(t,e)}}),S.fn.extend({bind:function(e,t,n){return this.on(e,null,t,n)},unbind:function(e,t){return this.off(e,null,t)},delegate:function(e,t,n,r){return this.on(t,e,n,r)},undelegate:function(e,t,n){return 1===arguments.length?this.off(e,"**"):this.off(t,e||"**",n)},hover:function(e,t){return this.mouseenter(e).mouseleave(t||e)}}),S.each("blur focus focusin focusout resize scroll click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup contextmenu".split(" "),function(e,n){S.fn[n]=function(e,t){return 0<arguments.length?this.on(n,null,e,t):this.trigger(n)}});var Xt=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g;S.proxy=function(e,t){var n,r,i;if("string"==typeof t&&(n=e[t],t=e,e=n),m(e))return r=s.call(arguments,2),(i=function(){return e.apply(t||this,r.concat(s.call(arguments)))}).guid=e.guid=e.guid||S.guid++,i},S.holdReady=function(e){e?S.readyWait++:S.ready(!0)},S.isArray=Array.isArray,S.parseJSON=JSON.parse,S.nodeName=A,S.isFunction=m,S.isWindow=x,S.camelCase=X,S.type=w,S.now=Date.now,S.isNumeric=function(e){var t=S.type(e);return("number"===t||"string"===t)&&!isNaN(e-parseFloat(e))},S.trim=function(e){return null==e?"":(e+"").replace(Xt,"")},"function"==typeof define&&define.amd&&define("jquery",[],function(){return S});var Vt=C.jQuery,Gt=C.$;return S.noConflict=function(e){return C.$===S&&(C.$=Gt),e&&C.jQuery===S&&(C.jQuery=Vt),S},"undefined"==typeof e&&(C.jQuery=C.$=S),S});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 300;
src: url(data:font/ttf;base64,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) format('truetype');
}
@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 400;
src: url(data:font/ttf;base64,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) format('truetype');
}
@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 500;
src: url(data:font/ttf;base64,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) format('truetype');
}
@font-face {
font-family: 'Roboto';
font-style: normal;
font-weight: 700;
src: url(data:font/ttf;base64,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) format('truetype');
}
html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:bold}dfn{font-style:italic}h1{font-size:2em;margin:0.67em 0}mark{background:#ff0;color:#000}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-0.5em}sub{bottom:-0.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;height:0}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace, monospace;font-size:1em}button,input,optgroup,select,textarea{color:inherit;font:inherit;margin:0}button{overflow:visible}button,select{text-transform:none}button,html input[type="button"],input[type="reset"],input[type="submit"]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0}input{line-height:normal}input[type="checkbox"],input[type="radio"]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type="number"]::-webkit-inner-spin-button,input[type="number"]::-webkit-outer-spin-button{height:auto}input[type="search"]{-webkit-appearance:textfield;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}input[type="search"]::-webkit-search-cancel-button,input[type="search"]::-webkit-search-decoration{-webkit-appearance:none}fieldset{border:1px solid #c0c0c0;margin:0 2px;padding:0.35em 0.625em 0.75em}legend{border:0;padding:0}textarea{overflow:auto}optgroup{font-weight:bold}table{border-collapse:collapse;border-spacing:0}td,th{padding:0}@media print{*,*:before,*:after{background:transparent !important;color:#000 !important;-webkit-box-shadow:none !important;box-shadow:none !important;text-shadow:none !important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="#"]:after,a[href^="javascript:"]:after{content:""}pre,blockquote{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}tr,img{page-break-inside:avoid}img{max-width:100% !important}p,h2,h3{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000 !important}.label{border:1px solid #000}.table{border-collapse:collapse !important}.table td,.table th{background-color:#fff !important}.table-bordered th,.table-bordered td{border:1px solid #ddd !important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,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);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:font/woff;base64,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) format('woff'),url(data:font/ttf;base64,AAEAAAAPAIAAAwBwRkZUTW0ql9wAAAD8AAAAHEdERUYBRAAEAAABGAAAACBPUy8yZ7lriQAAATgAAABgY21hcNqt44EAAAGYAAAGcmN2dCAAKAL4AAAIDAAAAARnYXNw//8AAwAACBAAAAAIZ2x5Zn1dwm8AAAgYAACUpGhlYWQFTS/YAACcvAAAADZoaGVhCkQEEQAAnPQAAAAkaG10eNLHIGAAAJ0YAAADdGxvY2Fv+5XOAACgjAAAAjBtYXhwAWoA2AAAorwAAAAgbmFtZbMsoJsAAKLcAAADonBvc3S6o+U1AACmgAAACtF3ZWJmwxhUUAAAsVQAAAAGAAAAAQAAAADMPaLPAAAAANB2gXUAAAAA0HZzlwABAAAADgAAABgAAAAAAAIAAQABARYAAQAEAAAAAgAAAAMEiwGQAAUABAMMAtAAAABaAwwC0AAAAaQAMgK4AAAAAAUAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAFVLV04AQAAg//8DwP8QAAAFFAB7AAAAAQAAAAAAAAAAAAAAIAABAAAABQAAAAMAAAAsAAAACgAAAdwAAQAAAAAEaAADAAEAAAAsAAMACgAAAdwABAGwAAAAaABAAAUAKAAgACsAoAClIAogLyBfIKwgvSISIxsl/CYBJvonCScP4APgCeAZ4CngOeBJ4FngYOBp4HngieCX4QnhGeEp4TnhRuFJ4VnhaeF54YnhleGZ4gbiCeIW4hniIeIn4jniSeJZ4mD4////AAAAIAAqAKAApSAAIC8gXyCsIL0iEiMbJfwmASb6JwknD+AB4AXgEOAg4DDgQOBQ4GDgYuBw4IDgkOEB4RDhIOEw4UDhSOFQ4WDhcOGA4ZDhl+IA4gniEOIY4iHiI+Iw4kDiUOJg+P/////j/9r/Zv9i4Ajf5N+132nfWd4F3P3aHdoZ2SHZE9kOIB0gHCAWIBAgCiAEH/4f+B/3H/Ef6x/lH3wfdh9wH2ofZB9jH10fVx9RH0sfRR9EHt4e3B7WHtUezh7NHsUevx65HrMIFQABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAAAAAACjAAAAAAAAAA1AAAAIAAAACAAAAADAAAAKgAAACsAAAAEAAAAoAAAAKAAAAAGAAAApQAAAKUAAAAHAAAgAAAAIAoAAAAIAAAgLwAAIC8AAAATAAAgXwAAIF8AAAAUAAAgrAAAIKwAAAAVAAAgvQAAIL0AAAAWAAAiEgAAIhIAAAAXAAAjGwAAIxsAAAAYAAAl/AAAJfwAAAAZAAAmAQAAJgEAAAAaAAAm+gAAJvoAAAAbAAAnCQAAJwkAAAAcAAAnDwAAJw8AAAAdAADgAQAA4AMAAAAeAADgBQAA4AkAAAAhAADgEAAA4BkAAAAmAADgIAAA4CkAAAAwAADgMAAA4DkAAAA6AADgQAAA4EkAAABEAADgUAAA4FkAAABOAADgYAAA4GAAAABYAADgYgAA4GkAAABZAADgcAAA4HkAAABhAADggAAA4IkAAABrAADgkAAA4JcAAAB1AADhAQAA4QkAAAB9AADhEAAA4RkAAACGAADhIAAA4SkAAACQAADhMAAA4TkAAACaAADhQAAA4UYAAACkAADhSAAA4UkAAACrAADhUAAA4VkAAACtAADhYAAA4WkAAAC3AADhcAAA4XkAAADBAADhgAAA4YkAAADLAADhkAAA4ZUAAADVAADhlwAA4ZkAAADbAADiAAAA4gYAAADeAADiCQAA4gkAAADlAADiEAAA4hYAAADmAADiGAAA4hkAAADtAADiIQAA4iEAAADvAADiIwAA4icAAADwAADiMAAA4jkAAAD1AADiQAAA4kkAAAD/AADiUAAA4lkAAAEJAADiYAAA4mAAAAETAAD4/wAA+P8AAAEUAAH1EQAB9REAAAEVAAH2qgAB9qoAAAEWAAYCCgAAAAABAAABAAAAAAAAAAAAAAAAAAAAAQACAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAwAAAAAAAAAAAAAAAAAAAAAAAAAEAAUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKAL4AAAAAf//AAIAAgAoAAABaAMgAAMABwAusQEALzyyBwQA7TKxBgXcPLIDAgDtMgCxAwAvPLIFBADtMrIHBgH8PLIBAgDtMjMRIRElMxEjKAFA/ujw8AMg/OAoAtAAAQBkAGQETARMAFsAAAEyFh8BHgEdATc+AR8BFgYPATMyFhcWFRQGDwEOASsBFx4BDwEGJi8BFRQGBwYjIiYvAS4BPQEHDgEvASY2PwEjIiYnJjU0Nj8BPgE7AScuAT8BNhYfATU0Njc2AlgPJgsLCg+eBxYIagcCB57gChECBgMCAQIRCuCeBwIHaggWB54PCikiDyYLCwoPngcWCGoHAgee4AoRAgYDAgECEQrgngcCB2oIFgeeDwopBEwDAgECEQrgngcCB2oIFgeeDwopIg8mCwsKD54HFghqBwIHnuAKEQIGAwIBAhEK4J4HAgdqCBYHng8KKSIPJgsLCg+eBxYIagcCB57gChECBgAAAAABAAAAAARMBEwAIwAAATMyFhURITIWHQEUBiMhERQGKwEiJjURISImPQE0NjMhETQ2AcLIFR0BXhUdHRX+oh0VyBUd/qIVHR0VAV4dBEwdFf6iHRXIFR3+ohUdHRUBXh0VyBUdAV4VHQAAAAABAHAAAARABEwARQAAATMyFgcBBgchMhYPAQ4BKwEVITIWDwEOASsBFRQGKwEiJj0BISImPwE+ATsBNSEiJj8BPgE7ASYnASY2OwEyHwEWMj8BNgM5+goFCP6UBgUBDAoGBngGGAp9ARMKBgZ4BhgKfQ8LlAsP/u0KBgZ4BhgKff7tCgYGeAYYCnYFBv6UCAUK+hkSpAgUCKQSBEwKCP6UBgwMCKAIDGQMCKAIDK4LDw8LrgwIoAgMZAwIoAgMDAYBbAgKEqQICKQSAAABAGQABQSMBK4AOwAAATIXFhcjNC4DIyIOAwchByEGFSEHIR4EMzI+AzUzBgcGIyInLgEnIzczNjcjNzM+ATc2AujycDwGtSM0QDkXEys4MjAPAXtk/tQGAZZk/tQJMDlCNBUWOUA0I64eYmunznYkQgzZZHABBdpkhhQ+H3UErr1oaS1LMCEPCx4uTzJkMjJkSnRCKw8PIjBKK6trdZ4wqndkLzVkV4UljQAAAgB7AAAETASwAD4ARwAAASEyHgUVHAEVFA4FKwEHITIWDwEOASsBFRQGKwEiJj0BISImPwE+ATsBNSEiJj8BPgE7ARE0NhcRMzI2NTQmIwGsAV5DakIwFgwBAQwWMEJqQ7ICASAKBgZ4BhgKigsKlQoP/vUKBgZ4BhgKdf71CgYGeAYYCnUPtstALS1ABLAaJD8yTyokCwsLJCpQMkAlGmQMCKAIDK8LDg8KrwwIoAgMZAwIoAgMAdsKD8j+1EJWVEAAAAEAyAGQBEwCvAAPAAATITIWHQEUBiMhIiY9ATQ2+gMgFR0dFfzgFR0dArwdFcgVHR0VyBUdAAAAAgDIAAAD6ASwACUAQQAAARUUBisBFRQGBx4BHQEzMhYdASE1NDY7ATU0NjcuAT0BIyImPQEXFRQWFx4BFAYHDgEdASE1NCYnLgE0Njc+AT0BA+gdFTJjUVFjMhUd/OAdFTJjUVFjMhUdyEE3HCAgHDdBAZBBNxwgIBw3QQSwlhUdZFuVIyOVW5YdFZaWFR2WW5UjI5VbZB0VlshkPGMYDDI8MgwYYzyWljxjGAwyPDIMGGM8ZAAAAAEAAAAAAAAAAAAAAAAxAAAB//IBLATCBEEAFgAAATIWFzYzMhYVFAYjISImNTQ2NyY1NDYB9261LCwueKqqeP0ST3FVQgLYBEF3YQ6teHmtclBFaw4MGZnXAAAAAgAAAGQEsASvABoAHgAAAB4BDwEBMzIWHQEhNTQ2OwEBJyY+ARYfATc2AyEnAwL2IAkKiAHTHhQe+1AeFB4B1IcKCSAkCm9wCXoBebbDBLMTIxC7/RYlFSoqFSUC6rcQJBQJEJSWEPwecAIWAAAAAAQAAABkBLAETAALABcAIwA3AAATITIWBwEGIicBJjYXARYUBwEGJjURNDYJATYWFREUBicBJjQHARYGIyEiJjcBNjIfARYyPwE2MhkEfgoFCP3MCBQI/cwIBQMBCAgI/vgICgoDjAEICAoKCP74CFwBbAgFCvuCCgUIAWwIFAikCBQIpAgUBEwKCP3JCAgCNwgK2v74CBQI/vgIBQoCJgoF/vABCAgFCv3aCgUIAQgIFID+lAgKCggBbAgIpAgIpAgAAAAD//D/8AS6BLoACQANABAAAAAyHwEWFA8BJzcTAScJAQUTA+AmDpkNDWPWXyL9mdYCZv4f/rNuBLoNmQ4mDlzWYP50/ZrWAmb8anABTwAAAAEAAAAABLAEsAAPAAABETMyFh0BITU0NjsBEQEhArz6FR384B0V+v4MBLACiv3aHRUyMhUdAiYCJgAAAAEADgAIBEwEnAAfAAABJTYWFREUBgcGLgE2NzYXEQURFAYHBi4BNjc2FxE0NgFwAoUnMFNGT4gkV09IQv2oWEFPiCRXT0hCHQP5ow8eIvzBN1EXGSltchkYEAIJm/2iKmAVGilucRoYEQJ/JioAAAACAAn/+AS7BKcAHQApAAAAMh4CFQcXFAcBFgYPAQYiJwEGIycHIi4CND4BBCIOARQeATI+ATQmAZDItoNOAQFOARMXARY7GikT/u13jgUCZLaDTk6DAXKwlFZWlLCUVlYEp06DtmQCBY15/u4aJRg6FBQBEk0BAU6Dtsi2g1tWlLCUVlaUsJQAAQBkAFgErwREABkAAAE+Ah4CFRQOAwcuBDU0PgIeAQKJMHt4dVg2Q3mEqD4+p4V4Qzhadnh5A7VESAUtU3ZAOXmAf7JVVbJ/gHk5QHZTLQVIAAAAAf/TAF4EewSUABgAAAETNjIXEyEyFgcFExYGJyUFBiY3EyUmNjMBl4MHFQeBAaUVBhH+qoIHDxH+qf6qEQ8Hgv6lEQYUAyABYRMT/p8RDPn+bxQLDPb3DAsUAZD7DBEAAv/TAF4EewSUABgAIgAAARM2MhcTITIWBwUTFgYnJQUGJjcTJSY2MwUjFwc3Fyc3IycBl4MHFQeBAaUVBhH+qoIHDxH+qf6qEQ8Hgv6lEQYUAfPwxUrBw0rA6k4DIAFhExP+nxEM+f5vFAsM9vcMCxQBkPsMEWSO4ouM5YzTAAABAAAAAASwBLAAJgAAATIWHQEUBiMVFBYXBR4BHQEUBiMhIiY9ATQ2NyU+AT0BIiY9ATQ2Alh8sD4mDAkBZgkMDwr7ggoPDAkBZgkMJj6wBLCwfPouaEsKFwbmBRcKXQoPDwpdChcF5gYXCktoLvp8sAAAAA0AAAAABLAETAAPABMAIwAnACsALwAzADcARwBLAE8AUwBXAAATITIWFREUBiMhIiY1ETQ2FxUzNSkBIgYVERQWMyEyNjURNCYzFTM1BRUzNSEVMzUFFTM1IRUzNQchIgYVERQWMyEyNjURNCYFFTM1IRUzNQUVMzUhFTM1GQR+Cg8PCvuCCg8PVWQCo/3aCg8PCgImCg8Pc2T8GGQDIGT8GGQDIGTh/doKDw8KAiYKDw/872QDIGT8GGQDIGQETA8K++YKDw8KBBoKD2RkZA8K/qIKDw8KAV4KD2RkyGRkZGTIZGRkZGQPCv6iCg8PCgFeCg9kZGRkZMhkZGRkAAAEAAAAAARMBEwADwAfAC8APwAAEyEyFhURFAYjISImNRE0NikBMhYVERQGIyEiJjURNDYBITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NjIBkBUdHRX+cBUdHQJtAZAVHR0V/nAVHR39vQGQFR0dFf5wFR0dAm0BkBUdHRX+cBUdHQRMHRX+cBUdHRUBkBUdHRX+cBUdHRUBkBUd/agdFf5wFR0dFQGQFR0dFf5wFR0dFQGQFR0AAAkAAAAABEwETAAPAB8ALwA/AE8AXwBvAH8AjwAAEzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2MsgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR0ETB0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHf5wHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUd/nAdFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0ABgAAAAAEsARMAA8AHwAvAD8ATwBfAAATMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYyyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHQRMHRXIFR0dFcgVHR0VyBUdHRXIFR3+cB0VyBUdHRXIFR0dFcgVHR0VyBUd/nAdFcgVHR0VyBUdHRXIFR0dFcgVHQAAAAABACYALAToBCAAFwAACQE2Mh8BFhQHAQYiJwEmND8BNjIfARYyAdECOwgUB7EICPzxBxUH/oAICLEHFAirBxYB3QI7CAixBxQI/PAICAGACBQHsQgIqwcAAQBuAG4EQgRCACMAAAEXFhQHCQEWFA8BBiInCQEGIi8BJjQ3CQEmND8BNjIXCQE2MgOIsggI/vUBCwgIsggVB/70/vQHFQiyCAgBC/71CAiyCBUHAQwBDAcVBDuzCBUH/vT+9AcVCLIICAEL/vUICLIIFQcBDAEMBxUIsggI/vUBDAcAAwAX/+sExQSZABkAJQBJAAAAMh4CFRQHARYUDwEGIicBBiMiLgI0PgEEIg4BFB4BMj4BNCYFMzIWHQEzMhYdARQGKwEVFAYrASImPQEjIiY9ATQ2OwE1NDYBmcSzgk1OASwICG0HFQj+1HeOYrSBTU2BAW+zmFhYmLOZWFj+vJYKD0sKDw8KSw8KlgoPSwoPDwpLDwSZTYKzYo15/tUIFQhsCAgBK01NgbTEs4JNWJmzmFhYmLOZIw8KSw8KlgoPSwoPDwpLDwqWCg9LCg8AAAMAF//rBMUEmQAZACUANQAAADIeAhUUBwEWFA8BBiInAQYjIi4CND4BBCIOARQeATI+ATQmBSEyFh0BFAYjISImPQE0NgGZxLOCTU4BLAgIbQcVCP7Ud45itIFNTYEBb7OYWFiYs5lYWP5YAV4KDw8K/qIKDw8EmU2Cs2KNef7VCBUIbAgIAStNTYG0xLOCTViZs5hYWJizmYcPCpYKDw8KlgoPAAAAAAIAFwAXBJkEsAAPAC0AAAEzMhYVERQGKwEiJjURNDYFNRYSFRQOAiIuAjU0EjcVDgEVFB4BMj4BNTQmAiZkFR0dFWQVHR0BD6fSW5vW6tabW9KnZ3xyxejFcnwEsB0V/nAVHR0VAZAVHeGmPv7ZuHXWm1tbm9Z1uAEnPqY3yHh0xXJyxXR4yAAEAGQAAASwBLAADwAfAC8APwAAATMyFhURFAYrASImNRE0NgEzMhYVERQGKwEiJjURNDYBMzIWFREUBisBIiY1ETQ2BTMyFh0BFAYrASImPQE0NgQBlgoPDwqWCg8P/t6WCg8PCpYKDw/+3pYKDw8KlgoPD/7elgoPDwqWCg8PBLAPCvuCCg8PCgR+Cg/+cA8K/RIKDw8KAu4KD/7UDwr+PgoPDwoBwgoPyA8K+goPDwr6Cg8AAAAAAgAaABsElgSWAEcATwAAATIfAhYfATcWFwcXFh8CFhUUDwIGDwEXBgcnBwYPAgYjIi8CJi8BByYnNycmLwImNTQ/AjY/ASc2Nxc3Nj8CNhIiBhQWMjY0AlghKSYFMS0Fhj0rUAMZDgGYBQWYAQ8YA1AwOIYFLDIFJisfISkmBTEtBYY8LFADGQ0ClwYGlwINGQNQLzqFBS0xBSYreLJ+frJ+BJYFmAEOGQJQMDmGBSwxBiYrHiIoJgYxLAWGPSxRAxkOApcFBZcCDhkDUTA5hgUtMAYmKiAhKCYGMC0Fhj0sUAIZDgGYBf6ZfrF+frEABwBkAAAEsAUUABMAFwAhACUAKQAtADEAAAEhMhYdASEyFh0BITU0NjMhNTQ2FxUhNQERFAYjISImNREXETMRMxEzETMRMxEzETMRAfQBLCk7ARMKD/u0DwoBEzspASwBLDsp/UQpO2RkZGRkZGRkBRQ7KWQPCktLCg9kKTtkZGT+1PzgKTs7KQMgZP1EArz9RAK8/UQCvP1EArwAAQAMAAAFCATRAB8AABMBNjIXARYGKwERFAYrASImNREhERQGKwEiJjURIyImEgJsCBUHAmAIBQqvDwr6Cg/+1A8K+goPrwoFAmoCYAcH/aAICv3BCg8PCgF3/okKDw8KAj8KAAIAZAAAA+gEsAARABcAAAERFBYzIREUBiMhIiY1ETQ2MwEjIiY9AQJYOykBLB0V/OAVHR0VA1L6FR0EsP5wKTv9dhUdHRUETBUd/nAdFfoAAwAXABcEmQSZAA8AGwAwAAAAMh4CFA4CIi4CND4BBCIOARQeATI+ATQmBTMyFhURMzIWHQEUBisBIiY1ETQ2AePq1ptbW5vW6tabW1ubAb/oxXJyxejFcnL+fDIKD68KDw8K+goPDwSZW5vW6tabW1ub1urWmztyxejFcnLF6MUNDwr+7Q8KMgoPDwoBXgoPAAAAAAL/nAAABRQEsAALAA8AACkBAyMDIQEzAzMDMwEDMwMFFP3mKfIp/eYBr9EVohTQ/p4b4BsBkP5wBLD+1AEs/nD+1AEsAAAAAAIAZAAABLAEsAAVAC8AAAEzMhYVETMyFgcBBiInASY2OwERNDYBMzIWFREUBiMhIiY1ETQ2OwEyFh0BITU0NgImyBUdvxQLDf65DSYN/rkNCxS/HQJUMgoPDwr75goPDwoyCg8DhA8EsB0V/j4XEP5wEBABkBAXAcIVHfzgDwr+ogoPDwoBXgoPDwqvrwoPAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgUzMhYVETMyFgcDBiInAyY2OwERNDYB4+rWm1tbm9bq1ptbW5sBv+jFcnLF6MVycv58lgoPiRUKDd8NJg3fDQoViQ8EmVub1urWm1tbm9bq1ps7csXoxXJyxejFDQ8K/u0XEP7tEBABExAXARMKDwAAAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JiUTFgYrAREUBisBIiY1ESMiJjcTNjIB4+rWm1tbm9bq1ptbW5sBv+jFcnLF6MVycv7n3w0KFYkPCpYKD4kVCg3fDSYEmVub1urWm1tbm9bq1ps7csXoxXJyxejFAf7tEBf+7QoPDwoBExcQARMQAAAAAAIAAAAABLAEsAAZADkAABMhMhYXExYVERQGBwYjISImJyY1EzQ3Ez4BBSEiBgcDBhY7ATIWHwEeATsBMjY/AT4BOwEyNicDLgHhAu4KEwO6BwgFDBn7tAweAgYBB7kDEwKX/dQKEgJXAgwKlgoTAiYCEwr6ChMCJgITCpYKDAJXAhIEsA4K/XQYGf5XDB4CBggEDRkBqRkYAowKDsgOC/4+Cw4OCpgKDg4KmAoODgsBwgsOAAMAFwAXBJkEmQAPABsAJwAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgUXFhQPAQYmNRE0NgHj6tabW1ub1urWm1tbmwG/6MVycsXoxXJy/ov9ERH9EBgYBJlbm9bq1ptbW5vW6tabO3LF6MVycsXoxV2+DCQMvgwLFQGQFQsAAQAXABcEmQSwACgAAAE3NhYVERQGIyEiJj8BJiMiDgEUHgEyPgE1MxQOAiIuAjQ+AjMyA7OHBwsPCv6WCwQHhW2BdMVycsXoxXKWW5vW6tabW1ub1nXABCSHBwQL/pYKDwsHhUxyxejFcnLFdHXWm1tbm9bq1ptbAAAAAAIAFwABBJkEsAAaADUAAAE3NhYVERQGIyEiJj8BJiMiDgEVIzQ+AjMyEzMUDgIjIicHBiY1ETQ2MyEyFg8BFjMyPgEDs4cHCw8L/pcLBAeGboF0xXKWW5vWdcDrllub1nXAnIYHCw8LAWgKBQiFboJ0xXIEJIcHBAv+lwsPCweGS3LFdHXWm1v9v3XWm1t2hggFCgFoCw8LB4VMcsUAAAAKAGQAAASwBLAADwAfAC8APwBPAF8AbwB/AI8AnwAAEyEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0NgczMhYdARQGKwEiJj0BNDYzITIWHQEUBiMhIiY9ATQ2BzMyFh0BFAYrASImPQE0NjMhMhYdARQGIyEiJj0BNDYHMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0Nn0EGgoPDwr75goPDwPA/K4KDw8KA1IKDw/9CDIKDw8KMgoPD9IBwgoPDwr+PgoPD74yCg8PCjIKDw/SAcIKDw8K/j4KDw++MgoPDwoyCg8P0gHCCg8PCv4+Cg8PvjIKDw8KMgoPD9IBwgoPDwr+PgoPDwSwDwr7ggoPDwoEfgoPyA8K/K4KDw8KA1IKD2QPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKDwAAAAACAAAAAARMBLAAGQAjAAABNTQmIyEiBh0BIyIGFREUFjMhMjY1ETQmIyE1NDY7ATIWHQEDhHVT/tRSdmQpOzspA4QpOzsp/ageFMgUHgMgyFN1dlLIOyn9qCk7OykCWCk7lhUdHRWWAAIAZAAABEwETAAJADcAABMzMhYVESMRNDYFMhcWFREUBw4DIyIuAScuAiMiBwYjIicmNRE+ATc2HgMXHgIzMjc2fTIKD2QPA8AEBRADIUNAMRwaPyonKSxHHlVLBwgGBQ4WeDsXKC4TOQQpLUUdZ1AHBEwPCvvNBDMKDzACBhH+WwYGO1AkDQ0ODg8PDzkFAwcPAbY3VwMCAwsGFAEODg5XCAAAAwAAAAAEsASXACEAMQBBAAAAMh4CFREUBisBIiY1ETQuASAOARURFAYrASImNRE0PgEDMzIWFREUBisBIiY1ETQ2ITMyFhURFAYrASImNRE0NgHk6N6jYw8KMgoPjeT++uSNDwoyCg9joyqgCAwMCKAIDAwCYKAIDAwIoAgMDASXY6PedP7UCg8PCgEsf9FyctF//tQKDw8KASx03qP9wAwI/jQIDAwIAcwIDAwI/jQIDAwIAcwIDAAAAAACAAAA0wRHA90AFQA5AAABJTYWFREUBiclJisBIiY1ETQ2OwEyBTc2Mh8BFhQPARcWFA8BBiIvAQcGIi8BJjQ/AScmND8BNjIXAUEBAgkMDAn+/hUZ+goPDwr6GQJYeAcUByIHB3h4BwciBxQHeHgHFAciBwd3dwcHIgcUBwMurAYHCv0SCgcGrA4PCgFeCg+EeAcHIgcUB3h4BxQHIgcHd3cHByIHFAd4eAcUByIICAAAAAACAAAA0wNyA90AFQAvAAABJTYWFREUBiclJisBIiY1ETQ2OwEyJTMWFxYVFAcGDwEiLwEuATc2NTQnJjY/ATYBQQECCQwMCf7+FRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcDLqwGBwr9EgoHBqwODwoBXgoPZAEJgaGafwkBAQYXBxMIZ36EaggUBxYFAAAAAAMAAADEBGID7AAbADEASwAAATMWFxYVFAYHBgcjIi8BLgE3NjU0JicmNj8BNgUlNhYVERQGJyUmKwEiJjURNDY7ATIlMxYXFhUUBwYPASIvAS4BNzY1NCcmNj8BNgPHAwsGh0RABwoDCQcqCAIGbzs3BgIJKgf9ggECCQwMCf7+FRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcD7AEJs9lpy1QJAQYiBhQIlrJarEcJFAYhBb6sBgcK/RIKBwasDg8KAV4KD2QBCYGhmn8JAQEGFwcTCGd+hGoIFQYWBQAAAAANAAAAAASwBLAACQAVABkAHQAhACUALQA7AD8AQwBHAEsATwAAATMVIxUhFSMRIQEjFTMVIREjESM1IQURIREhESERBSM1MwUjNTMBMxEhETM1MwEzFSMVIzUjNTM1IzUhBREhEQcjNTMFIzUzASM1MwUhNSEB9GRk/nBkAfQCvMjI/tTIZAJY+7QBLAGQASz84GRkArxkZP1EyP4MyGQB9MhkyGRkyAEs/UQBLGRkZAOEZGT+DGRkAfT+1AEsA4RkZGQCWP4MZMgBLAEsyGT+1AEs/tQBLMhkZGT+DP4MAfRk/tRkZGRkyGTI/tQBLMhkZGT+1GRkZAAAAAAJAAAAAASwBLAAAwAHAAsADwATABcAGwAfACMAADcjETMTIxEzASMRMxMjETMBIxEzASE1IRcjNTMXIzUzBSM1M2RkZMhkZAGQyMjIZGQBLMjI/OD+1AEsyGRkyGRkASzIyMgD6PwYA+j8GAPo/BgD6PwYA+j7UGRkW1tbW1sAAAIAAAAKBKYEsAANABUAAAkBFhQHAQYiJwETNDYzBCYiBhQWMjYB9AKqCAj+MAgUCP1WAQ8KAUM7Uzs7UzsEsP1WCBQI/jAICAKqAdsKD807O1Q7OwAAAAADAAAACgXSBLAADQAZACEAAAkBFhQHAQYiJwETNDYzIQEWFAcBBiIvAQkBBCYiBhQWMjYB9AKqCAj+MAgUCP1WAQ8KAwYCqggI/jAIFAg4Aaj9RP7TO1M7O1M7BLD9VggUCP4wCAgCqgHbCg/9VggUCP4wCAg4AaoCvM07O1Q7OwAAAAABAGQAAASwBLAAJgAAASEyFREUDwEGJjURNCYjISIPAQYWMyEyFhURFAYjISImNRE0PwE2ASwDOUsSQAgKDwr9RBkSQAgFCgK8Cg8PCvyuCg8SixIEsEv8fBkSQAgFCgO2Cg8SQAgKDwr8SgoPDwoDzxkSixIAAAABAMj//wRMBLAACgAAEyEyFhURCQERNDb6AyAVHf4+/j4dBLAdFfuCAbz+QwR/FR0AAAAAAwAAAAAEsASwABUARQBVAAABISIGBwMGHwEeATMhMjY/ATYnAy4BASMiBg8BDgEjISImLwEuASsBIgYVERQWOwEyNj0BNDYzITIWHQEUFjsBMjY1ETQmASEiBg8BBhYzITI2LwEuAQM2/kQLEAFOBw45BhcKAcIKFwY+DgdTARABVpYKFgROBBYK/doKFgROBBYKlgoPDwqWCg8PCgLuCg8PCpYKDw/+sf4MChMCJgILCgJYCgsCJgITBLAPCv7TGBVsCQwMCWwVGAEtCg/+cA0JnAkNDQmcCQ0PCv12Cg8PCpYKDw8KlgoPDwoCigoP/agOCpgKDg4KmAoOAAAAAAQAAABkBLAETAAdACEAKQAxAAABMzIeAh8BMzIWFREUBiMhIiY1ETQ2OwE+BAEVMzUEIgYUFjI2NCQyFhQGIiY0AfTIOF00JAcGlik7Oyn8GCk7OymWAgknM10ByGT+z76Hh76H/u9WPDxWPARMKTs7FRQ7Kf2oKTs7KQJYKTsIG0U1K/7UZGRGh76Hh74IPFY8PFYAAAAAAgA1AAAEsASvACAAIwAACQEWFx4BHwEVITUyNi8BIQYHBh4CMxUhNTY3PgE/AQEDIQMCqQGBFCgSJQkK/l81LBFS/nk6IgsJKjIe/pM4HAwaBwcBj6wBVKIEr/waMioTFQECQkJXLd6RWSIuHAxCQhgcDCUNDQPu/VoByQAAAAADAGQAAAPwBLAAJwAyADsAAAEeBhUUDgMjITU+ATURNC4EJzUFMh4CFRQOAgclMzI2NTQuAisBETMyNjU0JisBAvEFEzUwOyodN1htbDD+DCk7AQYLFyEaAdc5dWM+Hy0tEP6Pi05pESpTPnbYUFJ9Xp8CgQEHGB0zOlIuQ3VONxpZBzMoAzsYFBwLEAkHRwEpSXNDM1s6KwkxYUopOzQb/K5lUFqBAAABAMgAAANvBLAAGQAAARcOAQcDBhYXFSE1NjcTNjQuBCcmJzUDbQJTQgeECSxK/gy6Dq0DAw8MHxUXDQYEsDkTNSj8uTEoBmFhEFIDQBEaExAJCwYHAwI5AAAAAAL/tQAABRQEsAAlAC8AAAEjNC4FKwERFBYfARUhNTI+AzURIyIOBRUjESEFIxEzByczESM3BRQyCAsZEyYYGcgyGRn+cAQOIhoWyBkYJhMZCwgyA+j7m0tLfX1LS30DhBUgFQ4IAwH8rhYZAQJkZAEFCRUOA1IBAwgOFSAVASzI/OCnpwMgpwACACH/tQSPBLAAJQAvAAABIzQuBSsBERQWHwEVITUyPgM1ESMiDgUVIxEhEwc1IRUnNxUhNQRMMggLGRMmGBnIMhkZ/nAEDiIaFsgZGCYTGQsIMgPoQ6f84KenAyADhBUgFQ4IAwH9dhYZAQJkZAEFCRUOAooBAwgOFSAVASz7gn1LS319S0sABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyAlgVHR0V/agVHR0VA+gVHR0V/BgVHR0VAyAVHR0V/OAVHR0VBEwVHR0V+7QVHR0ETB0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYDITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NgMhMhYdARQGIyEiJj0BNDb6ArwVHR0V/UQVHR2zBEwVHR0V+7QVHR3dArwVHR0V/UQVHR2zBEwVHR0V+7QVHR0ETB0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AAAE1NDYzITIWHQEUBiMhIiYBNTQ2MyEyFh0BFAYjISImEzU0NjMhMhYdARQGIyEiJgE1NDYzITIWHQEUBiMhIiYB9B0VAlgVHR0V/agVHf5wHRUD6BUdHRX8GBUdyB0VAyAVHR0V/OAVHf7UHRUETBUdHRX7tBUdA7ZkFR0dFWQVHR3+6WQVHR0VZBUdHf7pZBUdHRVkFR0d/ulkFR0dFWQVHR0AAAQAAAAABLAETAAPAB8ALwA/AAATITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2MgRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dBEwdFWQVHR0VZBUd/tQdFWQVHR0VZBUd/tQdFWQVHR0VZBUd/tQdFWQVHR0VZBUdAAgAAAAABLAETAAPAB8ALwA/AE8AXwBvAH8AABMzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2MmQVHR0VZBUdHQFBAyAVHR0V/OAVHR3+6WQVHR0VZBUdHQFBAyAVHR0V/OAVHR3+6WQVHR0VZBUdHQFBAyAVHR0V/OAVHR3+6WQVHR0VZBUdHQFBAyAVHR0V/OAVHR0ETB0VZBUdHRVkFR0dFWQVHR0VZBUd/tQdFWQVHR0VZBUdHRVkFR0dFWQVHf7UHRVkFR0dFWQVHR0VZBUdHRVkFR3+1B0VZBUdHRVkFR0dFWQVHR0VZBUdAAAG/5wAAASwBEwAAwATACMAKgA6AEoAACEjETsCMhYdARQGKwEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2BQc1IzUzNQUhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2AZBkZJZkFR0dFWQVHR0VAfQVHR0V/gwVHR3++qfIyAHCASwVHR0V/tQVHR0VAlgVHR0V/agVHR0ETB0VZBUdHRVkFR3+1B0VZBUdHRVkFR36fUtkS68dFWQVHR0VZBUd/tQdFWQVHR0VZBUdAAAABgAAAAAFFARMAA8AEwAjACoAOgBKAAATMzIWHQEUBisBIiY9ATQ2ASMRMwEhMhYdARQGIyEiJj0BNDYFMxUjFSc3BSEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyZBUdHRVkFR0dA2dkZPyuAfQVHR0V/gwVHR0EL8jIp6f75gEsFR0dFf7UFR0dFQJYFR0dFf2oFR0dBEwdFWQVHR0VZBUd+7QETP7UHRVkFR0dFWQVHchkS319rx0VZBUdHRVkFR3+1B0VZBUdHRVkFR0AAAAAAgAAAMgEsAPoAA8AEgAAEyEyFhURFAYjISImNRE0NgkCSwLuHywsH/0SHywsBIT+1AEsA+gsH/12HywsHwKKHyz9RAEsASwAAwAAAAAEsARMAA8AFwAfAAATITIWFREUBiMhIiY1ETQ2FxE3BScBExEEMhYUBiImNCwEWBIaGhL7qBIaGkr3ASpKASXs/NJwTk5wTgRMGhL8DBIaGhID9BIaZP0ftoOcAT7+4AH0dE5vT09vAAAAAAIA2wAFBDYEkQAWAB4AAAEyHgEVFAcOAQ8BLgQnJjU0PgIWIgYUFjI2NAKIdcZzRkWyNjYJIV5YbSk8RHOft7eCgreCBJF4ynVzj23pPz4IIWZomEiEdVijeUjDgriBgbgAAAACABcAFwSZBJkADwAXAAAAMh4CFA4CIi4CND4BAREiDgEUHgEB4+rWm1tbm9bq1ptbW5sBS3TFcnLFBJlbm9bq1ptbW5vW6tab/G8DVnLF6MVyAAACAHUAAwPfBQ8AGgA1AAABHgYVFA4DBy4DNTQ+BQMOAhceBBcWNj8BNiYnLgInJjc2IyYCKhVJT1dOPiUzVnB9P1SbfEokP0xXUEm8FykoAwEbITEcExUWAgYCCQkFEikMGiACCAgFD0iPdXdzdYdFR4BeRiYEBTpjl1lFh3ZzeHaQ/f4hS4I6JUEnIw4IBwwQIgoYBwQQQSlZtgsBAAAAAwAAAAAEywRsAAwAKgAvAAABNz4CHgEXHgEPAiUhMhcHISIGFREUFjMhMjY9ATcRFAYjISImNRE0NgkBBzcBA+hsAgYUFR0OFgoFBmz9BQGQMje7/pApOzspAfQpO8i7o/5wpbm5Azj+lqE3AWMD9XMBAgIEDw4WKgsKc8gNuzsp/gwpOzsptsj+tKW5uaUBkKW5/tf+ljKqAWMAAgAAAAAEkwRMABsANgAAASEGByMiBhURFBYzITI2NTcVFAYjISImNRE0NgUBFhQHAQYmJzUmDgMHPgY3NT4BAV4BaaQ0wyk7OykB9Ck7yLml/nClubkCfwFTCAj+rAcLARo5ZFRYGgouOUlARioTAQsETJI2Oyn+DCk7OymZZ6W5uaUBkKW5G/7TBxUH/s4GBAnLAQINFjAhO2JBNB0UBwHSCgUAAAAAAgAAAAAEnQRMAB0ANQAAASEyFwchIgYVERQWMyEyNj0BNxUUBiMhIiY1ETQ2CQE2Mh8BFhQHAQYiLwEmND8BNjIfARYyAV4BXjxDsv6jKTs7KQH0KTvIuaX+cKW5uQHKAYsHFQdlBwf97QcVB/gHB2UHFQdvCBQETBexOyn+DCk7OylFyNulubmlAZCluf4zAYsHB2UHFQf97AcH+AcVB2UHB28HAAAAAQAKAAoEpgSmADsAAAkBNjIXARYGKwEVMzU0NhcBFhQHAQYmPQEjFTMyFgcBBiInASY2OwE1IxUUBicBJjQ3ATYWHQEzNSMiJgE+AQgIFAgBBAcFCqrICggBCAgI/vgICsiqCgUH/vwIFAj++AgFCq/ICgj++AgIAQgICsivCgUDlgEICAj++AgKyK0KBAf+/AcVB/73BwQKrcgKCP74CAgBCAgKyK0KBAcBCQcVBwEEBwQKrcgKAAEAyAAAA4QETAAZAAATMzIWFREBNhYVERQGJwERFAYrASImNRE0NvpkFR0B0A8VFQ/+MB0VZBUdHQRMHRX+SgHFDggV/BgVCA4Bxf5KFR0dFQPoFR0AAAABAAAAAASwBEwAIwAAEzMyFhURATYWFREBNhYVERQGJwERFAYnAREUBisBIiY1ETQ2MmQVHQHQDxUB0A8VFQ/+MBUP/jAdFWQVHR0ETB0V/koBxQ4IFf5KAcUOCBX8GBUIDgHF/koVCA4Bxf5KFR0dFQPoFR0AAAABAJ0AGQSwBDMAFQAAAREUBicBERQGJwEmNDcBNhYVEQE2FgSwFQ/+MBUP/hQPDwHsDxUB0A8VBBr8GBUIDgHF/koVCA4B4A4qDgHgDggV/koBxQ4IAAAAAQDIABYEMwQ2AAsAABMBFhQHAQYmNRE0NvMDLhIS/NISGRkEMv4OCx4L/g4LDhUD6BUOAAIAyABkA4QD6AAPAB8AABMzMhYVERQGKwEiJjURNDYhMzIWFREUBisBIiY1ETQ2+sgVHR0VyBUdHQGlyBUdHRXIFR0dA+gdFfzgFR0dFQMgFR0dFfzgFR0dFQMgFR0AAAEAyABkBEwD6AAPAAABERQGIyEiJjURNDYzITIWBEwdFfzgFR0dFQMgFR0DtvzgFR0dFQMgFR0dAAAAAAEAAAAZBBMEMwAVAAABETQ2FwEWFAcBBiY1EQEGJjURNDYXAfQVDwHsDw/+FA8V/jAPFRUPAmQBthUIDv4gDioO/iAOCBUBtv47DggVA+gVCA4AAAH//gACBLMETwAjAAABNzIWFRMUBiMHIiY1AwEGJjUDAQYmNQM0NhcBAzQ2FwEDNDYEGGQUHgUdFWQVHQL+MQ4VAv4yDxUFFQ8B0gIVDwHSAh0ETgEdFfwYFR0BHRUBtf46DwkVAbX+OQ4JFAPoFQkP/j4BthQJDv49AbYVHQAAAQEsAAAD6ARMABkAAAEzMhYVERQGKwEiJjURAQYmNRE0NhcBETQ2A1JkFR0dFWQVHf4wDxUVDwHQHQRMHRX8GBUdHRUBtv47DggVA+gVCA7+OwG2FR0AAAIAZADIBLAESAALABsAAAkBFgYjISImNwE2MgEhMhYdARQGIyEiJj0BNDYCrgH1DwkW++4WCQ8B9Q8q/fcD6BUdHRX8GBUdHQQ5/eQPFhYPAhwP/UgdFWQVHR0VZBUdAAEAiP/8A3UESgAFAAAJAgcJAQN1/qABYMX92AIoA4T+n/6fxgIoAiYAAAAAAQE7//wEKARKAAUAAAkBJwkBNwQo/dnGAWH+n8YCI/3ZxgFhAWHGAAIAFwAXBJkEmQAPADMAAAAyHgIUDgIiLgI0PgEFIyIGHQEjIgYdARQWOwEVFBY7ATI2PQEzMjY9ATQmKwE1NCYB4+rWm1tbm9bq1ptbW5sBfWQVHZYVHR0Vlh0VZBUdlhUdHRWWHQSZW5vW6tabW1ub1urWm7odFZYdFWQVHZYVHR0Vlh0VZBUdlhUdAAAAAAIAFwAXBJkEmQAPAB8AAAAyHgIUDgIiLgI0PgEBISIGHQEUFjMhMjY9ATQmAePq1ptbW5vW6tabW1ubAkX+DBUdHRUB9BUdHQSZW5vW6tabW1ub1urWm/5+HRVkFR0dFWQVHQACABcAFwSZBJkADwAzAAAAMh4CFA4CIi4CND4BBCIPAScmIg8BBhQfAQcGFB8BFjI/ARcWMj8BNjQvATc2NC8BAePq1ptbW5vW6tabW1ubAeUZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0JCXh4CQmNBJlbm9bq1ptbW5vW6tabrQl4eAkJjQkZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0AAgAXABcEmQSZAA8AJAAAADIeAhQOAiIuAjQ+AQEnJiIPAQYUHwEWMjcBNjQvASYiBwHj6tabW1ub1urWm1tbmwEVVAcVCIsHB/IHFQcBdwcHiwcVBwSZW5vW6tabW1ub1urWm/4xVQcHiwgUCPEICAF3BxUIiwcHAAAAAAMAFwAXBJkEmQAPADsASwAAADIeAhQOAiIuAjQ+AQUiDgMVFDsBFjc+ATMyFhUUBgciDgUHBhY7ATI+AzU0LgMTIyIGHQEUFjsBMjY9ATQmAePq1ptbW5vW6tabW1ubAT8dPEIyIRSDHgUGHR8UFw4TARkOGhITDAIBDQ6tBx4oIxgiM0Q8OpYKDw8KlgoPDwSZW5vW6tabW1ub1urWm5ELHi9PMhkFEBQQFRIXFgcIBw4UHCoZCBEQKDhcNi9IKhsJ/eMPCpYKDw8KlgoPAAADABcAFwSZBJkADwAfAD4AAAAyHgIUDgIiLgI0PgEFIyIGHQEUFjsBMjY9ATQmAyMiBh0BFBY7ARUjIgYdARQWMyEyNj0BNCYrARE0JgHj6tabW1ub1urWm1tbmwGWlgoPDwqWCg8PCvoKDw8KS0sKDw8KAV4KDw8KSw8EmVub1urWm1tbm9bq1ptWDwqWCg8PCpYKD/7UDwoyCg/IDwoyCg8PCjIKDwETCg8AAgAAAAAEsASwAC8AXwAAATMyFh0BHgEXMzIWHQEUBisBDgEHFRQGKwEiJj0BLgEnIyImPQE0NjsBPgE3NTQ2ExUUBisBIiY9AQ4BBzMyFh0BFAYrAR4BFzU0NjsBMhYdAT4BNyMiJj0BNDY7AS4BAg2WCg9nlxvCCg8PCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw+5DwqWCg9EZheoCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmBLAPCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw8KlgoPZ5cbwgoP/s2oCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmRA8KlgoPRGYAAwAXABcEmQSZAA8AGwA/AAAAMh4CFA4CIi4CND4BBCIOARQeATI+ATQmBxcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyAePq1ptbW5vW6tabW1ubAb/oxXJyxejFcnKaQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwdABxUHfHwHFQSZW5vW6tabW1ub1urWmztyxejFcnLF6MVaQAcVB3x8BxUHQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwAAAAMAFwAXBJkEmQAPABsAMAAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgcXFhQHAQYiLwEmND8BNjIfATc2MgHj6tabW1ub1urWm1tbmwG/6MVycsXoxXJyg2oHB/7ACBQIyggIagcVB0/FBxUEmVub1urWm1tbm9bq1ps7csXoxXJyxejFfWoHFQf+vwcHywcVB2oICE/FBwAAAAMAFwAXBJkEmQAPABgAIQAAADIeAhQOAiIuAjQ+AQUiDgEVFBcBJhcBFjMyPgE1NAHj6tabW1ub1urWm1tbmwFLdMVyQQJLafX9uGhzdMVyBJlbm9bq1ptbW5vW6tabO3LFdHhpAktB0P24PnLFdHMAAAAAAQAXAFMEsAP5ABUAABMBNhYVESEyFh0BFAYjIREUBicBJjQnAgoQFwImFR0dFf3aFxD99hACRgGrDQoV/t0dFcgVHf7dFQoNAasNJgAAAAABAAAAUwSZA/kAFQAACQEWFAcBBiY1ESEiJj0BNDYzIRE0NgJ/AgoQEP32EBf92hUdHRUCJhcD8f5VDSYN/lUNChUBIx0VyBUdASMVCgAAAAEAtwAABF0EmQAVAAAJARYGIyERFAYrASImNREhIiY3ATYyAqoBqw0KFf7dHRXIFR3+3RUKDQGrDSYEif32EBf92hUdHRUCJhcQAgoQAAAAAQC3ABcEXQSwABUAAAEzMhYVESEyFgcBBiInASY2MyERNDYCJsgVHQEjFQoN/lUNJg3+VQ0KFQEjHQSwHRX92hcQ/fYQEAIKEBcCJhUdAAABAAAAtwSZBF0AFwAACQEWFAcBBiY1EQ4DBz4ENxE0NgJ/AgoQEP32EBdesKWBJAUsW4fHfhcEVf5VDSYN/lUNChUBIwIkRHVNabGdcUYHAQYVCgACAAAAAASwBLAAFQArAAABITIWFREUBi8BBwYiLwEmND8BJyY2ASEiJjURNDYfATc2Mh8BFhQPARcWBgNSASwVHRUOXvkIFAhqBwf5Xg4I/iH+1BUdFQ5e+QgUCGoHB/leDggEsB0V/tQVCA5e+QcHaggUCPleDhX7UB0VASwVCA5e+QcHaggUCPleDhUAAAACAEkASQRnBGcAFQArAAABFxYUDwEXFgYjISImNRE0Nh8BNzYyASEyFhURFAYvAQcGIi8BJjQ/AScmNgP2agcH+V4OCBX+1BUdFQ5e+QgU/QwBLBUdFQ5e+QgUCGoHB/leDggEYGoIFAj5Xg4VHRUBLBUIDl75B/3xHRX+1BUIDl75BwdqCBQI+V4OFQAAAAADABcAFwSZBJkADwAfAC8AAAAyHgIUDgIiLgI0PgEFIyIGFxMeATsBMjY3EzYmAyMiBh0BFBY7ATI2PQE0JgHj6tabW1ub1urWm1tbmwGz0BQYBDoEIxQ2FCMEOgQYMZYKDw8KlgoPDwSZW5vW6tabW1ub1urWm7odFP7SFB0dFAEuFB3+DA8KlgoPDwqWCg8AAAAABQAAAAAEsASwAEkAVQBhAGgAbwAAATIWHwEWHwEWFxY3Nj8BNjc2MzIWHwEWHwIeATsBMhYdARQGKwEiBh0BIREjESE1NCYrASImPQE0NjsBMjY1ND8BNjc+BAUHBhY7ATI2LwEuAQUnJgYPAQYWOwEyNhMhIiY1ESkBERQGIyERAQQJFAUFFhbEFQ8dCAsmxBYXERUXMA0NDgQZCAEPCj0KDw8KMgoP/nDI/nAPCjIKDw8KPQsOCRkFDgIGFRYfAp2mBwQK2woKAzMDEP41sQgQAzMDCgrnCwMe/okKDwGQAlgPCv6JBLAEAgIKDXYNCxUJDRZ2DQoHIREQFRh7LAkLDwoyCg8PCq8BLP7UrwoPDwoyCg8GBQQwgBkUAwgWEQ55ogcKDgqVCgSqnQcECo8KDgr8cg8KAXf+iQoPAZAAAAAAAgAAAAwErwSmACsASQAAATYWFQYCDgQuAScmByYOAQ8BBiY1NDc+ATc+AScuAT4BNz4GFyYGBw4BDwEOBAcOARY2Nz4CNz4DNz4BBI0IGgItQmxhi2KORDg9EQQRMxuZGhYqCFUYEyADCQIQOjEnUmFch3vAJQgdHyaiPT44XHRZUhcYDhItIRmKcVtGYWtbKRYEBKYDEwiy/t3IlVgxEQgLCwwBAQIbG5kYEyJAJghKFRE8Hzdff4U/M0o1JSMbL0QJGCYvcSEhHjZST2c1ODwEJygeW0AxJUBff1UyFAABAF0AHgRyBM8ATwAAAQ4BHgQXLgc+ATceAwYHDgQHBicmNzY3PgQuAScWDgMmJy4BJyY+BDcGHgM3PgEuAicmPgMCjScfCic4R0IgBBsKGAoQAwEJEg5gikggBhANPkpTPhZINx8SBgsNJysiCRZOQQoVNU1bYC9QZwICBAUWITsoCAYdJzIYHw8YIiYHDyJJYlkEz0OAZVxEOSQMBzgXOB42IzElKRIqg5Gnl0o3Z0c6IAYWCwYNAwQFIDhHXGF1OWiqb0sdBxUknF0XNTQ8PEUiNWNROBYJDS5AQVUhVZloUSkAAAAAA//cAGoE1ARGABsAPwBRAAAAMh4FFA4FIi4FND4EBSYGFxYVFAYiJjU0NzYmBwYHDgEXHgQyPgM3NiYnJgUHDgEXFhcWNj8BNiYnJicuAQIGpJ17bk85HBw6T257naKde25POhwcOU9uewIPDwYIGbD4sBcIBw5GWg0ECxYyWl+DiINfWjIWCwQMWv3/Iw8JCSU4EC0OIw4DDywtCyIERi1JXGJcSSpJXGJcSS0tSVxiXEkqSVxiXEncDwYTOT58sLB8OzcTBg9FcxAxEiRGXkQxMEVeRSQSMRF1HiQPLxJEMA0EDyIPJQ8sSRIEAAAABP/cAAAE1ASwABQAJwA7AEwAACEjNy4ENTQ+BTMyFzczEzceARUUDgMHNz4BNzYmJyYlBgcOARceBBc3LgE1NDc2JhcHDgEXFhcWNj8CJyYnLgECUJQfW6l2WSwcOU9ue51SPUEglCYvbIknUGqYUi5NdiYLBAw2/VFGWg0ECxIqSExoNSlrjxcIB3wjDwkJJTgQLQ4MFgMsLQsieBRhdHpiGxVJXGJcSS0Pef5StVXWNBpacm5jGq0xiD8SMRFGckVzEDESHjxRQTkNmhKnbjs3EwZwJA8vEkQwDQQPC1YELEkSBAAAAAP/ngAABRIEqwALABgAKAAAJwE2FhcBFgYjISImJSE1NDY7ATIWHQEhAQczMhYPAQ4BKwEiJi8BJjZaAoIUOBQCghUbJfryJRsBCgFZDwqWCg8BWf5DaNAUGAQ6BCMUNhQjBDoEGGQEKh8FIfvgIEdEhEsKDw8KSwLT3x0U/BQdHRT8FB0AAAABAGQAFQSwBLAAKAAAADIWFREBHgEdARQGJyURFh0BFAYvAQcGJj0BNDcRBQYmPQE0NjcBETQCTHxYAWsPFhgR/plkGhPNzRMaZP6ZERgWDwFrBLBYPv6t/rsOMRQpFA0M+f75XRRAFRAJgIAJEBVAFF0BB/kMDRQpFDEOAUUBUz4AAAARAAAAAARMBLAAHQAnACsALwAzADcAOwA/AEMARwBLAE8AUwBXAFsAXwBjAAABMzIWHQEzMhYdASE1NDY7ATU0NjsBMhYdASE1NDYBERQGIyEiJjURFxUzNTMVMzUzFTM1MxUzNTMVMzUFFTM1MxUzNTMVMzUzFTM1MxUzNQUVMzUzFTM1MxUzNTMVMzUzFTM1A1JkFR0yFR37tB0VMh0VZBUdAfQdAQ8dFfwYFR1kZGRkZGRkZGRk/HxkZGRkZGRkZGT8fGRkZGRkZGRkZASwHRUyHRWWlhUdMhUdHRUyMhUd/nD9EhUdHRUC7shkZGRkZGRkZGRkyGRkZGRkZGRkZGTIZGRkZGRkZGRkZAAAAAMAAAAZBXcElwAZACUANwAAARcWFA8BBiY9ASMBISImPQE0NjsBATM1NDYBBycjIiY9ATQ2MyEBFxYUDwEGJj0BIyc3FzM1NDYEb/kPD/kOFZ/9qP7dFR0dFdECWPEV/amNetEVHR0VASMDGvkPD/kOFfG1jXqfFQSN5g4qDuYOCBWW/agdFWQVHQJYlhUI/piNeh0VZBUd/k3mDioO5g4IFZa1jXqWFQgAAAABAAAAAASwBEwAEgAAEyEyFhURFAYjIQERIyImNRE0NmQD6Ck7Oyn9rP7QZCk7OwRMOyn9qCk7/tQBLDspAlgpOwAAAAMAZAAABEwEsAAJABMAPwAAEzMyFh0BITU0NiEzMhYdASE1NDYBERQOBSIuBTURIRUUFRwBHgYyPgYmNTQ9AZbIFR3+1B0C0cgVHf7UHQEPBhgoTGacwJxmTCgYBgEsAwcNFB8nNkI2Jx8TDwUFAQSwHRX6+hUdHRX6+hUd/nD+1ClJalZcPigoPlxWakkpASz6CRIVKyclIRsWEAgJEBccISUnKhURCPoAAAAB//8A1ARMA8IABQAAAQcJAScBBEzG/p/+n8UCJwGbxwFh/p/HAicAAQAAAO4ETQPcAAUAAAkCNwkBBE392v3ZxgFhAWEDFf3ZAifH/p8BYQAAAAAC/1EAZAVfA+gAFAApAAABITIWFREzMhYPAQYiLwEmNjsBESElFxYGKwERIRchIiY1ESMiJj8BNjIBlALqFR2WFQgO5g4qDuYOCBWW/oP+HOYOCBWWAYHX/RIVHZYVCA7mDioD6B0V/dkVDvkPD/kOFQGRuPkOFf5wyB0VAiYVDvkPAAABAAYAAASeBLAAMAAAEzMyFh8BITIWBwMOASMhFyEyFhQGKwEVFAYiJj0BIRUUBiImPQEjIiYvAQMjIiY0NjheERwEJgOAGB4FZAUsIf2HMAIXFR0dFTIdKh3+1B0qHR8SHQYFyTYUHh4EsBYQoiUY/iUVK8gdKh0yFR0dFTIyFR0dFTIUCQoDwR0qHQAAAAACAAAAAASwBEwACwAPAAABFSE1MzQ2MyEyFhUFIREhBLD7UMg7KQEsKTv9RASw+1AD6GRkKTs7Kcj84AACAAAAAAXcBEwADAAQAAATAxEzNDYzITIWFSEVBQEhAcjIyDspASwqOgH0ASz+1PtQASwDIP5wAlgpOzspyGT9RAK8AAEBRQAAA2sErwAbAAABFxYGKwERMzIWDwEGIi8BJjY7AREjIiY/ATYyAnvmDggVlpYVCA7mDioO5g4IFZaWFQgO5g4qBKD5DhX9pxUO+Q8P+Q4VAlkVDvkPAAAAAQABAUQErwNrABsAAAEXFhQPAQYmPQEhFRQGLwEmND8BNhYdASE1NDYDqPkODvkPFf2oFQ/5Dg75DxUCWBUDYOUPKQ/lDwkUl5cUCQ/lDykP5Q8JFZWVFQkAAAAEAAAAAASwBLAACQAZAB0AIQAAAQMuASMhIgYHAwUhIgYdARQWMyEyNj0BNCYFNTMVMzUzFQSRrAUkFP1gFCQFrAQt/BgpOzspA+gpOzv+q2RkZAGQAtwXLSgV/R1kOylkKTs7KWQpO8hkZGRkAAAAA/+cAGQEsARMAAsAIwAxAAAAMhYVERQGIiY1ETQDJSMTFgYjIisBIiYnAj0BNDU0PgE7ASUBFSIuAz0BND4CNwRpKh0dKh1k/V0mLwMRFQUCVBQdBDcCCwzIAqP8GAQOIhoWFR0dCwRMHRX8rhUdHRUDUhX8mcj+7BAIHBUBUQ76AgQQDw36/tT6AQsTKRwyGigUDAEAAAACAEoAAARmBLAALAA1AAABMzIWDwEeARcTFzMyFhQGBw4EIyIuBC8BLgE0NjsBNxM+ATcnJjYDFjMyNw4BIiYCKV4UEgYSU3oPP3YRExwaEggeZGqfTzl0XFU+LwwLEhocExF2Pw96UxIGEyQyNDUxDDdGOASwFRMlE39N/rmtHSkoBwQLHBYSCg4REg4FBAgoKR2tAUdNfhQgExr7vgYGMT09AAEAFAAUBJwEnAAXAAABNwcXBxcHFycHJwcnBzcnNyc3Jxc3FzcDIOBO6rS06k7gLZubLeBO6rS06k7gLZubA7JO4C2bmy3gTuq0tOpO4C2bmy3gTuq0tAADAAAAZASwBLAAIQAtAD0AAAEzMhYdAQchMhYdARQHAw4BKwEiJi8BIyImNRE0PwI+ARcPAREzFzMTNSE3NQEzMhYVERQGKwEiJjURNDYCijIoPBwBSCg8He4QLBf6B0YfHz0tNxSRYA0xG2SWZIjW+v4+Mv12ZBUdHRVkFR0dBLBRLJZ9USxkLR3+qBghMhkZJCcBkCQbxMYcKGTU1f6JZAF3feGv/tQdFf4MFR0dFQH0FR0AAAAAAwAAAAAEsARMACAAMAA8AAABMzIWFxMWHQEUBiMhFh0BFAYrASImLwImNRE0NjsBNgUzMhYVERQGKwEiJjURNDYhByMRHwEzNSchNQMCWPoXLBDuHTwo/rgcPCgyGzENYJEUNy09fP3pZBUdHRVkFR0dAl+IZJZkMjIBwvoETCEY/qgdLWQsUXYHlixRKBzGxBskAZAnJGRkHRX+DBUdHRUB9BUdZP6J1dSv4X0BdwADAAAAZAUOBE8AGwA3AEcAAAElNh8BHgEPASEyFhQGKwEDDgEjISImNRE0NjcXERchEz4BOwEyNiYjISoDLgQnJj8BJwUzMhYVERQGKwEiJjURNDYBZAFrHxZuDQEMVAEuVGxuVGqDBhsP/qoHphwOOmQBJYMGGw/LFRMSFv44AgoCCQMHAwUDAQwRklb9T2QVHR0VZBUdHQNp5hAWcA0mD3lMkE7+rRUoog0CDRElCkj+CVkBUxUoMjIBAgIDBQIZFrdT5B0V/gwVHR0VAfQVHQAAAAP/nABkBLAETwAdADYARgAAAQUeBBURFAYjISImJwMjIiY0NjMhJyY2PwE2BxcWBw4FKgIjIRUzMhYXEyE3ESUFMzIWFREUBisBIiY1ETQ2AdsBbgIIFBANrAf+qg8bBoNqVW1sVAEuVQsBDW4WSpIRDAIDBQMHAwkDCgH+Jd0PHAaCASZq/qoCUGQVHR0VZBUdHQRP5gEFEBEXC/3zDaIoFQFTTpBMeQ8mDXAWrrcWGQIFAwICAWQoFf6tWQH37OQdFf4MFR0dFQH0FR0AAAADAGEAAARMBQ4AGwA3AEcAAAAyFh0BBR4BFREUBiMhIiYvAQMmPwE+AR8BETQXNTQmBhURHAMOBAcGLwEHEyE3ESUuAQMhMhYdARQGIyEiJj0BNDYB3pBOAVMVKKIN/fMRJQoJ5hAWcA0mD3nGMjIBAgIDBQIZFrdT7AH3Wf6tFSiWAfQVHR0V/gwVHR0FDm5UaoMGGw/+qgemHA4OAWsfFm4NAQxUAS5U1ssVExIW/jgCCgIJAwcDBQMBDBGSVv6tZAElgwYb/QsdFWQVHR0VZBUdAAP//QAGA+gFFAAPAC0ASQAAASEyNj0BNCYjISIGHQEUFgEVFAYiJjURBwYmLwEmNxM+BDMhMhYVERQGBwEDFzc2Fx4FHAIVERQWNj0BNDY3JREnAV4B9BUdHRX+DBUdHQEPTpBMeQ8mDXAWEOYBBRARFwsCDQ2iKBX9iexTtxYZAgUDAgIBMjIoFQFTWQRMHRVkFR0dFWQVHfzmalRubFQBLlQMAQ1uFh8BawIIEw8Mpgf+qg8bBgHP/q1WkhEMAQMFAwcDCQIKAv44FhITFcsPGwaDASVkAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBJSYGHQEhIgYdARQWMyEVFBY3JTY0AeLs1ptbW5vW7NabW1ubAob+7RAX/u0KDw8KARMXEAETEASaW5vW7NabW1ub1uzWm/453w0KFYkPCpYKD4kVCg3fDSYAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgENAQYUFwUWNj0BITI2PQE0JiMhNTQmAeLs1ptbW5vW7NabW1ubASX+7RAQARMQFwETCg8PCv7tFwSaW5vW7NabW1ub1uzWm+jfDSYN3w0KFYkPCpYKD4kVCgAAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBAyYiBwMGFjsBERQWOwEyNjURMzI2AeLs1ptbW5vW7NabW1ubAkvfDSYN3w0KFYkPCpYKD4kVCgSaW5vW7NabW1ub1uzWm/5AARMQEP7tEBf+7QoPDwoBExcAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEFIyIGFREjIgYXExYyNxM2JisBETQmAeLs1ptbW5vW7NabW1ubAZeWCg+JFQoN3w0mDd8NChWJDwSaW5vW7NabW1ub1uzWm7sPCv7tFxD+7RAQARMQFwETCg8AAAMAGAAYBJgEmAAPAJYApgAAADIeAhQOAiIuAjQ+ASUOAwcGJgcOAQcGFgcOAQcGFgcUFgcyHgEXHgIXHgI3Fg4BFx4CFxQGFBcWNz4CNy4BJy4BJyIOAgcGJyY2NS4BJzYuAQYHBicmNzY3HgIXHgMfAT4CJyY+ATc+AzcmNzIWMjY3LgMnND4CJiceAT8BNi4CJwYHFB4BFS4CJz4BNxYyPgEB5OjVm1xcm9Xo1ZtcXJsBZA8rHDoKDz0PFD8DAxMBAzEFCRwGIgEMFhkHECIvCxU/OR0HFBkDDRQjEwcFaHUeISQDDTAMD0UREi4oLBAzDwQBBikEAQMLGhIXExMLBhAGKBsGBxYVEwYFAgsFAwMNFwQGCQcYFgYQCCARFwkKKiFBCwQCAQMDHzcLDAUdLDgNEiEQEgg/KhADGgMKEgoRBJhcm9Xo1ZtcXJvV6NWbEQwRBwkCAwYFBycPCxcHInIWInYcCUcYChQECA4QBAkuHgQPJioRFRscBAcSCgwCch0kPiAIAQcHEAsBAgsLIxcBMQENCQIPHxkCFBkdHB4QBgEBBwoMGBENBAMMJSAQEhYXDQ4qFBkKEhIDCQsXJxQiBgEOCQwHAQ0DBAUcJAwSCwRnETIoAwEJCwsLJQcKDBEAAAAAAQAAAAIErwSFABYAAAE2FwUXNxYGBw4BJwEGIi8BJjQ3ASY2AvSkjv79kfsGUE08hjv9rA8rD28PDwJYIk8EhVxliuh+WYcrIgsW/awQEG4PKxACV2XJAAYAAABgBLAErAAPABMAIwAnADcAOwAAEyEyFh0BFAYjISImPQE0NgUjFTMFITIWHQEUBiMhIiY9ATQ2BSEVIQUhMhYdARQGIyEiJj0BNDYFIRUhZAPoKTs7KfwYKTs7BBHIyPwYA+gpOzsp/BgpOzsEEf4MAfT8GAPoKTs7KfwYKTs7BBH+1AEsBKw7KWQpOzspZCk7ZGTIOylkKTs7KWQpO2RkyDspZCk7OylkKTtkZAAAAAIAZAAABEwEsAALABEAABMhMhYUBiMhIiY0NgERBxEBIZYDhBUdHRX8fBUdHQI7yP6iA4QEsB0qHR0qHf1E/tTIAfQB9AAAAAMAAABkBLAEsAAXABsAJQAAATMyFh0BITIWFREhNSMVIRE0NjMhNTQ2FxUzNQEVFAYjISImPQEB9MgpOwEsKTv+DMj+DDspASw7KcgB9Dsp/BgpOwSwOylkOyn+cGRkAZApO2QpO2RkZP1EyCk7OynIAAAABAAAAAAEsASwABUAKwBBAFcAABMhMhYPARcWFA8BBiIvAQcGJjURNDYpATIWFREUBi8BBwYiLwEmND8BJyY2ARcWFA8BFxYGIyEiJjURNDYfATc2MgU3NhYVERQGIyEiJj8BJyY0PwE2MhcyASwVCA5exwcHaggUCMdeDhUdAzUBLBUdFQ5exwgUCGoHB8deDgj+L2oHB8deDggV/tQVHRUOXscIFALLXg4VHRX+1BUIDl7HBwdqCBQIBLAVDl7HCBQIagcHx14OCBUBLBUdHRX+1BUIDl7HBwdqCBQIx14OFf0maggUCMdeDhUdFQEsFQgOXscHzl4OCBX+1BUdFQ5exwgUCGoHBwAAAAYAAAAABKgEqAAPABsAIwA7AEMASwAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JiQyFhQGIiY0JDIWFAYjIicHFhUUBiImNTQ2PwImNTQEMhYUBiImNCQyFhQGIiY0Advy3Z9fX5/d8t2gXl6gAcbgv29vv+C/b2/+LS0gIC0gAUwtICAWDg83ETNIMykfegEJ/octICAtIAIdLSAgLSAEqF+f3fLdoF5eoN3y3Z9Xb7/gv29vv+C/BiAtISEtICAtIQqRFxwkMzMkIDEFfgEODhekIC0gIC0gIC0gIC0AAf/YAFoEuQS8AFsAACUBNjc2JicmIyIOAwcABw4EFx4BMzI3ATYnLgEjIgcGBwEOASY0NwA3PgEzMhceARcWBgcOBgcGIyImJyY2NwE2NzYzMhceARcWBgcBDgEnLgECIgHVWwgHdl8WGSJBMD8hIP6IDx4eLRMNBQlZN0ozAiQkEAcdEhoYDRr+qw8pHA4BRyIjQS4ODyw9DQ4YIwwod26La1YOOEBGdiIwGkQB/0coW2tQSE5nDxE4Qv4eDyoQEAOtAdZbZWKbEQQUGjIhH/6JDxsdNSg3HT5CMwIkJCcQFBcMGv6uDwEcKQ4BTSIjIQEINykvYyMLKnhuiWZMBxtAOU6+RAH/SBg3ISSGV121Qv4kDwIPDyYAAAACAGQAWASvBEQAGQBEAAABPgIeAhUUDgMHLgQ1ND4CHgEFIg4DIi4DIyIGFRQeAhcWFx4EMj4DNzY3PgQ1NCYCiTB7eHVYNkN5hKg+PqeFeEM4WnZ4eQEjIT8yLSohJyktPyJDbxtBMjMPBw86KzEhDSIzKUAMBAgrKT8dF2oDtURIBS1TdkA5eYB/slVVsn+AeTlAdlMtBUgtJjY1JiY1NiZvTRc4SjQxDwcOPCouGBgwKEALBAkpKkQqMhNPbQACADn/8gR3BL4AFwAuAAAAMh8BFhUUBg8BJi8BNycBFwcvASY0NwEDNxYfARYUBwEGIi8BJjQ/ARYfAQcXAQKru0KNQjgiHR8uEl/3/nvUaRONQkIBGxJpCgmNQkL+5UK6Qo1CQjcdLhJf9wGFBL5CjUJeKmsiHTUuEl/4/nvUahKNQrpCARv+RmkICY1CukL+5UJCjUK7Qjc3LxFf+AGFAAAAAAMAyAAAA+gEsAARABUAHQAAADIeAhURFAYjISImNRE0PgEHESERACIGFBYyNjQCBqqaZDo7Kf2oKTs8Zj4CWP7/Vj09Vj0EsB4uMhX8Ryk7OykDuRUzLar9RAK8/RY9Vj09VgABAAAAAASwBLAAFgAACQEWFAYiLwEBEScBBRMBJyEBJyY0NjIDhgEbDx0qDiT+6dT+zP7oywEz0gEsAQsjDx0qBKH+5g8qHQ8j/vX+1NL+zcsBGAE01AEXJA4qHQAAAAADAScAEQQJBOAAMgBAAEsAAAEVHgQXIy4DJxEXHgQVFAYHFSM1JicuASczHgEXEScuBDU0PgI3NRkBDgMVFB4DFxYXET4ENC4CArwmRVI8LAKfBA0dMydAIjxQNyiym2SWVygZA4sFV0obLkJOMCAyVWg6HSoqFQ4TJhkZCWgWKTEiGBkzNwTgTgUTLD9pQiQuLBsH/s0NBxMtPGQ+i6oMTU8QVyhrVk1iEAFPCA4ZLzlYNkZwSCoGTf4SARIEDh02Jh0rGRQIBgPQ/soCCRYgNEM0JRkAAAABAGQAZgOUBK0ASgAAATIeARUjNC4CIyIGBwYVFB4BFxYXMxUjFgYHBgc+ATM2FjMyNxcOAyMiLgEHDgEPASc+BTc+AScjNTMmJy4CPgE3NgIxVJlemSc8OxolVBQpGxoYBgPxxQgVFS02ImIWIIwiUzUyHzY4HCAXanQmJ1YYFzcEGAcTDBEJMAwk3aYXFQcKAg4tJGEErVCLTig/IhIdFSw5GkowKgkFZDKCHj4yCg8BIh6TExcIASIfBAMaDAuRAxAFDQsRCjePR2QvORQrREFMIVgAAAACABn//wSXBLAADwAfAAABMzIWDwEGIi8BJjY7AREzBRcWBisBESMRIyImPwE2MgGQlhUIDuYOKg7mDggVlsgCF+YOCBWWyJYVCA7mDioBLBYO+g8P+g4WA4QQ+Q4V/HwDhBUO+Q8AAAQAGf//A+gEsAAHABcAGwAlAAABIzUjFSMRIQEzMhYPAQYiLwEmNjsBETMFFTM1EwczFSE1NyM1IQPoZGRkASz9qJYVCA7mDioO5g4IFZbIAZFkY8jI/tTIyAEsArxkZAH0/HwWDvoPD/oOFgOEZMjI/RL6ZJb6ZAAAAAAEABn//wPoBLAADwAZACEAJQAAATMyFg8BBiIvASY2OwERMwUHMxUhNTcjNSERIzUjFSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAljIyP7UyMgBLGRkZAEsx2QBLBYO+g8P+g4WA4SW+mSW+mT7UGRkAfRkyMgAAAAEABn//wRMBLAADwAVABsAHwAAATMyFg8BBiIvASY2OwERMwEjESM1MxMjNSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAlhkZMhkZMgBLMdkASwWDvoPD/oOFgOE/gwBkGT7UGQBkGTIyAAAAAAEABn//wRMBLAADwAVABkAHwAAATMyFg8BBiIvASY2OwERMwEjNSMRIQcVMzUDIxEjNTMBkJYVCA7mDioO5g4IFZbIArxkyAEsx2QBZGTIASwWDvoPD/oOFgOE/gxkAZBkyMj7tAGQZAAAAAAFABn//wSwBLAADwATABcAGwAfAAABMzIWDwEGIi8BJjY7AREzBSM1MxMhNSETITUhEyE1IQGQlhUIDuYOKg7mDggVlsgB9MjIZP7UASxk/nABkGT+DAH0ASwWDvoPD/oOFgOEyMj+DMj+DMj+DMgABQAZ//8EsASwAA8AEwAXABsAHwAAATMyFg8BBiIvASY2OwERMwUhNSEDITUhAyE1IQMjNTMBkJYVCA7mDioO5g4IFZbIAyD+DAH0ZP5wAZBk/tQBLGTIyAEsFg76Dw/6DhYDhMjI/gzI/gzI/gzIAAIAAAAABEwETAAPAB8AAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmAV4BkKK8u6P+cKW5uQJn/gwpOzspAfQpOzsETLuj/nClubmlAZClucg7Kf4MKTs7KQH0KTsAAAAAAwAAAAAETARMAA8AHwArAAABITIWFREUBiMhIiY1ETQ2BSEiBhURFBYzITI2NRE0JgUXFhQPAQYmNRE0NgFeAZClubml/nCju7wCZP4MKTs7KQH0KTs7/m/9ERH9EBgYBEy5pf5wpbm5pQGQo7vIOyn+DCk7OykB9Ck7gr4MJAy+DAsVAZAVCwAAAAADAAAAAARMBEwADwAfACsAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFg8BBiIvASY2AV4BkKO7uaX+cKW5uQJn/gwpOzspAfQpOzv+FQGQFQsMvgwkDL4MCwRMvKL+cKW5uaUBkKO7yDsp/gwpOzspAfQpO8gYEP0REf0QGAAAAAMAAAAABEwETAAPAB8AKwAAASEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFFxYGIyEiJj8BNjIBXgGQpbm5pf5wo7u5Amf+DCk7OykB9Ck7O/77vgwLFf5wFQsMvgwkBEy5pf5wo7u8ogGQpbnIOyn+DCk7OykB9Ck7z/0QGBgQ/REAAAAAAgAAAAAFFARMAB8ANQAAASEyFhURFAYjISImPQE0NjMhMjY1ETQmIyEiJj0BNDYHARYUBwEGJj0BIyImPQE0NjsBNTQ2AiYBkKW5uaX+cBUdHRUBwik7Oyn+PhUdHb8BRBAQ/rwQFvoVHR0V+hYETLml/nCluR0VZBUdOykB9Ck7HRVkFR3p/uQOJg7+5A4KFZYdFcgVHZYVCgAAAQDZAAID1wSeACMAAAEXFgcGAgclMhYHIggBBwYrAScmNz4BPwEhIicmNzYANjc2MwMZCQgDA5gCASwYEQ4B/vf+8wQMDgkJCQUCUCcn/tIXCAoQSwENuwUJEASeCQoRC/5TBwEjEv7K/sUFDwgLFQnlbm4TFRRWAS/TBhAAAAACAAAAAAT+BEwAHwA1AAABITIWHQEUBiMhIgYVERQWMyEyFh0BFAYjISImNRE0NgUBFhQHAQYmPQEjIiY9ATQ2OwE1NDYBXgGQFR0dFf4+KTs7KQHCFR0dFf5wpbm5AvEBRBAQ/rwQFvoVHR0V+hYETB0VZBUdOyn+DCk7HRVkFR25pQGQpbnp/uQOJg7+5A4KFZYdFcgVHZYVCgACAAAAAASwBLAAFQAxAAABITIWFREUBi8BAQYiLwEmNDcBJyY2ASMiBhURFBYzITI2PQE3ERQGIyEiJjURNDYzIQLuAZAVHRUObf7IDykPjQ8PAThtDgj+75wpOzspAfQpO8i7o/5wpbm5pQEsBLAdFf5wFQgObf7IDw+NDykPAThtDhX+1Dsp/gwpOzsplMj+1qW5uaUBkKW5AAADAA4ADgSiBKIADwAbACMAAAAyHgIUDgIiLgI0PgEEIg4BFB4BMj4BNCYEMhYUBiImNAHh7tmdXV2d2e7ZnV1dnQHD5sJxccLmwnFx/nugcnKgcgSiXZ3Z7tmdXV2d2e7ZnUdxwubCcXHC5sJzcqBycqAAAAMAAAAABEwEsAAVAB8AIwAAATMyFhURMzIWBwEGIicBJjY7ARE0NgEhMhYdASE1NDYFFTM1AcLIFR31FAoO/oEOJw3+hQ0JFfod/oUD6BUd+7QdA2dkBLAdFf6iFg/+Vg8PAaoPFgFeFR38fB0V+voVHWQyMgAAAAMAAAAABEwErAAVAB8AIwAACQEWBisBFRQGKwEiJj0BIyImNwE+AQEhMhYdASE1NDYFFTM1AkcBeg4KFfQiFsgUGPoUCw4Bfw4n/fkD6BUd+7QdA2dkBJ7+TQ8g+hQeHRX6IQ8BrxAC/H8dFfr6FR1kMjIAAwAAAAAETARLABQAHgAiAAAJATYyHwEWFAcBBiInASY0PwE2MhcDITIWHQEhNTQ2BRUzNQGMAXEHFQeLBwf98wcVB/7cBweLCBUH1APoFR37tB0DZ2QC0wFxBweLCBUH/fMICAEjCBQIiwcH/dIdFfr6FR1kMjIABAAAAAAETASbAAkAGQAjACcAABM3NjIfAQcnJjQFNzYWFQMOASMFIiY/ASc3ASEyFh0BITU0NgUVMzWHjg4qDk3UTQ4CFtIOFQIBHRX9qxUIDtCa1P49A+gVHfu0HQNnZAP/jg4OTdRMDyqa0g4IFf2pFB4BFQ7Qm9T9Oh0V+voVHWQyMgAAAAQAAAAABEwEsAAPABkAIwAnAAABBR4BFRMUBi8BByc3JyY2EwcGIi8BJjQ/AQEhMhYdASE1NDYFFTM1AV4CVxQeARUO0JvUm9IOCMNMDyoOjg4OTf76A+gVHfu0HQNnZASwAgEdFf2rFQgO0JrUmtIOFf1QTQ4Ojg4qDk3+WB0V+voVHWQyMgACAAT/7ASwBK8ABQAIAAAlCQERIQkBFQEEsP4d/sb+cQSs/TMCq2cBFP5xAacDHPz55gO5AAAAAAIAAABkBEwEsAAVABkAAAERFAYrAREhESMiJjURNDY7AREhETMHIzUzBEwdFZb9RJYVHR0V+gH0ZMhkZAPo/K4VHQGQ/nAdFQPoFB7+1AEsyMgAAAMAAABFBN0EsAAWABoALwAAAQcBJyYiDwEhESMiJjURNDY7AREhETMHIzUzARcWFAcBBiIvASY0PwE2Mh8BATYyBEwC/tVfCRkJlf7IlhUdHRX6AfRkyGRkAbBqBwf+XAgUCMoICGoHFQdPASkHFQPolf7VXwkJk/5wHRUD6BQe/tQBLMjI/c5qBxUH/lsHB8sHFQdqCAhPASkHAAMAAAANBQcEsAAWABoAPgAAAREHJy4BBwEhESMiJjURNDY7AREhETMHIzUzARcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyBExnhg8lEP72/reWFR0dFfoB9GTIZGQB9kYPD4ODDw9GDykPg4MPKQ9GDw+Dgw8PRg8pD4ODDykD6P7zZ4YPAw7+9v5wHRUD6BQe/tQBLMjI/YxGDykPg4MPKQ9GDw+Dgw8PRg8pD4ODDykPRg8Pg4MPAAADAAAAFQSXBLAAFQAZAC8AAAERISIGHQEhESMiJjURNDY7AREhETMHIzUzEzMyFh0BMzIWDwEGIi8BJjY7ATU0NgRM/qIVHf4MlhUdHRX6AfRkyGRklmQVHZYVCA7mDioO5g4IFZYdA+j+1B0Vlv5wHRUD6BQe/tQBLMjI/agdFfoVDuYODuYOFfoVHQAAAAADAAAAAASXBLAAFQAZAC8AAAERJyYiBwEhESMiJjURNDY7AREhETMHIzUzExcWBisBFRQGKwEiJj0BIyImPwE2MgRMpQ4qDv75/m6WFR0dFfoB9GTIZGTr5g4IFZYdFWQVHZYVCA7mDioD6P5wpQ8P/vf+cB0VA+gUHv7UASzIyP2F5Q8V+hQeHhT6FQ/lDwADAAAAyASwBEwACQATABcAABMhMhYdASE1NDYBERQGIyEiJjURExUhNTIETBUd+1AdBJMdFfu0FR1kAZAETB0VlpYVHf7U/doVHR0VAib+1MjIAAAGAAMAfQStBJcADwAZAB0ALQAxADsAAAEXFhQPAQYmPQEhNSE1NDYBIyImPQE0NjsBFyM1MwE3NhYdASEVIRUUBi8BJjQFIzU7AjIWHQEUBisBA6f4Dg74DhX+cAGQFf0vMhUdHRUyyGRk/oL3DhUBkP5wFQ73DwOBZGRkMxQdHRQzBI3mDioO5g4IFZbIlhUI/oUdFWQVHcjI/cvmDggVlsiWFQgO5g4qecgdFWQVHQAAAAACAGQAAASwBLAAFgBRAAABJTYWFREUBisBIiY1ES4ENRE0NiUyFh8BERQOAg8BERQGKwEiJjURLgQ1ETQ+AzMyFh8BETMRPAE+AjMyFh8BETMRND4DA14BFBklHRXIFR0EDiIaFiX+4RYZAgEVHR0LCh0VyBUdBA4iGhYBBwoTDRQZAgNkBQkVDxcZAQFkAQUJFQQxdBIUH/uuFR0dFQGNAQgbHzUeAWcfRJEZDA3+Phw/MSkLC/5BFR0dFQG/BA8uLkAcAcICBxENCxkMDf6iAV4CBxENCxkMDf6iAV4CBxENCwABAGQAAASwBEwAMwAAARUiDgMVERQWHwEVITUyNjURIREUFjMVITUyPgM1ETQmLwE1IRUiBhURIRE0JiM1BLAEDiIaFjIZGf5wSxn+DBlL/nAEDiIaFjIZGQGQSxkB9BlLBEw4AQUKFA78iBYZAQI4OA0lAYr+diUNODgBBQoUDgN4FhkBAjg4DSX+dgGKJQ04AAAABgAAAAAETARMAAwAHAAgACQAKAA0AAABITIWHQEjBTUnITchBSEyFhURFAYjISImNRE0NhcVITUBBTUlBRUhNQUVFAYjIQchJyE3MwKjAXcVHWn+2cj+cGQBd/4lASwpOzsp/tQpOzspASwCvP5wAZD8GAEsArwdFf6JZP6JZAGQyGkD6B0VlmJiyGTIOyn+DCk7OykB9Ck7ZMjI/veFo4XGyMhm+BUdZGTIAAEAEAAQBJ8EnwAmAAATNzYWHwEWBg8BHgEXNz4BHwEeAQ8BBiIuBicuBTcRohEuDosOBhF3ZvyNdxEzE8ATBxGjAw0uMUxPZWZ4O0p3RjITCwED76IRBhPCFDERdo78ZXYRBA6IDi8RogEECBUgNUNjO0qZfHNVQBAAAAACAAAAAASwBEwAIwBBAAAAMh4EHwEVFAYvAS4BPQEmIAcVFAYPAQYmPQE+BRIyHgIfARUBHgEdARQGIyEiJj0BNDY3ATU0PgIB/LimdWQ/LAkJHRTKFB2N/sKNHRTKFB0DDTE7ZnTKcFImFgEBAW0OFR0V+7QVHRUOAW0CFiYETBUhKCgiCgrIFRgDIgMiFZIYGJIVIgMiAxgVyAQNJyQrIP7kExwcCgoy/tEPMhTUFR0dFdQUMg8BLzIEDSEZAAADAAAAAASwBLAADQAdACcAAAEHIScRMxUzNTMVMzUzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYETMj9qMjIyMjIyPyuArwVHR0VDIn8SokMFR0dswRMFR37UB0CvMjIAfTIyMjI/OAdKh1kZB0qHf7UHRUyMhUdAAAAAwBkAAAEsARMAAkAEwAdAAABIyIGFREhETQmASMiBhURIRE0JgEhETQ2OwEyFhUCvGQpOwEsOwFnZCk7ASw7/Rv+1DspZCk7BEw7KfwYA+gpO/7UOyn9RAK8KTv84AGQKTs7KQAAAAAF/5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQURByMRMwcRMxHIArx8sLB8/UR8sLAYA4T+DMjI/tTIyAEsAZBkyMhkZARMsHz+DHywsHwB9HywyP1EArzIZP7UZGQBLGT+1GQB9GT+1AEsAAAABf+cAAAEsARMAA8AEwAfACUAKQAAEyEyFhURFAYjISImNRE0NhcRIREBIzUjFSMRMxUzNTMFEQcjETMHETMRyAK8fLCwfP1EfLCwGAOE/gxkZGRkZGQBkGTIyGRkBEywfP4MfLCwfAH0fLDI/UQCvP2oyMgB9MjIZP7UZAH0ZP7UASwABP+cAAAEsARMAA8AEwAbACMAABMhMhYVERQGIyEiJjURNDYXESERBSMRMxUhESEFIxEzFSERIcgCvHywsHz9RHywsBgDhP4MyMj+1AEsAZDIyP7UASwETLB8/gx8sLB8AfR8sMj9RAK8yP7UZAH0ZP7UZAH0AAAABP+cAAAEsARMAA8AEwAWABkAABMhMhYVERQGIyEiJjURNDYXESERAS0BDQERyAK8fLCwfP1EfLCwGAOE/gz+1AEsAZD+1ARMsHz+DHywsHwB9HywyP1EArz+DJaWlpYBLAAAAAX/nAAABLAETAAPABMAFwAgACkAABMhMhYVERQGIyEiJjURNDYXESERAyERIQcjIgYVFBY7AQERMzI2NTQmI8gCvHywsHz9RHywsBgDhGT9RAK8ZIImOTYpgv4Mgik2OSYETLB8/gx8sLB8AfR8sMj9RAK8/agB9GRWQUFUASz+1FRBQVYAAAAF/5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQEjESM1MwMjNTPIArx8sLB8/UR8sLAYA4T+DMjI/tTIyAEsAZBkZMjIZGQETLB8/gx8sLB8AfR8sMj9RAK8yGT+1GRkASz+DAGQZP4MZAAG/5wAAASwBEwADwATABkAHwAjACcAABMhMhYVERQGIyEiJjURNDYXESERBTMRIREzASMRIzUzBRUzNQEjNTPIArx8sLB8/UR8sLAYA4T9RMj+1GQCWGRkyP2oZAEsZGQETLB8/gx8sLB8AfR8sMj9RAK8yP5wAfT+DAGQZMjIyP7UZAAF/5wAAASwBEwADwATABwAIgAmAAATITIWFREUBiMhIiY1ETQ2FxEhEQEHIzU3NSM1IQEjESM1MwMjNTPIArx8sLB8/UR8sLAYA4T+DMdkx8gBLAGQZGTIx2RkBEywfP4MfLCwfAH0fLDI/UQCvP5wyDLIlmT+DAGQZP4MZAAAAAMACQAJBKcEpwAPABsAJQAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgchFSEVISc1NyEB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWz+1AEs/tRkZAEsBKdentvw255eXp7b8NueTHHC5MJxccLkwtDIZGTIZAAAAAAEAAkACQSnBKcADwAbACcAKwAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgcVBxcVIycjFSMRIQcVMzUB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWwyZGRklmQBLMjIBKdentvw255eXp7b8NueTHHC5MJxccLkwtBkMmQyZGQBkGRkZAAAAv/y/50EwgRBACAANgAAATIWFzYzMhYUBisBNTQmIyEiBh0BIyImNTQ2NyY1ND4BEzMyFhURMzIWDwEGIi8BJjY7ARE0NgH3brUsLC54qqp4gB0V/tQVHd5QcFZBAmKqepYKD4kVCg3fDSYN3w0KFYkPBEF3YQ6t8a36FR0dFfpzT0VrDhMSZKpi/bMPCv7tFxD0EBD0EBcBEwoPAAAAAAL/8v+cBMMEQQAcADMAAAEyFhc2MzIWFxQGBwEmIgcBIyImNTQ2NyY1ND4BExcWBisBERQGKwEiJjURIyImNzY3NjIB9m62LCsueaoBeFr+hg0lDf6DCU9xVkECYqnm3w0KFYkPCpYKD4kVCg3HGBMZBEF3YQ+teGOkHAFoEBD+k3NPRWsOExNkqWP9kuQQF/7tCg8PCgETFxDMGBMAAAABAGQAAARMBG0AGAAAJTUhATMBMwkBMwEzASEVIyIGHQEhNTQmIwK8AZD+8qr+8qr+1P7Uqv7yqv7yAZAyFR0BkB0VZGQBLAEsAU3+s/7U/tRkHRUyMhUdAAAAAAEAeQAABDcEmwAvAAABMhYXHgEVFAYHFhUUBiMiJxUyFh0BITU0NjM1BiMiJjU0Ny4BNTQ2MzIXNCY1NDYCWF6TGll7OzIJaUo3LRUd/tQdFS03SmkELzlpSgUSAqMEm3FZBoNaPWcfHRpKaR77HRUyMhUd+x5pShIUFVg1SmkCAhAFdKMAAAAGACcAFASJBJwAEQAqAEIASgBiAHsAAAEWEgIHDgEiJicmAhI3PgEyFgUiBw4BBwYWHwEWMzI3Njc2Nz4BLwEmJyYXIgcOAQcGFh8BFjMyNz4BNz4BLwEmJyYWJiIGFBYyNjciBw4BBw4BHwEWFxYzMjc+ATc2Ji8BJhciBwYHBgcOAR8BFhcWMzI3PgE3NiYvASYD8m9PT29T2dzZU29PT29T2dzZ/j0EBHmxIgQNDCQDBBcGG0dGYAsNAwkDCwccBAVQdRgEDA0iBAQWBhJROQwMAwkDCwf5Y4xjY4xjVhYGElE6CwwDCQMLBwgEBVB1GAQNDCIEjRcGG0dGYAsNAwkDCwcIBAR5sSIEDQwkAwPyb/7V/tVvU1dXU28BKwErb1NXVxwBIrF5DBYDCQEWYEZHGwMVDCMNBgSRAhh1UA0WAwkBFTpREgMVCyMMBwT6Y2OMY2MVFTpREQQVCyMMBwQCGHVQDRYDCQEkFmBGRxsDFQwjDQYEASKxeQwWAwkBAAAABQBkAAAD6ASwAAwADwAWABwAIgAAASERIzUhFSERNDYzIQEjNQMzByczNTMDISImNREFFRQGKwECvAEstP6s/oQPCgI/ASzIZKLU1KJktP51Cg8DhA8KwwMg/oTIyALzCg/+1Mj84NTUyP4MDwoBi8jDCg8AAAAABQBkAAAD6ASwAAkADAATABoAIQAAASERCQERNDYzIQEjNRMjFSM1IzcDISImPQEpARUUBisBNQK8ASz+ov3aDwoCPwEsyD6iZKLUqv6dCg8BfAIIDwqbAyD9+AFe/doERwoP/tTI/HzIyNT+ZA8KNzcKD1AAAAAAAwAAAAAEsAP0AAgAGQAfAAABIxUzFyERIzcFMzIeAhUhFSEDETM0PgIBMwMhASEEiqJkZP7UotT9EsgbGiEOASz9qMhkDiEaAnPw8PzgASwB9AMgyGQBLNTUBBErJGT+ogHCJCsRBP5w/nAB9AAAAAMAAAAABEwETAAZADIAOQAAATMyFh0BMzIWHQEUBiMhIiY9ATQ2OwE1NDYFNTIWFREUBiMhIic3ARE0NjMVFBYzITI2AQc1IzUzNQKKZBUdMhUdHRX+1BUdHRUyHQFzKTs7Kf2oARP2/ro7KVg+ASw+WP201MjIBEwdFTIdFWQVHR0VZBUdMhUd+pY7KfzgKTsE9gFGAUQpO5Y+WFj95tSiZKIAAwBkAAAEvARMABkANgA9AAABMzIWHQEzMhYdARQGIyEiJj0BNDY7ATU0NgU1MhYVESMRMxQOAiMhIiY1ETQ2MxUUFjMhMjYBBzUjNTM1AcJkFR0yFR0dFf7UFR0dFTIdAXMpO8jIDiEaG/2oKTs7KVg+ASw+WAGc1MjIBEwdFTIdFWQVHR0VZBUdMhUd+pY7Kf4M/tQkKxEEOykDICk7lj5YWP3m1KJkogAAAAP/ogAABRYE1AALABsAHwAACQEWBiMhIiY3ATYyEyMiBhcTHgE7ATI2NxM2JgMVMzUCkgJ9FyAs+wQsIBcCfRZARNAUGAQ6BCMUNhQjBDoEGODIBK37sCY3NyYEUCf+TB0U/tIUHR0UAS4UHf4MZGQAAAAACQAAAAAETARMAA8AHwAvAD8ATwBfAG8AfwCPAAABMzIWHQEUBisBIiY9ATQ2EzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBqfoKDw8K+goPDwr6Cg8PCvoKDw8BmvoKDw8K+goPD/zq+goPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K+goPD/zq+goPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K+goPDwRMDwqWCg8PCpYKD/7UDwqWCg8PCpYKDw8KlgoPDwqWCg/+1A8KlgoPDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKD/7UDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKDw8KlgoPAAAAAwAAAAAEsAUUABkAKQAzAAABMxUjFSEyFg8BBgchJi8BJjYzITUjNTM1MwEhMhYUBisBFyE3IyImNDYDITIWHQEhNTQ2ArxkZAFePjEcQiko/PwoKUIcMT4BXmRkyP4+ArwVHR0VDIn8SooNFR0dswRMFR37UB0EsMhkTzeEUzMzU4Q3T2TIZPx8HSodZGQdKh3+1B0VMjIVHQAABAAAAAAEsAUUAAUAGQArADUAAAAyFhUjNAchFhUUByEyFg8BIScmNjMhJjU0AyEyFhQGKwEVBSElNSMiJjQ2AyEyFh0BITU0NgIwUDnCPAE6EgMBSCkHIq/9WrIiCikBSAOvArwVHR0VlgET/EoBE5YVHR2zBEwVHftQHQUUOykpjSUmCBEhFpGRFiERCCb+lR0qHcjIyMgdKh39qB0VMjIVHQAEAAAAAASwBJ0ABwAUACQALgAAADIWFAYiJjQTMzIWFRQXITY1NDYzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYCDZZqapZqty4iKyf+vCcrI/7NArwVHR0VDYr8SokMFR0dswRMFR37UB0EnWqWamqW/us5Okxra0w6Of5yHSodZGQdKh3+1B0VMjIVHQAEAAAAAASwBRQADwAcACwANgAAATIeARUUBiImNTQ3FzcnNhMzMhYVFBchNjU0NjMBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYL1szb5xvIpBvoyIfLiIrJ/68Jysj/s0CvBUdHRUNivxKiQwVHR2zBEwVHftQHQUUa4s2Tm9vTj5Rj2+jGv4KOTpMa2tMOjn+ch0qHWRkHSod/tQdFTIyFR0AAAADAAAAAASwBRIAEgAiACwAAAEFFSEUHgMXIS4BNTQ+AjcBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYASz+1CU/P00T/e48PUJtj0r+ogK8FR0dFQ2K/EqJDBUdHbMETBUd+1AdBLChizlmUT9IGVO9VFShdksE/H4dKh1kZB0qHf7UHRUyMhUdAAIAyAAAA+gFFAAPACkAAAAyFh0BHgEdASE1NDY3NTQDITIWFyMVMxUjFTMVIxUzFAYjISImNRE0NgIvUjsuNv5wNi5kAZA2XBqsyMjIyMh1U/5wU3V1BRQ7KU4aXDYyMjZcGk4p/kc2LmRkZGRkU3V1UwGQU3UAAAMAZP//BEwETAAPAC8AMwAAEyEyFhURFAYjISImNRE0NgMhMhYdARQGIyEXFhQGIi8BIQcGIiY0PwEhIiY9ATQ2BQchJ5YDhBUdHRX8fBUdHQQDtgoPDwr+5eANGiUNWP30Vw0mGg3g/t8KDw8BqmQBRGQETB0V/gwVHR0VAfQVHf1EDwoyCg/gDSUbDVhYDRslDeAPCjIKD2RkZAAAAAAEAAAAAASwBEwAGQAjAC0ANwAAEyEyFh0BIzQmKwEiBhUjNCYrASIGFSM1NDYDITIWFREhETQ2ExUUBisBIiY9ASEVFAYrASImPQHIAyBTdWQ7KfopO2Q7KfopO2R1EQPoKTv7UDvxHRVkFR0D6B0VZBUdBEx1U8gpOzspKTs7KchTdf4MOyn+1AEsKTv+DDIVHR0VMjIVHR0VMgADAAEAAASpBKwADQARABsAAAkBFhQPASEBJjQ3ATYyCQMDITIWHQEhNTQ2AeACqh8fg/4f/fsgIAEnH1n+rAFWAS/+q6IDIBUd/HwdBI39VR9ZH4MCBh9ZHwEoH/5u/qoBMAFV/BsdFTIyFR0AAAAAAgCPAAAEIQSwABcALwAAAQMuASMhIgYHAwYWMyEVFBYyNj0BMzI2AyE1NDY7ATU0NjsBETMRMzIWHQEzMhYVBCG9CCcV/nAVJwi9CBMVAnEdKh19FROo/a0dFTIdFTDILxUdMhUdAocB+hMcHBP+BhMclhUdHRWWHP2MMhUdMhUdASz+1B0VMh0VAAAEAAAAAASwBLAADQAQAB8AIgAAASERFAYjIREBNTQ2MyEBIzUBIREUBiMhIiY1ETQ2MyEBIzUDhAEsDwr+if7UDwoBdwEsyP2oASwPCv12Cg8PCgF3ASzIAyD9wQoPAk8BLFQKD/7UyP4M/cEKDw8KA7YKD/7UyAAC/5wAZAUUBEcARgBWAAABMzIeAhcWFxY2NzYnJjc+ARYXFgcOASsBDgEPAQ4BKwEiJj8BBisBIicHDgErASImPwEmLwEuAT0BNDY7ATY3JyY2OwE2BSMiBh0BFBY7ATI2PQE0JgHkw0uOakkMEhEfQwoKGRMKBQ8XDCkCA1Y9Pgc4HCcDIhVkFRgDDDEqwxgpCwMiFWQVGAMaVCyfExwdFXwLLW8QBxXLdAFF+goPDwr6Cg8PBEdBa4pJDgYKISAiJRsQCAYIDCw9P1c3fCbqFB0dFEYOCEAUHR0UnUplNQcmFTIVHVdPXw4TZV8PCjIKDw8KMgoPAAb/nP/mBRQEfgAJACQANAA8AFIAYgAAASU2Fh8BFgYPASUzMhYfASEyFh0BFAYHBQYmJyYjISImPQE0NhcjIgYdARQ7ATI2NTQmJyYEIgYUFjI2NAE3PgEeARceAT8BFxYGDwEGJi8BJjYlBwYfAR4BPwE2Jy4BJy4BAoEBpxMuDiAOAxCL/CtqQ0geZgM3FR0cE/0fFyIJKjr+1D5YWLlQExIqhhALIAsSAYBALS1ALf4PmBIgHhMQHC0aPzANITNQL3wpgigJASlmHyElDR0RPRMFAhQHCxADhPcICxAmDyoNeMgiNtQdFTIVJgeEBBQPQ1g+yD5YrBwVODMQEAtEERzJLUAtLUD+24ITChESEyMgAwWzPUkrRSgJL5cvfRxYGyYrDwkLNRAhFEgJDAQAAAAAAwBkAAAEOQSwAFEAYABvAAABMzIWHQEeARcWDgIPATIeBRUUDgUjFRQGKwEiJj0BIxUUBisBIiY9ASMiJj0BNDY7AREjIiY9ATQ2OwE1NDY7ATIWHQEzNTQ2AxUhMj4CNTc0LgMjARUhMj4CNTc0LgMjAnGWCg9PaAEBIC4uEBEGEjQwOiodFyI2LUAjGg8KlgoPZA8KlgoPrwoPDwpLSwoPDwqvDwqWCg9kD9cBBxwpEwsBAQsTKRz++QFrHCkTCwEBCxMpHASwDwptIW1KLk0tHwYGAw8UKDJOLTtdPCoVCwJLCg8PCktLCg8PCksPCpYKDwJYDwqWCg9LCg8PCktLCg/+1MgVHR0LCgQOIhoW/nDIFR0dCwoEDiIaFgAAAwAEAAIEsASuABcAKQAsAAATITIWFREUBg8BDgEjISImJy4CNRE0NgQiDgQPARchNy4FAyMT1AMMVnokEhIdgVL9xFKCHAgYKHoCIIx9VkcrHQYGnAIwnAIIIClJVSGdwwSuelb+YDO3QkJXd3ZYHFrFMwGgVnqZFyYtLSUMDPPzBQ8sKDEj/sIBBQACAMgAAAOEBRQADwAZAAABMzIWFREUBiMhIiY1ETQ2ARUUBisBIiY9AQHblmesVCn+PilUrAFINhWWFTYFFKxn/gwpVFQpAfRnrPwY4RU2NhXhAAACAMgAAAOEBRQADwAZAAABMxQWMxEUBiMhIiY1ETQ2ARUUBisBIiY9AQHbYLOWVCn+PilUrAFINhWWFTYFFJaz/kIpVFQpAfRnrPwY4RU2NhXhAAACAAAAFAUOBBoAFAAaAAAJASUHFRcVJwc1NzU0Jj4CPwEnCQEFJTUFJQUO/YL+hk5klpZkAQEBBQQvkwKCAVz+ov6iAV4BXgL//uWqPOCWx5SVyJb6BA0GCgYDKEEBG/1ipqaTpaUAAAMAZAH0BLADIAAHAA8AFwAAEjIWFAYiJjQkMhYUBiImNCQyFhQGIiY0vHxYWHxYAeh8WFh8WAHofFhYfFgDIFh8WFh8WFh8WFh8WFh8WFh8AAAAAAMBkAAAArwETAAHAA8AFwAAADIWFAYiJjQSMhYUBiImNBIyFhQGIiY0Aeh8WFh8WFh8WFh8WFh8WFh8WARMWHxYWHz+yFh8WFh8/shYfFhYfAAAAAMAZABkBEwETAAPAB8ALwAAEyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2fQO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PBEwPCpYKDw8KlgoP/nAPCpYKDw8KlgoP/nAPCpYKDw8KlgoPAAAABAAAAAAEsASwAA8AHwAvADMAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFhURFAYjISImNRE0NhcVITUBXgH0ory7o/4Mpbm5Asv9qCk7OykCWCk7O/2xAfQVHR0V/gwVHR1HAZAEsLuj/gylubmlAfSlucg7Kf2oKTs7KQJYKTtkHRX+1BUdHRUBLBUdZMjIAAAAAAEAZABkBLAETAA7AAATITIWFAYrARUzMhYUBisBFTMyFhQGKwEVMzIWFAYjISImNDY7ATUjIiY0NjsBNSMiJjQ2OwE1IyImNDaWA+gVHR0VMjIVHR0VMjIVHR0VMjIVHR0V/BgVHR0VMjIVHR0VMjIVHR0VMjIVHR0ETB0qHcgdKh3IHSodyB0qHR0qHcgdKh3IHSodyB0qHQAAAAYBLAAFA+gEowAHAA0AEwAZAB8AKgAAAR4BBgcuATYBMhYVIiYlFAYjNDYBMhYVIiYlFAYjNDYDFRQGIiY9ARYzMgKKVz8/V1c/P/75fLB8sAK8sHyw/cB8sHywArywfLCwHSodKAMRBKNDsrJCQrKy/sCwfLB8fLB8sP7UsHywfHywfLD+05AVHR0VjgQAAAH/tQDIBJQDgQBCAAABNzYXAR4BBw4BKwEyFRQOBCsBIhE0NyYiBxYVECsBIi4DNTQzIyImJyY2NwE2HwEeAQ4BLwEHIScHBi4BNgLpRRkUASoLCAYFGg8IAQQNGyc/KZK4ChRUFQu4jjBJJxkHAgcPGQYGCAsBKhQaTBQVCiMUM7YDe7YsFCMKFgNuEwYS/tkLHw8OEw0dNkY4MhwBIBgXBAQYF/7gKjxTQyMNEw4PHwoBKBIHEwUjKBYGDMHBDAUWKCMAAAAAAgAAAAAEsASwACUAQwAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjNC4DKwERFBYXMxUjNTI1ESMiDgMVIzUhBLAyCAsZEyYYGcgyGRn+cAQOIhoWyBkYJhMZCwgyA+j9RBkIChgQEWQZDQzIMmQREBgKCBkB9AOEFSAVDggDAfyuFhkBAmRkAQUJFQ4DUgEDCA4VIBUBLP0SDxMKBQH+VwsNATIyGQGpAQUKEw+WAAAAAAMAAAAABEwErgAdACAAMAAAATUiJy4BLwEBIwEGBw4BDwEVITUiJj8BIRcWBiMVARsBARUUBiMhIiY9ATQ2MyEyFgPoGR4OFgUE/t9F/tQSFQkfCwsBETE7EkUBJT0NISf+7IZ5AbEdFfwYFR0dFQPoFR0BLDIgDiIKCwLr/Q4jFQkTBQUyMisusKYiQTIBhwFW/qr942QVHR0VZBUdHQADAAAAAASwBLAADwBHAEoAABMhMhYVERQGIyEiJjURNDYFIyIHAQYHBgcGHQEUFjMhMjY9ATQmIyInJj8BIRcWBwYjIgYdARQWMyEyNj0BNCYnIicmJyMBJhMjEzIETBUdHRX7tBUdHQJGRg0F/tUREhImDAsJAREIDAwINxAKCj8BCjkLEQwYCAwMCAE5CAwLCBEZGQ8B/uAFDsVnBLAdFfu0FR0dFQRMFR1SDP0PIBMSEAUNMggMDAgyCAwXDhmjmR8YEQwIMggMDAgyBwwBGRskAuwM/gUBCAAABAAAAAAEsASwAAMAEwAjACcAAAEhNSEFITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NhcRIREEsPtQBLD7ggGQFR0dFf5wFR0dAm0BkBUdHRX+cBUdHUcBLARMZMgdFfx8FR0dFQOEFR0dFf5wFR0dFQGQFR1k/tQBLAAEAAAAAASwBLAADwAfACMAJwAAEyEyFhURFAYjISImNRE0NgEhMhYVERQGIyEiJjURNDYXESEREyE1ITIBkBUdHRX+cBUdHQJtAZAVHR0V/nAVHR1HASzI+1AEsASwHRX8fBUdHRUDhBUd/gwdFf5wFR0dFQGQFR1k/tQBLP2oZAAAAAACAAAAZASwA+gAJwArAAATITIWFREzNTQ2MyEyFh0BMxUjFRQGIyEiJj0BIxEUBiMhIiY1ETQ2AREhETIBkBUdZB0VAZAVHWRkHRX+cBUdZB0V/nAVHR0CnwEsA+gdFf6ilhUdHRWWZJYVHR0Vlv6iFR0dFQMgFR3+1P7UASwAAAQAAAAABLAEsAADABMAFwAnAAAzIxEzFyEyFhURFAYjISImNRE0NhcRIREBITIWFREUBiMhIiY1ETQ2ZGRklgGQFR0dFf5wFR0dRwEs/qIDhBUdHRX8fBUdHQSwZB0V/nAVHR0VAZAVHWT+1AEs/gwdFf5wFR0dFQGQFR0AAAAAAgBkAAAETASwACcAKwAAATMyFhURFAYrARUhMhYVERQGIyEiJjURNDYzITUjIiY1ETQ2OwE1MwcRIRECWJYVHR0VlgHCFR0dFfx8FR0dFQFelhUdHRWWZMgBLARMHRX+cBUdZB0V/nAVHR0VAZAVHWQdFQGQFR1kyP7UASwAAAAEAAAAAASwBLAAAwATABcAJwAAISMRMwUhMhYVERQGIyEiJjURNDYXESERASEyFhURFAYjISImNRE0NgSwZGT9dgGQFR0dFf5wFR0dRwEs/K4DhBUdHRX8fBUdHQSwZB0V/nAVHR0VAZAVHWT+1AEs/gwdFf5wFR0dFQGQFR0AAAEBLAAwA28EgAAPAAAJAQYjIiY1ETQ2MzIXARYUA2H+EhcSDhAQDhIXAe4OAjX+EhcbGQPoGRsX/hIOKgAAAAABAUEAMgOEBH4ACwAACQE2FhURFAYnASY0AU8B7h0qKh3+Eg4CewHuHREp/BgpER0B7g4qAAAAAAEAMgFBBH4DhAALAAATITIWBwEGIicBJjZkA+gpER3+Eg4qDv4SHREDhCod/hIODgHuHSoAAAAAAQAyASwEfgNvAAsAAAkBFgYjISImNwE2MgJ7Ae4dESn8GCkRHQHuDioDYf4SHSoqHQHuDgAAAAACAAgAAASwBCgABgAKAAABFQE1LQE1ASE1IQK8/UwBnf5jBKj84AMgAuW2/r3dwcHd+9jIAAAAAAIAAABkBLAEsAALADEAAAEjFTMVIREzNSM1IQEzND4FOwERFAYPARUhNSIuAzURMzIeBRUzESEEsMjI/tTIyAEs+1AyCAsZEyYYGWQyGRkBkAQOIhoWZBkYJhMZCwgy/OADhGRkASxkZP4MFSAVDggDAf3aFhkBAmRkAQUJFQ4CJgEDCA4VIBUBLAAAAgAAAAAETAPoACUAMQAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjFTMVIREzNSM1IQMgMggLGRMmGBlkMhkZ/nAEDiIaFmQZGCYTGQsIMgMgASzIyP7UyMgBLAK8FSAVDggDAf3aFhkCAWRkAQUJFQ4CJgEDCA4VIBUBLPzgZGQBLGRkAAABAMgAZgNyBEoAEgAAATMyFgcJARYGKwEiJwEmNDcBNgK9oBAKDP4wAdAMChCgDQr+KQcHAdcKBEoWDP4w/jAMFgkB1wgUCAHXCQAAAQE+AGYD6ARKABIAAAEzMhcBFhQHAQYrASImNwkBJjYBU6ANCgHXBwf+KQoNoBAKDAHQ/jAMCgRKCf4pCBQI/ikJFgwB0AHQDBYAAAEAZgDIBEoDcgASAAAAFh0BFAcBBiInASY9ATQ2FwkBBDQWCf4pCBQI/ikJFgwB0AHQA3cKEKANCv4pBwcB1woNoBAKDP4wAdAAAAABAGYBPgRKA+gAEgAACQEWHQEUBicJAQYmPQE0NwE2MgJqAdcJFgz+MP4wDBYJAdcIFAPh/ikKDaAQCgwB0P4wDAoQoA0KAdcHAAAAAgDZ//kEPQSwAAUAOgAAARQGIzQ2BTMyFh8BNjc+Ah4EBgcOBgcGIiYjIgYiJy4DLwEuAT4EHgEXJyY2A+iwfLD+VmQVJgdPBQsiKFAzRyorDwURAQQSFyozTSwNOkkLDkc3EDlfNyYHBw8GDyUqPjdGMR+TDA0EsHywfLDIHBPCAQIGBwcFDx81S21DBxlLR1xKQhEFBQcHGWt0bCQjP2hJNyATBwMGBcASGAAAAAACAMgAFQOEBLAAFgAaAAATITIWFREUBisBEQcGJjURIyImNRE0NhcVITX6AlgVHR0Vlv8TGpYVHR2rASwEsB0V/nAVHf4MsgkQFQKKHRUBkBUdZGRkAAAAAgDIABkETASwAA4AEgAAEyEyFhURBRElIREjETQ2ARU3NfoC7ic9/UQCWP1EZB8BDWQEsFEs/Ft1A7Z9/BgEARc0/V1kFGQAAQAAAAECTW/DBF9fDzz1AB8EsAAAAADQdnOXAAAAANB2c5f/Uf+cBdwFFAAAAAgAAgAAAAAAAAABAAAFFP+FAAAFFP9R/tQF3AABAAAAAAAAAAAAAAAAAAAAowG4ACgAAAAAAZAAAASwAAAEsABkBLAAAASwAAAEsABwAooAAAUUAAACigAABRQAAAGxAAABRQAAANgAAADYAAAAogAAAQQAAABIAAABBAAAAUUAAASwAGQEsAB7BLAAyASwAMgB9AAABLD/8gSwAAAEsAAABLD/8ASwAAAEsAAOBLAACQSwAGQEsP/TBLD/0wSwAAAEsAAABLAAAASwAAAEsAAABLAAJgSwAG4EsAAXBLAAFwSwABcEsABkBLAAGgSwAGQEsAAMBLAAZASwABcEsP+cBLAAZASwABcEsAAXBLAAAASwABcEsAAXBLAAFwSwAGQEsAAABLAAZASwAAAEsAAABLAAAASwAAAEsAAABLAAAASwAAAEsAAABLAAZASwAMgEsAAABLAAAASwADUEsABkBLAAyASw/7UEsAAhBLAAAASwAAAEsAAABLAAAASwAAAEsP+cBLAAAASwAAAEsAAABLAA2wSwABcEsAB1BLAAAASwAAAEsAAABLAACgSwAMgEsAAABLAAnQSwAMgEsADIBLAAyASwAAAEsP/+BLABLASwAGQEsACIBLABOwSwABcEsAAXBLAAFwSwABcEsAAXBLAAFwSwAAAEsAAXBLAAFwSwABcEsAAXBLAAAASwALcEsAC3BLAAAASwAAAEsABJBLAAFwSwAAAEsAAABLAAXQSw/9wEsP/cBLD/nwSwAGQEsAAABLAAAASwAAAEsABkBLD//wSwAAAEsP9RBLAABgSwAAAEsAAABLABRQSwAAEEsAAABLD/nASwAEoEsAAUBLAAAASwAAAEsAAABLD/nASwAGEEsP/9BLAAFgSwABYEsAAWBLAAFgSwABgEsAAABMQAAASwAGQAAAAAAAD/2ABkADkAyAAAAScAZAAZABkAGQAZABkAGQAZAAAAAAAAAAAAAADZAAAAAAAOAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAMAZABkAAAAEAAAAAAAZP+c/5z/nP+c/5z/nP+c/5wACQAJ//L/8gBkAHkAJwBkAGQAAAAAAGT/ogAAAAAAAAAAAAAAAADIAGQAAAABAI8AAP+c/5wAZAAEAMgAyAAAAGQBkABkAAAAZAEs/7UAAAAAAAAAAAAAAAAAAABkAAABLAFBADIAMgAIAAAAAADIAT4AZgBmANkAyADIAAAAKgAqACoAKgCyAOgA6AFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BpAIGAiICfgKGAqwC5ANGA24DjAPEBAgEMgRiBKIE3AVcBboGcgb0ByAHYgfKCB4IYgi+CTYJhAm2Cd4KKApMCpQK4gswC4oLygwIDFgNKg1eDbAODg5oDrQPKA+mD+YQEhBUEJAQqhEqEXYRthIKEjgSfBLAExoTdBPQFCoU1BU8FagVzBYEFjYWYBawFv4XUhemGAIYLhhqGJYYsBjgGP4ZKBloGZQZxBnaGe4aNhpoGrga9hteG7QcMhyUHOIdHB1EHWwdlB28HeYeLh52HsAfYh/SIEYgviEyIXYhuCJAIpYiuCMOIyIjOCN6I8Ij4CQCJDAkXiSWJOIlNCVgJbwmFCZ+JuYnUCe8J/goNChwKKwpoCnMKiYqSiqEKworeiwILGgsuizsLRwtiC30LiguZi6iLtgvDi9GL34vsi/4MD4whDDSMRIxYDGuMegyJDJeMpoy3jMiMz4zaDO2NBg0YDSoNNI1LDWeNeg2PjZ8Ntw3GjdON5I31DgQOEI4hjjIOQo5SjmIOcw6HDpsOpo63jugO9w8GDxQPKI8+D0yPew+Oj6MPtQ/KD9uP6o/+kBIQIBAxkECQX5CGEKoQu5DGENCQ3ZDoEPKRBBEYESuRPZFWkW2RgZGdEa0RvZHNkd2R7ZH9kgWSDJITkhqSIZIzEkSSThJXkmESapKAkouSlIAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAAAAABAAxgABAAAAAAATABIAAAADAAEECQAAAGoAEgADAAEECQABACgAfAADAAEECQACAA4ApAADAAEECQADAEwAsgADAAEECQAEADgA/gADAAEECQAFAHgBNgADAAEECQAGADYBrgADAAEECQAIABYB5AADAAEECQAJABYB+gADAAEECQALACQCEAADAAEECQAMACQCNAADAAEECQATACQCWAADAAEECQDIABYCfAADAAEECQDJADACkgADAAEECdkDABoCwnd3dy5nbHlwaGljb25zLmNvbQBDAG8AcAB5AHIAaQBnAGgAdAAgAKkAIAAyADAAMQA0ACAAYgB5ACAASgBhAG4AIABLAG8AdgBhAHIAaQBrAC4AIABBAGwAbAAgAHIAaQBnAGgAdABzACAAcgBlAHMAZQByAHYAZQBkAC4ARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAFIAZQBnAHUAbABhAHIAMQAuADAAMAA5ADsAVQBLAFcATgA7AEcATABZAFAASABJAEMATwBOAFMASABhAGwAZgBsAGkAbgBnAHMALQBSAGUAZwB1AGwAYQByAEcATABZAFAASABJAEMATwBOAFMAIABIAGEAbABmAGwAaQBuAGcAcwAgAFIAZQBnAHUAbABhAHIAVgBlAHIAcwBpAG8AbgAgADEALgAwADAAOQA7AFAAUwAgADAAMAAxAC4AMAAwADkAOwBoAG8AdABjAG8AbgB2ACAAMQAuADAALgA3ADAAOwBtAGEAawBlAG8AdABmAC4AbABpAGIAMgAuADUALgA1ADgAMwAyADkARwBMAFkAUABIAEkAQwBPAE4AUwBIAGEAbABmAGwAaQBuAGcAcwAtAFIAZQBnAHUAbABhAHIASgBhAG4AIABLAG8AdgBhAHIAaQBrAEoAYQBuACAASwBvAHYAYQByAGkAawB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQBXAGUAYgBmAG8AbgB0ACAAMQAuADAAVwBlAGQAIABPAGMAdAAgADIAOQAgADAANgA6ADMANgA6ADAANwAgADIAMAAxADQARgBvAG4AdAAgAFMAcQB1AGkAcgByAGUAbAAAAAIAAAAAAAD/tQAyAAAAAAAAAAAAAAAAAAAAAAAAAAABFwAAAQIBAwADAA0ADgEEAJYBBQEGAQcBCAEJAQoBCwEMAQ0BDgEPARABEQESARMA7wEUARUBFgEXARgBGQEaARsBHAEdAR4BHwEgASEBIgEjASQBJQEmAScBKAEpASoBKwEsAS0BLgEvATABMQEyATMBNAE1ATYBNwE4ATkBOgE7ATwBPQE+AT8BQAFBAUIBQwFEAUUBRgFHAUgBSQFKAUsBTAFNAU4BTwFQAVEBUgFTAVQBVQFWAVcBWAFZAVoBWwFcAV0BXgFfAWABYQFiAWMBZAFlAWYBZwFoAWkBagFrAWwBbQFuAW8BcAFxAXIBcwF0AXUBdgF3AXgBeQF6AXsBfAF9AX4BfwGAAYEBggGDAYQBhQGGAYcBiAGJAYoBiwGMAY0BjgGPAZABkQGSAZMBlAGVAZYBlwGYAZkBmgGbAZwBnQGeAZ8BoAGhAaIBowGkAaUBpgGnAagBqQGqAasBrAGtAa4BrwGwAbEBsgGzAbQBtQG2AbcBuAG5AboBuwG8Ab0BvgG/AcABwQHCAcMBxAHFAcYBxwHIAckBygHLAcwBzQHOAc8B0AHRAdIB0wHUAdUB1gHXAdgB2QHaAdsB3AHdAd4B3wHgAeEB4gHjAeQB5QHmAecB6AHpAeoB6wHsAe0B7gHvAfAB8QHyAfMB9AH1AfYB9wH4AfkB+gH7AfwB/QH+Af8CAAIBAgICAwIEAgUCBgIHAggCCQIKAgsCDAINAg4CDwIQAhECEgZnbHlwaDEGZ2x5cGgyB3VuaTAwQTAHdW5pMjAwMAd1bmkyMDAxB3VuaTIwMDIHdW5pMjAwMwd1bmkyMDA0B3VuaTIwMDUHdW5pMjAwNgd1bmkyMDA3B3VuaTIwMDgHdW5pMjAwOQd1bmkyMDBBB3VuaTIwMkYHdW5pMjA1RgRFdXJvB3VuaTIwQkQHdW5pMjMxQgd1bmkyNUZDB3VuaTI2MDEHdW5pMjZGQQd1bmkyNzA5B3VuaTI3MEYHdW5pRTAwMQd1bmlFMDAyB3VuaUUwMDMHdW5pRTAwNQd1bmlFMDA2B3VuaUUwMDcHdW5pRTAwOAd1bmlFMDA5B3VuaUUwMTAHdW5pRTAxMQd1bmlFMDEyB3VuaUUwMTMHdW5pRTAxNAd1bmlFMDE1B3VuaUUwMTYHdW5pRTAxNwd1bmlFMDE4B3VuaUUwMTkHdW5pRTAyMAd1bmlFMDIxB3VuaUUwMjIHdW5pRTAyMwd1bmlFMDI0B3VuaUUwMjUHdW5pRTAyNgd1bmlFMDI3B3VuaUUwMjgHdW5pRTAyOQd1bmlFMDMwB3VuaUUwMzEHdW5pRTAzMgd1bmlFMDMzB3VuaUUwMzQHdW5pRTAzNQd1bmlFMDM2B3VuaUUwMzcHdW5pRTAzOAd1bmlFMDM5B3VuaUUwNDAHdW5pRTA0MQd1bmlFMDQyB3VuaUUwNDMHdW5pRTA0NAd1bmlFMDQ1B3VuaUUwNDYHdW5pRTA0Nwd1bmlFMDQ4B3VuaUUwNDkHdW5pRTA1MAd1bmlFMDUxB3VuaUUwNTIHdW5pRTA1Mwd1bmlFMDU0B3VuaUUwNTUHdW5pRTA1Ngd1bmlFMDU3B3VuaUUwNTgHdW5pRTA1OQd1bmlFMDYwB3VuaUUwNjIHdW5pRTA2Mwd1bmlFMDY0B3VuaUUwNjUHdW5pRTA2Ngd1bmlFMDY3B3VuaUUwNjgHdW5pRTA2OQd1bmlFMDcwB3VuaUUwNzEHdW5pRTA3Mgd1bmlFMDczB3VuaUUwNzQHdW5pRTA3NQd1bmlFMDc2B3VuaUUwNzcHdW5pRTA3OAd1bmlFMDc5B3VuaUUwODAHdW5pRTA4MQd1bmlFMDgyB3VuaUUwODMHdW5pRTA4NAd1bmlFMDg1B3VuaUUwODYHdW5pRTA4Nwd1bmlFMDg4B3VuaUUwODkHdW5pRTA5MAd1bmlFMDkxB3VuaUUwOTIHdW5pRTA5Mwd1bmlFMDk0B3VuaUUwOTUHdW5pRTA5Ngd1bmlFMDk3B3VuaUUxMDEHdW5pRTEwMgd1bmlFMTAzB3VuaUUxMDQHdW5pRTEwNQd1bmlFMTA2B3VuaUUxMDcHdW5pRTEwOAd1bmlFMTA5B3VuaUUxMTAHdW5pRTExMQd1bmlFMTEyB3VuaUUxMTMHdW5pRTExNAd1bmlFMTE1B3VuaUUxMTYHdW5pRTExNwd1bmlFMTE4B3VuaUUxMTkHdW5pRTEyMAd1bmlFMTIxB3VuaUUxMjIHdW5pRTEyMwd1bmlFMTI0B3VuaUUxMjUHdW5pRTEyNgd1bmlFMTI3B3VuaUUxMjgHdW5pRTEyOQd1bmlFMTMwB3VuaUUxMzEHdW5pRTEzMgd1bmlFMTMzB3VuaUUxMzQHdW5pRTEzNQd1bmlFMTM2B3VuaUUxMzcHdW5pRTEzOAd1bmlFMTM5B3VuaUUxNDAHdW5pRTE0MQd1bmlFMTQyB3VuaUUxNDMHdW5pRTE0NAd1bmlFMTQ1B3VuaUUxNDYHdW5pRTE0OAd1bmlFMTQ5B3VuaUUxNTAHdW5pRTE1MQd1bmlFMTUyB3VuaUUxNTMHdW5pRTE1NAd1bmlFMTU1B3VuaUUxNTYHdW5pRTE1Nwd1bmlFMTU4B3VuaUUxNTkHdW5pRTE2MAd1bmlFMTYxB3VuaUUxNjIHdW5pRTE2Mwd1bmlFMTY0B3VuaUUxNjUHdW5pRTE2Ngd1bmlFMTY3B3VuaUUxNjgHdW5pRTE2OQd1bmlFMTcwB3VuaUUxNzEHdW5pRTE3Mgd1bmlFMTczB3VuaUUxNzQHdW5pRTE3NQd1bmlFMTc2B3VuaUUxNzcHdW5pRTE3OAd1bmlFMTc5B3VuaUUxODAHdW5pRTE4MQd1bmlFMTgyB3VuaUUxODMHdW5pRTE4NAd1bmlFMTg1B3VuaUUxODYHdW5pRTE4Nwd1bmlFMTg4B3VuaUUxODkHdW5pRTE5MAd1bmlFMTkxB3VuaUUxOTIHdW5pRTE5Mwd1bmlFMTk0B3VuaUUxOTUHdW5pRTE5Nwd1bmlFMTk4B3VuaUUxOTkHdW5pRTIwMAd1bmlFMjAxB3VuaUUyMDIHdW5pRTIwMwd1bmlFMjA0B3VuaUUyMDUHdW5pRTIwNgd1bmlFMjA5B3VuaUUyMTAHdW5pRTIxMQd1bmlFMjEyB3VuaUUyMTMHdW5pRTIxNAd1bmlFMjE1B3VuaUUyMTYHdW5pRTIxOAd1bmlFMjE5B3VuaUUyMjEHdW5pRTIyMwd1bmlFMjI0B3VuaUUyMjUHdW5pRTIyNgd1bmlFMjI3B3VuaUUyMzAHdW5pRTIzMQd1bmlFMjMyB3VuaUUyMzMHdW5pRTIzNAd1bmlFMjM1B3VuaUUyMzYHdW5pRTIzNwd1bmlFMjM4B3VuaUUyMzkHdW5pRTI0MAd1bmlFMjQxB3VuaUUyNDIHdW5pRTI0Mwd1bmlFMjQ0B3VuaUUyNDUHdW5pRTI0Ngd1bmlFMjQ3B3VuaUUyNDgHdW5pRTI0OQd1bmlFMjUwB3VuaUUyNTEHdW5pRTI1Mgd1bmlFMjUzB3VuaUUyNTQHdW5pRTI1NQd1bmlFMjU2B3VuaUUyNTcHdW5pRTI1OAd1bmlFMjU5B3VuaUUyNjAHdW5pRjhGRgZ1MUY1MTEGdTFGNkFBAAAAAAFUUMMXAAA=) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:normal;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\002a"}.glyphicon-plus:before{content:"\002b"}.glyphicon-euro:before,.glyphicon-eur:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}*:before,*:after{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Roboto","Helvetica Neue",Helvetica,Arial,sans-serif;font-size:13px;line-height:1.846;color:#666666;background-color:#ffffff}input,button,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#2196f3;text-decoration:none}a:hover,a:focus{color:#0a6ebd;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.img-responsive,.thumbnail>img,.thumbnail a>img,.carousel-inner>.item>img,.carousel-inner>.item>a>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:3px}.img-thumbnail{padding:4px;line-height:1.846;background-color:#ffffff;border:1px solid #dddddd;border-radius:3px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out;display:inline-block;max-width:100%;height:auto}.img-circle{border-radius:50%}hr{margin-top:23px;margin-bottom:23px;border:0;border-top:1px solid #eeeeee}.sr-only{position:absolute;width:1px;height:1px;margin:-1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role="button"]{cursor:pointer}h1,h2,h3,h4,h5,h6,.h1,.h2,.h3,.h4,.h5,.h6{font-family:inherit;font-weight:400;line-height:1.1;color:#444444}h1 small,h2 small,h3 small,h4 small,h5 small,h6 small,.h1 small,.h2 small,.h3 small,.h4 small,.h5 small,.h6 small,h1 .small,h2 .small,h3 .small,h4 .small,h5 .small,h6 .small,.h1 .small,.h2 .small,.h3 .small,.h4 .small,.h5 .small,.h6 .small{font-weight:normal;line-height:1;color:#bbbbbb}h1,.h1,h2,.h2,h3,.h3{margin-top:23px;margin-bottom:11.5px}h1 small,.h1 small,h2 small,.h2 small,h3 small,.h3 small,h1 .small,.h1 .small,h2 .small,.h2 .small,h3 .small,.h3 .small{font-size:65%}h4,.h4,h5,.h5,h6,.h6{margin-top:11.5px;margin-bottom:11.5px}h4 small,.h4 small,h5 small,.h5 small,h6 small,.h6 small,h4 .small,.h4 .small,h5 .small,.h5 .small,h6 .small,.h6 .small{font-size:75%}h1,.h1{font-size:56px}h2,.h2{font-size:45px}h3,.h3{font-size:34px}h4,.h4{font-size:24px}h5,.h5{font-size:20px}h6,.h6{font-size:14px}p{margin:0 0 11.5px}.lead{margin-bottom:23px;font-size:14px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:19.5px}}small,.small{font-size:92%}mark,.mark{background-color:#ffe0b2;padding:.2em}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#bbbbbb}.text-primary{color:#2196f3}a.text-primary:hover,a.text-primary:focus{color:#0c7cd5}.text-success{color:#4caf50}a.text-success:hover,a.text-success:focus{color:#3d8b40}.text-info{color:#9c27b0}a.text-info:hover,a.text-info:focus{color:#771e86}.text-warning{color:#ff9800}a.text-warning:hover,a.text-warning:focus{color:#cc7a00}.text-danger{color:#e51c23}a.text-danger:hover,a.text-danger:focus{color:#b9151b}.bg-primary{color:#fff;background-color:#2196f3}a.bg-primary:hover,a.bg-primary:focus{background-color:#0c7cd5}.bg-success{background-color:#dff0d8}a.bg-success:hover,a.bg-success:focus{background-color:#c1e2b3}.bg-info{background-color:#e1bee7}a.bg-info:hover,a.bg-info:focus{background-color:#d099d9}.bg-warning{background-color:#ffe0b2}a.bg-warning:hover,a.bg-warning:focus{background-color:#ffcb7f}.bg-danger{background-color:#f9bdbb}a.bg-danger:hover,a.bg-danger:focus{background-color:#f5908c}.page-header{padding-bottom:10.5px;margin:46px 0 23px;border-bottom:1px solid #eeeeee}ul,ol{margin-top:0;margin-bottom:11.5px}ul ul,ol ul,ul ol,ol ol{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;list-style:none;margin-left:-5px}.list-inline>li{display:inline-block;padding-left:5px;padding-right:5px}dl{margin-top:0;margin-bottom:23px}dt,dd{line-height:1.846}dt{font-weight:bold}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;clear:left;text-align:right;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[title],abbr[data-original-title]{cursor:help;border-bottom:1px dotted #bbbbbb}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:11.5px 23px;margin:0 0 23px;font-size:16.25px;border-left:5px solid #eeeeee}blockquote p:last-child,blockquote ul:last-child,blockquote ol:last-child{margin-bottom:0}blockquote footer,blockquote small,blockquote .small{display:block;font-size:80%;line-height:1.846;color:#bbbbbb}blockquote footer:before,blockquote small:before,blockquote .small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;border-right:5px solid #eeeeee;border-left:0;text-align:right}.blockquote-reverse footer:before,blockquote.pull-right footer:before,.blockquote-reverse small:before,blockquote.pull-right small:before,.blockquote-reverse .small:before,blockquote.pull-right .small:before{content:''}.blockquote-reverse footer:after,blockquote.pull-right footer:after,.blockquote-reverse small:after,blockquote.pull-right small:after,.blockquote-reverse .small:after,blockquote.pull-right .small:after{content:'\00A0 \2014'}address{margin-bottom:23px;font-style:normal;line-height:1.846}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:3px}kbd{padding:2px 4px;font-size:90%;color:#ffffff;background-color:#333333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,0.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,0.25)}kbd kbd{padding:0;font-size:100%;font-weight:bold;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:11px;margin:0 0 11.5px;font-size:12px;line-height:1.846;word-break:break-all;word-wrap:break-word;color:#212121;background-color:#f5f5f5;border:1px solid #cccccc;border-radius:3px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.col-xs-1,.col-sm-1,.col-md-1,.col-lg-1,.col-xs-2,.col-sm-2,.col-md-2,.col-lg-2,.col-xs-3,.col-sm-3,.col-md-3,.col-lg-3,.col-xs-4,.col-sm-4,.col-md-4,.col-lg-4,.col-xs-5,.col-sm-5,.col-md-5,.col-lg-5,.col-xs-6,.col-sm-6,.col-md-6,.col-lg-6,.col-xs-7,.col-sm-7,.col-md-7,.col-lg-7,.col-xs-8,.col-sm-8,.col-md-8,.col-lg-8,.col-xs-9,.col-sm-9,.col-md-9,.col-lg-9,.col-xs-10,.col-sm-10,.col-md-10,.col-lg-10,.col-xs-11,.col-sm-11,.col-md-11,.col-lg-11,.col-xs-12,.col-sm-12,.col-md-12,.col-lg-12{position:relative;min-height:1px;padding-left:15px;padding-right:15px}.col-xs-1,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9,.col-xs-10,.col-xs-11,.col-xs-12{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0%}@media (min-width:768px){.col-sm-1,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-sm-10,.col-sm-11,.col-sm-12{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0%}}@media (min-width:992px){.col-md-1,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-md-10,.col-md-11,.col-md-12{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0%}}@media (min-width:1200px){.col-lg-1,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-lg-10,.col-lg-11,.col-lg-12{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0%}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#bbbbbb;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:23px}.table>thead>tr>th,.table>tbody>tr>th,.table>tfoot>tr>th,.table>thead>tr>td,.table>tbody>tr>td,.table>tfoot>tr>td{padding:8px;line-height:1.846;vertical-align:top;border-top:1px solid #dddddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #dddddd}.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>th,.table>caption+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>td,.table>thead:first-child>tr:first-child>td{border-top:0}.table>tbody+tbody{border-top:2px solid #dddddd}.table .table{background-color:#ffffff}.table-condensed>thead>tr>th,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>tbody>tr>td,.table-condensed>tfoot>tr>td{padding:5px}.table-bordered{border:1px solid #dddddd}.table-bordered>thead>tr>th,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>tbody>tr>td,.table-bordered>tfoot>tr>td{border:1px solid #dddddd}.table-bordered>thead>tr>th,.table-bordered>thead>tr>td{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*="col-"]{position:static;float:none;display:table-column}table td[class*="col-"],table th[class*="col-"]{position:static;float:none;display:table-cell}.table>thead>tr>td.active,.table>tbody>tr>td.active,.table>tfoot>tr>td.active,.table>thead>tr>th.active,.table>tbody>tr>th.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>tbody>tr.active>td,.table>tfoot>tr.active>td,.table>thead>tr.active>th,.table>tbody>tr.active>th,.table>tfoot>tr.active>th{background-color:#f5f5f5}.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover,.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr.active:hover>th{background-color:#e8e8e8}.table>thead>tr>td.success,.table>tbody>tr>td.success,.table>tfoot>tr>td.success,.table>thead>tr>th.success,.table>tbody>tr>th.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>tbody>tr.success>td,.table>tfoot>tr.success>td,.table>thead>tr.success>th,.table>tbody>tr.success>th,.table>tfoot>tr.success>th{background-color:#dff0d8}.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover,.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr.success:hover>th{background-color:#d0e9c6}.table>thead>tr>td.info,.table>tbody>tr>td.info,.table>tfoot>tr>td.info,.table>thead>tr>th.info,.table>tbody>tr>th.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>tbody>tr.info>td,.table>tfoot>tr.info>td,.table>thead>tr.info>th,.table>tbody>tr.info>th,.table>tfoot>tr.info>th{background-color:#e1bee7}.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover,.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr.info:hover>th{background-color:#d8abe0}.table>thead>tr>td.warning,.table>tbody>tr>td.warning,.table>tfoot>tr>td.warning,.table>thead>tr>th.warning,.table>tbody>tr>th.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>tbody>tr.warning>td,.table>tfoot>tr.warning>td,.table>thead>tr.warning>th,.table>tbody>tr.warning>th,.table>tfoot>tr.warning>th{background-color:#ffe0b2}.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover,.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr.warning:hover>th{background-color:#ffd699}.table>thead>tr>td.danger,.table>tbody>tr>td.danger,.table>tfoot>tr>td.danger,.table>thead>tr>th.danger,.table>tbody>tr>th.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>tbody>tr.danger>td,.table>tfoot>tr.danger>td,.table>thead>tr.danger>th,.table>tbody>tr.danger>th,.table>tfoot>tr.danger>th{background-color:#f9bdbb}.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover,.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr.danger:hover>th{background-color:#f7a6a4}.table-responsive{overflow-x:auto;min-height:0.01%}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:17.25px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #dddddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>thead>tr>th,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tfoot>tr>td{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>thead>tr>th:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child{border-left:0}.table-responsive>.table-bordered>thead>tr>th:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>th,.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>td{border-bottom:0}}fieldset{padding:0;margin:0;border:0;min-width:0}legend{display:block;width:100%;padding:0;margin-bottom:23px;font-size:19.5px;line-height:inherit;color:#212121;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:bold}input[type="search"]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type="radio"],input[type="checkbox"]{margin:4px 0 0;margin-top:1px \9;line-height:normal}input[type="file"]{display:block}input[type="range"]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type="file"]:focus,input[type="radio"]:focus,input[type="checkbox"]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:13px;line-height:1.846;color:#666666}.form-control{display:block;width:100%;height:37px;padding:6px 16px;font-size:13px;line-height:1.846;color:#666666;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 8px rgba(102,175,233,0.6);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 8px rgba(102,175,233,0.6)}.form-control::-moz-placeholder{color:#bbbbbb;opacity:1}.form-control:-ms-input-placeholder{color:#bbbbbb}.form-control::-webkit-input-placeholder{color:#bbbbbb}.form-control::-ms-expand{border:0;background-color:transparent}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:transparent;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type="search"]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type="date"].form-control,input[type="time"].form-control,input[type="datetime-local"].form-control,input[type="month"].form-control{line-height:37px}input[type="date"].input-sm,input[type="time"].input-sm,input[type="datetime-local"].input-sm,input[type="month"].input-sm,.input-group-sm input[type="date"],.input-group-sm input[type="time"],.input-group-sm input[type="datetime-local"],.input-group-sm input[type="month"]{line-height:30px}input[type="date"].input-lg,input[type="time"].input-lg,input[type="datetime-local"].input-lg,input[type="month"].input-lg,.input-group-lg input[type="date"],.input-group-lg input[type="time"],.input-group-lg input[type="datetime-local"],.input-group-lg input[type="month"]{line-height:45px}}.form-group{margin-bottom:15px}.radio,.checkbox{position:relative;display:block;margin-top:10px;margin-bottom:10px}.radio label,.checkbox label{min-height:23px;padding-left:20px;margin-bottom:0;font-weight:normal;cursor:pointer}.radio input[type="radio"],.radio-inline input[type="radio"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{position:absolute;margin-left:-20px;margin-top:4px \9}.radio+.radio,.checkbox+.checkbox{margin-top:-5px}.radio-inline,.checkbox-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;vertical-align:middle;font-weight:normal;cursor:pointer}.radio-inline+.radio-inline,.checkbox-inline+.checkbox-inline{margin-top:0;margin-left:10px}input[type="radio"][disabled],input[type="checkbox"][disabled],input[type="radio"].disabled,input[type="checkbox"].disabled,fieldset[disabled] input[type="radio"],fieldset[disabled] input[type="checkbox"]{cursor:not-allowed}.radio-inline.disabled,.checkbox-inline.disabled,fieldset[disabled] .radio-inline,fieldset[disabled] .checkbox-inline{cursor:not-allowed}.radio.disabled label,.checkbox.disabled label,fieldset[disabled] .radio label,fieldset[disabled] .checkbox label{cursor:not-allowed}.form-control-static{padding-top:7px;padding-bottom:7px;margin-bottom:0;min-height:36px}.form-control-static.input-lg,.form-control-static.input-sm{padding-left:0;padding-right:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}textarea.input-sm,select[multiple].input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm textarea.form-control,.form-group-sm select[multiple].form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:35px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:45px;padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}select.input-lg{height:45px;line-height:45px}textarea.input-lg,select[multiple].input-lg{height:auto}.form-group-lg .form-control{height:45px;padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}.form-group-lg select.form-control{height:45px;line-height:45px}.form-group-lg textarea.form-control,.form-group-lg select[multiple].form-control{height:auto}.form-group-lg .form-control-static{height:45px;min-height:40px;padding:11px 16px;font-size:17px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:46.25px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:37px;height:37px;line-height:37px;text-align:center;pointer-events:none}.input-lg+.form-control-feedback,.input-group-lg+.form-control-feedback,.form-group-lg .form-control+.form-control-feedback{width:45px;height:45px;line-height:45px}.input-sm+.form-control-feedback,.input-group-sm+.form-control-feedback,.form-group-sm .form-control+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .help-block,.has-success .control-label,.has-success .radio,.has-success .checkbox,.has-success .radio-inline,.has-success .checkbox-inline,.has-success.radio label,.has-success.checkbox label,.has-success.radio-inline label,.has-success.checkbox-inline label{color:#4caf50}.has-success .form-control{border-color:#4caf50;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-success .form-control:focus{border-color:#3d8b40;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #92cf94;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #92cf94}.has-success .input-group-addon{color:#4caf50;border-color:#4caf50;background-color:#dff0d8}.has-success .form-control-feedback{color:#4caf50}.has-warning .help-block,.has-warning .control-label,.has-warning .radio,.has-warning .checkbox,.has-warning .radio-inline,.has-warning .checkbox-inline,.has-warning.radio label,.has-warning.checkbox label,.has-warning.radio-inline label,.has-warning.checkbox-inline label{color:#ff9800}.has-warning .form-control{border-color:#ff9800;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-warning .form-control:focus{border-color:#cc7a00;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ffc166;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ffc166}.has-warning .input-group-addon{color:#ff9800;border-color:#ff9800;background-color:#ffe0b2}.has-warning .form-control-feedback{color:#ff9800}.has-error .help-block,.has-error .control-label,.has-error .radio,.has-error .checkbox,.has-error .radio-inline,.has-error .checkbox-inline,.has-error.radio label,.has-error.checkbox label,.has-error.radio-inline label,.has-error.checkbox-inline label{color:#e51c23}.has-error .form-control{border-color:#e51c23;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-error .form-control:focus{border-color:#b9151b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ef787c;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #ef787c}.has-error .input-group-addon{color:#e51c23;border-color:#e51c23;background-color:#f9bdbb}.has-error .form-control-feedback{color:#e51c23}.has-feedback label~.form-control-feedback{top:28px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#a6a6a6}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn,.form-inline .input-group .form-control{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .radio,.form-inline .checkbox{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .radio label,.form-inline .checkbox label{padding-left:0}.form-inline .radio input[type="radio"],.form-inline .checkbox input[type="checkbox"]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .radio,.form-horizontal .checkbox,.form-horizontal .radio-inline,.form-horizontal .checkbox-inline{margin-top:0;margin-bottom:0;padding-top:7px}.form-horizontal .radio,.form-horizontal .checkbox{min-height:30px}.form-horizontal .form-group{margin-left:-15px;margin-right:-15px}@media (min-width:768px){.form-horizontal .control-label{text-align:right;margin-bottom:0;padding-top:7px}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:11px;font-size:17px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;margin-bottom:0;font-weight:normal;text-align:center;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;background-image:none;border:1px solid transparent;white-space:nowrap;padding:6px 16px;font-size:13px;line-height:1.846;border-radius:3px;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.btn:focus,.btn:active:focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn.active.focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn:hover,.btn:focus,.btn.focus{color:#444444;text-decoration:none}.btn:active,.btn.active{outline:0;background-image:none;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,0.125);box-shadow:inset 0 3px 5px rgba(0,0,0,0.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;opacity:0.65;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#444444;background-color:#ffffff;border-color:transparent}.btn-default:focus,.btn-default.focus{color:#444444;background-color:#e6e6e6;border-color:rgba(0,0,0,0)}.btn-default:hover{color:#444444;background-color:#e6e6e6;border-color:rgba(0,0,0,0)}.btn-default:active,.btn-default.active,.open>.dropdown-toggle.btn-default{color:#444444;background-color:#e6e6e6;border-color:rgba(0,0,0,0)}.btn-default:active:hover,.btn-default.active:hover,.open>.dropdown-toggle.btn-default:hover,.btn-default:active:focus,.btn-default.active:focus,.open>.dropdown-toggle.btn-default:focus,.btn-default:active.focus,.btn-default.active.focus,.open>.dropdown-toggle.btn-default.focus{color:#444444;background-color:#d4d4d4;border-color:rgba(0,0,0,0)}.btn-default:active,.btn-default.active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled:hover,.btn-default[disabled]:hover,fieldset[disabled] .btn-default:hover,.btn-default.disabled:focus,.btn-default[disabled]:focus,fieldset[disabled] .btn-default:focus,.btn-default.disabled.focus,.btn-default[disabled].focus,fieldset[disabled] .btn-default.focus{background-color:#ffffff;border-color:transparent}.btn-default .badge{color:#ffffff;background-color:#444444}.btn-primary{color:#ffffff;background-color:#2196f3;border-color:transparent}.btn-primary:focus,.btn-primary.focus{color:#ffffff;background-color:#0c7cd5;border-color:rgba(0,0,0,0)}.btn-primary:hover{color:#ffffff;background-color:#0c7cd5;border-color:rgba(0,0,0,0)}.btn-primary:active,.btn-primary.active,.open>.dropdown-toggle.btn-primary{color:#ffffff;background-color:#0c7cd5;border-color:rgba(0,0,0,0)}.btn-primary:active:hover,.btn-primary.active:hover,.open>.dropdown-toggle.btn-primary:hover,.btn-primary:active:focus,.btn-primary.active:focus,.open>.dropdown-toggle.btn-primary:focus,.btn-primary:active.focus,.btn-primary.active.focus,.open>.dropdown-toggle.btn-primary.focus{color:#ffffff;background-color:#0a68b4;border-color:rgba(0,0,0,0)}.btn-primary:active,.btn-primary.active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled:hover,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary:hover,.btn-primary.disabled:focus,.btn-primary[disabled]:focus,fieldset[disabled] .btn-primary:focus,.btn-primary.disabled.focus,.btn-primary[disabled].focus,fieldset[disabled] .btn-primary.focus{background-color:#2196f3;border-color:transparent}.btn-primary .badge{color:#2196f3;background-color:#ffffff}.btn-success{color:#ffffff;background-color:#4caf50;border-color:transparent}.btn-success:focus,.btn-success.focus{color:#ffffff;background-color:#3d8b40;border-color:rgba(0,0,0,0)}.btn-success:hover{color:#ffffff;background-color:#3d8b40;border-color:rgba(0,0,0,0)}.btn-success:active,.btn-success.active,.open>.dropdown-toggle.btn-success{color:#ffffff;background-color:#3d8b40;border-color:rgba(0,0,0,0)}.btn-success:active:hover,.btn-success.active:hover,.open>.dropdown-toggle.btn-success:hover,.btn-success:active:focus,.btn-success.active:focus,.open>.dropdown-toggle.btn-success:focus,.btn-success:active.focus,.btn-success.active.focus,.open>.dropdown-toggle.btn-success.focus{color:#ffffff;background-color:#327334;border-color:rgba(0,0,0,0)}.btn-success:active,.btn-success.active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled:hover,.btn-success[disabled]:hover,fieldset[disabled] .btn-success:hover,.btn-success.disabled:focus,.btn-success[disabled]:focus,fieldset[disabled] .btn-success:focus,.btn-success.disabled.focus,.btn-success[disabled].focus,fieldset[disabled] .btn-success.focus{background-color:#4caf50;border-color:transparent}.btn-success .badge{color:#4caf50;background-color:#ffffff}.btn-info{color:#ffffff;background-color:#9c27b0;border-color:transparent}.btn-info:focus,.btn-info.focus{color:#ffffff;background-color:#771e86;border-color:rgba(0,0,0,0)}.btn-info:hover{color:#ffffff;background-color:#771e86;border-color:rgba(0,0,0,0)}.btn-info:active,.btn-info.active,.open>.dropdown-toggle.btn-info{color:#ffffff;background-color:#771e86;border-color:rgba(0,0,0,0)}.btn-info:active:hover,.btn-info.active:hover,.open>.dropdown-toggle.btn-info:hover,.btn-info:active:focus,.btn-info.active:focus,.open>.dropdown-toggle.btn-info:focus,.btn-info:active.focus,.btn-info.active.focus,.open>.dropdown-toggle.btn-info.focus{color:#ffffff;background-color:#5d1769;border-color:rgba(0,0,0,0)}.btn-info:active,.btn-info.active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled:hover,.btn-info[disabled]:hover,fieldset[disabled] .btn-info:hover,.btn-info.disabled:focus,.btn-info[disabled]:focus,fieldset[disabled] .btn-info:focus,.btn-info.disabled.focus,.btn-info[disabled].focus,fieldset[disabled] .btn-info.focus{background-color:#9c27b0;border-color:transparent}.btn-info .badge{color:#9c27b0;background-color:#ffffff}.btn-warning{color:#ffffff;background-color:#ff9800;border-color:transparent}.btn-warning:focus,.btn-warning.focus{color:#ffffff;background-color:#cc7a00;border-color:rgba(0,0,0,0)}.btn-warning:hover{color:#ffffff;background-color:#cc7a00;border-color:rgba(0,0,0,0)}.btn-warning:active,.btn-warning.active,.open>.dropdown-toggle.btn-warning{color:#ffffff;background-color:#cc7a00;border-color:rgba(0,0,0,0)}.btn-warning:active:hover,.btn-warning.active:hover,.open>.dropdown-toggle.btn-warning:hover,.btn-warning:active:focus,.btn-warning.active:focus,.open>.dropdown-toggle.btn-warning:focus,.btn-warning:active.focus,.btn-warning.active.focus,.open>.dropdown-toggle.btn-warning.focus{color:#ffffff;background-color:#a86400;border-color:rgba(0,0,0,0)}.btn-warning:active,.btn-warning.active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled:hover,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning:hover,.btn-warning.disabled:focus,.btn-warning[disabled]:focus,fieldset[disabled] .btn-warning:focus,.btn-warning.disabled.focus,.btn-warning[disabled].focus,fieldset[disabled] .btn-warning.focus{background-color:#ff9800;border-color:transparent}.btn-warning .badge{color:#ff9800;background-color:#ffffff}.btn-danger{color:#ffffff;background-color:#e51c23;border-color:transparent}.btn-danger:focus,.btn-danger.focus{color:#ffffff;background-color:#b9151b;border-color:rgba(0,0,0,0)}.btn-danger:hover{color:#ffffff;background-color:#b9151b;border-color:rgba(0,0,0,0)}.btn-danger:active,.btn-danger.active,.open>.dropdown-toggle.btn-danger{color:#ffffff;background-color:#b9151b;border-color:rgba(0,0,0,0)}.btn-danger:active:hover,.btn-danger.active:hover,.open>.dropdown-toggle.btn-danger:hover,.btn-danger:active:focus,.btn-danger.active:focus,.open>.dropdown-toggle.btn-danger:focus,.btn-danger:active.focus,.btn-danger.active.focus,.open>.dropdown-toggle.btn-danger.focus{color:#ffffff;background-color:#991216;border-color:rgba(0,0,0,0)}.btn-danger:active,.btn-danger.active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled:hover,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger:hover,.btn-danger.disabled:focus,.btn-danger[disabled]:focus,fieldset[disabled] .btn-danger:focus,.btn-danger.disabled.focus,.btn-danger[disabled].focus,fieldset[disabled] .btn-danger.focus{background-color:#e51c23;border-color:transparent}.btn-danger .badge{color:#e51c23;background-color:#ffffff}.btn-link{color:#2196f3;font-weight:normal;border-radius:0}.btn-link,.btn-link:active,.btn-link.active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:hover,.btn-link:focus,.btn-link:active{border-color:transparent}.btn-link:hover,.btn-link:focus{color:#0a6ebd;text-decoration:underline;background-color:transparent}.btn-link[disabled]:hover,fieldset[disabled] .btn-link:hover,.btn-link[disabled]:focus,fieldset[disabled] .btn-link:focus{color:#bbbbbb;text-decoration:none}.btn-lg,.btn-group-lg>.btn{padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}.btn-sm,.btn-group-sm>.btn{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-xs,.btn-group-xs>.btn{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type="submit"].btn-block,input[type="reset"].btn-block,input[type="button"].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity 0.15s linear;-o-transition:opacity 0.15s linear;transition:opacity 0.15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-property:height, visibility;-o-transition-property:height, visibility;transition-property:height, visibility;-webkit-transition-duration:0.35s;-o-transition-duration:0.35s;transition-duration:0.35s;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid \9;border-right:4px solid transparent;border-left:4px solid transparent}.dropup,.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;list-style:none;font-size:13px;text-align:left;background-color:#ffffff;border:1px solid #cccccc;border:1px solid rgba(0,0,0,0.15);border-radius:3px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,0.175);box-shadow:0 6px 12px rgba(0,0,0,0.175);-webkit-background-clip:padding-box;background-clip:padding-box}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:10.5px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:normal;line-height:1.846;color:#666666;white-space:nowrap}.dropdown-menu>li>a:hover,.dropdown-menu>li>a:focus{text-decoration:none;color:#141414;background-color:#eeeeee}.dropdown-menu>.active>a,.dropdown-menu>.active>a:hover,.dropdown-menu>.active>a:focus{color:#ffffff;text-decoration:none;outline:0;background-color:#2196f3}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:hover,.dropdown-menu>.disabled>a:focus{color:#bbbbbb}.dropdown-menu>.disabled>a:hover,.dropdown-menu>.disabled>a:focus{text-decoration:none;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false);cursor:not-allowed}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{left:auto;right:0}.dropdown-menu-left{left:0;right:auto}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.846;color:#bbbbbb;white-space:nowrap}.dropdown-backdrop{position:fixed;left:0;right:0;bottom:0;top:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{border-top:0;border-bottom:4px dashed;border-bottom:4px solid \9;content:""}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{left:auto;right:0}.navbar-right .dropdown-menu-left{left:0;right:auto}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group>.btn,.btn-group-vertical>.btn{position:relative;float:left}.btn-group>.btn:hover,.btn-group-vertical>.btn:hover,.btn-group>.btn:focus,.btn-group-vertical>.btn:focus,.btn-group>.btn:active,.btn-group-vertical>.btn:active,.btn-group>.btn.active,.btn-group-vertical>.btn.active{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-bottom-right-radius:0;border-top-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-bottom-left-radius:0;border-top-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-top-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-bottom-left-radius:0;border-top-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-left:8px;padding-right:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-left:12px;padding-right:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,0.125);box-shadow:inset 0 3px 5px rgba(0,0,0,0.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:3px;border-top-left-radius:3px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-right-radius:0;border-top-left-radius:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-right-radius:0;border-top-left-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{float:none;display:table-cell;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle="buttons"]>.btn input[type="radio"],[data-toggle="buttons"]>.btn-group>.btn input[type="radio"],[data-toggle="buttons"]>.btn input[type="checkbox"],[data-toggle="buttons"]>.btn-group>.btn input[type="checkbox"]{position:absolute;clip:rect(0, 0, 0, 0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*="col-"]{float:none;padding-left:0;padding-right:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group .form-control:focus{z-index:3}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:45px;padding:10px 16px;font-size:17px;line-height:1.3333333;border-radius:3px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:45px;line-height:45px}textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn,select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn,select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn{height:auto}.input-group-addon,.input-group-btn,.input-group .form-control{display:table-cell}.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child),.input-group .form-control:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 16px;font-size:13px;font-weight:normal;line-height:1;color:#666666;text-align:center;background-color:transparent;border:1px solid transparent;border-radius:3px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:17px;border-radius:3px}.input-group-addon input[type="radio"],.input-group-addon input[type="checkbox"]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle),.input-group-btn:last-child>.btn-group:not(:last-child)>.btn{border-bottom-right-radius:0;border-top-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:first-child>.btn-group:not(:first-child)>.btn{border-bottom-left-radius:0;border-top-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:hover,.input-group-btn>.btn:focus,.input-group-btn>.btn:active{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:hover,.nav>li>a:focus{text-decoration:none;background-color:#eeeeee}.nav>li.disabled>a{color:#bbbbbb}.nav>li.disabled>a:hover,.nav>li.disabled>a:focus{color:#bbbbbb;text-decoration:none;background-color:transparent;cursor:not-allowed}.nav .open>a,.nav .open>a:hover,.nav .open>a:focus{background-color:#eeeeee;border-color:#2196f3}.nav .nav-divider{height:1px;margin:10.5px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid transparent}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.846;border:1px solid transparent;border-radius:3px 3px 0 0}.nav-tabs>li>a:hover{border-color:#eeeeee #eeeeee transparent}.nav-tabs>li.active>a,.nav-tabs>li.active>a:hover,.nav-tabs>li.active>a:focus{color:#666666;background-color:transparent;border:1px solid transparent;border-bottom-color:transparent;cursor:default}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{text-align:center;margin-bottom:5px}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:3px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border:1px solid transparent}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid transparent;border-radius:3px 3px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border-bottom-color:#ffffff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:3px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:hover,.nav-pills>li.active>a:focus{color:#ffffff;background-color:#2196f3}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{text-align:center;margin-bottom:5px}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:3px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:hover,.nav-tabs-justified>.active>a:focus{border:1px solid transparent}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid transparent;border-radius:3px 3px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:hover,.nav-tabs-justified>.active>a:focus{border-bottom-color:#ffffff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-right-radius:0;border-top-left-radius:0}.navbar{position:relative;min-height:64px;margin-bottom:23px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:3px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{overflow-x:visible;padding-right:15px;padding-left:15px;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,0.1);box-shadow:inset 0 1px 0 rgba(255,255,255,0.1);-webkit-overflow-scrolling:touch}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block !important;height:auto !important;padding-bottom:0;overflow:visible !important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{padding-left:0;padding-right:0}}.navbar-fixed-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{max-height:200px}}.container>.navbar-header,.container-fluid>.navbar-header,.container>.navbar-collapse,.container-fluid>.navbar-collapse{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header,.container-fluid>.navbar-header,.container>.navbar-collapse,.container-fluid>.navbar-collapse{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-top,.navbar-fixed-bottom{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top,.navbar-fixed-bottom{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;padding:20.5px 15px;font-size:17px;line-height:23px;height:64px}.navbar-brand:hover,.navbar-brand:focus{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;margin-right:15px;padding:9px 10px;margin-top:15px;margin-bottom:15px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:3px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:10.25px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:23px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu>li>a,.navbar-nav .open .dropdown-menu .dropdown-header{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:23px}.navbar-nav .open .dropdown-menu>li>a:hover,.navbar-nav .open .dropdown-menu>li>a:focus{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:20.5px;padding-bottom:20.5px}}.navbar-form{margin-left:-15px;margin-right:-15px;padding:10px 15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,0.1),0 1px 0 rgba(255,255,255,0.1);box-shadow:inset 0 1px 0 rgba(255,255,255,0.1),0 1px 0 rgba(255,255,255,0.1);margin-top:13.5px;margin-bottom:13.5px}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn,.navbar-form .input-group .form-control{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .radio,.navbar-form .checkbox{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .radio label,.navbar-form .checkbox label{padding-left:0}.navbar-form .radio input[type="radio"],.navbar-form .checkbox input[type="checkbox"]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;border:0;margin-left:0;margin-right:0;padding-top:0;padding-bottom:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-right-radius:0;border-top-left-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-right-radius:3px;border-top-left-radius:3px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:13.5px;margin-bottom:13.5px}.navbar-btn.btn-sm{margin-top:17px;margin-bottom:17px}.navbar-btn.btn-xs{margin-top:21px;margin-bottom:21px}.navbar-text{margin-top:20.5px;margin-bottom:20.5px}@media (min-width:768px){.navbar-text{float:left;margin-left:15px;margin-right:15px}}@media (min-width:768px){.navbar-left{float:left !important}.navbar-right{float:right !important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#ffffff;border-color:transparent}.navbar-default .navbar-brand{color:#666666}.navbar-default .navbar-brand:hover,.navbar-default .navbar-brand:focus{color:#212121;background-color:transparent}.navbar-default .navbar-text{color:#bbbbbb}.navbar-default .navbar-nav>li>a{color:#666666}.navbar-default .navbar-nav>li>a:hover,.navbar-default .navbar-nav>li>a:focus{color:#212121;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:hover,.navbar-default .navbar-nav>.active>a:focus{color:#212121;background-color:#eeeeee}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:hover,.navbar-default .navbar-nav>.disabled>a:focus{color:#cccccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:transparent}.navbar-default .navbar-toggle:hover,.navbar-default .navbar-toggle:focus{background-color:transparent}.navbar-default .navbar-toggle .icon-bar{background-color:rgba(0,0,0,0.5)}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:transparent}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:hover,.navbar-default .navbar-nav>.open>a:focus{background-color:#eeeeee;color:#212121}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#666666}.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus{color:#212121;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus{color:#212121;background-color:#eeeeee}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus{color:#cccccc;background-color:transparent}}.navbar-default .navbar-link{color:#666666}.navbar-default .navbar-link:hover{color:#212121}.navbar-default .btn-link{color:#666666}.navbar-default .btn-link:hover,.navbar-default .btn-link:focus{color:#212121}.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:hover,.navbar-default .btn-link[disabled]:focus,fieldset[disabled] .navbar-default .btn-link:focus{color:#cccccc}.navbar-inverse{background-color:#2196f3;border-color:transparent}.navbar-inverse .navbar-brand{color:#b2dbfb}.navbar-inverse .navbar-brand:hover,.navbar-inverse .navbar-brand:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-text{color:#bbbbbb}.navbar-inverse .navbar-nav>li>a{color:#b2dbfb}.navbar-inverse .navbar-nav>li>a:hover,.navbar-inverse .navbar-nav>li>a:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:hover,.navbar-inverse .navbar-nav>.active>a:focus{color:#ffffff;background-color:#0c7cd5}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:hover,.navbar-inverse .navbar-nav>.disabled>a:focus{color:#444444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:transparent}.navbar-inverse .navbar-toggle:hover,.navbar-inverse .navbar-toggle:focus{background-color:transparent}.navbar-inverse .navbar-toggle .icon-bar{background-color:rgba(0,0,0,0.5)}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#0c84e4}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:hover,.navbar-inverse .navbar-nav>.open>a:focus{background-color:#0c7cd5;color:#ffffff}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#b2dbfb}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus{color:#ffffff;background-color:#0c7cd5}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus{color:#444444;background-color:transparent}}.navbar-inverse .navbar-link{color:#b2dbfb}.navbar-inverse .navbar-link:hover{color:#ffffff}.navbar-inverse .btn-link{color:#b2dbfb}.navbar-inverse .btn-link:hover,.navbar-inverse .btn-link:focus{color:#ffffff}.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:hover,.navbar-inverse .btn-link[disabled]:focus,fieldset[disabled] .navbar-inverse .btn-link:focus{color:#444444}.breadcrumb{padding:8px 15px;margin-bottom:23px;list-style:none;background-color:#f5f5f5;border-radius:3px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{content:"/\00a0";padding:0 5px;color:#cccccc}.breadcrumb>.active{color:#bbbbbb}.pagination{display:inline-block;padding-left:0;margin:23px 0;border-radius:3px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 16px;line-height:1.846;text-decoration:none;color:#2196f3;background-color:#ffffff;border:1px solid #dddddd;margin-left:-1px}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-bottom-left-radius:3px;border-top-left-radius:3px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-bottom-right-radius:3px;border-top-right-radius:3px}.pagination>li>a:hover,.pagination>li>span:hover,.pagination>li>a:focus,.pagination>li>span:focus{z-index:2;color:#0a6ebd;background-color:#eeeeee;border-color:#dddddd}.pagination>.active>a,.pagination>.active>span,.pagination>.active>a:hover,.pagination>.active>span:hover,.pagination>.active>a:focus,.pagination>.active>span:focus{z-index:3;color:#ffffff;background-color:#2196f3;border-color:#2196f3;cursor:default}.pagination>.disabled>span,.pagination>.disabled>span:hover,.pagination>.disabled>span:focus,.pagination>.disabled>a,.pagination>.disabled>a:hover,.pagination>.disabled>a:focus{color:#bbbbbb;background-color:#ffffff;border-color:#dddddd;cursor:not-allowed}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:17px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-bottom-left-radius:3px;border-top-left-radius:3px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-bottom-right-radius:3px;border-top-right-radius:3px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-bottom-left-radius:3px;border-top-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-bottom-right-radius:3px;border-top-right-radius:3px}.pager{padding-left:0;margin:23px 0;list-style:none;text-align:center}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#ffffff;border:1px solid #dddddd;border-radius:15px}.pager li>a:hover,.pager li>a:focus{text-decoration:none;background-color:#eeeeee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:hover,.pager .disabled>a:focus,.pager .disabled>span{color:#bbbbbb;background-color:#ffffff;cursor:not-allowed}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:bold;line-height:1;color:#ffffff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:hover,a.label:focus{color:#ffffff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#bbbbbb}.label-default[href]:hover,.label-default[href]:focus{background-color:#a2a2a2}.label-primary{background-color:#2196f3}.label-primary[href]:hover,.label-primary[href]:focus{background-color:#0c7cd5}.label-success{background-color:#4caf50}.label-success[href]:hover,.label-success[href]:focus{background-color:#3d8b40}.label-info{background-color:#9c27b0}.label-info[href]:hover,.label-info[href]:focus{background-color:#771e86}.label-warning{background-color:#ff9800}.label-warning[href]:hover,.label-warning[href]:focus{background-color:#cc7a00}.label-danger{background-color:#e51c23}.label-danger[href]:hover,.label-danger[href]:focus{background-color:#b9151b}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:normal;color:#ffffff;line-height:1;vertical-align:middle;white-space:nowrap;text-align:center;background-color:#bbbbbb;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-xs .badge,.btn-group-xs>.btn .badge{top:0;padding:1px 5px}a.badge:hover,a.badge:focus{color:#ffffff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#2196f3;background-color:#ffffff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#f9f9f9}.jumbotron h1,.jumbotron .h1{color:#444444}.jumbotron p{margin-bottom:15px;font-size:20px;font-weight:200}.jumbotron>hr{border-top-color:#e0e0e0}.container .jumbotron,.container-fluid .jumbotron{border-radius:3px;padding-left:15px;padding-right:15px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-left:60px;padding-right:60px}.jumbotron h1,.jumbotron .h1{font-size:59px}}.thumbnail{display:block;padding:4px;margin-bottom:23px;line-height:1.846;background-color:#ffffff;border:1px solid #dddddd;border-radius:3px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail>img,.thumbnail a>img{margin-left:auto;margin-right:auto}a.thumbnail:hover,a.thumbnail:focus,a.thumbnail.active{border-color:#2196f3}.thumbnail .caption{padding:9px;color:#666666}.alert{padding:15px;margin-bottom:23px;border:1px solid transparent;border-radius:3px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:bold}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{background-color:#dff0d8;border-color:#d6e9c6;color:#4caf50}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#3d8b40}.alert-info{background-color:#e1bee7;border-color:#cba4dd;color:#9c27b0}.alert-info hr{border-top-color:#c191d6}.alert-info .alert-link{color:#771e86}.alert-warning{background-color:#ffe0b2;border-color:#ffc599;color:#ff9800}.alert-warning hr{border-top-color:#ffb67f}.alert-warning .alert-link{color:#cc7a00}.alert-danger{background-color:#f9bdbb;border-color:#f7a4af;color:#e51c23}.alert-danger hr{border-top-color:#f58c9a}.alert-danger .alert-link{color:#b9151b}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{overflow:hidden;height:23px;margin-bottom:23px;background-color:#f5f5f5;border-radius:3px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,0.1);box-shadow:inset 0 1px 2px rgba(0,0,0,0.1)}.progress-bar{float:left;width:0%;height:100%;font-size:12px;line-height:23px;color:#ffffff;text-align:center;background-color:#2196f3;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,0.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,0.15);-webkit-transition:width 0.6s ease;-o-transition:width 0.6s ease;transition:width 0.6s ease}.progress-striped .progress-bar,.progress-bar-striped{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress.active .progress-bar,.progress-bar.active{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#4caf50}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-info{background-color:#9c27b0}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-warning{background-color:#ff9800}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-danger{background-color:#e51c23}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{zoom:1;overflow:hidden}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-left,.media-right,.media-body{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{margin-bottom:20px;padding-left:0}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#ffffff;border:1px solid #dddddd}.list-group-item:first-child{border-top-right-radius:3px;border-top-left-radius:3px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}a.list-group-item,button.list-group-item{color:#555555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333333}a.list-group-item:hover,button.list-group-item:hover,a.list-group-item:focus,button.list-group-item:focus{text-decoration:none;color:#555555;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:hover,.list-group-item.disabled:focus{background-color:#eeeeee;color:#bbbbbb;cursor:not-allowed}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text{color:#bbbbbb}.list-group-item.active,.list-group-item.active:hover,.list-group-item.active:focus{z-index:2;color:#ffffff;background-color:#2196f3;border-color:#2196f3}.list-group-item.active .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>.small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:hover .list-group-item-text,.list-group-item.active:focus .list-group-item-text{color:#e3f2fd}.list-group-item-success{color:#4caf50;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#4caf50}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:hover,button.list-group-item-success:hover,a.list-group-item-success:focus,button.list-group-item-success:focus{color:#4caf50;background-color:#d0e9c6}a.list-group-item-success.active,button.list-group-item-success.active,a.list-group-item-success.active:hover,button.list-group-item-success.active:hover,a.list-group-item-success.active:focus,button.list-group-item-success.active:focus{color:#fff;background-color:#4caf50;border-color:#4caf50}.list-group-item-info{color:#9c27b0;background-color:#e1bee7}a.list-group-item-info,button.list-group-item-info{color:#9c27b0}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:hover,button.list-group-item-info:hover,a.list-group-item-info:focus,button.list-group-item-info:focus{color:#9c27b0;background-color:#d8abe0}a.list-group-item-info.active,button.list-group-item-info.active,a.list-group-item-info.active:hover,button.list-group-item-info.active:hover,a.list-group-item-info.active:focus,button.list-group-item-info.active:focus{color:#fff;background-color:#9c27b0;border-color:#9c27b0}.list-group-item-warning{color:#ff9800;background-color:#ffe0b2}a.list-group-item-warning,button.list-group-item-warning{color:#ff9800}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:hover,button.list-group-item-warning:hover,a.list-group-item-warning:focus,button.list-group-item-warning:focus{color:#ff9800;background-color:#ffd699}a.list-group-item-warning.active,button.list-group-item-warning.active,a.list-group-item-warning.active:hover,button.list-group-item-warning.active:hover,a.list-group-item-warning.active:focus,button.list-group-item-warning.active:focus{color:#fff;background-color:#ff9800;border-color:#ff9800}.list-group-item-danger{color:#e51c23;background-color:#f9bdbb}a.list-group-item-danger,button.list-group-item-danger{color:#e51c23}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:hover,button.list-group-item-danger:hover,a.list-group-item-danger:focus,button.list-group-item-danger:focus{color:#e51c23;background-color:#f7a6a4}a.list-group-item-danger.active,button.list-group-item-danger.active,a.list-group-item-danger.active:hover,button.list-group-item-danger.active:hover,a.list-group-item-danger.active:focus,button.list-group-item-danger.active:focus{color:#fff;background-color:#e51c23;border-color:#e51c23}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:23px;background-color:#ffffff;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,0.05);box-shadow:0 1px 1px rgba(0,0,0,0.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-right-radius:2px;border-top-left-radius:2px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:15px;color:inherit}.panel-title>a,.panel-title>small,.panel-title>.small,.panel-title>small>a,.panel-title>.small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #dddddd;border-bottom-right-radius:2px;border-bottom-left-radius:2px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-right-radius:2px;border-top-left-radius:2px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:2px;border-bottom-left-radius:2px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-right-radius:0;border-top-left-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.table,.panel>.table-responsive>.table,.panel>.panel-collapse>.table{margin-bottom:0}.panel>.table caption,.panel>.table-responsive>.table caption,.panel>.panel-collapse>.table caption{padding-left:15px;padding-right:15px}.panel>.table:first-child,.panel>.table-responsive:first-child>.table:first-child{border-top-right-radius:2px;border-top-left-radius:2px}.panel>.table:first-child>thead:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child{border-top-left-radius:2px;border-top-right-radius:2px}.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child{border-top-left-radius:2px}.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child{border-top-right-radius:2px}.panel>.table:last-child,.panel>.table-responsive:last-child>.table:last-child{border-bottom-right-radius:2px;border-bottom-left-radius:2px}.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-left-radius:2px;border-bottom-right-radius:2px}.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:2px}.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:2px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #dddddd}.panel>.table>tbody:first-child>tr:first-child th,.panel>.table>tbody:first-child>tr:first-child td{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child{border-left:0}.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child{border-right:0}.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{border:0;margin-bottom:0}.panel-group{margin-bottom:23px}.panel-group .panel{margin-bottom:0;border-radius:3px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.panel-body,.panel-group .panel-heading+.panel-collapse>.list-group{border-top:1px solid #dddddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #dddddd}.panel-default{border-color:#dddddd}.panel-default>.panel-heading{color:#212121;background-color:#f5f5f5;border-color:#dddddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#dddddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#212121}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#dddddd}.panel-primary{border-color:#2196f3}.panel-primary>.panel-heading{color:#ffffff;background-color:#2196f3;border-color:#2196f3}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#2196f3}.panel-primary>.panel-heading .badge{color:#2196f3;background-color:#ffffff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#2196f3}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#ffffff;background-color:#4caf50;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#4caf50;background-color:#ffffff}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#cba4dd}.panel-info>.panel-heading{color:#ffffff;background-color:#9c27b0;border-color:#cba4dd}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#cba4dd}.panel-info>.panel-heading .badge{color:#9c27b0;background-color:#ffffff}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#cba4dd}.panel-warning{border-color:#ffc599}.panel-warning>.panel-heading{color:#ffffff;background-color:#ff9800;border-color:#ffc599}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ffc599}.panel-warning>.panel-heading .badge{color:#ff9800;background-color:#ffffff}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ffc599}.panel-danger{border-color:#f7a4af}.panel-danger>.panel-heading{color:#ffffff;background-color:#e51c23;border-color:#f7a4af}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#f7a4af}.panel-danger>.panel-heading .badge{color:#e51c23;background-color:#ffffff}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#f7a4af}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive iframe,.embed-responsive embed,.embed-responsive object,.embed-responsive video{position:absolute;top:0;left:0;bottom:0;height:100%;width:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f9f9f9;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.05);box-shadow:inset 0 1px 1px rgba(0,0,0,0.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,0.15)}.well-lg{padding:24px;border-radius:3px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:19.5px;font-weight:normal;line-height:1;color:#000000;text-shadow:none;opacity:0.2;filter:alpha(opacity=20)}.close:hover,.close:focus{color:#000000;text-decoration:none;cursor:pointer;opacity:0.5;filter:alpha(opacity=50)}button.close{padding:0;cursor:pointer;background:transparent;border:0;-webkit-appearance:none}.modal-open{overflow:hidden}.modal{display:none;overflow:hidden;position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transform:translate(0, -25%);-ms-transform:translate(0, -25%);-o-transform:translate(0, -25%);transform:translate(0, -25%);-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out}.modal.in .modal-dialog{-webkit-transform:translate(0, 0);-ms-transform:translate(0, 0);-o-transform:translate(0, 0);transform:translate(0, 0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#ffffff;border:1px solid #999999;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:0 3px 9px rgba(0,0,0,0.5);box-shadow:0 3px 9px rgba(0,0,0,0.5);-webkit-background-clip:padding-box;background-clip:padding-box;outline:0}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000000}.modal-backdrop.fade{opacity:0;filter:alpha(opacity=0)}.modal-backdrop.in{opacity:0.5;filter:alpha(opacity=50)}.modal-header{padding:15px;border-bottom:1px solid transparent}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.846}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid transparent}.modal-footer .btn+.btn{margin-left:5px;margin-bottom:0}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,0.5);box-shadow:0 5px 15px rgba(0,0,0,0.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Roboto","Helvetica Neue",Helvetica,Arial,sans-serif;font-style:normal;font-weight:normal;letter-spacing:normal;line-break:auto;line-height:1.846;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;white-space:normal;word-break:normal;word-spacing:normal;word-wrap:normal;font-size:12px;opacity:0;filter:alpha(opacity=0)}.tooltip.in{opacity:0.9;filter:alpha(opacity=90)}.tooltip.top{margin-top:-3px;padding:5px 0}.tooltip.right{margin-left:3px;padding:0 5px}.tooltip.bottom{margin-top:3px;padding:5px 0}.tooltip.left{margin-left:-3px;padding:0 5px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#ffffff;text-align:center;background-color:#727272;border-radius:3px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#727272}.tooltip.top-left .tooltip-arrow{bottom:0;right:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#727272}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#727272}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#727272}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#727272}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#727272}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#727272}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#727272}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Roboto","Helvetica Neue",Helvetica,Arial,sans-serif;font-style:normal;font-weight:normal;letter-spacing:normal;line-break:auto;line-height:1.846;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;white-space:normal;word-break:normal;word-spacing:normal;word-wrap:normal;font-size:13px;background-color:#ffffff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid transparent;border-radius:3px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,0.2);box-shadow:0 5px 10px rgba(0,0,0,0.2)}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{margin:0;padding:8px 14px;font-size:13px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:2px 2px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{border-width:10px;content:""}.popover.top>.arrow{left:50%;margin-left:-11px;border-bottom-width:0;border-top-color:rgba(0,0,0,0);border-top-color:rgba(0,0,0,0.075);bottom:-11px}.popover.top>.arrow:after{content:" ";bottom:1px;margin-left:-10px;border-bottom-width:0;border-top-color:#ffffff}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-left-width:0;border-right-color:rgba(0,0,0,0);border-right-color:rgba(0,0,0,0.075)}.popover.right>.arrow:after{content:" ";left:1px;bottom:-10px;border-left-width:0;border-right-color:#ffffff}.popover.bottom>.arrow{left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:rgba(0,0,0,0);border-bottom-color:rgba(0,0,0,0.075);top:-11px}.popover.bottom>.arrow:after{content:" ";top:1px;margin-left:-10px;border-top-width:0;border-bottom-color:#ffffff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:rgba(0,0,0,0);border-left-color:rgba(0,0,0,0.075)}.popover.left>.arrow:after{content:" ";right:1px;border-right-width:0;border-left-color:#ffffff;bottom:-10px}.carousel{position:relative}.carousel-inner{position:relative;overflow:hidden;width:100%}.carousel-inner>.item{display:none;position:relative;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>img,.carousel-inner>.item>a>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.next,.carousel-inner>.item.active.right{-webkit-transform:translate3d(100%, 0, 0);transform:translate3d(100%, 0, 0);left:0}.carousel-inner>.item.prev,.carousel-inner>.item.active.left{-webkit-transform:translate3d(-100%, 0, 0);transform:translate3d(-100%, 0, 0);left:0}.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right,.carousel-inner>.item.active{-webkit-transform:translate3d(0, 0, 0);transform:translate3d(0, 0, 0);left:0}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;left:0;bottom:0;width:15%;opacity:0.5;filter:alpha(opacity=50);font-size:20px;color:#ffffff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,0.6);background-color:rgba(0,0,0,0)}.carousel-control.left{background-image:-webkit-linear-gradient(left, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-image:-o-linear-gradient(left, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-image:-webkit-gradient(linear, left top, right top, from(rgba(0,0,0,0.5)), to(rgba(0,0,0,0.0001)));background-image:linear-gradient(to right, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1)}.carousel-control.right{left:auto;right:0;background-image:-webkit-linear-gradient(left, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-image:-o-linear-gradient(left, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-image:-webkit-gradient(linear, left top, right top, from(rgba(0,0,0,0.0001)), to(rgba(0,0,0,0.5)));background-image:linear-gradient(to right, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1)}.carousel-control:hover,.carousel-control:focus{outline:0;color:#ffffff;text-decoration:none;opacity:0.9;filter:alpha(opacity=90)}.carousel-control .icon-prev,.carousel-control .icon-next,.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right{position:absolute;top:50%;margin-top:-10px;z-index:5;display:inline-block}.carousel-control .icon-prev,.carousel-control .glyphicon-chevron-left{left:50%;margin-left:-10px}.carousel-control .icon-next,.carousel-control .glyphicon-chevron-right{right:50%;margin-right:-10px}.carousel-control .icon-prev,.carousel-control .icon-next{width:20px;height:20px;line-height:1;font-family:serif}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;margin-left:-30%;padding-left:0;list-style:none;text-align:center}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;border:1px solid #ffffff;border-radius:10px;cursor:pointer;background-color:#000 \9;background-color:rgba(0,0,0,0)}.carousel-indicators .active{margin:0;width:12px;height:12px;background-color:#ffffff}.carousel-caption{position:absolute;left:15%;right:15%;bottom:20px;z-index:10;padding-top:20px;padding-bottom:20px;color:#ffffff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,0.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-prev,.carousel-control .icon-next{width:30px;height:30px;margin-top:-10px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-10px}.carousel-caption{left:20%;right:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.clearfix:before,.clearfix:after,.dl-horizontal dd:before,.dl-horizontal dd:after,.container:before,.container:after,.container-fluid:before,.container-fluid:after,.row:before,.row:after,.form-horizontal .form-group:before,.form-horizontal .form-group:after,.btn-toolbar:before,.btn-toolbar:after,.btn-group-vertical>.btn-group:before,.btn-group-vertical>.btn-group:after,.nav:before,.nav:after,.navbar:before,.navbar:after,.navbar-header:before,.navbar-header:after,.navbar-collapse:before,.navbar-collapse:after,.pager:before,.pager:after,.panel-body:before,.panel-body:after,.modal-header:before,.modal-header:after,.modal-footer:before,.modal-footer:after{content:" ";display:table}.clearfix:after,.dl-horizontal dd:after,.container:after,.container-fluid:after,.row:after,.form-horizontal .form-group:after,.btn-toolbar:after,.btn-group-vertical>.btn-group:after,.nav:after,.navbar:after,.navbar-header:after,.navbar-collapse:after,.pager:after,.panel-body:after,.modal-header:after,.modal-footer:after{clear:both}.center-block{display:block;margin-left:auto;margin-right:auto}.pull-right{float:right !important}.pull-left{float:left !important}.hide{display:none !important}.show{display:block !important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none !important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-xs,.visible-sm,.visible-md,.visible-lg{display:none !important}.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block{display:none !important}@media (max-width:767px){.visible-xs{display:block !important}table.visible-xs{display:table !important}tr.visible-xs{display:table-row !important}th.visible-xs,td.visible-xs{display:table-cell !important}}@media (max-width:767px){.visible-xs-block{display:block !important}}@media (max-width:767px){.visible-xs-inline{display:inline !important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block !important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block !important}table.visible-sm{display:table !important}tr.visible-sm{display:table-row !important}th.visible-sm,td.visible-sm{display:table-cell !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block !important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block !important}table.visible-md{display:table !important}tr.visible-md{display:table-row !important}th.visible-md,td.visible-md{display:table-cell !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block !important}}@media (min-width:1200px){.visible-lg{display:block !important}table.visible-lg{display:table !important}tr.visible-lg{display:table-row !important}th.visible-lg,td.visible-lg{display:table-cell !important}}@media (min-width:1200px){.visible-lg-block{display:block !important}}@media (min-width:1200px){.visible-lg-inline{display:inline !important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block !important}}@media (max-width:767px){.hidden-xs{display:none !important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none !important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none !important}}@media (min-width:1200px){.hidden-lg{display:none !important}}.visible-print{display:none !important}@media print{.visible-print{display:block !important}table.visible-print{display:table !important}tr.visible-print{display:table-row !important}th.visible-print,td.visible-print{display:table-cell !important}}.visible-print-block{display:none !important}@media print{.visible-print-block{display:block !important}}.visible-print-inline{display:none !important}@media print{.visible-print-inline{display:inline !important}}.visible-print-inline-block{display:none !important}@media print{.visible-print-inline-block{display:inline-block !important}}@media print{.hidden-print{display:none !important}}.navbar{border:none;-webkit-box-shadow:0 1px 2px rgba(0,0,0,0.3);box-shadow:0 1px 2px rgba(0,0,0,0.3)}.navbar-brand{font-size:24px}.navbar-inverse .navbar-form input[type=text],.navbar-inverse .navbar-form input[type=password]{color:#fff;-webkit-box-shadow:inset 0 -1px 0 #b2dbfb;box-shadow:inset 0 -1px 0 #b2dbfb}.navbar-inverse .navbar-form input[type=text]::-moz-placeholder,.navbar-inverse .navbar-form input[type=password]::-moz-placeholder{color:#b2dbfb;opacity:1}.navbar-inverse .navbar-form input[type=text]:-ms-input-placeholder,.navbar-inverse .navbar-form input[type=password]:-ms-input-placeholder{color:#b2dbfb}.navbar-inverse .navbar-form input[type=text]::-webkit-input-placeholder,.navbar-inverse .navbar-form input[type=password]::-webkit-input-placeholder{color:#b2dbfb}.navbar-inverse .navbar-form input[type=text]:focus,.navbar-inverse .navbar-form input[type=password]:focus{-webkit-box-shadow:inset 0 -2px 0 #fff;box-shadow:inset 0 -2px 0 #fff}.btn-default{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-default:focus{background-color:#ffffff}.btn-default:hover,.btn-default:active:hover{background-color:#f0f0f0}.btn-default:active{background-color:#e0e0e0;background-image:-webkit-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:-o-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-primary{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-primary:focus{background-color:#2196f3}.btn-primary:hover,.btn-primary:active:hover{background-color:#0d87e9}.btn-primary:active{background-color:#0b76cc;background-image:-webkit-radial-gradient(circle, #0b76cc 10%, #2196f3 11%);background-image:-o-radial-gradient(circle, #0b76cc 10%, #2196f3 11%);background-image:radial-gradient(circle, #0b76cc 10%, #2196f3 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-success{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-success:focus{background-color:#4caf50}.btn-success:hover,.btn-success:active:hover{background-color:#439a46}.btn-success:active{background-color:#39843c;background-image:-webkit-radial-gradient(circle, #39843c 10%, #4caf50 11%);background-image:-o-radial-gradient(circle, #39843c 10%, #4caf50 11%);background-image:radial-gradient(circle, #39843c 10%, #4caf50 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-info{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-info:focus{background-color:#9c27b0}.btn-info:hover,.btn-info:active:hover{background-color:#862197}.btn-info:active{background-color:#701c7e;background-image:-webkit-radial-gradient(circle, #701c7e 10%, #9c27b0 11%);background-image:-o-radial-gradient(circle, #701c7e 10%, #9c27b0 11%);background-image:radial-gradient(circle, #701c7e 10%, #9c27b0 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-warning{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-warning:focus{background-color:#ff9800}.btn-warning:hover,.btn-warning:active:hover{background-color:#e08600}.btn-warning:active{background-color:#c27400;background-image:-webkit-radial-gradient(circle, #c27400 10%, #ff9800 11%);background-image:-o-radial-gradient(circle, #c27400 10%, #ff9800 11%);background-image:radial-gradient(circle, #c27400 10%, #ff9800 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-danger{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-danger:focus{background-color:#e51c23}.btn-danger:hover,.btn-danger:active:hover{background-color:#cb171e}.btn-danger:active{background-color:#b0141a;background-image:-webkit-radial-gradient(circle, #b0141a 10%, #e51c23 11%);background-image:-o-radial-gradient(circle, #b0141a 10%, #e51c23 11%);background-image:radial-gradient(circle, #b0141a 10%, #e51c23 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn-link{-webkit-background-size:200% 200%;background-size:200%;background-position:50%}.btn-link:focus{background-color:#ffffff}.btn-link:hover,.btn-link:active:hover{background-color:#f0f0f0}.btn-link:active{background-color:#e0e0e0;background-image:-webkit-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:-o-radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-image:radial-gradient(circle, #e0e0e0 10%, #fff 11%);background-repeat:no-repeat;-webkit-background-size:1000% 1000%;background-size:1000%;-webkit-box-shadow:2px 2px 4px rgba(0,0,0,0.4);box-shadow:2px 2px 4px rgba(0,0,0,0.4)}.btn{text-transform:uppercase;border:none;-webkit-box-shadow:1px 1px 4px rgba(0,0,0,0.4);box-shadow:1px 1px 4px rgba(0,0,0,0.4);-webkit-transition:all 0.4s;-o-transition:all 0.4s;transition:all 0.4s}.btn-link{border-radius:3px;-webkit-box-shadow:none;box-shadow:none;color:#444444}.btn-link:hover,.btn-link:focus{-webkit-box-shadow:none;box-shadow:none;color:#444444;text-decoration:none}.btn-default.disabled{background-color:rgba(0,0,0,0.1);color:rgba(0,0,0,0.4);opacity:1}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:0}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:0}body{-webkit-font-smoothing:antialiased;letter-spacing:.1px}p{margin:0 0 1em}input,button{-webkit-font-smoothing:antialiased;letter-spacing:.1px}a{-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}.table-hover>tbody>tr,.table-hover>tbody>tr>th,.table-hover>tbody>tr>td{-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}label{font-weight:normal}textarea,textarea.form-control,input.form-control,input[type=text],input[type=password],input[type=email],input[type=number],[type=text].form-control,[type=password].form-control,[type=email].form-control,[type=tel].form-control,[contenteditable].form-control{padding:0;border:none;border-radius:0;-webkit-appearance:none;-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd;font-size:16px}textarea:focus,textarea.form-control:focus,input.form-control:focus,input[type=text]:focus,input[type=password]:focus,input[type=email]:focus,input[type=number]:focus,[type=text].form-control:focus,[type=password].form-control:focus,[type=email].form-control:focus,[type=tel].form-control:focus,[contenteditable].form-control:focus{-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3}textarea[disabled],textarea.form-control[disabled],input.form-control[disabled],input[type=text][disabled],input[type=password][disabled],input[type=email][disabled],input[type=number][disabled],[type=text].form-control[disabled],[type=password].form-control[disabled],[type=email].form-control[disabled],[type=tel].form-control[disabled],[contenteditable].form-control[disabled],textarea[readonly],textarea.form-control[readonly],input.form-control[readonly],input[type=text][readonly],input[type=password][readonly],input[type=email][readonly],input[type=number][readonly],[type=text].form-control[readonly],[type=password].form-control[readonly],[type=email].form-control[readonly],[type=tel].form-control[readonly],[contenteditable].form-control[readonly]{-webkit-box-shadow:none;box-shadow:none;border-bottom:1px dotted #ddd}textarea.input-sm,textarea.form-control.input-sm,input.form-control.input-sm,input[type=text].input-sm,input[type=password].input-sm,input[type=email].input-sm,input[type=number].input-sm,[type=text].form-control.input-sm,[type=password].form-control.input-sm,[type=email].form-control.input-sm,[type=tel].form-control.input-sm,[contenteditable].form-control.input-sm{font-size:12px}textarea.input-lg,textarea.form-control.input-lg,input.form-control.input-lg,input[type=text].input-lg,input[type=password].input-lg,input[type=email].input-lg,input[type=number].input-lg,[type=text].form-control.input-lg,[type=password].form-control.input-lg,[type=email].form-control.input-lg,[type=tel].form-control.input-lg,[contenteditable].form-control.input-lg{font-size:17px}select,select.form-control{border:0;border-radius:0;-webkit-appearance:none;-moz-appearance:none;appearance:none;padding-left:0;padding-right:0\9;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABoAAAAaCAMAAACelLz8AAAAJ1BMVEVmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmZmaP/QSjAAAADHRSTlMAAgMJC0uWpKa6wMxMdjkoAAAANUlEQVR4AeXJyQEAERAAsNl7Hf3X6xt0QL6JpZWq30pdvdadme+0PMdzvHm8YThHcT1H7K0BtOMDniZhWOgAAAAASUVORK5CYII=);-webkit-background-size:13px 13px;background-size:13px;background-repeat:no-repeat;background-position:right center;-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd;font-size:16px;line-height:1.5}select::-ms-expand,select.form-control::-ms-expand{display:none}select.input-sm,select.form-control.input-sm{font-size:12px}select.input-lg,select.form-control.input-lg{font-size:17px}select:focus,select.form-control:focus{-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABoAAAAaCAMAAACelLz8AAAAJ1BMVEUhISEhISEhISEhISEhISEhISEhISEhISEhISEhISEhISEhISEhISF8S9ewAAAADHRSTlMAAgMJC0uWpKa6wMxMdjkoAAAANUlEQVR4AeXJyQEAERAAsNl7Hf3X6xt0QL6JpZWq30pdvdadme+0PMdzvHm8YThHcT1H7K0BtOMDniZhWOgAAAAASUVORK5CYII=)}select[multiple],select.form-control[multiple]{background:none}.radio label,.radio-inline label,.checkbox label,.checkbox-inline label{padding-left:25px}.radio input[type="radio"],.radio-inline input[type="radio"],.checkbox input[type="radio"],.checkbox-inline input[type="radio"],.radio input[type="checkbox"],.radio-inline input[type="checkbox"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{margin-left:-25px}input[type="radio"],.radio input[type="radio"],.radio-inline input[type="radio"]{position:relative;margin-top:6px;margin-right:4px;vertical-align:top;border:none;background-color:transparent;-webkit-appearance:none;appearance:none;cursor:pointer}input[type="radio"]:focus,.radio input[type="radio"]:focus,.radio-inline input[type="radio"]:focus{outline:none}input[type="radio"]:before,.radio input[type="radio"]:before,.radio-inline input[type="radio"]:before,input[type="radio"]:after,.radio input[type="radio"]:after,.radio-inline input[type="radio"]:after{content:"";display:block;width:18px;height:18px;border-radius:50%;-webkit-transition:240ms;-o-transition:240ms;transition:240ms}input[type="radio"]:before,.radio input[type="radio"]:before,.radio-inline input[type="radio"]:before{position:absolute;left:0;top:-3px;background-color:#2196f3;-webkit-transform:scale(0);-ms-transform:scale(0);-o-transform:scale(0);transform:scale(0)}input[type="radio"]:after,.radio input[type="radio"]:after,.radio-inline input[type="radio"]:after{position:relative;top:-3px;border:2px solid #666666}input[type="radio"]:checked:before,.radio input[type="radio"]:checked:before,.radio-inline input[type="radio"]:checked:before{-webkit-transform:scale(.5);-ms-transform:scale(.5);-o-transform:scale(.5);transform:scale(.5)}input[type="radio"]:disabled:checked:before,.radio input[type="radio"]:disabled:checked:before,.radio-inline input[type="radio"]:disabled:checked:before{background-color:#bbbbbb}input[type="radio"]:checked:after,.radio input[type="radio"]:checked:after,.radio-inline input[type="radio"]:checked:after{border-color:#2196f3}input[type="radio"]:disabled:after,.radio input[type="radio"]:disabled:after,.radio-inline input[type="radio"]:disabled:after,input[type="radio"]:disabled:checked:after,.radio input[type="radio"]:disabled:checked:after,.radio-inline input[type="radio"]:disabled:checked:after{border-color:#bbbbbb}input[type="checkbox"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{position:relative;border:none;margin-bottom:-4px;-webkit-appearance:none;appearance:none;cursor:pointer}input[type="checkbox"]:focus,.checkbox input[type="checkbox"]:focus,.checkbox-inline input[type="checkbox"]:focus{outline:none}input[type="checkbox"]:focus:after,.checkbox input[type="checkbox"]:focus:after,.checkbox-inline input[type="checkbox"]:focus:after{border-color:#2196f3}input[type="checkbox"]:after,.checkbox input[type="checkbox"]:after,.checkbox-inline input[type="checkbox"]:after{content:"";display:block;width:18px;height:18px;margin-top:-2px;margin-right:5px;border:2px solid #666666;border-radius:2px;-webkit-transition:240ms;-o-transition:240ms;transition:240ms}input[type="checkbox"]:checked:before,.checkbox input[type="checkbox"]:checked:before,.checkbox-inline input[type="checkbox"]:checked:before{content:"";position:absolute;top:0;left:6px;display:table;width:6px;height:12px;border:2px solid #fff;border-top-width:0;border-left-width:0;-webkit-transform:rotate(45deg);-ms-transform:rotate(45deg);-o-transform:rotate(45deg);transform:rotate(45deg)}input[type="checkbox"]:checked:after,.checkbox input[type="checkbox"]:checked:after,.checkbox-inline input[type="checkbox"]:checked:after{background-color:#2196f3;border-color:#2196f3}input[type="checkbox"]:disabled:after,.checkbox input[type="checkbox"]:disabled:after,.checkbox-inline input[type="checkbox"]:disabled:after{border-color:#bbbbbb}input[type="checkbox"]:disabled:checked:after,.checkbox input[type="checkbox"]:disabled:checked:after,.checkbox-inline input[type="checkbox"]:disabled:checked:after{background-color:#bbbbbb;border-color:transparent}.has-warning input:not([type=checkbox]),.has-warning .form-control,.has-warning input.form-control[readonly],.has-warning input[type=text][readonly],.has-warning [type=text].form-control[readonly],.has-warning input:not([type=checkbox]):focus,.has-warning .form-control:focus{border-bottom:none;-webkit-box-shadow:inset 0 -2px 0 #ff9800;box-shadow:inset 0 -2px 0 #ff9800}.has-error input:not([type=checkbox]),.has-error .form-control,.has-error input.form-control[readonly],.has-error input[type=text][readonly],.has-error [type=text].form-control[readonly],.has-error input:not([type=checkbox]):focus,.has-error .form-control:focus{border-bottom:none;-webkit-box-shadow:inset 0 -2px 0 #e51c23;box-shadow:inset 0 -2px 0 #e51c23}.has-success input:not([type=checkbox]),.has-success .form-control,.has-success input.form-control[readonly],.has-success input[type=text][readonly],.has-success [type=text].form-control[readonly],.has-success input:not([type=checkbox]):focus,.has-success .form-control:focus{border-bottom:none;-webkit-box-shadow:inset 0 -2px 0 #4caf50;box-shadow:inset 0 -2px 0 #4caf50}.has-warning .input-group-addon,.has-error .input-group-addon,.has-success .input-group-addon{color:#666666;border-color:transparent;background-color:transparent}.nav-tabs>li>a,.nav-tabs>li>a:focus{margin-right:0;background-color:transparent;border:none;color:#666666;-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd;-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}.nav-tabs>li>a:hover,.nav-tabs>li>a:focus:hover{background-color:transparent;-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3;color:#2196f3}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus{border:none;-webkit-box-shadow:inset 0 -2px 0 #2196f3;box-shadow:inset 0 -2px 0 #2196f3;color:#2196f3}.nav-tabs>li.active>a:hover,.nav-tabs>li.active>a:focus:hover{border:none;color:#2196f3}.nav-tabs>li.disabled>a{-webkit-box-shadow:inset 0 -1px 0 #ddd;box-shadow:inset 0 -1px 0 #ddd}.nav-tabs.nav-justified>li>a,.nav-tabs.nav-justified>li>a:hover,.nav-tabs.nav-justified>li>a:focus,.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border:none}.nav-tabs .dropdown-menu{margin-top:0}.dropdown-menu{margin-top:0;border:none;-webkit-box-shadow:0 1px 4px rgba(0,0,0,0.3);box-shadow:0 1px 4px rgba(0,0,0,0.3)}.alert{border:none;color:#fff}.alert-success{background-color:#4caf50}.alert-info{background-color:#9c27b0}.alert-warning{background-color:#ff9800}.alert-danger{background-color:#e51c23}.alert a:not(.close),.alert .alert-link{color:#fff;font-weight:bold}.alert .close{color:#fff}.badge{padding:4px 6px 4px}.progress{position:relative;z-index:1;height:6px;border-radius:0;-webkit-box-shadow:none;box-shadow:none}.progress-bar{-webkit-box-shadow:none;box-shadow:none}.progress-bar:last-child{border-radius:0 3px 3px 0}.progress-bar:last-child:before{display:block;content:"";position:absolute;width:100%;height:100%;left:0;right:0;z-index:-1;background-color:#cae6fc}.progress-bar-success:last-child.progress-bar:before{background-color:#c7e7c8}.progress-bar-info:last-child.progress-bar:before{background-color:#edc9f3}.progress-bar-warning:last-child.progress-bar:before{background-color:#ffe0b3}.progress-bar-danger:last-child.progress-bar:before{background-color:#f28e92}.close{font-size:34px;font-weight:300;line-height:24px;opacity:0.6;-webkit-transition:all 0.2s;-o-transition:all 0.2s;transition:all 0.2s}.close:hover{opacity:1}.list-group-item{padding:15px}.list-group-item-text{color:#bbbbbb}.well{border-radius:0;-webkit-box-shadow:none;box-shadow:none}.panel{border:none;border-radius:2px;-webkit-box-shadow:0 1px 4px rgba(0,0,0,0.3);box-shadow:0 1px 4px rgba(0,0,0,0.3)}.panel-heading{border-bottom:none}.panel-footer{border-top:none}.popover{border:none;-webkit-box-shadow:0 1px 4px rgba(0,0,0,0.3);box-shadow:0 1px 4px rgba(0,0,0,0.3)}.carousel-caption h1,.carousel-caption h2,.carousel-caption h3,.carousel-caption h4,.carousel-caption h5,.carousel-caption h6{color:inherit}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<style>h1 {font-size: 34px;}
h1.title {font-size: 38px;}
h2 {font-size: 30px;}
h3 {font-size: 24px;}
h4 {font-size: 18px;}
h5 {font-size: 16px;}
h6 {font-size: 12px;}
code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
pre:not([class]) { background-color: white }</style>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ background-color: #f8f8f8; }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ef2929; } 
code span.an { color: #8f5902; font-weight: bold; font-style: italic; } 
code span.at { color: #c4a000; } 
code span.bn { color: #0000cf; } 
code span.cf { color: #204a87; font-weight: bold; } 
code span.ch { color: #4e9a06; } 
code span.cn { color: #000000; } 
code span.co { color: #8f5902; font-style: italic; } 
code span.cv { color: #8f5902; font-weight: bold; font-style: italic; } 
code span.do { color: #8f5902; font-weight: bold; font-style: italic; } 
code span.dt { color: #204a87; } 
code span.dv { color: #0000cf; } 
code span.er { color: #a40000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #0000cf; } 
code span.fu { color: #000000; } 
code span.im { } 
code span.in { color: #8f5902; font-weight: bold; font-style: italic; } 
code span.kw { color: #204a87; font-weight: bold; } 
code span.op { color: #ce5c00; font-weight: bold; } 
code span.ot { color: #8f5902; } 
code span.pp { color: #8f5902; font-style: italic; } 
code span.sc { color: #000000; } 
code span.ss { color: #4e9a06; } 
code span.st { color: #4e9a06; } 
code span.va { color: #000000; } 
code span.vs { color: #4e9a06; } 
code span.wa { color: #8f5902; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>







<style type="text/css">
.main-container {
max-width: 940px;
margin-left: auto;
margin-right: auto;
}
img {
max-width:100%;
}
.tabbed-pane {
padding-top: 12px;
}
.html-widget {
margin-bottom: 20px;
}
button.code-folding-btn:focus {
outline: none;
}
summary {
display: list-item;
}
details > summary > p:only-child {
display: inline;
}
pre code {
padding: 0;
}
</style>



<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
display: inline-table;
max-height: 500px;
min-height: 44px;
overflow-y: auto;
border: 1px solid #ddd;
border-radius: 4px;
}
.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
content: "\e259";
font-family: 'Glyphicons Halflings';
display: inline-block;
padding: 10px;
border-right: 1px solid #ddd;
}
.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
content: "\e258";
font-family: 'Glyphicons Halflings';
border: none;
}
.tabset-dropdown > .nav-tabs > li.active {
display: block;
}
.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
border: none;
display: inline-block;
border-radius: 4px;
background-color: transparent;
}
.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
display: block;
float: none;
}
.tabset-dropdown > .nav-tabs > li {
display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div id="header">



<h1 class="title toc-ignore">BMIN503/EPID600 Project Template</h1>
<h4 class="author">Godefroy Chery</h4>

</div>


<hr />
<p>Use this template to complete your project throughout the course.
Your Final Project presentation will be based on the contents of this
document. Replace the title/name above and text below with your own, but
keep the headers. Feel free to change the theme and other display
settings, but this is not required.</p>
<div id="overview" class="section level3">
<h3>Overview</h3>
<p>For this project, we are seeking to determine the feasibility,
diagnostic and predictive power of unstructured text data (from medical
notes) to diagnose heart failure with reduced ejection fraction (HFrEF).
We are using the Medical Information Mart for Intensive Care (MIMIC)-III
dataset for this project. Specifically, we are seeking to determine the
feasibility of extracting pertinent components of the unstructured text
of medical note (e.g.discharge summary) using natural language
processing (NLP) methods to assist in making a heart failure diagnosis.
Secondarily, we aim to compare the diagnostic and predictic power of the
unstructured text to conventional factors in making a heart failure
diagnosis.</p>
</div>
<div id="introduction" class="section level3">
<h3>Introduction</h3>
<p>Heart failure (HF) is a progressive clinical syndrome resulting from
any structural or functional cardiac disorder that impairs ability of
the ventricle to fill or eject blood. It carries a poor prognosis with
50% mortality within the first 5 years of diagnosis, and is associated
with significant co-morbidity and remarkable decrease in quality of life
and functional status. Unfortunately, recent data suggest HF-associated
mortality and morbidity are on the rise. While the reason for the
HF-related poor outcomes is multifactorial, underdiagnosis and
time-sensitive diagnosis play a significant contributory role leading to
poor cardiovascular outcomes. This is mainly because the diagnosis of
heart failure is a clinical and thus, it requires compilation of various
data points including detailed and thorough history and physical
exam.</p>
</div>
<div id="methods" class="section level3">
<h3>Methods</h3>
<p>For this project, we are using MIMIC-III which is a large,
freely-available database comprising deidentified health-related data
associated with over forty thousand patients who stayed in critical care
units of the Beth Israel Deaconess Medical Center between 2001 and 2012.
This is a vast dataset with many variables and limited access. It comes
in form of various datasets which were then cleaned. Datatables
containing basic demographics, ICD codes and note events were then
merged. Heart failure with reduced ejection fraction (HFrEF) definition
(using definition from <a href="https://phekb.org/" class="uri">https://phekb.org/</a> was used to define case and control
populations.</p>
<p>#Retrieving datatables</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(data.table)</span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(ggplot2)</span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span></code></pre></div>
<pre><code>## 
## Attaching package: &#39;dplyr&#39;</code></pre>
<pre><code>## The following objects are masked from &#39;package:data.table&#39;:
## 
##     between, first, last</code></pre>
<pre><code>## The following objects are masked from &#39;package:stats&#39;:
## 
##     filter, lag</code></pre>
<pre><code>## The following objects are masked from &#39;package:base&#39;:
## 
##     intersect, setdiff, setequal, union</code></pre>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(magrittr)</span>
<span id="cb6-2"><a href="#cb6-2" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(pROC)</span></code></pre></div>
<pre><code>## Type &#39;citation(&quot;pROC&quot;)&#39; for a citation.</code></pre>
<pre><code>## 
## Attaching package: &#39;pROC&#39;</code></pre>
<pre><code>## The following objects are masked from &#39;package:stats&#39;:
## 
##     cov, smooth, var</code></pre>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" aria-hidden="true" tabindex="-1"></a>NOTEEVENTS <span class="ot">&lt;-</span> <span class="fu">read.csv</span>(<span class="st">&quot;~/Downloads/NOTEEVENTS.csv&quot;</span>, <span class="at">comment.char=</span><span class="st">&quot;#&quot;</span>)</span>
<span id="cb10-2"><a href="#cb10-2" aria-hidden="true" tabindex="-1"></a>PATIENTS <span class="ot">&lt;-</span> <span class="fu">read.csv</span>(<span class="st">&quot;~/Downloads/PATIENTS.csv&quot;</span>)</span>
<span id="cb10-3"><a href="#cb10-3" aria-hidden="true" tabindex="-1"></a><span class="co">#Diagnoses_icd_2 &lt;- read.csv(&quot;~/Downloads/DIAGNOSES_ICD (1).csv&quot;, header=TRUE)</span></span>
<span id="cb10-4"><a href="#cb10-4" aria-hidden="true" tabindex="-1"></a>DIAGNOSES_ICD_3 <span class="ot">&lt;-</span>  <span class="fu">read.csv</span>(<span class="st">&quot;~/Downloads/DIAGNOSES_ICD_3.csv&quot;</span>, <span class="at">header=</span><span class="cn">TRUE</span>)</span>
<span id="cb10-5"><a href="#cb10-5" aria-hidden="true" tabindex="-1"></a>DIAGNOSES_ICD <span class="ot">&lt;-</span> DIAGNOSES_ICD_3</span>
<span id="cb10-6"><a href="#cb10-6" aria-hidden="true" tabindex="-1"></a>ADMISSIONS <span class="ot">&lt;-</span> <span class="fu">read.csv</span>(<span class="st">&quot;~/Downloads/ADMISSIONS.csv&quot;</span>, <span class="at">header=</span><span class="cn">TRUE</span>)</span></code></pre></div>
<p>#Query the data, QI and cleaning</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Quering the dataset</span></span>
<span id="cb11-2"><a href="#cb11-2" aria-hidden="true" tabindex="-1"></a><span class="fu">head</span>(PATIENTS)</span></code></pre></div>
<pre><code>##   ROW_ID SUBJECT_ID GENDER                 DOB                 DOD
## 1    234        249      F 2075-03-13 00:00:00                    
## 2    235        250      F 2164-12-27 00:00:00 2188-11-22 00:00:00
## 3    236        251      M 2090-03-15 00:00:00                    
## 4    237        252      M 2078-03-06 00:00:00                    
## 5    238        253      F 2089-11-26 00:00:00                    
## 6    239        255      M 2109-08-05 00:00:00                    
##              DOD_HOSP DOD_SSN EXPIRE_FLAG
## 1                                       0
## 2 2188-11-22 00:00:00                   1
## 3                                       0
## 4                                       0
## 5                                       0
## 6                                       0</code></pre>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" aria-hidden="true" tabindex="-1"></a><span class="fu">head</span>(DIAGNOSES_ICD)</span></code></pre></div>
<pre><code>##   ROW_ID SUBJECT_ID HADM_ID SEQ_NUM ICD9_CODE
## 1   1297        109  172335       1     40301
## 2   1298        109  172335       2       486
## 3   1299        109  172335       3     58281
## 4   1300        109  172335       4      5855
## 5   1301        109  172335       5      4254
## 6   1302        109  172335       6      2762</code></pre>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" aria-hidden="true" tabindex="-1"></a><span class="fu">head</span>(NOTEEVENTS)</span></code></pre></div>
<pre><code>##   ROW_ID SUBJECT_ID HADM_ID  CHARTDATE CHARTTIME STORETIME          CATEGORY
## 1    174      22532  167853 2151-08-04                     Discharge summary
## 2    175      13702  107527 2118-06-14                     Discharge summary
## 3    176      13702  167118 2119-05-25                     Discharge summary
## 4    177      13702  196489 2124-08-18                     Discharge summary
## 5    178      26880  135453 2162-03-25                     Discharge summary
## 6    179      53181  170490 2172-03-08                     Discharge summary
##   DESCRIPTION CGID ISERROR
## 1      Report   NA      NA
## 2      Report   NA      NA
## 3      Report   NA      NA
## 4      Report   NA      NA
## 5      Report   NA      NA
## 6      Report   NA      NA
##                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  TEXT
## 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Admission Date:  [**2151-7-16**]       Discharge Date:  [**2151-8-4**]\n\n\nService:\nADDENDUM:\n\nRADIOLOGIC STUDIES:  Radiologic studies also included a chest\nCT, which confirmed cavitary lesions in the left lung apex\nconsistent with infectious process/tuberculosis.  This also\nmoderate-sized left pleural effusion.\n\nHEAD CT:  Head CT showed no intracranial hemorrhage or mass\neffect, but old infarction consistent with past medical\nhistory.\n\nABDOMINAL CT:  Abdominal CT showed lesions of\nT10 and sacrum most likely secondary to osteoporosis. These can\nbe followed by repeat imaging as an outpatient.\n\n\n\n                            [**First Name8 (NamePattern2) **] [**First Name4 (NamePattern1) 1775**] [**Last Name (NamePattern1) **], M.D.  [**MD Number(1) 1776**]\n\nDictated By:[**Hospital 1807**]\nMEDQUIST36\n\nD:  [**2151-8-5**]  12:11\nT:  [**2151-8-5**]  12:21\nJOB#:  [**Job Number 1808**]\n
## 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Admission Date:  [**2118-6-2**]       Discharge Date:  [**2118-6-14**]\n\nDate of Birth:                    Sex:  F\n\nService:  MICU and then to [**Doctor Last Name **] Medicine\n\nHISTORY OF PRESENT ILLNESS:  This is an 81-year-old female\nwith a history of emphysema (not on home O2), who presents\nwith three days of shortness of breath thought by her primary\ncare doctor to be a COPD flare.  Two days prior to admission,\nshe was started on a prednisone taper and one day prior to\nadmission she required oxygen at home in order to maintain\noxygen saturation greater than 90%.  She has also been on\nlevofloxacin and nebulizers, and was not getting better, and\npresented to the [**Hospital1 18**] Emergency Room.\n\nIn the [**Hospital3 **] Emergency Room, her oxygen saturation was\n100% on CPAP.  She was not able to be weaned off of this\ndespite nebulizer treatment and Solu-Medrol 125 mg IV x2.\n\nReview of systems is negative for the following:  Fevers,\nchills, nausea, vomiting, night sweats, change in weight,\ngastrointestinal complaints, neurologic changes, rashes,\npalpitations, orthopnea.  Is positive for the following:\nChest pressure occasionally with shortness of breath with\nexertion, some shortness of breath that is positionally\nrelated, but is improved with nebulizer treatment.\n\nPAST MEDICAL HISTORY:\n1. COPD.  Last pulmonary function tests in [**2117-11-3**]\ndemonstrated a FVC of 52% of predicted, a FEV1 of 54% of\npredicted, a MMF of 23% of predicted, and a FEV1:FVC ratio of\n67% of predicted, that does not improve with bronchodilator\ntreatment.  The FVC, however, does significantly improve with\nbronchodilator treatment consistent with her known reversible\nair flow obstruction in addition to an underlying restrictive\nventilatory defect.  The patient has never been on home\noxygen prior to this recent episode.  She has never been on\nsteroid taper or been intubated in the past.\n2. Lacunar CVA.  MRI of the head in [**2114-11-4**]\ndemonstrates &quot;mild degree of multiple small foci of high T2\nsignal within the white matter of both cerebral hemispheres\nas well as the pons, in the latter region predominantly to\nthe right of midline.  The abnormalities, while nonspecific\nin etiology, are most likely secondary to chronic\nmicrovascular infarction.  There is no mass, lesion, shift of\nthe normal midline strictures or hydrocephalus.  The major\nvascular flow patterns are preserved.  There is moderate\nright maxillary, moderate bilateral ethmoid, mild left\nmaxillary, minimal right sphenoid, and frontal sinus mucosal\nthickening.  These abnormalities could represent an allergic\nor some other type of inflammatory process.  Additionally\nnoted is a moderately enlarged subtotally empty sella\nturcica&quot;.\n3. Angina:  Most recent stress test was in [**2118-1-3**]\ngoing for four minutes with a rate pressure product of\n10,000, 64% of maximum predicted heart rate without evidence\nof ischemic EKG changes or symptoms.  The imaging portion of\nthe study demonstrated no evidence of myocardial ischemia and\na calculated ejection fraction of 84%.  The patient denies\nangina at rest and gets angina with walking a few blocks.\nAre alleviated by sublingual nitroglycerin.\n4. Hypothyroidism on Synthroid.\n5. Depression on Lexapro.\n6. Motor vehicle accident with head injury approximately 10\nyears ago.\n\nMEDICATIONS ON ADMISSION:\n1. Hydrochlorothiazide 25 q.d.\n2. Prednisone 60 mg, 50 mg, 40 mg, 20 mg.\n3. Levofloxacin 500 mg q.d.\n4. Imdur 60 mg q.d.\n5. Synthroid 75 mcg q.d.\n6. Pulmicort nebulizer b.i.d.\n7. Albuterol nebulizer q.4. prn.\n8. Lexapro 10 mg q.d.\n9. Protonix 40 mg q.d.\n10. Aspirin 81 mg q.d.\n\nALLERGIES:  Norvasc leads to lightheadedness and headache.\n\nFAMILY HISTORY:  Noncontributory.\n\nSOCIAL HISTORY:  Lives with her husband, Dr. [**Known lastname 1809**] an\neminent Pediatric Neurologist at [**Hospital3 1810**].  The\npatient is a prior smoker, but has not smoked in over 10\nyears.  She has no known alcohol use and she is a full code.\n\nPHYSICAL EXAM AT TIME OF ADMISSION:  Blood pressure 142/76,\nheart rate 100 and regular, respirations at 17-21, and 97%\naxillary temperature.  She was saturating at 100% on CPAP\nwith dry mucous membranes.  An elderly female in no apparent\ndistress.  Pupils are equal, round, and reactive to light and\naccommodation.  Extraocular movements are intact.  Oropharynx\ndifficult to assess due to CPAP machine.  No evidence of\njugular venous pressure, however, the strap from the CPAP\nmachine obscures the neck exam.  Cranial nerves II through\nXII are grossly intact.  Neck is supple without\nlymphadenopathy.  Heart exam:  Tachycardic, regular, obscured\nby loud bilateral wheezing with increase in the expiratory\nphase as well as profuse scattered rhonchi throughout the\nlung fields.  Positive bowel sounds, soft, nontender,\nnondistended, obese, no masses.  Mild edema of the lower\nextremities without clubbing or cyanosis, no rashes.  There\nis a right hand hematoma.  Strength is assessed as [**5-9**] in the\nlower extremities, [**5-9**] in the upper extremities with a normal\nmental status and cognition.\n\nLABORATORY STUDIES:  White count 19, hematocrit 41, platelets\n300.  Chem-7:  127, 3.6, 88, 29, 17, 0.6, 143.  Troponin was\nnegative.  CKs were negative times three.  Initial blood gas\nshowed a pH of 7.4, pO2 of 66, pCO2 of 54.\n\nChest x-ray demonstrates a moderate sized hiatal hernia,\nsegmental atelectasis, left lower lobe infiltrate versus\nsegmental atelectasis.\n\nEKG shows normal sinus rhythm at 113 beats per minute, normal\naxis, no evidence of ST-T wave changes.\n\nBRIEF SUMMARY OF HOSPITAL COURSE:\n1. COPD/dyspnea/pneumonia:  The patient was initially placed\non an aggressive steroid taper and admitted to the Medical\nIntensive Care Unit due to her difficulty with oxygenation\ndespite CPAP machine.  She was also given nebulizer\ntreatments q.4h. as well as chest PT.  The nebulizers were\nincreased to q.1h. due to the fact that she continued to have\nlabored breathing.\n\nDue to persistent respiratory failure and labored breathing,\nthe patient was intubated on [**2118-6-7**] in order to improve\noxygenation, ventilation, and ability to suction.  A\nbronchoscopy was performed on [**2118-6-7**], which demonstrated\nmarked narrowing of the airways with expiration consistent\nwith tracheomalacia.\n\nOn [**2118-6-9**], two silicone stents were placed, one in the left\nmain stem (12 x 25 and one in the trachea 16 x 40) by Dr.\n[**First Name (STitle) **] [**Name (STitle) **] under rigid bronchoscopy with general anesthesia.\n\nOn [**2118-6-11**], the patient was extubated to a cool mist shovel\nmask and her oxygen was titrated down to 2 liters nasal\ncannula at which time she was transferred to the medical\nfloor.  On the medical floor, the steroids were weaned to off\non [**2118-6-14**], and the patient was saturating at 97% on 2\nliters, 92% on room air.\n\nOn [**2118-6-14**], the patient was seen again by the Interventional\nPulmonology service, who agreed that she looked much improved\nand recommended that she go to pulmonary rehabilitation with\nfollowup within six weeks&#39; time status post placement of\nstents in respiratory failure.\n\n2. Cardiovascular:  The patient was ruled out for a MI.  She\ndid have another episode on the medical floor of chest pain,\nwhich showed no evidence of EKG changes and negative\ntroponin, negative CKs x3.  She was continued on aspirin,\nImdur, and diltiazem for rate control per her outpatient\nregimen.\n\n3. Hypertension:  She was maintained on diltiazem and\nhydrochlorothiazide with adequate blood pressure control and\nnormalization of electrolytes.\n\n4. Hematuria:  The patient had intermittent hematuria likely\nsecondary to Foley placement.  The Foley catheter was\ndiscontinued on [**2118-6-14**].  She had serial urinalyses, which\nwere all negative for signs of infection.\n\n5. Hyperglycemia:  Patient was placed on insulin-sliding\nscale due to hyperglycemia, which was steroid induced.  This\nworked quite well and her glucose came back to normal levels\nonce the steroids were tapered to off.\n\n6. Leukocytosis:  Patient did have a profound leukocytosis of\n20 to 22 during much of her hospital course.  As the steroids\nwere tapered to off, her white blood cell count on [**2118-6-14**]\nwas 15,000.  It was felt that the leukocytosis was secondary\nto both steroids as well as question of a left lower lobe\npneumonia.\n\n7. For the left lower lobe pneumonia, the patient had\ninitially received a course of levofloxacin 500 p.o. q.d.\nfrom [**2118-6-4**] to [**2118-6-10**].  This was restarted on [**2118-6-12**]\nfor an additional seven day course given the fact that she\nstill had the leukocytosis and still had marked rales at the\nleft lower lobe.\n\n8. Hypothyroidism:  The patient was continued on outpatient\nmedical regimen.\n\n9. Depression:  The patient was continued on Lexapro per\noutpatient regimen.  It is recommended that she follow up\nwith a therapist as an outpatient due to the fact that she\ndid have a blunted affect throughout much of the hospital\ncourse, and did appear clinically to be depressed.\n\n10. Prophylaxis:  She was maintained on proton-pump inhibitor\nwith subQ Heparin.\n\n11. Sore throat:  The patient did have a sore throat for much\nof the hospital course post extubation.  This was treated\nwith Cepacol lozenges as well as KBL liquid (a solution\ncontaining Kaopectate, Bismuth, and lidocaine) at bedtime.\n\n12. Communication/code status:  The patient was full code\nthroughout her hospital course, and communication was\nmaintained with the patient and her husband.\n\n13. Muscle weakness:  The patient did have profound muscle\nweakness and was evaluated by Physical Therapy, and was found\nto have impaired functional mobility, impaired\nmusculoskeletal performance, impaired gas exchange, impaired\nendurance, impaired ventilation, and needed help with supine\nto sit.  However, she was able to tolerate sitting in a chair\nfor approximately one hour.\n\nOn motor exam, her flexors and extensors of the lower\nextremities were [**4-8**] at the knee, [**4-8**] at the ankle, [**4-8**] at\nthe elbows, and [**4-8**] hips.  It was felt that this weakness was\nmost likely due to a combination of steroid myopathy as well\nas muscle atrophy secondary to deconditioning after a\nprolonged hospital course.\n\n14. Speech/swallow:  The patient had a Speech and Swallow\nevaluation showing no evidence of dysphagia, no evidence of\nvocal cord damage status post tracheal stent placement.\n\nDISCHARGE CONDITION:  The patient was able to oxygenate on\nroom air at 93% at the time of discharge.  She was profoundly\nweak, but was no longer tachycardic and had a normal blood\npressure.  Her respirations were much improved albeit with\ntransmitted upper airway sounds.\n\nDISCHARGE STATUS:  The patient will be discharged to [**Hospital1 **]\nfor both pulmonary and physical rehabilitation.\n\nDISCHARGE MEDICATIONS:\n1. Levothyroxine 75 mcg p.o. q.d.\n2. Citalopram 10 mg p.o. q.d.\n3. Aspirin 81 mg p.o. q.d.\n4. Fluticasone 110 mcg two puffs inhaled b.i.d.\n5. Salmeterol Diskus one inhalation b.i.d.\n6. Acetaminophen 325-650 mg p.o. q.4-6h. prn.\n7. Ipratropium bromide MDI two puffs inhaled q.2h. prn.\n8. Albuterol 1-2 puffs inhaled q.2h. prn.\n9. Zolpidem tartrate 5 mg p.o. q.h.s. prn.\n10. Isosorbide dinitrate 10 mg p.o. t.i.d.\n11. Diltiazem 60 mg p.o. q.i.d.\n12. Pantoprazole 40 mg p.o. q.24h.\n13. Trazodone 25 mg p.o. q.h.s. prn.\n14. SubQ Heparin 5000 units subcutaneous b.i.d. until such\ntime that the patient is able to get out of bed twice a day.\n15. Cepacol lozenges q.2h. prn.\n16. Levofloxacin 500 mg p.o. q.d. for a seven day course to\nbe completed on [**2118-6-21**].\n17. Kaopectate/Benadryl/lidocaine 5 mL p.o. b.i.d. prn, not\nto be given around mealtimes for concern of dysphagia induced\nby lidocaine.\n18. Lorazepam 0.5-2 mg IV q.6h. prn.\n\nFOLLOW-UP PLANS:  The patient is recommended to followup with\nDr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1407**], [**Telephone/Fax (1) 1408**] within two weeks of leaving\nof the hospital.  She is also recommended to followup with\nthe Interventional Pulmonary service for followup status post\nstent placement.  She is also recommended to followup with a\nneurologist if her muscle weakness does not improve within\none week on physical therapy with concern for steroid-induced\nmyopathy.\n\nFINAL DIAGNOSES:\n1. Tracheomalacia status post tracheal and left main stem\nbronchial stent placement.\n2. Hypertension.\n3. Hypothyroidism.\n4. Restrictive lung defect.\n5. Depression.\n\n\n                     DR.[**Last Name (STitle) **],[**First Name3 (LF) **] 12-207\n\n\nDictated By:[**Last Name (NamePattern1) 1811**]\nMEDQUIST36\n\nD:  [**2118-6-14**]  11:30\nT:  [**2118-6-14**]  11:33\nJOB#:  [**Job Number 1812**]\n
## 3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Admission Date:  [**2119-5-4**]              Discharge Date:   [**2119-5-25**]\n\n\nService: CARDIOTHORACIC\n\nAllergies:\nAmlodipine\n\nAttending:[**Last Name (NamePattern1) 1561**]\nChief Complaint:\n81 yo F smoker w/ COPD, severe TBM, s/p tracheobronchoplasty [**5-5**]\ns/p perc trach [**5-13**]\n\nMajor Surgical or Invasive Procedure:\nbronchoscopy 3/31,4/2,3,[**6-12**], [**5-17**], [**5-19**]\ns/p trachealplasty [**5-5**]\npercutaneous tracheostomy [**5-13**] after failed extubation\ndown size trach on [**5-25**] to size 6 cuffless\n\n\nHistory of Present Illness:\nThis 81 year old woman has a history of COPD. Over the past five\n\nyears she has had progressive difficulties with her breathing.\nIn\n[**2118-6-4**] she was admitted to [**Hospital1 18**] for respiratory failure\ndue\nto a COPD exacerbation. Due to persistent hypoxemia, she\nrequired\nintubation and a eventual bronchoscopy on [**2118-6-9**] revealed marked\n\nnarrowing of the airways on expiration consistent with\ntracheomalacia.\nShe subsequently underwent placement of two\nsilicone stents, one in the left main stem and one in the\ntrachea. During the admission the patient had complaints of\nchest\npain and ruled out for an MI. She was subsequently discharged to\n\n[**Hospital1 **] for physical and pulmonary rehab. Repeat bronchoscopy\non\n[**2118-8-1**] revealed granulation tissue at the distal right lateral\nwall of the tracheal stent. There was significant malacia of the\n\nperipheral and central airways with complete collapse of the\nairways on coughing and forced expiration. Small nodules were\nalso noted on the vocal cords. She has noticed improvement in\nher\nrespiratory status, but most recently has been in discussion\nwith Dr. [**First Name4 (NamePattern1) 951**] [**Last Name (NamePattern1) 952**] regarding possible tracheobronchial plasty\n\nwith mesh. Tracheal stents d/c [**2119-4-19**] in anticipation of\nsurgery.\nIn terms of symptoms, she describes many years of intermittent\nchest pain that she describes as left sided and occurring at any\n\ntime. Currently, she notices it about three times a week, and\nstates that it seems to resolve after three nitroglycerin.\nShe currently is dependent on oxygen and wears 1.5-2 liters\naround the clock. She has frequent coughing and brings up &quot;dark\nsputum&quot;.\n\n\n\nPast Medical History:\nCOPD flare [**6-7**] s/p intubation, s/p distal tracheal to Left Main\nStem stents placed [**2118-6-9**]. Stents d/c&#39;d [**2119-4-19**], CAD w/ atypical\nangina (LAD 30%, RCA 30%, EF 63%), ^chol, hypothyroidism, htn,\nhiatal hernia, lacunar CVA, s/p ped struck -&gt; head injury &amp; rib\nfx, depression\nPMH:\nCOPD, s/p admit [**6-7**] for exacerbation requiring intubation\ntracheobronchomalacia, s/p bronchial stenting\nLarge hiatal hernia\nLacunar CVA\nHypothyroidism by records in CCC, although patient denies and is\n\nnot taking any medication\nDepression\nMVA, s/p head injury approximately 10 years ago\nHypertension\nHysterectomy\n\n\nSocial History:\nSocial History: The patient is married and worked as a clinical\npsychologist. Her husband is a pediatric neurologist at\n[**Hospital3 **]. They have several children, one of which is\n\na nurse.\n\n\nFamily History:\nFamily History: (+) FHx CAD; Father with an MI in his 40&#39;s, died\n\nof a CVA at age 59\n\n\nPhysical Exam:\nAdmit H+P\nGeneral-lovely 81 yr old feamle in NAD.\nNeuro- intermittently anxious, MAE, PERRLA, L eye ptosis,\nsymetrical smile, gossly intact.\nHEENT-PERRLA, sclera anicteric, pharynx- no exud or erythema\nResp-clear upper, diffuse ronchi, intermit exp wheezes\nCor- RRR, No M, R, G\nAbd- soft, NT, ND, no masses. Slight protrusion at area of\nhiatal hernia\nExt- no edema or clubbing\n\nBrief Hospital Course:\n82 y/o female admitted [**2119-5-4**] for consideration of\ntracheoplasty.\nBronchoscopy done [**5-4**] confirming severe TBM. Underwent\ntracheoplasty [**5-5**], complicated by resp failure d/t mucous\nplugging, hypoxia requiring re-intubation resulting in prolonged\nICU and hospital course. Also developed right upper extrem DVT\nfrom mid line.\n\nPain- Epidural accidently d/c&#39;d POD#1, pt briefly used dilaudid\nPCA intermittently w/ fair pain control. Pt required\nre-intubation for resp failure d/t secretions and PCA d/c at\nthat time. Propofol for sedation while intubated. Sedation d/c&#39;d\n[**5-12**] for weaning trial w/ ETT- failed trial. Trach [**5-13**]-weaning\nefforts as below. Minimal c/o pain since [**5-13**]. Presently pain\nfree.\n\nNeuro- Initially intact- post op aggitation, inhibiting weaning\nefforts [**5-16**]. Psych eval [**5-18**]-Started on zyprexa and ativan w/\nimprovement in anxiety. Presently A+Ox3- cooperative and lovely.\n\nResp- Extubated POD#2 then required re-intub  [**5-7**] for hypoxia\nd/t poor cough and mucous plugging. SIMV/PS alt w/CMV at night\nx4-5d, with CPAP attempts during day.\nBronchoscopy qd [**Date range (1) 1813**] for secretion management. Bronch [**5-9**]\nrevealed swollen epiglottis, bronch [**5-10**] - good leak w/ ETT cuff\ndeflated. Bronch [**5-13**] for eval/trach placement. Last bronch [**5-19**]\nw/ min secretions present, sputum sent.\n[**5-13**] perc trach done(#8 Portex- cuffed low pressure maintained to\npreserve tracheoplasty site). [**5-13**] CPAP15/peep5 initiated post\ntrach placement. Weaning ongoing.  [**Date range (1) 1814**]- Aggressive weaning\nw/ increasing episodes of CPAP, progressing to Trach Mask.\n[**2033-5-20**]-Trach mask overnight w/ no episodes of SOB, or\nhemodynamic instability. Trach changed to #6 portex- capped and\n[**Last Name (un) 1815**] well x48hrs on 2LNP. productive cough. Aggressive PT as\nwell w/ OOB &gt; chair [**Hospital1 **]-tid to total 4-6hr qd. Ambulation\n~100-120 ft [**5-22**] w/ PT assist.\n\nID- Vancomycin started post-op for graft prophylaxis. Fever\nspike [**2119-5-8**] w/ BAl &amp; sputum sent&gt; + MRSA. Vanco cont to [**4-7**]\nweeks post trachealplasty. Fever low grade [**5-12**], [**5-15**]&gt; cultured-\nno new results. [**5-19**]- WBC 20.8 .\n\nCardiac-Hypertension controlled w/ hydralazine IV, then d/c and\ncont controlled. HR 65-75 NSR. Avoiding B Blockers. Lasix 20mg\nIV qd.\n[**5-15**]- RUE redness and swelling at site of midline, RUE DVT by\nultrasound, midline d/c; heparin gtt started and therapeutic\nrange monitored. [**5-22**]  changed to Lovenox sq [**Hospital1 **]. Coags in good\ncontrol [**5-23**] (48.2/13.8/1.2)\nAccess- R midline placed [**2119-5-9**] for access- clotted [**2119-5-15**] and\nd/c&#39;d.  RUE redness and swelling and DVT via ultrasound. [**5-15**]- L\nbrachial PICC line placed- TPN resumed.\n\nGI-Large hiatal hernia- unable to place enteral feeding tube at\nbedside or underfluoro. Re-attempt [**5-17**] by EGD doboff tube\nplaced distal esophagus, dislodged in 12hours and removed.\n\nNutrition- PPN/TPN initiated [**2119-5-8**]- [**2119-5-25**]. PICC placed\n[**2119-5-15**]. Speech and Swallow eval [**5-22**]- rec change trach form #8\nto #6 Portex to allow improved epiglotis and oropharyngeal\nmovement to assist w/ swallowing. Then re-eval.  Trach changed\n[**5-23**] to #6 cuffless portex trach. Passed repeat swallow eval and\n[**Last Name (un) 1815**] diet of regular solids w/ thin liquids- CHIN TUCK to\nswallow thin liquids. Give meds whole w/ apple sauce. WOULD\nRECOMMEND repeat video swallow eval in [**8-17**] days to possibly\neliminate chin tuck- see page 3 referral.\n\nEndo- Hypothyroid, maintained on levoxyl.\n\nMuscu/Skel- OOB&gt; chair 4-6hours/day, PT consulting.\n\n\nMedications on Admission:\nadvair 250/50&quot;, atrovent, imdur 60&#39;, lasix 40&#39;, lexapro 20&#39;,\nlipitor 10&#39;, prilosec 20&#39;, mucinex 600&quot;, synthroid 75&#39;, detrol\nLA 4&#39;, ambien 5&#39;, trazadone 75&#39;, melatonin prn\n\nDischarge Medications:\n1. Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation\nQ6H (every 6 hours) as needed for wheezing.\n2. Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation\nQ6H (every 6 hours) as needed for wheezing.\n3. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:\nOne (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).\n4. Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation\nQ6H (every 6 hours) as needed.\n5. Ipratropium Bromide 18 mcg/Actuation Aerosol Sig: Two (2)\nPuff Inhalation QID (4 times a day).\n6. Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every\n4 to 6 hours) as needed.\n7. Sodium Chloride 0.65 % Aerosol, Spray Sig: [**2-5**] Sprays Nasal\nQID (4 times a day) as needed.\n8. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical\nTID (3 times a day) as needed.\n9. Enoxaparin Sodium 60 mg/0.6mL Syringe Sig: One (1)\nSubcutaneous Q12H (every 12 hours).\n10. Trazodone HCl 50 mg Tablet Sig: 1.5 Tablets PO HS (at\nbedtime) as needed.\n11. Escitalopram Oxalate 10 mg Tablet Sig: Two (2) Tablet PO\nDAILY (Daily).\n12. Nystatin 100,000 unit/g Cream Sig: One (1) Appl Topical  [**Hospital1 **]\n(2 times a day).\n13. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)\nSig: One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24\nhours).\n14. Tolterodine Tartrate 2 mg Tablet Sig: One (1) Tablet PO BID\n(2 times a day).\n15. Levothyroxine Sodium 75 mcg Tablet Sig: One (1) Tablet PO\nDAILY (Daily).\n16. Heparin Lock Flush (Porcine) 100 unit/mL Syringe Sig: One\n(1) ML Intravenous  DAILY (Daily) as needed.\n\n\nDischarge Disposition:\nExtended Care\n\nFacility:\n[**Hospital3 7**] &amp; Rehab Center - [**Hospital1 8**]\n\nDischarge Diagnosis:\nCOPD, Coronary Artery Disease/atypical angina (LAD 30%, RCA 30%,\nEF 63%), hypercholesterolemia, hypothyroidism, Hypertension,\nhiatal hernia, Cerebral Vascular Accident,s/p Motor Vehicle\nColision-&gt; head injury &amp; rib fracture.\nTBM- s/p tracheoplasty.\n\n\nDischarge Condition:\ngood\n\nDischarge Instructions:\nplease update Dr.[**Name (NI) 1816**] [**Telephone/Fax (1) 170**] office for:  fever,\nshortness of breath, chest pain , productive cough or if you\nhave any questions or concerns.\n\n\nCompleted by:[**2119-5-25**]
## 4 Admission Date:  [**2124-7-21**]              Discharge Date:   [**2124-8-18**]\n\n\nService: MEDICINE\n\nAllergies:\nAmlodipine\n\nAttending:[**First Name3 (LF) 898**]\nChief Complaint:\nCOPD exacerbation/Shortness of Breath\n\nMajor Surgical or Invasive Procedure:\nIntubation\narterial line placement\nPICC line placement\nEsophagogastroduodenoscopy\n\n\nHistory of Present Illness:\n87 yo F with h/o CHF, COPD on 5 L oxygen at baseline,\ntracheobronchomalacia s/p stent, presents with acute dyspnea\nover several days, and lethargy. This morning patient developed\nan acute worsening in dyspnea, and called EMS. EMS found patient\ntachypnic at saturating 90% on 5L. Patient was noted to be\ntripoding. She was given a nebulizer and brought to the ER.\n.\nAccording the patient&#39;s husband, she was experiencing symptoms\nconsistent with prior COPD flares. Apparently patient was\nwithout cough, chest pain, fevers, chills, orthopnea, PND,\ndysuria, diarrhea, confusion and neck pain. Her husband is a\nphysician and gave her a dose of levaquin this morning.\n.\nIn the ED, patient was saturating 96% on NRB. CXR did not reveal\nany consolidation. Per report EKG was unremarkable. Laboratory\nevaluation revealed a leukocytosis if 14 and lactate of 2.2.\nPatient received combivent nebs, solumedrol 125 mg IV x1,\naspirin 325 mg po x1. Mg sulfate 2 g IV x1, azithromycin 500 mg\nIVx1, levofloxacin 750 mg IVx1, and Cefrtiaxone 1g IVx1. Patient\nbecame tachpnic so was trialed on non-invasive ventilation but\nbecame hypotensive to systolics of 80, so noninvasive was\nremoved and patient did well on NRB and nebulizers for about 2\nhours. At that time patient became agitated, hypoxic to 87% and\ntachypnic to the 40s, so patient was intubated. Post intubation\nABG was 7.3/60/88/31. Propafol was switched to\nfentanyl/midazolam for hypotension to the 80s. Received 2L of\nNS. On transfer, patient VS were 102, 87/33, 100% on 60% 450 x\n18 PEEP 5. Patient has peripheral access x2.\n.\nIn the ICU, patient appeared comfortable.\n\nReview of sytems:\nlimited due to patient sedation\n\n\nPast Medical History:\n# COPD flare FEV1 40% in [**2120**], on 5L oxygen, s/p intubation\n[**6-6**], s/p distal tracheal to Left Main Stem stents placed\n[**2118-6-9**]. Stents d/c&#39;d [**2119-4-19**]. Tracheobronchoplasty performed [**6-6**], [**2119**]\n# CAD w/ atypical angina (cath [**2119**] - LAD 30%, RCA 30%, EF 63%)\n# Dyslipidemia\n# Hypothyroidism,\n# Hypertension\n# Hiatal hernia,\n# lacunar CVA,\n# s/p ped struck -&gt; head injury &amp; rib fx,\n# depression\n\nSocial History:\nThe patient is married and worked as a clinical\npsychologist. Her husband is a pediatric neurologist at\n[**Hospital3 **]. They have several children, one of which is\na nurse. [**First Name (Titles) 1817**] [**Last Name (Titles) 1818**] with 40 pack years, quit 5 years ago.\nSocial ethanol user. No history of IVDU, but remote history of\nmarijuana use.\n\nFamily History:\n(+) FHx CAD; Father with an MI in his 40&#39;s, died\nof a CVA at age 59\n\nPhysical Exam:\nOn admission\nVitals: T: BP: 116/46 P: 92 O2: 100%\nTV 60% 450 x 18 PEEP 5\nGeneral: Intubated, sedated, no apparent discomfort\nHEENT: Sclera anicteric, MMM, oropharynx clear\nNeck: supple, JVP not elevated, no LAD\nLungs: crackles bases bilaterally\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,\ngallops\nAbdomen: soft, non-tender, non-distended, bowel sounds present,\nno rebound tenderness or guarding, no organomegaly\nGU: no foley\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or\nedema\n\n\nPertinent Results:\nInitial Labs\n[**2124-7-21**] 10:55AM BLOOD WBC-14.1*# RBC-4.20# Hgb-12.6# Hct-39.1#\nMCV-93 MCH-30.1 MCHC-32.3 RDW-12.6 Plt Ct-319\n[**2124-7-21**] 10:55AM BLOOD Neuts-93.9* Lymphs-4.4* Monos-1.3*\nEos-0.2 Baso-0.2\n[**2124-7-22**] 03:50AM BLOOD PT-11.0 PTT-28.7 INR(PT)-0.9\n[**2124-7-21**] 10:55AM BLOOD Glucose-168* UreaN-13 Creat-0.8 Na-140\nK-3.5 Cl-92* HCO3-36* AnGap-16\n[**2124-7-22**] 03:50AM BLOOD Calcium-8.8 Phos-3.4 Mg-2.1\n\nCardiac Biomarkers\n[**2124-7-21**] 10:55AM BLOOD CK(CPK)-321* cTropnT-0.02*\n[**2124-7-21**] 06:25PM BLOOD CK(CPK)-345* CK-MB-14* MB Indx-4.1\ncTropnT-0.01\n[**2124-7-22**] 03:50AM BLOOD CK(CPK)-845* CK-MB-15* MB Indx-1.8\ncTropnT-0.01\n[**2124-7-22**] 12:04PM BLOOD CK(CPK)-1030* CK-MB-15* MB Indx-1.5\ncTropnT-0.01\n[**2124-7-23**] 03:15AM BLOOD CK(CPK)-530* CK-MB-9 cTropnT-0.01\nproBNP-2535*\n\nCXR ([**2124-7-21**]) - IMPRESSION: Hiatal hernia, otherwise\nunremarkable. Limited exam.\n\nEcho ([**2124-7-24**]) - There is mild symmetric left ventricular\nhypertrophy with normal cavity size and regional/global systolic\nfunction (LVEF&gt;55%). The estimated cardiac index is normal\n(&gt;=2.5L/min/m2). Tissue Doppler imaging suggests an increased\nleft ventricular filling pressure (PCWP&gt;18mmHg). Right\nventricular chamber size is normal. with normal free wall\ncontractility. The aortic valve leaflets (3) are mildly\nthickened but aortic stenosis is not present. No aortic\nregurgitation is seen. The mitral valve leaflets are mildly\nthickened. There is no mitral valve prolapse. Mild (1+) mitral\nregurgitation is seen. The tricuspid valve leaflets are mildly\nthickened. There is moderate pulmonary artery systolic\nhypertension. There is an anterior space which most likely\nrepresents a prominent fat pad.\nIMPRESSION: Normal biventricular systolic function. Moderate\npulmonary artery systolic hypertension.\n\nCXR ([**2124-8-5**]) - Kyphotic positioning. Compared with one day\nearlier and allowing for technical differences, the right-sided\neffusion may be slightly larger. Otherwise, no significant\nchange is detected. Again seen is retrocardiac opacity\nconsistent with left lower lobe collapse and/or consolidation\nand a small left effusion. As noted, a right effusion is again\nseen, possibly slightly larger on the current examination, with\nunderlying collapse and/or consolidation. Doubt CHF.\nDegenerative changes of the thoracic spine are noted.\n\nCardiac Enzymes [**2124-8-12**]: Trop&lt;0.01\n                [**2124-8-13**]: Trop 0.03\n                [**2124-8-14**]: Trop 0.02\n\nLABS AT DISCHARGE:\n\n[**2124-8-16**] 05:40AM BLOOD WBC-9.5 RBC-3.08* Hgb-9.6* Hct-28.3*\nMCV-92 MCH-31.2 MCHC-33.9 RDW-13.5 Plt Ct-360\n[**2124-8-16**] 05:40AM BLOOD PT-10.4 PTT-22.8 INR(PT)-0.8*\n[**2124-8-17**] 05:30AM BLOOD Glucose-114* UreaN-18 Creat-0.8 Na-142\nK-3.5 Cl-101 HCO3-36* AnGap-9\n[**2124-8-16**] 05:40AM BLOOD Calcium-8.9 Phos-2.8 Mg-2.3\n[**2124-8-16**] 05:40AM BLOOD TSH-0.87\n\nBrief Hospital Course:\n87 yo F with h/o CHF, COPD on 5 L oxygen at baseline,\ntracheobronchomalacia s/p stent, presents with acute dyspnea\nover several days, no s/p intubation for hypercarbic respiratory\nfailure.\n\n# Hypercarbic respiratory failure: Presents with dyspnea, but no\nclear cough or fevers. Per report, patient felt like this with\nprior COPD exacerbations. Leukocytosis supports possible\npneumonia, but history and CXR not entirely consistent with\nthis. EKG with signs of demand, but ROMI negative. Sputum gram\nstain unremarkable, but respitatory viral culture grew\nparainfluenze type 3 on [**7-24**]. Patient was initially managed on\nsolumedrol 60 mg IV Q8H, and was eventually tapered. With no\nevidence of pneumonia on CXR and sputum gram stain, antibiotics\nwere stopped [**7-25**]. Beta-agonists and anticholinergics were\ncontinued around the clock. TTE revealed mild symmetric lvh with\nnormal ef, increased pcwp (&gt;18mmHg), Normal RV, and moderate\npulmonary artery systolic hypertension. On [**7-26**], bronchoscopy\nrevealed collapsible, unremarkable airways. Patient had\ndifficulty weaning from the vent, and would become\ninterimittenty hypertensive to SBP 200s and tachypnic to the\n50s. Patient was extubatied on [**7-27**] after passing SBT 0/5, but\nrequired re-intubation 30 minutes later for worsening\nsecretions, lack of gag reflex, and tachypnea to the 50s. Of\nnote, on [**8-1**], the patient was found to have MRSA growing in\nsputum samples. Although it was felt that this likely\nrepresented colonization as opposed to true infection, the\npatient was started on a course of vancomycin (which was stopped\nafter 5 days). After multiple discussions between the patient&#39;s\nfamily and the ICU team, the patient&#39;s PCP, [**Name10 (NameIs) **] the palliative\ncare service, the patient&#39;s family ultimately decided that she\nwould not want a tracheostomy. On [**2124-8-3**], extubation was pursued\nagain and was successful. After extubation, her respiratory\nstatus improved and she was ultimately called out to the medical\nfloor. On the floor she was progressively weaned to 2LNC with\nnebs (better than her baseline 5L @home). Because of clinical\nexams revealing mild volume overload, she was intermittently\ndiuresed. She also experienced intermittent shortness of breath\nwith tachypnea but this was thought to be the result of attacks\nof anxiety with tachypnea. After receiving prn morphine, her\nbreathing status would typically improve. A steroid taper was\nbegun. The patient should continue prednisone 30 mg daily for 3\nmore days, then 20 mg daily for 4 days, then 10 mg daily for 4\ndays, then 5 mg daily for 4 days, then stop.\n.\n# Upper GI bleeding: On [**7-22**], patient had coffee grounds from OG\ntube. Lavage for approx 600ccs with clearance. GI perfomred EGD\nwhich revealed esophagitis, ulcers and blood in the stomach\nbody, D2 diverticulum and large hiatal hernia. H pylori was\nnegative. Patient was continued on IV PPI, with plan for repeat\nEGD in 8 weeks, and upper GI series once clinically improved\ngiven abnormal anatomy on EGD. Her hematocrit remained stable\nwith no further episodes of upper GI bleeding throughout the\npatient&#39;s hospitalization. On the floor she was switched to PO\npantoprazole twice daily. Aspirin was held.\n.\n# Weakness: The patient was found to have generalized weakness\nat the end of her hospitalization. Neurology was consulted and\nthey felt it was likely due to a combination of steroid myopathy\nand deconditioning from her prolonged bedbound status. A TSH was\nchecked which was normal. They recommended pulmonary and\nphysical rehab.\n.\n# CAD: History of LAD and RCA stenosis on Cath, but no stents.\nContinued statin and beta blocker, but held aspirin for GI\nbleeding (see above)\n.\n# Nutrition: Unable to pass NG without direct visualization due\nto hiatal hernia. IR guided post pyloric NG tube was placed on\n[**7-26**] for TFs and po medications. NG tube was pulled when patient\nwas extubated on [**2124-8-3**]. Speech and swallow were consulted\nfollowing the patient&#39;s extubation and she was eventually moved\nto soft solids and thin liquids with 1:1 supervision.\n\n# Goals of care: PCP [**Last Name (NamePattern4) **]. [**Last Name (STitle) 1407**] was very involved in discussions\nregarding patient&#39;s code status. Palliative care also followed\nalong with the patient. Ultimately, at the time of the patient&#39;s\nextubation on [**2124-8-3**], it was decided that the patient would be\nDNR/DNI (although this was later change). The patient&#39;s family\nfelt that she would not want a tracheostomy. It was decided that\nshe would not be reintubated and that, if her respiratory status\nwere to worsen after intubation, care would be focused on\ncomfort. However, her status improved in the MICU and on the\nfloor and it was then decided that she would remain DNR with\nintubation (but no tracheostomy) if her breathing deteriorated.\nAfter several days with stable or improved overall clinical\nstatus, she was deemed suitable for rehabilitation. At the timem\nof discharge, the patient&#39;s code status was do not resuscitate,\nokay to intubate.\n\nMedications on Admission:\n# Omeprazole 20 mg daily\n# Furosemide 20 mg daily\n# Toprol XL 50 mg daily\n# Lipitor 20 mg daily\n# Folic Acid 1 mg daily\n# Centrum daily\n# Diovan 80 mg daily\n# Trazodone 75-100 mg qhs\n# Melatonin 3 mg qhs\n# [**Doctor Last Name 1819**] Aspirin 325 mg daily\n# Albuterol neb prn\n# Duoneb prn\n# Advair 250/50 [**Hospital1 **]\n# Zolpidem 2.5 mg qhs prn\n# Synthroid 100 mcg daily\n# Lexapro 20 mg daily\n\n\nDischarge Medications:\n1. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr\nSig: One (1) Tablet Sustained Release 24 hr PO once a day.\n2. Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY\n(Daily).\n3. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\n\n4. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).\n\n5. Trazodone 50 mg Tablet Sig: One (1) Tablet PO at bedtime as\nneeded for insomnia.\n6. Melatonin 3 mg Tablet Sig: One (1) Tablet PO at bedtime.\n7. Valsartan 160 mg Tablet Sig: 1.5 Tablets PO once a day.\n8. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for\nNebulization Sig: One (1) neb Inhalation every 4-6 hours as\nneeded for shortness of breath or wheezing.\n9. DuoNeb 0.5 mg-3 mg(2.5 mg base)/3 mL Solution for\nNebulization Sig: One (1) neb Inhalation every six (6) hours as\nneeded for shortness of breath or wheezing.\n10. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:\nOne (1) puff Inhalation twice a day.\n11. Escitalopram 10 mg Tablet Sig: Two (2) Tablet PO DAILY\n(Daily).\n12. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY\n(Daily).\n13. Prednisone 20 mg Tablet Sig: One (1) Tablet PO daily () for\n4 days: Start after 3 days of 30 mg daily.\n14. Prednisone 10 mg Tablet Sig: One (1) Tablet PO daily () for\n4 days: Start after 4 days of 20 mg daily.\n15. Prednisone 5 mg Tablet Sig: One (1) Tablet PO daily () for 4\ndays: Start after 4 days of 10 mg daily.\n16. Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO\nDAILY (Daily).\n17. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One\n(1) Tablet, Delayed Release (E.C.) PO twice a day.\n18. Morphine 10 mg/5 mL Solution Sig: Five (5) mg PO every four\n(4) hours as needed for respiratory discomfort: Hold for\noversedation or RR&lt;12.\n19. Prednisone 10 mg Tablet Sig: Three (3) Tablet PO once a day\nfor 3 days.\n20. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.\n21. Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as\nneeded for constipation.\n22. Humalog insulin sliding scale\nPlease use attached Humalog insulin sliding scale while on\nsteroids.\n\n\nDischarge Disposition:\nExtended Care\n\nFacility:\n[**Location 1820**] center at [**Location (un) 1821**]\n\nDischarge Diagnosis:\nPrimary:\n1. Chronic Obstructive Pulmonary Disease Exacerbation\n2. Respiratory failure with intubation\n3. Upper gastrointestinal bleed/Peptic Ulcer Disease\n4. Hypertension\n5. Anxiety\n\nSecondary:\n1. Coronary Artery Disease\n2. Hypothyroidism\n\n\nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or\nwheelchair.\n\n\nDischarge Instructions:\nYou were admitted to the hospital with shortness of breath and\nrespiratory failure and lethargy. In the emergency department,\nyou were breathing very fast and a breathing tube was inserted\ninto your airway to help you breathe. You were admitted to the\nintensive care unit. There, you were managed with steroids and\nantibiotics and the tube was eventually removed from your\nairway, allowing you to breathe on your own. You also underwent\nbronchoscopy which looked at the inside of your airways.\n.\nDuring your time in the intensive care unit, you developed a\ngastrointestinal bleed. A tube was placed into your stomach and\nyou underwent an endoscopic procedure to look at your esophagus\nand stomach. This showed inflammation in your esophagusand\nulcers in your stomach.\n.\nYou should continue to use nasal oxygen by nasal cannula as\nneeded. You should continue the steroid taper as instructed. You\nshould call your doctor or return to the emergency room if you\nhave increasing difficulty breathing or shortness of breath,\nwheezing, chest pain, blood in your stool or vomiting blood.\n.\nThere are some changes in your medications.\nSTART pantoprazole 40 mg twice daily and STOP omeprazole\nSTART hydrochlorothiazide\nSTART prednisone, taking 30 mg for 3 days, then 20 mg for 4\ndays, then 10 mg for 4 days, then 5 mg for 4 days, then stop.\nSTART colace and senna as needed for constipation\nCan use morphine to alleviate symptoms of respiratory discomfort\nSTOP furosemide\nSTOP zolpidem\nSTOP aspirin\nINCREASE Diovan to 240 mg daily\nDECREASE trazodone to 50 mg daily\n.\nFollow up as indicated below.\n\nFollowup Instructions:\nYou have an appointment to follow up with Dr. [**Last Name (STitle) 1407**], your\nprimary care physician, [**Name10 (NameIs) **] [**8-29**] at 1pm. His address is [**Location (un) 1822**], [**Apartment Address(1) 1823**], [**Location (un) **],[**Numeric Identifier 1700**]. The phone is\n[**Telephone/Fax (1) 1408**].\n\nYou have an appointment to follow up with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 174**] in\nthe  [**Hospital **] clinic on [**8-30**] at 3pm in the [**Hospital Unit Name 1824**] at [**Hospital1 18**] on the [**Location (un) 453**]. Their phone number is\n[**Telephone/Fax (1) 463**].\n\nDepartment: DIV. OF GASTROENTEROLOGY\nWhen: WEDNESDAY [**2124-8-30**] at 3:00 PM\nWith: [**First Name4 (NamePattern1) 1386**] [**Last Name (NamePattern1) **], MD [**Telephone/Fax (1) 463**]\nBuilding: Ra [**Hospital Unit Name 1825**] ([**Hospital Ward Name 1826**]/[**Hospital Ward Name 1827**] Complex) [**Location (un) **]\nCampus: EAST     Best Parking: Main Garage\n\n\n\n
## 5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Admission Date:  [**2162-3-3**]              Discharge Date:   [**2162-3-25**]\n\nDate of Birth:  [**2080-1-4**]             Sex:   M\n\nService: MEDICINE\n\nAllergies:\nPatient recorded as having No Known Allergies to Drugs\n\nAttending:[**First Name3 (LF) 1828**]\nChief Complaint:\nMr. [**Known lastname 1829**] was seen at [**Hospital1 18**] after a mechanical fall from\na height of 10 feet.  CT scan noted unstable fracture of C6-7 &amp;\nposterior elements.\n\nMajor Surgical or Invasive Procedure:\n1. Anterior cervical osteotomy, C6-C7, with decompression and\nexcision of ossification of the posterior longitudinal ligament.\n2. Anterior cervical deformity correction.\n3. Interbody reconstruction.\n4. Anterior cervical fusion, C5-C6-C7.\n5. Plate instrumentation, C5-C6-C7.\n6. Cervical laminectomy C6-C7, T1.\n7. Posterior cervical arthrodesis C4-T1.\n8. Cervical instrumentation C4-T1.\n9. Arthrodesis augmentation with autograft, allograft and\ndemineralized bone matrix.\n\n\nHistory of Present Illness:\nMr. [**Known lastname 1829**] is a 82 year old male who had a slip and fall\nof approximately 10 feet from a balcony.  He was ambulatory at\nthe scene.  He presented to the ED here at [**Hospital1 18**].  CT scan\nrevealed unstable C spine fracture.  He was intubated secondary\nto agitation.\n\nPatient admitted to trauma surgery service\n\nPast Medical History:\nCoronary artery disease s/p CABG\nCHF\nHTN\nAICD\nAtrial fibrillation\nStroke\n\nSocial History:\nPatient recently discharged from [**Hospital1 **] for severe\ndepression. Family reports patient was very sad and attempted to\nkill himself by wrapping a telephone cord around his neck. Lives\nwith his elderly wife, worked as a chemist in [**Country 532**].\n\nFamily History:\nNon contributory\n\nPhysical Exam:\nPhycial exam prior to surgery was not obtained since patient was\nintubated and sedated.\n\nPost surgical physical exam: (TSICU per surgery team)\n\nBreathing without assistance\nNAD\nVitals: T 97.5, HR 61, BP 145/67, RR22, SaO2 98\nA-fib, rate controlled\nAbd soft non-tender\nAnterior/Posterior cervical incisions [**Name (NI) 1830**]\nPt is edemitous in all four extremities, no facial edema\nAble to grossly move all four extremities, neurointact to light\ntouch\nDistal pulses weakly intact\n\nMedicine Consult:\nVS: Tm/c 98.9 142/70 61 20 96%RA\nI/O BM yesterday 220/770\nGen: awake, calm, cooperative and pleasant, lying in bed\nNeck: c-collar removed\nCV: irregular, normal S1, S2. No m/r/g.\nlungs: cta anteriolry\nAbd: Obese, Soft, NTND, decreased bs\nExt: trace b/l le edema, 1+ UE edema\nneuro/cognition: thought [**3-17**], &quot;8&quot;, not to place,\n\n\nPertinent Results:\n====================\n ADMISSION LABS\n====================\n\nWBC-8.4 RBC-4.43* Hgb-11.9* Hct-38.6* MCV-87 MCH-26.9*\nMCHC-30.9* RDW-17.3* Plt Ct-191\nPT-20.4* PTT-28.1 INR(PT)-1.9*\nCK(CPK)-183* Amylase-70\nCalcium-8.5 Phos-2.0* Mg-1.9\nGlucose-121* Lactate-2.3* Na-140 K-4.3 Cl-101 calHCO3-26\n\n==================\n   RADIOLOGY\n==================\n\nCT scan C spine [**2162-3-3**]:\nIMPRESSION:\n1.  Fracture of the C6 as described involving the right pedicle\n(extending to the inferior facet) and left lamina. Anterior\nwidening at the C6-7 disc space and mild widening of left C6-7\nfacet also noted. Prevertebral hematoma at C6 with likely\nrupture of the anterior longitudinal ligament.\n\n2.  Lucency in the right posterior C1 ring may represent a\nchronic injury.\nLikely old avulsion fracture at T2 pedicle on the left.\n\n3. Ossification of both anterior and posterior longitudinal\nligaments with\ncompromise of the central spinal canal. Degenerative disease is\nfurther\ndescribed above.\n\nCT ABDOMEN/PELVIS ([**2162-3-3**])\nIMPRESSION:\n1. No acute injuries in the chest, abdomen, or pelvis.\n2. Three discrete pleural fluid collections in the right\nhemithorax, likely pseudotumors.\n3. Small hypodense lesion in the pancreatic body is of unclear\netiology, may represent pseudicyst or cystic tumor. Further\nevaluation with MRI may be performed on a non- emergent basis.\n4. Bilateral renal cysts.\n5. Foley catheter balloon inflated within the prostatic urethra.\nRecommend emergent repositioning.\n\nCT SINUS/MAXILLOFACIAL ([**2162-3-3**])\n1. Bilateral nasal bone fractures.\n2. Left frontal scalp hematoma with preseptal soft tissue\nswelling. Question foreign body anterior to the left globe.\nRecommend clinical correlation. Small amount of extraconal\nhematoma in the superior aspect of the left orbit.\n3. Linear lucency in the right posterior ring of C1. Correlate\nwith CT C- spine performed concurrently.\n\nHEAD CT ([**2162-3-3**])\n1. No acute intracranial hemprrhage.\n2. Left frontal scalp hematoma.\n3. Nasal bone fractures. Recommend correlation with report from\nfacial bone CT scan.\n4. Lucency in the right posterior ring of C1. Please refer to\ndedeicated CT C-spine for further detail.\n5. Left cerebellar encephalomalacia, likely due to old\ninfarction.\n\nCHEST [**2162-3-10**]\nThe Dobbhoff tube passes below the diaphragm with its tip most\nlikely terminating in the stomach. The bilateral pacemakers are\ndemonstrated with one lead terminating in right atrium and three\nleads terminating in right ventricle. The patient is in mild\npulmonary edema with no change in the loculated pleural fluid\nwithin the major fissure.\n\nCT HEAD [**2162-3-11**]\n1. A tiny amount of intraventricular hemorrhage layers along the\noccipital horns of the ventricles bilaterally. Recommend followp\nimaging.\n2. Left frontal scalp hematoma has decreased in size.\n3. Unchanged left cerebellar encephalomalacia.\n4. Nasal bone fractures are better evaluated on dedicated\nmaxillofacial CT.\n\nRIGHT SHOULDER X-RAY ([**2162-3-11**])\nMild glenohumeral and acromioclavicular joint osteoarthritis.\nNonspecific ossification projecting over the upper margin of the\nscapular body and adjacent to the lesser tuberosity. Diagnostic\nconsiderations include the sequela of chronic calcific bursitis,\nintraarticular bodies, and/or calcific tendinitis of the\nsubscapularis tendon.\nIncreased opacity projecting over the right hemithorax and minor\nfissure, better delineated on recent chest radiographs and chest\nCT\n\nRIGHT UPPER EXTREMITY ULTRASOUND ([**2162-3-13**])\n1. Deep venous thrombosis in the right axillary vein, extending\nproximally into the right subclavian vein, and distally to\ninvolve the brachial veins, portion of the basilic vein, and the\nright cephalic vein.\n2. Likely 2.0 cm left axillary lymph node, with unusual\nson[**Name (NI) 493**] features somewhat suspicious for malignancy.\nFollowup ultrasound is recommended in 4 weeks, and FNA/biopsy\nmay be considered at that time if no interval improvement.\n\n[**2162-3-14**]\nCT ABDOMEN WITH IV CONTRAST: There are small-to-moderate\nbilateral pleural effusions, on the right with a loculated\nappearance. There is associated compressive atelectasis. The\nvisualized portion of the heart suggests mild cardiomegaly.\nThere is no pericardial effusion. There is a 9-mm\nhypoattenuating, well-defined lesion in the left lobe of the\nliver (2:12) too small to accurately characterize but\nstatistically most likely representing a cyst. There are\nbilateral, partially exophytic renal cysts. The spleen is normal\nin size. There is a 5-mm hypoattenuating focus in the pancreatic\nbody, most likely representing focal fat. The gallbladder and\nadrenal glands are unremarkable. An NG tube terminates in the\nstomach. There is no ascites. The large and small bowel loops\nappear unremarkable without wall thickening or pneumatosis. Oral\ncontrast material has passed into the ascending colon without\nevidence of obstruction. There is no ascites and no free air.\nThere is a small pocket of air in the left rectus muscle,\ntracking over a distance of approximately 10 cm.\n\nCT PELVIS WITH IV CONTRAST: The pelvic small and large bowel\nloops, collapsed bladder containing Foley catheter and seminal\nvesicles appear unremarkable. The prostate is enlarged,\nmeasuring 5.9 cm in transverse diameter. The rectum contains a\nmoderate amount of dried stool. There is no free air or free\nfluid.\n\nBONE WINDOWS: No suspicious lytic or sclerotic lesions. There is\nDISH of the entire visualized thoracolumbar spine. There also\nare degenerative changes about the hip joints with large\nacetabular osteophytes.\n\nIMPRESSION:\n1. Stable bilateral pleural effusions, loculated on the right.\n2. New focus of air tracking within the left rectus muscle with\nassociated tiny amount of extraperitoneal air (2:53). No\nassociated stranding or fluid collection. Please correlate\nclinically if this could be iatrogenic, such as due to s.q.\ninjections.\n3. 5-mm hypoattenuating focus in the pancreatic body. This could\nrepresent focal fat, although a cystic tumor cannot be excluded.\nIf this is of concern, then MRI is again recommended for further\nevaluation.\n4. Hypoattenuating focus in the left lobe of the liver, too\nsmall to accurately characterize.\n5. Bilateral partially exophytic renal cysts.\n6. Moderate amount of dried stool within the rectum.\n\nA wet read was placed and the pertinent findings were discussed\nby Dr. [**First Name (STitle) 1831**] [**Name (STitle) 1832**] with Dr. [**First Name (STitle) 1833**] at 11:30 p.m. on [**2162-3-14**].\n\n[**2162-3-16**]\nVIDEO OROPHARYNGEAL SWALLOW FINDINGS: Real-time video\nfluoroscopic evaluation was performed after oral administration\nof thin and puree consistency of barium, in conjunction with the\nspeech pathologist.\n\nORAL PHASE: Normal bolus formation, bolus control, AP tongue\nmovement, oral transit time, and no oral cavity residue.\n\nPHARYNGEAL PHASE: There is normal swallow initiation and velar\nelevation. There is mild-to-moderate impairment of laryngeal\nelevation with absent epiglottic deflection. There is\nmoderate-to-severe increase in pharyngeal transit time. There is\nresidue in the valleculae and piriform sinuses with moderate\nimpairment of bolus propulsion. There was aspiration of both\nthin and puree barium.\n\nIMPRESSION: Aspiration of thin liquids and puree. For additional\ninformation, please see the speech and swallow therapist&#39;s\nreport from the same day.\n\n[**2162-3-18**] CT Head w/out:\nFINDINGS: There is a small amount of blood layering in the\noccipital horns of both lateral ventricles, unchanged though not\nas dense given evolution. No new hemorrhage is identified. The\nventricles, cisterns, and sulci are enlarged secondary to\ninvolutional change. Periventricular white matter hyperdensities\nare sequelae of chronic small vessel ischemia. Encephalomalacia\nin the left cerebellar hemisphere secondary to old infarction is\nunchanged. The osseous structures are unremarkable. The\nvisualized paranasal sinuses and mastoid air cells are clear.\nSkin staples are noted along the superior- posterior neck\nsecondary to recent spinal surgery.\n\nIMPRESSION: No interval change with a very small\nintraventricular hemorrhage.\n\nNo discharge labs as patient CMO.\n\nBrief Hospital Course:\nMr. [**Known lastname 1829**] was seen at [**Hospital1 18**] after his fall from a height\nof approximatly 10 feet.  CT scans of his chest, abdomen and\npelvis were negative for pathology.  CT scan of his C-spine\nshowed fracture of anterior and posterior elements at C6-7.  He\nwas also shown to have a right nasal bone fracture.\n\nC-spine fracture: Mr. [**Known lastname 1829**] [**Last Name (Titles) 1834**] two surgical\nprocedures to stabilized his c-spine.  [**2162-3-4**]: anterior\ncervical decompression/fusion at C6-7.  [**2162-3-5**]: Cervical\nlaminectomy C6-C7 &amp; T1 with Posterior cervical arthrodesis\nC4-T1.  He tolerated the procedures well.  He was extubated\nwithout complication.\n\nAfter his surgical procedures, Mr. [**Known lastname 1829**] was transfered\nto the medicine service at [**Hospital1 18**] for his medical care. While on\nthe medicine service, patient was found to be persistently\naspirating and failed his speech and swallow evaluation. Patient\nand family were not interested in an NG tube or PEG for\nnutrition. Patient also developed a venous clot of the right\nupper extremity and the decision was made to not proceed with\nmedical treatment. Goals of care were changed to comfort\nmeasures only. A foley was placed after patient had difficulty\nwith urinary retention and straight cathing. A palliative care\nconsult was obtained for symptom management and patient was\ndischarged to hospice with morphine, olanzapine, and a foley in\nplace for symptomatic relief.\n\nMedications on Admission:\nCoumadin\nseroquel\ndocusate\nmetoprolol\nfolate\nlovastatin\ncaptopril\nASA\nipratroium inhaler\nFerrous sulfate\nfurosemide\ncitalopram\nisosorbide\nmeprazole\n\nDischarge Medications:\n1. Bisacodyl 10 mg Suppository Sig: [**12-30**] Suppositorys Rectal\nDAILY (Daily) as needed for constipation.\n2. Ipratropium Bromide 0.02 % Solution Sig: One (1) nebulizer\nInhalation Q6H (every 6 hours) as needed for wheezing.\n3. Albuterol Sulfate 2.5 mg/3 mL Solution for Nebulization Sig:\nOne (1) solution Inhalation Q6H (every 6 hours) as needed for\nwheezing.\n4. Morphine Concentrate 20 mg/mL Solution Sig: 5-10 mg PO Q4H\n(every 4 hours) as needed for pain: may shorten interval as\nneeded to control pain.\n5. Olanzapine 5 mg Tablet, Rapid Dissolve Sig: 0.5 Tablet, Rapid\nDissolve PO QHS (once a day (at bedtime)) as needed for\nagitation.\n6. Tamsulosin 0.4 mg Capsule, Sust. Release 24 hr Sig: One (1)\nCapsule, Sust. Release 24 hr PO DAILY (Daily): may be\ndiscontinued if patient not tolerating pills or refusing to\ntake.\n\n\nDischarge Disposition:\nExtended Care\n\nFacility:\n[**Hospital1 599**] of [**Location (un) 55**]\n\nDischarge Diagnosis:\n1. Cervical spondylosis with calcification of posterior\nlongitudinal ligament.\n2. Fracture dislocation C6-C7.\n3. Ossification of the posterior longitudinal ligament.\n4. Aspiration Pneumonia\n\n\n1. Cervical spondylosis with calcification of posterior\n    longitudinal ligament.\n2. Fracture dislocation C6-C7.\n3. Ossification of the posterior longitudinal ligament.\n4. Aspiration Pneumonia\n\n1. Cervical spondylosis with calcification of posterior\n    longitudinal ligament.\n2. Fracture dislocation C6-C7.\n3. Ossification of the posterior longitudinal ligament.\n4. Aspiration Pneumonia\n\n\nDischarge Condition:\nStable to outside facility\n\n\nDischarge Instructions:\nPatient has been made CMO at the request of him and his family.\nHe has a foley placed for urinary retention. Please use morphine\nas needed for pain and olanzapine as needed for agitiation.\nPatient has known history of aspiration documented on speech and\nswallow. It is the patient and the family&#39;s wish for him to\ncontinue to eat and drink as desired.\n\nFollowup Instructions:\nFollow up with your primary care physician as needed.\n\n\n\n
## 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Admission Date:  [**2172-3-5**]              Discharge Date:   [**2172-3-8**]\n\nDate of Birth:  [**2109-10-8**]             Sex:   F\n\nService: NEUROSURGERY\n\nAllergies:\nNo Known Allergies / Adverse Drug Reactions\n\nAttending:[**First Name3 (LF) 1835**]\nChief Complaint:\nMeningioma\n\nMajor Surgical or Invasive Procedure:\nRight Craniotomy\n\n\nHistory of Present Illness:\n[**Known firstname 622**] [**Known lastname 1836**] is a 62-year-old woman, with longstanding\nhistory of rheumatoid arthritis, probable Sweet&#39;s syndrome, and\nmultiple joint complications requiring orthopedic interventions.\nShe was found to hve a right cavernous sinus and nasopharyngeal\nmass.  She underwent a biopsy of hte nasopharyngeal mass by Dr.\n[**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1837**] and the pathology, including flow\ncytometry,\nwas reactive for T-cell lymphoid hyperplasia only.\n\nShe has a longstanding history of rheumatoid arthritis that\ninvolved small and large joints in her body.  Her disease is\ncurrently controlled by abatacept, hydroxychloroquine, and\nmethotrexate.  She also has a remote history of erythematous\nnodules at her shins, dermatosis (probable Sweet&#39;s disease),\nsevere holocranial headache with an intensity of [**9-28**], and\ndysphagia.  But her symptoms resolved with treatment for\nautoimmune disease.  Please refer additional past medical\nhistory, past surgical history, facial history, and social\nhistory to the initial note on [**2171-11-4**].\n\nShe cam to the BTC for discussion about management of her right\ncavernous sinus mass that extends into the middle cranial fossa.\n\n\nShe had a recent head CT at the [**Hospital1 756**] and Woman&#39;s Hospital on\n[**2171-11-29**], when she went for a consultation there.\nShe is neurologically stable without headache, nausea, vomiting,\nseizure, imbalance, or fall. She has no new systemic complaints.\n\nHer neurological problem started [**9-/2171**] when she experienced\nfrontal pressure-like sensations.  There was no temporal\npattern;\nbut they may occur more often in the evening.\nShe had fullness in her ear and she also had a cold coinciding\nto\nthe onset of her headache.  By late [**Month (only) 359**] and early [**2171-10-21**], she also developed a sharp pain intermittently in the\nright\ntemple region.\nShe did not have nausea, vomiting, blurry vision, imbalance, or\nfall.  A gadolinium-enhanced head MRI, performed at [**Hospital1 346**] on [**2171-10-30**], showed a bright mass\ninvolving the cavernous sinus.\n\nPast Medical History:\nShe has a history of rheumatoid arthritis unspecified\ndermatosis, right knee replacement, left hip replacement, and\nfusion of subtalar joint, and resection of a benign left parotid\ngland tumor.\n\n\nSocial History:\nShe is married.  She had smoked for approximately a year and a\nhalf when she was younger, but is not currently smoking.  She\nhas approximately one glass of wine per week.  She is retired\nbut was employed as a teacher.\n\n\nFamily History:\nCancer, diabetes, hearing loss, and heart disease.\n\n\nPhysical Exam:\nAF VSS\nHEENT normal\nno LNN\nNeck supple.\nRRR\nCTA\nNTTP\nwarm peripherals\n\nNeurological Examination:  Her Karnofsky Performance Score is\n100.  She is neurologically intact.\n\n\nPertinent Results:\nMRI [**3-5**]\nRight middle cranial fossa mass likely represents a meningioma\nand is stable since MRI of [**2172-2-11**]. The previously seen\nmidline nasopharyngeal mass has decreased in size since MRI of\n[**2168-2-11**]. Direct visual inspection would be helpful for\nfurther assessment of the nasopharyngeal mass.\n\n\nBrief Hospital Course:\nPatient presented electively for meningioma resection of [**3-5**].\nShe tolerated the procedure well and was extubated in the\noperating room. She was trasnported to the ICU post-operatively\nfor management. She had no complications and was transferred to\nthe floor and observed for 24 hours. Prelim path is consistent\nwith meningioma.\nShe has dissolvable sutures, and will need to come to\nneurosurgery clinic in [**6-28**] days for wound check only.\nShe will need to be scheduled for brain tumor clinic. She will\ncomplete Decadron taper on [**3-10**] and then restart her maintenance\ndose of prednisone. She will also be taking Keppra for seizure\nprophlyaxis.\nHer neurologic examination was intact with no deficits at\ndischarge. She was tolerating regular diet. She should continue\nto take over the counter laxatives as needed.\n\nMedications on Admission:\nbactrim, famotidine,folic acid, fosamax, lorezapam,\nmethotrexate, mvi, orencia, plaquenil, prednisone 20qd\n\n\nDischarge Medications:\n1. hydroxychloroquine 200 mg Tablet Sig: One (1) Tablet PO DAILY\n(Daily).\n2. levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2\ntimes a day).\nDisp:*60 Tablet(s)* Refills:*2*\n3. prednisone 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily):\nstart the day after Decadron taper is complete-.\n4. dexamethasone 0.5 mg Tablet Sig: Four (4) Tablet PO q6h ()\nfor 2 days: take 4 tabs every 6 hours on [**3-9**] and take 2 tabs\nevery 6 hours on [**3-10**] then stop.\nDisp:*20 Tablet(s)* Refills:*0*\n5. famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a\nday).\nDisp:*60 Tablet(s)* Refills:*2*\n\n\nDischarge Disposition:\nHome\n\nDischarge Diagnosis:\nbrain lesion\n\nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\nNeuro exam intact.\n\nDischarge Instructions:\n??????\tHave a friend/family member check your incision daily for\nsigns of infection.\n??????\tTake your pain medicine as prescribed.\n??????\tExercise should be limited to walking; no lifting, straining,\nor excessive bending.\n??????\tYou have dissolvable sutures, you must keep that area dry for\n10 days.\n??????\tYou may shower before this time using a shower cap to cover\nyour head.\n??????\tIncrease your intake of fluids and fiber, as narcotic pain\nmedicine can cause constipation. We generally recommend taking\nan over the counter stool softener, such as Docusate (Colace)\nwhile taking narcotic pain medication.\n??????\tUnless directed by your doctor, do not take any\nanti-inflammatory medicines such as Motrin, Aspirin, Advil, and\nIbuprofen etc.\n??????\tIf you have been prescribed Dilantin (Phenytoin) for\nanti-seizure medicine, take it as prescribed and follow up with\nlaboratory blood drawing in one week.  This can be drawn at your\nPCP??????s office, but please have the results faxed to [**Telephone/Fax (1) 87**].\nIf you have been discharged on Keppra (Levetiracetam), you will\nnot require blood work monitoring.\n??????\tIf you are being sent home on steroid medication, make sure\nyou are taking a medication to protect your stomach (Prilosec,\nProtonix, or Pepcid), as these medications can cause stomach\nirritation.  Make sure to take your steroid medication with\nmeals, or a glass of milk.\n??????\tClearance to drive and return to work will be addressed at\nyour post-operative office visit.\n??????\tMake sure to continue to use your incentive spirometer while\nat home.\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE\nFOLLOWING\n\n??????\tNew onset of tremors or seizures.\n??????\tAny confusion or change in mental status.\n??????\tAny numbness, tingling, weakness in your extremities.\n??????\tPain or headache that is continually increasing, or not\nrelieved by pain medication.\n??????\tAny signs of infection at the wound site: increasing redness,\nincreased swelling, increased tenderness, or drainage.\n??????\tFever greater than or equal to 101?????? F.\n\nFollowup Instructions:\n??????\tPlease return to the office in [**6-28**] days (from your date of\nsurgery) for a wound check. This appointment can be made with\nthe Nurse Practitioner.  Please make this appointment by calling\n[**Telephone/Fax (1) 1669**]. If you live quite a distance from our office,\nplease make arrangements for the same, with your PCP.\n\n\n\n</code></pre>
<div class="sourceCode" id="cb17"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb17-1"><a href="#cb17-1" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(DIAGNOSES_ICD<span class="sc">$</span>SUBJECT_ID)) <span class="co">#46,520 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 46520</code></pre>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb19-1"><a href="#cb19-1" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(PATIENTS<span class="sc">$</span>SUBJECT_ID)) <span class="co">#46,520 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 46520</code></pre>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb21-1"><a href="#cb21-1" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(NOTEEVENTS<span class="sc">$</span>SUBJECT_ID)) <span class="co">#46146 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 46146</code></pre>
<div class="sourceCode" id="cb23"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb23-1"><a href="#cb23-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Duplicates in subject ID for patient dataset. </span></span>
<span id="cb23-2"><a href="#cb23-2" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span>
<span id="cb23-3"><a href="#cb23-3" aria-hidden="true" tabindex="-1"></a>PATIENTS <span class="sc">%&gt;%</span> </span>
<span id="cb23-4"><a href="#cb23-4" aria-hidden="true" tabindex="-1"></a>  <span class="fu">group_by</span>(SUBJECT_ID) <span class="sc">%&gt;%</span> </span>
<span id="cb23-5"><a href="#cb23-5" aria-hidden="true" tabindex="-1"></a>   <span class="fu">filter</span>(<span class="fu">n</span>()<span class="sc">&gt;</span><span class="dv">1</span>) <span class="co">#There is no duplicate. </span></span></code></pre></div>
<pre><code>## # A tibble: 0  8
## # Groups:   SUBJECT_ID [0]
## #  with 8 variables: ROW_ID &lt;int&gt;, SUBJECT_ID &lt;int&gt;, GENDER &lt;chr&gt;, DOB &lt;chr&gt;,
## #   DOD &lt;chr&gt;, DOD_HOSP &lt;chr&gt;, DOD_SSN &lt;chr&gt;, EXPIRE_FLAG &lt;int&gt;</code></pre>
<div class="sourceCode" id="cb25"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb25-1"><a href="#cb25-1" aria-hidden="true" tabindex="-1"></a><span class="co">#For our project, we are interested in unstructured text data. As such, we will drop observations without discharge summaries. </span></span>
<span id="cb25-2"><a href="#cb25-2" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb25-3"><a href="#cb25-3" aria-hidden="true" tabindex="-1"></a><span class="co">#First let&#39;s look at the various types of notes in category </span></span>
<span id="cb25-4"><a href="#cb25-4" aria-hidden="true" tabindex="-1"></a><span class="fu">unique</span>(NOTEEVENTS<span class="sc">$</span>CATEGORY) <span class="co">#type of notes listed in category including discharge summary</span></span></code></pre></div>
<pre><code>##  [1] &quot;Discharge summary&quot; &quot;Echo&quot;              &quot;ECG&quot;              
##  [4] &quot;Nursing&quot;           &quot;Physician &quot;        &quot;Rehab Services&quot;   
##  [7] &quot;Case Management &quot;  &quot;Respiratory &quot;      &quot;Nutrition&quot;        
## [10] &quot;General&quot;           &quot;Social Work&quot;       &quot;Pharmacy&quot;         
## [13] &quot;Consult&quot;           &quot;Radiology&quot;         &quot;Nursing/other&quot;</code></pre>
<div class="sourceCode" id="cb27"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb27-1"><a href="#cb27-1" aria-hidden="true" tabindex="-1"></a><span class="fu">unique</span>(NOTEEVENTS<span class="sc">$</span>DESCRIPTION)</span></code></pre></div>
<pre><code>##    [1] &quot;Report&quot;                                                                          
##    [2] &quot;Addendum&quot;                                                                        
##    [3] &quot;Nursing Transfer Note&quot;                                                           
##    [4] &quot;Nursing Progress Note&quot;                                                           
##    [5] &quot;Physician Resident Progress Note&quot;                                                
##    [6] &quot;Physical Therapy Evaluation Note&quot;                                                
##    [7] &quot;PT/Rehab Services&quot;                                                               
##    [8] &quot;Case Management Continued Stay Review&quot;                                           
##    [9] &quot;Respiratory Care Shift Note&quot;                                                     
##   [10] &quot;Clinical Nutrition Note&quot;                                                         
##   [11] &quot;Physician Resident Admission Note&quot;                                               
##   [12] &quot;Physician Attending Admission Note&quot;                                              
##   [13] &quot;ICU Event Note&quot;                                                                  
##   [14] &quot;Generic Note&quot;                                                                    
##   [15] &quot;Physician Attending Progress Note&quot;                                               
##   [16] &quot;Social Work Progress Note&quot;                                                       
##   [17] &quot;Pharmacy Care Note&quot;                                                              
##   [18] &quot;PT/Rehab&quot;                                                                        
##   [19] &quot;Physical Therapy Progress Note&quot;                                                  
##   [20] &quot;Case Managment Initial Patient Assessment&quot;                                       
##   [21] &quot;Physical Therapy Contact Note&quot;                                                   
##   [22] &quot;Social Work Admission Note&quot;                                                      
##   [23] &quot;Arterial Line&quot;                                                                   
##   [24] &quot;Intensivist Note&quot;                                                                
##   [25] &quot;Attending Progress Note&quot;                                                         
##   [26] &quot;Case Management Dicharge Plan&quot;                                                   
##   [27] &quot;Resident Progress Note&quot;                                                          
##   [28] &quot;Transfer Planning&quot;                                                               
##   [29] &quot;Rehab/PT&quot;                                                                        
##   [30] &quot;Critical Care Staff Addendum&quot;                                                    
##   [31] &quot;ICU Staff Addendum&quot;                                                              
##   [32] &quot;Contact note&quot;                                                                    
##   [33] &quot;Family Meeting Note&quot;                                                             
##   [34] &quot;central line placement attempt&quot;                                                  
##   [35] &quot;Pharmacy Vancomycin&quot;                                                             
##   [36] &quot;Respiratory Care&quot;                                                                
##   [37] &quot;Pharmacy - Sedation&quot;                                                             
##   [38] &quot;Pharmacy - Sedation/Agitation&quot;                                                   
##   [39] &quot;MS4 Progress Note&quot;                                                               
##   [40] &quot;Overnight Intensivist Admission&quot;                                                 
##   [41] &quot;Overnight Intensivist (Fellow) Admit&quot;                                            
##   [42] &quot;Nursing discharge note&quot;                                                          
##   [43] &quot;Pharmacy - Vanco in CRRT&quot;                                                        
##   [44] &quot;Pharmacy - Methadone&quot;                                                            
##   [45] &quot;Physician Progress Note - Resident and Attending&quot;                                
##   [46] &quot;ICU Physician Progress Note -- Attending and Resid&quot;                              
##   [47] &quot;MS4 Admission Note&quot;                                                              
##   [48] &quot;Resident progress note&quot;                                                          
##   [49] &quot;Sedation and NMBAs&quot;                                                              
##   [50] &quot;Resident Note / Attending Addendum&quot;                                              
##   [51] &quot;Dialysis Catheter Insertion&quot;                                                     
##   [52] &quot;ICU Attending Note&quot;                                                              
##   [53] &quot;Physician Surgical Progress Note&quot;                                                
##   [54] &quot;Attending ICU note&quot;                                                              
##   [55] &quot;ICU Attending  Note&quot;                                                             
##   [56] &quot;MICU Attending note&quot;                                                             
##   [57] &quot;Respiratory&quot;                                                                     
##   [58] &quot;Attending&quot;                                                                       
##   [59] &quot;--error--&quot;                                                                       
##   [60] &quot;ERROR&quot;                                                                           
##   [61] &quot;Physical Therapy Re-evaluation Note&quot;                                             
##   [62] &quot;Physician Resident and Attending Progress Note&quot;                                  
##   [63] &quot;PT Contact Note&quot;                                                                 
##   [64] &quot;Bronchoscopy&quot;                                                                    
##   [65] &quot;Critical Care Attending Addendum&quot;                                                
##   [66] &quot;Physical Therapy D/C Note&quot;                                                       
##   [67] &quot;Resident Progress Note/Attending Addendum&quot;                                       
##   [68] &quot;Attending Note&quot;                                                                  
##   [69] &quot;Resident Progress Note / Attending Addendum&quot;                                     
##   [70] &quot;Physician Attending Admission Note - Howell&quot;                                     
##   [71] &quot;Sedation&quot;                                                                        
##   [72] &quot;Phhysical Therapy Contact Note&quot;                                                  
##   [73] &quot;Contact Note&quot;                                                                    
##   [74] &quot;Precedex&quot;                                                                        
##   [75] &quot;error&quot;                                                                           
##   [76] &quot;Attending Addendum&quot;                                                              
##   [77] &quot;Medication Note&quot;                                                                 
##   [78] &quot;Physical Therapy Re-Evaluation Note&quot;                                             
##   [79] &quot;Physician Resident and Attending Admission Note&quot;                                 
##   [80] &quot;ICU Daily Note&quot;                                                                  
##   [81] &quot;Respiratory note&quot;                                                                
##   [82] &quot;BP meds&quot;                                                                         
##   [83] &quot;Physician Admission Note&quot;                                                        
##   [84] &quot;Addendum to transfer Note&quot;                                                       
##   [85] &quot;Medication Confirmation&quot;                                                         
##   [86] &quot;note entered in error&quot;                                                           
##   [87] &quot;Physical Therapy Contact  Note&quot;                                                  
##   [88] &quot;PT/Rehab Contact Note&quot;                                                           
##   [89] &quot;progress note&quot;                                                                   
##   [90] &quot;HCP Phone number&quot;                                                                
##   [91] &quot;Telephone Call&quot;                                                                  
##   [92] &quot;set as error&quot;                                                                    
##   [93] &quot;Telephone Communication&quot;                                                         
##   [94] &quot;Resident Note/Attending Addendum&quot;                                                
##   [95] &quot;Critical Care Attending&quot;                                                         
##   [96] &quot;Attending addendum&quot;                                                              
##   [97] &quot;Resident / Attending Progress Note&quot;                                              
##   [98] &quot;Nursing 1900-  0700&quot;                                                             
##   [99] &quot;Vancomycin&quot;                                                                      
##  [100] &quot;Nursing 1900-0700&quot;                                                               
##  [101] &quot;Physician Resident/Attending Admission Note&quot;                                     
##  [102] &quot;Nursing Note&quot;                                                                    
##  [103] &quot;Physician Attending / Resident Progress Note&quot;                                    
##  [104] &quot;MICU Attending Admission Note&quot;                                                   
##  [105] &quot;Attending / Resident Progress Note&quot;                                              
##  [106] &quot;Attending / Resident Admission Note&quot;                                             
##  [107] &quot;Respiratory Note&quot;                                                                
##  [108] &quot;Physician Resident/ Attending  Progress Note&quot;                                    
##  [109] &quot;Physician/Attending Resident Admission Note&quot;                                     
##  [110] &quot;MICU Attending / Resident Progress Note&quot;                                         
##  [111] &quot;Physician Resident / Attending Progress Note&quot;                                    
##  [112] &quot;Physician Resident / Attending Admission Note&quot;                                   
##  [113] &quot;Physician Resident and Attending  Progress Note&quot;                                 
##  [114] &quot;ICU Event Note - Family Meeting&quot;                                                 
##  [115] &quot;MICU Attending Progress Note&quot;                                                    
##  [116] &quot;CODE STATUS/ Family discussion&quot;                                                  
##  [117] &quot;Physician Resident and fellow Admission Note&quot;                                    
##  [118] &quot;Physician Resident /Attending Progress Note&quot;                                     
##  [119] &quot;Physician Resident and attending Progress Note&quot;                                  
##  [120] &quot;Physician Resident and attending  Progress Note&quot;                                 
##  [121] &quot;Physician Residentand Attending  Progress Note&quot;                                  
##  [122] &quot;Physician Residentand attending  Progress Note&quot;                                  
##  [123] &quot;Attending Admission Note&quot;                                                        
##  [124] &quot;Resident Admit Note / Attending Addendum&quot;                                        
##  [125] &quot;Non standard trach tube;problem list item&quot;                                       
##  [126] &quot;Physician Fellow Admission Note&quot;                                                 
##  [127] &quot;Attending addendum to resident admission note&quot;                                   
##  [128] &quot;Physician Resident/Attending Progress Note&quot;                                      
##  [129] &quot;Physician Attending Admission Notel&quot;                                             
##  [130] &quot;Attending note&quot;                                                                  
##  [131] &quot;MICU&quot;                                                                            
##  [132] &quot;PT contact note&quot;                                                                 
##  [133] &quot;Physician Attending Admission Note - MICU&quot;                                       
##  [134] &quot;Code status and goals of care&quot;                                                   
##  [135] &quot;Initial H&amp;P&quot;                                                                     
##  [136] &quot;ICU Attending&quot;                                                                   
##  [137] &quot;Physician Fellow / Attending Progress Note - MICU&quot;                               
##  [138] &quot;Physician Fellow / Attending Admission Note - MICU&quot;                              
##  [139] &quot;Respiratory Care Note&quot;                                                           
##  [140] &quot;ICU attending addendum&quot;                                                          
##  [141] &quot;MICU resident transfer accept note&quot;                                              
##  [142] &quot;Physician Attending/Resident Progress Note&quot;                                      
##  [143] &quot;ICU Intensivist Note&quot;                                                            
##  [144] &quot;Resident Admission H&amp;P&quot;                                                          
##  [145] &quot;ICU Attending Addendum&quot;                                                          
##  [146] &quot;Resident and Attending Note&quot;                                                     
##  [147] &quot;Resident and Attending Notes&quot;                                                    
##  [148] &quot;Daily Note&quot;                                                                      
##  [149] &quot;Physician Resident / Attending Admission Note - MI&quot;                              
##  [150] &quot;Interventional Cardiology Attending F/U&quot;                                         
##  [151] &quot;Pallliative Care Consult Follow up&quot;                                              
##  [152] &quot;Nursing Admission/Progress Note&quot;                                                 
##  [153] &quot;Nursing admit note 2300-0700&quot;                                                    
##  [154] &quot;Admit Note&quot;                                                                      
##  [155] &quot;Physician fellow Progress Note&quot;                                                  
##  [156] &quot;Resident H&amp;P&quot;                                                                    
##  [157] &quot;Physician Resident/Attending  Progress Note&quot;                                     
##  [158] &quot;MICU Attendning Addendum&quot;                                                        
##  [159] &quot;Physician Fellow Progress Note&quot;                                                  
##  [160] &quot;Pain Agitation&quot;                                                                  
##  [161] &quot;Physician Resident-Attending Progress Note&quot;                                      
##  [162] &quot;Resident/Attending Admission H&amp;P&quot;                                                
##  [163] &quot;MICU Attending Note&quot;                                                             
##  [164] &quot;MICU Attending Progress NOte&quot;                                                    
##  [165] &quot;Pain Sedation&quot;                                                                   
##  [166] &quot;Gentamcin in HD&quot;                                                                 
##  [167] &quot;Physician Attending  Admission Note&quot;                                             
##  [168] &quot;Critical Care Staff&quot;                                                             
##  [169] &quot;ICU Event Note intubation&quot;                                                       
##  [170] &quot;Resident Admission Note / Attending Addendum&quot;                                    
##  [171] &quot;Resident Admission Note/Attending Addendum&quot;                                      
##  [172] &quot;ICU Event Note death&quot;                                                            
##  [173] &quot;Nursing 0100-0700&quot;                                                               
##  [174] &quot;MICU Attending NOte&quot;                                                             
##  [175] &quot;NURSING 1900-0700&quot;                                                               
##  [176] &quot;Critical Care Note&quot;                                                              
##  [177] &quot;MICU attending Addendum&quot;                                                         
##  [178] &quot;ICU Attending Admission Note&quot;                                                    
##  [179] &quot;NPN&quot;                                                                             
##  [180] &quot;Nursing 2300 - 0700&quot;                                                             
##  [181] &quot;Physician Attending/ Resident Admission Note - MIC&quot;                              
##  [182] &quot;Physician Resident/Attending Progress Note - MICU&quot;                               
##  [183] &quot;ICU Fellow Admission Note - MICU attending addendu&quot;                              
##  [184] &quot;Physician Surgical Admission Note&quot;                                               
##  [185] &quot;Physician Resident/Attending Admission Note - MICU&quot;                              
##  [186] &quot;ICU Fellow Progress Note - MICU attending addendum&quot;                              
##  [187] &quot;ICU Fellow Progress Note - MICU&quot;                                                 
##  [188] &quot;micu attending progress note&quot;                                                    
##  [189] &quot;MICU attending addendum/progress note&quot;                                           
##  [190] &quot;ICU Fellow Admission Note - MICU&quot;                                                
##  [191] &quot;ICU Note - CVI&quot;                                                                  
##  [192] &quot;Social Work&quot;                                                                     
##  [193] &quot;ICU Fellow Progress Note - MICU attedning addendum&quot;                              
##  [194] &quot;Fellow/Attending Notes - MICU&quot;                                                   
##  [195] &quot;Physician Fellow/Attending Progress Note - MICU&quot;                                 
##  [196] &quot;Fellow / Attending Notes&quot;                                                        
##  [197] &quot;MICU Attending Admit Addendum&quot;                                                   
##  [198] &quot;Resident / Attending Notes&quot;                                                      
##  [199] &quot;Case Management Discharge Plan&quot;                                                  
##  [200] &quot;Physician Fellow/Attending Admission Note - MICU&quot;                                
##  [201] &quot;Fellow and Attending Notes&quot;                                                      
##  [202] &quot;Physician Fellow Progress Note - MICU&quot;                                           
##  [203] &quot;Physician Fellow Admission Note - MICU&quot;                                          
##  [204] &quot;Nursing Admission Note&quot;                                                          
##  [205] &quot;Physician Resident / Attending Progress Note - MIC&quot;                              
##  [206] &quot;Physician Fellow Progress Note -attending addendum&quot;                              
##  [207] &quot;Physician Fellow Progress Note -MICU attending add&quot;                              
##  [208] &quot;Physician Fellow Progress Note/MICU attending adde&quot;                              
##  [209] &quot;Nursing admit note.&quot;                                                             
##  [210] &quot;ICU Fellow Progress Note -attending addendum-MICU&quot;                               
##  [211] &quot;ICU Fellow Progress Note /attending addendum- MICU&quot;                              
##  [212] &quot;ICU Fellow Progress Note - attending addendum-MICU&quot;                              
##  [213] &quot;ICU Fellow Admission Note -attending addendum- MIC&quot;                              
##  [214] &quot;Physician Fellow Progress Note - MICU attending ad&quot;                              
##  [215] &quot;Physician Fellow Admission Note - MICU attending a&quot;                              
##  [216] &quot;Resident/Attending Admission Notes&quot;                                              
##  [217] &quot;critical care attending&quot;                                                         
##  [218] &quot;Physician Resident and  MICU attending --MICU prog&quot;                              
##  [219] &quot;MICU attending progress note&quot;                                                    
##  [220] &quot;Nursing admit 2100 - 0700&quot;                                                       
##  [221] &quot;Admission Note&quot;                                                                  
##  [222] &quot;Nursing admit&quot;                                                                   
##  [223] &quot;Discharge Planning Note&quot;                                                         
##  [224] &quot;Physician Resident and Attending Admission Note -&quot;                               
##  [225] &quot;Resident Progress Note - MICU&quot;                                                   
##  [226] &quot;MICU Resident Transfer Note&quot;                                                     
##  [227] &quot;MICU Resident Admission Note&quot;                                                    
##  [228] &quot;Flumazenil Challenge&quot;                                                            
##  [229] &quot;ICU Event Note - Family meeting&quot;                                                 
##  [230] &quot;Transfer Note&quot;                                                                   
##  [231] &quot;Discharge Plan - Update&quot;                                                         
##  [232] &quot;Resident/Attending Progress Note - MICU&quot;                                         
##  [233] &quot;procedure note: A-line&quot;                                                          
##  [234] &quot;ICU attending&quot;                                                                   
##  [235] &quot;ICU Resident Admission Note&quot;                                                     
##  [236] &quot;NF med - diazoxide&quot;                                                              
##  [237] &quot;ICU Attending Attending&quot;                                                         
##  [238] &quot;ICU Attending Progress Note&quot;                                                     
##  [239] &quot;Resident admission note&quot;                                                         
##  [240] &quot;ICU Resident admission note&quot;                                                     
##  [241] &quot;Critical Care Attending note&quot;                                                    
##  [242] &quot;Arterial Line Placement&quot;                                                         
##  [243] &quot;Overnight Intensivist&quot;                                                           
##  [244] &quot;ICU Atending Progress note&quot;                                                      
##  [245] &quot;Resp Care&quot;                                                                       
##  [246] &quot;Nursing 0130-0700&quot;                                                               
##  [247] &quot;ICU Note - SOB&quot;                                                                  
##  [248] &quot;ICU Attending Daily Note&quot;                                                        
##  [249] &quot;Physician Felow/Attending Progress Note - MICU&quot;                                  
##  [250] &quot;MICU Resident/Attending Transfer Note&quot;                                           
##  [251] &quot;Physician Consult Progress Note&quot;                                                 
##  [252] &quot;Case Management Discharge Planning&quot;                                              
##  [253] &quot;CVL Insertion&quot;                                                                   
##  [254] &quot;Physician Felllow/Attending Progress Note - MICU&quot;                                
##  [255] &quot;Physician Residentand attending  Progress Note - M&quot;                              
##  [256] &quot;Procedure note&quot;                                                                  
##  [257] &quot;general&quot;                                                                         
##  [258] &quot;MICU attending admit note&quot;                                                       
##  [259] &quot;Physician Resident and Attg Admission Note - MICU&quot;                               
##  [260] &quot;Physician Resident and Attending Progress Note - M&quot;                              
##  [261] &quot;A-Line Attempt&quot;                                                                  
##  [262] &quot;ICU Event Note: Line Placement&quot;                                                  
##  [263] &quot;Physician Resident Transfer/Accept/ Note - MICU&quot;                                 
##  [264] &quot;micu attending event note&quot;                                                       
##  [265] &quot;event note: afib w rvr and hypotn&quot;                                               
##  [266] &quot;Physician Resident/attending Progress Note - MICU&quot;                               
##  [267] &quot;Psych Contact Information&quot;                                                       
##  [268] &quot;IV Placement with Ultrasound&quot;                                                    
##  [269] &quot;Resident / Attending Admission Note&quot;                                             
##  [270] &quot;Physician Resident /attending Progress Note - MICU&quot;                              
##  [271] &quot;ICU Attending Critical Care Note&quot;                                                
##  [272] &quot;Discharge Note&quot;                                                                  
##  [273] &quot;Physician Resident/Atending Progress Note - MICU&quot;                                
##  [274] &quot;attending procedure note&quot;                                                        
##  [275] &quot;CVL Procedure Note&quot;                                                              
##  [276] &quot;Critical Care Attending Note&quot;                                                    
##  [277] &quot;Antibiotics in HD&quot;                                                               
##  [278] &quot;ICU Critical Care Attending Note&quot;                                                
##  [279] &quot;ICU Note&quot;                                                                        
##  [280] &quot;Case Management - Discharge Planning&quot;                                            
##  [281] &quot;Vancomycin in HD&quot;                                                                
##  [282] &quot;MICU resident physician progress note&quot;                                           
##  [283] &quot;Physician Attending - Resident Admission Note - MI&quot;                              
##  [284] &quot;Nursing Admit Note&quot;                                                              
##  [285] &quot;CCU Resident Progress Note&quot;                                                      
##  [286] &quot;Physician Attending/Resident Admission Note - MICU&quot;                              
##  [287] &quot;Attedning  Note&quot;                                                                 
##  [288] &quot;resident admission note&quot;                                                         
##  [289] &quot;Resident / Attending admission note&quot;                                             
##  [290] &quot;MICU Admission Note&quot;                                                             
##  [291] &quot;Case Management Note&quot;                                                            
##  [292] &quot;Physician Resident Admission/Progress Note - CCU&quot;                                
##  [293] &quot;ICU Attending Event Note&quot;                                                        
##  [294] &quot;Cardiology Physician Note&quot;                                                       
##  [295] &quot;Cardiology Comprehensive Physician Note&quot;                                         
##  [296] &quot;Resident Progress Not - MICU&quot;                                                    
##  [297] &quot;Methadone&quot;                                                                       
##  [298] &quot;Family Contact&quot;                                                                  
##  [299] &quot;PT/Rehab Services Contact Note&quot;                                                  
##  [300] &quot;Bedside Swallow Evaluation&quot;                                                      
##  [301] &quot;Cardiology Resident Progress Note&quot;                                               
##  [302] &quot;Cardiology Resident Progress Note - CCU&quot;                                         
##  [303] &quot;CVICU Note&quot;                                                                      
##  [304] &quot;Medical Student Progress Note - MICU&quot;                                            
##  [305] &quot;Resident/MICU attending Note&quot;                                                    
##  [306] &quot;Cardiology Fellow Admission Note Addendum&quot;                                       
##  [307] &quot;MICU Resident Progress Note&quot;                                                     
##  [308] &quot;Progress Note&quot;                                                                   
##  [309] &quot;Resident Note&quot;                                                                   
##  [310] &quot;ICU note&quot;                                                                        
##  [311] &quot;Fellow Admit Addendum&quot;                                                           
##  [312] &quot;MICU attending goals of care discussion&quot;                                         
##  [313] &quot;CVI&quot;                                                                             
##  [314] &quot;RESPIRATORY CARE:&quot;                                                               
##  [315] &quot;Respiratory Care:&quot;                                                               
##  [316] &quot;MICU staff family mtg note&quot;                                                      
##  [317] &quot;Attending  Note&quot;                                                                 
##  [318] &quot;MICU staff event note&quot;                                                           
##  [319] &quot;MICU Overnight Intensivist Fellow Admission&quot;                                     
##  [320] &quot;MICU Attending&quot;                                                                  
##  [321] &quot;Overnight Intensivist Admission Addendum&quot;                                        
##  [322] &quot;Fellow Admission&quot;                                                                
##  [323] &quot;Physician Attending / Resident Admission Note - MI&quot;                              
##  [324] &quot;Physician Resident/attending  Progress Note - MICU&quot;                              
##  [325] &quot;Physician Resident/ attending Progress Note - MICU&quot;                              
##  [326] &quot;Medical Student Progress Note&quot;                                                   
##  [327] &quot;Surgical Intensive Care Intensivist&quot;                                             
##  [328] &quot;Cardiology fellow addendum- CCU&quot;                                                 
##  [329] &quot;Surgical Critical Care Intensivist&quot;                                              
##  [330] &quot;Bedside Swallowing Evaluation&quot;                                                   
##  [331] &quot;EP consult note&quot;                                                                 
##  [332] &quot;Death Certificate&quot;                                                               
##  [333] &quot;Cardiology Fellow Addendum&quot;                                                      
##  [334] &quot;Case Management Initial Assessment&quot;                                              
##  [335] &quot;Physician Attending/Resident Progress Note - MICU&quot;                               
##  [336] &quot;Cardiology Fellow Addendum to Admission note&quot;                                    
##  [337] &quot;MICU Resident/Attending Admission Note&quot;                                          
##  [338] &quot;Physician Medical Student/Attending Progress Note&quot;                               
##  [339] &quot;Attending/Physician Resident Progress Note - MICU&quot;                               
##  [340] &quot;EP follow up note&quot;                                                               
##  [341] &quot;Nursing 1900 - 0700&quot;                                                             
##  [342] &quot;EP Staff&quot;                                                                        
##  [343] &quot;Swallowing Follow-Up&quot;                                                            
##  [344] &quot;Nursing 2000-0700&quot;                                                               
##  [345] &quot;Swallow Evaluation&quot;                                                              
##  [346] &quot;Cardiology Comprehensive Physician Note - Resident&quot;                              
##  [347] &quot;Physician Resident Transfer Note: CCU&quot;                                           
##  [348] &quot;Cardiology fellow Addendum&quot;                                                      
##  [349] &quot;MICU Attending Event Note - Family Meeting&quot;                                      
##  [350] &quot;Physician Initial Consult Note&quot;                                                  
##  [351] &quot;Swallow Consult&quot;                                                                 
##  [352] &quot;ICU Event Note - Cardiac Arrest&quot;                                                 
##  [353] &quot;Tracheostomy Procedure Note&quot;                                                     
##  [354] &quot;EP fellow&quot;                                                                       
##  [355] &quot;PMV &amp; Swallow Evaluation&quot;                                                        
##  [356] &quot;ICU Atteding Note&quot;                                                               
##  [357] &quot;Cardiology Teaching Physician Note&quot;                                              
##  [358] &quot;cards fellow addendum&quot;                                                           
##  [359] &quot;ICU Attending Admission Physician Note&quot;                                          
##  [360] &quot;Physician Resident PN&quot;                                                           
##  [361] &quot;Speech &amp; Swallow Evaluation&quot;                                                     
##  [362] &quot;Video Swallow Study&quot;                                                             
##  [363] &quot;MICU staff admit note&quot;                                                           
##  [364] &quot;Gentamicin&quot;                                                                      
##  [365] &quot;Arterial line placement&quot;                                                         
##  [366] &quot;Video Swallow Evaluation&quot;                                                        
##  [367] &quot;Procedure Note: A-line placement&quot;                                                
##  [368] &quot;Swallowing Follow Up&quot;                                                            
##  [369] &quot;Swallow Follow Up&quot;                                                               
##  [370] &quot;Physician Resident ACCEPT Note - MICU&quot;                                           
##  [371] &quot;Physician Resident ACCEPT Note - FICU&quot;                                           
##  [372] &quot;admit/cpr note&quot;                                                                  
##  [373] &quot;Cardiology fellow follow up note&quot;                                                
##  [374] &quot;Cardiology Consult&quot;                                                              
##  [375] &quot;Cardiology Fellow Admission Note Admission&quot;                                      
##  [376] &quot;Attending Admit Note&quot;                                                            
##  [377] &quot;Death Note&quot;                                                                      
##  [378] &quot;ICU Attending/Fellow Progress Note - MICU&quot;                                       
##  [379] &quot;ICU Fellow/Attending Admission Note - MICU&quot;                                      
##  [380] &quot;CVICU&quot;                                                                           
##  [381] &quot;Death note&quot;                                                                      
##  [382] &quot;Cardiology fellow addendum&quot;                                                      
##  [383] &quot;Occupational Therapy Abbreviated Evaluation Note&quot;                                
##  [384] &quot;Nuirsing 1900-0700&quot;                                                              
##  [385] &quot;Repeat Bedside Swallowing Evaluation&quot;                                            
##  [386] &quot;Repeat Bedside Swallow Evaluation&quot;                                               
##  [387] &quot;EP note&quot;                                                                         
##  [388] &quot;Occupational Therapy Evaluation Note&quot;                                            
##  [389] &quot;Cardiology fellow note&quot;                                                          
##  [390] &quot;Central Line&quot;                                                                    
##  [391] &quot;MICU Attg Addendum&quot;                                                              
##  [392] &quot;PMV Evaluation&quot;                                                                  
##  [393] &quot;Physician Resident and attending  Progress Note -&quot;                               
##  [394] &quot;Deferred Bedside Swallowing Evaluation&quot;                                          
##  [395] &quot;Telephone Conferences with daughters&quot;                                            
##  [396] &quot;MICU Attg Update&quot;                                                                
##  [397] &quot;CCU Resident Admission Note&quot;                                                     
##  [398] &quot;Discussion with PCP&quot;                                                             
##  [399] &quot;Physician Resident MICU ADMIT note&quot;                                              
##  [400] &quot;Physician Resident / attending Admission Note - MI&quot;                              
##  [401] &quot;Resident / Attending Admission Notes&quot;                                            
##  [402] &quot;Physician Resident Attending/Admission Note - MICU&quot;                              
##  [403] &quot;ICU Resident Note&quot;                                                               
##  [404] &quot;micu attending pn&quot;                                                               
##  [405] &quot;MICU staff PN&quot;                                                                   
##  [406] &quot;MICU attending note&quot;                                                             
##  [407] &quot;MICU attending PN&quot;                                                               
##  [408] &quot;MICU attending family mtg note&quot;                                                  
##  [409] &quot;micu staff pn/bronchoscopy note&quot;                                                 
##  [410] &quot;micu staff pn&quot;                                                                   
##  [411] &quot;Case Management - Discharge Plan&quot;                                                
##  [412] &quot;Initial Assessment Note&quot;                                                         
##  [413] &quot;Case Management Assessment&quot;                                                      
##  [414] &quot;Dicharge Planning&quot;                                                               
##  [415] &quot;Physician Admission Note - MICU&quot;                                                 
##  [416] &quot;Electrophysiology Consult&quot;                                                       
##  [417] &quot;Attending Addendum to Resident MICU Admit Note&quot;                                  
##  [418] &quot;Discharge Plan&quot;                                                                  
##  [419] &quot;Code Note&quot;                                                                       
##  [420] &quot;Fellow Progress Note - MICU&quot;                                                     
##  [421] &quot;Fellow Progress Note&quot;                                                            
##  [422] &quot;MICU Fellow Progress Note&quot;                                                       
##  [423] &quot;Repeat Swallowing Evaluation&quot;                                                    
##  [424] &quot;Argatroban monitoring&quot;                                                           
##  [425] &quot;Deferred Swallowing Evaluation&quot;                                                  
##  [426] &quot;MICU staff admission note&quot;                                                       
##  [427] &quot;Critical Care Attending - Brain Death Note&quot;                                      
##  [428] &quot;Initial Assessment&quot;                                                              
##  [429] &quot;micu staff note&quot;                                                                 
##  [430] &quot;Case Management Discharge Note&quot;                                                  
##  [431] &quot;critical care attending note&quot;                                                    
##  [432] &quot;Critical care attending PN&quot;                                                      
##  [433] &quot;Discharge Plan - LTACH Transfer&quot;                                                 
##  [434] &quot;Attempted Bedside Swallow Evaluation&quot;                                            
##  [435] &quot;critical staff PN&quot;                                                               
##  [436] &quot;micu staff PN&quot;                                                                   
##  [437] &quot;Vascular Consult Note&quot;                                                           
##  [438] &quot;critical care attending PN&quot;                                                      
##  [439] &quot;Telephone Contact&quot;                                                               
##  [440] &quot;critical care attending progress note&quot;                                           
##  [441] &quot;Attempted Bedside Swallowing Evaluation&quot;                                         
##  [442] &quot;Cardiology fellow brief note&quot;                                                    
##  [443] &quot;critical care staff PN&quot;                                                          
##  [444] &quot;critical care staff pn&quot;                                                          
##  [445] &quot;critical care family mtg note&quot;                                                   
##  [446] &quot;Cardiology consult&quot;                                                              
##  [447] &quot;CCU Staff&quot;                                                                       
##  [448] &quot;Cardiac Arrest Consult&quot;                                                          
##  [449] &quot;Cardiology ICU Staff&quot;                                                            
##  [450] &quot;Cardiology&quot;                                                                      
##  [451] &quot;Cardiology Consult F/u&quot;                                                          
##  [452] &quot;Cardiology Consult Follow-up&quot;                                                    
##  [453] &quot;EP f/u&quot;                                                                          
##  [454] &quot;CCU Fellow Admit Note&quot;                                                           
##  [455] &quot;Electrophysiology Physician Note&quot;                                                
##  [456] &quot;Initial Patient Assessment&quot;                                                      
##  [457] &quot;Occupational Therapy Progress Note&quot;                                              
##  [458] &quot;EP Fellow&quot;                                                                       
##  [459] &quot;Initial Assessment &amp; Discharge Planning Note&quot;                                    
##  [460] &quot;nursing 1900-0700&quot;                                                               
##  [461] &quot;Assessment &amp; Discharge Planning Note&quot;                                            
##  [462] &quot;Cardiology Fellow&quot;                                                               
##  [463] &quot;Pronouncement of Death&quot;                                                          
##  [464] &quot;critical care note&quot;                                                              
##  [465] &quot;Weekend Intensivist&quot;                                                             
##  [466] &quot;Cardiology fellow/attending&quot;                                                     
##  [467] &quot;Weekend Intensivist Addendum&quot;                                                    
##  [468] &quot;Physician Progress Note-CCU&quot;                                                     
##  [469] &quot;Procedure Note&quot;                                                                  
##  [470] &quot;Cardiology Fellow Admission Note&quot;                                                
##  [471] &quot;Cardiology fellow&quot;                                                               
##  [472] &quot;Arterial Line Placement Note&quot;                                                    
##  [473] &quot;EP Consult Note&quot;                                                                 
##  [474] &quot;EP Note&quot;                                                                         
##  [475] &quot;Attempted Swallowing Follow-Up&quot;                                                  
##  [476] &quot;CVI-ICU note&quot;                                                                    
##  [477] &quot;Chest Tube Insertion&quot;                                                            
##  [478] &quot;EP  Physician Note&quot;                                                              
##  [479] &quot;PROGRESS NOTE&quot;                                                                   
##  [480] &quot;CCU Fellow Admission Note&quot;                                                       
##  [481] &quot;EP Physician Note&quot;                                                               
##  [482] &quot;Physician Attending and fellow Progress Note - MIC&quot;                              
##  [483] &quot;Physician Attending/Fellow Progress Note - MICU&quot;                                 
##  [484] &quot;Discahrge Plan&quot;                                                                  
##  [485] &quot;Physician Intensivist ICU  Note&quot;                                                 
##  [486] &quot;Residnet / Attending Admission Notes&quot;                                            
##  [487] &quot;PMV Evaluation and Green-Dye Bedside Swallowing Ev&quot;                              
##  [488] &quot;Assessment &amp; Initial Discharge Planning&quot;                                         
##  [489] &quot;Cardiology Fellow Note&quot;                                                          
##  [490] &quot;CCU Resident Transfer Note&quot;                                                      
##  [491] &quot;Daily Progress Note&quot;                                                             
##  [492] &quot;Physician Fellow/ Attending Progress Note - MICU&quot;                                
##  [493] &quot;Attending Daily Progress Note&quot;                                                   
##  [494] &quot;Cardiology Fellow CCU Admission Note&quot;                                            
##  [495] &quot;Caridology Fellow Admission Note/ Addendum&quot;                                      
##  [496] &quot;Cardiology Attending Consult Addendum&quot;                                           
##  [497] &quot;Cardiology Consult Note&quot;                                                         
##  [498] &quot;PGY1 - progress note MICU&quot;                                                       
##  [499] &quot;PGY1/Attending Daily Progress note MICU&quot;                                         
##  [500] &quot;Cardiology Fellow Admission Note/ Addendum&quot;                                      
##  [501] &quot;Critical Care Attending Addendum Note&quot;                                           
##  [502] &quot;Weekend Intensivisit&quot;                                                            
##  [503] &quot;Critical Care attending admission&quot;                                               
##  [504] &quot;Critical care attending admission note&quot;                                          
##  [505] &quot;Procedure/Event Note&quot;                                                            
##  [506] &quot;EP Admission Note&quot;                                                               
##  [507] &quot;CCU Fellow addendum&quot;                                                             
##  [508] &quot;CCU Fellow Addendum&quot;                                                             
##  [509] &quot;MICU Attending - Family Meeting&quot;                                                 
##  [510] &quot;Cardiology follow-up&quot;                                                            
##  [511] &quot;Critical care staff admission note&quot;                                              
##  [512] &quot;CV ICU&quot;                                                                          
##  [513] &quot;critical care attending admission note&quot;                                          
##  [514] &quot;Critical care attending progress note&quot;                                           
##  [515] &quot;crit care staff progress note&quot;                                                   
##  [516] &quot;Deferred PMV Evaluation&quot;                                                         
##  [517] &quot;Green-Dye Bedside Swallowing Evaluation&quot;                                         
##  [518] &quot;Case Management Discharge Plan - Addendum&quot;                                       
##  [519] &quot;Event Note&quot;                                                                      
##  [520] &quot;Comfort Measures Only&quot;                                                           
##  [521] &quot;Attending Progress Note - MICU&quot;                                                  
##  [522] &quot;Dishcarge Planning Note&quot;                                                         
##  [523] &quot;PMV Consult&quot;                                                                     
##  [524] &quot;PMV Evaluation &amp; Dispense&quot;                                                       
##  [525] &quot;EP follow-up&quot;                                                                    
##  [526] &quot;Phone call to wife&quot;                                                              
##  [527] &quot;EP Followup Note&quot;                                                                
##  [528] &quot;Right Heart Catheterization&quot;                                                     
##  [529] &quot;Clinical Nutrition Assessment&quot;                                                   
##  [530] &quot;RIJ TLC Insertion Note&quot;                                                          
##  [531] &quot;Cardiology fellow CCU admit note&quot;                                                
##  [532] &quot;transfer note&quot;                                                                   
##  [533] &quot;DC Planning&quot;                                                                     
##  [534] &quot;Nursing  note&quot;                                                                   
##  [535] &quot;ICU attending note&quot;                                                              
##  [536] &quot;MICU Admission&quot;                                                                  
##  [537] &quot;Attending progress note&quot;                                                         
##  [538] &quot;Discharge Pplanniing Update&quot;                                                     
##  [539] &quot;MICU Resident / Attending Progress Note&quot;                                         
##  [540] &quot;Critical Care note&quot;                                                              
##  [541] &quot;DC Plan&quot;                                                                         
##  [542] &quot;CM Follow-up&quot;                                                                    
##  [543] &quot;Cardiology Consult Follow-Up&quot;                                                    
##  [544] &quot;PT / Rehab Services Contact Note&quot;                                                
##  [545] &quot;Resident Progress Note - CCU&quot;                                                    
##  [546] &quot;Physician resident post-procedure check&quot;                                         
##  [547] &quot;MICU TRANSFER NOTE&quot;                                                              
##  [548] &quot;Code Discussion&quot;                                                                 
##  [549] &quot;Physician Attending/ Resident Progress Note - MICU&quot;                              
##  [550] &quot;Dc Planning&quot;                                                                     
##  [551] &quot;Resident Admission Note&quot;                                                         
##  [552] &quot;CVL Insertion Replacement Procedure Note&quot;                                        
##  [553] &quot;Attendinding Progress Note&quot;                                                      
##  [554] &quot;Infection control&quot;                                                               
##  [555] &quot;MICU ATTENDING Note&quot;                                                             
##  [556] &quot;Tobramycin&quot;                                                                      
##  [557] &quot;Rehab Services/PT&quot;                                                               
##  [558] &quot;Lumbar Puncture Procedure Note&quot;                                                  
##  [559] &quot;THORACENTESIS: ICU Event Note&quot;                                                   
##  [560] &quot;Event note&quot;                                                                      
##  [561] &quot;Physical Therapy RE- Evaluation Note&quot;                                            
##  [562] &quot;Critical Care&quot;                                                                   
##  [563] &quot;Attending Progress note&quot;                                                         
##  [564] &quot;Arterial Line Insertion Procedure Note&quot;                                          
##  [565] &quot;Attending Brief Note&quot;                                                            
##  [566] &quot;Cardiology consultation&quot;                                                         
##  [567] &quot;Nasogastric Tube Placement&quot;                                                      
##  [568] &quot;DC planning&quot;                                                                     
##  [569] &quot;Physician Resident/Attending Progress Note - MICUf&quot;                              
##  [570] &quot;critical care Progress note&quot;                                                     
##  [571] &quot;critical care admit note&quot;                                                        
##  [572] &quot;Physical Therapy&quot;                                                                
##  [573] &quot;ICU Fellow Progress Note -attending addendum- MICU&quot;                              
##  [574] &quot;Inital&quot;                                                                          
##  [575] &quot;Physician Fellow Progress Note /attending addendum&quot;                              
##  [576] &quot;ICU Fellow Transfer Accept Note - MICU attending a&quot;                              
##  [577] &quot;ICU Fellow Admission Note - MICU attednign addendu&quot;                              
##  [578] &quot;Progress note&quot;                                                                   
##  [579] &quot;ICU Fellow Transfer Accept Note - MICU&quot;                                          
##  [580] &quot;Resp.care extubation note&quot;                                                       
##  [581] &quot;Fellow/Attending Progress Note - MICU&quot;                                           
##  [582] &quot;Nursing admit 0001 - 0700&quot;                                                       
##  [583] &quot;Moderate Sedation and NG placement&quot;                                              
##  [584] &quot;Pain Analgesia&quot;                                                                  
##  [585] &quot;Digibind&quot;                                                                        
##  [586] &quot;Accept Note&quot;                                                                     
##  [587] &quot;Hypertension Agitation Meds&quot;                                                     
##  [588] &quot;Physician Attending Resident Admission Note - MICU&quot;                              
##  [589] &quot;ICU Attending Admit Note&quot;                                                        
##  [590] &quot;TSICU Resident Admission Note&quot;                                                   
##  [591] &quot;Cardiology Weekend Consult Attending&quot;                                            
##  [592] &quot;Social work&quot;                                                                     
##  [593] &quot;Resident/ Attending Notes&quot;                                                       
##  [594] &quot;ICU Fellow Note&quot;                                                                 
##  [595] &quot;Resident Admission note - TSICU&quot;                                                 
##  [596] &quot;ICU Fellow Progress Note - MICU atending addendum&quot;                               
##  [597] &quot;Physician Resident Note - MICU&quot;                                                  
##  [598] &quot;Physician Resodent Admission Note - MICU&quot;                                        
##  [599] &quot;TSICU progress note&quot;                                                             
##  [600] &quot;CCU resident progress note&quot;                                                      
##  [601] &quot;Resident Physician Progress Note&quot;                                                
##  [602] &quot;Resp. Therapy&quot;                                                                   
##  [603] &quot;Resident Progress Note, CCU&quot;                                                     
##  [604] &quot;MICU resident progress note&quot;                                                     
##  [605] &quot;CCU resident&quot;                                                                    
##  [606] &quot;Case Management - Initial Assessment&quot;                                            
##  [607] &quot;MICU staff progress note&quot;                                                        
##  [608] &quot;Resident Admission note&quot;                                                         
##  [609] &quot;Chest tube insertion&quot;                                                            
##  [610] &quot;Resp.Care note&quot;                                                                  
##  [611] &quot;PT Contact note&quot;                                                                 
##  [612] &quot;Fosphenytoin&quot;                                                                    
##  [613] &quot;LTAC Denial Clarification&quot;                                                       
##  [614] &quot;Resident Progress Note CCU&quot;                                                      
##  [615] &quot;CVI note&quot;                                                                        
##  [616] &quot;Nursong Progress Note&quot;                                                           
##  [617] &quot;Resident / Attending Admit Notes&quot;                                                
##  [618] &quot;Addendum to Housestaff Admission Note&quot;                                           
##  [619] &quot;MDI&#39;&#39;S&quot;                                                                          
##  [620] &quot;Physician Resident/attending Admission Note - MICU&quot;                              
##  [621] &quot;ICU Event Note1&quot;                                                                 
##  [622] &quot;Physician Resident / attending Progress Note - MIC&quot;                              
##  [623] &quot;Physical Therapy Evaluation&quot;                                                     
##  [624] &quot;Transfer Accept Note&quot;                                                            
##  [625] &quot;MICU staff addendum&quot;                                                             
##  [626] &quot;Attg Progress Note&quot;                                                              
##  [627] &quot;RESPIRATORY CARE&quot;                                                                
##  [628] &quot;Nursing 1900+-0700&quot;                                                              
##  [629] &quot;MICU Overnight Fellow Admission&quot;                                                 
##  [630] &quot;ICU Event Note- Death Note&quot;                                                      
##  [631] &quot;Critical Care Event Note&quot;                                                        
##  [632] &quot;PMV and Swallow Follow-Up&quot;                                                       
##  [633] &quot;Physician Resident/Attending  Progress Note - MICU&quot;                              
##  [634] &quot;ICU Physician Note&quot;                                                              
##  [635] &quot;Cardiology Fellow Addendum to H. Officer Admission&quot;                              
##  [636] &quot;Nursing 0300-0700&quot;                                                               
##  [637] &quot;MICU Resident Progres Note&quot;                                                      
##  [638] &quot;MICU Attending Event Note&quot;                                                       
##  [639] &quot;Cardiology Fellow Addendum to Admission Note&quot;                                    
##  [640] &quot;MICU - Resident Progress Note&quot;                                                   
##  [641] &quot;Cardiology fellow addendum to admission note&quot;                                    
##  [642] &quot;Bedside Swallowing evaluation&quot;                                                   
##  [643] &quot;Nursing 0100 - 0700&quot;                                                             
##  [644] &quot;Videoswallow study&quot;                                                              
##  [645] &quot;Cardiology Fellow Addendum to admission note&quot;                                    
##  [646] &quot;Green Dye Swallowing Evaluation&quot;                                                 
##  [647] &quot;social work&quot;                                                                     
##  [648] &quot;Physician Progress Note&quot;                                                         
##  [649] &quot;EP Consult follow-up&quot;                                                            
##  [650] &quot;EP follow-up note&quot;                                                               
##  [651] &quot;CVL Insertion R-IJ&quot;                                                              
##  [652] &quot;CCU ADMIT NOTE&quot;                                                                  
##  [653] &quot;Swallowing Consult&quot;                                                              
##  [654] &quot;CARDIOLOGY FELLOW INITIAL NOTE&quot;                                                  
##  [655] &quot;CCU ACCEPT NOTE&quot;                                                                 
##  [656] &quot;Rectus Sheeth block note&quot;                                                        
##  [657] &quot;Overnight intensivist admission&quot;                                                 
##  [658] &quot;PGY1 Progress Note&quot;                                                              
##  [659] &quot;PGY 1 progress note&quot;                                                             
##  [660] &quot;MICU Fellow&quot;                                                                     
##  [661] &quot;Cardiology Addendum to Admission Note&quot;                                           
##  [662] &quot;Cardiology Fellow Addendum to Resident H&amp;P&quot;                                      
##  [663] &quot;Surgical Intensivist Note Attending&quot;                                             
##  [664] &quot;Admission Note - MICU&quot;                                                           
##  [665] &quot;ICU Intubation Note&quot;                                                             
##  [666] &quot;Physician Resident (Attending Addendum) Admission&quot;                               
##  [667] &quot;procedure note&quot;                                                                  
##  [668] &quot;Procedure&quot;                                                                       
##  [669] &quot;CCU Admit: Cardiology Comprehensive Physician Note&quot;                              
##  [670] &quot;CARDIOLOGY FELLOW NOTE&quot;                                                          
##  [671] &quot;Cardioversion note&quot;                                                              
##  [672] &quot;Overnight Intensivist / Fellow Admission&quot;                                        
##  [673] &quot;Cardiology Fellow Admission Addendum&quot;                                            
##  [674] &quot;Overnight Intensivist Fellow Admission&quot;                                          
##  [675] &quot;Cards Fellow Admit Note addendum&quot;                                                
##  [676] &quot;Resident / Attending notes&quot;                                                      
##  [677] &quot;MICU Attenidng Addendum&quot;                                                         
##  [678] &quot;Cardiology Fellow Admit Addendum&quot;                                                
##  [679] &quot;MICU Attending Progress Note - Family Meeting&quot;                                   
##  [680] &quot;ICU Attending Note - Reintubation&quot;                                               
##  [681] &quot;Speech &amp; Swallowing Follow-Up Note&quot;                                              
##  [682] &quot;MICU ATTENDING  Note&quot;                                                            
##  [683] &quot;Contact info&quot;                                                                    
##  [684] &quot;Speech &amp; Swallow Consult; Bedside Swallow Eval&quot;                                  
##  [685] &quot;PMV/Swallow&quot;                                                                     
##  [686] &quot;PGY1 Resident Progress note&quot;                                                     
##  [687] &quot;Chest tube insertion in OR&quot;                                                      
##  [688] &quot;EP fellow note&quot;                                                                  
##  [689] &quot;steroid dose clarification&quot;                                                      
##  [690] &quot;ICU Fellow/Attending Progress Note - MICU&quot;                                       
##  [691] &quot;PGY1 Procedure Note&quot;                                                             
##  [692] &quot;Physician Resident and attedning Admission Note -&quot;                               
##  [693] &quot;CVI Note&quot;                                                                        
##  [694] &quot;Deferred Bedside Swallow Evaluation&quot;                                             
##  [695] &quot;ICU Event Note - bleeding&quot;                                                       
##  [696] &quot;Attending Family Meeting&quot;                                                        
##  [697] &quot;MICU Attending Critical Care note&quot;                                               
##  [698] &quot;RNCM Initial Assessment&quot;                                                         
##  [699] &quot;Hospice Referral&quot;                                                                
##  [700] &quot;MICU Attending Critical Care Note&quot;                                               
##  [701] &quot;Surgical Intensivist Note&quot;                                                       
##  [702] &quot;call to HCP&quot;                                                                     
##  [703] &quot;Sub-Intern (4th year med student) Admission Note&quot;                                
##  [704] &quot;EP fellow Note&quot;                                                                  
##  [705] &quot;Physician Resident and Attg Progress Note - MICU&quot;                                
##  [706] &quot;ICU Attending Progress Report&quot;                                                   
##  [707] &quot;Discharge Plan - Home with Hospice&quot;                                              
##  [708] &quot;Physician Resident/ attending Admission Note - MIC&quot;                              
##  [709] &quot;Attg ICU Event Note&quot;                                                             
##  [710] &quot;PMV Follow Up&quot;                                                                   
##  [711] &quot;Attempted PMV Evaluation&quot;                                                        
##  [712] &quot;Cardiology Fellow Addendum to Housestaff admission&quot;                              
##  [713] &quot;Attending Event Note- ARREST and GIB&quot;                                            
##  [714] &quot;CCU Fellow Admit Addendum&quot;                                                       
##  [715] &quot;MICU Resident/Attending Daily Progress Note&quot;                                     
##  [716] &quot;Bronchoscopy Procedure Note&quot;                                                     
##  [717] &quot;Telephone contact&quot;                                                               
##  [718] &quot;PMV Evaluation / Dispense&quot;                                                       
##  [719] &quot;ICU Admission Note&quot;                                                              
##  [720] &quot;Cardiology note&quot;                                                                 
##  [721] &quot;EP Admit H &amp; P&quot;                                                                  
##  [722] &quot;Central Line Revision&quot;                                                           
##  [723] &quot;Resident / Attending Admission Note - MICU&quot;                                      
##  [724] &quot;Fellow Addendum&quot;                                                                 
##  [725] &quot;Resident and Attending Admission Notes - MICU&quot;                                   
##  [726] &quot;EP Progress Note&quot;                                                                
##  [727] &quot;Physician Resident Transfer Off-Service Note&quot;                                    
##  [728] &quot;Chest tube procedure note&quot;                                                       
##  [729] &quot;micu staff admission note&quot;                                                       
##  [730] &quot;PMV Follow-Up&quot;                                                                   
##  [731] &quot;MICU attending procedure note&quot;                                                   
##  [732] &quot;MICU attending pn&quot;                                                               
##  [733] &quot;MICU Resident/Attending Progress Note&quot;                                           
##  [734] &quot;MICU Resident Daily Progress Note&quot;                                               
##  [735] &quot;Nursing 1900-2217&quot;                                                               
##  [736] &quot;MICU attending Progress Note&quot;                                                    
##  [737] &quot;Physician Resident/attending  Admission Note - MIC&quot;                              
##  [738] &quot;Attempted FEES Exam&quot;                                                             
##  [739] &quot;RESIDENT ADMISSION NOTE&quot;                                                         
##  [740] &quot;Cardiology consult note&quot;                                                         
##  [741] &quot;EP Service&quot;                                                                      
##  [742] &quot;Pre-Op Risk Stratification&quot;                                                      
##  [743] &quot;Physician Resident /Attending Admission Note - MIC&quot;                              
##  [744] &quot;Cancelled Bedside Swallow Evaluation&quot;                                            
##  [745] &quot;Pre-Op Risk Assessment&quot;                                                          
##  [746] &quot;PMV follow up/Swallow Consult&quot;                                                   
##  [747] &quot;MICU Attending Addendum&quot;                                                         
##  [748] &quot;MICU Attending Addendum and  Event Note&quot;                                         
##  [749] &quot;MICU Attending Addendum and Event NOte&quot;                                          
##  [750] &quot;Hypertension&quot;                                                                    
##  [751] &quot;Passy Muir Speaking Valve Evaluation&quot;                                            
##  [752] &quot;Physical Therapy Re- Evaluation Note&quot;                                            
##  [753] &quot;Swallowing Therapy&quot;                                                              
##  [754] &quot;Rash&quot;                                                                            
##  [755] &quot;Cancelled Swallowing Consult&quot;                                                    
##  [756] &quot;PM check&quot;                                                                        
##  [757] &quot;EVENT NOTE -READMISSION&quot;                                                         
##  [758] &quot;Overnight Intensivist - Brief Note&quot;                                              
##  [759] &quot;Overnight Intensivisty&quot;                                                          
##  [760] &quot;Admission Note - Surgical Critical Care&quot;                                         
##  [761] &quot;Swallowing Follow up&quot;                                                            
##  [762] &quot;MICU attending Admit Addendum&quot;                                                   
##  [763] &quot;critical care progress note&quot;                                                     
##  [764] &quot;Physician progress note&quot;                                                         
##  [765] &quot;Case Management Discharge Planning Assessment&quot;                                   
##  [766] &quot;critical care PN&quot;                                                                
##  [767] &quot;Preliminary Discharge Planniing&quot;                                                 
##  [768] &quot;Attempted Percutaneous Tracheostomy&quot;                                             
##  [769] &quot;Green Dye Bedside Swallow Evaluation&quot;                                            
##  [770] &quot;Medicine resident Admission note&quot;                                                
##  [771] &quot;Cancelled Video Swallow&quot;                                                         
##  [772] &quot;ICU Critical Care Note&quot;                                                          
##  [773] &quot;Cardiology Consultation&quot;                                                         
##  [774] &quot;LTACH Discharge Plan&quot;                                                            
##  [775] &quot;CT insertion&quot;                                                                    
##  [776] &quot;Case Management Assessment Note&quot;                                                 
##  [777] &quot;Case Management ICU Note&quot;                                                        
##  [778] &quot;Initial Assessment &amp; Discharge Planning&quot;                                         
##  [779] &quot;Case Management Assessment &amp; Preliminary Dishcarge&quot;                              
##  [780] &quot;Electrophysiology Consult Note&quot;                                                  
##  [781] &quot;MICU Resident Note&quot;                                                              
##  [782] &quot;physician intensivist note&quot;                                                      
##  [783] &quot;Lumbar Puncture&quot;                                                                 
##  [784] &quot;Electrophysiology&quot;                                                               
##  [785] &quot;Case Management Follow-up&quot;                                                       
##  [786] &quot;Case Management&quot;                                                                 
##  [787] &quot;Bactrim&quot;                                                                         
##  [788] &quot;critical care attending  PN&quot;                                                     
##  [789] &quot;Physician Resident/Atending Admission Note - MICU&quot;                               
##  [790] &quot;Case Management Assessment &amp; Discharge Planning&quot;                                 
##  [791] &quot;PMV Evaluation/Dispense&quot;                                                         
##  [792] &quot;Case Management Assessment and Dishcarge Planning&quot;                               
##  [793] &quot;Nursing&quot;                                                                         
##  [794] &quot;PMV Evaluation/Dispense and Bedside Swallowing Eva&quot;                              
##  [795] &quot;Speech/Swallow Follow Up&quot;                                                        
##  [796] &quot;MICU Fellow Progress note&quot;                                                       
##  [797] &quot;ICU attending Note&quot;                                                              
##  [798] &quot;Physican Resident Admission Note&quot;                                                
##  [799] &quot;Pulm / Critical Care Consult Note&quot;                                               
##  [800] &quot;Respiratory Care Shift Not&quot;                                                      
##  [801] &quot;Case Management Initial Discharge Planning Note&quot;                                 
##  [802] &quot;Physician Progress Note - MICU&quot;                                                  
##  [803] &quot;Code Blue, Cardiac Arrest, Death&quot;                                                
##  [804] &quot;Attending Addendum to Resident Admit Note&quot;                                       
##  [805] &quot;Initial Assessment &amp; Family Contact&quot;                                             
##  [806] &quot;Speech Therapy&quot;                                                                  
##  [807] &quot;Physician Resident Accept Note - CCU-&gt;MICU&quot;                                      
##  [808] &quot;Green Dye Repeat Bedside Swallowing Evaluation&quot;                                  
##  [809] &quot;Fellow admission Note&quot;                                                           
##  [810] &quot;CCU fellow admit note&quot;                                                           
##  [811] &quot;Discharge Note - Hospice&quot;                                                        
##  [812] &quot;CCU fellow admit ntoe&quot;                                                           
##  [813] &quot;RESIDENT PROGRESS NOTE-CCU&quot;                                                      
##  [814] &quot;Discahrge Planning Note&quot;                                                         
##  [815] &quot;A-line placement&quot;                                                                
##  [816] &quot;Fellow / Physician Attending Admission Note - MICU&quot;                              
##  [817] &quot;Felllow / Physician Attending Progress Note - MICU&quot;                              
##  [818] &quot;Physician Felllow / Attending Progress Note - MICU&quot;                              
##  [819] &quot;Blue Dye Bedside Swallowing Evaluation&quot;                                          
##  [820] &quot;Communication Evaluation&quot;                                                        
##  [821] &quot;PMV Evaluation/Dispense and Green-Dye Bedside Swal&quot;                              
##  [822] &quot;Speech Therapy Follow Up&quot;                                                        
##  [823] &quot;Bronchoscopy Note&quot;                                                               
##  [824] &quot;Bronchcopscopy&quot;                                                                  
##  [825] &quot;Speech Therapy # 2&quot;                                                              
##  [826] &quot;MICU attending&quot;                                                                  
##  [827] &quot;MICU/CCU Nursing Admission Note&quot;                                                 
##  [828] &quot;ICU Physican Progress Note&quot;                                                      
##  [829] &quot;Electrophysiology Consultation&quot;                                                  
##  [830] &quot;CCU Staff Note&quot;                                                                  
##  [831] &quot;Initial Patient Assessment - Case Management&quot;                                    
##  [832] &quot;ICU Event Note -- Family Meeting / CMO&quot;                                          
##  [833] &quot;Nursing 19000 -2250&quot;                                                             
##  [834] &quot;Assessment and Initial Discharge Planning Note&quot;                                  
##  [835] &quot;CCU Admit note&quot;                                                                  
##  [836] &quot;ICU intensivist&quot;                                                                 
##  [837] &quot;Deferred PMV &amp; Swallow Evaluation&quot;                                               
##  [838] &quot;FEES Exam&quot;                                                                       
##  [839] &quot;CCU Note&quot;                                                                        
##  [840] &quot;Cardiology Consult Staff Note&quot;                                                   
##  [841] &quot;Cardiology fellow admit note&quot;                                                    
##  [842] &quot;PMV and Swallowing Follow-Up&quot;                                                    
##  [843] &quot;Initail Patient Assessment&quot;                                                      
##  [844] &quot;Assessment and Discharge Plan Note&quot;                                              
##  [845] &quot;CCU Attending&quot;                                                                   
##  [846] &quot;Physician Attending and Fellow Progress Note - MIC&quot;                              
##  [847] &quot;Cardiology fellow CCU Admit note&quot;                                                
##  [848] &quot;EP Consult f/u&quot;                                                                  
##  [849] &quot;Silibinin IV&quot;                                                                    
##  [850] &quot;Physician Fellow and Attending Progress Note - MIC&quot;                              
##  [851] &quot;Physician Attending Fellow Progress Note - MICU&quot;                                 
##  [852] &quot;MICU Fellow Note&quot;                                                                
##  [853] &quot;ICU Event Note --Family Note&quot;                                                    
##  [854] &quot;Assessment and Dishcarge Planning&quot;                                               
##  [855] &quot;nurisng&quot;                                                                         
##  [856] &quot;ICU Event Note -- death note&quot;                                                    
##  [857] &quot;Patient Assessment Note&quot;                                                         
##  [858] &quot;MICU attending admission note&quot;                                                   
##  [859] &quot;Arterial Line Procedure Note&quot;                                                    
##  [860] &quot;CCU Attending Note&quot;                                                              
##  [861] &quot;Speech consult&quot;                                                                  
##  [862] &quot;surgical intensivist note&quot;                                                       
##  [863] &quot;EPS Progress Note&quot;                                                               
##  [864] &quot;ICU Procedure note&quot;                                                              
##  [865] &quot;Overnight Intensivisist Addendum&quot;                                                
##  [866] &quot;Electrophysiology Consult Progress Note&quot;                                         
##  [867] &quot;admission note&quot;                                                                  
##  [868] &quot;ICU Atttending Note&quot;                                                             
##  [869] &quot;Critical care admit note&quot;                                                        
##  [870] &quot;Cardiology Consult Follow-Up Note&quot;                                               
##  [871] &quot;Procedure Note - Arterial Line Placement (left rad&quot;                              
##  [872] &quot;Repeat PMV Evaluation&quot;                                                           
##  [873] &quot;Repeat Green-Dye Bedside Swallowing Evaluation&quot;                                  
##  [874] &quot;Cardiology Consult Note Initial&quot;                                                 
##  [875] &quot;Admission H&amp;P&quot;                                                                   
##  [876] &quot;MICU Physician Progress Note&quot;                                                    
##  [877] &quot;Cardiac Arrest Consult Service&quot;                                                  
##  [878] &quot;CCU - Admit Note, History and Physical&quot;                                          
##  [879] &quot;Resident Physician Progress Note - CCU&quot;                                          
##  [880] &quot;Physical Therapy Initial Evaluation&quot;                                             
##  [881] &quot;Cardiology Follow-up&quot;                                                            
##  [882] &quot;Deferred Video Swallow Evaluation&quot;                                               
##  [883] &quot;Death  Note&quot;                                                                     
##  [884] &quot;Assessment and Discharge Planning&quot;                                               
##  [885] &quot;Analgesia/sedation&quot;                                                              
##  [886] &quot;CMO&quot;                                                                             
##  [887] &quot;Physician Resident/Attending Progress Note - CCU&quot;                                
##  [888] &quot;Physician Attending/Resident Progress Note - CCU&quot;                                
##  [889] &quot;meeting with attorney&quot;                                                           
##  [890] &quot;discussion with daughter&quot;                                                        
##  [891] &quot;Weekend Physician&quot;                                                               
##  [892] &quot;Pacemaker interrogation&quot;                                                         
##  [893] &quot;Physical Therapy. Rehab Services&quot;                                                
##  [894] &quot;Intensvist note&quot;                                                                 
##  [895] &quot;Social Work Note&quot;                                                                
##  [896] &quot;Cardioversion&quot;                                                                   
##  [897] &quot;MICU attending admission&quot;                                                        
##  [898] &quot;Physician Resident Note&quot;                                                         
##  [899] &quot;Cardiology follow up&quot;                                                            
##  [900] &quot;Cardiology f/u&quot;                                                                  
##  [901] &quot;MICU Attending Progress / Family Meeting Note&quot;                                   
##  [902] &quot;EP Follow-Up&quot;                                                                    
##  [903] &quot;admit note&quot;                                                                      
##  [904] &quot;PGY-1 Progress Note&quot;                                                             
##  [905] &quot;error- no note&quot;                                                                  
##  [906] &quot;Speech and Swallow Follow Up&quot;                                                    
##  [907] &quot;REPEAT BEDSIDE SWALLOWING EVALUATION&quot;                                            
##  [908] &quot;SWALLOWING FOLLOW-UP&quot;                                                            
##  [909] &quot;PGY1- Daily Progress Note, MICU&quot;                                                 
##  [910] &quot;Critical care attending admit/addendum&quot;                                          
##  [911] &quot;Case Mangement Planning&quot;                                                         
##  [912] &quot;IABP Removal&quot;                                                                    
##  [913] &quot;Pericardial drain removal&quot;                                                       
##  [914] &quot;Critical care attending admit&quot;                                                   
##  [915] &quot;ICU Progress Note - family meeting&quot;                                              
##  [916] &quot;Critical care PN&quot;                                                                
##  [917] &quot;Medical Student Progress Note - CCU&quot;                                             
##  [918] &quot;ICU Resident Progress Note&quot;                                                      
##  [919] &quot;EP Fellow Progress Note&quot;                                                         
##  [920] &quot;CCU Fellow Admission Addendum&quot;                                                   
##  [921] &quot;Brief EP Admit Note&quot;                                                             
##  [922] &quot;MICU Attending Admit Note&quot;                                                       
##  [923] &quot;EP Consult&quot;                                                                      
##  [924] &quot;Medical Student CCU Progress Note&quot;                                               
##  [925] &quot;ArterialLineInsertionProcedureNote&quot;                                              
##  [926] &quot;ICU Event Note - Death Note&quot;                                                     
##  [927] &quot;Med Student Progress Note - CCU&quot;                                                 
##  [928] &quot;Resident Admission Note - CCU&quot;                                                   
##  [929] &quot;CCU nursing Progress&quot;                                                            
##  [930] &quot;Cardiology Fellow Note/ Addendum&quot;                                                
##  [931] &quot;Cardiology Initial Consult&quot;                                                      
##  [932] &quot;Critical Care attendign note and addendum&quot;                                       
##  [933] &quot;Critical Care attendign note&quot;                                                    
##  [934] &quot;Critical care attending Progress note&quot;                                           
##  [935] &quot;Fellow Admission Note/ Addendum&quot;                                                 
##  [936] &quot;Resident / Attending Note&quot;                                                       
##  [937] &quot;Bedside Swallowing Eval&quot;                                                         
##  [938] &quot;Medical Student Progress Note CCU&quot;                                               
##  [939] &quot;Deferred Swallow Follow Up&quot;                                                      
##  [940] &quot;EP Device Interrogation&quot;                                                         
##  [941] &quot;Aphasia Evaluation&quot;                                                              
##  [942] &quot;Deferred Repeat Swallowing Evaluation&quot;                                           
##  [943] &quot;Speech and Language Therapy&quot;                                                     
##  [944] &quot;ICU attdg admit note&quot;                                                            
##  [945] &quot;Deferred Bedside Swallow Study&quot;                                                  
##  [946] &quot;Initial Cardiology Consultation&quot;                                                 
##  [947] &quot;PMV Eval / Dispense&quot;                                                             
##  [948] &quot;ICU Event Note - Death&quot;                                                          
##  [949] &quot;EP staff&quot;                                                                        
##  [950] &quot;Cardiology Fellow CCU admission note&quot;                                            
##  [951] &quot;Limited Green-Dye Bedside Swallowing Evaluation&quot;                                 
##  [952] &quot;Dc planning&quot;                                                                     
##  [953] &quot;Cardiology HVMA staff&quot;                                                           
##  [954] &quot;MICU Resident / Attending Admission Note&quot;                                        
##  [955] &quot;MICU RESIDENT RE-ADMIT NOTE&quot;                                                     
##  [956] &quot;Intensivsist note&quot;                                                               
##  [957] &quot;ICU - Resident Progress Note&quot;                                                    
##  [958] &quot;ADDENDUM TO ASSESSMT/PLAN ADMIT NOTE&quot;                                            
##  [959] &quot;ICU staff&quot;                                                                       
##  [960] &quot;Nursiong Progress Note&quot;                                                          
##  [961] &quot;Bedside Swallow Evaluation and Communication&quot;                                    
##  [962] &quot;Physician Attending  Progress Note&quot;                                              
##  [963] &quot;Voice Consult&quot;                                                                   
##  [964] &quot;Swallow Therapy&quot;                                                                 
##  [965] &quot;Physician ICU Admission Note&quot;                                                    
##  [966] &quot;Dc Plan&quot;                                                                         
##  [967] &quot;Attending Physician Note&quot;                                                        
##  [968] &quot;Cardiology HVMA&quot;                                                                 
##  [969] &quot;Critical care atttending&quot;                                                        
##  [970] &quot;Inpatient Cardiology Consult&quot;                                                    
##  [971] &quot;Attempted Repeat Bedside Swallow Evaluation&quot;                                     
##  [972] &quot;Physician Residen/Attending Progress Note - MICU&quot;                                
##  [973] &quot;ICU Procedure Note&quot;                                                              
##  [974] &quot;Resident progress Note&quot;                                                          
##  [975] &quot;MICU Attg Admit Addendum&quot;                                                        
##  [976] &quot;Physician Fellow Progress Note -MICU attending not&quot;                              
##  [977] &quot;Paracentesis Procedure Note&quot;                                                     
##  [978] &quot;Physician Attending Admit Note - MICU&quot;                                           
##  [979] &quot;ICU note - CVI&quot;                                                                  
##  [980] &quot;Resp. Care note&quot;                                                                 
##  [981] &quot;L subclavian line placement&quot;                                                     
##  [982] &quot;TRICU resident progress note&quot;                                                    
##  [983] &quot;MICU attending event note&quot;                                                       
##  [984] &quot;Resident Progress Note CCu&quot;                                                      
##  [985] &quot;ICU Physician Progress Note&quot;                                                     
##  [986] &quot;ICU resident admission note&quot;                                                     
##  [987] &quot;a-line placement note&quot;                                                           
##  [988] &quot;Nursing 2100-0700&quot;                                                               
##  [989] &quot;ICU Event - Intubation&quot;                                                          
##  [990] &quot;Physician Resident/ICU Attending Admission Note -&quot;                               
##  [991] &quot;Attending ICU Event Note&quot;                                                        
##  [992] &quot;Resident Procedure Note&quot;                                                         
##  [993] &quot;Cardiology Physician note&quot;                                                       
##  [994] &quot;Cardiology Comprehensive Physician Note/BACH consu&quot;                              
##  [995] &quot;Cardiology Physician Note EP&quot;                                                    
##  [996] &quot;Respiratory Shift Note&quot;                                                          
##  [997] &quot;EP Follow Up&quot;                                                                    
##  [998] &quot;Chest Tube Procedure Note&quot;                                                       
##  [999] &quot;Temperature curve&quot;                                                               
## [1000] &quot;Thoracentesis discussion&quot;                                                        
## [1001] &quot;Medical student Progress Note - MICU&quot;                                            
## [1002] &quot;ICU Attending addendum&quot;                                                          
## [1003] &quot;CCU team addendum&quot;                                                               
## [1004] &quot;ICU Attending Progress Note - family meeting&quot;                                    
## [1005] &quot;Nursing 1900-0001&quot;                                                               
## [1006] &quot;Thoracentesis&quot;                                                                   
## [1007] &quot;ICU Event Note - Line Removed&quot;                                                   
## [1008] &quot;Speech + Swallow Consult&quot;                                                        
## [1009] &quot;ICU Event Note-Aline&quot;                                                            
## [1010] &quot;Discharge Plan - Hospice&quot;                                                        
## [1011] &quot;Deferred Evaluation&quot;                                                             
## [1012] &quot;Overnight Intensivist Fellow Admission Note - MICU&quot;                              
## [1013] &quot;Overnight Intensivist Admit&quot;                                                     
## [1014] &quot;Cardiology- Electrophysiology Progress Note&quot;                                     
## [1015] &quot;Physical Therapy Progress Note Addendum&quot;                                         
## [1016] &quot;MICU Attending Admission Addendum&quot;                                               
## [1017] &quot;ICU intensivist note&quot;                                                            
## [1018] &quot;CVICU note&quot;                                                                      
## [1019] &quot;PROGRESS NOTE - RESIDENT&quot;                                                        
## [1020] &quot;Progress note - Resident&quot;                                                        
## [1021] &quot;Progress Note - Resident&quot;                                                        
## [1022] &quot;Intensvist&quot;                                                                      
## [1023] &quot;MICU Attending Physician Progress Note&quot;                                          
## [1024] &quot;PGY1 Resident Note&quot;                                                              
## [1025] &quot;MICU Fellow/Attending Progress Note&quot;                                             
## [1026] &quot;PGYI progress note&quot;                                                              
## [1027] &quot;PGY1 Progress note&quot;                                                              
## [1028] &quot;Physician Residen Progress Note&quot;                                                 
## [1029] &quot;cardiology fellow note&quot;                                                          
## [1030] &quot;Physician Resident Transfer Note - MICU&quot;                                         
## [1031] &quot;ICU Event and Death NOte&quot;                                                        
## [1032] &quot;Nursing \&quot;B\&quot;&quot;                                                                   
## [1033] &quot;Passy Muir Valve Evaluation / Dispense&quot;                                          
## [1034] &quot;CCU Addendum&quot;                                                                    
## [1035] &quot;Resident progress note ICU&quot;                                                      
## [1036] &quot;Passy Muir Speaking Valve Eval /Dispense&quot;                                        
## [1037] &quot;Cyclosporine serum levels&quot;                                                       
## [1038] &quot;PMV Speaking Valve re-evaluation&quot;                                                
## [1039] &quot;Medication management&quot;                                                           
## [1040] &quot;Cardiology Felllow Procedure Note&quot;                                               
## [1041] &quot;Cardiology Fellow Addendum to housestaff H&amp;P&quot;                                    
## [1042] &quot;PMV Evaluation and Green Dye Bedside Swallow Evalu&quot;                              
## [1043] &quot;Attempted Video Swallow&quot;                                                         
## [1044] &quot;MICU Attending Admission&quot;                                                        
## [1045] &quot;Cardiology Fellow Admit&quot;                                                         
## [1046] &quot;family discussion&quot;                                                               
## [1047] &quot;Physician Resident and attg Admission Note - MICU&quot;                               
## [1048] &quot;Daily ICU Note&quot;                                                                  
## [1049] &quot;Green Dye Swallow Evaluation&quot;                                                    
## [1050] &quot;Accept Note - MICU&quot;                                                              
## [1051] &quot;Post Cath Check&quot;                                                                 
## [1052] &quot;Physician Resident/Attening Admission Note - MICU&quot;                               
## [1053] &quot;micu attending admission note&quot;                                                   
## [1054] &quot;Physician Resident Accept Note - FICU accept from&quot;                               
## [1055] &quot;Micu staff progress note&quot;                                                        
## [1056] &quot;Physician Resident attending  Progress Note - MICU&quot;                              
## [1057] &quot;PMV / Swallow Follow Up&quot;                                                         
## [1058] &quot;SURGICAL INTENSIVIST NOTE&quot;                                                       
## [1059] &quot;Cardiology follow up note&quot;                                                       
## [1060] &quot;MICU Resident progress note&quot;                                                     
## [1061] &quot;Nursing AdmissionNote&quot;                                                           
## [1062] &quot;Brief Death Note&quot;                                                                
## [1063] &quot;Discussion with family&quot;                                                          
## [1064] &quot;Progress Note CCU&quot;                                                               
## [1065] &quot;HCP discussion&quot;                                                                  
## [1066] &quot;ICU Family Meeting Note&quot;                                                         
## [1067] &quot;Precedex Sedation&quot;                                                               
## [1068] &quot;Intubation&quot;                                                                      
## [1069] &quot;Initial EP Consult Note&quot;                                                         
## [1070] &quot;Rehab Services/PT contact note&quot;                                                  
## [1071] &quot;Right Heart Catherization&quot;                                                       
## [1072] &quot;Critical Care Attending Admit Note&quot;                                              
## [1073] &quot;FICU resident progress note/MICU staff addendum&quot;                                 
## [1074] &quot;FICU resident progress note&quot;                                                     
## [1075] &quot;Attempted Bedside Evaluation&quot;                                                    
## [1076] &quot;Case Mangement Initial Assessment&quot;                                               
## [1077] &quot;Speech and Language Evaluation&quot;                                                  
## [1078] &quot;Resident MICU Progress Note&quot;                                                     
## [1079] &quot;attending&quot;                                                                       
## [1080] &quot;MRI Consent&quot;                                                                     
## [1081] &quot;CVL placement&quot;                                                                   
## [1082] &quot;MICU attending -critical care note&quot;                                              
## [1083] &quot;MICU MS-IV/Attending Progress Note&quot;                                              
## [1084] &quot;transfere note&quot;                                                                  
## [1085] &quot;EP service&quot;                                                                      
## [1086] &quot;CCU Admission Note&quot;                                                              
## [1087] &quot;Physician Resident /attending Admission Note - MIC&quot;                              
## [1088] &quot;Critical Care Note Addendum&quot;                                                     
## [1089] &quot;Resident / Attending Progress Notes&quot;                                             
## [1090] &quot;PMV Evaluation / Swallowing Evaluation&quot;                                          
## [1091] &quot;Attending Addendum to MICU Admission Note&quot;                                       
## [1092] &quot;Attempted Repeat Bedside Swallowing Evaluation&quot;                                  
## [1093] &quot;Physician Resident Progess Note&quot;                                                 
## [1094] &quot;Physician Resident/Attending Progess Note&quot;                                       
## [1095] &quot;Clinical Nutrition Not&quot;                                                          
## [1096] &quot;ICU Death Note&quot;                                                                  
## [1097] &quot;Case Management Assessment &amp; D/C Planning&quot;                                       
## [1098] &quot;Discharge Plan Update&quot;                                                           
## [1099] &quot;PMV Evaluation/ Dispense&quot;                                                        
## [1100] &quot;ICU Physican Note&quot;                                                               
## [1101] &quot;Physician Resident MICU Progression Note&quot;                                        
## [1102] &quot;Case Management Assessment and Discharge Planning&quot;                               
## [1103] &quot;Deferred Repeat PMV Evaluation&quot;                                                  
## [1104] &quot;Case Management Discharge Plan - Final&quot;                                          
## [1105] &quot;Physician Intensivist Note&quot;                                                      
## [1106] &quot;Electrophysiology F/U&quot;                                                           
## [1107] &quot;Fellow / Physician Attending Progress Note - MICU&quot;                               
## [1108] &quot;CVI-cardiac surgery&quot;                                                             
## [1109] &quot;Resident Admission/ Attending Admission note&quot;                                    
## [1110] &quot;Transition to Inpatient Hospice Benefit&quot;                                         
## [1111] &quot;Cardiology Fellow Note Addendum&quot;                                                 
## [1112] &quot;Admission addendum&quot;                                                              
## [1113] &quot;ICU Physician Intensivist Note&quot;                                                  
## [1114] &quot;Discharge Plan Note&quot;                                                             
## [1115] &quot;Surgical Intensivist ICU&quot;                                                        
## [1116] &quot;Physician Note&quot;                                                                  
## [1117] &quot;Physical Therapy/Rehabilitation Services&quot;                                        
## [1118] &quot;EP consult&quot;                                                                      
## [1119] &quot;Cardiology Fellow Admit Note&quot;                                                    
## [1120] &quot;Critical care&quot;                                                                   
## [1121] &quot;Attending admit note&quot;                                                            
## [1122] &quot;Right knee aspiration&quot;                                                           
## [1123] &quot;Physician Intensivist Daily Note&quot;                                                
## [1124] &quot;Passy Muir Valve Evaluation, Deferred Swallow Eval&quot;                              
## [1125] &quot;Resident / Attending Transfer Notes&quot;                                             
## [1126] &quot;Discharge Plan - Fianl&quot;                                                          
## [1127] &quot;Discharge Plan - Final&quot;                                                          
## [1128] &quot;PMV and Green Dye Swallowing Evaluation&quot;                                         
## [1129] &quot;cardiology follow up&quot;                                                            
## [1130] &quot;Cardiology follow-up attending note&quot;                                             
## [1131] &quot;Resident Physician Progress Note-CCU&quot;                                            
## [1132] &quot;Physician Progress Note - CCU&quot;                                                   
## [1133] &quot;CCU Staff Progress Note&quot;                                                         
## [1134] &quot;Cardiology Fellow CCU Admit addendum&quot;                                            
## [1135] &quot;CCU attending&quot;                                                                   
## [1136] &quot;ICU Event Note -- Family Meeting&quot;                                                
## [1137] &quot;Physicial Resident Progress Note - MICU&quot;                                         
## [1138] &quot;MICU Attending Addendum to Admission Note&quot;                                       
## [1139] &quot;Respiratory CAre&quot;                                                                
## [1140] &quot;Electrolarynx Evaluation&quot;                                                        
## [1141] &quot;EP Consult Follow-up&quot;                                                            
## [1142] &quot;Cardiology fellow admission note&quot;                                                
## [1143] &quot;PGY1 - Daily Progress Note&quot;                                                      
## [1144] &quot;MICU Fellow Admission Note&quot;                                                      
## [1145] &quot;PMV &amp; Green Dye Swallow Evaluation&quot;                                              
## [1146] &quot;Surgery Progress note&quot;                                                           
## [1147] &quot;Physician Resident Admission/Transfer Note - MICU&quot;                               
## [1148] &quot;EP H&amp;P&quot;                                                                          
## [1149] &quot;Resident / Attending Notes, and Family Meeting&quot;                                  
## [1150] &quot;Discharge Plan Note - Final&quot;                                                     
## [1151] &quot;Blue Dye bedside Swallow Evaluation&quot;                                             
## [1152] &quot;Discharge Plan - Delay&quot;                                                          
## [1153] &quot;Repeat PMV Evaluation/Dispense&quot;                                                  
## [1154] &quot;Phone conversation with NSY&quot;                                                     
## [1155] &quot;Family mtg (MICU / Neurology)&quot;                                                   
## [1156] &quot;Swallow Re-Consult&quot;                                                              
## [1157] &quot;critical care staff admission note&quot;                                              
## [1158] &quot;Physician Resident&quot;                                                              
## [1159] &quot;MICU Attending Note - Phone Call&quot;                                                
## [1160] &quot;CCU FELLOW ADMISSION NOTE&quot;                                                       
## [1161] &quot;Critical care staff admit note&quot;                                                  
## [1162] &quot;BEDSIDE SWALLOWING EVALUATION&quot;                                                   
## [1163] &quot;CCU Event Note--Consent for Impella&quot;                                             
## [1164] &quot;med student CCU&quot;                                                                 
## [1165] &quot;CCU Resident Physician - post-catherization note.&quot;                               
## [1166] &quot;CVL and Art line procedure notes&quot;                                                
## [1167] &quot;ICU Progress Note&quot;                                                               
## [1168] &quot;EP staff HVMA&quot;                                                                   
## [1169] &quot;Medical Student - CCU&quot;                                                           
## [1170] &quot;CVLInsertionReplacementProcedureNote&quot;                                            
## [1171] &quot;CCU Fellow Note&quot;                                                                 
## [1172] &quot;Physician Attending Admission Note - CCU&quot;                                        
## [1173] &quot;Deferred Repeat Bedside Swallowing Evaluation&quot;                                   
## [1174] &quot;Cardiology Consult follow-up&quot;                                                    
## [1175] &quot;Electrophysiology Note&quot;                                                          
## [1176] &quot;Post-cath check&quot;                                                                 
## [1177] &quot;Resident/Attending Progress Note&quot;                                                
## [1178] &quot;Resident/Attending Admit Note&quot;                                                   
## [1179] &quot;GI  Consult Progress Note&quot;                                                       
## [1180] &quot;MICU Resident Transfer Accept Note&quot;                                              
## [1181] &quot;MICU Attending Accept Note&quot;                                                      
## [1182] &quot;cardioversion&quot;                                                                   
## [1183] &quot;EP Consultation&quot;                                                                 
## [1184] &quot;Sedation/NMBA&quot;                                                                   
## [1185] &quot;MICU Attending Admit note&quot;                                                       
## [1186] &quot;ICU Attdg Admit Note&quot;                                                            
## [1187] &quot;Bedside Swallowing + Communication Board&quot;                                        
## [1188] &quot;acceptance note&quot;                                                                 
## [1189] &quot;Deferred Swallowing &amp; Aphasia Evaluations&quot;                                       
## [1190] &quot;MICU Attdg Admit Note&quot;                                                           
## [1191] &quot;PMV &amp; Swallow Follow Up&quot;                                                         
## [1192] &quot;Pulmonary Fellow Initial Consult Note&quot;                                           
## [1193] &quot;metavision logout caused duplicate note&quot;                                         
## [1194] &quot;MICU staff Progress Note&quot;                                                        
## [1195] &quot;Post-Arrest Consult Service&quot;                                                     
## [1196] &quot;ICU Event Note- AMA&quot;                                                             
## [1197] &quot;Family discussion&quot;                                                               
## [1198] &quot;ICU Attdg Admit&quot;                                                                 
## [1199] &quot;Critical care progress note&quot;                                                     
## [1200] &quot;Attending progress note (ERROR)&quot;                                                 
## [1201] &quot;Resident Admission/Observation Note&quot;                                             
## [1202] &quot;RESIDENT MICU PROGRESS NOTE&quot;                                                     
## [1203] &quot;Cardiology Weekend Consult Progress Note&quot;                                        
## [1204] &quot;micu attending family meeting note&quot;                                              
## [1205] &quot;Physician Fellow Progress Note/Attendign progress&quot;                               
## [1206] &quot;Cardiology Attending Consult Note&quot;                                               
## [1207] &quot;Cardiology Weekend Consult Attending Progress Note&quot;                              
## [1208] &quot;Critical Care Consult&quot;                                                           
## [1209] &quot;Physician Resident and Attending  Admission Note -&quot;                              
## [1210] &quot;Trauma SICU admission note&quot;                                                      
## [1211] &quot;Fellow / Attending notes&quot;                                                        
## [1212] &quot;ICU Fellow Progress Note - attending addendum MICU&quot;                              
## [1213] &quot;Physician Fellow Progress Note - MICU attending pr&quot;                              
## [1214] &quot;Physician Fellow Progress Note-MICU attending adde&quot;                              
## [1215] &quot;ICU Atending Event Note&quot;                                                         
## [1216] &quot;Nursing 2300-0700&quot;                                                               
## [1217] &quot;MICU Resident Accept Note&quot;                                                       
## [1218] &quot;Physician Fellow Admit Note - MICU&quot;                                              
## [1219] &quot;Fem Line Removal&quot;                                                                
## [1220] &quot;MICU Fellow/Attending Progess Note&quot;                                              
## [1221] &quot;MICU ADMISSION NOTE&quot;                                                             
## [1222] &quot;ICU Procedure - Failed Lines&quot;                                                    
## [1223] &quot;MICU Attending Arrest Notice&quot;                                                    
## [1224] &quot;Intesivist Note Surgical Critical Care&quot;                                          
## [1225] &quot;Attending critical care&quot;                                                         
## [1226] &quot;Resident Progress Note, CCu&quot;                                                     
## [1227] &quot;CCU Post Cath Check&quot;                                                             
## [1228] &quot;Info from pt&#39;&#39;s PCP re pre-hosp course, social wor&quot;                              
## [1229] &quot;CCU Progress Note&quot;                                                               
## [1230] &quot;Fellow Admission note&quot;                                                           
## [1231] &quot;MICU Resident Progress note&quot;                                                     
## [1232] &quot;Procedure note - L femoral line&quot;                                                 
## [1233] &quot;RESIDEN ADMISSION NOTE&quot;                                                          
## [1234] &quot;Resident Death Note&quot;                                                             
## [1235] &quot;Resident progress note - TSICU&quot;                                                  
## [1236] &quot;Resident / Attending Physician Note&quot;                                             
## [1237] &quot;Resident Progess Note&quot;                                                           
## [1238] &quot;Chest Tube Insertion Note&quot;                                                       
## [1239] &quot;Physician Resident /Attending Progress Note - MICU&quot;                              
## [1240] &quot;MICU attending event note/update&quot;                                                
## [1241] &quot;Resident Physician Progress Note - MICU&quot;                                         
## [1242] &quot;MICU  staff progress note&quot;                                                       
## [1243] &quot;Fellow Admission Addendum&quot;                                                       
## [1244] &quot;Resident/Attending Notes&quot;                                                        
## [1245] &quot;NG placement&quot;                                                                    
## [1246] &quot;Family mtg&quot;                                                                      
## [1247] &quot;PARACENTESIS&quot;                                                                    
## [1248] &quot;Sedation Analgesia&quot;                                                              
## [1249] &quot;Cardiology Follow-Up&quot;                                                            
## [1250] &quot;Medical Student Admission Note - MICU&quot;                                           
## [1251] &quot;Progress Notes&quot;                                                                  
## [1252] &quot;Death note/Event note&quot;                                                           
## [1253] &quot;Resident MICU progress note&quot;                                                     
## [1254] &quot;Procedure note, LP&quot;                                                              
## [1255] &quot;CCU ADMISSION NOTE&quot;                                                              
## [1256] &quot;Cardiology Fellow Addendum to Resident Admission N&quot;                              
## [1257] &quot;PGYI progess note&quot;                                                               
## [1258] &quot;Epidural Placement&quot;                                                              
## [1259] &quot;SICU resident admission note&quot;                                                    
## [1260] &quot;DISTINCT PROCEDURAL SERVICE&quot;                                                     
## [1261] &quot;Case Management Initial Assessment.&quot;                                             
## [1262] &quot;Medical Student/Attending Progress Note - MICU&quot;                                  
## [1263] &quot;Admission - Overnight Intensivist&quot;                                               
## [1264] &quot;Cardiology Comprehensive Physician Note - CCU Resi&quot;                              
## [1265] &quot;Small-bore feeding tube placement&quot;                                               
## [1266] &quot;ICU Attending Note Admission Note&quot;                                               
## [1267] &quot;Physician Progress Note CCU&quot;                                                     
## [1268] &quot;EP Follow-up&quot;                                                                    
## [1269] &quot;Medical Student/Attending Admission Note - MICU&quot;                                 
## [1270] &quot;Physician Residentand Attending  Admission Note -&quot;                               
## [1271] &quot;DISCHARGE PLAN&quot;                                                                  
## [1272] &quot;CVIVU note&quot;                                                                      
## [1273] &quot;Post Cath Note&quot;                                                                  
## [1274] &quot;EP Fellow Follow-Up&quot;                                                             
## [1275] &quot;Aphasia Therapy&quot;                                                                 
## [1276] &quot;ICU Attending/Resident Note&quot;                                                     
## [1277] &quot;SICU admission note&quot;                                                             
## [1278] &quot;Medication rec&quot;                                                                  
## [1279] &quot;cardiology consult note&quot;                                                         
## [1280] &quot;ICU Event Note - sputum cytology&quot;                                                
## [1281] &quot;Resident Progress Note- MICU&quot;                                                    
## [1282] &quot;Resident Progress Note-MICU&quot;                                                     
## [1283] &quot;Fellow Admit&quot;                                                                    
## [1284] &quot;SURGICAL INTENSIVIST NOTE CVICU&quot;                                                 
## [1285] &quot;Surgical Intensivist Note CVICU&quot;                                                 
## [1286] &quot;Resident Daily Progress Note&quot;                                                    
## [1287] &quot;ICU Event Note - intubation&quot;                                                     
## [1288] &quot;Code discussion&quot;                                                                 
## [1289] &quot;Deferred Swallow Evaluation&quot;                                                     
## [1290] &quot;Physician note&quot;                                                                  
## [1291] &quot;Procedure Note- Bronchoscopy with BAL&quot;                                           
## [1292] &quot;Drug interactions Warfarin&quot;                                                      
## [1293] &quot;Resident / Attending Admission notes&quot;                                            
## [1294] &quot;Discharge Plan - Home with Hospice Services&quot;                                     
## [1295] &quot;Repeat Bedside swallowing Evaluation&quot;                                            
## [1296] &quot;Physician Resident Transfer Note - FICU&quot;                                         
## [1297] &quot;FEES Exam and Repeat Bedside Swallow Evaluation&quot;                                 
## [1298] &quot;Cardiology Comprehensive Physician Note EP consult&quot;                              
## [1299] &quot;Case Management Discharge Planning - Update&quot;                                     
## [1300] &quot;event&quot;                                                                           
## [1301] &quot;PCP correspondence&quot;                                                              
## [1302] &quot;Central line placement&quot;                                                          
## [1303] &quot;Case Management Discharge Planning update&quot;                                       
## [1304] &quot;attending critical care note&quot;                                                    
## [1305] &quot;Resident Progress note&quot;                                                          
## [1306] &quot;Assessment &amp; Discharge Planning&quot;                                                 
## [1307] &quot;Speech Therapy Follow-Up&quot;                                                        
## [1308] &quot;PMV Evaluation /Swallowing Evaluation&quot;                                           
## [1309] &quot;critical care attending pn&quot;                                                      
## [1310] &quot;PMV Speaking Evaluation&quot;                                                         
## [1311] &quot;CCU Fellow&quot;                                                                      
## [1312] &quot;MICU Attending Readmission Note&quot;                                                 
## [1313] &quot;ICU Event Note- Family Meeting&quot;                                                  
## [1314] &quot;Addendum to Admission Note&quot;                                                      
## [1315] &quot;Case Management Assessment &amp; D/C Plan&quot;                                           
## [1316] &quot;Dischaarge Planning Update&quot;                                                      
## [1317] &quot;Consult-Cardiology, CVI&quot;                                                         
## [1318] &quot;Resident Progress Note MICU&quot;                                                     
## [1319] &quot;CCU progress note&quot;                                                               
## [1320] &quot;Cardiology fellow H&amp;P&quot;                                                           
## [1321] &quot;ICU Family Meeting&quot;                                                              
## [1322] &quot;Discharge Plan - Final Update&quot;                                                   
## [1323] &quot;FEES&quot;                                                                            
## [1324] &quot;Initial Assessment &amp; Discharge Plan&quot;                                             
## [1325] &quot;Chest tube placement note&quot;                                                       
## [1326] &quot;Assessment &amp; Initial Discharge Planning Note&quot;                                    
## [1327] &quot;CCU Fellow Admit&quot;                                                                
## [1328] &quot;PMV Evaluation/Dispense and Attempted Green-dye Be&quot;                              
## [1329] &quot;Physician Medical Student Progress Note - MICU&quot;                                  
## [1330] &quot;Hypotension- Attg Critical Care&quot;                                                 
## [1331] &quot;ICU Attending note&quot;                                                              
## [1332] &quot;PMV &amp; Swallowing Evaluations&quot;                                                    
## [1333] &quot;Quinidine duration&quot;                                                              
## [1334] &quot;CCU Resident Daily Progress Note&quot;                                                
## [1335] &quot;Resident Daily Progress note&quot;                                                    
## [1336] &quot;CVI - ICU note&quot;                                                                  
## [1337] &quot;Critical Care admission note&quot;                                                    
## [1338] &quot;CCU fellow addendum&quot;                                                             
## [1339] &quot;Cardiology Staff&quot;                                                                
## [1340] &quot;Speech-Language Aphasia Evaluation&quot;                                              
## [1341] &quot;Deferred Passy Muir Speaking Valve Evaluation&quot;                                   
## [1342] &quot;Percutaneous tracheostomy note&quot;                                                  
## [1343] &quot;Bedside PEG insertion note&quot;                                                      
## [1344] &quot;PGY1 CCU Team Progress Note&quot;                                                     
## [1345] &quot;Computer error - blank note.&quot;                                                    
## [1346] &quot;Physician Fellow /  Attending Progress Note - MICU&quot;                              
## [1347] &quot;Physician Resident Accept Note - MICU&quot;                                           
## [1348] &quot;Cardiology fellow Admission Note&quot;                                                
## [1349] &quot;Subclavian Attempt&quot;                                                              
## [1350] &quot;Cardiologyl Consult Note&quot;                                                        
## [1351] &quot;Physican Resident Progress Note&quot;                                                 
## [1352] &quot;Initial Discharge Planning&quot;                                                      
## [1353] &quot;Comfort measures only&quot;                                                           
## [1354] &quot;Cardiology fellow CCU admission note&quot;                                            
## [1355] &quot;Peramivir - Attending Physician Note&quot;                                            
## [1356] &quot;Line placement Note&quot;                                                             
## [1357] &quot;ERROR; WRONG PATIENT&quot;                                                            
## [1358] &quot;RESIDENT PROGRESS NOTE - CCU&quot;                                                    
## [1359] &quot;EP NOTE&quot;                                                                         
## [1360] &quot;Repeat Bedside Swallow Study&quot;                                                    
## [1361] &quot;Physician Resident Floor Transfer Note&quot;                                          
## [1362] &quot;Resident Progress Note- CCU&quot;                                                     
## [1363] &quot;Assessment and Discharge Plan&quot;                                                   
## [1364] &quot;Cardiology Fellow CCU Admission Noted&quot;                                           
## [1365] &quot;A-line insertion&quot;                                                                
## [1366] &quot;Deferred PMV Trial and Green-Dye Bedside Swallowin&quot;                              
## [1367] &quot;Crit care attending admit note&quot;                                                  
## [1368] &quot;Electrophysiology  Physician Note&quot;                                               
## [1369] &quot;Student and Attending Notes&quot;                                                     
## [1370] &quot;Attempted Swallowing Evaluation&quot;                                                 
## [1371] &quot;Cardiology Fellow Admission&quot;                                                     
## [1372] &quot;bedside RHC&quot;                                                                     
## [1373] &quot;Speech-Language Evaluation&quot;                                                      
## [1374] &quot;Physican Resident Admission Note - MICU attending&quot;                               
## [1375] &quot;MICU - Resident/Attending Progress Note&quot;                                         
## [1376] &quot;CCU Fellow Admission Note/ Addendum&quot;                                             
## [1377] &quot;PMV Trial&quot;                                                                       
## [1378] &quot;Green Dye Bedside Swallowing Eval&quot;                                               
## [1379] &quot;LP&quot;                                                                              
## [1380] &quot;Cardiology Follow Up&quot;                                                            
## [1381] &quot;Resident Admission Note-critical care addendum&quot;                                  
## [1382] &quot;Cardiology Admission Note/ Addendum&quot;                                             
## [1383] &quot;Resident MICU Transfer Note&quot;                                                     
## [1384] &quot;ICU Team&quot;                                                                        
## [1385] &quot;Deferred PMV&quot;                                                                    
## [1386] &quot;Physician Resident/Attending Progress Note - MICU`&quot;                              
## [1387] &quot;Procedure Note- Arterial Line Placement&quot;                                         
## [1388] &quot;Deferred Cognitive-Linguistic Evaluation&quot;                                        
## [1389] &quot;EP Initial Consult Note&quot;                                                         
## [1390] &quot;Speech and Swallowing Follow-Up&quot;                                                 
## [1391] &quot;CCU Attending Physician Note&quot;                                                    
## [1392] &quot;ICU Attending Update Note&quot;                                                       
## [1393] &quot;Addendum to admission note&quot;                                                      
## [1394] &quot;Renal dosing&quot;                                                                    
## [1395] &quot;Pt/Rehab Services&quot;                                                               
## [1396] &quot;Surgical Intensive Care&quot;                                                         
## [1397] &quot;ICU - Family Meeting&quot;                                                            
## [1398] &quot;PMV Evaluation and Dispense&quot;                                                     
## [1399] &quot;Physician ICU  Admission Note&quot;                                                   
## [1400] &quot;MICU attend brief note&quot;                                                          
## [1401] &quot;MICU Staff&quot;                                                                      
## [1402] &quot;CHEST (PORTABLE AP)&quot;                                                             
## [1403] &quot;CT PELVIS W/CONTRAST&quot;                                                            
## [1404] &quot;CT HEAD W/O CONTRAST&quot;                                                            
## [1405] &quot;ICU Attending Physican Note&quot;                                                     
## [1406] &quot;ICU Physician Attending Note&quot;                                                    
## [1407] &quot;Attending Teaching Physician Note&quot;                                               
## [1408] &quot;chest tube insertion&quot;                                                            
## [1409] &quot;Physical Therapy Contact Note.&quot;                                                  
## [1410] &quot;Nursing Discharge Note&quot;                                                          
## [1411] &quot;PRE OPERATIVE EVALUATION&quot;                                                        
## [1412] &quot;Physician Progress&quot;                                                              
## [1413] &quot;Please disregard&quot;                                                                
## [1414] &quot;CHEST (PA &amp; LAT)&quot;                                                                
## [1415] &quot;CT CHEST W/O CONTRAST&quot;                                                           
## [1416] &quot;CT GUIDANCE DRAINAGE&quot;                                                            
## [1417] &quot;CHEST (SINGLE VIEW)&quot;                                                             
## [1418] &quot;CT ABDOMEN W/O CONTRAST&quot;                                                         
## [1419] &quot;CVL/PICC&quot;                                                                        
## [1420] &quot;IMPLANT VENOUS ACCESS PORT&quot;                                                      
## [1421] &quot;PORTABLE ABDOMEN&quot;                                                                
## [1422] &quot;MR HEAD W &amp; W/O CONTRAST&quot;                                                        
## [1423] &quot;T-SPINE&quot;                                                                         
## [1424] &quot;R TIB/FIB (AP &amp; LAT) RIGHT&quot;                                                      
## [1425] &quot;EXERCISE MIBI&quot;                                                                   
## [1426] &quot;UD GUID FOR NEEDLE PLACMENT&quot;                                                     
## [1427] &quot;CHEST U.S.&quot;                                                                      
## [1428] &quot;CT CHEST W/CONTRAST&quot;                                                             
## [1429] &quot;O CHEST FLUORO WITHOUT RADIOLOGIST IN O.R.&quot;                                      
## [1430] &quot;CHEST (PRE-OP PA &amp; LAT)&quot;                                                         
## [1431] &quot;CHG NEPHROTOMY/PYLOSTOMY TUBE&quot;                                                   
## [1432] &quot;RETRO UROGRAM (74450,51610)&quot;                                                     
## [1433] &quot;RENAL U.S.&quot;                                                                      
## [1434] &quot;B CHEST (LAT DECUB ONLY) BILAT&quot;                                                  
## [1435] &quot;R TOE(S), 2+ VIEW RIGHT&quot;                                                         
## [1436] &quot;R WRIST (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                            
## [1437] &quot;R FEMUR (AP &amp; LAT) RIGHT&quot;                                                        
## [1438] &quot;RP HIP UNILAT MIN 2 VIEWS RIGHT PORT&quot;                                            
## [1439] &quot;CT EMERGENCY HEAD W/O CONTRAST&quot;                                                  
## [1440] &quot;CT PELVIS W/O CONTRAST&quot;                                                          
## [1441] &quot;CHEST CTA WITH CONTRAST&quot;                                                         
## [1442] &quot;C-SPINE, TRAUMA&quot;                                                                 
## [1443] &quot;ABDOMEN U.S. (COMPLETE STUDY)&quot;                                                   
## [1444] &quot;CT CHEST W/CONT+RECONSTRUCTION&quot;                                                  
## [1445] &quot;CT HEAD W/ CONTRAST&quot;                                                             
## [1446] &quot;R PLEURAL ASP BY RADIOLOGIST RIGHT&quot;                                              
## [1447] &quot;RO LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST RIGHT IN O.R.&quot;                     
## [1448] &quot;RP TIB/FIB (AP &amp; LAT) RIGHT PORT&quot;                                                
## [1449] &quot;R UNILAT LOWER EXT VEINS RIGHT&quot;                                                  
## [1450] &quot;CT LOC BX&quot;                                                                       
## [1451] &quot;ESOPHAGUS&quot;                                                                       
## [1452] &quot;R CHEST U.S. RIGHT&quot;                                                              
## [1453] &quot;LUNG SCAN&quot;                                                                       
## [1454] &quot;ABDOMEN (SUPINE &amp; ERECT)&quot;                                                        
## [1455] &quot;VEN DUP EXTEXT BIL (MAP/DVT)&quot;                                                    
## [1456] &quot;R VENOUS DUP EXT UNI (MAP/DVT) RIGHT&quot;                                            
## [1457] &quot;PERSANTINE MIBI&quot;                                                                 
## [1458] &quot;P PELVIS (AP ONLY) PORT&quot;                                                         
## [1459] &quot;ART EXT (REST ONLY)&quot;                                                             
## [1460] &quot;MR LIVER WITH CONTRAST&quot;                                                          
## [1461] &quot;MR HEAD NEURO&quot;                                                                   
## [1462] &quot;MR SPINAL CANAL (ENTIRE)&quot;                                                        
## [1463] &quot;CT,CORONAL,SAGITAL,OBL RECONSTRUCTION&quot;                                           
## [1464] &quot;CT ABDOMEN W/CONTRAST&quot;                                                           
## [1465] &quot;US ABD LIMIT, SINGLE ORGAN&quot;                                                      
## [1466] &quot;ART DUP EXT LO UNI;F/U&quot;                                                          
## [1467] &quot;CAROTID SERIES COMPLETE&quot;                                                         
## [1468] &quot;RVG&quot;                                                                             
## [1469] &quot;CT ABD W&amp;W/O C&quot;                                                                  
## [1470] &quot;CHEST (PRE-OP AP ONLY)&quot;                                                          
## [1471] &quot;B UNILAT LOWER EXT VEINS BILAT&quot;                                                  
## [1472] &quot;GASTRIC EMPTYING STUDY&quot;                                                          
## [1473] &quot;REST THALLIUM&quot;                                                                   
## [1474] &quot;L-SPINE (WITH FLEX &amp; EXT)&quot;                                                       
## [1475] &quot;LUMBO-SACRAL SPINE (AP &amp; LAT)&quot;                                                   
## [1476] &quot;INTRO CATH OR STENT INTO URETHER&quot;                                                
## [1477] &quot;INTRO CATH RENAL PELVIS FOR DRAINAGE&quot;                                            
## [1478] &quot;PELVIS, NON-OBSTETRIC&quot;                                                           
## [1479] &quot;R HUMERUS (AP &amp; LAT) RIGHT&quot;                                                      
## [1480] &quot;INTRO AORTA FEM/AXIL&quot;                                                            
## [1481] &quot;EA 1ST ORDER ABD/PEL/LOWER EXT A-GRAM&quot;                                           
## [1482] &quot;CT HEAD W/ &amp; W/O CONTRAST&quot;                                                       
## [1483] &quot;MR KIDNEY ANGIOGRAM&quot;                                                             
## [1484] &quot;R KNEE (AP, LAT &amp; OBLIQUE) RIGHT&quot;                                                
## [1485] &quot;MR CERVICAL SPINE&quot;                                                               
## [1486] &quot;L TIB/FIB (AP &amp; LAT) LEFT&quot;                                                       
## [1487] &quot;CT ORBITS, SELLA &amp; IAC W/ &amp; W/O CONTRAST&quot;                                        
## [1488] &quot;CT 150CC NONIONIC CONTRAST&quot;                                                      
## [1489] &quot;MR SPINAL CANAL W &amp; W.O CONTRAST&quot;                                                
## [1490] &quot;R MR KNEE RIGHT&quot;                                                                 
## [1491] &quot;EMBO NON NEURO&quot;                                                                  
## [1492] &quot;QUANTITATIVE LUNG SCAN&quot;                                                          
## [1493] &quot;RENAL TRANSPLANT U.S.&quot;                                                           
## [1494] &quot;C-SPINE, NON-TRAUMA&quot;                                                             
## [1495] &quot;R RENAL TRANSPLANT U.S. RIGHT&quot;                                                   
## [1496] &quot;ABDOMEN U.S. (PORTABLE)&quot;                                                         
## [1497] &quot;R CHEST (LAT DECUB ONLY) RIGHT&quot;                                                  
## [1498] &quot;REST MIBI&quot;                                                                       
## [1499] &quot;COCCYX&quot;                                                                          
## [1500] &quot;L SHOULDER 2-3 VIEWS NON TRAUMA LEFT&quot;                                            
## [1501] &quot;MR HEAD W/ CONTRAST&quot;                                                             
## [1502] &quot;O C-SPINE (PORTABLE) IN O.R.&quot;                                                    
## [1503] &quot;MR-ANGIO HEAD W/OUT CONTRAST&quot;                                                    
## [1504] &quot;IMPLANT VEN PORT&quot;                                                                
## [1505] &quot;P CHEST (PRE-OP AP ONLY) PORT&quot;                                                   
## [1506] &quot;R MR LEG ANGIOGRAM RIGHT&quot;                                                        
## [1507] &quot;REPOSITION GASTRIC TUBE INTO DUODENUM&quot;                                           
## [1508] &quot;C-SPINE, TRAUMA (WITH FLEX &amp; EXT)&quot;                                               
## [1509] &quot;CHANGE PERC TUBE OR CATH W/CONTRAST&quot;                                             
## [1510] &quot;RENAL U.S. (PORTABLE)&quot;                                                           
## [1511] &quot;ABDOMINAL A-GRAM&quot;                                                                
## [1512] &quot;VIDEO OROPHARYNGEAL SWALLOW&quot;                                                     
## [1513] &quot;MR ABDOMEN W/ CONTRAST&quot;                                                          
## [1514] &quot;VENOUS DUP EXT UNI (MAP/DVT)&quot;                                                    
## [1515] &quot;GI BLEEDING STUDY&quot;                                                               
## [1516] &quot;CHEST FLUORO WITHOUT RADIOLOGIST&quot;                                                
## [1517] &quot;INTERUP IVC&quot;                                                                     
## [1518] &quot;LIVER OR GALLBLADDER US (SINGLE ORGAN)&quot;                                          
## [1519] &quot;B CHEST WALL U.S. SCAN BILAT&quot;                                                    
## [1520] &quot;PELVIS PORTABLE&quot;                                                                 
## [1521] &quot;R KNEE (2 VIEWS) RIGHT&quot;                                                          
## [1522] &quot;R HIP UNILAT MIN 2 VIEWS RIGHT&quot;                                                  
## [1523] &quot;CAROTID DUPLEX US&quot;                                                               
## [1524] &quot;MR PELVIS W &amp; W/O CONTRAST&quot;                                                      
## [1525] &quot;BP CHEST (LAT DECUB ONLY) BILAT PORT&quot;                                            
## [1526] &quot;P ABDOMEN (SUPINE ONLY) PORT&quot;                                                    
## [1527] &quot;MANDIBLE (PANOREX ONLY)&quot;                                                         
## [1528] &quot;3ED ORDER THOR/BRACHIOCEPHALIC&quot;                                                  
## [1529] &quot;R BX-NEEDLE KIDNEY BY NEPHROLOGIST RIGHT&quot;                                        
## [1530] &quot;MR C-SPINE SCAN WITH CONTRAST&quot;                                                   
## [1531] &quot;MAMMOGRAM (SCREENING)&quot;                                                           
## [1532] &quot;BAS/UGI&quot;                                                                         
## [1533] &quot;MR ABDOMEN&quot;                                                                      
## [1534] &quot;MULTI-PROCEDURE SAME DAY&quot;                                                        
## [1535] &quot;CT C-SPINE W/O CONTRAST&quot;                                                         
## [1536] &quot;C-SPINE (PORTABLE)&quot;                                                              
## [1537] &quot;P ABDOMEN (SUPINE &amp; ERECT) PORT&quot;                                                 
## [1538] &quot;F/U STATUS INFUSION/EMBO&quot;                                                        
## [1539] &quot;L UPPER EXTREM VEINS US LEFT&quot;                                                    
## [1540] &quot;SKULL (AP, TOWNES &amp; LAT) TRAUMA&quot;                                                 
## [1541] &quot;EMBO INTRACRANIAL/SPINAL CORD&quot;                                                   
## [1542] &quot;BONE SCAN&quot;                                                                       
## [1543] &quot;L AP WRIST &amp; HAND LEFT&quot;                                                          
## [1544] &quot;ENDOVAS ABD REP W/MOD BIF PROS&quot;                                                  
## [1545] &quot;BILAT LOWER EXT VEINS&quot;                                                           
## [1546] &quot;R 36215 1SR ORDER THOR/BRACHIOCEPHALIC RIGHT&quot;                                    
## [1547] &quot;L ART DUP EXT LO UNI;F/U LEFT&quot;                                                   
## [1548] &quot;TRAUMA SERIES (LAT C-SPINE, AP CXR, AP PELVIS PORT)&quot;                             
## [1549] &quot;P TRAUMA SERIES (LAT C-SPINE, AP CXR, AP PELVIS PORT) PORT&quot;                      
## [1550] &quot;P CHEST (SINGLE VIEW) PORT&quot;                                                      
## [1551] &quot;P BILAT LOWER EXT VEINS PORT&quot;                                                    
## [1552] &quot;PTA FEMORAL/POPLITEAL&quot;                                                           
## [1553] &quot;PANCREAS US&quot;                                                                     
## [1554] &quot;L KNEE (2 VIEWS) LEFT&quot;                                                           
## [1555] &quot;FEE ADJUSTED IN SPECIFIC SITUATION&quot;                                              
## [1556] &quot;CT 100CC NON IONIC CONTRAST&quot;                                                     
## [1557] &quot;ART DUP EXT LOW/BILAT COMP&quot;                                                      
## [1558] &quot;GUIDANCE FOR THORA/ABD/PARA CENTESIS US&quot;                                         
## [1559] &quot;GALLIUM SCAN&quot;                                                                    
## [1560] &quot;MR RECONSTRUCTION IMAGING&quot;                                                       
## [1561] &quot;TRANSCATHETER INFUSION FOR LYSIS&quot;                                                
## [1562] &quot;P C-SPINE, NON-TRAUMA PORT&quot;                                                      
## [1563] &quot;ABDOMEN (SUPINE ONLY)&quot;                                                           
## [1564] &quot;BX-NEEDLE LIVER BY RADIOLOGIST&quot;                                                  
## [1565] &quot;PELVIS (AP ONLY)&quot;                                                                
## [1566] &quot;THORACIC ANGIOGRAM&quot;                                                              
## [1567] &quot;ERCP S&amp;I (74330)&quot;                                                                
## [1568] &quot;MR CHEST ANGIOGRAM&quot;                                                              
## [1569] &quot;CT CHEST W&amp;W/O C&quot;                                                                
## [1570] &quot;CT FINE NEEDLE ASP&quot;                                                              
## [1571] &quot;R UPPER EXTREM VEINS US RIGHT&quot;                                                   
## [1572] &quot;CT RECONSTRUCTION&quot;                                                               
## [1573] &quot;N-G TUBE PLACEMENT (W/ FLUORO)&quot;                                                  
## [1574] &quot;PTA ILIAC&quot;                                                                       
## [1575] &quot;DOBUTAMINE MIBI&quot;                                                                 
## [1576] &quot;R EMERG. LOWER EXT VEINS RIGHT&quot;                                                  
## [1577] &quot;CT ABD W&amp;W/O C &amp; RECONSTRUCTION&quot;                                                 
## [1578] &quot;MANDIBLE (PA, TOWNES &amp; BOTH OBLS)&quot;                                               
## [1579] &quot;L FOOT AP,LAT &amp; OBL LEFT&quot;                                                        
## [1580] &quot;UGI AIR W/ SBFT&quot;                                                                 
## [1581] &quot;INITAL 2ND ORDER ABD/PEL/LOWER EXT A-GRAM&quot;                                       
## [1582] &quot;MR L SPINE SCAN&quot;                                                                 
## [1583] &quot;P RENAL U.S. PORT&quot;                                                               
## [1584] &quot;RP PLEURAL ASP BY RADIOLOGIST RIGHT PORT&quot;                                        
## [1585] &quot;MR-ANGIO HEAD&quot;                                                                   
## [1586] &quot;L PLEURAL ASP BY RADIOLOGIST LEFT&quot;                                               
## [1587] &quot;CHEST AP ONLY&quot;                                                                   
## [1588] &quot;P LIVER OR GALLBLADDER US (SINGLE ORGAN) PORT&quot;                                   
## [1589] &quot;TEETH (PANOREX FOR DENTAL)&quot;                                                      
## [1590] &quot;L ABDOMEN (WITH LAT DECUB) LEFT&quot;                                                 
## [1591] &quot;R FEMORAL VASCULAR US RIGHT&quot;                                                     
## [1592] &quot;CT SINUS/MAXLIOFACIAL W/O CONTRAST&quot;                                              
## [1593] &quot;L NEPHROSTOGRAM LEFT&quot;                                                            
## [1594] &quot;LP FEMORAL VASCULAR US LEFT PORT&quot;                                                
## [1595] &quot;L UNILAT LOWER EXT VEINS LEFT&quot;                                                   
## [1596] &quot;CT LOC DRAINAGE&quot;                                                                 
## [1597] &quot;INJ-VENO/PAC/HICKMAN INCL INTRO OF CATH&quot;                                         
## [1598] &quot;P CHEST FLUORO WITHOUT RADIOLOGIST PORT&quot;                                         
## [1599] &quot;L HAND (AP, LAT &amp; OBLIQUE) LEFT&quot;                                                 
## [1600] &quot;L SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA LEFT&quot;                                 
## [1601] &quot;INTRA VAS FB RETRIEVAL&quot;                                                          
## [1602] &quot;MR L-SPINE W &amp; W/O CONTRAST&quot;                                                     
## [1603] &quot;P US ABD LIMIT, SINGLE ORGAN PORT&quot;                                               
## [1604] &quot;CT PELVIS ORTHO W/O C&quot;                                                           
## [1605] &quot;LOOPOGRAM/ILEOGRAM&quot;                                                              
## [1606] &quot;R KNEE (3 VIEWS) RIGHT&quot;                                                          
## [1607] &quot;MRA PELVIS&quot;                                                                      
## [1608] &quot;CT T-SPINE W/O CONTRAST&quot;                                                         
## [1609] &quot;OL KNEE( (SINGLE VIEW) IN O.R. LEFT&quot;                                             
## [1610] &quot;UNILAT LOWER EXT VEINS&quot;                                                          
## [1611] &quot;R WRIST(3 + VIEWS) RIGHT&quot;                                                        
## [1612] &quot;C-SPINE (WITH FLEX &amp; EXT ONLY) **&quot;                                               
## [1613] &quot;BP PELVIS WITH JUDET VIEWS BILAT PORT&quot;                                           
## [1614] &quot;L HIP UNILAT MIN 2 VIEWS LEFT&quot;                                                   
## [1615] &quot;SMALL BOWEL ONLY (BARIUM)&quot;                                                       
## [1616] &quot;BILAT DIAGNOSTIC MAMMOGRAM&quot;                                                      
## [1617] &quot;P G/GJ TUBE CHECK PORT&quot;                                                          
## [1618] &quot;R FOOT AP,LAT &amp; OBL RIGHT&quot;                                                       
## [1619] &quot;US INTR-OP 60 MINS&quot;                                                              
## [1620] &quot;RENAL SCAN&quot;                                                                      
## [1621] &quot;LP ANKLE (2 VIEWS) LEFT PORT&quot;                                                    
## [1622] &quot;PERC PLCMT GASTROMY TUBE&quot;                                                        
## [1623] &quot;ART VENEOUS SHUNT&quot;                                                               
## [1624] &quot;GUIDANCE/LOCALIZATION FOR NEEDLE BIOPSY US (S&amp;I)&quot;                                
## [1625] &quot;EXT BILAT A-GRAM&quot;                                                                
## [1626] &quot;L CT LOWER LIMB W/O CONTRAST LEFT&quot;                                               
## [1627] &quot;REPEAT, (REQUEST BY RADIOLOGIST)&quot;                                                
## [1628] &quot;MR BRACHIAL PLEXUS&quot;                                                              
## [1629] &quot;RECTAL US&quot;                                                                       
## [1630] &quot;B 50394 INJ NEPHROSTOMY/PYLOSTOMY BILAT&quot;                                         
## [1631] &quot;ADD&#39;L 2ND/3RD OR&gt; THOR/BRACHIOCEPHALIC&quot;                                          
## [1632] &quot;P ABDOMEN U.S. (COMPLETE STUDY) PORT&quot;                                            
## [1633] &quot;DUPLEX DOPP ABD/PEL&quot;                                                             
## [1634] &quot;PR SHOULDER 1 VIEW PORT RIGHT&quot;                                                   
## [1635] &quot;CHALNAGIOGRAPHY VIA EXISTING CATHETER&quot;                                           
## [1636] &quot;L LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST LEFT&quot;                               
## [1637] &quot;MR IAC W &amp;W/O CONTRAST&quot;                                                          
## [1638] &quot;LOOPOGRAM&quot;                                                                       
## [1639] &quot;B FEMUR (AP &amp; LAT) BILAT&quot;                                                        
## [1640] &quot;COLON (GASTROGRAF)&quot;                                                              
## [1641] &quot;PLCT GJ TUBE&quot;                                                                    
## [1642] &quot;OPOP ABDOMEN (SUPINE ONLY) IN O.R. PORT IN O.R. PORT&quot;                            
## [1643] &quot;OP CHEST (SINGLE VIEW) IN O.R. PORT&quot;                                             
## [1644] &quot;LO LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST LEFT IN O.R.&quot;                      
## [1645] &quot;P PARACENTESIS DIAG. OR THERAPEUTIC PORT&quot;                                        
## [1646] &quot;CERVICOCERBRAL&quot;                                                                  
## [1647] &quot;RP SHOULDER 2-3 VIEWS NON TRAUMA RIGHT PORT&quot;                                     
## [1648] &quot;L CLAVICLE LEFT&quot;                                                                 
## [1649] &quot;RP CHEST U.S. RIGHT PORT&quot;                                                        
## [1650] &quot;O PORTABLE ABDOMEN IN O.R.&quot;                                                      
## [1651] &quot;L TOE(S), 2+ VIEW LEFT&quot;                                                          
## [1652] &quot;VOIDING CYSTOGRAM&quot;                                                               
## [1653] &quot;L KNEE (AP, LAT &amp; OBLIQUE) LEFT&quot;                                                 
## [1654] &quot;L HUMERUS (AP &amp; LAT) LEFT&quot;                                                       
## [1655] &quot;GASTRO ENDOSCOPIC TUBE PLCMT&quot;                                                    
## [1656] &quot;B CHEST U.S. BILAT&quot;                                                              
## [1657] &quot;L ABDOMEN (LAT DECUB ONLY) LEFT&quot;                                                 
## [1658] &quot;CTU W&amp; W/O CONTRAST&quot;                                                             
## [1659] &quot;MR KIDNEY W &amp;W/O CONTRAST&quot;                                                       
## [1660] &quot;R ARTHROGRAM,HIP RIGHT&quot;                                                          
## [1661] &quot;L FEMUR (AP &amp; LAT) LEFT&quot;                                                         
## [1662] &quot;B KNEE (2 VIEWS) BILAT&quot;                                                          
## [1663] &quot;LP UNILAT LOWER EXT VEINS LEFT PORT&quot;                                             
## [1664] &quot;PELVIS (AP &amp; FROG HIPS)&quot;                                                         
## [1665] &quot;P CHEST FLUORO PORT&quot;                                                             
## [1666] &quot;PELVIS U.S., TRANSVAGINAL&quot;                                                       
## [1667] &quot;OL HIP 1 VIEW IN O.R. LEFT&quot;                                                      
## [1668] &quot;RP ANKLE/FOOT (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                 
## [1669] &quot;CT NECK W/CONTRAST (EG:PAROTIDS)&quot;                                                
## [1670] &quot;L ANKLE (AP, MORTISE &amp; LAT) LEFT&quot;                                                
## [1671] &quot;C-SPINE, TRAUMA (WITH OBLS)&quot;                                                     
## [1672] &quot;L MR LEG ANGIOGRAM LEFT&quot;                                                         
## [1673] &quot;B AP WRIST &amp; HAND BILAT&quot;                                                         
## [1674] &quot;ARTERIAL CATH FOR SAMPLING OR MONITORING&quot;                                        
## [1675] &quot;RP RENAL TRANSPLANT U.S. RIGHT PORT&quot;                                             
## [1676] &quot;MR HEAD &amp; NECK ANGIO&quot;                                                            
## [1677] &quot;CT NECK W/O CONTRAST (EG: PAROTIDS)&quot;                                             
## [1678] &quot;R ANKLE/FOOT (AP, LAT &amp; OBL) RIGHT&quot;                                              
## [1679] &quot;C-SPINE (SINGLE VIEW ONLY)&quot;                                                      
## [1680] &quot;R SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA RIGHT&quot;                                
## [1681] &quot;MR MEDIASTINUM&quot;                                                                  
## [1682] &quot;VISERAL SEL/SUPERSEL A-GRAM&quot;                                                     
## [1683] &quot;SPINAL FLUORO&quot;                                                                   
## [1684] &quot;PELVIS (AP, INLET &amp; OUTLET)&quot;                                                     
## [1685] &quot;MR DOUBLE DOSE CONTRAST&quot;                                                         
## [1686] &quot;ABD (SINGLE VIEW ONLY)&quot;                                                          
## [1687] &quot;PL ABDOMEN (WITH LAT DECUB) PORT LEFT&quot;                                           
## [1688] &quot;REPOSITION CENTRAL VENOUS CATH W/FLUORO&quot;                                         
## [1689] &quot;RP FEMUR (AP &amp; LAT) RIGHT PORT&quot;                                                  
## [1690] &quot;L-SPINE (AP &amp; LAT)&quot;                                                              
## [1691] &quot;R VENOUS DUP EXT UNI (MAP) RIGHT&quot;                                                
## [1692] &quot;MR S.T. NECK W &amp; W/O GADO&quot;                                                       
## [1693] &quot;PARACENTESIS DIAG. OR THERAPEUTIC&quot;                                               
## [1694] &quot;P T-TUBE CHOLANGIO (POST-OP) PORT&quot;                                               
## [1695] &quot;NON-IONIC 100 CC&quot;                                                                
## [1696] &quot;PL ABDOMEN (LAT DECUB ONLY) PORT LEFT&quot;                                           
## [1697] &quot;LUNBAR SPINAL PUNCTURE&quot;                                                          
## [1698] &quot;SCROTAL U.S.&quot;                                                                    
## [1699] &quot;R TIB/FIB (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                          
## [1700] &quot;CAROTID SERIES LMTD&quot;                                                             
## [1701] &quot;R MR ANKLE RIGHT&quot;                                                                
## [1702] &quot;T-TUBE CHOLANGIO (POST-OP)&quot;                                                      
## [1703] &quot;R MR CALF W &amp; W/O CONTRAST RIGHT&quot;                                                
## [1704] &quot;P BX-NEEDLE LIVER BY RADIOLOGIST PORT&quot;                                           
## [1705] &quot;Physical Therapy Re - Evaluation Note&quot;                                           
## [1706] &quot;LIMITED EXTREM VENOUS US&quot;                                                        
## [1707] &quot;MR CHEST/MEDIASTINUM W&amp;W/O CONTRAST&quot;                                             
## [1708] &quot;T-L SPINE 3&#39; FILM AP &amp; LAT&quot;                                                      
## [1709] &quot;CT STEREOTAXIS W/O CONTRAST&quot;                                                     
## [1710] &quot;R FINGER(S),2+VIEWS RIGHT&quot;                                                       
## [1711] &quot;CHANGE PERC BILIARY DRAINAGE CATHETER&quot;                                           
## [1712] &quot;R ELBOW (AP, LAT &amp; OBLIQUE) RIGHT&quot;                                               
## [1713] &quot;LP CHEST (LAT DECUB ONLY) LEFT PORT&quot;                                             
## [1714] &quot;RP FOREARM (AP &amp; LAT) RIGHT PORT&quot;                                                
## [1715] &quot;L FINGER(S),2+VIEWS LEFT&quot;                                                        
## [1716] &quot;MRA KIDNEY&quot;                                                                      
## [1717] &quot;R US EXTREMITY NONVASCULAR RIGHT&quot;                                                
## [1718] &quot;ABDOMINAL FLUORO&quot;                                                                
## [1719] &quot;INTRO CATH SVC/IVC&quot;                                                              
## [1720] &quot;MR ABDOMEN W&amp;W/O CONTRAST&quot;                                                       
## [1721] &quot;CT L-SPINE W/O CONTRAST&quot;                                                         
## [1722] &quot;TRANSCATHETER INFUSION NOT LYSIS&quot;                                                
## [1723] &quot;MR CARDIAC WITH CONTRAST&quot;                                                        
## [1724] &quot;PLEURAL ASP BY RADIOLOGIST&quot;                                                      
## [1725] &quot;INITAL 3RD ORDER ABD/PEL/LOWER EXT A-GRAM&quot;                                       
## [1726] &quot;BP TIB/FIB (AP &amp; LAT) BILAT PORT&quot;                                                
## [1727] &quot;O CHEST (PORTABLE AP) IN O.R.&quot;                                                   
## [1728] &quot;CTA CHEST W&amp;W/O C &amp;RECONS&quot;                                                       
## [1729] &quot;OB LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. BILAT&quot;                     
## [1730] &quot;PARATHYROID U.S.&quot;                                                                
## [1731] &quot;MR THORACIC SPINE&quot;                                                               
## [1732] &quot;L BX SUPERFISCAL CER,AXL OR ING LEFT&quot;                                            
## [1733] &quot;PTA RENAL/VISERAL&quot;                                                               
## [1734] &quot;P VEN DUP EXTEXT BIL (MAP/DVT) PORT&quot;                                             
## [1735] &quot;MR SELLA WITH AND WITHOUT CONTRAST&quot;                                              
## [1736] &quot;RP ELBOW (AP, LAT &amp; OBLIQUE) RIGHT PORT&quot;                                         
## [1737] &quot;L FOREARM (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                           
## [1738] &quot;MR SPECTROSCOPY&quot;                                                                 
## [1739] &quot;L ANKLE (AP, LAT &amp; OBLIQUE) LEFT&quot;                                                
## [1740] &quot;CTA HEAD W&amp;W/O C &amp; RECONS&quot;                                                       
## [1741] &quot;LAB RECONSTRUCTIONS&quot;                                                             
## [1742] &quot;PR TIB/FIB (AP &amp; LAT) PORT RIGHT&quot;                                                
## [1743] &quot;LUMBAR PUNCTURE (W/ FLUORO)&quot;                                                     
## [1744] &quot;L 36216 2ND ORDER THOR/BRACHIOCEPHALIC LEFT&quot;                                     
## [1745] &quot;P GB DRAINAGE,INTRO PERC TRANHEP BIL US PORT&quot;                                    
## [1746] &quot;OR ANKLE (AP, MORTISE &amp; LAT) IN O.R. RIGHT&quot;                                      
## [1747] &quot;CT NECK W/CONT +RECONSTRUCTION&quot;                                                  
## [1748] &quot;L CHEST (LAT DECUB ONLY) LEFT&quot;                                                   
## [1749] &quot;O LUMBAR SP,SINGLE FILM IN O.R.&quot;                                                 
## [1750] &quot;B UPPER EXTREM VEINS US BILAT&quot;                                                   
## [1751] &quot;P PLEURAL ASP BY RADIOLOGIST PORT&quot;                                               
## [1752] &quot;PTA BRACHIOCEPHALIC&quot;                                                             
## [1753] &quot;L FOOT (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                              
## [1754] &quot;R LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST RIGHT&quot;                              
## [1755] &quot;NECK,SOFT TISSUE US&quot;                                                             
## [1756] &quot;LP TIB/FIB (AP &amp; LAT) LEFT PORT&quot;                                                 
## [1757] &quot;MR HEAD W/O CONTRAST&quot;                                                            
## [1758] &quot;G/GJ TUBE CHECK&quot;                                                                 
## [1759] &quot;R SHOULDER 2-3 VIEWS NON TRAUMA RIGHT&quot;                                           
## [1760] &quot;EMERG. LOWER EXT VEINS&quot;                                                          
## [1761] &quot;MR C-SPINE W&amp; W/O CONTRAST&quot;                                                      
## [1762] &quot;CT STEREOTAXIS W/ CONTRAST&quot;                                                      
## [1763] &quot;RP CHEST (LAT DECUB ONLY) RIGHT PORT&quot;                                            
## [1764] &quot;LP FOREARM (AP &amp; LAT) LEFT PORT&quot;                                                 
## [1765] &quot;BP EMERG. LOWER EXT VEINS BILAT PORT&quot;                                            
## [1766] &quot;B HAND, AP &amp; LAT. VIEWS BILAT&quot;                                                   
## [1767] &quot;OR LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. RIGHT&quot;                     
## [1768] &quot;MR-ANGIO NECK WITHOUT CONTRAST&quot;                                                  
## [1769] &quot;B BILAT HIPS (AP,LAT &amp; AP PELVIS) BILAT&quot;                                         
## [1770] &quot;BABYGRAM (CHEST &amp; ABDOMEN)&quot;                                                      
## [1771] &quot;BABYGRAM (CHEST ONLY)&quot;                                                           
## [1772] &quot;LP SHOULDER 2-3 VIEWS NON TRAUMA LEFT PORT&quot;                                      
## [1773] &quot;L FOOT 2 VIEWS LEFT&quot;                                                             
## [1774] &quot;O CHEST (SINGLE VIEW) IN O.R.&quot;                                                   
## [1775] &quot;BX RETROPERITONEAL MASS PERCUT NEEDLE&quot;                                           
## [1776] &quot;P BABYGRAM (CHEST &amp; ABDOMEN) PORT&quot;                                               
## [1777] &quot;CT ORBIT, SELLA &amp; IAC W/O CONTRAST&quot;                                              
## [1778] &quot;L VENOUS DUP EXT UNI (MAP/DVT) LEFT&quot;                                             
## [1779] &quot;P BABYGRAM (ABD ANY SGL VIEW) (74000) PORT&quot;                                      
## [1780] &quot;P SKULL (AP, TOWNES &amp; LAT) TRAUMA PORT&quot;                                          
## [1781] &quot;CAROTID/CEREBRAL BILAT&quot;                                                          
## [1782] &quot;P NECK,SOFT TISSUE US PORT&quot;                                                      
## [1783] &quot;L SCAPULA LEFT&quot;                                                                  
## [1784] &quot;COLON (BARIUM ENEMA)&quot;                                                            
## [1785] &quot;BAS/UGI AIR/SBFT&quot;                                                                
## [1786] &quot;IVP WITH TOMOGRAPHY&quot;                                                             
## [1787] &quot;GALLBLADDER SCAN&quot;                                                                
## [1788] &quot;ABDOMEN SGL VIEW&quot;                                                                
## [1789] &quot;L US EXTREMITY NONVASCULAR LEFT&quot;                                                 
## [1790] &quot;LP UNILAT BREAST US LEFT PORT&quot;                                                   
## [1791] &quot;B BILAT DIAGNOSTIC MAMMOGRAM BILAT&quot;                                              
## [1792] &quot;TRANCATHETER EMBOLIZATION&quot;                                                       
## [1793] &quot;L SHOULDER 1 VIEW LEFT&quot;                                                          
## [1794] &quot;P RENAL TRANSPLANT U.S. PORT&quot;                                                    
## [1795] &quot;ABDOMINAL FLUORO WITHOUT RADIOLOGIST&quot;                                            
## [1796] &quot;PP CHEST FLUORO WITHOUT RADIOLOGIST PORT PORT&quot;                                   
## [1797] &quot;PERC TRANSHEPATIC CHOLANGIOGRAPHY&quot;                                               
## [1798] &quot;B EMERG. LOWER EXT VEINS BILAT&quot;                                                  
## [1799] &quot;MRI PELVIS WITHOUT CONTRAST&quot;                                                     
## [1800] &quot;CT NECK W/ &amp; W/O CONTRAST&quot;                                                       
## [1801] &quot;PARATHYROID SCAN&quot;                                                                
## [1802] &quot;O C-SPINE (SINGLE VIEW ONLY) IN O.R.&quot;                                            
## [1803] &quot;RP UNILAT LOWER EXT VEINS RIGHT PORT&quot;                                            
## [1804] &quot;RPO CHEST (LAT DECUB ONLY) RIGHT PORT IN O.R.&quot;                                   
## [1805] &quot;C-SPINE, NON-TRAUMA (WITH FLEX &amp; EXT)&quot;                                           
## [1806] &quot;L EMERG. LOWER EXT VEINS LEFT&quot;                                                   
## [1807] &quot;P CHEST (LAT DECUB ONLY) PORT&quot;                                                   
## [1808] &quot;R 36216 2ND ORDER THOR/BRACHIOCEPHALIC RIGHT&quot;                                    
## [1809] &quot;CT PERITONEAL DRAINAGE&quot;                                                          
## [1810] &quot;CT AIRWAY W/C &amp; W/RECONS&quot;                                                        
## [1811] &quot;L PELVIS WITH JUDET VIEWS LEFT&quot;                                                  
## [1812] &quot;P GUIDANCE FOR THORA/ABD/PARA CENTESIS US PORT&quot;                                  
## [1813] &quot;EXT UNILAT A-GRAM&quot;                                                               
## [1814] &quot;L CHEST U.S. LEFT&quot;                                                               
## [1815] &quot;UGI AIR&quot;                                                                         
## [1816] &quot;CT ORBITS, SELLA &amp; IAC W/ CONTRAST&quot;                                              
## [1817] &quot;LP PLEURAL ASP BY RADIOLOGIST LEFT PORT&quot;                                         
## [1818] &quot;CT THORACENTESIS W/TUBE PLACMENT&quot;                                                
## [1819] &quot;P ORBITS (WATERS, CALDWELL &amp; LAT) PORT&quot;                                          
## [1820] &quot;CT PERIRENAL DRIANAGE&quot;                                                           
## [1821] &quot;R WRIST, AP &amp; LAT VIEWS RIGHT&quot;                                                   
## [1822] &quot;B WRIST(3 + VIEWS) BILAT&quot;                                                        
## [1823] &quot;L FNA BRSEAST, THYROID OR PROSTATE LEFT&quot;                                         
## [1824] &quot;R KNEE (PORTABLE) RIGHT&quot;                                                         
## [1825] &quot;NON-IONIC 30 CC&quot;                                                                 
## [1826] &quot;B KNEE (AP, LAT &amp; OBLIQUE) BILAT&quot;                                                
## [1827] &quot;R FOREARM (AP &amp; LAT) RIGHT&quot;                                                      
## [1828] &quot;LP SCAPULA LEFT PORT&quot;                                                            
## [1829] &quot;P T-SPINE PORT&quot;                                                                  
## [1830] &quot;BP UPPER EXTREM VEINS US BILAT PORT&quot;                                             
## [1831] &quot;IN-111 WHITE BLOOD CELL STUDY&quot;                                                   
## [1832] &quot;RP HAND (AP, LAT &amp; OBLIQUE) RIGHT PORT&quot;                                          
## [1833] &quot;CAROTID/CERVICAL/BILAT A-GRAM&quot;                                                   
## [1834] &quot;B TIB/FIB (AP &amp; LAT) BILAT&quot;                                                      
## [1835] &quot;LP UPPER EXTREM VEINS US LEFT PORT&quot;                                              
## [1836] &quot;PELVIS WITH JUDET VIEWS&quot;                                                         
## [1837] &quot;MR HIP&quot;                                                                          
## [1838] &quot;CT SINUS W/ CONTRAST&quot;                                                            
## [1839] &quot;CHEST (APICAL LORD ONLY)&quot;                                                        
## [1840] &quot;R FEMUR (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                            
## [1841] &quot;L WRIST(3 + VIEWS) LEFT&quot;                                                         
## [1842] &quot;PERC ASP/INJ RENAL CYST OR PELVIS&quot;                                               
## [1843] &quot;THYROID U.S.&quot;                                                                    
## [1844] &quot;THOR SP,SINGLE FILM&quot;                                                             
## [1845] &quot;CT PELVIS W&amp;W/O C&quot;                                                               
## [1846] &quot;P NEONATAL HEAD PORTABLE PORT&quot;                                                   
## [1847] &quot;PELVIS LIMITED&quot;                                                                  
## [1848] &quot;B FOOT AP,LAT &amp; OBL BILAT&quot;                                                       
## [1849] &quot;VERT/CAROTID A-GRAM&quot;                                                             
## [1850] &quot;SEL CATH 3RD ORDER THOR&quot;                                                         
## [1851] &quot;L FOREARM (AP &amp; LAT) LEFT&quot;                                                       
## [1852] &quot;EMERGENCY PELVIC U.S.&quot;                                                           
## [1853] &quot;SEL CATH 1ST ORDER&quot;                                                              
## [1854] &quot;LP ANKLE/FOOT (AP, LAT &amp; OBL) LEFT PORT&quot;                                         
## [1855] &quot;NEONATAL HEAD PORTABLE&quot;                                                          
## [1856] &quot;INTRO PERC TRNASHEPATIC STENT&quot;                                                   
## [1857] &quot;O T-L SPINE 3&#39; FILM AP &amp; LAT IN O.R.&quot;                                            
## [1858] &quot;COMPLETE GU U.S. (BLADDER &amp; RENAL)&quot;                                              
## [1859] &quot;L MR UPPER XT-JT W/O CONTRAST LEFT&quot;                                              
## [1860] &quot;MR SPINAL CANAL LIMITED&quot;                                                         
## [1861] &quot;EMERGENCY ABDOMEN U.S.&quot;                                                          
## [1862] &quot;P T-L SPINE 3&#39; FILM AP &amp; LAT PORT&quot;                                               
## [1863] &quot;INTRO DIALYSIS FISTULA&quot;                                                          
## [1864] &quot;L ANKLE/FOOT (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                        
## [1865] &quot;PELVIS (AP &amp; LAT)&quot;                                                               
## [1866] &quot;CT FISTULOGRAM/SINOGRAM&quot;                                                         
## [1867] &quot;SINUSES (WATERS, CALDWELL &amp; LAT)&quot;                                                
## [1868] &quot;PULMONARY EMBOECTOMY&quot;                                                            
## [1869] &quot;L ELBOW (AP, LAT &amp; OBLIQUE) LEFT&quot;                                                
## [1870] &quot;LP HUMERUS (AP &amp; LAT) LEFT PORT&quot;                                                 
## [1871] &quot;OR UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. RIGHT&quot;                     
## [1872] &quot;L MR LOWER EXT (NOT JT) W&amp;W/O CONTRAST LEFT&quot;                                     
## [1873] &quot;L ANKLE/FOOT (AP, LAT &amp; OBL) LEFT&quot;                                               
## [1874] &quot;LP CHEST WALL U.S. SCAN LEFT PORT&quot;                                               
## [1875] &quot;THY BX GUID-RADIOLOGIST&quot;                                                         
## [1876] &quot;P BABYGRAM (CHEST ONLY) PORT&quot;                                                    
## [1877] &quot;RETROPERITONEAL US&quot;                                                              
## [1878] &quot;BABYGRAM (ABD ANY SGL VIEW) (74000)&quot;                                             
## [1879] &quot;MR SPINAL CANAL LIMITED W &amp;W/O CONTRAST&quot;                                         
## [1880] &quot;CTU W/ &amp;W/O CONTRAST&quot;                                                            
## [1881] &quot;UPPER EXTREM VEINS US&quot;                                                           
## [1882] &quot;PTA VENOUS&quot;                                                                      
## [1883] &quot;PELVIS, EARLY OB US&quot;                                                             
## [1884] &quot;CT LIMITED 1-2 SCANS&quot;                                                            
## [1885] &quot;IVC GRAM&quot;                                                                        
## [1886] &quot;R SCAPULA RIGHT&quot;                                                                 
## [1887] &quot;MR PELVIS W/ CONTRAST&quot;                                                           
## [1888] &quot;P CHEST (PA &amp; LAT) PORT&quot;                                                         
## [1889] &quot;GB DRAINAGE,INTRO PERC TRANHEP BIL US&quot;                                           
## [1890] &quot;SEL CATH 2ND ORDER&quot;                                                              
## [1891] &quot;PERC PLCMT ENTROCLYSIS TUBE&quot;                                                     
## [1892] &quot;CT UPPER LIMB W/O CONTRAST&quot;                                                      
## [1893] &quot;L 50398 CHG NEPHROSTOMY UNILAT LEFT&quot;                                             
## [1894] &quot;BONE DENSITOMETRY&quot;                                                               
## [1895] &quot;R CT LOWER LIMB W/O CONTRAST RIGHT&quot;                                              
## [1896] &quot;MR T-SPINE W &amp;W/O CONTRAST&quot;                                                      
## [1897] &quot;EMBO TRANSCRANIAL&quot;                                                               
## [1898] &quot;B SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA BILAT&quot;                                
## [1899] &quot;RO CHEST FLUORO WITHOUT RADIOLOGIST RIGHT IN O.R.&quot;                               
## [1900] &quot;P CAROTID SERIES LMTD PORT&quot;                                                      
## [1901] &quot;BABYGRAM ABD WITH DECUB (74020)&quot;                                                 
## [1902] &quot;CT AIRWAY W/O C WITH RECONS&quot;                                                     
## [1903] &quot;L GLENO-HUMERAL SHOULDER (W/ Y VIEW) LEFT&quot;                                       
## [1904] &quot;FLUORO 1 HR W/RADIOLOGIST&quot;                                                       
## [1905] &quot;BX-NEEDLE KIDNEY BY NEPHROLOGIST&quot;                                                
## [1906] &quot;RO TIB/FIB (AP &amp; LAT) RIGHT IN O.R.&quot;                                             
## [1907] &quot;LP WRIST(3 + VIEWS) LEFT PORT&quot;                                                   
## [1908] &quot;INTRO NEEDL/CATH VEIN&quot;                                                           
## [1909] &quot;TUBE CHOLANGIOGRAM&quot;                                                              
## [1910] &quot;P EMERGENCY ABDOMEN U.S. PORT&quot;                                                   
## [1911] &quot;LP FOOT 1 VIEW LEFT PORT&quot;                                                        
## [1912] &quot;REDUCED SERVICES&quot;                                                                
## [1913] &quot;REMOVAL IMPLANT VEN PORT&quot;                                                        
## [1914] &quot;LP US EXTREMITY NONVASCULAR LEFT PORT&quot;                                           
## [1915] &quot;SEL CATH PLACMT LT/RT PUL ARTERY&quot;                                                
## [1916] &quot;THYROID UPTAKE&quot;                                                                  
## [1917] &quot;MR NECK W/O CONTRAST&quot;                                                            
## [1918] &quot;R CLAVICLE RIGHT&quot;                                                                
## [1919] &quot;R ANKLE (2 VIEWS) RIGHT&quot;                                                         
## [1920] &quot;L UNILAT BREAST US LEFT&quot;                                                         
## [1921] &quot;P THOR SP,SINGLE FILM PORT&quot;                                                      
## [1922] &quot;P CHEST (PORTABLE AP) PORT&quot;                                                      
## [1923] &quot;L WRIST, AP &amp; LAT VIEWS LEFT&quot;                                                    
## [1924] &quot;B MR LEG ANGIOGRAM BILAT&quot;                                                        
## [1925] &quot;L KNEE (PORTABLE) LEFT&quot;                                                          
## [1926] &quot;L UNILAT DIAGNOSTIC MAMMOGRAM LEFT&quot;                                              
## [1927] &quot;SVC GRAM&quot;                                                                        
## [1928] &quot;O CHEST (PA &amp; LAT) IN O.R.&quot;                                                      
## [1929] &quot;INJ MYELO SPINAL (NOT -)&quot;                                                        
## [1930] &quot;ART DUP EXT UP BILAT COMP&quot;                                                       
## [1931] &quot;DECLOT, THROM AG IMPLT VAS DEV&quot;                                                  
## [1932] &quot;RP SHOULDER 1 VIEW RIGHT PORT&quot;                                                   
## [1933] &quot;RP ANKLE (AP, MORTISE &amp; LAT) RIGHT PORT&quot;                                         
## [1934] &quot;OOR TIB/FIB (AP &amp; LAT) IN O.R. IN O.R. RIGHT&quot;                                    
## [1935] &quot;R FOOT (AP &amp; LAT) STANDING RIGHT&quot;                                                
## [1936] &quot;SKULL FLUORO&quot;                                                                    
## [1937] &quot;CLINICAL RESEARCH GRANT&quot;                                                         
## [1938] &quot;ABDOMEN, SINGLE VIEW&quot;                                                            
## [1939] &quot;O ABDOMEN, SINGLE VIEW IN O.R.&quot;                                                  
## [1940] &quot;CT GUIDANCE FOR BX&quot;                                                              
## [1941] &quot;P C-SPINE (SINGLE VIEW ONLY) PORT&quot;                                               
## [1942] &quot;LL UPPER EXTREM VEINS US LEFT LEFT&quot;                                              
## [1943] &quot;L MR LOWER EXT-JOINT W/O CONTRAST LEFT&quot;                                          
## [1944] &quot;B 50390-50 BILAT PERC ASP/INJ RENAL BY NEEDLE BILAT&quot;                             
## [1945] &quot;MR PELVIS W/O CONTRAST&quot;                                                          
## [1946] &quot;TRANSCATH PLCMT INTRAVAS STENT&quot;                                                  
## [1947] &quot;CAROTID LMTD/ DPP&quot;                                                               
## [1948] &quot;MANOMETRICS VIA NEPHROSTOMY/PYLOSTOMY&quot;                                           
## [1949] &quot;CHEST (PA, LAT &amp; OBLIQUES)&quot;                                                      
## [1950] &quot;PR ANKLE (2 VIEWS) PORT RIGHT&quot;                                                   
## [1951] &quot;MR ORBIT W/O CONTRAST&quot;                                                           
## [1952] &quot;TRANSCATH THROMBOYSUS INFUSION&quot;                                                  
## [1953] &quot;FOLLOW-UP,REQUEST BY RAD.&quot;                                                       
## [1954] &quot;P C-SPINE, TRAUMA PORT&quot;                                                          
## [1955] &quot;CT PANC BX&quot;                                                                      
## [1956] &quot;O SKULL FLUORO IN O.R.&quot;                                                          
## [1957] &quot;O ABDOMEN (SUPINE ONLY) IN O.R.&quot;                                                 
## [1958] &quot;BLADDER US&quot;                                                                      
## [1959] &quot;CHEST FLUORO&quot;                                                                    
## [1960] &quot;BRAIN SCAN&quot;                                                                      
## [1961] &quot;L HUMERUS (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                           
## [1962] &quot;CHEST (LAT DECUB ONLY)&quot;                                                          
## [1963] &quot;FISTULOGRAM/SINOGRAM&quot;                                                            
## [1964] &quot;OCTREOTIDE SCAN (SOMATOSTATIN)&quot;                                                  
## [1965] &quot;TRANSCATHETER BIOPSY&quot;                                                            
## [1966] &quot;-PUNCTURE&quot;                                                                       
## [1967] &quot;CC NON IONIC CONTRAST SUPPLY&quot;                                                    
## [1968] &quot;O SPINAL FLUORO WITHOUT RADIOLOGIST IN O.R.&quot;                                     
## [1969] &quot;PP ABDOMEN (SUPINE ONLY) PORT PORT&quot;                                              
## [1970] &quot;O ABDOMINAL FLUORO WITHOUT RADIOLOGIST IN O.R.&quot;                                  
## [1971] &quot;FDG MYOCARDIAL VIABILITY&quot;                                                        
## [1972] &quot;CT ABD W/CONT + RECONSTRUCTION&quot;                                                  
## [1973] &quot;PB ABDOMEN (LAT DECUB ONLY) PORT BILAT&quot;                                          
## [1974] &quot;B CT LOWER LIMB W/O CONTRAST BILAT&quot;                                              
## [1975] &quot;LP SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA LEFT PORT&quot;                           
## [1976] &quot;OL UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. LEFT&quot;                      
## [1977] &quot;C-SPINE CAROTID ON O.R. W/ CONTRAST&quot;                                             
## [1978] &quot;MR ABDOMEN W/O CONTRAST&quot;                                                         
## [1979] &quot;R HAND (AP, LAT &amp; OBLIQUE) RIGHT&quot;                                                
## [1980] &quot;INJ SINUS TRACT&quot;                                                                 
## [1981] &quot;L BABYGRAM CHEST DECUB ONLY (71035) LEFT&quot;                                        
## [1982] &quot;R ELBOW, AP &amp; LAT VIEWS RIGHT&quot;                                                   
## [1983] &quot;R ANKLE (AP, MORTISE &amp; LAT) RIGHT&quot;                                               
## [1984] &quot;RP ANKLE (2 VIEWS) RIGHT PORT&quot;                                                   
## [1985] &quot;L UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST LEFT&quot;                               
## [1986] &quot;LP HIP UNILAT MIN 2 VIEWS LEFT PORT&quot;                                             
## [1987] &quot;LUMBAR-SACRAL MYELOGRAM&quot;                                                         
## [1988] &quot;LP ABDOMEN (WITH LAT DECUB) LEFT PORT&quot;                                           
## [1989] &quot;CT PLEURAL BX&quot;                                                                   
## [1990] &quot;MR L SPINE WITH CONTRAST&quot;                                                        
## [1991] &quot;LP HAND (AP, LAT &amp; OBLIQUE) LEFT PORT&quot;                                           
## [1992] &quot;SKELETAL SURVEY (INCLUD LONG BONES)&quot;                                             
## [1993] &quot;MR SPINAL CANAL LIMITED W/ CONTRAST&quot;                                             
## [1994] &quot;SEL EA ADD&#39;L&quot;                                                                    
## [1995] &quot;P ABDOMEN U.S. (PORTABLE) PORT&quot;                                                  
## [1996] &quot;RP UPPER EXTREM VEINS US RIGHT PORT&quot;                                             
## [1997] &quot;L CT LOWER LIMB W/ CONTRAST LEFT&quot;                                                
## [1998] &quot;TRANSCATH THERAPY&quot;                                                               
## [1999] &quot;LO UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST LEFT IN O.R.&quot;                      
## [2000] &quot;T-M JOINTS BILATERAL&quot;                                                            
## [2001] &quot;NASAL BONE (WATERS &amp; BILAT LAT)&quot;                                                 
## [2002] &quot;OL LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. LEFT&quot;                      
## [2003] &quot;B FOOT 2 VIEWS BILAT&quot;                                                            
## [2004] &quot;R ART DUP EXT LO UNI;F/U RIGHT&quot;                                                  
## [2005] &quot;R 75894 TRANS THERAPY, EMBO S&amp;I RIGHT&quot;                                           
## [2006] &quot;OL FEMUR (AP &amp; LAT) IN O.R. LEFT&quot;                                                
## [2007] &quot;R HEEL (AXIAL &amp; LATERAL) RIGHT&quot;                                                  
## [2008] &quot;MR CONTRAST GADOLIN&quot;                                                             
## [2009] &quot;EMERGENCY RENAL U.S.&quot;                                                            
## [2010] &quot;P GUIDANCE/LOCALIZATION FOR NEEDLE BIOPSY US (S&amp;I) PORT&quot;                         
## [2011] &quot;L ARTHROGRAM,HIP LEFT&quot;                                                           
## [2012] &quot;US SIMPLE/SING ABSC/CYST DRAIN/INCISION&quot;                                         
## [2013] &quot;MR ABDOMEN W/CONTRAST&quot;                                                           
## [2014] &quot;P PERITONEAL ABSCESS DRAINAGE US PORT&quot;                                           
## [2015] &quot;RP HUMERUS (AP &amp; LAT) RIGHT PORT&quot;                                                
## [2016] &quot;CYSTOGRAM&quot;                                                                       
## [2017] &quot;RO ELBOW, AP &amp; LAT VIEWS RIGHT IN O.R.&quot;                                          
## [2018] &quot;L FOOT 1 VIEW LEFT&quot;                                                              
## [2019] &quot;R HAND (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                             
## [2020] &quot;TRANSCATH PLCT STENTS, INITIAL VESSEL&quot;                                           
## [2021] &quot;P L-SPINE (AP &amp; LAT) PORT&quot;                                                       
## [2022] &quot;R UNILAT BREAST US RIGHT&quot;                                                        
## [2023] &quot;GUIDANCE FOR ABSCESS (75989)&quot;                                                    
## [2024] &quot;L ELBOW, AP &amp; LAT VIEWS LEFT&quot;                                                    
## [2025] &quot;GUIDANCE PERC TRANS BIL DRAINAGE US&quot;                                             
## [2026] &quot;P NECK SOFT TISSUES PORT&quot;                                                        
## [2027] &quot;LP TIB/FIB (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                     
## [2028] &quot;ENTEROSTOMT/CECOSTOMY&quot;                                                           
## [2029] &quot;R ANKLE 1 VIEW RIGHT&quot;                                                            
## [2030] &quot;R MRA UPER EXT RIGHT&quot;                                                            
## [2031] &quot;I-131 TOTAL BODY SCAN&quot;                                                           
## [2032] &quot;THYROID ABLATION: CARCINOMA&quot;                                                     
## [2033] &quot;L FEMUR (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                             
## [2034] &quot;L MR SHOULDER W/O CONTRAST LEFT&quot;                                                 
## [2035] &quot;FDG TUMOR IMAGING&quot;                                                               
## [2036] &quot;CAROTID/CEREBRAL UNILAT&quot;                                                         
## [2037] &quot;R AP WRIST &amp; HAND RIGHT&quot;                                                         
## [2038] &quot;CT HEAD W/ ANESTHESIA W/ CONTRAST&quot;                                               
## [2039] &quot;INJ NEPHROSTOMY/PYLOSTOMY&quot;                                                       
## [2040] &quot;LP ELBOW (AP, LAT &amp; OBLIQUE) LEFT PORT&quot;                                          
## [2041] &quot;CT THORACENTESIS DRAINAGE&quot;                                                       
## [2042] &quot;L HAND, AP &amp; LAT. VIEWS LEFT&quot;                                                    
## [2043] &quot;CT COLONOSCOPY W/O CONTRAST&quot;                                                     
## [2044] &quot;R 50398 CHG NEPHROSTOMY UNILAT RIGHT&quot;                                            
## [2045] &quot;UGI SGL CONTRAST W/ KUB&quot;                                                         
## [2046] &quot;CT HEAD W/ ANESTHESIA W/O CONTRAST&quot;                                              
## [2047] &quot;UGI SGL W/ SBFT&quot;                                                                 
## [2048] &quot;PO SKULL (AP, TOWNES &amp; LAT) TRAUMA PORT IN O.R.&quot;                                 
## [2049] &quot;OR HIP 1 VIEW IN O.R. RIGHT&quot;                                                     
## [2050] &quot;R LEG ARTERIOGRAM IN OR RIGHT&quot;                                                   
## [2051] &quot;US HEMATOMA SUBCUT DRAIN INCISION&quot;                                               
## [2052] &quot;P SCROTAL U.S. PORT&quot;                                                             
## [2053] &quot;PERC VERTEBROPSTY, LUMBAR&quot;                                                       
## [2054] &quot;NEONATAL ABDOMEN&quot;                                                                
## [2055] &quot;L SHOULDER (AP, NEUTRAL &amp; AXILLARY) SOFT TISSUE LEFT&quot;                            
## [2056] &quot;B KNEE (3 VIEWS) BILAT&quot;                                                          
## [2057] &quot;P SPINAL CANAL CONTENTS US PORT&quot;                                                 
## [2058] &quot;ORBITS (WATERS, CALDWELL &amp; LAT)&quot;                                                 
## [2059] &quot;C-SPINE, NON-TRAUMA (WITH FLEX, EXT &amp; OBLS)&quot;                                     
## [2060] &quot;CT LIVER BX&quot;                                                                     
## [2061] &quot;R MR ARM W&amp;W/O CONTRAST RIGHT&quot;                                                   
## [2062] &quot;NEPHROSTOGRAM&quot;                                                                   
## [2063] &quot;CHEST WALL U.S. SCAN&quot;                                                            
## [2064] &quot;PERC PLCMT IVC FILTER&quot;                                                           
## [2065] &quot;BP CHEST U.S. BILAT PORT&quot;                                                        
## [2066] &quot;O SCOLIOSIS SERIES IN O.R.&quot;                                                      
## [2067] &quot;LP EMERG. LOWER EXT VEINS LEFT PORT&quot;                                             
## [2068] &quot;R MR CALF W&amp;W/O CONTRAST RIGHT&quot;                                                  
## [2069] &quot;P NEONATAL ABDOMEN PORT&quot;                                                         
## [2070] &quot;O THOR SP,SINGLE FILM IN O.R.&quot;                                                   
## [2071] &quot;B 47511-50 BILAT PRC T/H STNT I/E BIL DRN BILAT&quot;                                 
## [2072] &quot;LUMBAR SPINAL PUNCTURE&quot;                                                          
## [2073] &quot;ART EXT SGL LEVEL&quot;                                                               
## [2074] &quot;I-123 TOTAL BODY SCAN&quot;                                                           
## [2075] &quot;US HEPATOTOMY DRAIN ABSCESS/CYST&quot;                                                
## [2076] &quot;PR FOOT 2 VIEWS PORT RIGHT&quot;                                                      
## [2077] &quot;1SR ORDER BRANCH VENOUS SYSTEM&quot;                                                  
## [2078] &quot;CHANGE GASTROSTOMY TUBE&quot;                                                         
## [2079] &quot;B 36245-50 BILAT CATH 1ST ORD ABD/PEL/LWR BILAT&quot;                                 
## [2080] &quot;INITIAL 2ND ORDER&quot;                                                               
## [2081] &quot;P BABYGRAM ABD WITH DECUB (74020) PORT&quot;                                          
## [2082] &quot;SACRUM/COCCYX&quot;                                                                   
## [2083] &quot;SACRUM&quot;                                                                          
## [2084] &quot;B ANKLE/FOOT (AP, LAT &amp; OBL) BILAT&quot;                                              
## [2085] &quot;R MR KNEE W/O CONTRAST RIGHT&quot;                                                    
## [2086] &quot;L MR KNEE W/O CONTRAST LEFT&quot;                                                     
## [2087] &quot;OL HAND, AP &amp; LAT. VIEWS IN O.R. LEFT&quot;                                           
## [2088] &quot;IV CONSCIOUTIOUS SEDATION PRO FEE ONLY&quot;                                          
## [2089] &quot;RP WRIST(3 + VIEWS) RIGHT PORT&quot;                                                  
## [2090] &quot;LP HAND (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                        
## [2091] &quot;P ABDOMINAL FLUORO WITHOUT RADIOLOGIST PORT&quot;                                     
## [2092] &quot;LP SHOULDER (AP, NEUTRAL &amp; AXILLARY) SOFT TISSUE LEFT PORT&quot;                      
## [2093] &quot;B ELBOW (AP, LAT &amp; OBLIQUE) BILAT&quot;                                               
## [2094] &quot;PICC LINE PLACMENT SCH&quot;                                                          
## [2095] &quot;CT HEPATIC DRAINAGE&quot;                                                             
## [2096] &quot;L WRIST (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                             
## [2097] &quot;PR UNILAT LOWER EXT VEINS PORT RIGHT&quot;                                            
## [2098] &quot;L 36215 1SR ORDER THOR/BRACHIOCEPHALIC LEFT&quot;                                     
## [2099] &quot;RO HUMERUS (AP &amp; LAT) RIGHT IN O.R.&quot;                                             
## [2100] &quot;EMBO EXTRACRAINIAL&quot;                                                              
## [2101] &quot;RETROPERITONEAL LIMITED US&quot;                                                      
## [2102] &quot;TC WHITE BLOOD CELL STUDY&quot;                                                       
## [2103] &quot;B KNEE STANDING 2 VIEWS BILAT&quot;                                                   
## [2104] &quot;B KNEE, STANDING (AP &amp; LAT IN 30 DEG FLEX) BILAT&quot;                                
## [2105] &quot;LIVER/LUNG SCAN&quot;                                                                 
## [2106] &quot;LEVEEN SHUNT&quot;                                                                    
## [2107] &quot;TRANSCATHETER INFUSION&quot;                                                          
## [2108] &quot;LO TIB/FIB (AP &amp; LAT) LEFT IN O.R.&quot;                                              
## [2109] &quot;MYELOGRAPHY LUMBAR 72265&quot;                                                        
## [2110] &quot;PR WRIST(3 + VIEWS) PORT RIGHT&quot;                                                  
## [2111] &quot;R UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST RIGHT&quot;                              
## [2112] &quot;R SHOULDER (AP, NEUTRAL &amp; AXILLARY) SOFT TISSUE RIGHT&quot;                           
## [2113] &quot;ADD&#39;L 2ND/3RD ORDER&quot;                                                             
## [2114] &quot;CT RETROPERITONEAL DRAINAGE&quot;                                                     
## [2115] &quot;P SPINE, SINGLE FILM PORT&quot;                                                       
## [2116] &quot;LO ELBOW, AP &amp; LAT VIEWS LEFT IN O.R.&quot;                                           
## [2117] &quot;B LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST BILAT&quot;                              
## [2118] &quot;P NEONATAL HIP PORT&quot;                                                             
## [2119] &quot;INJ SINUS TRACT, THERAPUTIC&quot;                                                     
## [2120] &quot;LP CHEST U.S. LEFT PORT&quot;                                                         
## [2121] &quot;C-SPINE, NON-TRAUMA (WITH OBLS)&quot;                                                 
## [2122] &quot;THYROID SCAN W/UPTAKE (IODINE)&quot;                                                  
## [2123] &quot;P PELVIS (AP, INLET &amp; OUTLET) PORT&quot;                                              
## [2124] &quot;MR T SPINE SCAN WITH CONTRAST&quot;                                                   
## [2125] &quot;CT BONE DEEP BX&quot;                                                                 
## [2126] &quot;ART DUP EXT UP UNI LMTD&quot;                                                         
## [2127] &quot;R SHOULDER 1 VIEW RIGHT&quot;                                                         
## [2128] &quot;OL FOREARM (AP &amp; LAT) IN O.R. LEFT&quot;                                              
## [2129] &quot;R FOOT 2 VIEWS RIGHT&quot;                                                            
## [2130] &quot;LP FINGER(S),2+VIEWS LEFT PORT&quot;                                                  
## [2131] &quot;R HIP NAILING IN OR W/FILMS &amp; FLUORO RIGHT&quot;                                      
## [2132] &quot;CT COLONOSCOPY W&amp;W/O CONTRAST&quot;                                                   
## [2133] &quot;B GLENO-HUMERAL SHOULDER (W/ Y VIEW) BILAT&quot;                                      
## [2134] &quot;LP SHOULDER 1 VIEW LEFT PORT&quot;                                                    
## [2135] &quot;FLUORO LOCALIZATION FOR NEEDLE BIOPSY&quot;                                           
## [2136] &quot;MR-ANGIO HEAD W/ CONTRAST&quot;                                                       
## [2137] &quot;L ART DUP EXT UP UNI LMTD LEFT&quot;                                                  
## [2138] &quot;P PROSTATE U.S. PORT&quot;                                                            
## [2139] &quot;BP BILAT HIPS (AP,LAT &amp; AP PELVIS) BILAT PORT&quot;                                   
## [2140] &quot;P BILAT HIPS (AP,LAT &amp; AP PELVIS) PORT&quot;                                          
## [2141] &quot;L KNEE (3 VIEWS) LEFT&quot;                                                           
## [2142] &quot;NECK SOFT TISSUES&quot;                                                               
## [2143] &quot;OP LUMBAR SP,SINGLE FILM IN O.R. PORT&quot;                                           
## [2144] &quot;L MRA LEG W&amp;W/OC LEFT&quot;                                                           
## [2145] &quot;P DUPLEX DOPP ABD/PEL PORT&quot;                                                      
## [2146] &quot;INTRO PERC TRANHEPATIC CATH&quot;                                                     
## [2147] &quot;UNILAT DIAGNOSTIC MAMMOGRAM&quot;                                                     
## [2148] &quot;BP PLEURAL ASP BY RADIOLOGIST BILAT PORT&quot;                                        
## [2149] &quot;R CT UPPER LIMB W/ &amp; W/O CONTRAST RIGHT&quot;                                         
## [2150] &quot;P SKELETAL SURVEY (INCLUD LONG BONES) PORT&quot;                                      
## [2151] &quot;BP HUMERUS (AP &amp; LAT) BILAT PORT&quot;                                                
## [2152] &quot;L MR THIGH W/CONTRAST LEFT&quot;                                                      
## [2153] &quot;BILIARY BIOSPY VIA T-TUBE&quot;                                                       
## [2154] &quot;CTA ABD W&amp;W/O C &amp; RECONS&quot;                                                        
## [2155] &quot;L KNEE, STANDING (AP &amp; LAT IN 30 DEG FLEX) LEFT&quot;                                 
## [2156] &quot;CT C-SPINE W/CONTRAST&quot;                                                           
## [2157] &quot;ENTEROCLYSIS&quot;                                                                    
## [2158] &quot;L MAMMOGRAPHY SPECIMEN LEFT&quot;                                                     
## [2159] &quot;PTA BRACHIOCEPHAL EA VESSEL&quot;                                                     
## [2160] &quot;MANDIBLE SERIES INCLUD PANOREX&quot;                                                  
## [2161] &quot;BILIARY STRICTURE DILATION WITH STENT&quot;                                           
## [2162] &quot;CT RENAL BX W/RADIOLOGIST&quot;                                                       
## [2163] &quot;L CT LOW.EXT W/C +RECONSTRUCTION LEFT&quot;                                           
## [2164] &quot;INTRO CFA/SFA/ILIAC/POP GRAFT&quot;                                                   
## [2165] &quot;R US DRAIN PELV ABSCESS RIGHT&quot;                                                   
## [2166] &quot;CAUTERIZE GRANULATION TISSUE&quot;                                                    
## [2167] &quot;SCOLIOSIS SERIES&quot;                                                                
## [2168] &quot;L FEMORAL VASCULAR US LEFT&quot;                                                      
## [2169] &quot;CT TRACHEA W/O C W/RECONS&quot;                                                       
## [2170] &quot;R MR FOOT W/O CONTRAST RIGHT&quot;                                                    
## [2171] &quot;PAROTID US&quot;                                                                      
## [2172] &quot;L 75894 TRANS THERAPY, EMBO S&amp;I LEFT&quot;                                            
## [2173] &quot;RP TOE(S), 2+ VIEW RIGHT PORT&quot;                                                   
## [2174] &quot;RP EMERG. LOWER EXT VEINS RIGHT PORT&quot;                                            
## [2175] &quot;EXTREM UNILAT VENOGRAPHY&quot;                                                        
## [2176] &quot;L CHEST FLUORO WITHOUT RADIOLOGIST LEFT&quot;                                         
## [2177] &quot;REDUCED CHARGE&quot;                                                                  
## [2178] &quot;P ABD (SINGLE VIEW ONLY) PORT&quot;                                                   
## [2179] &quot;US INTRA-OP 30 MINS&quot;                                                             
## [2180] &quot;ADD&#39;L 2ND/3RD ORDER ABD/PEL/LOWER EXT A-GRAM&quot;                                    
## [2181] &quot;SKULL (CALDWELL, LFT LAT, TOWNES &amp; BASE)&quot;                                        
## [2182] &quot;B FOOT (AP &amp; LAT) STANDING BILAT&quot;                                                
## [2183] &quot;L MRA UPER EXT LEFT&quot;                                                             
## [2184] &quot;MR FUSION SCAN&quot;                                                                  
## [2185] &quot;L KNEE STANDING 2 VIEWS LEFT&quot;                                                    
## [2186] &quot;C-SPINE, TRAUMA (WITH FLEX, EXT &amp; OBLS)&quot;                                         
## [2187] &quot;R PLACT OF WIRE FOR LOC US RIGHT&quot;                                                
## [2188] &quot;POUCHOGRAM&quot;                                                                      
## [2189] &quot;OL TIB/FIB (AP &amp; LAT) IN O.R. LEFT&quot;                                              
## [2190] &quot;LYMPHOSCINTIGRAPHY&quot;                                                              
## [2191] &quot;DEEP BONE BX&quot;                                                                    
## [2192] &quot;L ANKLE (2 VIEWS) LEFT&quot;                                                          
## [2193] &quot;RP KNEE (AP, LAT &amp; OBLIQUE) RIGHT PORT&quot;                                          
## [2194] &quot;L MR THIGH W/O CONTRAST LEFT&quot;                                                    
## [2195] &quot;CT T-SPINE W/ CONTRAST&quot;                                                          
## [2196] &quot;P LUMBO-SACRAL SPINE (AP &amp; LAT) PORT&quot;                                            
## [2197] &quot;R GLENO-HUMERAL SHOULDER (W/O Y VIEW) RIGHT&quot;                                     
## [2198] &quot;B FOREARM (AP &amp; LAT) BILAT&quot;                                                      
## [2199] &quot;B MRA LEG W&amp;W/OC BILAT&quot;                                                          
## [2200] &quot;BILIARY STRICTURE DILATION NO STENT&quot;                                             
## [2201] &quot;CSF SHUNT STUDY&quot;                                                                 
## [2202] &quot;R CT LOWER LIMB W/ CONTRAST RIGHT&quot;                                               
## [2203] &quot;INTRAVAS STENT ADD&#39;L VESSEL&quot;                                                     
## [2204] &quot;L MR FOOT W&amp;W/O CONTRAST LEFT&quot;                                                   
## [2205] &quot;L MR HIP W/O CONRAST LEFT&quot;                                                       
## [2206] &quot;R ABDOMEN (WITH LAT DECUB) RIGHT&quot;                                                
## [2207] &quot;L RENAL TRANSPLANT U.S. LEFT&quot;                                                    
## [2208] &quot;LO FOREARM (AP &amp; LAT) LEFT IN O.R.&quot;                                              
## [2209] &quot;MRA KIDNEY W &amp;W/O C (ABD)&quot;                                                       
## [2210] &quot;PR ABDOMEN (WITH LAT DECUB) PORT RIGHT&quot;                                          
## [2211] &quot;R MAMMOGRAPHY SPECIMEN RIGHT&quot;                                                    
## [2212] &quot;CT ABD BX&quot;                                                                       
## [2213] &quot;B 47525-50 BILAT CHNG PERC BIL DRAIN CATH BILAT&quot;                                 
## [2214] &quot;ANTEGRADE UROGRAPHY&quot;                                                             
## [2215] &quot;RO KNEE (PORTABLE) RIGHT IN O.R.&quot;                                                
## [2216] &quot;OR KNEE (PORTABLE) IN O.R. RIGHT&quot;                                                
## [2217] &quot;SMALL BOWEL ONLY (GASTROGRAF)&quot;                                                   
## [2218] &quot;PP C-SPINE, TRAUMA PORT PORT&quot;                                                    
## [2219] &quot;OTHER SERVICE,DEPT,UNIT&quot;                                                         
## [2220] &quot;MRA ABD W&amp;W/O CONTRAST&quot;                                                          
## [2221] &quot;SPINAL CANAL CONTENTS US&quot;                                                        
## [2222] &quot;CT L-SPINE W/ CONTRAST&quot;                                                          
## [2223] &quot;MR CARDIAC&quot;                                                                      
## [2224] &quot;THROMBOCTMY, PERC AVF&quot;                                                           
## [2225] &quot;NEONATAL HIP&quot;                                                                    
## [2226] &quot;EA ADD&#39;L VESSEL AFTER BASIC A-GRAM&quot;                                              
## [2227] &quot;RP FOREARM (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                    
## [2228] &quot;US MULT/COMP ABSC/CYST DRAIN/INCISION&quot;                                           
## [2229] &quot;PPL ANKLE (2 VIEWS) PORT PORT LEFT&quot;                                              
## [2230] &quot;IVP NO TOMO&quot;                                                                     
## [2231] &quot;PORIES MAMMO NEEDLE LOCALIZATION&quot;                                                
## [2232] &quot;B 47505-50 BILAT INJ CHOLANG EXIST PERC/TUBE BILAT&quot;                              
## [2233] &quot;P ENTIRE SPINE (AP &amp; LAT ONLY) PORT&quot;                                             
## [2234] &quot;CT TRACHEA&quot;                                                                      
## [2235] &quot;OL KNEE (2 VIEWS) IN O.R. LEFT&quot;                                                  
## [2236] &quot;R THUMB (AP &amp; LATERAL) RIGHT&quot;                                                    
## [2237] &quot;PL FEMUR (AP &amp; LAT) PORT LEFT&quot;                                                   
## [2238] &quot;OP C-SPINE (PORTABLE) IN O.R. PORT&quot;                                              
## [2239] &quot;B PELVIS WITH JUDET VIEWS BILAT&quot;                                                 
## [2240] &quot;CTA AORTA/BIFEM/ILIAC RUNOFF W/W&amp;WO C AND RECONS&quot;                                
## [2241] &quot;FACIAL BONE (CALDWELL, WATERS, LAT &amp; BASE)&quot;                                      
## [2242] &quot;FACIAL BONE (WATERS &amp; LAT)&quot;                                                      
## [2243] &quot;LUMBAR SP,SINGLE FILM&quot;                                                           
## [2244] &quot;PERITONEAL ABSCESS DRAINAGE US&quot;                                                  
## [2245] &quot;CT CHANGE PERCUTANEOUS TUBE&quot;                                                     
## [2246] &quot;OPL FEMUR (AP &amp; LAT) IN O.R. PORT LEFT&quot;                                          
## [2247] &quot;L HIP 1 VIEW LEFT&quot;                                                               
## [2248] &quot;FULL FETAL (COMPLETE FETAL &amp; MATERNAL EVAL 18 WKS OR &gt;)&quot;                         
## [2249] &quot;R FOOT (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                             
## [2250] &quot;P FACIAL BONE (WATERS &amp; LAT) PORT&quot;                                               
## [2251] &quot;BP HAND, AP &amp; LAT. VIEWS BILAT PORT&quot;                                             
## [2252] &quot;BP KNEE (AP, LAT &amp; OBLIQUE) BILAT PORT&quot;                                          
## [2253] &quot;R MR SHOULDER W/O CONTRAST RIGHT&quot;                                                
## [2254] &quot;INTRO INTRAVASCULAR STENT&quot;                                                       
## [2255] &quot;TRAUMA #2 (AP CXR &amp; PELVIS PORT)&quot;                                                
## [2256] &quot;NON-IONIC 200 CC SUPPLY&quot;                                                         
## [2257] &quot;EXTCHG/INF CATH&quot;                                                                 
## [2258] &quot;R UNILAT DIAGNOSTIC MAMMOGRAM RIGHT&quot;                                             
## [2259] &quot;NEONATAL HEAD&quot;                                                                   
## [2260] &quot;NON-IONIC 150 CC&quot;                                                                
## [2261] &quot;R GLENO-HUMERAL SHOULDER (W/ Y VIEW) RIGHT&quot;                                      
## [2262] &quot;OL ANKLE 1 VIEW IN O.R. LEFT&quot;                                                    
## [2263] &quot;CT ABD CHEMO EMBO&quot;                                                               
## [2264] &quot;RP FOOT AP,LAT &amp; OBL RIGHT PORT&quot;                                                 
## [2265] &quot;MRA KIDNEY W/C (ABD)&quot;                                                            
## [2266] &quot;SHUNT SERIES FOR NEONATES&quot;                                                       
## [2267] &quot;OP C-SPINE (SINGLE VIEW ONLY) IN O.R. PORT&quot;                                      
## [2268] &quot;P PELVIS, EARLY OB US PORT&quot;                                                      
## [2269] &quot;CT TRACHEA W/C &amp; W/RECONS&quot;                                                       
## [2270] &quot;RP FOOT (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                       
## [2271] &quot;ENTIRE SPINE (AP &amp; LAT ONLY)&quot;                                                    
## [2272] &quot;NECK WITH CONTRAST&quot;                                                              
## [2273] &quot;R ELBOW (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                            
## [2274] &quot;US DRAIN PELV ABSCESS&quot;                                                           
## [2275] &quot;P CHEST U.S. PORT&quot;                                                               
## [2276] &quot;ATHERECTOMY FEM/POP&quot;                                                             
## [2277] &quot;B VENOUS DUP EXT UNI (MAP/DVT) BILAT&quot;                                            
## [2278] &quot;B ANKLE (AP, MORTISE &amp; LAT) BILAT&quot;                                               
## [2279] &quot;UNILAT UP EXT VEINS US&quot;                                                          
## [2280] &quot;PERC PLCMT GASTROSOTMY TUBE&quot;                                                     
## [2281] &quot;P UNILAT UP EXT VEINS US PORT&quot;                                                   
## [2282] &quot;BX SUPERFISCAL CER,AXL OR ING&quot;                                                   
## [2283] &quot;L UNILAT UP EXT VEINS US LEFT&quot;                                                   
## [2284] &quot;MR HIP W/O CONRAST&quot;                                                              
## [2285] &quot;ABSCESSOGRAM&quot;                                                                    
## [2286] &quot;B UNILAT UP EXT VEINS US BILAT&quot;                                                  
## [2287] &quot;P TRAUMA #2 (AP CXR &amp; PELVIS PORT) PORT&quot;                                         
## [2288] &quot;FEMUR (AP &amp; LAT)&quot;                                                                
## [2289] &quot;GUIDANCE CYST OR RENAL ANY LOC US&quot;                                               
## [2290] &quot;LO FEMUR (AP &amp; LAT) LEFT IN O.R.&quot;                                                
## [2291] &quot;EXT CAROTID UNILAT&quot;                                                              
## [2292] &quot;2ND ORDER OR&gt; VENOUS SYSTEM&quot;                                                     
## [2293] &quot;B HAND (AP, LAT &amp; OBLIQUE) BILAT&quot;                                                
## [2294] &quot;R PATELLA (AP, LAT &amp; SUNRISE) RIGHT&quot;                                             
## [2295] &quot;PL ELBOW, AP &amp; LAT VIEWS PORT LEFT&quot;                                              
## [2296] &quot;MRA CHEST W&amp;W/O C&quot;                                                               
## [2297] &quot;R ANKLE (AP, LAT &amp; OBLIQUE) RIGHT&quot;                                               
## [2298] &quot;MR ANKLE W/O CONTRAST&quot;                                                           
## [2299] &quot;PELVIS US  LIMIT TRANSVAG&quot;                                                       
## [2300] &quot;C-SPINE FLEX AND EXT ONLY 2 VIEWS&quot;                                               
## [2301] &quot;LP KNEE (2 VIEWS) LEFT PORT&quot;                                                     
## [2302] &quot;C-SPINE NON-TRAUMA 2 VIEWS&quot;                                                      
## [2303] &quot;SPINAL FLUORO WITH RADIOLOGIST&quot;                                                  
## [2304] &quot;R LOWER EXTREMITY FLUORO RIGHT&quot;                                                  
## [2305] &quot;F/U TRANS CATH THERAPY&quot;                                                          
## [2306] &quot;P CHEST (PRE-OP PA &amp; LAT) PORT&quot;                                                  
## [2307] &quot;MR ORBIT W &amp;W/O CONTRAST&quot;                                                        
## [2308] &quot;MRA KIDNEY W/O C (ABD)&quot;                                                          
## [2309] &quot;PERC VERTEBROPLSTY, THORACIC&quot;                                                    
## [2310] &quot;LP FEMUR (AP &amp; LAT) LEFT PORT&quot;                                                   
## [2311] &quot;RP FEMORAL VASCULAR US RIGHT PORT&quot;                                               
## [2312] &quot;L RIB UNILAT, W/ AP CHEST LEFT&quot;                                                  
## [2313] &quot;RP RIB UNILAT, W/ AP CHEST RIGHT PORT&quot;                                           
## [2314] &quot;R MR HIP W&amp;W/O CONTRAST RIGHT&quot;                                                   
## [2315] &quot;R RIB UNILAT, W/ AP CHEST RIGHT&quot;                                                 
## [2316] &quot;B RIB BILAT, W/AP CHEST BILAT&quot;                                                   
## [2317] &quot;B HIP UNILAT MIN 2 VIEWS BILAT&quot;                                                  
## [2318] &quot;OO LUMBAR SP,SINGLE FILM IN O.R. IN O.R.&quot;                                        
## [2319] &quot;LP FOREARM (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                     
## [2320] &quot;US RETROPER ABSCESS DRAIN PERC&quot;                                                  
## [2321] &quot;US INTRA-OP 120 MINS&quot;                                                            
## [2322] &quot;R MR THIGH W&amp;W/O CONTRAST RIGHT&quot;                                                 
## [2323] &quot;MR FOOT W&amp;W/O CONTRAST&quot;                                                          
## [2324] &quot;L MR WRIST W/O CONTRAST LEFT&quot;                                                    
## [2325] &quot;R HIP 1 VIEW RIGHT&quot;                                                              
## [2326] &quot;L HIP NAILING IN OR W/FILMS &amp; FLUORO LEFT&quot;                                       
## [2327] &quot;C-SPINE SGL 1 VIEW&quot;                                                              
## [2328] &quot;P US DRAIN PELV ABSCESS PORT&quot;                                                    
## [2329] &quot;R UNILAT UP EXT VEINS US RIGHT&quot;                                                  
## [2330] &quot;C-SPINE TRAUMA W.OBL 4 VIEWS&quot;                                                    
## [2331] &quot;TRANSCATH STENT EA ADD&#39;L VESSEL&quot;                                                 
## [2332] &quot;LO HIP UNILAT MIN 2 VIEWS LEFT IN O.R.&quot;                                          
## [2333] &quot;POL SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA PORT IN O.R. LEFT&quot;                  
## [2334] &quot;BP HAND (AP, LAT &amp; OBLIQUE) BILAT PORT&quot;                                          
## [2335] &quot;P SKULL (CALDWELL, LFT LAT, TOWNES &amp; BASE) PORT&quot;                                 
## [2336] &quot;BP KNEE (2 VIEWS) BILAT PORT&quot;                                                    
## [2337] &quot;CT LUNG/MEDIASTINAL BX&quot;                                                          
## [2338] &quot;ROP ANKLE 1 VIEW RIGHT IN O.R. PORT&quot;                                             
## [2339] &quot;C-SPINE TRAUMA W/FLEX &amp; EXT 5 VIEWS&quot;                                             
## [2340] &quot;OL FOREARM (AP &amp; LAT) SOFT TISSUE IN O.R. LEFT&quot;                                  
## [2341] &quot;O C-SPINE SGL 1 VIEW IN O.R.&quot;                                                    
## [2342] &quot;BILAT HIPS (AP,LAT &amp; AP PELVIS)&quot;                                                 
## [2343] &quot;LP ANKLE (AP, MORTISE &amp; LAT) LEFT PORT&quot;                                          
## [2344] &quot;RP SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA RIGHT PORT&quot;                          
## [2345] &quot;OP PELVIS (AP ONLY) IN O.R. PORT&quot;                                                
## [2346] &quot;B US EXTREMITY NONVASCULAR BILAT&quot;                                                
## [2347] &quot;B WRIST (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                            
## [2348] &quot;BO FEMUR (AP &amp; LAT) BILAT IN O.R.&quot;                                               
## [2349] &quot;P BILAT UP EXT VEINS US PORT&quot;                                                    
## [2350] &quot;THYROID BIOPSY BY RADIOLOGIST&quot;                                                   
## [2351] &quot;P ABDOMEN (WITH LAT DECUB) PORT&quot;                                                 
## [2352] &quot;OL HIP UNILAT MIN 2 VIEWS IN O.R. LEFT&quot;                                          
## [2353] &quot;L MR CALF W&amp;W/O CONTRAST LEFT&quot;                                                   
## [2354] &quot;OL GLENO-HUMERAL SHOULDER (W/ Y VIEW) IN O.R. LEFT&quot;                              
## [2355] &quot;MRA CHEST W/C&quot;                                                                   
## [2356] &quot;FLOW STUDY&quot;                                                                      
## [2357] &quot;SEL CATH SEGMENTAL/SUBSEG PUL ARTERY&quot;                                            
## [2358] &quot;R HAND, AP &amp; LAT. VIEWS RIGHT&quot;                                                   
## [2359] &quot;P MANDIBLE (PA, TOWNES &amp; BOTH OBLS) PORT&quot;                                        
## [2360] &quot;P ABDOMEN (LAT DECUB ONLY) PORT&quot;                                                 
## [2361] &quot;L TIB/FIB (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                           
## [2362] &quot;PROSTATE U.S.&quot;                                                                   
## [2363] &quot;LP FOOT AP,LAT &amp; OBL LEFT PORT&quot;                                                  
## [2364] &quot;R CT LOW EXT W/O C &amp; RECONS RIGHT&quot;                                               
## [2365] &quot;RP US EXTREMITY NONVASCULAR RIGHT PORT&quot;                                          
## [2366] &quot;R US MAJOR JOINT ASP./INJ. RIGHT&quot;                                                
## [2367] &quot;SERVIC BY SAME MD DURING POST OPERATIVE&quot;                                         
## [2368] &quot;C-SPINE NON-TRAUMA W/FLEX &amp; EXT 4 VIEWS&quot;                                         
## [2369] &quot;CTA PELVIS W&amp;W/O C &amp; RECONS&quot;                                                     
## [2370] &quot;PL UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST PORT LEFT&quot;                         
## [2371] &quot;MRA CHEST&quot;                                                                       
## [2372] &quot;INTRO BRACHIA&quot;                                                                   
## [2373] &quot;CT SINUS/MANDIBLE/MAXILLOFACIAL W/O CONTRAST&quot;                                    
## [2374] &quot;CTU (ABD/PEL) W/&amp;W/O CONTRAST&quot;                                                   
## [2375] &quot;P RIB BILAT, W/AP CHEST PORT&quot;                                                    
## [2376] &quot;RIB BILAT, W/AP CHEST&quot;                                                           
## [2377] &quot;RP AP WRIST &amp; HAND RIGHT PORT&quot;                                                   
## [2378] &quot;IVC AND TRIBUTARIES US&quot;                                                          
## [2379] &quot;AORTO-ILIAC A-GRAM&quot;                                                              
## [2380] &quot;R MR THIGH W/O CONTRAST RIGHT&quot;                                                   
## [2381] &quot;CERVICOCEREBRAL A-GRAM&quot;                                                          
## [2382] &quot;R FOREARM (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                          
## [2383] &quot;CT MAX/MAND DENTA SCAN&quot;                                                          
## [2384] &quot;SPINAL FLUORO WITHOUT RADIOLOGIST&quot;                                               
## [2385] &quot;O SKULL (AP, TOWNES &amp; LAT) TRAUMA IN O.R.&quot;                                       
## [2386] &quot;P ERCP S&amp;I (74330) PORT&quot;                                                         
## [2387] &quot;MR-ANGIO HEAD W &amp; W/O CONTRAST&quot;                                                  
## [2388] &quot;CT DESTUCT TUMOR EXTEN&quot;                                                          
## [2389] &quot;O ABD (SINGLE VIEW ONLY) IN O.R.&quot;                                                
## [2390] &quot;C-SPINE NON-TRAUMA W/OBLS 3 VIEWS&quot;                                               
## [2391] &quot;MIBG SCAN&quot;                                                                       
## [2392] &quot;OP THOR SP,SINGLE FILM IN O.R. PORT&quot;                                             
## [2393] &quot;CATH INFUSN,PER/CENT/MID(NOT DIAL)&quot;                                              
## [2394] &quot;B MRA LEG W/O C BILAT&quot;                                                           
## [2395] &quot;B CT LOW EXT W/O C &amp; RECONS BILAT&quot;                                               
## [2396] &quot;SHUNT RVG&quot;                                                                       
## [2397] &quot;L ANKLE 1 VIEW LEFT&quot;                                                             
## [2398] &quot;P ABDOMEN &amp; PELVIS US PORT&quot;                                                      
## [2399] &quot;LOC FOR PLEURAL ASP W/O RADIOLOGIST&quot;                                             
## [2400] &quot;PR LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST PORT RIGHT&quot;                        
## [2401] &quot;PTA AORTA&quot;                                                                       
## [2402] &quot;P VOIDING CYSTOGRAM PORT&quot;                                                        
## [2403] &quot;L CT LOW EXT W/O C &amp; RECONS LEFT&quot;                                                
## [2404] &quot;DIG SCREENING BILAT&quot;                                                             
## [2405] &quot;MRA CHEST W/O C&quot;                                                                 
## [2406] &quot;CT UP LIMB W/O C &amp; RECONS&quot;                                                       
## [2407] &quot;R 93990 AVF/DUPLEX HEMO/DIAL ACCESS RIGHT&quot;                                       
## [2408] &quot;ILEOGRAPHY/LOOPOGRAM&quot;                                                            
## [2409] &quot;P PARATHYROID U.S. PORT&quot;                                                         
## [2410] &quot;P SPLEEN ULTRASOUND PORT&quot;                                                        
## [2411] &quot;L MAMMO CORE BIOPSY LEFT&quot;                                                        
## [2412] &quot;OOL WRIST, AP &amp; LAT VIEWS IN O.R. IN O.R. LEFT&quot;                                  
## [2413] &quot;PL FOOT 2 VIEWS PORT LEFT&quot;                                                       
## [2414] &quot;R ART DUP EXT UP UNI LMTD RIGHT&quot;                                                 
## [2415] &quot;L MR HIP W&amp;W/O CONTRAST LEFT&quot;                                                    
## [2416] &quot;B PATELLA (AP, LAT &amp; SUNRISE) BILAT&quot;                                             
## [2417] &quot;METASTATIC SURVEY (ROUTINE)&quot;                                                     
## [2418] &quot;R 36002 INJ PSEUDOANERYSM RIGHT&quot;                                                 
## [2419] &quot;PL UNILAT LOWER EXT VEINS PORT LEFT&quot;                                             
## [2420] &quot;R CT LOW EXT W/C &amp; RECONS RIGHT&quot;                                                 
## [2421] &quot;CT TRACHEA W&amp;W/O C &amp; RECONS&quot;                                                     
## [2422] &quot;AORTA AND BRANCHES&quot;                                                              
## [2423] &quot;FETAL CARDIAC LIMITED&quot;                                                           
## [2424] &quot;AMNIOCENTESIS BY OB&quot;                                                             
## [2425] &quot;OB FOLLOW UP (FOLLOW UP OR REPEAT)&quot;                                              
## [2426] &quot;P ART DUP EXT LO UNI;F/U PORT&quot;                                                   
## [2427] &quot;ART EXT (REST&amp;EXERCISE)&quot;                                                         
## [2428] &quot;BP FEMUR (AP &amp; LAT) BILAT PORT&quot;                                                  
## [2429] &quot;B SHOULDER 1 VIEW BILAT&quot;                                                         
## [2430] &quot;B MR HIP W/O CONRAST BILAT&quot;                                                      
## [2431] &quot;NASAL/OROGASTRC TUBE PLMT, PRO FEE ONLY&quot;                                         
## [2432] &quot;O PELVIS (AP ONLY) IN O.R.&quot;                                                      
## [2433] &quot;P C-SPINE (PORTABLE) PORT&quot;                                                       
## [2434] &quot;OL HUMERUS (AP &amp; LAT) IN O.R. LEFT&quot;                                              
## [2435] &quot;CTU (ABD/PEL) W/O CONTRAST&quot;                                                      
## [2436] &quot;L 93990 AVF/DUPLEX HEMO/DIAL ACCESS LEFT&quot;                                        
## [2437] &quot;LO ANKLE (AP, LAT &amp; OBLIQUE) LEFT IN O.R.&quot;                                       
## [2438] &quot;O L-SPINE (AP &amp; LAT) IN O.R.&quot;                                                    
## [2439] &quot;RIB, UNILAT (NO CXR)&quot;                                                            
## [2440] &quot;R MR FOOT W&amp;W/O CONTRAST RIGHT&quot;                                                  
## [2441] &quot;GUID WIRES INCL INF&quot;                                                             
## [2442] &quot;C-SPINE NON-TRAUMA W/OBLS, FLEX &amp;EXT 5 VIEWS&quot;                                    
## [2443] &quot;MRHAND W/O&amp;W/CONTRAST&quot;                                                           
## [2444] &quot;L PATELLA (AP, LAT &amp; SUNRISE) LEFT&quot;                                              
## [2445] &quot;L MR ARM W&amp;W/O CONTRAST LEFT&quot;                                                    
## [2446] &quot;TRANSCATH EMBO THERAPY&quot;                                                          
## [2447] &quot;B HAND (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                             
## [2448] &quot;L MRHAND W/O&amp;W/CONTRAST LEFT&quot;                                                    
## [2449] &quot;GUID FOR PSEUDOANUREYSM (INJECTION)&quot;                                             
## [2450] &quot;B SHOULDER 2-3 VIEWS NON TRAUMA BILAT&quot;                                           
## [2451] &quot;B MR CALF W&amp;W/O CONTRAST BILAT&quot;                                                  
## [2452] &quot;VENA CAVA FILTER&quot;                                                                
## [2453] &quot;PO PELVIS (AP ONLY) PORT IN O.R.&quot;                                                
## [2454] &quot;US EXTREMITY NONVASCULAR&quot;                                                        
## [2455] &quot;LP US MAJOR JOINT ASP./INJ. LEFT PORT&quot;                                           
## [2456] &quot;P VIDEO OROPHARYNGEAL SWALLOW PORT&quot;                                              
## [2457] &quot;LO FOOT AP,LAT &amp; OBL LEFT IN O.R.&quot;                                               
## [2458] &quot;LP HIP 1 VIEW LEFT PORT&quot;                                                         
## [2459] &quot;OL LOWER EXTREMITY FLUORO IN O.R. LEFT&quot;                                          
## [2460] &quot;R DIG DIAGNOSTIC MAMMO UNLIAT RIGHT&quot;                                             
## [2461] &quot;PROSTATE BX-OLUMI&quot;                                                               
## [2462] &quot;STENT NOCOAT.NOCOVER W/DEL SYSTEM&quot;                                               
## [2463] &quot;CT LUMBAR W&amp;W/O CONTRAST&quot;                                                        
## [2464] &quot;MR HIP W&amp;W/O CONTRAST&quot;                                                           
## [2465] &quot;RO KNEE (2 VIEWS) RIGHT IN O.R.&quot;                                                 
## [2466] &quot;CT ABD &amp; PELVIS&quot;                                                                 
## [2467] &quot;LP AP WRIST &amp; HAND LEFT PORT&quot;                                                    
## [2468] &quot;RR MR HIP W/O CONRAST RIGHT RIGHT&quot;                                               
## [2469] &quot;B MR THIGH W/O CONTRAST BILAT&quot;                                                   
## [2470] &quot;MR THIGH W&amp;W/O CONTRAST&quot;                                                         
## [2471] &quot;BP FOOT AP,LAT &amp; OBL BILAT PORT&quot;                                                 
## [2472] &quot;P PELVIS, NON-OBSTETRIC PORT&quot;                                                    
## [2473] &quot;CT ABD/PEL W/OC, COLON TECHNIQUE&quot;                                                
## [2474] &quot;L MR ANKLE W&amp;W/O CONTRAST LEFT&quot;                                                  
## [2475] &quot;R MR CALF W/O CONTRAST RIGHT&quot;                                                    
## [2476] &quot;PB LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST PORT BILAT&quot;                        
## [2477] &quot;R MR SHOULDER W&amp;W/O CONTRAST RIGHT&quot;                                              
## [2478] &quot;OPL ANKLE (2 VIEWS) IN O.R. PORT LEFT&quot;                                           
## [2479] &quot;B FEMORAL VASCULAR US BILAT&quot;                                                     
## [2480] &quot;LOP HUMERUS (AP &amp; LAT) LEFT IN O.R. PORT&quot;                                        
## [2481] &quot;L MR SHOULDER W/CONTRAST LEFT&quot;                                                   
## [2482] &quot;LO UPPER EXTREMITY FLUORO LEFT IN O.R.&quot;                                          
## [2483] &quot;PR HIP 1 VIEW PORT RIGHT&quot;                                                        
## [2484] &quot;INT.SHTH NOT/GUID,EP,NONLASER&quot;                                                   
## [2485] &quot;MECKEL&#39;S SCAN&quot;                                                                   
## [2486] &quot;P C-SPINE SGL 1 VIEW PORT&quot;                                                       
## [2487] &quot;OO ABDOMEN (SUPINE ONLY) IN O.R. IN O.R.&quot;                                        
## [2488] &quot;EXTRA CHARGE&quot;                                                                    
## [2489] &quot;GUID WIRES INFU/PERF&quot;                                                            
## [2490] &quot;CATHETER, DRAINAGE&quot;                                                              
## [2491] &quot;OR TIB/FIB (AP &amp; LAT) IN O.R. RIGHT&quot;                                             
## [2492] &quot;CT SPINAL DRAINAGE&quot;                                                              
## [2493] &quot;BP ANKLE (2 VIEWS) BILAT PORT&quot;                                                   
## [2494] &quot;ROP HIP UNILAT MIN 2 VIEWS RIGHT IN O.R. PORT&quot;                                   
## [2495] &quot;OP ABDOMINAL FLUORO WITHOUT RADIOLOGIST IN O.R. PORT&quot;                            
## [2496] &quot;B MR THIGH W&amp;W/O CONTRAST BILAT&quot;                                                 
## [2497] &quot;MR PITUITARY W&amp;W/O CONTRAST&quot;                                                     
## [2498] &quot;B RENAL TRANSPLANT U.S. BILAT&quot;                                                   
## [2499] &quot;THYROID ABLATION: GRAVES&quot;                                                        
## [2500] &quot;R KNEE STANDING 2 VIEWS RIGHT&quot;                                                   
## [2501] &quot;CONSULT READING MAMMOGRAPHY ONLY&quot;                                                
## [2502] &quot;L MR ELBOW W&amp;W/O CONTRATS LEFT&quot;                                                  
## [2503] &quot;LO FOOT 1 VIEW LEFT IN O.R.&quot;                                                     
## [2504] &quot;RO HIP UNILAT MIN 2 VIEWS RIGHT IN O.R.&quot;                                         
## [2505] &quot;P TEETH (PANOREX FOR DENTAL) PORT&quot;                                               
## [2506] &quot;C-SPINE NON-TRAUMA 2-3 VIEWS&quot;                                                    
## [2507] &quot;FNA BRSEAST, THYROID OR PROSTATE&quot;                                                
## [2508] &quot;CHOLANGIOGRAM,IN OR W FILMS&quot;                                                     
## [2509] &quot;PERC PORTAL VEIN CATH&quot;                                                           
## [2510] &quot;RP ANKLE (AP, LAT &amp; OBLIQUE) RIGHT PORT&quot;                                         
## [2511] &quot;R MRA LEG W&amp;W/OC RIGHT&quot;                                                          
## [2512] &quot;P SINUSES (WATERS, CALDWELL, LAT &amp; BASE) PORT&quot;                                   
## [2513] &quot;BILAT BREAST US&quot;                                                                 
## [2514] &quot;B DIG DIAGNOSTIC MAMMO BILATERAL BILAT&quot;                                          
## [2515] &quot;RO FOOT AP,LAT &amp; OBL RIGHT IN O.R.&quot;                                              
## [2516] &quot;LO ANKLE 1 VIEW LEFT IN O.R.&quot;                                                    
## [2517] &quot;B HIP 1 VIEW BILAT&quot;                                                              
## [2518] &quot;RP WRIST, AP &amp; LAT VIEWS RIGHT PORT&quot;                                             
## [2519] &quot;UNILAT BREAST US&quot;                                                                
## [2520] &quot;PL LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST PORT LEFT&quot;                         
## [2521] &quot;L KNEE (MIN 4 VIEWS) LEFT&quot;                                                       
## [2522] &quot;L CT UP EXT W/C +RECONSTRUCTION LEFT&quot;                                            
## [2523] &quot;L CT LOW EXT W/O C LEFT&quot;                                                         
## [2524] &quot;B CT LOW EXT W/O C BILAT&quot;                                                        
## [2525] &quot;B HEEL (AXIAL &amp; LATERAL) BILAT&quot;                                                  
## [2526] &quot;B MR CALF W/O CONTRAST BILAT&quot;                                                    
## [2527] &quot;FLUORO GUID FOR SPINE INJ&quot;                                                       
## [2528] &quot;L BX-NEEDLE KIDNEY BY NEPHROLOGIST LEFT&quot;                                         
## [2529] &quot;CATH,HEM/PERTI DIALYSIS SHORT TERM&quot;                                              
## [2530] &quot;L MR SHOULDER W&amp;W/O CONTRAST LEFT&quot;                                               
## [2531] &quot;BLADDER VOLUMETRIC US&quot;                                                           
## [2532] &quot;CT UP EXT W/O C&quot;                                                                 
## [2533] &quot;-50 BILAT INJ CHOLANG EXIST PERC/TUBE&quot;                                           
## [2534] &quot;INJEC PROC SIALOGRAPHY&quot;                                                          
## [2535] &quot;L EMERG BILAT LOWER EXT VEINS LEFT&quot;                                              
## [2536] &quot;OB F/U W/MEASUREMENTS&quot;                                                           
## [2537] &quot;INT/SHTH,EP,FXD CURVE/PELL AWY&quot;                                                  
## [2538] &quot;CATHETER, THROMBOECTMY/EMBOECTMY&quot;                                                
## [2539] &quot;MR CARDIAC MORPHOLOGY W/O C&quot;                                                     
## [2540] &quot;HEPATIC VENOGRAM NO PRESSURES&quot;                                                   
## [2541] &quot;CT TORSO W/CONTRAST&quot;                                                             
## [2542] &quot;B MR HIP W&amp;W/O CONTRAST BILAT&quot;                                                   
## [2543] &quot;R CT UP EXT W/C +RECONSTRUCTION RIGHT&quot;                                           
## [2544] &quot;OL ELBOW, AP &amp; LAT VIEWS IN O.R. LEFT&quot;                                           
## [2545] &quot;NON-IONIC 50 CC&quot;                                                                 
## [2546] &quot;PL BABYGRAM CHEST DECUB ONLY (71035) PORT LEFT&quot;                                  
## [2547] &quot;RO FEMUR (AP &amp; LAT) RIGHT IN O.R.&quot;                                               
## [2548] &quot;ABD COMPL INCLUDING LAT DECUB&quot;                                                   
## [2549] &quot;B ANKLE (AP, LAT &amp; OBLIQUE) BILAT&quot;                                               
## [2550] &quot;MR-ANGIO NECK W &amp; W/O CONTRAST&quot;                                                  
## [2551] &quot;RP KNEE (2 VIEWS) RIGHT PORT&quot;                                                    
## [2552] &quot;BILAT UP EXT VEINS US&quot;                                                           
## [2553] &quot;R CT LOW EXT W/O C RIGHT&quot;                                                        
## [2554] &quot;FDG TUMOR IMAGING (PET-CT)&quot;                                                      
## [2555] &quot;L MR CALF W/CONTRAST LEFT&quot;                                                       
## [2556] &quot;P BLADDER US PORT&quot;                                                               
## [2557] &quot;O LUMBO-SACRAL SPINE (AP &amp; LAT) IN O.R.&quot;                                         
## [2558] &quot;L HEEL (AXIAL &amp; LATERAL) LEFT&quot;                                                   
## [2559] &quot;P ABD COMPL INCLUDING LAT DECUB PORT&quot;                                            
## [2560] &quot;R ANKLE/FOOT (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                       
## [2561] &quot;P CHEST (APICAL LORD ONLY) PORT&quot;                                                 
## [2562] &quot;SPINE, SINGLE FILM&quot;                                                              
## [2563] &quot;L MR CALF W/O CONTRAST LEFT&quot;                                                     
## [2564] &quot;BP WRIST(3 + VIEWS) BILAT PORT&quot;                                                  
## [2565] &quot;PL HAND, AP &amp; LAT. VIEWS PORT LEFT&quot;                                              
## [2566] &quot;L 36002 THROMBIN INJ PSEUDOANERYSM LEFT&quot;                                         
## [2567] &quot;OPR HIP UNILAT MIN 2 VIEWS IN O.R. PORT RIGHT&quot;                                   
## [2568] &quot;CT BONE BX&quot;                                                                      
## [2569] &quot;FULL FETAL HIGH RISK&quot;                                                            
## [2570] &quot;ACUTE ABD SERIES (2-3 VIEWS OF ABD &amp; SGL CHEST VIEW)&quot;                            
## [2571] &quot;INSERT HEPATIC HUNT TIPS&quot;                                                        
## [2572] &quot;L ELBOW (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                             
## [2573] &quot;CT GUIDED NEEDLE PLACTMENT&quot;                                                      
## [2574] &quot;L BREAST CYST ASPIRATION LEFT&quot;                                                   
## [2575] &quot;B MR SHOULDER W/O CONTRAST BILAT&quot;                                                
## [2576] &quot;PR ANKLE (AP, MORTISE &amp; LAT) PORT RIGHT&quot;                                         
## [2577] &quot;RP ELBOW (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                      
## [2578] &quot;SPLEEN ULTRASOUND&quot;                                                               
## [2579] &quot;RP FOOT 2 VIEWS RIGHT PORT&quot;                                                      
## [2580] &quot;PB TIB/FIB (AP &amp; LAT) PORT BILAT&quot;                                                
## [2581] &quot;MR SOFT TISSUE ENCK W/O CONTRAST&quot;                                                
## [2582] &quot;SEL CATH ART, 1ST ORDER&quot;                                                         
## [2583] &quot;R NAVICULAR (SCAPHOID) VIEW ONLY RIGHT&quot;                                          
## [2584] &quot;ABSCESS CHG &amp; REINSERT&quot;                                                          
## [2585] &quot;PP BABYGRAM (CHEST ONLY) PORT PORT&quot;                                              
## [2586] &quot;LP ABDOMEN (LAT DECUB ONLY) LEFT PORT&quot;                                           
## [2587] &quot;OP NECK SOFT TISSUES IN O.R. PORT&quot;                                               
## [2588] &quot;BX PAROTID/SAL GLAND&quot;                                                            
## [2589] &quot;O L-SPINE (WITH OBLIQUE) IN O.R.&quot;                                                
## [2590] &quot;CT COLON TECH ABD/PEL W&amp;W/O C&quot;                                                   
## [2591] &quot;FEMORAL VASCULAR US&quot;                                                             
## [2592] &quot;B WRIST, AP &amp; LAT VIEWS BILAT&quot;                                                   
## [2593] &quot;P CENTRAL VENOUS LINE PLACEMENT PORT&quot;                                            
## [2594] &quot;PERC VERTEBROPSTY, FLUOR RAD S&amp;I&quot;                                                
## [2595] &quot;B RIB UNILAT, W/ AP CHEST BILAT&quot;                                                 
## [2596] &quot;CT COLON TECH ABD/PEL W/OC&quot;                                                      
## [2597] &quot;O SPINE, SINGLE FILM IN O.R.&quot;                                                    
## [2598] &quot;UNRELATED PROC FOR NEW PROBLEM&quot;                                                  
## [2599] &quot;P TRACHEA PORT&quot;                                                                  
## [2600] &quot;HIP UNILAT MIN 2 VIEWS&quot;                                                          
## [2601] &quot;O CHEST FLUORO IN O.R.&quot;                                                          
## [2602] &quot;UNRELATED PROCEDURE/SERVICE DURING POSTOPERATIVE PERIOD&quot;                         
## [2603] &quot;RO WRIST(3 + VIEWS) RIGHT IN O.R.&quot;                                               
## [2604] &quot;BO FEMUR (AP &amp; LAT) SOFT TISSUE BILAT IN O.R.&quot;                                   
## [2605] &quot;PR ABDOMEN (LAT DECUB ONLY) PORT RIGHT&quot;                                          
## [2606] &quot;LP CLAVICLE LEFT PORT&quot;                                                           
## [2607] &quot;B SHOULDER (AP, NEUTRAL &amp; AXILLARY) SOFT TISSUE BILAT&quot;                           
## [2608] &quot;OB KNEE (2 VIEWS) IN O.R. BILAT&quot;                                                 
## [2609] &quot;LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST&quot;                                      
## [2610] &quot;RP FINGER(S),2+VIEWS RIGHT PORT&quot;                                                 
## [2611] &quot;ZYGOMAS (5 VIEWS)&quot;                                                               
## [2612] &quot;L-SPINE (WITH OBLIQUE)&quot;                                                          
## [2613] &quot;LO ANKLE (AP, MORTISE &amp; LAT) LEFT IN O.R.&quot;                                       
## [2614] &quot;OPOPR FOREARM (AP &amp; LAT) SOFT TISSUE IN O.R. PORT IN O.R. PORT RIGHT&quot;            
## [2615] &quot;OPR FEMUR (AP &amp; LAT) IN O.R. PORT RIGHT&quot;                                         
## [2616] &quot;BP AP WRIST &amp; HAND BILAT PORT&quot;                                                   
## [2617] &quot;MR CARDIAC/FUNCTION, COMPL&quot;                                                      
## [2618] &quot;ANGIOGRAPHY, EXTREMITY&quot;                                                          
## [2619] &quot;MR CHEST/MEDIAATINUM W/O CONTRAST&quot;                                               
## [2620] &quot;OP T-SPINE IN O.R. PORT&quot;                                                         
## [2621] &quot;O C-SPINE NON-TRAUMA 2-3 VIEWS IN O.R.&quot;                                          
## [2622] &quot;US INTR-OP 90 MINS&quot;                                                              
## [2623] &quot;BP ANKLE (AP, MORTISE &amp; LAT) BILAT PORT&quot;                                         
## [2624] &quot;L NAVICULAR (SCAPHOID) VIEW ONLY LEFT&quot;                                           
## [2625] &quot;L-SPINE (AP,LAT,FLEX,EXT)&quot;                                                       
## [2626] &quot;L MR FOOT W/O CONTRAST LEFT&quot;                                                     
## [2627] &quot;P C-SPINE NON-TRAUMA 2-3 VIEWS PORT&quot;                                             
## [2628] &quot;INTRO CATH TO PELVIS FOR DRAINAGE AND INJ&quot;                                       
## [2629] &quot;TRANSCATH INTRO STENT&quot;                                                           
## [2630] &quot;PPP ABDOMEN (SUPINE ONLY) PORT PORT PORT&quot;                                        
## [2631] &quot;HIP 1 VIEW&quot;                                                                      
## [2632] &quot;BIL ENDOSCOPY&quot;                                                                   
## [2633] &quot;DUPLEX DOP ABD/PEL LIMITED&quot;                                                      
## [2634] &quot;INJ PROC. FOR MYLEO&quot;                                                             
## [2635] &quot;OB F/U WITH MEASUREMENT&#39;&quot;                                                        
## [2636] &quot;RELATED PROCEDURE DURING POSTOPERATIVE PERIOD&quot;                                   
## [2637] &quot;REVISN HEPATIC SHUNT TIPS&quot;                                                       
## [2638] &quot;OPR LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. PORT RIGHT&quot;               
## [2639] &quot;PERC CHOLECCYSTOMY&quot;                                                              
## [2640] &quot;OPOP HIP UNILAT MIN 2 VIEWS IN O.R. PORT IN O.R. PORT&quot;                           
## [2641] &quot;LO WRIST(3 + VIEWS) LEFT IN O.R.&quot;                                                
## [2642] &quot;P CHEST WALL U.S. SCAN PORT&quot;                                                     
## [2643] &quot;OPL UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. PORT LEFT&quot;                
## [2644] &quot;RENAL ENDOSCOPY W/ URETERAL CATH&quot;                                                
## [2645] &quot;MAMMO NEEDLE LOC&quot;                                                                
## [2646] &quot;RO UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST RIGHT IN O.R.&quot;                     
## [2647] &quot;EARLY OB US &lt;14WEEKS&quot;                                                            
## [2648] &quot;US PER DRAIN SUBDIAPHRAM ABSCESS&quot;                                                
## [2649] &quot;B CT LOW WXT W/C BILAT&quot;                                                          
## [2650] &quot;L CT UP EXT W&amp;W/O C LEFT&quot;                                                        
## [2651] &quot;DIG DIAGNOSTIC MAMMO UNLIAT&quot;                                                     
## [2652] &quot;CENTRAL VENOUS LINE PLACEMENT&quot;                                                   
## [2653] &quot;P HIP 1 VIEW PORT&quot;                                                               
## [2654] &quot;OLO TIB/FIB (AP &amp; LAT) IN O.R. LEFT IN O.R.&quot;                                     
## [2655] &quot;EMERG BILAT LOWER EXT VEINS&quot;                                                     
## [2656] &quot;R ART DUP LOW EXT RIGHT&quot;                                                         
## [2657] &quot;LP KNEE (AP, LAT &amp; OBLIQUE) LEFT PORT&quot;                                           
## [2658] &quot;P PORTABLE ABDOMEN PORT&quot;                                                         
## [2659] &quot;ROP SHOULDER 1 VIEW RIGHT IN O.R. PORT&quot;                                          
## [2660] &quot;OP ABDOMEN, SINGLE VIEW IN O.R. PORT&quot;                                            
## [2661] &quot;FLUOR GUID FOR SPINE INJ&quot;                                                        
## [2662] &quot;RP SHOULDER (AP, NEUTRAL &amp; AXILLARY) SOFT TISSUE RIGHT PORT&quot;                     
## [2663] &quot;OR FOREARM (AP &amp; LAT) IN O.R. RIGHT&quot;                                             
## [2664] &quot;PPL FEMUR (AP &amp; LAT) PORT PORT LEFT&quot;                                             
## [2665] &quot;B ART DUP EXT LO UNI;F/U BILAT&quot;                                                  
## [2666] &quot;RO ANKLE (2 VIEWS) RIGHT IN O.R.&quot;                                                
## [2667] &quot;P CAROTID SERIES COMPLETE PORT&quot;                                                  
## [2668] &quot;P BABYGRAM SEPARATE CXR &amp; ABD VIEWS 2 FILMS PORT&quot;                                
## [2669] &quot;THERAPY FOR BONE PAIN&quot;                                                           
## [2670] &quot;L CT LOW WXT W/C LEFT&quot;                                                           
## [2671] &quot;P EMERG BILAT LOWER EXT VEINS PORT&quot;                                              
## [2672] &quot;OP SPINAL FLUORO WITHOUT RADIOLOGIST IN O.R. PORT&quot;                               
## [2673] &quot;MRA CHEST W&amp;W/O CONTRAST&quot;                                                        
## [2674] &quot;BABYGRAM SEPARATE CXR &amp; ABD VIEWS 2 FILMS&quot;                                       
## [2675] &quot;P C-SPINE FLEX AND EXT ONLY 2 VIEWS PORT&quot;                                        
## [2676] &quot;BY SAME PHYSICIAN&quot;                                                               
## [2677] &quot;BY DIFFERENT PHYSICIAN&quot;                                                          
## [2678] &quot;CT DENTASCAN MAX/MANDIBLE&quot;                                                       
## [2679] &quot;L MR ANKLE W/O CONTRAST LEFT&quot;                                                    
## [2680] &quot;P ACUTE ABD SERIES (2-3 VIEWS OF ABD &amp; SGL CHEST VIEW) PORT&quot;                     
## [2681] &quot;OP HIP UNILAT MIN 2 VIEWS IN O.R. PORT&quot;                                          
## [2682] &quot;RO FOREARM (AP &amp; LAT) RIGHT IN O.R.&quot;                                             
## [2683] &quot;OL KNEE (PORTABLE) IN O.R. LEFT&quot;                                                 
## [2684] &quot;OR WRIST, AP &amp; LAT VIEWS IN O.R. RIGHT&quot;                                          
## [2685] &quot;SKULL AP&amp;LAT/C-SP/CXR/ABD SLG VIEWS ME SCREENING&quot;                                
## [2686] &quot;P ART EXT (REST ONLY) PORT&quot;                                                      
## [2687] &quot;PL VENOUS DUP EXT UNI (MAP/DVT) PORT LEFT&quot;                                       
## [2688] &quot;MR ANGIO SPINE W&amp;W/O CONTRAST&quot;                                                   
## [2689] &quot;R MR ELBOW W/O CONTRAST RIGHT&quot;                                                   
## [2690] &quot;MR PITUITARY&quot;                                                                    
## [2691] &quot;OLO WRIST(3 + VIEWS) IN O.R. LEFT IN O.R.&quot;                                       
## [2692] &quot;OP C-SPINE NON-TRAUMA 2-3 VIEWS IN O.R. PORT&quot;                                    
## [2693] &quot;O C-SPINE NON-TRAUMA W/OBLS 3 VIEWS IN O.R.&quot;                                     
## [2694] &quot;BP US MAJOR JOINT ASP./INJ. BILAT PORT&quot;                                          
## [2695] &quot;P US INTR-OP 60 MINS PORT&quot;                                                       
## [2696] &quot;CTA NECK W&amp;W/OC &amp; RECONS&quot;                                                        
## [2697] &quot;L BREAST CORE BIOSPY UNDER US LEFT&quot;                                              
## [2698] &quot;CATH, TRANSLUM ANGIO NONLASER&quot;                                                   
## [2699] &quot;O HIP UNILAT MIN 2 VIEWS IN O.R.&quot;                                                
## [2700] &quot;P ANKLE (2 VIEWS) PORT&quot;                                                          
## [2701] &quot;P HIP UNILAT MIN 2 VIEWS PORT&quot;                                                   
## [2702] &quot;P LUMBAR SP,SINGLE FILM PORT&quot;                                                    
## [2703] &quot;P ABDOMEN, SINGLE VIEW PORT&quot;                                                     
## [2704] &quot;P SKULL AP&amp;LAT/C-SP/CXR/ABD SLG VIEWS ME SCREENING PORT&quot;                         
## [2705] &quot;REMOVE CVA LUMEN OBSTRUCT&quot;                                                       
## [2706] &quot;CATH,HEMO/PERTI DIALYSIS LONG TERM&quot;                                              
## [2707] &quot;L KNEE (AP, LAT &amp; TUNNEL) LEFT&quot;                                                  
## [2708] &quot;VENOUS CATH FOR SEL ORGAN BLOOD SAMPLING&quot;                                        
## [2709] &quot;DIG DIAGNOSTIC MAMMO BILATERAL&quot;                                                  
## [2710] &quot;OR SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA IN O.R. RIGHT&quot;                       
## [2711] &quot;MR UROGRAM(MR ABD&amp;PEL W&amp;W/OC)&quot;                                                   
## [2712] &quot;ENDOVASCUALR REPAIR OF ABD AORTA&quot;                                                
## [2713] &quot;INJ DISK, EA LEVEL LUMBAR&quot;                                                       
## [2714] &quot;MRA NECK W&amp;W/O CONTRAST&quot;                                                         
## [2715] &quot;P PANCREAS US PORT&quot;                                                              
## [2716] &quot;MR CARDIAC VELOCITY FLOW MAP&quot;                                                    
## [2717] &quot;P CAROTID DUPLEX US PORT&quot;                                                        
## [2718] &quot;R MR HIP W/O CONRAST RIGHT&quot;                                                      
## [2719] &quot;O T-SPINE IN O.R.&quot;                                                               
## [2720] &quot;P ART EXT SGL LEVEL PORT&quot;                                                        
## [2721] &quot;PICC W/O PORT&quot;                                                                   
## [2722] &quot;BX-NEEDLE KIDNEY BY RADIOLOGIST&quot;                                                 
## [2723] &quot;P BABYGRAM CHEST &amp; ABD (TOGETHER ONE FILM) PORT&quot;                                 
## [2724] &quot;BABYGRAM AP ABD ONLY&quot;                                                            
## [2725] &quot;CT CERVICAL W&amp;W/O CONSTRAST&quot;                                                     
## [2726] &quot;R HAND FILM IN OR RIGHT&quot;                                                         
## [2727] &quot;MR PROSTATE W &amp; W/O CONTRAST&quot;                                                    
## [2728] &quot;MRI PELVIS W/O &amp; W/CONTRAST&quot;                                                     
## [2729] &quot;BP US EXTREMITY NONVASCULAR BILAT PORT&quot;                                          
## [2730] &quot;P BABYGRAM CHEST &amp; ABD (2 FILMS STANDARD) PORT&quot;                                  
## [2731] &quot;PARACENTESIS  INITAL PROC&quot;                                                       
## [2732] &quot;R HUMERUS (AP &amp; LAT) SOFT TISSUE RIGHT&quot;                                          
## [2733] &quot;P BABYGRAM AP ABD ONLY PORT&quot;                                                     
## [2734] &quot;R 36002 THROMBIN INJ PSEUDOANERYSM RIGHT&quot;                                        
## [2735] &quot;BABYGRAM CHEST &amp; ABD (TOGETHER ONE FILM)&quot;                                        
## [2736] &quot;PO PORTABLE ABDOMEN PORT IN O.R.&quot;                                                
## [2737] &quot;MRI ABDOMEN W/O &amp; W/CONTRAST&quot;                                                    
## [2738] &quot;OPL ELBOW, AP &amp; LAT VIEWS IN O.R. PORT LEFT&quot;                                     
## [2739] &quot;MRI CHEST/MEDIASTINUM W/O CONTRAST&quot;                                              
## [2740] &quot;BABYGRAM CHEST &amp; ABD (2 FILMS STANDARD)&quot;                                         
## [2741] &quot;LOP KNEE (AP, LAT &amp; OBLIQUE) LEFT IN O.R. PORT&quot;                                  
## [2742] &quot;PLEURAL ASPIRATION&quot;                                                              
## [2743] &quot;CT THORACIC W&amp;W/O CONTRAST&quot;                                                      
## [2744] &quot;PR FOOT AP,LAT &amp; OBL PORT RIGHT&quot;                                                 
## [2745] &quot;INTRO GUIDE TO PELVIS OR URETHER&quot;                                                
## [2746] &quot;THY NODULE CLINIC BX&quot;                                                            
## [2747] &quot;ERCP(SURG) (43260)&quot;                                                              
## [2748] &quot;OR ELBOW, AP &amp; LAT VIEWS IN O.R. RIGHT&quot;                                          
## [2749] &quot;PL HAND (AP, LAT &amp; OBLIQUE) PORT LEFT&quot;                                           
## [2750] &quot;HEPATIC VENOGRAM WITH PRESSURES&quot;                                                 
## [2751] &quot;L FOOT (AP &amp; LAT) STANDING LEFT&quot;                                                 
## [2752] &quot;REINSERT TRANSHEPATIC T-TUBE&quot;                                                    
## [2753] &quot;R KNEE (MIN 4 VIEWS) RIGHT&quot;                                                      
## [2754] &quot;R CT LOW WXT W/C RIGHT&quot;                                                          
## [2755] &quot;OPR FOOT AP,LAT &amp; OBL IN O.R. PORT RIGHT&quot;                                        
## [2756] &quot;C-SPINE TRAUMA W/OBLS &amp; FLEX &amp; EXT 6 VIEWS&quot;                                      
## [2757] &quot;MRA ABDOMEN W&amp;W/O CONTRAST&quot;                                                      
## [2758] &quot;MRA KIDNEY W&amp;W/O CONTRAST&quot;                                                       
## [2759] &quot;LP UNILAT UP EXT VEINS US LEFT PORT&quot;                                             
## [2760] &quot;CENTRAL TUNNELED W/O PORT&quot;                                                       
## [2761] &quot;NASO-INTESTINAL TUBE PLACEMENT (W/FLUORO)&quot;                                       
## [2762] &quot;O PELVIS (AP, INLET &amp; OUTLET) IN O.R.&quot;                                           
## [2763] &quot;RP UNILAT UP EXT VEINS US RIGHT PORT&quot;                                            
## [2764] &quot;MRI CHEST/MEDIASTINUM W/O &amp; W/CONTRAST&quot;                                          
## [2765] &quot;MRI SOFT TISSUE NECK, W/O &amp; W/CONTRAST&quot;                                          
## [2766] &quot;NON-TUNNELED&quot;                                                                    
## [2767] &quot;AVF/DUPLEX HEMO/DIAL ACCESS&quot;                                                     
## [2768] &quot;LP ELBOW, AP &amp; LAT VIEWS LEFT PORT&quot;                                              
## [2769] &quot;O HIP 1 VIEW IN O.R.&quot;                                                            
## [2770] &quot;UGI AIR W/KUB&quot;                                                                   
## [2771] &quot;TUNNELED W/O PORT&quot;                                                               
## [2772] &quot;TUNNELED CENTRAL W/O PORT&quot;                                                       
## [2773] &quot;B ANKLE 1 VIEW BILAT&quot;                                                            
## [2774] &quot;CT PERITINEAL DRAIN EXCLUDING APPENDICEAL&quot;                                       
## [2775] &quot;MRI ABDOMEN W/O CONTRAST&quot;                                                        
## [2776] &quot;MRA CHEST W/O CONTRAST&quot;                                                          
## [2777] &quot;LP KNEE( (SINGLE VIEW) LEFT PORT&quot;                                                
## [2778] &quot;B TIB/FIB (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                          
## [2779] &quot;MRA BRAIN W/O CONTRAST&quot;                                                          
## [2780] &quot;P DUPLEX DOP ABD/PEL LIMITED PORT&quot;                                               
## [2781] &quot;CLOSURE DEVICE VASC IMP/INS&quot;                                                     
## [2782] &quot;PERSANTINE MIBI MIBI&quot;                                                            
## [2783] &quot;CT BONE BX SUPERFICIAL&quot;                                                          
## [2784] &quot;FLUOR GUID PLCT/REPLCT/REMOVE&quot;                                                   
## [2785] &quot;PR VENOUS DUP EXT UNI (MAP/DVT) PORT RIGHT&quot;                                      
## [2786] &quot;L KNEE 2 VIEW PORTABLE LEFT&quot;                                                     
## [2787] &quot;PR UNILAT UP EXT VEINS US PORT RIGHT&quot;                                            
## [2788] &quot;R MR ARM W/O CONTRAST RIGHT&quot;                                                     
## [2789] &quot;MRA CHEST W/CONTRAST&quot;                                                            
## [2790] &quot;REMOVE CVA LUMEN OBSTRUCT S&amp;I&quot;                                                   
## [2791] &quot;SKULL AP&amp;LAT/C-SP/CXR/ABD SLG VIEWS MR SCREENING&quot;                                
## [2792] &quot;P COMPLETE GU U.S. (BLADDER &amp; RENAL) PORT&quot;                                       
## [2793] &quot;FIBRIN STRIPPING SEPERATE ACCESS&quot;                                                
## [2794] &quot;INCOMPLETE/UNSCUCCESSFUL&quot;                                                        
## [2795] &quot;RP HUMERUS (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                    
## [2796] &quot;MRCP (MR ABD W&amp;W/OC)&quot;                                                            
## [2797] &quot;PERIPHERAL W/O PORT&quot;                                                             
## [2798] &quot;REPOSITION CATHETER&quot;                                                             
## [2799] &quot;US GUID FOR VAS. ACCESS&quot;                                                         
## [2800] &quot;P ART DUP EXT LOW/BILAT COMP PORT&quot;                                               
## [2801] &quot;MRA CAROTID/VERTEBRAL W/O CONTRAST&quot;                                              
## [2802] &quot;R CT UP EXT W/C RIGHT&quot;                                                           
## [2803] &quot;MAMMOGRAPHY CONSULT NON-BIDMC FILMS&quot;                                             
## [2804] &quot;HEB REB PRO FEE ONLY&quot;                                                            
## [2805] &quot;R MR WRIST W/O CONTRAST RIGHT&quot;                                                   
## [2806] &quot;B MR KNEE W/O CONTRAST BILAT&quot;                                                    
## [2807] &quot;AORTOGRAPHY, ABDOMINAL&quot;                                                          
## [2808] &quot;OR FEMUR (AP &amp; LAT) IN O.R. RIGHT&quot;                                               
## [2809] &quot;R BREAST CORE BIOSPY UNDER US RIGHT&quot;                                             
## [2810] &quot;MR ANGIOGRAM NECK, W/O &amp; W/CONTRAST&quot;                                             
## [2811] &quot;PO T-SPINE PORT IN O.R.&quot;                                                         
## [2812] &quot;RP HAND (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                       
## [2813] &quot;L MR KNEE W&amp;W/O CONTRAST LEFT&quot;                                                   
## [2814] &quot;B ANKLE (2 VIEWS) BILAT&quot;                                                         
## [2815] &quot;MR ANGIOGRAM NECK, W/O CONTRAST&quot;                                                 
## [2816] &quot;B HUMERUS (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                          
## [2817] &quot;EXERCISE MIBI MIBI&quot;                                                              
## [2818] &quot;RO HAND (AP, LAT &amp; OBLIQUE) RIGHT IN O.R.&quot;                                       
## [2819] &quot;CT SINUS CORONAL ONLY&quot;                                                           
## [2820] &quot;MR CARDIAC MORPHOLOGY W/CONTRAST&quot;                                                
## [2821] &quot;PR HUMERUS (AP &amp; LAT) PORT RIGHT&quot;                                                
## [2822] &quot;P KUB FOR COLONIC TRANSIT PORT&quot;                                                  
## [2823] &quot;R FOOT 1 VIEW RIGHT&quot;                                                             
## [2824] &quot;MRI PELVIS W/O CONTRAST&quot;                                                         
## [2825] &quot;R MRHAND W/O&amp;W/CONTRAST RIGHT&quot;                                                   
## [2826] &quot;NASO-INTESTINAL TIBE PLACEMENT (W/FLUORO)&quot;                                       
## [2827] &quot;INTRO INTRO EXTREMITY ARTERY&quot;                                                    
## [2828] &quot;O C-SPINE NON-TRAUMA W/FLEX &amp; EXT 4 VIEWS IN O.R.&quot;                               
## [2829] &quot;CENTRAL NON-TUNNELED&quot;                                                            
## [2830] &quot;TV OB US&quot;                                                                        
## [2831] &quot;MR ANGIOGRAM RENAL ARTERIES W/CONTRAST&quot;                                          
## [2832] &quot;O C-SPINE NON-TRAUMA W/OBLS, FLEX &amp;EXT 5 VIEWS IN O.R.&quot;                          
## [2833] &quot;B CLAVICLE BILAT&quot;                                                                
## [2834] &quot;TRANSLUMIN BAL ANGIOPLASTY, PERIPHERAL&quot;                                          
## [2835] &quot;BP UNILAT LOWER EXT VEINS BILAT PORT&quot;                                            
## [2836] &quot;ANGIO EXT BILAT S&amp;I&quot;                                                             
## [2837] &quot;XT RENAL BX W/RENAL MD&quot;                                                          
## [2838] &quot;ALL TYPES/SITES W/O PORT&quot;                                                        
## [2839] &quot;PTA TIBIOPERONEAL &amp; BRANCHES&quot;                                                    
## [2840] &quot;LP WRIST, AP &amp; LAT VIEWS LEFT PORT&quot;                                              
## [2841] &quot;R MR ANKLE W&amp;W/O CONTRAST RIGHT&quot;                                                 
## [2842] &quot;PR SHOULDER 2-3 VIEWS NON TRAUMA PORT RIGHT&quot;                                     
## [2843] &quot;FETAL BPP WITH MEASUREMENTS&quot;                                                     
## [2844] &quot;LP HEEL (AXIAL &amp; LATERAL) LEFT PORT&quot;                                             
## [2845] &quot;PELVIS &amp; SACRO-ILIAC&quot;                                                            
## [2846] &quot;UGI AIR W/O KUB&quot;                                                                 
## [2847] &quot;P NASO-INTESTINAL TUBE PLACEMENT (W/FLUORO) PORT&quot;                                
## [2848] &quot;P CAROTID LMTD/ DPP PORT&quot;                                                        
## [2849] &quot;P US SIMPLE/SING ABSC/CYST DRAIN/INCISION PORT&quot;                                  
## [2850] &quot;OP HIP 1 VIEW IN O.R. PORT&quot;                                                      
## [2851] &quot;CAD SCREENING&quot;                                                                   
## [2852] &quot;OO LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. IN O.R.&quot;                   
## [2853] &quot;ACRI NLST 1 VIEW CHEST&quot;                                                          
## [2854] &quot;PPP ABDOMEN (LAT DECUB ONLY) PORT PORT PORT&quot;                                     
## [2855] &quot;PERCU PLCT IVC FILTER S&amp;I&quot;                                                       
## [2856] &quot;P PAROTID US  PORT&quot;                                                              
## [2857] &quot;MRA PELVIS W&amp;W/O CONTRAST&quot;                                                       
## [2858] &quot;INT/SHTH NOT/GUID EP NON-LASER&quot;                                                  
## [2859] &quot;RP GLENO-HUMERAL SHOULDER (W/ Y VIEW) RIGHT PORT&quot;                                
## [2860] &quot;BAS/UGI W/KUB&quot;                                                                   
## [2861] &quot;OPB FEMUR (AP &amp; LAT) IN O.R. PORT BILAT&quot;                                         
## [2862] &quot;PR ELBOW, AP &amp; LAT VIEWS PORT RIGHT&quot;                                             
## [2863] &quot;BP SHOULDER 1 VIEW BILAT PORT&quot;                                                   
## [2864] &quot;RETROGRADE URETHROCYSTOGRAM&quot;                                                     
## [2865] &quot;R BABYGRAM CHEST DECUB ONLY (71035) RIGHT&quot;                                       
## [2866] &quot;TRANSCATH INTRO INTRAVAS STENT(S)&quot;                                               
## [2867] &quot;C-SPINE NON TRAUMA FLEX &amp; EXT ONLY&quot;                                              
## [2868] &quot;L HAND (AP &amp; LAT) SOFT TISSUE LEFT&quot;                                              
## [2869] &quot;B KNEE 2 VIEW PORTABLE BILAT&quot;                                                    
## [2870] &quot;FINGER(S),2+VIEWS&quot;                                                               
## [2871] &quot;L US MAJOR JOINT ASP./INJ. LEFT&quot;                                                 
## [2872] &quot;MRA LOWER EXT W&amp;W/O CONTRAST&quot;                                                    
## [2873] &quot;LP HUMERUS (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                     
## [2874] &quot;B BILAT LOWER EXT VEINS BILAT&quot;                                                   
## [2875] &quot;R KNEE (AP, LAT &amp; TUNNEL) RIGHT&quot;                                                 
## [2876] &quot;ROP KNEE (2 VIEWS) RIGHT IN O.R. PORT&quot;                                           
## [2877] &quot;O PELVIS &amp; SACRO-ILIAC IN O.R.&quot;                                                  
## [2878] &quot;CT NECK DRAINAGE&quot;                                                                
## [2879] &quot;DEFOGRAM&quot;                                                                        
## [2880] &quot;OFFICE CONSULTATION&quot;                                                             
## [2881] &quot;OPL KNEE (2 VIEWS) IN O.R. PORT LEFT&quot;                                            
## [2882] &quot;BIL DUCT STONE EXT PERC OR T-TUBE&quot;                                               
## [2883] &quot;O IVP NO TOMO IN O.R.&quot;                                                           
## [2884] &quot;B ELBOW (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                            
## [2885] &quot;SINUSES, COMPLETE MIN 3 VIEWS&quot;                                                   
## [2886] &quot;NLSA CT CHEST WITHOUT CONTRAST&quot;                                                  
## [2887] &quot;RP FOOT 1 VIEW RIGHT PORT&quot;                                                       
## [2888] &quot;R KNEE 2 VIEW PORTABLE RIGHT&quot;                                                    
## [2889] &quot;DRAINAGE HEMATOMA/FLUID&quot;                                                         
## [2890] &quot;L GLENO-HUMERAL SHOULDER (W/O Y VIEW) LEFT&quot;                                      
## [2891] &quot;CT LOW WXT W/C&quot;                                                                  
## [2892] &quot;R THY BX BY MCARDLE RIGHT&quot;                                                       
## [2893] &quot;PORIES US NEEDLE LOCALIZATION&quot;                                                   
## [2894] &quot;P AORTA AND BRANCHES PORT&quot;                                                       
## [2895] &quot;B FINGER(S),2+VIEWS BILAT&quot;                                                       
## [2896] &quot;P OB F/U WITH MEASUREMENT&#39; PORT&quot;                                                 
## [2897] &quot;OPL LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. PORT LEFT&quot;                
## [2898] &quot;CAROT/CEREB BI&quot;                                                                  
## [2899] &quot;STENT CER/CAROTID ART W/ EMBOLIC PROTECTION&quot;                                     
## [2900] &quot;NG/OG TUBE PLACEMENT BY MD UNDER FLUORO&quot;                                         
## [2901] &quot;UGI SGL W/O KUB&quot;                                                                 
## [2902] &quot;CT RFA LIVER 1 OR MORE&quot;                                                          
## [2903] &quot;POSSIS MECHANICAL THROMBECTOMY&quot;                                                  
## [2904] &quot;B KNEE( (SINGLE VIEW) BILAT&quot;                                                     
## [2905] &quot;PL UNILAT UP EXT VEINS US PORT LEFT&quot;                                             
## [2906] &quot;O C-SPINE, TRAUMA IN O.R.&quot;                                                       
## [2907] &quot;R CT LOW EXT W&amp;W/O C RIGHT&quot;                                                      
## [2908] &quot;O THOR SP WITH OBL IN O.R.&quot;                                                      
## [2909] &quot;RO SHOULDER 1 VIEW RIGHT IN O.R.&quot;                                                
## [2910] &quot;PO CHEST (SINGLE VIEW) PORT IN O.R.&quot;                                             
## [2911] &quot;P BABYGRAM CHEST DECUB ONLY (71035) PORT&quot;                                        
## [2912] &quot;PR KNEE (2 VIEWS) PORT RIGHT&quot;                                                    
## [2913] &quot;B HUMERUS (AP &amp; LAT) BILAT&quot;                                                      
## [2914] &quot;PL FEMORAL VASCULAR US PORT LEFT&quot;                                                
## [2915] &quot;C-SPINE NON TRAUMA W/OBLS 4 VIEWS&quot;                                               
## [2916] &quot;R 75676 ANGIO CAROTID, CERVICAL UNILAT S&amp;I RIGHT&quot;                                
## [2917] &quot;LO KNEE( (SINGLE VIEW) LEFT IN O.R.&quot;                                             
## [2918] &quot;NON-IONIC LESS THAN 100CC&quot;                                                       
## [2919] &quot;CONSULT READING BILATERAL MAMMOGRAM ONLY&quot;                                        
## [2920] &quot;RO KNEE( (SINGLE VIEW) RIGHT IN O.R.&quot;                                            
## [2921] &quot;L CT UP EXT W/C LEFT&quot;                                                            
## [2922] &quot;CT SUBDIA &amp; SUBPHRENIC DRAINAGE&quot;                                                 
## [2923] &quot;OR HIP UNILAT MIN 2 VIEWS IN O.R. RIGHT&quot;                                         
## [2924] &quot;R MAMMO CORE BIOPSY RIGHT&quot;                                                       
## [2925] &quot;MMS SUGICAL PLANNING SERVICE&quot;                                                    
## [2926] &quot;L MR THIGH W&amp;W/O CONTRAST LEFT&quot;                                                  
## [2927] &quot;MRA PELVIS W/O CONTRAST&quot;                                                         
## [2928] &quot;P PELVIS (AP &amp; LAT) PORT&quot;                                                        
## [2929] &quot;PROSTATE BX-BERG&quot;                                                                
## [2930] &quot;O PELVIS PORTABLE IN O.R.&quot;                                                       
## [2931] &quot;SINUS/JUGULAR VENOGRAPHY&quot;                                                        
## [2932] &quot;R BREAST WIRE LOC US RIGHT&quot;                                                      
## [2933] &quot;MRA KIDNEY W/CONTRAST&quot;                                                           
## [2934] &quot;SNARE-RETRIEVAL DEVICE INSERT&quot;                                                   
## [2935] &quot;T PLACT STENT EXTRACRAINAL/VERTIBRAL ART&quot;                                        
## [2936] &quot;L STAND FEET (AP&amp;LAT) NON-STAND OBL 3 VIEWS LEFT&quot;                                
## [2937] &quot;MRI NASO PHARYNX/SKULL BASE&quot;                                                     
## [2938] &quot;RO WRIST, AP &amp; LAT VIEWS RIGHT IN O.R.&quot;                                          
## [2939] &quot;CATH/STENT FOR INT/EXT BILIARY DRAINAGE&quot;                                         
## [2940] &quot;O 3 VIEW THORACIC SPINE IN O.R.&quot;                                                 
## [2941] &quot;PERC VERTEBROPSTY L/T EA ADDL&quot;                                                   
## [2942] &quot;RO FOOT 2 VIEWS RIGHT IN O.R.&quot;                                                   
## [2943] &quot;SINUSES 1-2 VIEWS&quot;                                                               
## [2944] &quot;CT ABSESSOGRAM&quot;                                                                  
## [2945] &quot;P US INTR-OP 90 MINS PORT&quot;                                                       
## [2946] &quot;CAROTID/CERVICAL UNILAT&quot;                                                         
## [2947] &quot;L KNEE( (SINGLE VIEW) LEFT&quot;                                                      
## [2948] &quot;A/C JOINTS BILAT&quot;                                                                
## [2949] &quot;O PELVIS WITH JUDET VIEWS IN O.R.&quot;                                               
## [2950] &quot;CT ABD&amp;PELVIS W/O C COLON TECHNIQUE&quot;                                             
## [2951] &quot;O NECK SOFT TISSUES IN O.R.&quot;                                                     
## [2952] &quot;INSERT ABD PORT&quot;                                                                 
## [2953] &quot;CT FISTULOGRAM S&amp;I&quot;                                                              
## [2954] &quot;BP ELBOW (AP &amp; LAT) SOFT TISSUE BILAT PORT&quot;                                      
## [2955] &quot;R CTA LOWER EXT W/&amp;W/O C &amp; RECONS RIGHT&quot;                                         
## [2956] &quot;MR TMJ&quot;                                                                          
## [2957] &quot;R MRA UPPER EXT W/O CONTRAST RIGHT&quot;                                              
## [2958] &quot;PL FOREARM (AP &amp; LAT) PORT LEFT&quot;                                                 
## [2959] &quot;P EMERGENCY PELVIC U.S. PORT&quot;                                                    
## [2960] &quot;B ANKLE/FOOT (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                       
## [2961] &quot;OP L-SPINE (AP &amp; LAT) IN O.R. PORT&quot;                                              
## [2962] &quot;SHUNT STUDY&quot;                                                                     
## [2963] &quot;POB SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA PORT IN O.R. BILAT&quot;                 
## [2964] &quot;SPINAL PUNCTURE/DRAINAGE&quot;                                                        
## [2965] &quot;CHEST PORT. LINE PLACEMENT&quot;                                                      
## [2966] &quot;PR BABYGRAM CHEST DECUB ONLY (71035) PORT RIGHT&quot;                                 
## [2967] &quot;J TUBE REPOSITION&quot;                                                               
## [2968] &quot;MRA CAROTID/VERTEBRAL W&amp;W/O CONTRAST&quot;                                            
## [2969] &quot;FIBRIN STRIPPING THRU LUMEN&quot;                                                     
## [2970] &quot;P SACRUM/COCCYX PORT&quot;                                                            
## [2971] &quot;LO SHOULDER 2-3 VIEWS NON TRAUMA LEFT IN O.R.&quot;                                   
## [2972] &quot;RP ELBOW, AP &amp; LAT VIEWS RIGHT PORT&quot;                                             
## [2973] &quot;CT SINUS AXIAL W/VTI&quot;                                                            
## [2974] &quot;P CHEST PORT. LINE PLACEMENT PORT&quot;                                               
## [2975] &quot;R KNEE (TUNNEL ONLY) RIGHT&quot;                                                      
## [2976] &quot;R MR HAND W/O&amp;W/CONTRAST RIGHT&quot;                                                  
## [2977] &quot;PO C-SPINE SGL 1 VIEW PORT IN O.R.&quot;                                              
## [2978] &quot;PR ART DUP EXT UP UNI LMTD PORT RIGHT&quot;                                           
## [2979] &quot;R MRA UPPER EXTREMITY RIGHT&quot;                                                     
## [2980] &quot;THORACENTESIS W/TUBE INSERTION&quot;                                                  
## [2981] &quot;OPR TIB/FIB (AP &amp; LAT) IN O.R. PORT RIGHT&quot;                                       
## [2982] &quot;CHEST SGL VIEW/LINE PLACEMENT&quot;                                                   
## [2983] &quot;LP ANKLE/FOOT (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                  
## [2984] &quot;L MR ARM W/O CONTRAST LEFT&quot;                                                      
## [2985] &quot;FISUTLOGRAM INJ THRU SINUS TRACT&quot;                                                
## [2986] &quot;CT GUID/MONIT VISCERAL TISSUE ABLATION&quot;                                          
## [2987] &quot;L CTA UPPER EXT W&amp;W/O C &amp; RECONS LEFT&quot;                                           
## [2988] &quot;OPR ELBOW, AP &amp; LAT VIEWS IN O.R. PORT RIGHT&quot;                                    
## [2989] &quot;REMOVE ABD PORT&quot;                                                                 
## [2990] &quot;L MRA UPPER EXTREMITY LEFT&quot;                                                      
## [2991] &quot;BO TIB/FIB (AP &amp; LAT) BILAT IN O.R.&quot;                                             
## [2992] &quot;OL ANKLE (AP, MORTISE &amp; LAT) IN O.R. LEFT&quot;                                       
## [2993] &quot;OR FEMUR (AP &amp; LAT) SOFT TISSUE IN O.R. RIGHT&quot;                                   
## [2994] &quot;FULL FETAL LOW RISK&quot;                                                             
## [2995] &quot;O L-SPINE (AP,LAT,FLEX,EXT) IN O.R.&quot;                                             
## [2996] &quot;CHEST PORTABLE LINE PLACMENT&quot;                                                    
## [2997] &quot;T ENDO, STENT GRAFT THORACIC ANYSM W/O SUBCLVN&quot;                                  
## [2998] &quot;P BX-NEEDLE KIDNEY BY NEPHROLOGIST PORT&quot;                                         
## [2999] &quot;LP ELBOW (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                       
## [3000] &quot;POST MORTEM RADIOGRAPHS&quot;                                                         
## [3001] &quot;OR WRIST(3 + VIEWS) IN O.R. RIGHT&quot;                                               
## [3002] &quot;OOR ANKLE (AP, LAT &amp; OBLIQUE) IN O.R. IN O.R. RIGHT&quot;                             
## [3003] &quot;B STAND FEET (AP&amp;LAT) NON-STAND OBL 3 VIEWS BILAT&quot;                               
## [3004] &quot;LO KNEE (2 VIEWS) LEFT IN O.R.&quot;                                                  
## [3005] &quot;L MR ELBOW W/O CONTRAST LEFT&quot;                                                    
## [3006] &quot;PERC TRANHEP PORTOGRAPHY WITH PRESSURES&quot;                                         
## [3007] &quot;OR ANKLE (2 VIEWS) IN O.R. RIGHT&quot;                                                
## [3008] &quot;CXR WITH NIPPLE MARKERS 2 VIEWS&quot;                                                 
## [3009] &quot;PL KNEE (2 VIEWS) PORT LEFT&quot;                                                     
## [3010] &quot;PUNC ASP ABS HEM BUL CYST&quot;                                                       
## [3011] &quot;STENT GRAPH FOR ILIAC ANURYSM&quot;                                                   
## [3012] &quot;OO HIP 1 VIEW IN O.R. IN O.R.&quot;                                                   
## [3013] &quot;OPROP ANKLE (AP, LAT &amp; OBLIQUE) IN O.R. PORT RIGHT IN O.R. PORT&quot;                 
## [3014] &quot;MAMMO NEEDLE LOCALIZATION LEFT&quot;                                                  
## [3015] &quot;CYBER-INS MARKER SPINE&quot;                                                          
## [3016] &quot;EXTREM BILAT VENOGRAPHY&quot;                                                         
## [3017] &quot;ABDOMINAL AORTOGRAM&quot;                                                             
## [3018] &quot;PLCT EXT PROTHESIS FOR ENDOVAS REPAIR&quot;                                           
## [3019] &quot;L CT LOW EXT W&amp;W/O C LEFT&quot;                                                       
## [3020] &quot;T ENDO STENT GRAFT THORAC ANEURYSM W/SUB&quot;                                        
## [3021] &quot;BILATERAL&quot;                                                                       
## [3022] &quot;PL ANKLE 1 VIEW PORT LEFT&quot;                                                       
## [3023] &quot;P CHEST SGL VIEW/LINE PLACEMENT PORT&quot;                                            
## [3024] &quot;B ELBOW, AP &amp; LAT VIEWS BILAT&quot;                                                   
## [3025] &quot;MRI SOFT TISUUE NECK, W/O CONTRAST&quot;                                              
## [3026] &quot;O L-SPINE (WITH FLEX, EXT &amp; OBL) IN O.R.&quot;                                        
## [3027] &quot;CT LOW EXT W/O C&quot;                                                                
## [3028] &quot;INTRO CATH OR STENT TO URETHER&quot;                                                  
## [3029] &quot;CT ABSCESS CATH CHANGE&quot;                                                          
## [3030] &quot;L INJ/ASO MAJOR JT W/FLUORO LEFT&quot;                                                
## [3031] &quot;LO HUMERUS (AP &amp; LAT) LEFT IN O.R.&quot;                                              
## [3032] &quot;OL ANKLE (2 VIEWS) IN O.R. LEFT&quot;                                                 
## [3033] &quot;ARTHROGRAM,SHOULDER&quot;                                                             
## [3034] &quot;L MR SHOULDER W/ARTHROGRAM LEFT&quot;                                                 
## [3035] &quot;LP TOE(S), 2+ VIEW LEFT PORT&quot;                                                    
## [3036] &quot;OL WRIST(3 + VIEWS) IN O.R. LEFT&quot;                                                
## [3037] &quot;CT MUSCLE (SOFT TISSUE) BX&quot;                                                      
## [3038] &quot;ARCHER MAMMO NEEDLE LOCALIZATION&quot;                                                
## [3039] &quot;R STAND FEET (AP&amp;LAT) NON-STAND OBL 3 VIEWS RIGHT&quot;                               
## [3040] &quot;NUCHAL TRANSLUENCY US&quot;                                                           
## [3041] &quot;ABDOMEN &amp; PELVIS US&quot;                                                             
## [3042] &quot;OP CHEST FLUORO WITHOUT RADIOLOGIST IN O.R. PORT&quot;                                
## [3043] &quot;CTA LOWER EXT W/&amp;W/O C &amp; RECONS&quot;                                                 
## [3044] &quot;MAMMO NEEDLE LOCALIZATION RIGHT&quot;                                                 
## [3045] &quot;PR FEMORAL VASCULAR US PORT RIGHT&quot;                                               
## [3046] &quot;CT LOW EXT W&amp;W/O C&quot;                                                              
## [3047] &quot;P BLADDER VOLUMETRIC US PORT&quot;                                                    
## [3048] &quot;BP WRIST (AP &amp; LAT) SOFT TISSUE BILAT PORT&quot;                                      
## [3049] &quot;LOP FOREARM (AP &amp; LAT) LEFT IN O.R. PORT&quot;                                        
## [3050] &quot;RETROGRADE UROGRAPHY (FILMS ONLY) IN CYSTO&quot;                                      
## [3051] &quot;LP ANKLE (AP, LAT &amp; OBLIQUE) LEFT PORT&quot;                                          
## [3052] &quot;B CTA LOWER EXT W/&amp;W/O C &amp; RECONS BILAT&quot;                                         
## [3053] &quot;BOTH KNEES STANDING AP ONLY&quot;                                                     
## [3054] &quot;SPINAL SEL ANGIOGRAM&quot;                                                            
## [3055] &quot;CVL INJ/EVAL INCLUDES FLUORO/IMAGES/REPORT&quot;                                      
## [3056] &quot;URIN CATH CHECK&quot;                                                                 
## [3057] &quot;LO KNEE 2 VIEW PORTABLE LEFT IN O.R.&quot;                                            
## [3058] &quot;OP PELVIS (AP, INLET &amp; OUTLET) IN O.R. PORT&quot;                                     
## [3059] &quot;P SKULL AP&amp;LAT/C-SP/CXR/ABD SLG VIEWS MR SCREENING PORT&quot;                         
## [3060] &quot;R KNEE( (SINGLE VIEW) RIGHT&quot;                                                     
## [3061] &quot;BX PROST BY UROLOGIST&quot;                                                           
## [3062] &quot;P US INTRA-OP 30 MINS PORT&quot;                                                      
## [3063] &quot;RP WRIST (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                      
## [3064] &quot;CENTRAL TUNNELED W/PORT&quot;                                                         
## [3065] &quot;OR KNEE (2 VIEWS) IN O.R. RIGHT&quot;                                                 
## [3066] &quot;CT STEREOTAXIS CHEST W/ CONTRAST&quot;                                                
## [3067] &quot;PANC PSEUDOCYST DRNGE&quot;                                                           
## [3068] &quot;O CHEST (LAT DECUB ONLY) IN O.R.&quot;                                                
## [3069] &quot;OPR HEEL (AXIAL &amp; LATERAL) IN O.R. PORT RIGHT&quot;                                   
## [3070] &quot;CYBER US GUID-NEEDL PLMT MAR&quot;                                                    
## [3071] &quot;GUIDANCE FOR NEEDLE PLACEMENT&quot;                                                   
## [3072] &quot;ROP ANKLE (AP, LAT &amp; OBLIQUE) RIGHT IN O.R. PORT&quot;                                
## [3073] &quot;O LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R.&quot;                            
## [3074] &quot;OR ANKLE (AP, LAT &amp; OBLIQUE) IN O.R. RIGHT&quot;                                      
## [3075] &quot;CT STEREOTAXIS NEURO W/ CONTRAST&quot;                                                
## [3076] &quot;RP ART DUP EXT UP UNI LMTD RIGHT PORT&quot;                                           
## [3077] &quot;TUNNELED CENTRAL OR PICC W/PORT&quot;                                                 
## [3078] &quot;BP ELBOW, AP &amp; LAT VIEWS BILAT PORT&quot;                                             
## [3079] &quot;CYBER-INS MARKER PANCREAS&quot;                                                       
## [3080] &quot;FINE NEED ASP W/GUID&quot;                                                            
## [3081] &quot;OB WRIST(3 + VIEWS) IN O.R. BILAT&quot;                                               
## [3082] &quot;ERCP BILIARY ONLY PORTABLY BY TECH&quot;                                              
## [3083] &quot;R MR ELBOW W&amp;W/O CONTRATS RIGHT&quot;                                                 
## [3084] &quot;CT BILIARY DRAIN EXTERNAL&quot;                                                       
## [3085] &quot;CT STEREOTAXIS ABDOMINAL W/CONTRAST&quot;                                             
## [3086] &quot;ORO FOREARM (AP &amp; LAT) IN O.R. RIGHT IN O.R.&quot;                                    
## [3087] &quot;LYMPHANGIOGRAPHY UNILAT EXT&quot;                                                     
## [3088] &quot;OR FOOT AP,LAT &amp; OBL IN O.R. RIGHT&quot;                                              
## [3089] &quot;ERCP BILIARY ONLY BY GI UNIT&quot;                                                    
## [3090] &quot;RENAL/URET STONE REMOVAL&quot;                                                        
## [3091] &quot;O FACIAL BONE (WATERS &amp; LAT) IN O.R.&quot;                                            
## [3092] &quot;BALLON ANGIOPLASTY, INTRACRANIAL, PERCUTANEOUS&quot;                                  
## [3093] &quot;P MANDIBLE (PANOREX ONLY) PORT&quot;                                                  
## [3094] &quot;UNCLOG G/GJ TUBE&quot;                                                                
## [3095] &quot;B 3&#39; FILM ORTHO AP LOWER EXT BILAT&quot;                                              
## [3096] &quot;ENDO STENT GRAFT THORACIC ANEURYSM W/SUB&quot;                                        
## [3097] &quot;CT TRACHEA W/O C W/3D REND&quot;                                                      
## [3098] &quot;MR 3D RENDERING W/POST PROCESSING ON INDEPENDENT WS&quot;                             
## [3099] &quot;EXCHANGE DRAIN CATH&quot;                                                             
## [3100] &quot;MRA CAROTID/VERTEBRAL W/CONTRAST&quot;                                                
## [3101] &quot;INTRODUCTION LONG GI TUBE&quot;                                                       
## [3102] &quot;PR HAND (AP, LAT &amp; OBLIQUE) PORT RIGHT&quot;                                          
## [3103] &quot;OR FOOT 2 VIEWS IN O.R. RIGHT&quot;                                                   
## [3104] &quot;R MR SHOULDER W/ARTHROGRAM RIGHT&quot;                                                
## [3105] &quot;R KNEE, STANDING (AP &amp; LAT IN 30 DEG FLEX) RIGHT&quot;                                
## [3106] &quot;CTA PANCREAS W/ CTCP&quot;                                                            
## [3107] &quot;OPOP HIP 1 VIEW IN O.R. PORT IN O.R. PORT&quot;                                       
## [3108] &quot;ERCP BILIARY&amp;PANCREAS BY GI UNIT&quot;                                                
## [3109] &quot;RP BABYGRAM CHEST DECUB ONLY (71035) RIGHT PORT&quot;                                 
## [3110] &quot;C-SPINE OBLS ONLY 2 VIEWS&quot;                                                       
## [3111] &quot;ANGIOGRAPHY ARTERIO SHUNT&quot;                                                       
## [3112] &quot;ERCP PANCREAS ONLY BY GI UNIT&quot;                                                   
## [3113] &quot;OL HEEL (AXIAL &amp; LATERAL) IN O.R. LEFT&quot;                                          
## [3114] &quot;B CT LOW EXT W&amp;W/O C BILAT&quot;                                                      
## [3115] &quot;RO SHOULDER 2-3 VIEWS NON TRAUMA RIGHT IN O.R.&quot;                                  
## [3116] &quot;TRANS CATH INFUSSION&quot;                                                            
## [3117] &quot;BP WRIST, AP &amp; LAT VIEWS BILAT PORT&quot;                                             
## [3118] &quot;HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW)&quot;                                           
## [3119] &quot;ED STROKE HEAD CT W/O CONTRAST&quot;                                                  
## [3120] &quot;P UNILAT BREAST US PORT&quot;                                                         
## [3121] &quot;RP 3&#39; FILM ORTHO AP LOWER EXT RIGHT PORT&quot;                                        
## [3122] &quot;L ARTHROGRAM,SHOULDER LEFT&quot;                                                      
## [3123] &quot;CISTERNOGRAM&quot;                                                                    
## [3124] &quot;MRA NECK W/CONTRAST&quot;                                                             
## [3125] &quot;BP FOREARM (AP &amp; LAT) BILAT PORT&quot;                                                
## [3126] &quot;OR HUMERUS (AP &amp; LAT) IN O.R. RIGHT&quot;                                             
## [3127] &quot;P PELVIS LIMITED PORT&quot;                                                           
## [3128] &quot;P HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) PORT&quot;                                    
## [3129] &quot;MOD SEDATION, EACH ADDL 15 MIN.&quot;                                                 
## [3130] &quot;C-SPINE (AP, FLEX &amp; EXT) 3 VIEWS&quot;                                                
## [3131] &quot;US INTRA-OP NO RAD 60 MINS&quot;                                                      
## [3132] &quot;O UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R.&quot;                            
## [3133] &quot;CHEST (BOTH OBLIQUES ONLY)&quot;                                                      
## [3134] &quot;P OB F/U WITH MEASUREMENT PORT&quot;                                                  
## [3135] &quot;RP HAND, AP &amp; LAT. VIEWS RIGHT PORT&quot;                                             
## [3136] &quot;BO KNEE (2 VIEWS) BILAT IN O.R.&quot;                                                 
## [3137] &quot;COLON (DOUBLE CONTRAST BARIUM ENEMA)&quot;                                            
## [3138] &quot;LO FINGER(S),2+VIEWS LEFT IN O.R.&quot;                                               
## [3139] &quot;P SPINAL FLUORO WITHOUT RADIOLOGIST PORT&quot;                                        
## [3140] &quot;FDG BRAIN&quot;                                                                       
## [3141] &quot;PERC MECHANICAL THROMBECTOMY INCL LYTIC INJ, VENOUS&quot;                             
## [3142] &quot;ENDO STENT GRAFT THORACIC ANEURYSM W/O SUBCLVN&quot;                                  
## [3143] &quot;PL TIB/FIB (AP &amp; LAT) PORT LEFT&quot;                                                 
## [3144] &quot;J TUBE CHANGE&quot;                                                                   
## [3145] &quot;PENILE ULTRASOUND&quot;                                                               
## [3146] &quot;OL SHOULDER 2-3 VIEWS NON TRAUMA IN O.R. LEFT&quot;                                   
## [3147] &quot;CYBER-FLUOR GUID NEEDLE PLMT&quot;                                                    
## [3148] &quot;RO KNEE (AP, LAT &amp; OBLIQUE) RIGHT IN O.R.&quot;                                       
## [3149] &quot;L MAMMARY DUCTOGRAM,SINGLE DUCT LEFT&quot;                                            
## [3150] &quot;OL FOOT AP,LAT &amp; OBL IN O.R. LEFT&quot;                                               
## [3151] &quot;PL ART DUP EXT UP UNI LMTD PORT LEFT&quot;                                            
## [3152] &quot;REM/REPLACE EXT TRANSNEPHRIC URETERAL STENT&quot;                                     
## [3153] &quot;B ANKLE AP &amp; LAT STANDING BILAT&quot;                                                 
## [3154] &quot;CT STEREOTAXIS NEURO W/O C&quot;                                                      
## [3155] &quot;MRA NECK W/O CONTRAST&quot;                                                           
## [3156] &quot;B CT UP EXT W/C BILAT&quot;                                                           
## [3157] &quot;MR L SPINE W/O CONTRAST&quot;                                                         
## [3158] &quot;FITULOGRAM/SINOGRAM W/DR.J. FISCHER&quot;                                             
## [3159] &quot;CT CARDIAC STRUCTURE/MORPH W/CTA W/QUANTITATIVE CALCIUM&quot;                         
## [3160] &quot;BO WRIST, AP &amp; LAT VIEWS BILAT IN O.R.&quot;                                          
## [3161] &quot;R INJ/ASO MAJOR JT W/FLUORO RIGHT&quot;                                               
## [3162] &quot;KAUFMAN MAMMO NEEDLE LOCALIZATION&quot;                                               
## [3163] &quot;L-SPINE FLEX AND EXT (2 VIEWS)&quot;                                                  
## [3164] &quot;CT TRACHEA W/C &amp; W/3D REND&quot;                                                      
## [3165] &quot;EXT CAROTID BILAT&quot;                                                               
## [3166] &quot;MR THORACIC SPINE W/O CONTRAST&quot;                                                  
## [3167] &quot;R MR ANKLE W/O CONTRAST RIGHT&quot;                                                   
## [3168] &quot;OPL ANKLE (AP, LAT &amp; OBLIQUE) IN O.R. PORT LEFT&quot;                                 
## [3169] &quot;P C-SPINE TRAUMA W/FLEX &amp; EXT 5 VIEWS PORT&quot;                                      
## [3170] &quot;LO KNEE (AP, LAT &amp; OBLIQUE) LEFT IN O.R.&quot;                                        
## [3171] &quot;LOP FEMUR (AP &amp; LAT) LEFT IN O.R. PORT&quot;                                          
## [3172] &quot;MRA LIVER W&amp;W/O CONTRAST&quot;                                                        
## [3173] &quot;MRI CHEST/MEDIASTINUM W/CONTRAST&quot;                                                
## [3174] &quot;OR LOWER EXTREMITY FLUORO IN O.R. RIGHT&quot;                                         
## [3175] &quot;INTRO CATH AORTA&quot;                                                                
## [3176] &quot;INJ EXTREMITY VENOGRAM&quot;                                                          
## [3177] &quot;REPEAT PERC MECH THROMBECTOMY/LYTIC INJ, VENOUS&quot;                                 
## [3178] &quot;B KNEE (MIN 4 VIEWS) BILAT&quot;                                                      
## [3179] &quot;P FEMORAL VASCULAR US PORT&quot;                                                      
## [3180] &quot;MRI INCOMPLETE STUDY&quot;                                                            
## [3181] &quot;ORBITS PRE-MRI (WATERS LOOK UP&amp;DOWN)&quot;                                            
## [3182] &quot;OR KNEE (AP, LAT &amp; OBLIQUE) IN O.R. RIGHT&quot;                                       
## [3183] &quot;RP HEEL (AXIAL &amp; LATERAL) RIGHT PORT&quot;                                            
## [3184] &quot;L CTA LOWER EXT W/&amp;W/O C &amp; RECONS LEFT&quot;                                          
## [3185] &quot;ASP OF RENAL CYST (S&amp;I)&quot;                                                         
## [3186] &quot;L BX-NEEDLE KIDNEY BY RADIOLOGIST LEFT&quot;                                          
## [3187] &quot;MRA KIDNEY W/O CONTRAST&quot;                                                         
## [3188] &quot;OLO LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. LEFT IN O.R.&quot;             
## [3189] &quot;PUNC ASP ABSCESS/HEMATOM/BULA/CYST&quot;                                              
## [3190] &quot;MRA ABDOMEN W/O CONTRAST&quot;                                                        
## [3191] &quot;TUNNELED W/ PORT&quot;                                                                
## [3192] &quot;US PERC NEEDLE BX MUSCLE&quot;                                                        
## [3193] &quot;LIVER BLOOD POOL STUDY&quot;                                                          
## [3194] &quot;CT TRACHEA W&amp;W/O C &amp; 3D REND&quot;                                                    
## [3195] &quot;MR CERVICAL SPINE W/O CONTRAST&quot;                                                  
## [3196] &quot;MRA THORACIC SPINE&quot;                                                              
## [3197] &quot;MOD SEDATION, FIRST 30 MIN.&quot;                                                     
## [3198] &quot;MYELOGRAM 2 OR MORE REGIONS, S&amp;I&quot;                                                
## [3199] &quot;ERCP S/P DUODENAL/ENTERAL STENT PLACEMENT&quot;                                       
## [3200] &quot;B FOOT (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                             
## [3201] &quot;MRA LUMBAR SPINE&quot;                                                                
## [3202] &quot;PERCU BALLON DILATION URETER&quot;                                                    
## [3203] &quot;PR WRIST, AP &amp; LAT VIEWS PORT RIGHT&quot;                                             
## [3204] &quot;OOR FEMUR (AP &amp; LAT) IN O.R. IN O.R. RIGHT&quot;                                      
## [3205] &quot;OPR ANKLE 1 VIEW IN O.R. PORT RIGHT&quot;                                             
## [3206] &quot;P PELVIS U.S., TRANSVAGINAL PORT&quot;                                                
## [3207] &quot;PB FOOT 2 VIEWS PORT BILAT&quot;                                                      
## [3208] &quot;VIEW THORACIC SPINE&quot;                                                             
## [3209] &quot;ORO FEMUR (AP &amp; LAT) IN O.R. RIGHT IN O.R.&quot;                                      
## [3210] &quot;P EARLY OB US &lt;14WEEKS PORT&quot;                                                     
## [3211] &quot;RO HEEL (AXIAL &amp; LATERAL) RIGHT IN O.R.&quot;                                         
## [3212] &quot;PL US EXTREMITY NONVASCULAR PORT LEFT&quot;                                           
## [3213] &quot;LUMBOSACRAL MYELOGRAM, S&amp;I&quot;                                                      
## [3214] &quot;BABYGRAM UPPER EXT,MIN 2 VIEWS&quot;                                                  
## [3215] &quot;BP TIB/FIB (AP &amp; LAT) SOFT TISSUE BILAT PORT&quot;                                    
## [3216] &quot;RP TIB/FIB (AP &amp; LAT) SOFT TISSUE RIGHT PORT&quot;                                    
## [3217] &quot;RP VENOUS DUP EXT UNI (MAP/DVT) RIGHT PORT&quot;                                      
## [3218] &quot;PLP TIB/FIB (AP &amp; LAT) PORT LEFT PORT&quot;                                           
## [3219] &quot;P ADULT HEAD US PORT&quot;                                                            
## [3220] &quot;RO ANKLE (AP, LAT &amp; OBLIQUE) RIGHT IN O.R.&quot;                                      
## [3221] &quot;P US HEPATOTOMY DRAIN ABSCESS/CYST PORT&quot;                                         
## [3222] &quot;R MR KNEE W&amp;W/O CONTRAST RIGHT&quot;                                                  
## [3223] &quot;OL ANKLE (AP, LAT &amp; OBLIQUE) IN O.R. LEFT&quot;                                       
## [3224] &quot;RO PATELLA (AP, LAT &amp; SUNRISE) RIGHT IN O.R.&quot;                                    
## [3225] &quot;OO SACRUM IN O.R. IN O.R.&quot;                                                       
## [3226] &quot;BO ANKLE (AP, MORTISE &amp; LAT) BILAT IN O.R.&quot;                                      
## [3227] &quot;P THYROID U.S. PORT&quot;                                                             
## [3228] &quot;P SINUSES, COMPLETE MIN 3 VIEWS PORT&quot;                                            
## [3229] &quot;SUPRAPUBIC CATH INSERTION&quot;                                                       
## [3230] &quot;THORACOSTOMY TUBE INSERTION&quot;                                                     
## [3231] &quot;OR KNEE (3 VIEWS) IN O.R. RIGHT&quot;                                                 
## [3232] &quot;CTA CHEST W&amp;W/O C&amp;RECONS, NON-CORONARY&quot;                                          
## [3233] &quot;FLUORO GUID PLCT/REPLCT/REMOVE CENTRAL LINE&quot;                                     
## [3234] &quot;EXERCISE MIBI 2-DAY&quot;                                                             
## [3235] &quot;NEONATALDOPPLER INTRACRANIAL ART LIMITED&quot;                                        
## [3236] &quot;FNA, BREAST&quot;                                                                     
## [3237] &quot;P ORBITS PRE-MRI (WATERS LOOK UP&amp;DOWN) PORT&quot;                                     
## [3238] &quot;P BABYGRAM THORACIC AP/LAT PORT&quot;                                                 
## [3239] &quot;HEAT DAMAGED RBC&quot;                                                                
## [3240] &quot;ADULT HEAD US&quot;                                                                   
## [3241] &quot;O ENTIRE SPINE (AP &amp; LAT ONLY) IN O.R.&quot;                                          
## [3242] &quot;CT CHEST W/CONTRAST W/ONC TABLE&quot;                                                 
## [3243] &quot;TX SUPERFICIAL WND DEHISENCE&quot;                                                    
## [3244] &quot;O SACRUM IN O.R.&quot;                                                                
## [3245] &quot;CT SINUS W/ &amp; W/O CONTRAST&quot;                                                      
## [3246] &quot;P BABYGRAM SKULL AP/LAT PORT&quot;                                                    
## [3247] &quot;PL WRIST(3 + VIEWS) PORT LEFT&quot;                                                   
## [3248] &quot;STENT PLACEMENT POST-ESOPHAGEAL DILATATION&quot;                                      
## [3249] &quot;LP FOOT 2 VIEWS LEFT PORT&quot;                                                       
## [3250] &quot;OL WRIST, AP &amp; LAT VIEWS IN O.R. LEFT&quot;                                           
## [3251] &quot;ROO PATELLA (AP, LAT &amp; SUNRISE) RIGHT IN O.R. IN O.R.&quot;                           
## [3252] &quot;LP GLENO-HUMERAL SHOULDER (W/O Y VIEW) LEFT PORT&quot;                                
## [3253] &quot;UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST&quot;                                      
## [3254] &quot;ELBOW, AP &amp; LAT VIEWS&quot;                                                           
## [3255] &quot;ZEVALIN&quot;                                                                         
## [3256] &quot;RO FINGER(S),2+VIEWS RIGHT IN O.R.&quot;                                              
## [3257] &quot;BX LIVER, PERCUTANEOUS&quot;                                                          
## [3258] &quot;BABYGRAM LOWER EXT,MIN 2 VIEWS&quot;                                                  
## [3259] &quot;OPL WRIST(3 + VIEWS) IN O.R. PORT LEFT&quot;                                          
## [3260] &quot;L ANKLE AP &amp; LAT STANDING LEFT&quot;                                                  
## [3261] &quot;P SMALL BOWEL ONLY (GASTROGRAF) PORT&quot;                                            
## [3262] &quot;LO ANKLE (2 VIEWS) LEFT IN O.R.&quot;                                                 
## [3263] &quot;SML BOWEL VIA ENTROCLYSIS TUBE&quot;                                                  
## [3264] &quot;THALLIUM SCAN FOR TUMOR: BRAIN&quot;                                                  
## [3265] &quot;B SCAPULA BILAT&quot;                                                                 
## [3266] &quot;ERCP BILIARY&amp;PANCREAS PORTABLY BY TECH&quot;                                          
## [3267] &quot;RPR ALL TYPES/SITES W/O PORT&quot;                                                    
## [3268] &quot;EXCH PERPHERAL W/O PORT&quot;                                                         
## [3269] &quot;EXCH CENTRAL TUNNELED W/O PORT&quot;                                                  
## [3270] &quot;R ANKLE AP &amp; LAT STANDING RIGHT&quot;                                                 
## [3271] &quot;P OB F/U W/O MEASUREMENTS PORT&quot;                                                  
## [3272] &quot;MRCP W/SECRETIN (ABD W&amp;W/O C)&quot;                                                   
## [3273] &quot;BP FOOT 2 VIEWS BILAT PORT&quot;                                                      
## [3274] &quot;PERSANTINE MIBI 2-DAY&quot;                                                           
## [3275] &quot;FISTUOGRAM/SINOGRAM W/DR. FISCHER&quot;                                               
## [3276] &quot;FLUORO GUID FOR SPINE DIAG/THERAPEUTIC INJ&quot;                                      
## [3277] &quot;O PELVIS W/JUDET VIEWS (3V) IN O.R.&quot;                                             
## [3278] &quot;CT ABDOMEN W &amp; W/O CONTRAST W/ONC TABLES&quot;                                        
## [3279] &quot;P ART DUP EXT UP BILAT COMP PORT&quot;                                                
## [3280] &quot;B FEMUR (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                            
## [3281] &quot;EXCHG INF CATH&quot;                                                                  
## [3282] &quot;L-S SPINE (STANDING AP,FLEX &amp; EXT) 3 VIEWS&quot;                                      
## [3283] &quot;REMOVE TUNNELED CENTRAL W/O PORT&quot;                                                
## [3284] &quot;L LOWER EXT INFANT 2+ VIEWS LEFT&quot;                                                
## [3285] &quot;MR BRACHIAL PLEXUS W&amp;W/O CONTRAST&quot;                                               
## [3286] &quot;MR 3D RENDERING W/O POST PROCESSING ON INDEPENDENT WS&quot;                           
## [3287] &quot;&#39; FILM ORTHO AP LOWER EXT&quot;                                                       
## [3288] &quot;CT ABDOMEN W/CONTRAST W/ONC TABLE&quot;                                               
## [3289] &quot;LOP HAND (AP, LAT &amp; OBLIQUE) LEFT IN O.R. PORT&quot;                                  
## [3290] &quot;LP GLENO-HUMERAL SHOULDER (W/ Y VIEW) LEFT PORT&quot;                                 
## [3291] &quot;P US HEMATOMA SUBCUT DRAIN INCISION PORT&quot;                                        
## [3292] &quot;INJ/ASO MAJOR JT W/FLUORO&quot;                                                       
## [3293] &quot;PUNC ASP ABSECC/HEMATOMA/BULA/CYST&quot;                                              
## [3294] &quot;THYROGEN I-131 TOTAL BODY SCAN&quot;                                                  
## [3295] &quot;BABYGRAM LUMBAR&amp;THORACIC AP/LAT&quot;                                                 
## [3296] &quot;FLUORO GUIDANCE FOR NEEDLE PLACEMENT&quot;                                            
## [3297] &quot;MRI BREAST BIL W &amp;W/O C&quot;                                                         
## [3298] &quot;P RETROPERITONEAL US PORT&quot;                                                       
## [3299] &quot;BONE MARROW SCAN&quot;                                                                
## [3300] &quot;RP CLAVICLE RIGHT PORT&quot;                                                          
## [3301] &quot;STERNUM&quot;                                                                         
## [3302] &quot;TUBE/CATH CHNG BY NON RAD&quot;                                                       
## [3303] &quot;B 38790 INJ LYMPHANGIOGRAPHY BILAT&quot;                                              
## [3304] &quot;OB TIB/FIB (AP &amp; LAT) IN O.R. BILAT&quot;                                             
## [3305] &quot;CYSTOGRAM (51600, 74430)&quot;                                                        
## [3306] &quot;LPO SHOULDER 1 VIEW LEFT PORT IN O.R.&quot;                                           
## [3307] &quot;P BABYGRAM LOWER EXT,MIN 2 VIEWS PORT&quot;                                           
## [3308] &quot;CAD DIAGNOSTIC&quot;                                                                  
## [3309] &quot;ADRENAL UNILAT SEL A-GRAM&quot;                                                       
## [3310] &quot;CYBER-INS MARKER LUNG/PLEURA&quot;                                                    
## [3311] &quot;CT CYSTOGRAM (PEL) W/CONTRAST&quot;                                                   
## [3312] &quot;B FOOT AP, LAT &amp; HINDFOOT STANDING BILAT&quot;                                        
## [3313] &quot;CT RFA LUNGS/PLEURA, UNILATERAL&quot;                                                 
## [3314] &quot;L MR KNEE W/O C, LEX LEFT&quot;                                                       
## [3315] &quot;CT CYSTOGRAM (PEL) W&amp;W/O CONTRAST&quot;                                               
## [3316] &quot;STERNO-CLAVICULAR JOINTS&quot;                                                        
## [3317] &quot;O HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) IN O.R.&quot;                                 
## [3318] &quot;RO ELBOW (AP, LAT &amp; OBLIQUE) RIGHT IN O.R.&quot;                                      
## [3319] &quot;FETAL REDUC, MULTI GESTATION&quot;                                                    
## [3320] &quot;TRANSCATH EMBO&quot;                                                                  
## [3321] &quot;RO ANKLE (AP, MORTISE &amp; LAT) RIGHT IN O.R.&quot;                                      
## [3322] &quot;PL WRIST, AP &amp; LAT VIEWS PORT LEFT&quot;                                              
## [3323] &quot;L US BREAST BX WITH CLIP PLACEMENT LEFT&quot;                                         
## [3324] &quot;CT HEART W/O CONTRAST W/IMAGE PP AND QUANTITATIVE CALCIUM&quot;                       
## [3325] &quot;P TIB/FIB (AP &amp; LAT) PORT&quot;                                                       
## [3326] &quot;PL FOOT (AP &amp; LAT) SOFT TISSUE PORT LEFT&quot;                                        
## [3327] &quot;PRIMARY MECH THROMBECTOMY ART/BPG; INITIAL VESSEL&quot;                               
## [3328] &quot;TRAUMA #3 (PORT CHEST ONLY)&quot;                                                     
## [3329] &quot;CT ABD&amp;PELVIS W&amp;W/O C COLON TECHNIQUE&quot;                                           
## [3330] &quot;ART DUP EXT UP UNI OR LMTD&quot;                                                      
## [3331] &quot;CT BRAIN PERFUSION&quot;                                                              
## [3332] &quot;XMR ENTEROGRAPHY (SMALL BOWELL)&quot;                                                 
## [3333] &quot;LOP ELBOW, AP &amp; LAT VIEWS LEFT IN O.R. PORT&quot;                                     
## [3334] &quot;L MR FOOT W/O C, LEX LEFT&quot;                                                       
## [3335] &quot;SECONDARY THROMBECTOMY W/OTHER PERC PROCEDURE&quot;                                   
## [3336] &quot;CT CHEST W/O CONTRAST W/ONC TABLES&quot;                                              
## [3337] &quot;CT DRAIN PANCREATIC  CYST&quot;                                                       
## [3338] &quot;MR FUNCTIONAL BRAIN BY PHYS/PSYCH&quot;                                               
## [3339] &quot;MRV HEAD W/O CONTRAST&quot;                                                           
## [3340] &quot;L NAVICULAR (SCAPHOID ONLY) 4 VIEWS LEFT&quot;                                        
## [3341] &quot;OR ELBOW (AP, LAT &amp; OBLIQUE) IN O.R. RIGHT&quot;                                      
## [3342] &quot;MR BRACHIAL PLEXUS W/O CONTRAST&quot;                                                 
## [3343] &quot;R MR WRIST W/ARTHROGRAM RIGHT&quot;                                                   
## [3344] &quot;R MR WRIST W&amp;W/O CONTRAST RIGHT&quot;                                                 
## [3345] &quot;BABYGRAM CHEST DECUB ONLY (71035)&quot;                                               
## [3346] &quot;CT ABD&amp;PELVIS W/C COLON TECHNIQUE&quot;                                               
## [3347] &quot;THORACOSTOMY TUBE INSERTION FOR ABSCESS/HEMATHORAX&quot;                              
## [3348] &quot;INC/DRAINAGE ABCESS, SGL OR SIMPLE&quot;                                              
## [3349] &quot;CT 3D RENDERING W/POST PROCESSING ON INDEPENDENT WS&quot;                             
## [3350] &quot;PELVIS W/JUDET VIEWS (3V)&quot;                                                       
## [3351] &quot;CT CARDIAC STRUCTURE/MORPH W/CTA W/O QUANTITATIVE CALCIUM&quot;                       
## [3352] &quot;PB CLAVICLE PORT BILAT&quot;                                                          
## [3353] &quot;R NAVICULAR (SCAPHOID ONLY) 4 VIEWS RIGHT&quot;                                       
## [3354] &quot;R US INTERMED JT ASP RIGHT&quot;                                                      
## [3355] &quot;R ARTHROGRAM,WRIST RIGHT&quot;                                                        
## [3356] &quot;ANIOPLASTY EA ADD&#39;LL PERIPHERAL&quot;                                                 
## [3357] &quot;STENT INTRACRANIAL INCL PTA, ATHEROSCLEROSIS&quot;                                    
## [3358] &quot;REPLACE G OR C TUBE, ALL INCL.&quot;                                                  
## [3359] &quot;MR CARDIAC W/FLOW/VEL P/P CONTRAST&quot;                                              
## [3360] &quot;O ACUTE ABD SERIES (2-3 VIEWS OF ABD &amp; SGL CHEST VIEW) IN O.R.&quot;                  
## [3361] &quot;PROSTATE BX- SANDA&quot;                                                              
## [3362] &quot;G TUBE PLACMENT, ALL INCL.&quot;                                                      
## [3363] &quot;CT HEART W&amp;W/O CONTRAST;GATING/3D;L&amp;R VENT FUCTION,EJECTION FRACTION,WALL MOTION&quot;
## [3364] &quot;MR SHOULDER W/O CONTRAST&quot;                                                        
## [3365] &quot;THORACIC MYELOGRAM&quot;                                                              
## [3366] &quot;CARDIAC MORPHOLOGY W/CONTRAST&quot;                                                   
## [3367] &quot;G/GJ/GI TUBE CHECK&quot;                                                              
## [3368] &quot;INJ/EVAL ANY GI TUBE, ALL INCL.&quot;                                                 
## [3369] &quot;MRA LOWER EXT W/O CONTRAST&quot;                                                      
## [3370] &quot;LP HAND, AP &amp; LAT. VIEWS LEFT PORT&quot;                                              
## [3371] &quot;MR CARDIAC W/FLOW/VEL NO CONTRAST&quot;                                               
## [3372] &quot;O SINUSES 1-2 VIEWS IN O.R.&quot;                                                     
## [3373] &quot;SELLA TURCICA (2 VIEWS)&quot;                                                         
## [3374] &quot;STENT CERVICAL/CAROTID W/O EMBOLIC PROTECTION&quot;                                   
## [3375] &quot;MR BREAST CAD&quot;                                                                   
## [3376] &quot;MRA CERVICAL SPINE&quot;                                                              
## [3377] &quot;THY BX BY MCARDLE&quot;                                                               
## [3378] &quot;OL HAND (AP, LAT &amp; OBLIQUE) IN O.R. LEFT&quot;                                        
## [3379] &quot;CAROTID/CERVICAL BILAT&quot;                                                          
## [3380] &quot;1SR ORDER THOR/BRACHIOCEPHALIC&quot;                                                  
## [3381] &quot;O SPINAL FLUORO IN O.R.&quot;                                                         
## [3382] &quot;CYBER-INS MARKER LIVER&quot;                                                          
## [3383] &quot;SEL VISCERAL ANGIO - NO TECH FEE&quot;                                                
## [3384] &quot;VESSEL MAP PRE-OP HEMOD ACCESS&quot;                                                  
## [3385] &quot;OLO FEMUR (AP &amp; LAT) IN O.R. LEFT IN O.R.&quot;                                       
## [3386] &quot;OR CLAVICLE IN O.R. RIGHT&quot;                                                       
## [3387] &quot;PTA PERIPHEREAL ARTERY&quot;                                                          
## [3388] &quot;OO C-SPINE NON-TRAUMA 2-3 VIEWS IN O.R. IN O.R.&quot;                                 
## [3389] &quot;P ABDOMINAL FLUORO PORT&quot;                                                         
## [3390] &quot;OP PORTABLE ABDOMEN IN O.R. PORT&quot;                                                
## [3391] &quot;O PELVIS (AP &amp; LAT) IN O.R.&quot;                                                     
## [3392] &quot;O TRAUMA #2 (AP CXR &amp; PELVIS PORT) IN O.R.&quot;                                      
## [3393] &quot;REPLACE GJ TUBE, ALL INCL.&quot;                                                      
## [3394] &quot;CARDIAC PERFUSION PERSANTINE&quot;                                                    
## [3395] &quot;P G/GJ/GI TUBE CHECK PORT&quot;                                                       
## [3396] &quot;CARDIAC PERFUSION&quot;                                                               
## [3397] &quot;REPOSITION GTUBE THROUGH DUODENUM&quot;                                               
## [3398] &quot;P TRAUMA #3 (PORT CHEST ONLY) PORT&quot;                                              
## [3399] &quot;MR FETAL&quot;                                                                        
## [3400] &quot;CONVERT G TO GJ, ALL INCL.&quot;                                                      
## [3401] &quot;OO C-SPINE SGL 1 VIEW IN O.R. IN O.R.&quot;                                           
## [3402] &quot;US MCARDLE THYROID SCAN&quot;                                                         
## [3403] &quot;FNA, ANY LOCATION&quot;                                                               
## [3404] &quot;PL SHOULDER 2-3 VIEWS NON TRAUMA PORT LEFT&quot;                                      
## [3405] &quot;OB FEMUR (AP &amp; LAT) IN O.R. BILAT&quot;                                               
## [3406] &quot;OB FOREARM (AP &amp; LAT) IN O.R. BILAT&quot;                                             
## [3407] &quot;EXCH CENTRAL NON-TUNNELED&quot;                                                       
## [3408] &quot;CTA CORONARY ARTERIES W/O QUANT CALCIUM&quot;                                         
## [3409] &quot;OOR SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA IN O.R. IN O.R. RIGHT&quot;              
## [3410] &quot;P ART DUP EXT UP UNI OR LMTD PORT&quot;                                               
## [3411] &quot;TPA/STRIP/REPOS INTRAABD PORT&quot;                                                   
## [3412] &quot;MRA BRAIN W/CONTRAST&quot;                                                            
## [3413] &quot;CHEST (APICAL LORDOTIC ONLY)&quot;                                                    
## [3414] &quot;GUIDANCE FOR AMNIO-PERI&quot;                                                         
## [3415] &quot;PR ELBOW (AP, LAT &amp; OBLIQUE) PORT RIGHT&quot;                                         
## [3416] &quot;LO WRIST, AP &amp; LAT VIEWS LEFT IN O.R.&quot;                                           
## [3417] &quot;MR PROSTATE W/O CONTRAST&quot;                                                        
## [3418] &quot;CT PELVIS W/CONTRAST W/ONC TABLES&quot;                                               
## [3419] &quot;THALLIUM SCAN FOR TUMOR&quot;                                                         
## [3420] &quot;OL SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA IN O.R. LEFT&quot;                        
## [3421] &quot;L US GUID NEEDLE PLACEMENT-BX/ASP/INJ/LOC LEFT&quot;                                  
## [3422] &quot;US BREAST DRAIN W OR W/O CATHETER&quot;                                               
## [3423] &quot;WIRE LOCALIZATION, LUNG&quot;                                                         
## [3424] &quot;THYROGEN I-123 TOTAL BODY SCAN&quot;                                                  
## [3425] &quot;L MR HIP W/CONTRAST LEFT&quot;                                                        
## [3426] &quot;BP SHOULDER (AP, NEUTRAL &amp; AXILLARY) TRAUMA BILAT PORT&quot;                          
## [3427] &quot;P ESOPHAGUS PORT&quot;                                                                
## [3428] &quot;NO RAD MS 1ST 30\&quot;&quot;                                                              
## [3429] &quot;L ART DUP LOW EXT LEFT&quot;                                                          
## [3430] &quot;MR HEAD W/CNTRST&amp;TUMOR VOLUMETRIC&quot;                                               
## [3431] &quot;MRV CHEST W/O CONTRAST&quot;                                                          
## [3432] &quot;OO C-SPINE, TRAUMA IN O.R. IN O.R.&quot;                                              
## [3433] &quot;P MANDIBLE SERIES INCLUD PANOREX PORT&quot;                                           
## [3434] &quot;P CHEST (BOTH OBLIQUES ONLY) PORT&quot;                                               
## [3435] &quot;OR SHOULDER 2-3 VIEWS NON TRAUMA IN O.R. RIGHT&quot;                                  
## [3436] &quot;OL SHOULDER 1 VIEW IN O.R. LEFT&quot;                                                 
## [3437] &quot;ORO TIB/FIB (AP &amp; LAT) IN O.R. RIGHT IN O.R.&quot;                                    
## [3438] &quot;CTA CORONARY ARTERIES W/QUANTITATIVE CALCIUM&quot;                                    
## [3439] &quot;THYROID BX BY RADIOLOGIST&quot;                                                       
## [3440] &quot;L-SPINE (WITH FLEX, EXT &amp; OBL)&quot;                                                  
## [3441] &quot;LO HAND, AP &amp; LAT. VIEWS LEFT IN O.R.&quot;                                           
## [3442] &quot;REMOVE CVA OBSTRUCT S&amp;I&quot;                                                         
## [3443] &quot;REVISION TRANSHEP TUBE IN OR NO TECH FEE&quot;                                        
## [3444] &quot;CARDIAC PERFUSION REST&quot;                                                          
## [3445] &quot;OUTSIDE FILMS READ ONLY&quot;                                                         
## [3446] &quot;REMOVE TUNNELED CENTRAL/PICC W/PORT&quot;                                             
## [3447] &quot;R CT INJ/ASP MAJOR JOINT RIGHT&quot;                                                  
## [3448] &quot;CT CYSTOGRAM (PEL) W/O CONTRAST&quot;                                                 
## [3449] &quot;REPLACE D OR J TUBE, ALL INCL.&quot;                                                  
## [3450] &quot;MECH REM OBSTRUCTION GI TUBES&quot;                                                   
## [3451] &quot;MRI NASO PHARYNX W &amp; W/O CONTRAST&quot;                                               
## [3452] &quot;CARDIAC PERFUSION 2-DAY&quot;                                                         
## [3453] &quot;FOOT STANDING EXTRMEITY BILATERAL&quot;                                               
## [3454] &quot;SACRO-ILIAC JTS (AXIAL &amp; BILAT OBLS)&quot;                                            
## [3455] &quot;R ART DUP EXT UP UNI OR LMTD RIGHT&quot;                                              
## [3456] &quot;A-GRAM CAROTID/CERVICAL, UNILAT&quot;                                                 
## [3457] &quot;LYMPH NODE BX DEEP-RETROPERITONEAL&quot;                                              
## [3458] &quot;CARDIAC PERFUSION PERSAN 2-DAY&quot;                                                  
## [3459] &quot;CT ETOH ABLATION/TPA INFUSION LIVER&quot;                                             
## [3460] &quot;MR CARDIAC MORPH/FX P/P CONTRAST&quot;                                                
## [3461] &quot;R MR HIP W/CONTRAST RIGHT&quot;                                                       
## [3462] &quot;INJ/ASP MAJOR JT W/FLUORO&quot;                                                       
## [3463] &quot;OP LUMBO-SACRAL SPINE (AP &amp; LAT) IN O.R. PORT&quot;                                   
## [3464] &quot;US OVARIAN CYST DRAIN,ABD APPROACH&quot;                                              
## [3465] &quot;CT ALCOHOL LIVER ABLATION&quot;                                                       
## [3466] &quot;PR HAND (AP &amp; LAT) SOFT TISSUE PORT RIGHT&quot;                                       
## [3467] &quot;US GUID TISSUE ABLATION&quot;                                                         
## [3468] &quot;SPINE FLOURO (KEEL)&quot;                                                             
## [3469] &quot;ORAL CHOLECYSTOGRAM&quot;                                                             
## [3470] &quot;PERC DILATATION INTRACRANIAL VASOSPASM;INITIAL VESSEL&quot;                           
## [3471] &quot;D OR J TUBE PLACEMENT, ALL INCL.&quot;                                                
## [3472] &quot;OPR KNEE( (SINGLE VIEW) IN O.R. PORT RIGHT&quot;                                      
## [3473] &quot;B FOOT 1 VIEW BILAT&quot;                                                             
## [3474] &quot;R ARTHROGRAM,SHOULDER RIGHT&quot;                                                     
## [3475] &quot;PERC REMOVAL/SNARE/CAPTURE INT.DWELLING URETERAL STENT&quot;                          
## [3476] &quot;P CTA ABD W&amp;W/O C &amp; RECONS PORT&quot;                                                 
## [3477] &quot;B BREAST CORE BIOSPY UNDER US BILAT&quot;                                             
## [3478] &quot;L MR HAND W/O&amp;W/CONTRAST LEFT&quot;                                                   
## [3479] &quot;OPR UPPER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. PORT RIGHT&quot;               
## [3480] &quot;L THUMB (AP &amp; LATERAL) LEFT&quot;                                                     
## [3481] &quot;P PELVIS W/JUDET VIEWS (3V) PORT&quot;                                                
## [3482] &quot;BP TOE(S), 2+ VIEW BILAT PORT&quot;                                                   
## [3483] &quot;CT PELVIS W/O CONTRAST W/ONC TABLES&quot;                                             
## [3484] &quot;CT DRAIN FOR APPENDICEAL ABSCESS&quot;                                                
## [3485] &quot;BX LIVER&quot;                                                                        
## [3486] &quot;THYROID SCAN: TECHNETIUM&quot;                                                        
## [3487] &quot;P CTA CHEST W&amp;W/O C&amp;RECONS, NON-CORONARY PORT&quot;                                   
## [3488] &quot;EXCH CENTRAL TUNNELED W/PORT&quot;                                                    
## [3489] &quot;MRV PELVIS W&amp;W/O CONTRAST&quot;                                                       
## [3490] &quot;SVC FILTER PLACEMENT S&amp;I&quot;                                                        
## [3491] &quot;LO HAND (AP, LAT &amp; OBLIQUE) LEFT IN O.R.&quot;                                        
## [3492] &quot;PELVIS SEL/SUPERSEL A-GRAM&quot;                                                      
## [3493] &quot;P RIB, UNILAT (NO CXR) PORT&quot;                                                     
## [3494] &quot;ULTRASOUND, AAA SCREENING&quot;                                                       
## [3495] &quot;R CTA UPPER EXT W&amp;W/O C &amp; RECONS RIGHT&quot;                                          
## [3496] &quot;LP WRIST (AP &amp; LAT) SOFT TISSUE LEFT PORT&quot;                                       
## [3497] &quot;ANGIO, CAROTID.CEREBRAL UNILAT&quot;                                                  
## [3498] &quot;BP ELBOW (AP, LAT &amp; OBLIQUE) BILAT PORT&quot;                                         
## [3499] &quot;LO ELBOW (AP, LAT &amp; OBLIQUE) LEFT IN O.R.&quot;                                       
## [3500] &quot;R CT SHOULDER ARTHROGRAM RIGHT&quot;                                                  
## [3501] &quot;PERC TX EXTREMITY PSA&quot;                                                           
## [3502] &quot;CT PARACENTESIS&quot;                                                                 
## [3503] &quot;MR CALF W/O CONTRAST&quot;                                                            
## [3504] &quot;GASTROSTOMY TUBE CHANGE&quot;                                                         
## [3505] &quot;L MR WRIST W&amp;W/O CONTRAST LEFT&quot;                                                  
## [3506] &quot;CTA TORSO&quot;                                                                       
## [3507] &quot;INTRAOPERTIVE US GUIDANCE&quot;                                                       
## [3508] &quot;PERC REMOVE/SNARE/CAPTURE&amp;REPLACE INT DWELL URETERAL STENT&quot;                      
## [3509] &quot;ABD A-GRAM&quot;                                                                      
## [3510] &quot;SPINAL SEL A-GRAM&quot;                                                               
## [3511] &quot;MRV ABDOMEN W/O CONTRAST&quot;                                                        
## [3512] &quot;ED REQUEST FOR SECOND OPINION READ&quot;                                              
## [3513] &quot;CT CHEST AND ABDOMEN W/O CONTRAST&quot;                                               
## [3514] &quot;CT TORSO W/O CONTRAST&quot;                                                           
## [3515] &quot;MRV PELVIS W/O CONTRAST&quot;                                                         
## [3516] &quot;EXCHANGE PREV PLACED DRAINAGE CATHETER&quot;                                          
## [3517] &quot;RR KNEE (MIN 4 VIEWS) RIGHT RIGHT&quot;                                               
## [3518] &quot;MRV CHEST W&amp;W/O CONTRAST&quot;                                                        
## [3519] &quot;SHOULDER ARTHROGRAM W MR&quot;                                                        
## [3520] &quot;CTU (ABD/PEL) W/CONTRAST&quot;                                                        
## [3521] &quot;OR HAND (AP, LAT &amp; OBLIQUE) IN O.R. RIGHT&quot;                                       
## [3522] &quot;2ND ORDER THOR/BRACHIOCEPHALIC&quot;                                                  
## [3523] &quot;O CHOLANGIOGRAM,IN OR W FILMS IN O.R.&quot;                                           
## [3524] &quot;CONSULT DIAGNOSTIC MAMMOGRAM&quot;                                                    
## [3525] &quot;INJ-VENO/PAC&quot;                                                                    
## [3526] &quot;L CT INJ/ASP MAJOR JOINT LEFT&quot;                                                   
## [3527] &quot;OP SKULL (AP, TOWNES &amp; LAT) TRAUMA IN O.R. PORT&quot;                                 
## [3528] &quot;SHUNTOGRAM&quot;                                                                      
## [3529] &quot;PLCT CHOLEDOCHAL STENT&quot;                                                          
## [3530] &quot;MRI &amp; MRA BRAIN, W/O CONTRAST&quot;                                                   
## [3531] &quot;OOL FEMUR (AP &amp; LAT) IN O.R. IN O.R. LEFT&quot;                                       
## [3532] &quot;ORO HIP UNILAT MIN 2 VIEWS IN O.R. RIGHT IN O.R.&quot;                                
## [3533] &quot;MR ARM W&amp;W/O CONTRAST&quot;                                                           
## [3534] &quot;FLUORO S&amp;I PERC VERTEBRO/KYPHOPLASTY&quot;                                            
## [3535] &quot;R CT FOOT/ANKLE ARTHROGRAM RIGHT&quot;                                                
## [3536] &quot;OL KNEE (AP, LAT &amp; OBLIQUE) IN O.R. LEFT&quot;                                        
## [3537] &quot;MR RECTAL W &amp; W/O CONTRAST&quot;                                                      
## [3538] &quot;MRI FAILED SCREENING&quot;                                                            
## [3539] &quot;L 75741 UNILAT PUL SEL ANGIOGRAPHY LEFT&quot;                                         
## [3540] &quot;OB F/U W/O MEASUREMENTS&quot;                                                         
## [3541] &quot;R HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) RIGHT&quot;                                   
## [3542] &quot;O SKULL (CALDWELL, LFT LAT, TOWNES &amp; BASE) IN O.R.&quot;                              
## [3543] &quot;MR CARDIAC W/FLOW/VEL/STRESS P/P CONTRAST&quot;                                       
## [3544] &quot;PP C-SPINE NON-TRAUMA 2-3 VIEWS PORT PORT&quot;                                       
## [3545] &quot;FLUORO GUID NEEDLE PLCT SPINE/PARASPINOUS (KEEL)&quot;                                
## [3546] &quot;L HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) LEFT&quot;                                    
## [3547] &quot;CTC VIRTUAL COLONOGRAPHY W/O CONTRAST&quot;                                           
## [3548] &quot;ATHERECTOMY BRACHIOCEPHALIC&quot;                                                     
## [3549] &quot;R BREAST CYST ASPIRATION RIGHT&quot;                                                  
## [3550] &quot;O MANDIBLE (PA, TOWNES &amp; BOTH OBLS) IN O.R.&quot;                                     
## [3551] &quot;R CLIP PLACMENT FOLLOWING BREAST BX RIGHT&quot;                                       
## [3552] &quot;CT BONE DENSITY&quot;                                                                 
## [3553] &quot;L CT SHOULDER ARTHROGRAM LEFT&quot;                                                   
## [3554] &quot;CT LUNG/MED BX NON-RAD W/GUIDANCE&quot;                                               
## [3555] &quot;PERC TRANSHEPATIC BILIARY DRAINAGE&quot;                                              
## [3556] &quot;PO ABD (SINGLE VIEW ONLY) PORT IN O.R.&quot;                                          
## [3557] &quot;P ERCP BILIARY&amp;PANCREAS BY GI UNIT PORT&quot;                                         
## [3558] &quot;MR SHOULDER W&amp;W/O CONTRAST&quot;                                                      
## [3559] &quot;MR INCOMPLETE STUDY&quot;                                                             
## [3560] &quot;OB F/U WITH MEASUREMENT&quot;                                                         
## [3561] &quot;R UPPER EXTREMITY FLUORO RIGHT&quot;                                                  
## [3562] &quot;CHEMO ADM INTRATHECAL W/LP&quot;                                                      
## [3563] &quot;P BILAT BREAST US PORT&quot;                                                          
## [3564] &quot;O CHEST SGL VIEW/LINE PLACEMENT IN O.R.&quot;                                         
## [3565] &quot;PL ANKLE (2 VIEWS) PORT LEFT&quot;                                                    
## [3566] &quot;MRA BRAIN W&amp;W/O CONTRAST&quot;                                                        
## [3567] &quot;MR PITUITARY W/O CONTRAST&quot;                                                       
## [3568] &quot;OPL HIP UNILAT MIN 2 VIEWS IN O.R. PORT LEFT&quot;                                    
## [3569] &quot;ORO KNEE (2 VIEWS) IN O.R. RIGHT IN O.R.&quot;                                        
## [3570] &quot;F-18 BONE SCAN&quot;                                                                  
## [3571] &quot;TUBE THORACOSTOMY&quot;                                                               
## [3572] &quot;ED STROKE CTA HEAD &amp; NECK WITH PERFUSION&quot;                                        
## [3573] &quot;PRP FEMUR (AP &amp; LAT) PORT RIGHT PORT&quot;                                            
## [3574] &quot;MR CARDIAC VELOCITY FLOW MAP, ADD-ON&quot;                                            
## [3575] &quot;NUCHAL TRANSLUCENCY US, SINGLE/FIRST FETUS&quot;                                      
## [3576] &quot;DRAINAGE HEMATOMA/SEROMA/FLUID COLLECTION&quot;                                       
## [3577] &quot;CTC VIRTUAL COLONOGRAPHY W/ CONTRAST&quot;                                            
## [3578] &quot;THORACIC ANGIO&quot;                                                                  
## [3579] &quot;CHOLANGIOGRAPHY VIA EXISTING CATHETER&quot;                                           
## [3580] &quot;CTA CORONARY ARTERIES W/3D W/FUNCTION&quot;                                           
## [3581] &quot;US PERC DRAIN PANCREATIC PSEUDOCYST&quot;                                             
## [3582] &quot;NON-CONTRAST IFIR RENAL ANGIO MRI&quot;                                               
## [3583] &quot;PRIMARY MECH THROMBECTOMY, ARTERIAL/BPG, INITIAL&quot;                                
## [3584] &quot;MR NEURO SCOUTS ONLY, NO CHARGE&quot;                                                 
## [3585] &quot;L MAMMOTOME CLIP PLACEMENT LEFT&quot;                                                 
## [3586] &quot;MRI BREAST BILAT W/O C&quot;                                                          
## [3587] &quot;RP SCAPULA RIGHT PORT&quot;                                                           
## [3588] &quot;LPLP ELBOW (AP, LAT &amp; OBLIQUE) LEFT PORT LEFT PORT&quot;                              
## [3589] &quot;R VENOUS DUP UPPER EXT UNILATERAL RIGHT&quot;                                         
## [3590] &quot;BP NAVICULAR (SCAPHOID ONLY) 4 VIEWS BILAT PORT&quot;                                 
## [3591] &quot;ED CODE STROKE ONLY CT&quot;                                                          
## [3592] &quot;SHUNT SERIES AP &amp; LAT SKULL, AP CHEST, AP ABDOMEN&quot;                               
## [3593] &quot;OPR KNEE (2 VIEWS) IN O.R. PORT RIGHT&quot;                                           
## [3594] &quot;US GUID FOR NEEDLE PLACEMENT&quot;                                                    
## [3595] &quot;VENOGRAPHY IVC S&amp;I&quot;                                                              
## [3596] &quot;OBO FEMUR (AP &amp; LAT) IN O.R. BILAT IN O.R.&quot;                                      
## [3597] &quot;L VENOUS DUP UPPER EXT UNILATERAL LEFT&quot;                                          
## [3598] &quot;CT SINUS W/O CONTRAST FOR SURGICAL PLANNING&quot;                                     
## [3599] &quot;P BAS/UGI AIR/SBFT PORT&quot;                                                         
## [3600] &quot;MR BODY SCOUTS ONLY, NO CHARGE&quot;                                                  
## [3601] &quot;GUIDANCE FOR DRAINAGE/SPECIMEN COLLECTION&quot;                                       
## [3602] &quot;PERC TRANS-JEJUNAL CATH BILIARY DRAIN&quot;                                           
## [3603] &quot;SONOHYSTEROGRAM&quot;                                                                 
## [3604] &quot;C/OTHER COLONIC TUBE, ALL INCL.&quot;                                                 
## [3605] &quot;KYPHOPLASTY, THORACIC&quot;                                                           
## [3606] &quot;P RETRO UROGRAM (74450,51610) PORT&quot;                                              
## [3607] &quot;MR CARDIAC MORPH/FX NO CONTRAST&quot;                                                 
## [3608] &quot;L US MSK WRIST LEFT&quot;                                                             
## [3609] &quot;INJ/ASP INTERMED JT W/FLUORO&quot;                                                    
## [3610] &quot;INTRALUMINAL DILATION STRICTURE&quot;                                                 
## [3611] &quot;L THY BX BY MCARDLE LEFT&quot;                                                        
## [3612] &quot;VENOUS DUP UPPER EXT BILATERAL&quot;                                                  
## [3613] &quot;TRANSCATHETER RETRIEVAL INTRAVASCULAR FB&quot;                                        
## [3614] &quot;AP/PA SINGLE VIEW EXPIRATORY CHEST&quot;                                              
## [3615] &quot;VENOUS DUP UPPER EXT UNILATERAL&quot;                                                 
## [3616] &quot;FLOURO GUIDE FRO BX, INJ, ASP ANY LOCATION&quot;                                      
## [3617] &quot;P STERNUM PORT&quot;                                                                  
## [3618] &quot;CYBER-INS MARKER MEDIASTINUM&quot;                                                    
## [3619] &quot;OL FINGER(S),2+VIEWS IN O.R. LEFT&quot;                                               
## [3620] &quot;BX PERCU LUNG/MEDIASTINUM&quot;                                                       
## [3621] &quot;INJ SCLEROSISNG HEMORRHOIDS&quot;                                                     
## [3622] &quot;OPL ELBOW (AP, LAT &amp; OBLIQUE) IN O.R. PORT LEFT&quot;                                 
## [3623] &quot;RO FEMUR (AP &amp; LAT) SOFT TISSUE RIGHT IN O.R.&quot;                                   
## [3624] &quot;MR ENTEROGRAPHY (74183&amp;72197) SBFT&quot;                                              
## [3625] &quot;CT ABDOMEN W/O CONTRAST W/ONC TABLE&quot;                                             
## [3626] &quot;PARACENTESIS - NO RAD&quot;                                                           
## [3627] &quot;PP C-SPINE SGL 1 VIEW PORT PORT&quot;                                                 
## [3628] &quot;UTERINE FIBROID EMBO, ALL INCLUSIVE&quot;                                             
## [3629] &quot;OOL HUMERUS (AP &amp; LAT) IN O.R. IN O.R. LEFT&quot;                                     
## [3630] &quot;LIVER/SPLEEN SCAN&quot;                                                               
## [3631] &quot;LPO TIB/FIB (AP &amp; LAT) LEFT PORT IN O.R.&quot;                                        
## [3632] &quot;CT HEART W/O CONTRAST WITH CALCIUM EVALUATION&quot;                                   
## [3633] &quot;SPINE (BENDING VIEWS ONLY)&quot;                                                      
## [3634] &quot;INC/DRAINAGE ABSCESS COMPLEX&quot;                                                    
## [3635] &quot;MRV ABDOMEN W&amp;W/O CONTRAST&quot;                                                      
## [3636] &quot;L DIG DIAGNOSTIC MAMMO UNLIAT LEFT&quot;                                              
## [3637] &quot;RP THUMB (AP &amp; LATERAL) RIGHT PORT&quot;                                              
## [3638] &quot;L PUNC ASP ABSECC/HEMATOMA/BULA/CYST LEFT&quot;                                       
## [3639] &quot;CARDIAC PERFUSION DOBUTAMINE&quot;                                                    
## [3640] &quot;KUB FOR COLONIC TRANSIT&quot;                                                         
## [3641] &quot;GI COLON BALLOON DILATATION W/W/O STENT&quot;                                         
## [3642] &quot;US FISTULOGRAM S&amp;I&quot;                                                              
## [3643] &quot;B EMERG BILAT LOWER EXT VEINS BILAT&quot;                                             
## [3644] &quot;P RETROPERITONEAL LIMITED US PORT&quot;                                               
## [3645] &quot;MR CARDIAC W/STRESS P/P CONTRAST&quot;                                                
## [3646] &quot;R US MSK CYST (BAKERS) RIGHT&quot;                                                    
## [3647] &quot;GUIDANCE FOR SONOHYSTERO&quot;                                                        
## [3648] &quot;P CYSTOGRAM (51600, 74430) PORT&quot;                                                 
## [3649] &quot;R 38790 INJ LYMPHANGIOGRAPHY RIGHT&quot;                                              
## [3650] &quot;THORACIC DUCT CANNULATION&quot;                                                       
## [3651] &quot;RP KNEE( (SINGLE VIEW) RIGHT PORT&quot;                                               
## [3652] &quot;O ABD COMPL INCLUDING LAT DECUB IN O.R.&quot;                                         
## [3653] &quot;CT ABD &amp; PELVIS WITH CONTRAST&quot;                                                   
## [3654] &quot;CT ABD &amp; PELVIS W/O CONTRAST&quot;                                                    
## [3655] &quot;CT ABD &amp; PELVIS W &amp; W/O CONTRAST, ADDL SECTIONS&quot;                                 
## [3656] &quot;R PUNC ASP ABSECC/HEMATOMA/BULA/CYST RIGHT&quot;                                      
## [3657] &quot;R US GUID NEEDLE PLACEMENT-BX/ASP/INJ/LOC RIGHT&quot;                                 
## [3658] &quot;R MR ANKLE W/O C, LEX RIGHT&quot;                                                     
## [3659] &quot;CT NECK W/CONTRAST W/ONC TABLES&quot;                                                 
## [3660] &quot;R US MSK INJ AUT NERVE GANGLION RIGHT&quot;                                           
## [3661] &quot;LO HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) LEFT IN O.R.&quot;                           
## [3662] &quot;INTRODUCTION LONG GI TUBE, S&amp;I&quot;                                                  
## [3663] &quot;PERC TRANHEP PORTOGRAPHY NO PRESSURES&quot;                                           
## [3664] &quot;L HAND FILM IN OR LEFT&quot;                                                          
## [3665] &quot;LP VENOUS DUP UPPER EXT UNILATERAL LEFT PORT&quot;                                    
## [3666] &quot;PL FOOT AP,LAT &amp; OBL PORT LEFT&quot;                                                  
## [3667] &quot;BP HUMERUS (AP &amp; LAT) SOFT TISSUE BILAT PORT&quot;                                    
## [3668] &quot;CARDIAC STRUCTURE/MORPH, 3D, FUNCTION&quot;                                           
## [3669] &quot;INJ/ASP JT (KNEE, SHLD,HIP)&quot;                                                     
## [3670] &quot;DIG SCREENING WITH CAD MAMMOGRAM&quot;                                                
## [3671] &quot;L US MSK INJ SINGLE TEN/SHEATH/LIG LEFT&quot;                                         
## [3672] &quot;US OVARIAN CYST DRAINAGE;VAG APPROACH&quot;                                           
## [3673] &quot;R ABDOMEN (LAT DECUB ONLY) RIGHT&quot;                                                
## [3674] &quot;P 93990 AVF/DUPLEX HEMO/DIAL ACCESS PORT&quot;                                        
## [3675] &quot;LP VENOUS DUP EXT UNI (MAP/DVT) LEFT PORT&quot;                                       
## [3676] &quot;MR PELVIS W&amp;W/O CONTRAST&quot;                                                        
## [3677] &quot;FETAL BPP W/O MEASUREMENT&quot;                                                       
## [3678] &quot;PLP UNILAT UP EXT VEINS US PORT LEFT PORT&quot;                                       
## [3679] &quot;MR GYN PELVIS  W &amp; W/O CONTRAST&quot;                                                 
## [3680] &quot;MRA (CHEST &amp; ABD) W&amp;W/O CONTRAST&quot;                                                
## [3681] &quot;R US MSK SHOULDER RIGHT&quot;                                                         
## [3682] &quot;BO FINGER(S),2+VIEWS BILAT IN O.R.&quot;                                              
## [3683] &quot;BILIARY STONE REMOVAL&quot;                                                           
## [3684] &quot;INJ EPIDURAL BLOOD/CLOT PATCH&quot;                                                   
## [3685] &quot;US MSK FOOT/TOE&quot;                                                                 
## [3686] &quot;MRI PELVIS W/CONTRAST&quot;                                                           
## [3687] &quot;OL ELBOW (AP, LAT &amp; OBLIQUE) IN O.R. LEFT&quot;                                       
## [3688] &quot;R LOWER EXT. VENOGRAM RIGHT&quot;                                                     
## [3689] &quot;RP UNILAT BREAST US RIGHT PORT&quot;                                                  
## [3690] &quot;LO SHOULDER 1 VIEW LEFT IN O.R.&quot;                                                 
## [3691] &quot;MRA TORSO (CHEST &amp; ABD)&quot;                                                         
## [3692] &quot;PR VENOUS DUP UPPER EXT UNILATERAL PORT RIGHT&quot;                                   
## [3693] &quot;RO HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) RIGHT IN O.R.&quot;                          
## [3694] &quot;L ART DUP EXT UP UNI OR LMTD LEFT&quot;                                               
## [3695] &quot;R FOOT WEIGHTBEARING AP,MO,LAT RIGHT&quot;                                            
## [3696] &quot;DISCONTINUED PROCEDURE AFTER ANESTHESIA&quot;                                         
## [3697] &quot;RO CLAVICLE RIGHT IN O.R.&quot;                                                       
## [3698] &quot;BO LOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST BILAT IN O.R.&quot;                     
## [3699] &quot;R US BREAST DRAIN W OR W/O CATHETER RIGHT&quot;                                       
## [3700] &quot;RP ANKLE 1 VIEW RIGHT PORT&quot;                                                      
## [3701] &quot;BIL LOW EXT VEIN/REFLUX STUDY (90 MIN)&quot;                                          
## [3702] &quot;CYBER-CT GUID-NEEDL PLMT,MAR&quot;                                                    
## [3703] &quot;CONSULT OUTSIDE MAMMOGRAM&quot;                                                       
## [3704] &quot;CYBER-INS URINARY SYST&quot;                                                          
## [3705] &quot;INT/ND/CATH DIALSHT ADD ACSS&quot;                                                    
## [3706] &quot;R MR HAND W/O CONTRAST RIGHT&quot;                                                    
## [3707] &quot;REMOVE NEPH TUBE REQUIRING FLUORO&quot;                                               
## [3708] &quot;FNA ANY LOCATION&quot;                                                                
## [3709] &quot;PL VENOUS DUP UPPER EXT UNILATERAL PORT LEFT&quot;                                    
## [3710] &quot;LOO HUMERUS (AP &amp; LAT) LEFT IN O.R. IN O.R.&quot;                                     
## [3711] &quot;L FNA, BREAST ONLY LEFT&quot;                                                         
## [3712] &quot;KYPHOPLASTY, THORACIC NON-RAD&quot;                                                   
## [3713] &quot;RP GLENO-HUMERAL SHOULDER (W/O Y VIEW) RIGHT PORT&quot;                               
## [3714] &quot;L US MSK KNEE(PATELLA TENDON) LEFT&quot;                                              
## [3715] &quot;O SELLA TURCICA (2 VIEWS) IN O.R.&quot;                                               
## [3716] &quot;L STEREOTACTIC MAMMO CORE BIOPSY LEFT&quot;                                           
## [3717] &quot;R INJ/ASP MAJOR JT W/FLUORO RIGHT&quot;                                               
## [3718] &quot;INJ SCOLOSING AGENT IN LYMPHOCELE&quot;                                               
## [3719] &quot;L UNILAT POST PROCEDURE MAMMOGRAM LEFT&quot;                                          
## [3720] &quot;LP HIP (UNILAT 2 VIEW) W/PELVIS (1 VIEW) LEFT PORT&quot;                              
## [3721] &quot;R BREAST US DRAINAGE W/WO CATHETER RIGHT&quot;                                        
## [3722] &quot;PB KNEE (2 VIEWS) PORT BILAT&quot;                                                    
## [3723] &quot;L INJ/ASP MAJOR JT W/FLUORO LEFT&quot;                                                
## [3724] &quot;R BREAST US UNI OR BILAT RIGHT&quot;                                                  
## [3725] &quot;INJ PARAVERT F JNT L/S 1 LEV&quot;                                                    
## [3726] &quot;MRV NECK W/O CONTRAST&quot;                                                           
## [3727] &quot;NEEDLE LOCALIZATION RIGHT&quot;                                                       
## [3728] &quot;MR GYN PELVIS W&amp;W/O CONTRAST&quot;                                                    
## [3729] &quot;CYBER-INS MARKER SOFT TISSUE/MSK&quot;                                                
## [3730] &quot;MR HEAD W&amp;W/OC FOR PTS W/ DBS&quot;                                                   
## [3731] &quot;L MR HIP W/ ARTHROGRAM LEFT&quot;                                                     
## [3732] &quot;R STEREOTACTIC MAMMO CORE BIOPSY RIGHT&quot;                                          
## [3733] &quot;R UNILAT POST PROCEDURE MAMMOGRAM RIGHT&quot;                                         
## [3734] &quot;R US MSK ANKLE RIGHT&quot;                                                            
## [3735] &quot;P CT ABD &amp; PELVIS W &amp; W/O CONTRAST, ADDL SECTIONS PORT&quot;                          
## [3736] &quot;TRIGGER POINT INJ(S)-3/&gt;MUSCLE(S)&quot;                                               
## [3737] &quot;PARACENTESIS DIAG/THERAP W IMAGING GUID&quot;                                         
## [3738] &quot;PORTABLE HEAD CT W/O CONTRAST&quot;                                                   
## [3739] &quot;CTA ABD &amp; PELVIS&quot;                                                                
## [3740] &quot;CHEST (PRE OP CARDIAC AP,PA&amp;LAT)&quot;                                                
## [3741] &quot;P AP/PA SINGLE VIEW EXPIRATORY CHEST PORT&quot;                                       
## [3742] &quot;OPL HAND (AP, LAT &amp; OBLIQUE) IN O.R. PORT LEFT&quot;                                  
## [3743] &quot;NEEDLE LOCALIZATION LEFT&quot;                                                        
## [3744] &quot;O ABDOMINAL FLUORO IN O.R.&quot;                                                      
## [3745] &quot;R CT LOWER EXTREMITY MTS WITHOUT CONTRAST RIGHT&quot;                                 
## [3746] &quot;MRA TOTAL AORTA (CHEST,ABD,PELVIS) W&amp;W/O CONTRAST&quot;                               
## [3747] &quot;US RENAL ARTERY DOPPLER&quot;                                                         
## [3748] &quot;P US RENAL ARTERY DOPPLER PORT&quot;                                                  
## [3749] &quot;PL SHOULDER 1 VIEW PORT LEFT&quot;                                                    
## [3750] &quot;INSERT TUN IP CATH PERC&quot;                                                         
## [3751] &quot;L WERTHEIMER MAMMO NEEDLE LOC LEFT&quot;                                              
## [3752] &quot;P ERCP BILIARY ONLY PORTABLY BY TECH PORT&quot;                                       
## [3753] &quot;SIJ ING-ARTHROGR/ANESTHETIC&quot;                                                     
## [3754] &quot;LP RIB UNILAT, W/ AP CHEST LEFT PORT&quot;                                            
## [3755] &quot;MR SI JOINTS W&amp;W/O CONTRAST&quot;                                                     
## [3756] &quot;BB KNEE (3 VIEWS) BILAT BILAT&quot;                                                   
## [3757] &quot;L MR HAND W/O CONTRAST LEFT&quot;                                                     
## [3758] &quot;OR ANKLE 1 VIEW IN O.R. RIGHT&quot;                                                   
## [3759] &quot;US MSK ELBOW&quot;                                                                    
## [3760] &quot;OL THUMB (AP &amp; LATERAL) IN O.R. LEFT&quot;                                            
## [3761] &quot;CT ABD PARACENTESIS W/IMAGING&quot;                                                   
## [3762] &quot;INS ENDOVAS VENA CAVA FILTER&quot;                                                    
## [3763] &quot;MRA TORSO (CHEST &amp; ABD) W/CONTRAST&quot;                                              
## [3764] &quot;CHEST (CARDIAC PA,AP &amp; LAT)&quot;                                                     
## [3765] &quot;GALLBLADDER SCAN WITH EF&quot;                                                        
## [3766] &quot;CT DRAIN BILIARY INT/EXT&quot;                                                        
## [3767] &quot;PO ABDOMEN (SUPINE ONLY) PORT IN O.R.&quot;                                           
## [3768] &quot;OO ENTIRE SPINE (AP &amp; LAT ONLY) IN O.R. IN O.R.&quot;                                 
## [3769] &quot;CHEST (FRONT/LAT W/APICAL LORDOTIC)&quot;                                             
## [3770] &quot;R US MSK ELBOW RIGHT&quot;                                                            
## [3771] &quot;BO ANKLE (AP, LAT &amp; OBLIQUE) BILAT IN O.R.&quot;                                      
## [3772] &quot;B FOREARM (AP &amp; LAT) SOFT TISSUE BILAT&quot;                                          
## [3773] &quot;CT PELVIS ORTHO W/O CONTRAST W/3D&quot;                                               
## [3774] &quot;R CT UPPER EXTREMITY MTS WITHOUT CONTRAST RIGHT&quot;                                 
## [3775] &quot;L THYROID BIOPSY BY RADIOLOGIST LEFT&quot;                                            
## [3776] &quot;VIRTUAL SCREENING COLONOSCOPY&quot;                                                   
## [3777] &quot;LUMBAR SINGLE VIEW IN OR&quot;                                                        
## [3778] &quot;THORACIC SINGLE VIEW IN OR&quot;                                                      
## [3779] &quot;CT SINUS/MANDIBLE/MAXILLOFACIAL W/ CONTRAST&quot;                                     
## [3780] &quot;CERVICAL SINGLE VIEW IN OR&quot;                                                      
## [3781] &quot;REMOVE ENDOCAS VENA CAVA FILTER&quot;                                                 
## [3782] &quot;P GROIN, SOFT TISSUE PORT&quot;                                                       
## [3783] &quot;US ABDOMINAL WALL, SOFT TISSUE&quot;                                                  
## [3784] &quot;US NECK, SOFT TISSUE&quot;                                                            
## [3785] &quot;CYBER-CT GUID MARKER NON-NEEDLE&quot;                                                 
## [3786] &quot;US UPPER EXTREMITY, SOFT TISSUE&quot;                                                 
## [3787] &quot;PO HIP 1 VIEW PORT IN O.R.&quot;                                                      
## [3788] &quot;RP US MSK SHOULDER RIGHT PORT&quot;                                                   
## [3789] &quot;THORACOLUMBAR (AP &amp; LAT)&quot;                                                        
## [3790] &quot;OPL FOREARM (AP &amp; LAT) IN O.R. PORT LEFT&quot;                                        
## [3791] &quot;CT ABDOMEN AND PELVIS W/O CONTRAST W/ONC TABLES&quot;                                 
## [3792] &quot;US CHEST WALL SOFT TISSUE&quot;                                                       
## [3793] &quot;INJ PARAVERT F JNT C/T 1 LEV&quot;                                                    
## [3794] &quot;US GUIDANCE, UNLISTED PROCEDURE NO RAD&quot;                                          
## [3795] &quot;OR SHOULDER 1 VIEW IN O.R. RIGHT&quot;                                                
## [3796] &quot;R BREAST CORE BX WITH US GUIDANCE RIGHT&quot;                                         
## [3797] &quot;BOP ANKLE (AP, LAT &amp; OBLIQUE) BILAT IN O.R. PORT&quot;                                
## [3798] &quot;RO HAND FILM IN OR RIGHT IN O.R.&quot;                                                
## [3799] &quot;CARDIAC STRUCTURE/MORPHOLOGY IN CONGENITAL HEART DISEASE&quot;                        
## [3800] &quot;ROP SHOULDER 2-3 VIEWS NON TRAUMA RIGHT IN O.R. PORT&quot;                            
## [3801] &quot;L CLIP PLACMENT FOLLOWING BREAST BX LEFT&quot;                                        
## [3802] &quot;PRE-MRI ABDOMEN, SINGLE VIEW ONLY&quot;                                               
## [3803] &quot;ANAL ULTRASOUND&quot;                                                                 
## [3804] &quot;ABDOMEN (LAT DECUB ONLY)&quot;                                                        
## [3805] &quot;US LOWER EXTREMITY, SOFT TISSUE&quot;                                                 
## [3806] &quot;L US MSK HAND/FINGER LEFT&quot;                                                       
## [3807] &quot;P US NECK, SOFT TISSUE PORT&quot;                                                     
## [3808] &quot;LOP HIP UNILAT MIN 2 VIEWS LEFT IN O.R. PORT&quot;                                    
## [3809] &quot;R US BUTTOCKS, SOFT TISSUE RIGHT&quot;                                                
## [3810] &quot;US BUTTOCKS, SOFT TISSUE&quot;                                                        
## [3811] &quot;OB FOOT AP,LAT &amp; OBL IN O.R. BILAT&quot;                                              
## [3812] &quot;GROIN, SOFT TISSUE&quot;                                                              
## [3813] &quot;CT SINUS/MANDIBLE/MAXILLOFACIAL W &amp; W/O CONTRAST&quot;                                
## [3814] &quot;PYROPHOSPHATE SCAN&quot;                                                              
## [3815] &quot;CARDIAC PERFUSION PHARM&quot;                                                         
## [3816] &quot;ABDOMEN US (COMPLETE STUDY)&quot;                                                     
## [3817] &quot;B NAVICULAR (SCAPHOID ONLY) 4 VIEWS BILAT&quot;                                       
## [3818] &quot;US INJ SINUS TRACT&quot;                                                              
## [3819] &quot;O BILAT HIPS (AP,LAT &amp; AP PELVIS) IN O.R.&quot;                                       
## [3820] &quot;O SPINAL FLUORO WITH RADIOLOGIST IN O.R.&quot;                                        
## [3821] &quot;L US CHEST WALL SOFT TISSUE LEFT&quot;                                                
## [3822] &quot;INS CATH REN ART 1ST UNILAT&quot;                                                     
## [3823] &quot;R US INTERMED JOINT ASP/INJECT RIGHT&quot;                                            
## [3824] &quot;P ABDOMEN US (COMPLETE STUDY) PORT&quot;                                              
## [3825] &quot;DECLOT W/THROMB AGNT IMPLT VAD/VAC&quot;                                              
## [3826] &quot;CARDIAC PERFUSION PHARM 2-DAY&quot;                                                   
## [3827] &quot;P PARACENTESIS DIAG/THERAP W IMAGING GUID PORT&quot;                                  
## [3828] &quot;US PERINEUM, SOFT TISSUE&quot;                                                        
## [3829] &quot;US INTRA-OP NO RAD 90 MINS&quot;                                                      
## [3830] &quot;P US LOWER EXTREMITY, SOFT TISSUE PORT&quot;                                          
## [3831] &quot;R 75820 VENOGRAPHY EXT UNILAT S&amp;I RIGHT&quot;                                         
## [3832] &quot;US AXILLA, SOFT TISSUE&quot;                                                          
## [3833] &quot;INS CATH REN ART 2ND +UNILAT&quot;                                                    
## [3834] &quot;L US UPPER EXTREMITY, SOFT TISSUE LEFT&quot;                                          
## [3835] &quot;ORO HAND (AP, LAT &amp; OBLIQUE) IN O.R. RIGHT IN O.R.&quot;                              
## [3836] &quot;OLO FOREARM (AP &amp; LAT) IN O.R. LEFT IN O.R.&quot;                                     
## [3837] &quot;US THORACENTESIS NEEDLE/CATHETER ASP W IMAGING&quot;                                  
## [3838] &quot;AV SHUNT AGRAM S&amp;I&quot;                                                              
## [3839] &quot;DIGITAL SCREENING&quot;                                                               
## [3840] &quot;SUPRAPUBIC CATH INS W/BLADDER ASP&quot;                                               
## [3841] &quot;ASPIRATE PLEURA WITH IMAGING&quot;                                                    
## [3842] &quot;L US MSK FOOT/TOE LEFT&quot;                                                          
## [3843] &quot;P CHEST FLUORO WITHOUT RAD FOR LINE PLACEMENT PORT&quot;                              
## [3844] &quot;L LOWER EXT. VENOGRAM LEFT&quot;                                                      
## [3845] &quot;P ABD SUPINE &amp; LAT DECUB PORT&quot;                                                   
## [3846] &quot;PLACE CATH CAROTID/INOM ART&quot;                                                     
## [3847] &quot;L US MSK ASPIRATE/INJ GANGLION CYST LEFT&quot;                                        
## [3848] &quot;RO HIP NAILING IN OR W/FILMS &amp; FLUORO RIGHT IN O.R.&quot;</code></pre>
<div class="sourceCode" id="cb29"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb29-1"><a href="#cb29-1" aria-hidden="true" tabindex="-1"></a><span class="fu">sum</span>(NOTEEVENTS<span class="sc">$</span>CATEGORY <span class="sc">==</span> <span class="st">&quot;Discharge summary&quot;</span>)</span></code></pre></div>
<pre><code>## [1] 59652</code></pre>
<div class="sourceCode" id="cb31"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb31-1"><a href="#cb31-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Now, creating new subset of data with only discharge summaries. </span></span>
<span id="cb31-2"><a href="#cb31-2" aria-hidden="true" tabindex="-1"></a>NOTEEVENTS <span class="sc">%&gt;%</span> <span class="fu">group_by</span>(CATEGORY) <span class="sc">%&gt;%</span> <span class="fu">filter</span> (CATEGORY <span class="sc">==</span> <span class="st">&#39;Discharge summary&#39;</span>)</span></code></pre></div>
<pre><code>## # A tibble: 59,652  11
## # Groups:   CATEGORY [1]
##    ROW_ID SUBJEC HADM_ID CHART CHART STORE CATEG DESCR  CGID ISERROR
##     &lt;int&gt;    &lt;int&gt;   &lt;int&gt; &lt;chr&gt;   &lt;chr&gt;   &lt;chr&gt;   &lt;chr&gt;   &lt;chr&gt;   &lt;int&gt;   &lt;int&gt;
##  1    174    22532  167853 2151-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  2    175    13702  107527 2118-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  3    176    13702  167118 2119-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  4    177    13702  196489 2124-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  5    178    26880  135453 2162-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  6    179    53181  170490 2172-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  7    180    20646  134727 2112-1 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  8    181    42130  114236 2150-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
##  9    182    56174  163469 2118-0 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
## 10    183    56174  189681 2118-1 &quot;&quot;      &quot;&quot;      Discha Report     NA      NA
## #  with 59,642 more rows, 1 more variable: TEXT &lt;chr&gt;, and abbreviated
## #   variable names SUBJECT_ID, CHARTDATE, CHARTTIME, STORETIME, CATEGORY,
## #   DESCRIPTION</code></pre>
<div class="sourceCode" id="cb33"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb33-1"><a href="#cb33-1" aria-hidden="true" tabindex="-1"></a>NOTEEVENTS_DC <span class="ot">&lt;-</span> <span class="fu">filter</span>(NOTEEVENTS, CATEGORY <span class="sc">==</span> <span class="st">&#39;Discharge summary&#39;</span>) </span>
<span id="cb33-2"><a href="#cb33-2" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(NOTEEVENTS_DC<span class="sc">$</span>SUBJECT_ID)) <span class="co">#41,127 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 41127</code></pre>
<div class="sourceCode" id="cb35"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb35-1"><a href="#cb35-1" aria-hidden="true" tabindex="-1"></a>Subject_ID_Dup <span class="ot">&lt;-</span> <span class="fu">data.frame</span>(<span class="fu">table</span>(NOTEEVENTS_DC<span class="sc">$</span>SUBJECT_ID))</span>
<span id="cb35-2"><a href="#cb35-2" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb35-3"><a href="#cb35-3" aria-hidden="true" tabindex="-1"></a><span class="co">#Of note, Diagnoses_ICD dataset contain the patients with the ICD diagnosis codes. D_ICD_diagnoses is a data dictionary.Also, one may consider pulling echo reports as well using this code &#39;NOTEEVENTS_DC_ECHO &lt;- filter(NOTEEVENTS, CATEGORY == &#39;Discharge summary&#39; &amp; &#39;Echo&#39;)&#39; </span></span></code></pre></div>
<p>#Joining the tables Will set to join tables by the variable
SUBJECT_ID which is unique.</p>
<div class="sourceCode" id="cb36"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb36-1"><a href="#cb36-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Joining tables containing patients&#39; discharge summaries (NOTEEVENTS_DC) with table containing patients&#39; basic demographics (PATIENTS). Performing a left join to join patients with discharge summary to patients&#39; demographic in PATIENTS table</span></span>
<span id="cb36-2"><a href="#cb36-2" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span>
<span id="cb36-3"><a href="#cb36-3" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(plyr) </span></code></pre></div>
<pre><code>## ------------------------------------------------------------------------------</code></pre>
<pre><code>## You have loaded plyr after dplyr - this is likely to cause problems.
## If you need functions from both plyr and dplyr, please load plyr first, then dplyr:
## library(plyr); library(dplyr)</code></pre>
<pre><code>## ------------------------------------------------------------------------------</code></pre>
<pre><code>## 
## Attaching package: &#39;plyr&#39;</code></pre>
<pre><code>## The following objects are masked from &#39;package:dplyr&#39;:
## 
##     arrange, count, desc, failwith, id, mutate, rename, summarise,
##     summarize</code></pre>
<div class="sourceCode" id="cb42"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb42-1"><a href="#cb42-1" aria-hidden="true" tabindex="-1"></a>NOTEEVENTS_DC_PATIENTS <span class="ot">&lt;-</span> dplyr<span class="sc">::</span><span class="fu">left_join</span>(NOTEEVENTS_DC, PATIENTS, <span class="at">by =</span> <span class="st">&quot;SUBJECT_ID&quot;</span>)</span>
<span id="cb42-2"><a href="#cb42-2" aria-hidden="true" tabindex="-1"></a><span class="fu">dim</span>(NOTEEVENTS_DC_PATIENTS)</span></code></pre></div>
<pre><code>## [1] 59652    18</code></pre>
<div class="sourceCode" id="cb44"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb44-1"><a href="#cb44-1" aria-hidden="true" tabindex="-1"></a><span class="fu">tail</span>(NOTEEVENTS_DC_PATIENTS)</span></code></pre></div>
<pre><code>##       ROW_ID.x SUBJECT_ID HADM_ID  CHARTDATE CHARTTIME STORETIME
## 59647    59607       5733  122526 2141-01-30                    
## 59648    59608      93924  135672 2104-06-14                    
## 59649    59609      17782  155710 2112-03-31                    
## 59650    59621      96333  183951 2197-06-18                    
## 59651    59622      66717  169165 2129-08-14                    
## 59652    59623      73790  157100 2113-07-18                    
##                CATEGORY DESCRIPTION CGID ISERROR
## 59647 Discharge summary    Addendum   NA      NA
## 59648 Discharge summary    Addendum   NA      NA
## 59649 Discharge summary    Addendum   NA      NA
## 59650 Discharge summary    Addendum   NA      NA
## 59651 Discharge summary    Addendum   NA      NA
## 59652 Discharge summary    Addendum   NA      NA
##                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                TEXT
## 59647                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Name:  [**Known lastname 18311**], [**Known firstname 18312**]           Unit No:  [**Numeric Identifier 18313**]\n\nAdmission Date: [**2141-1-24**]        Discharge Date: [**2141-1-30**]\n\nDate of Birth:  [**2057-9-4**]        Sex:  F\n\nService:\n\n\nThis discharge summary addendum is from [**2141-1-29**] to [**2141-1-30**].\n\nHOSPITAL COURSE:\n1. Left hemothorax.  The patient is status post VATS and\n   evacuation status post chest tube removal likely secondary\n   to pacer placement and anticoagulation, holding all\n   anticoagulation.\n\n1. Acute renal failure, prerenal resolved with IV fluids.\n\n1. Hypertension.  Continued on Coreg for heart rate and blood\n   pressure control.\n\n1. Status post pacemaker placement.  She was to followup with\n   Device Clinic after D/C from rehab.\n\n1. Congestive heart failure, well compensated.  Currently\n   continue current Lasix dosing.\n\n\nDISPOSITION:  Discharge to rehab today.\n\nDISCHARGE STATUS:  Stable.\n\nDISCHARGE MEDICATIONS:\n1. Pantoprazole 40 mg p.o. q.d.\n2. Digoxin 125 mcg p.o. q.d.\n3. Celexa 10 mg p.o. q.d.\n4. Colace 100 mg p.o. b.i.d.\n5. Carvedilol 25 mg p.o. b.i.d.\n6. Flagyl 500 mg p.o. t.i.d. x2 weeks.\n7. Lisinopril 10 mg p.o. q.d.\n8. Percocet 5/325 mg 1-2 tablets p.o. q.4-6h. prn for two\n   weeks.\n9. Lasix 20 mg p.o. q.d.\n\n\nFOLLOW-UP PLANS:  Patient is to followup with [**Name6 (MD) 3812**]\n[**Name8 (MD) 18314**], NP on [**2141-1-31**] at 3:30 p.m.  The patient is also to\nfollowup with [**First Name8 (NamePattern2) 18315**] [**Location (un) **], a nurse from her primary care\nprovider&#39;s office.  She is to followup in the Device Clinic\nwith nurse practitioner, Doust on [**2141-2-9**] at 10 a.m.\n\n\n\n\n                        [**Name6 (MD) **] [**Name8 (MD) **], MD [**MD Number(2) 18316**]\n\nDictated By:[**Last Name (NamePattern1) 5109**]\nMEDQUIST36\nD:  [**2141-5-2**] 15:48:32\nT:  [**2141-5-3**] 05:12:48\nJob#:  [**Job Number 18317**]\n
## 59648 Name:  [**Known lastname 18321**],[**Known firstname 4572**]                  Unit No:   [**Numeric Identifier 18322**]\n\nAdmission Date:  [**2104-6-7**]              Discharge Date:   [**2104-6-14**]\n\nDate of Birth:  [**2031-2-5**]             Sex:   M\n\nService: MEDICINE\n\nAllergies:\nGluten / Gentamicin / Zithromax\n\nAttending:[**First Name3 (LF) 429**]\nAddendum:\nsee following medical hospitalization course.\n\nChief Complaint:\nsmall bowel perforation, gastrointestinal [**Hospital 18323**] transfer to\nmedicine\n\nMajor Surgical or Invasive Procedure:\ns/p ex-lap, SBR for SB perforation\n\n\nHistory of Present Illness:\n73 year old M with recent diagnosis of diffuse B-cell lymphoma,\ns/p CHOP #2 on steroid taper who was transferred from Caritas to\nED w/ acute onset, severe abdominal pain starting the night\nbefore admission.  The pain awoke pt from sleep, he had no prior\nepisodes, no N/V and his BM was the day prior.  He had no\nfevers.  CT at the OSH preliminarily showed free air, small\nbowel wall thickening, and he was transferred here to the\nsurgical service.  On evaluation here, he had peritoneal signs\nand was emergently taken to the OR for laparatomy and small\nbowel resection.  Intraoperatively he was found to  have a\nperforation mid-ileum with two other areas of near-perforation.\nHe was set up for d/c to rehab until pathology on the small\nbowel specimen was positive for CMV inclusions.  ID was\nconsulted and saw the patient on [**6-12**] and recommended IV\ngancicyclovir x 3 weeks with counts monitoring and transfer to\nmedicine.\n\nAt this point the patient reports that he has minimal pain at\nthe incision site.  He has loose stools that over the past day\nhave started to form.  He denies active bleeding, SOB, F/C.  He\nhas noticed  leg swelling x 1 day, bilaterally and\nsymmetrically, as well as bilateral arm swelling.  Pain 0/10.\n\nOther ROS: As above, some fatigue, chronic imbalance due to\nvestibulotoxicity form gentamicin, no hearing loss, no\nepistaxis, just runny nose, no visual changes or floaters, no\nheadache, no SOB/CP, no palpitations or cough, no N/V, minimal\nabd pain (incisional), no dysuria but has frequency, has LE\nedema, generally weak but no loss of sensation, feeling\ndysphoric from being here in the hospital, all other ROS are\nnegative.\n\nPast Medical History:\n# Diabetes Mellitus, Type II. last HbA1c 6.6 [**3-29**]\n# HTN\n# HLD\n# CAD s/p CABG 4 vessel [**2082**]\n# h/o shingles\n# esophagitis w/ hiatial hernia on EGD\n# anemia - at least partially r/t to autoimmune hemolytic anemia\n(DAT +). pt on B12 replacement.\n# myelodysplastic syndrome (see bone marrow biopsy from [**5-28**])\n# Vestibular nerve damage secondary to gentamycin\n# BPH s/p laser surgery\n# Spinal stenosis s/p laminectomy L4/L5 [**2100**]\n# celiac sprue\n# B-cell lymphoma, began in the spine, h/o cord compression\n# thrush\n\nSocial History:\nPatient is married with 3 grown children, 8 grandchildren.  He\nis retired from managing a pharmaceutical company.  Lives in\n[**Location 322**] with his wife.\n[**Name (NI) **] denies tobacco use and drinks alcohol very rarely.  He denies\n\na history of IV drug use.\n\n\nFamily History:\n[**Name (NI) **] son was diagnosed with thyroid cancer at age 40, doing well\nnow.  [**Name (NI) **] brother with prostate cancer.  [**Name (NI) **] mother died of an\nMI.\n\nPhysical Exam:\nGen: chronically ill appearing man in NAD, pale\nVS 98.4 116/66 86 20 93% RA FS 84, 151, 80\nHEENT anicteric, EOMI, pupils equal, OP clear without thrush\nNeck no JVD, no cervical LAD\nCV irreg irreg, no MRG\nPul decreased BS at bases\nAbd midline incision with staples, minimal tenderness on\npalpation, no HSM appreciated\nExt taut edema to knees bilaterally, no cord palpated, sacral\nedema, also with upper arm edema\nSkin ecchymoses of left hand, needlesticks in antecube regions\nNeuro CN 2-12 intact, muscle strength grossly intact (gait not\ntested), sensation intact to LT\nPsych appropriate, pleasant, fluent speech, normal affect,\noriented and alert\n\nPertinent Results:\n[**2104-6-10**] 07:40AM BLOOD WBC-9.6 RBC-2.84* Hgb-7.9* Hct-24.3*\nMCV-86 MCH-27.9 MCHC-32.6 RDW-18.1* Plt Ct-194\n[**2104-6-9**] 03:04AM BLOOD Neuts-93* Bands-3 Lymphs-1* Monos-0 Eos-0\nBaso-0 Atyps-0 Metas-3* Myelos-0\n[**2104-6-10**] 07:40AM BLOOD Plt Ct-194\n[**2104-6-10**] 07:40AM BLOOD Glucose-92 UreaN-14 Creat-0.6 Na-136\nK-3.6 Cl-105 HCO3-22 AnGap-13\n[**2104-6-9**] 03:04AM BLOOD LD(LDH)-142\n[**2104-6-10**] 07:40AM BLOOD Calcium-7.6* Phos-2.1* Mg-1.8\n[**2104-6-8**] 05:15AM BLOOD Albumin-2.1* Calcium-7.8* Phos-2.7 Mg-1.7\nUricAcd-2.4*\n\nSmall bowel specimen: Focal perforation with acute and chronic\ninflammation, serositis, and numerous CMV inclusions.\n\nRIJ tip culture [**2104-6-9**]\nSTAPHYLOCOCCUS, COAGULASE NEGATIVE.    &gt;15 colonies.\nSTAPHYLOCOCCUS, COAGULASE NEGATIVE.    &gt;15 colonies 2ND STRAIN.\nc/w MRSE\n\nCMV IgM, IgG positive\n\nCMV VL  3,170 copies/ml.\n\n\nBrief Hospital Course:\nAssessment/CC:[**CC Contact Info 18324**]\n# CMV involving the small bowel - ID following, confirmed by\nbiopsy, likely reactivation from chemotherapy/steroids.\nClinically seems to be improving based on patient&#39;s report of\ndecreasing diarrhea.  Needs 3 weeks of therapy and monitoring\nfor hematologic complications and to ensure renal function\nstability (as it is renally cleared).  IgG positive, IgM\nnegative, VL as above.  Needs o/p ophthalmologic evaluation for\n? any evidence of cmv retinitis.\n\n# B-cell lymphoma - Involving the bone and lymph nodes.\nChemotherapy is stalled for now due to reactivation vs. acute\ninfection due to immunosuppressed state.  His CBC remained\nstable.\n\n# line infection - Tip positive for two colony types of staph\nepi.  No blood cultures at the same time as the tip culture, so\nneed to screen for septicemia, although he already received\nvanco.  Discussed with ID attending at time of discharge, no\nneed for further vancomycin.  Surveillance culture negative for\n48 hours as of time of discharge.\n\n# Steroids - Was on it for chemotherapy and seems to have\nreceived it for 2 days for concern of adrenal insufficiency.  He\nis currently on prednisone 10 mg [**Hospital1 **].\n\n# DM2 controlled without complications - stable, on glipizide.\n\n# irregular HR on exam - No h/o AF, has h/o PVCs.\n\n# edema, NOS and hypoalbuminemia - Affecting legs, arms, sacrum.\n Likely due to hypoalbuminemia from small bowel inflammation\nwith malabsorption, celiac disease, and poor intake (this is\nsupported by slightly elevated INR).  Less likely to have\nchronic liver disease.  No evidence of CHF.\n\n# CAD/CABG - On lipitor, has not been on ASA or BB according to\noutpt med list.  Stable.\n\n# celiac sprue - On gluten free diet, stable.\n\n# Dispo - Would continue ongoing discussions with ID and case\nmanagement about eventual dispo.  Patient is unhappy about\nhaving to stay the full 3 weeks in the hospital for monitoring.\n\n\nMedications on Admission:\n(per surgery admit note)\n\nlipitor 20 daily\ndex 1 mg [**Hospital1 **]\nvalium 2.5 [**Hospital1 **] prn\nneupogen 480 daily since day 3 of chemo\nglipizide 5 [**Hospital1 **]\nmorphine 15-30 q4h prn\nnystatin S+S\nzofran 8 TID prn\npantoprazole 40 daily\nmiralax 1 tbsp [**Hospital1 **] prn\nviagra prn\n\ninpt meds currently\ninsulin sliding scale\nheparin SQ TID\nnystatin QID prn\nbacitracin TID to nose\npercocets [**11-23**] q6h prn\npantoprazole 40 daily\nprednisone 10 [**Hospital1 **]\nglipizide 5 [**Hospital1 **]\nlipitor 40 daily\ndocusate 100 [**Hospital1 **]\nganciclovir 350 IV q12h\ntamsulosin 0.4 mg QHS\nvanco 1000 mg IV q12h\n\n\nDischarge Medications:\n1. Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO\nQ6H (every 6 hours) as needed for pain for 2 weeks: do not take\nmore than 4000mg of acetaminophen in 24 hrs. .\nDisp:*45 Tablet(s)* Refills:*0*\n2. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One\n(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).\n3. Prednisone 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a\nday).\n4. Glipizide 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a\nday).\n5. Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY\n(Daily).\n6. Ganciclovir Sodium 500 mg Recon Soln Sig: Three [**Age over 90 2238**]y\n(350) mg Recon Soln Intravenous Q12H (every 12 hours) for 20\ndays.\nDisp:*[**Numeric Identifier 18325**] mg Recon Soln(s)* Refills:*0*\n7. Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY\n(Daily).\n8. Tamsulosin 0.4 mg Capsule, Sust. Release 24 hr Sig: One (1)\nCapsule, Sust. Release 24 hr PO HS (at bedtime).\n9. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2\ntimes a day) as needed for constipation.\n10. PICC CARE\nHeparin Flush (10 units/ml) 2 mL IV PRN line flush\nPICC, heparin dependent: Flush with 10mL Normal Saline followed\nby Heparin as above daily and PRN per lumen\n11. Outpatient Lab Work\nresults faxed to Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]: [**Telephone/Fax (1) 13115**]\n\nLabs Twice Weekly with  CBC/DIFF, BUN/Cr\n\nLab Weekly with CMV-Viral-Load\n\n\nDischarge Disposition:\nHome with Service\n\nFacility:\n[**Hospital **] Healthcare\n\nDischarge Diagnosis:\nPeritonitis secondary to small bowel perforation.\nCMV Enteritis\nB-Cell Lymphoma\nLine Infection\nType 2 Diabetes Controlled without Complications\nModerate Malnutrition\nCAD Bypass Vessle\n\n\nDischarge Condition:\nstable.\ntolerating regular diet\npain well controlled with oral medications.\n\n\nDischarge Instructions:\nYou are being discharged on an antiviral medication called\nganciclovir, which can make your diarhea worse for some time.\nPlease contact your doctor if you experience numbness, tingling\nor pain in hands or feet, as this may be a side effect of the\nmedication.\n\nYou will be having labs drawn every other day and sent to Dr.\n[**First Name (STitle) **] of infectious diseases for monitoring of your blood\ncounts.\n\n*Avoid lifting objects &gt; 5lbs until your follow-up appointment\nwith the surgeon.\n\n*Avoid driving or operating heavy machinery while taking pain\nmedications.\n\n* Continue to ambulate several times per day.\n\nIncision Care:\n-Your staples will be removed at your follow up appoinetment.\n-Steri-strips will be applied and will fall off on their own.\nPlease remove any remaining strips 7-10 days after application.\n-You may shower, and wash surgical incisions.\n-Avoid swimming and baths until your follow-up appointment.\n-Please call the doctor if you have increased pain, swelling,\nredness, or drainage from the incision sites.\n\nFollowup Instructions:\nYou will need to have an ophthalmalogic evaluation to make sure\nthat there is no evidence of CMV infection of the retina - this\nshould happen this week.  Please call: ([**Telephone/Fax (1) 17875**] to\nschedule this appointment; if you have any difficulty arranging\nthis, please discuss this with your primary doctor so that they\ncan facilitate/arrange this evaluation.\n\n1. Please call Dr.[**Name (NI) 18326**] office, [**Telephone/Fax (1) 18327**], to make a\nfollow up appointment in [**11-23**] weeks.\nScheduled Appointments :\nProvider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 18328**], [**MD Number(3) 6697**]:[**Telephone/Fax (1) 1578**]\nDate/Time:[**2104-6-16**] 10:30\nProvider: [**First Name8 (NamePattern2) 194**] [**Last Name (NamePattern1) **], RN Phone:[**Telephone/Fax (1) 18329**]\nDate/Time:[**2104-6-16**] 11:00\nProvider: [**Name10 (NameIs) 8835**] CHAIR 6  Date/Time:[**2104-6-16**] 11:00\n\n\n                             [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 430**] MD [**MD Number(2) 431**]\n\nCompleted by:[**2104-6-14**]
## 59649                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Name:  [**Known lastname 2706**], [**Known firstname **] I.                       Unit No:  [**Numeric Identifier 18257**]\n\nAdmission Date:  [**2112-3-12**]     Discharge Date:  [**2112-3-31**]\n\nDate of Birth:   [**2056-10-30**]     Sex:  F\n\nService:  [**Doctor Last Name **] ME\n\nADDENDUM:\n\nEvents following the first discharge summary:\n\n1.  The patient had difficulty finding a facility for\nrehabilitation.  She stayed in the hospital for several days\nwhile awaiting placement.  On [**2112-3-25**], the\npatient&#39;s course was complicated by an episode of\nunresponsiveness.  On the morning of [**2112-3-25**], the\npatient was felt to have evidence of increasing oxygen needs\nfrom two liters nasal cannula up to 4 liters nasal cannula to\nmaintain O2 saturations.  On examination, she demonstrated\nrales.\n\nIt became apparent that the patient&#39;s fluid status was not\nbeing adequately controlled by Hydrochlorothiazide alone and\nLasix 40 mg p.o. q. day was prescribed along with a dose of\nLasix intravenously.  Shortly after this examination, the\npatient was returning from the bathroom.  She had an episode\nwhere her eyes rolled into the back of her head and she\nbecame unresponsive.  Nursing personnel assisted the patient\ninto the bed and called a Code.\n\nFirst arriving physicians reported that the patient had never\nlost a pulse or respirations and appeared to have had a vagal\nepisode.  The patient regained consciousness rapidly,\nhowever, O2 saturations were falling and the patient&#39;s\nbreathing became labored.  The patient was felt to be in\nrespiratory distress secondary to flash pulmonary edema, the\nconsequence of rebound tachycardia from a vagal episode.  She\nwas given intravenous Lasix and a Nitroglycerin drip and she\nwas started on Bi-PAP with improvement in her O2 saturations.\n O2 saturations did not improve until Bi-PAP was initiated.\n\nThe patient was stabilized.  Arterial blood gases were\nchecked.  The patient&#39;s pCO2 remained stable on Bi-PAP,\nhowever, she was transferred to the Medical Intensive Care\nUnit for 24 hours in order to have Bi-PAP and ongoing\ndiuresis.  In the Medical Intensive Care Unit, the patient\nreceived ongoing diuresis and Bi-PAP.  She was called out to\nthe floor the following day.\n\nThereafter, the patient was seen by Cardiology Consultation\nService who felt that the patient most likely had diastolic\nheart disease and that it was unable to further image the\npatient secondary to her obesity.  She was not a candidate\nfor cardiac catheterization or MIBI examination.  She was\nrecommended to have a calcium channel blocker and Lasix and\nstart an ACE inhibitor, all of which was done, and the\npatient tolerated this well.  She remained stable thereafter\nwith adjustments in her cardiac medications while awaiting\nplacement to rehabilitation.\n\n2.  Hematologic:  The patient had an ongoing anemia with\nhematocrits as low as 26 following the Intensive Care Unit\nstay.  The patient refused blood transfusion because she is a\nJehovah&#39;s Witness.  Her hematocrit began to rise thereafter.\nIron studies were checked.  These were consistent with anemia\nof chronic disease.  The patient&#39;s source of bleeding was\nmost likely related to her vaginal bleeding as described\nabove and acute illness.  This will be followed up by her\nprimary care physician, [**Last Name (NamePattern4) **]. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], after discharge.\n\nDISCHARGE STATUS:  The patient is stable for discharge to a\nrehabilitation facility.\n\nDISCHARGE INSTRUCTIONS:\n1.  The patient should receive Physical Therapy for\nrehabilitation as tolerated.\n2.  She should have ongoing diuresis with Lasix, to a goal of\n1.5 liters negative per day.\n3.  To receive oxygen by nasal cannula to keep O2 saturation\nabove 90%.\n4.  She should have electrolytes checked twice weekly.\n\nDISCHARGE MEDICATIONS:\n1.  Albuterol and Ipratropium inhaler, two puffs four times a\nday.\n2.  Aspirin 325 mg p.o. q. day.\n3.  Dulcolax 10 mg p.o./p.r. twice a day p.r.n.\n4.  Colace 100 mg p.o. twice a day.\n5.  Prozac 40 mg p.o. q. day.\n6.  Fluticasone inhaler, two puffs INH twice a day.\n7.  Megace 40 mg p.o. q. day.\n8.  Albuterol inhaler q. four hours p.r.n.\n9.  Ipratropium inhaler q. four hours p.r.n.\n10. Heparin 5000 units subcutaneously twice a day.\n11. Lasix 40 mg p.o. q. day.\n12. Zestril 20 mg p.o. q. day.\n13. Diltiazem CD 120 mg p.o. q. day.\n\nDISCHARGE INSTRUCTIONS:\n1.  The patient to follow-up with her primary care physician,\n[**Last Name (NamePattern4) **]. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] at the Community Health Center.\n2.  Dr. [**Last Name (STitle) **] will arrange for OB/GYN follow-up for the\npatient as well.\n\n\n\n                          [**First Name11 (Name Pattern1) 986**] [**Last Name (NamePattern4) 14617**], M.D.  [**MD Number(1) 15691**]\n\nDictated By:[**Name8 (MD) 292**]\n\nMEDQUIST36\n\nD:  [**2112-3-30**]  15:59\nT:  [**2112-3-30**]  16:38\nJOB#:  [**Job Number **]\n
## 59650                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Name:  [**Known lastname 18357**]-[**Known lastname 5618**],[**Known firstname 194**]        Unit No:   [**Numeric Identifier 18358**]\n\nAdmission Date:  [**2197-6-14**]              Discharge Date:   [**2197-6-18**]\n\nDate of Birth:  [**2143-5-28**]             Sex:   F\n\nService: NEUROSURGERY\n\nAllergies:\nNo Known Allergies / Adverse Drug Reactions\n\nAttending:[**First Name3 (LF) 40**]\nAddendum:\nProcedures:\n\n[**2197-6-14**]: Right frontal EVD placement\n\n[**2197-6-14**]: Cerebral angiogram with coiling\n\n[**2197-6-15**]: Left sided hemicraniectomy for decompression\n\n\nDischarge Disposition:\nExpired\n\n                             [**Name6 (MD) **] [**Last Name (NamePattern4) 43**] MD [**MD Number(2) 44**]\n\nCompleted by:[**2197-7-5**]
## 59651                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Name:  [**Known lastname **],[**Known firstname 133**] J                  Unit No:   [**Numeric Identifier 18359**]\n\nAdmission Date:  [**2129-7-31**]              Discharge Date:   [**2129-8-14**]\n\nDate of Birth:  [**2049-11-27**]             Sex:   M\n\nService: CARDIOTHORACIC\n\nAllergies:\nNo Known Allergies / Adverse Drug Reactions\n\nAttending:[**First Name3 (LF) 265**]\nAddendum:\nMr. [**Known lastname **] discharge on [**2129-8-11**] was post poned due to runs of\nasymptomatic, afib w/ RVR which were initially thought to be\nnon-sustained VT. EP continued to follow Mr. [**Known lastname **] closely. On\nPOD# 13 Mr. [**Name14 (STitle) 18360**] was cleared for discharge to home with VNA and\nit was arranged for him to have [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] of Hearts Monitor upon\ndischarge. All follow up appointments and instructions were\nadvised.\n\nMedications on Admission:\nPreadmission medications listed are correct and complete.\nInformation was obtained from webOMR.\n1. Digoxin 0.25 mg PO DAILY\n2. Gabapentin 300 mg PO BID\n3. Gemfibrozil 600 mg PO BID\n4. GlipiZIDE 2.5 mg PO BID\n5. Lorazepam 0.5 mg PO HS:PRN insomnia\n6. MetFORMIN (Glucophage) 500 mg PO BID\n7. Potassium Chloride 20 mEq PO BID\n8. Pravastatin 40 mg PO DAILY\n9. Verapamil 240 mg PO Q24H\n10. Warfarin 5 mg PO DAILY16\n11. Ascorbic Acid 500 mg PO DAILY\n12. Aspirin 81 mg PO DAILY\n13. ZYRtec *NF* 10 mg Oral daily\n14. Vitamin D 1000 UNIT PO DAILY\n15. Centrum Complete *NF* (multivitamin-iron-folic acid) 18-400\nmg-mcg Oral daily\n16. Super B Complex + C *NF* (vitamin B comp &amp; C no.4) 150 mg\nOral daily\n17. Vitamin E 400 UNIT PO DAILY\n\n\nDischarge Medications:\n1. Aspirin 81 mg PO DAILY\nRX *Adult Low Dose Aspirin 81 mg 1 tablet(s) by mouth once a day\nDisp #*30 Tablet Refills:*0\n2. Gabapentin 300 mg PO BID\n3. Gemfibrozil 600 mg PO BID\n4. GlipiZIDE 2.5 mg PO DAILY\nRX *glipizide 5 mg 0.5 (One half) tablet(s) by mouth once a day\nDisp #*30 Tablet Refills:*0\n5. Potassium Chloride 20 mEq PO DAILY\nRX *potassium chloride 20 mEq 1 mEq(s) by mouth once a day Disp\n#*30 Tablet Refills:*0\n6. Pravastatin 40 mg PO DAILY\n7. Ascorbic Acid 500 mg PO DAILY\n8. Vitamin E 400 UNIT PO DAILY\n9. Docusate Sodium 100 mg PO BID\n10. Furosemide 20 mg PO DAILY\nRX *Lasix 40 mg 1 tablet(s) by mouth daily Disp #*7 Tablet\nRefills:*0\nRX *furosemide 20 mg 1 tablet(s) by mouth once a day Disp #*30\nTablet Refills:*0\n11. Metoprolol Tartrate 25 mg PO BID\nHold for HR &lt;55 or SBP &lt;95\nRX *metoprolol tartrate 25 mg 0.5 (One half) tablet(s) by mouth\ntwice a day Disp #*60 Tablet Refills:*0\n12. Pantoprazole 40 mg PO Q24H\nRX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30\nTablet Refills:*0\n13. Centrum Complete *NF* (multivitamin-iron-folic acid) 18-400\nmg-mcg Oral daily\n14. Lorazepam 0.5 mg PO HS:PRN insomnia\n15. MetFORMIN (Glucophage) 500 mg PO BID\n16. Super B Complex + C *NF* (vitamin B comp &amp; C no.4) 150 mg\nOral daily\n17. Vitamin D 1000 UNIT PO DAILY\n18. ZYRtec *NF* 10 mg Oral daily\n19. [**Hospital 18361**] Hospital Bed\nPatient has a medical condition which requires positioning of\nthe body not feasible in an ordinary bed to alleviate pain.\nDiagnosis CAD s/p CABG/AVR\n[**37**]. Warfarin 2.5 mg PO DAILY16\ndose to be determined by INR\n\n\nDischarge Disposition:\nExtended Care\n\nFacility:\ntba\n\nDischarge Instructions:\nyou will not be able to shower until your heart monitor is\nremoved. until then please wash daily including washing\nincisions gently with mild soap, no baths or swimming, and look\nat your incisions\nPlease NO lotions, cream, powder, or ointments to incisions\nEach morning you should weigh yourself and then in the evening\ntake your temperature, these should be written down on the chart\nNo driving for approximately one month and while taking\nnarcotics, will be discussed at follow up appointment with\nsurgeon when you will be able to drive\nNo lifting more than 10 pounds for 10 weeks\nPlease call with any questions or concerns [**Telephone/Fax (1) 1477**]\n**Please call cardiac surgery office with any questions or\nconcerns [**Telephone/Fax (1) 1477**]. Answering service will contact on call\nperson during off hours**\n\nLabs: PT/INR for Coumadin ?????? indication afib\nGoal INR 2.0-3.0\nFirst draw [**2129-8-15**]\nResults to phone fax Dr.[**Last Name (STitle) 18362**] [**Name (STitle) 17844**] [**Telephone/Fax (1) 18363**]\n\n\nFollowup Instructions:\nYou are scheduled for the following appointments:\nSurgeon: Dr. [**First Name (STitle) **] [**Telephone/Fax (1) 1477**] [**2129-9-6**] at 2:00p in the [**Hospital **]\nmedical office building, [**Doctor First Name **], Suite2A\n\nCardiogolist: Dr. [**Last Name (STitle) 86**] at [**Hospital1 8**] [**Hospital1 **] [**2129-8-23**] at 9:20 AM\n\nPlease call to schedule the following:\nPrimary Care Dr. [**Last Name (STitle) 17844**],[**Doctor Last Name 18362**] [**Telephone/Fax (1) 18363**] in [**4-21**] weeks\n\nLabs: PT/INR for Coumadin ?????? indication afib\nGoal INR 2.0-3.0\nFirst draw [**2129-8-15**]\nResults to phone fax Dr.[**Last Name (STitle) 18362**] [**Name (STitle) 17844**] [**Telephone/Fax (1) 18363**]\n\n**Please call cardiac surgery office with any questions or\nconcerns [**Telephone/Fax (1) 1477**]. Answering service will contact on call\nperson during off hours**\n\n*****Chest CT in 3 months to follow-up mediastinal lymph node\nenlargement on pre-op CT*****\n\n\n                             [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 266**]\n\nCompleted by:[**2129-8-14**]
## 59652                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Name:  [**Known lastname 12459**],[**Known firstname **] A                 Unit No:   [**Numeric Identifier 18364**]\n\nAdmission Date:  [**2113-7-12**]              Discharge Date:   [**2113-7-18**]\n\nDate of Birth:  [**2034-2-3**]             Sex:   M\n\nService: MEDICINE\n\nAllergies:\nNovocain / ciprofloxacin\n\nAttending:[**First Name3 (LF) 4148**]\nAddendum:\nThe esophageal varices are due to portal hypertension and the\nportal hypertension was likely due to liver metastases.\n\nDischarge Disposition:\nHome With Service\n\nFacility:\nVNA Assoc. of [**Hospital3 709**]\n\n                             [**Name6 (MD) **] [**Last Name (NamePattern4) 4150**] MD [**MD Number(2) 4151**]\n\nCompleted by:[**2113-9-15**]
##       ROW_ID.y GENDER                 DOB                 DOD
## 59647     5427      F 2057-09-04 00:00:00 2143-06-13 00:00:00
## 59648    44940      M 2031-02-05 00:00:00                    
## 59649    16811      F 2056-10-30 00:00:00 2115-03-31 00:00:00
## 59650    45552      F 2143-05-28 00:00:00 2197-06-18 00:00:00
## 59651    37873      M 2049-11-27 00:00:00                    
## 59652    39708      M 2034-02-03 00:00:00 2113-08-23 00:00:00
##                  DOD_HOSP             DOD_SSN EXPIRE_FLAG
## 59647                     2143-06-13 00:00:00           1
## 59648                                                   0
## 59649 2115-03-31 00:00:00 2115-03-31 00:00:00           1
## 59650 2197-06-18 00:00:00 2197-06-18 00:00:00           1
## 59651                                                   0
## 59652                     2113-08-23 00:00:00           1</code></pre>
<div class="sourceCode" id="cb46"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb46-1"><a href="#cb46-1" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(NOTEEVENTS_DC_PATIENTS<span class="sc">$</span>SUBJECT_ID)) <span class="co">#41127 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 41127</code></pre>
<div class="sourceCode" id="cb48"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb48-1"><a href="#cb48-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Joining the newly created table with ICD9 codes table. </span></span>
<span id="cb48-2"><a href="#cb48-2" aria-hidden="true" tabindex="-1"></a>NOTEEVENTS_DC_PATIENTS_ICD <span class="ot">&lt;-</span> dplyr<span class="sc">::</span><span class="fu">left_join</span>(NOTEEVENTS_DC_PATIENTS, DIAGNOSES_ICD, <span class="at">by =</span> <span class="st">&quot;SUBJECT_ID&quot;</span>)</span>
<span id="cb48-3"><a href="#cb48-3" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(NOTEEVENTS_DC_PATIENTS_ICD<span class="sc">$</span>SUBJECT_ID)) <span class="co">#41127 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 41127</code></pre>
<div class="sourceCode" id="cb50"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb50-1"><a href="#cb50-1" aria-hidden="true" tabindex="-1"></a><span class="co">#The new table &#39;NOTEEVENTS_DC_PATIENTS_ICD$SUBJECT_ID&#39; contains observations with discharge summaries, patients&#39; demographics and ICD codes (keep in mind that one patient often have more than one ICD code that it is dependent on billing). </span></span>
<span id="cb50-2"><a href="#cb50-2" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb50-3"><a href="#cb50-3" aria-hidden="true" tabindex="-1"></a><span class="co">#Joining the table &#39;NOTEEVENTS_DC_PATIENTS_ICD$SUBJECT_ID&#39; with admissions data which contain admission date. </span></span>
<span id="cb50-4"><a href="#cb50-4" aria-hidden="true" tabindex="-1"></a>NOTEEVENTS_DC_PATIENTS_ICD_ADM <span class="ot">&lt;-</span> dplyr<span class="sc">::</span><span class="fu">left_join</span>(NOTEEVENTS_DC_PATIENTS_ICD, ADMISSIONS, <span class="at">by =</span> <span class="st">&quot;SUBJECT_ID&quot;</span>)</span>
<span id="cb50-5"><a href="#cb50-5" aria-hidden="true" tabindex="-1"></a><span class="fu">length</span>(<span class="fu">unique</span>(NOTEEVENTS_DC_PATIENTS_ICD_ADM<span class="sc">$</span>SUBJECT_ID)) <span class="co">#41,127 unique subject IDs</span></span></code></pre></div>
<pre><code>## [1] 41127</code></pre>
<div class="sourceCode" id="cb52"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb52-1"><a href="#cb52-1" aria-hidden="true" tabindex="-1"></a><span class="fu">summary</span>(ADMISSIONS<span class="sc">$</span>SUBJECT_ID)</span></code></pre></div>
<pre><code>##    Min. 1st Qu.  Median    Mean 3rd Qu.    Max. 
##       2   11994   24134   33756   53852   99999</code></pre>
<div class="sourceCode" id="cb54"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb54-1"><a href="#cb54-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Herein will, we will drop variables that are not needed for our project.</span></span>
<span id="cb54-2"><a href="#cb54-2" aria-hidden="true" tabindex="-1"></a>MIMICIII <span class="ot">=</span> <span class="fu">select</span>(NOTEEVENTS_DC_PATIENTS_ICD_ADM, <span class="sc">-</span>ROW_ID.x, <span class="sc">-</span>ROW_ID.x.x, <span class="sc">-</span>HADM_ID.x, <span class="sc">-</span>HADM_ID.y, <span class="sc">-</span>ROW_ID.y.y, <span class="sc">-</span>HADM_ID, <span class="sc">-</span>DEATHTIME, <span class="sc">-</span>ADMISSION_LOCATION, <span class="sc">-</span>DISCHARGE_LOCATION, <span class="sc">-</span>LANGUAGE, <span class="sc">-</span>RELIGION, <span class="sc">-</span>MARITAL_STATUS, <span class="sc">-</span>EDREGTIME, <span class="sc">-</span>EDOUTTIME, <span class="sc">-</span>HOSPITAL_EXPIRE_FLAG, <span class="sc">-</span>HAS_CHARTEVENTS_DATA, <span class="sc">-</span>CHARTDATE, <span class="sc">-</span>CHARTTIME, <span class="sc">-</span>STORETIME, <span class="sc">-</span>ISERROR, <span class="sc">-</span>ROW_ID.y, <span class="sc">-</span>EXPIRE_FLAG, <span class="sc">-</span>ADMITTIME, <span class="sc">-</span>ADMISSION_TYPE, <span class="sc">-</span>DOD_HOSP, <span class="sc">-</span>DOD_SSN)</span>
<span id="cb54-3"><a href="#cb54-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb54-4"><a href="#cb54-4" aria-hidden="true" tabindex="-1"></a><span class="co">#Removing obs with &quot;addendum&quot; description as they are not needed</span></span>
<span id="cb54-5"><a href="#cb54-5" aria-hidden="true" tabindex="-1"></a><span class="fu">unique</span>(MIMICIII<span class="sc">$</span>DESCRIPTION)</span></code></pre></div>
<pre><code>## [1] &quot;Report&quot;   &quot;Addendum&quot;</code></pre>
<div class="sourceCode" id="cb56"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb56-1"><a href="#cb56-1" aria-hidden="true" tabindex="-1"></a>MIMICIII <span class="ot">&lt;-</span> <span class="fu">filter</span>(MIMICIII, DESCRIPTION <span class="sc">!=</span> <span class="st">&#39;Addendum&#39;</span>)</span>
<span id="cb56-2"><a href="#cb56-2" aria-hidden="true" tabindex="-1"></a><span class="fu">which</span>(<span class="fu">is.na</span>(MIMICIII<span class="sc">$</span>DESCRIPTION))</span></code></pre></div>
<pre><code>## integer(0)</code></pre>
<p>##Results #Creating a basic demographic table</p>
<div class="sourceCode" id="cb58"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb58-1"><a href="#cb58-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Pulling pertinent dataset to create demographic table. </span></span>
<span id="cb58-2"><a href="#cb58-2" aria-hidden="true" tabindex="-1"></a>Demographic <span class="ot">&lt;-</span> <span class="fu">select</span>(MIMICIII, GENDER, ETHNICITY, INSURANCE, DIAGNOSIS)</span>
<span id="cb58-3"><a href="#cb58-3" aria-hidden="true" tabindex="-1"></a>Demographic <span class="sc">%&gt;%</span> gtsummary<span class="sc">::</span><span class="fu">tbl_summary</span>()</span></code></pre></div>
<div id="cakrnlkcqt" style="overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>html {
font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;
}
#cakrnlkcqt .gt_table {
display: table;
border-collapse: collapse;
margin-left: auto;
margin-right: auto;
color: #333333;
font-size: 16px;
font-weight: normal;
font-style: normal;
background-color: #FFFFFF;
width: auto;
border-top-style: solid;
border-top-width: 2px;
border-top-color: #A8A8A8;
border-right-style: none;
border-right-width: 2px;
border-right-color: #D3D3D3;
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #A8A8A8;
border-left-style: none;
border-left-width: 2px;
border-left-color: #D3D3D3;
}
#cakrnlkcqt .gt_heading {
background-color: #FFFFFF;
text-align: center;
border-bottom-color: #FFFFFF;
border-left-style: none;
border-left-width: 1px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 1px;
border-right-color: #D3D3D3;
}
#cakrnlkcqt .gt_title {
color: #333333;
font-size: 125%;
font-weight: initial;
padding-top: 4px;
padding-bottom: 4px;
padding-left: 5px;
padding-right: 5px;
border-bottom-color: #FFFFFF;
border-bottom-width: 0;
}
#cakrnlkcqt .gt_subtitle {
color: #333333;
font-size: 85%;
font-weight: initial;
padding-top: 0;
padding-bottom: 6px;
padding-left: 5px;
padding-right: 5px;
border-top-color: #FFFFFF;
border-top-width: 0;
}
#cakrnlkcqt .gt_bottom_border {
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
}
#cakrnlkcqt .gt_col_headings {
border-top-style: solid;
border-top-width: 2px;
border-top-color: #D3D3D3;
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
border-left-style: none;
border-left-width: 1px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 1px;
border-right-color: #D3D3D3;
}
#cakrnlkcqt .gt_col_heading {
color: #333333;
background-color: #FFFFFF;
font-size: 100%;
font-weight: normal;
text-transform: inherit;
border-left-style: none;
border-left-width: 1px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 1px;
border-right-color: #D3D3D3;
vertical-align: bottom;
padding-top: 5px;
padding-bottom: 6px;
padding-left: 5px;
padding-right: 5px;
overflow-x: hidden;
}
#cakrnlkcqt .gt_column_spanner_outer {
color: #333333;
background-color: #FFFFFF;
font-size: 100%;
font-weight: normal;
text-transform: inherit;
padding-top: 0;
padding-bottom: 0;
padding-left: 4px;
padding-right: 4px;
}
#cakrnlkcqt .gt_column_spanner_outer:first-child {
padding-left: 0;
}
#cakrnlkcqt .gt_column_spanner_outer:last-child {
padding-right: 0;
}
#cakrnlkcqt .gt_column_spanner {
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
vertical-align: bottom;
padding-top: 5px;
padding-bottom: 5px;
overflow-x: hidden;
display: inline-block;
width: 100%;
}
#cakrnlkcqt .gt_group_heading {
padding-top: 8px;
padding-bottom: 8px;
padding-left: 5px;
padding-right: 5px;
color: #333333;
background-color: #FFFFFF;
font-size: 100%;
font-weight: initial;
text-transform: inherit;
border-top-style: solid;
border-top-width: 2px;
border-top-color: #D3D3D3;
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
border-left-style: none;
border-left-width: 1px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 1px;
border-right-color: #D3D3D3;
vertical-align: middle;
}
#cakrnlkcqt .gt_empty_group_heading {
padding: 0.5px;
color: #333333;
background-color: #FFFFFF;
font-size: 100%;
font-weight: initial;
border-top-style: solid;
border-top-width: 2px;
border-top-color: #D3D3D3;
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
vertical-align: middle;
}
#cakrnlkcqt .gt_from_md > :first-child {
margin-top: 0;
}
#cakrnlkcqt .gt_from_md > :last-child {
margin-bottom: 0;
}
#cakrnlkcqt .gt_row {
padding-top: 8px;
padding-bottom: 8px;
padding-left: 5px;
padding-right: 5px;
margin: 10px;
border-top-style: solid;
border-top-width: 1px;
border-top-color: #D3D3D3;
border-left-style: none;
border-left-width: 1px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 1px;
border-right-color: #D3D3D3;
vertical-align: middle;
overflow-x: hidden;
}
#cakrnlkcqt .gt_stub {
color: #333333;
background-color: #FFFFFF;
font-size: 100%;
font-weight: initial;
text-transform: inherit;
border-right-style: solid;
border-right-width: 2px;
border-right-color: #D3D3D3;
padding-left: 5px;
padding-right: 5px;
}
#cakrnlkcqt .gt_stub_row_group {
color: #333333;
background-color: #FFFFFF;
font-size: 100%;
font-weight: initial;
text-transform: inherit;
border-right-style: solid;
border-right-width: 2px;
border-right-color: #D3D3D3;
padding-left: 5px;
padding-right: 5px;
vertical-align: top;
}
#cakrnlkcqt .gt_row_group_first td {
border-top-width: 2px;
}
#cakrnlkcqt .gt_summary_row {
color: #333333;
background-color: #FFFFFF;
text-transform: inherit;
padding-top: 8px;
padding-bottom: 8px;
padding-left: 5px;
padding-right: 5px;
}
#cakrnlkcqt .gt_first_summary_row {
border-top-style: solid;
border-top-color: #D3D3D3;
}
#cakrnlkcqt .gt_first_summary_row.thick {
border-top-width: 2px;
}
#cakrnlkcqt .gt_last_summary_row {
padding-top: 8px;
padding-bottom: 8px;
padding-left: 5px;
padding-right: 5px;
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
}
#cakrnlkcqt .gt_grand_summary_row {
color: #333333;
background-color: #FFFFFF;
text-transform: inherit;
padding-top: 8px;
padding-bottom: 8px;
padding-left: 5px;
padding-right: 5px;
}
#cakrnlkcqt .gt_first_grand_summary_row {
padding-top: 8px;
padding-bottom: 8px;
padding-left: 5px;
padding-right: 5px;
border-top-style: double;
border-top-width: 6px;
border-top-color: #D3D3D3;
}
#cakrnlkcqt .gt_striped {
background-color: rgba(128, 128, 128, 0.05);
}
#cakrnlkcqt .gt_table_body {
border-top-style: solid;
border-top-width: 2px;
border-top-color: #D3D3D3;
border-bottom-style: solid;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
}
#cakrnlkcqt .gt_footnotes {
color: #333333;
background-color: #FFFFFF;
border-bottom-style: none;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
border-left-style: none;
border-left-width: 2px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 2px;
border-right-color: #D3D3D3;
}
#cakrnlkcqt .gt_footnote {
margin: 0px;
font-size: 90%;
padding-left: 4px;
padding-right: 4px;
padding-left: 5px;
padding-right: 5px;
}
#cakrnlkcqt .gt_sourcenotes {
color: #333333;
background-color: #FFFFFF;
border-bottom-style: none;
border-bottom-width: 2px;
border-bottom-color: #D3D3D3;
border-left-style: none;
border-left-width: 2px;
border-left-color: #D3D3D3;
border-right-style: none;
border-right-width: 2px;
border-right-color: #D3D3D3;
}
#cakrnlkcqt .gt_sourcenote {
font-size: 90%;
padding-top: 4px;
padding-bottom: 4px;
padding-left: 5px;
padding-right: 5px;
}
#cakrnlkcqt .gt_left {
text-align: left;
}
#cakrnlkcqt .gt_center {
text-align: center;
}
#cakrnlkcqt .gt_right {
text-align: right;
font-variant-numeric: tabular-nums;
}
#cakrnlkcqt .gt_font_normal {
font-weight: normal;
}
#cakrnlkcqt .gt_font_bold {
font-weight: bold;
}
#cakrnlkcqt .gt_font_italic {
font-style: italic;
}
#cakrnlkcqt .gt_super {
font-size: 65%;
}
#cakrnlkcqt .gt_footnote_marks {
font-style: italic;
font-weight: normal;
font-size: 75%;
vertical-align: 0.4em;
}
#cakrnlkcqt .gt_asterisk {
font-size: 100%;
vertical-align: 0;
}
#cakrnlkcqt .gt_indent_1 {
text-indent: 5px;
}
#cakrnlkcqt .gt_indent_2 {
text-indent: 10px;
}
#cakrnlkcqt .gt_indent_3 {
text-indent: 15px;
}
#cakrnlkcqt .gt_indent_4 {
text-indent: 20px;
}
#cakrnlkcqt .gt_indent_5 {
text-indent: 25px;
}
</style>
<table class="gt_table">
  
  <thead class="gt_col_headings">
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col"><strong>Characteristic</strong></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col"><strong>N = 7,639,436</strong><sup class="gt_footnote_marks">1</sup></th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td class="gt_row gt_left">GENDER</td>
<td class="gt_row gt_center"></td></tr>
    <tr><td class="gt_row gt_left">F</td>
<td class="gt_row gt_center">3,806,909 (50%)</td></tr>
    <tr><td class="gt_row gt_left">M</td>
<td class="gt_row gt_center">3,832,527 (50%)</td></tr>
    <tr><td class="gt_row gt_left">ETHNICITY</td>
<td class="gt_row gt_center"></td></tr>
    <tr><td class="gt_row gt_left">AMERICAN INDIAN/ALASKA NATIVE</td>
<td class="gt_row gt_center">1,381 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMERICAN INDIAN/ALASKA NATIVE FEDERALLY RECOGNIZED TRIBE</td>
<td class="gt_row gt_center">158 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN</td>
<td class="gt_row gt_center">38,835 (0.5%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - ASIAN INDIAN</td>
<td class="gt_row gt_center">66,782 (0.9%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - CAMBODIAN</td>
<td class="gt_row gt_center">2,305 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - CHINESE</td>
<td class="gt_row gt_center">9,278 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - FILIPINO</td>
<td class="gt_row gt_center">8,367 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - JAPANESE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - KOREAN</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - OTHER</td>
<td class="gt_row gt_center">381 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - THAI</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASIAN - VIETNAMESE</td>
<td class="gt_row gt_center">2,098 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLACK/AFRICAN</td>
<td class="gt_row gt_center">7,284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLACK/AFRICAN AMERICAN</td>
<td class="gt_row gt_center">3,437,950 (45%)</td></tr>
    <tr><td class="gt_row gt_left">BLACK/CAPE VERDEAN</td>
<td class="gt_row gt_center">7,344 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLACK/HAITIAN</td>
<td class="gt_row gt_center">7,280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARIBBEAN ISLAND</td>
<td class="gt_row gt_center">203 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC OR LATINO</td>
<td class="gt_row gt_center">122,116 (1.6%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - CENTRAL AMERICAN (OTHER)</td>
<td class="gt_row gt_center">664 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - COLOMBIAN</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - CUBAN</td>
<td class="gt_row gt_center">2,431 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - DOMINICAN</td>
<td class="gt_row gt_center">3,981 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - GUATEMALAN</td>
<td class="gt_row gt_center">14,566 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - HONDURAN</td>
<td class="gt_row gt_center">115 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - MEXICAN</td>
<td class="gt_row gt_center">175 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - PUERTO RICAN</td>
<td class="gt_row gt_center">109,920 (1.4%)</td></tr>
    <tr><td class="gt_row gt_left">HISPANIC/LATINO - SALVADORAN</td>
<td class="gt_row gt_center">1,189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIDDLE EASTERN</td>
<td class="gt_row gt_center">7,658 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI RACE ETHNICITY</td>
<td class="gt_row gt_center">5,874 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER</td>
<td class="gt_row gt_center">735 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OTHER</td>
<td class="gt_row gt_center">117,558 (1.5%)</td></tr>
    <tr><td class="gt_row gt_left">PATIENT DECLINED TO ANSWER</td>
<td class="gt_row gt_center">14,798 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">PORTUGUESE</td>
<td class="gt_row gt_center">21,894 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">SOUTH AMERICAN</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNABLE TO OBTAIN</td>
<td class="gt_row gt_center">13,081 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">UNKNOWN/NOT SPECIFIED</td>
<td class="gt_row gt_center">81,285 (1.1%)</td></tr>
    <tr><td class="gt_row gt_left">WHITE</td>
<td class="gt_row gt_center">3,508,540 (46%)</td></tr>
    <tr><td class="gt_row gt_left">WHITE - BRAZILIAN</td>
<td class="gt_row gt_center">3,008 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WHITE - EASTERN EUROPEAN</td>
<td class="gt_row gt_center">1,114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WHITE - OTHER EUROPEAN</td>
<td class="gt_row gt_center">2,355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WHITE - RUSSIAN</td>
<td class="gt_row gt_center">16,204 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">INSURANCE</td>
<td class="gt_row gt_center"></td></tr>
    <tr><td class="gt_row gt_left">Government</td>
<td class="gt_row gt_center">108,018 (1.4%)</td></tr>
    <tr><td class="gt_row gt_left">Medicaid</td>
<td class="gt_row gt_center">2,135,048 (28%)</td></tr>
    <tr><td class="gt_row gt_left">Medicare</td>
<td class="gt_row gt_center">4,189,279 (55%)</td></tr>
    <tr><td class="gt_row gt_left">Private</td>
<td class="gt_row gt_center">1,191,277 (16%)</td></tr>
    <tr><td class="gt_row gt_left">Self Pay</td>
<td class="gt_row gt_center">15,814 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">DIAGNOSIS</td>
<td class="gt_row gt_center"></td></tr>
    <tr><td class="gt_row gt_left"></td>
<td class="gt_row gt_center">3,422 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">        MITRAL STENOSIS\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">   DUODENAL MASS/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> ? SEROTONIN SYNDROME</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> ABDOMINAL AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> ABSENCE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> ADENOID CYSTIC CARCINOMA/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> ANALOMOUS PULMANARY VEIN\ REPAIR ANALOMOUS ; PULMONARY VEIN/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> AORTIC ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> AORTIC STENOSIS\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CAD\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CAS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CHARCOT DEFORMITY/DIABETIC MYELITIS/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CHEST PAIN</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CORONARY ARTERY DISEASE &amp; MITRAL REGURGITATION\ CORONARY ARTERY BYPASS GRAFT W/MVR/SDA</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CORONARY ARTERY DISEASE\ BENTAL PROCEDURE; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">1,377 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> CORONATY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> HYPOXIA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> INTRACTABLE EPILEPSY/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> LEFT FOOT GANGRENE/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> MELANOMA LOWER BACK/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> MITRAL REGURGITATION;CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR  ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> OPEN WOUND TO THE CHEST/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> PERFORATED DIVERTICULITIS STATUS/POST HARTMANN PROCEDURE/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> RESIDUAL ACOM ANEURYSM/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> STATUS/POST RIGHT COLON ESCHEMIA REQUIRING ILEOSTOMY/SDA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> STEMI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left"> THORACIC ANEURYSM\REPLACEMENT OF ASCENDING AORTIC / HEMI ARCH UNDER DEEP HYPOTHERMIC CIRCULATORY ARREST /SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? ABSCESS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? ACUTE MI\CATH</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? AORTIC DISSECTION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? AORTIC FILLING DEFECT</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? BABESIOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? BILE LEAK;HYPOXIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? BOWEL PERFORATION</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? BRAIN TUMOR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? BRONCHOPLEURAL FISTULA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? CABGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? CARDIOMYOPATHY</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? CAROTID DISSECTION</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? CHOLANGITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? CORD COMPRESSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? CVA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? ENDOCARDITIS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? ESOPHAGEAL FB; POSS MEDIASTINITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? FAILURE GRAFT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? FOCAL WEAKNESS;S/P SPINE SURGERY</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? FOREIGN BODY INGESTION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? GALLSTONES; PANCREATITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? GATROINTESTINAL BLEED</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? GI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? GRAFT INFECTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? GUILLIAN BARRE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? HEAD MASS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? INFECTED AORTA GRAFT</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? INGESTION</td>
<td class="gt_row gt_center">348 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? ISCHEMIC BOWEL</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? ISCHEMIC COLITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? KIDNEY TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? OVERDOSE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PANCREAS TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PERITONITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PNA INFILTRATE</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PSTERIOR FOSSA MASS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PULMONARY EMBOLUS WITH DESATURATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PULMONARY TUBERCULOSIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? PYELONEPHRITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? RHABDOMYLSIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? RUPTURED ILIAC ANEURYSM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SEIZURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SEPSIS</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SEPTIC ARTHRITIS</td>
<td class="gt_row gt_center">275 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SEPTIC KNEE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SKULL FX</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SPINAL INJURY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SPINE INJURY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? STERNAL WOUND INFECTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SUBDURAL HEMATOMA-SPINE FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? SYNCOPE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? TB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? THYROID STORM</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? UPPER GASTROINTESTINAL BLEED-NAUSEA-VOMITING</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? UROSEPSIS</td>
<td class="gt_row gt_center">343 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">? VOLVULUS</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?? CVA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?ANEURYSM</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?AORTIC DISSECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?AORTIC DISSECTION\ VALVE SPARING AND AORTIC ROUTE ARCH/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?CAD\CARDIAC CATH</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?CBD STONES, ABSCESS IN LIVER, BILE LEAK</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">1,910 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?ESOPHAGEAL FB</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?FREE AIR</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?LABOR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?LEEFT BASAL GANGLIA BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?LGIB/LIVER FAILURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?OBSTRUCTION</td>
<td class="gt_row gt_center">436 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?PANCREATITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?PCP PNEUMONIA VS. COPD EXACERBATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?PELVIC ABSCESS;TELEMETRY</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?PORTAL VEIN THROMBOSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?SEIZURES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?SEPSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?SEPSIS;PYELONEPHRITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?STERNAL ISSUES\STERNUM REVISION ? PLATING/SDA</td>
<td class="gt_row gt_center">350 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?STEROID PSYCHOSIS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?TB;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">?TIA;IV HEPARIN</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">.\VENTRICULAR TACHYCARDIA ABLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">(+)STRESS TEST;ANGINA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">(AML) ACUTE MYELOGENOUS LEUKEMIA</td>
<td class="gt_row gt_center">2,094 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">(AML) ACUTE MYELOGENOUS LEUKEMIA;HYPOTENSION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">(AML) ACUTE MYELOGENOUS LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ ETT\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ MI,UNSTABLE ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ MI\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ TROPONIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+\INITIATE DIALYSIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT</td>
<td class="gt_row gt_center">83 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT, S/P MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT; CHEST PAIN\CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT;ANGINA\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">103 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT;DYSPNEA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT;LEFT MAIN DISEASE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT;UNSTABLE ANGINA\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT/CATH/BALLOON PUMP/?CABG\CATH</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT\CATH</td>
<td class="gt_row gt_center">1,203 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+ETT\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">+MIBI;CATH;DEHYDRATION\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">02-239</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">02-ADU</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">0681</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">0778</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">12-AQV</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">14-AAA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">17 WEEKS IUFD, SEPTIC AB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">2 WEEKS/2DAYS POST PARTUM;BLEEDING</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">20 WKS;ABD PAIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">22 WEEKS PREGNANT;ULCER FLARE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">22WKS LUPUS</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">24 WEEKS PREGNANT;KIDNEY STONE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">25 WEEKS ABDOMINAL PAIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">26WKS,PIH,PREECLAMPSIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">28 WEEKS PANCREATIC CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">28 WEEKS PREGNANT;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">29WKS &amp; 2DAYS HYPERTENSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">29WKS,GALLSTONE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">2ND DEGREE BURN RIGHT LOWER LEG;CELLULITIS;DIABETES</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">2ND DEGREE HEART BLOCK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3 VESSEL CAD; ANGINA\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3 VESSEL CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3 VESSEL DISEASE</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3 VESSEL DISEASE REQUIRING CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3 VESSEL DISEASE;+ETT\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3 VESSELL CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3-VESSEL CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">32 WEEKS,TWINS,PRECLAMPSIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">34 WEEKS PLACENTA CREDA AND ABD PAIN</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">34 WEEKS;PREGNANCY INDUCED HYPERTENSION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">35.5 WKS TWINS FOR C/SECTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">37 WEEKS;ATRIAL FIBRILLATION;TELEMETRY;TACHYCARDIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">38 WK INDUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">39WKS LABOR</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD AV BLOCK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD DEGREE HB; S/P MVC</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD DEGREE HEART BLOCK</td>
<td class="gt_row gt_center">279 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD DEGREE HEART BLOCK SARCOID</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD DEGREE HEART BLOCK, AORTIC VEGETATION</td>
<td class="gt_row gt_center">477 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD NERVE PALSY</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD, 4TH, 5TH FINGER PARTIAL AMPUATION RIGHT HAND</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">3RD. DEGREE AV BLOCK</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">40 &amp; 6WKS LABOR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">4TH VENTRICULAR TUMOR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">5-7\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">6 WEEKS,HYPERGLYCEMIA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">7 DAYS PP,PULMONARY EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">90% LEFT MAIN CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A - FIB</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A FAILED RIGHT TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A FIB</td>
<td class="gt_row gt_center">297 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A FIB;DEHYDRATION</td>
<td class="gt_row gt_center">261 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A FIB;PACER LEAD INFECTION\ PACER LEAD EXTRACTION W/ PUMP STANDY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A FIB;PNEUMONIA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A TYPICAL CHEST PAIN\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A- FLUTTER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB,CAD,CRF</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB,R/O MI</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB,RVR/CHF,R/O MI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB;CONGESTIVE HEART FAILURE\TEE;CARDIOVERSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB;MR\ AORTIC &amp; MITRAL VALVE REPLACEMENT;MAZE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB;RVR</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB\MINI MAZE PROCEDURE BILATERAL; PULMONARY VEIN ISOLATION;VIDEO ASSISTED WITH RESECTION LEFT ATRIAL APPENDAGE  /SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB\TEE; CARDIOVERSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FIB\THORACOSCOPIC MAZE PROCEDURE LEFT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A-FLUTTER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A,FLUTTER W,RVR,? NEW BRAIN MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A. FIB</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A. FLUTTER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A.FIB</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">A/P ARREST</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA /SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA CAD\BENTALL PROCEDURE;CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA REPAIR</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA RUPTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA, RIGHT RENAL ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA;</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA/SDA</td>
<td class="gt_row gt_center">309 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\ ASCENDING AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\ RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\ACENDING AORTA REPAIR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\AORTIC VALVE REPLACEMENT; RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\AORTIC VALVE REPLACEMENT;ASCENDING AORTIC  REPLACEMENT;AORTIC ARCH REPLACEMENT;DHCA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\ASCENDING AORTIC ARCH REPAIR/REPLACEMENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AAA\RESECTION ANEURYSM THORACIC DESCENDING </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABCESS</td>
<td class="gt_row gt_center">384 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD ABSCESS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD AORTIC ANEURYSM</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN</td>
<td class="gt_row gt_center">2,132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN, LIKELY LGIB</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN, MASTOCYTOSIS</td>
<td class="gt_row gt_center">4,370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN,EKG CHANGES,TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN,NAUSEA,VOMITING,DIARRHEA,MENTAL STATUS CHANGES,R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN,PNA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD PAIN; CBD; DILATED DUCT\ERCP</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD TRAUMA,FREE FLUID IN ABD</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD WOUND</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD. PAIN</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABD. PAIN </td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">ABDMOMINAL PAIN</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ABCESS</td>
<td class="gt_row gt_center">812 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ABSCESS</td>
<td class="gt_row gt_center">1,048 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ABSCESS;BACTEREMIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ABSCESS;CHRON&#39;S DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ABSCESS;TELEMETRY</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ANEURYSM; NO RUPTURE/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM</td>
<td class="gt_row gt_center">2,946 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM /SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM DISECTION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM LEAK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM THROMBOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM;</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM;? ULCERATIVE COLITIS</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM;SEVERE ILIAC DISEASE/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM;TELEMETRY</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">7,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM\ABDOMINAL AORTIC ANEURYSM REPAIR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSM\CATH</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANEURYSMECTOMY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC ANURISM REPAIR</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL AORTIC OCCLUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL BLEED</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL BLEEDING</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL DISTENSION</td>
<td class="gt_row gt_center">714 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL DISTENTION;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL FISTULA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL FLUID COLLECTION</td>
<td class="gt_row gt_center">544 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL HERNIA; HYDRP OF GALLBLADDER/SDA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL INFECTION</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL LAXITY/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL MASS</td>
<td class="gt_row gt_center">231 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL MASS/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL METS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIM</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN</td>
<td class="gt_row gt_center">269,448 (3.5%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN INCREASED BILIRUBIN</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN S/P MVC</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-CHEST PAIN</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-DIARRHEA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-ELECTROLYTE ABNORMALITIES</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-FEVER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN-RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN, HYPERKALEMIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN, NAUSEA VOMITING</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN, NAUSEA, VOMITING</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN,?SEPSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN,FEVER</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN,HYPOTENSION</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN,R/O PANCREATIC CANCER IN COMMON BILE DUCT</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN,SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN; ? CHOLANGITIS</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN; HYPOTENSION</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;ABDOMINAL MASS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;ACUTE DIVERTICULITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;ANEMIA</td>
<td class="gt_row gt_center">528 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;AORTIC DISSECTION;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;ASCITES;TAHYCARDIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;ATRIAL FIBRILLATION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;CARDIAC ARREST</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;CELLULITIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;CHOLANGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;CIRRHOSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;COLITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;DIARRHEA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;EVALUATION FOR LYMPHOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;EXPLORATORY LAP</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;EXPLORATORY LAPAROSCOPY;BILE DUCT OBSTRUCTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;FEVER</td>
<td class="gt_row gt_center">317 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;FIBROMYALGIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;HYPOTENSION</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;INABILITY TO TOLERATE PO</td>
<td class="gt_row gt_center">528 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;JAUNDICE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;LEFT KIDNEY STONE;NEUTROPENIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;MALFUCNTION STENT GRAFT</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;MELENA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;NAUSEA,DIARRHEA</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">6,191 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;NEUTROPENIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;OBSTRUCTIVE JAUNDICE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;PANCREATITIS</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;PERFORATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;PNEUMONIA</td>
<td class="gt_row gt_center">660 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;PORTAL VEIN THROMBOSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;RECTAL CANCER</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;RISING WBC</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;S/P ERCP</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;SHORTNESS OF BREATH;ELEVATED LIVER FUNCTION TEST</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;SHORTNESS OF BREATH;HYPERKALEMIA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;STENT PLACEMENT</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;TELEMETRY</td>
<td class="gt_row gt_center">32,802 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;VOMITING</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN;VOMITING;INSULIN DEPENDENT DIABETES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN.</td>
<td class="gt_row gt_center">880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN&#39;</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN/ CIRRHOSIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN/ EXPLORATORY LAPAROTOMY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN/?CHOLANGITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN/ETOH INTOXICATION</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN\ERCP</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PAIN\ERCP </td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PERFORATION</td>
<td class="gt_row gt_center">234 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL PIAN;R/O BILE LEAK\ERCP</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL SEPSIS</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL STABBING</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL THORACIC ANEURYSM\ REPAIR ABDOMINAL THORACIC AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL TRAUMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL TRAUMA,HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL WALL BLEEDING</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL WALL HEMATOMA</td>
<td class="gt_row gt_center">457 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL WALL HERNIAS/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL WOUND EXPLORATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMINAL WOUND INFECTION</td>
<td class="gt_row gt_center">61 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABDOMONAL PAIN</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL AORTIC ANEURYSM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL EEG</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL EKG;ELEVATED TROPONIN</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL EKG\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL ELEKTROKARDIOGRAMM\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL ENDOMETRIUM</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL ENDOSCOPY\EUS</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL HEAD CT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL LABS</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL PAPS SMEAR</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABNORMAL STESS TEST\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABOMINAL PAIN</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS</td>
<td class="gt_row gt_center">1,949 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS CELLULITIS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS OF GALLSTONES/SDA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS, HYPERGLYCEMIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS,SEPSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS;NECROIZING FASCIITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ABSCESS;RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AC CHOLECYSTITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AC PANCREATITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACA ANEURYSM</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACALCULUS CHOLECYSTITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACCENDING AORTIC ANEURSYM\ASSCENDING AORTA REPLACEMENT/ MAZE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACENDING AORTA\  ROUTE REPLACEMENT VS DAVID PROCEDURE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACENDING AORTIC ANEYRYS\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACETABULAR FRACTURE</td>
<td class="gt_row gt_center">95 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACETAMINOPHEN  OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACETAMINOPHEN OVER DOSE;LIVER FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACETAMINOPHEN OVERDOSE</td>
<td class="gt_row gt_center">221 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACETAMINOPHEN TOXICITY</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACETOMENGOHEN OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACHALASIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACHALASIA;DEHYDRATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACHALASIA/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACIDEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACIDEMIA; ELECTROLYTE ABNORMALITIES</td>
<td class="gt_row gt_center">756 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACIDOSIS</td>
<td class="gt_row gt_center">2,957 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACIDOSIS-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACIDOSIS, RULE OUT  SEPSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACIDOSIS;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACITIC STENOSIS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACOM ANEURYSM/SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACOUSTIC NEUROMA LEFT EAR/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACOUSTIC NEUROMA RIGHT EAR/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACOUSTIC NEUROMA RIGHT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACOUSTIC NEUROMA, LEFT EAR/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACQUIRED CARDIAC SEPTAL DEFECT\VENTRICULAR SEPTAL DEFECT REPAIR; ? MVR/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACQUIRED RIGHT BREAST DEFORMITY/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACS/CHF</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACSITES</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACTIVE HEMOPTYSIS</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUT CORONARY SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUT RENAL FAILURE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE  RENAL FAILURE</td>
<td class="gt_row gt_center">18,360 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ABDOMEN</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ABDOMINAL PAIN;COLECTOMY;HYPOTENSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ALLERGIC REACTION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ANEMIA</td>
<td class="gt_row gt_center">1,880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ANT MI</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ANTERIOR MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE AORTIC DISSECTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE APPENDICITIS</td>
<td class="gt_row gt_center">1,900 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ASTHMA EXACERBATION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CEREBRAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CEREBRAL VASCULAR ACCIDENT VS SEIZURES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHEST CRISIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLANGITIS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLECYSTITIS</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLECYSTITIS/ACS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLENGITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLEYCISTITIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLEYCYSTITIS</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLEYSTITIS,LLL PNEUMONIA,URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHOLYCYSTITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHRONIC RENAL FAILURE;DIABETES MELLITUS</td>
<td class="gt_row gt_center">236 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CHRONIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE COROMARY SYNDROME;PEUMONIA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARUY SYNDROME</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY ARTERY SYNDROME</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY DISEASE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY STENT THROMBOSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">27,606 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME-SYNCOPE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME,CHF</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME; CHF</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME; TROPS; NAUSEA AND VOMITING</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;ALTERED MENTAL STATUS;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;CHEST PAIN</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;PNEUMONIA;INFLUENZA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;ST ELEVATION MI</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;STATUS EPILLECTUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;TELEMETRY</td>
<td class="gt_row gt_center">107 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME;TELEMTRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\CARDIAC CATH</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\CARDIAC INTERVENTION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\CATH</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">101 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROME\MITRAL VALVE REPLACEMENT; LVAD</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CORONARY SYNDROMES</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CVA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE CVA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE DISSEMINATED ENCEPHALOMYELITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE EPIGLOTITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE EPIGLOTTITIS </td>
<td class="gt_row gt_center">406 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE FEVER;SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE GASTROENTERISTIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE GI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE GI BLEED;VARICOSIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE HEPATIC FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE HEPATITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE HEPATITIS A</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE IMI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE INFECTED LEFT FOOT;ABSCESS;DIABETES</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE INFERIOR MI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE INFERIOR MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE INFERIOR MYOCARDIAL INFARCTION\RIGHT CORONARY ARTERY ANGIOPLASTY;STENT PLACEMENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE INTOXICATION</td>
<td class="gt_row gt_center">190 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ISCHEMIC STROKE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE JAUNDICE, HEPATITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE KETOACIDOSIS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE KIDNEY FAILURE;HYPERKALEMIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEAUKEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEFT CEREBRAL VASSCULAR ACCIDENT ISCHEMIC STROKE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEG PAIN;SYNCOPE;TELEMETRY;</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEUKEMIA</td>
<td class="gt_row gt_center">585 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEUKEMIA;INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEUKEMIA;NEUTROPENIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LEUKEMIC CRISIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LIVER DISEASE; TYLENOL TOXICITY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LIVER FAILURE</td>
<td class="gt_row gt_center">376 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LIVER FAILURE;2/2 TYLENOL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LIVER INJURY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LOWER EXTREMITY ISCHEMIA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LUKEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LYMPHOBLASTIC LEUKEMIA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LYMPHOCYTIC LEUKEMIA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LYMPHOCYTIC LEUKEMIA;DECREASED PULMONARY FUNCTION TEST</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LYMPHOCYTIC LEUKEMIA;FEBRILE NEUTROPENIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LYMPHOCYTIC LEUKEMIA;FEVER;NEUTROPENIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE LYMPHOCYTIC LEUKEMIA;NEUTROPENIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MENTAL STATUS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MENTAL STATUS CHANGES/RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI</td>
<td class="gt_row gt_center">974 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI, MOTOR VEHICAL CRASH</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI,CAD</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI,SEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI; AORTIC VALVE DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI&#39;</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI/GI BLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI\CATH</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MITRAL REGURITATION R/O MI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MIU\CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MONOCYTIC LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA</td>
<td class="gt_row gt_center">218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA,PHEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;BACK PAIN</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;CHEMOTHERAPY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;CTX</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;FEVER</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;FEVER;NEUTROPENIA;R/O TOOTH INFECTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;MYELODYSPLASTIC SYNDROMES</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;PAIN</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA: NEUTROPENIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LEUKEMIA\CHEMO</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOGENOUS LUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYELOID LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">127 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYLOGENOUS LEUKEMIA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCT\CARDIAC CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">4,346 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION-HEMOPTYSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION-SEPSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION-SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION; AT. FIB</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION; CHF;SHORTNESS OF BREATH\CATH</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION; ENDOCARDITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION; GI BLEED\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION; S/P FALL</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;AFIB W/RVR</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;CARDIOGENIC SHOCK</td>
<td class="gt_row gt_center">474 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;COLON CANCER</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;PNEUMONIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;S/P VFIB ARREST</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION;TELEMETRY\ANGIOPLASTY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION/CATH</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION/S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION\CARD CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">339 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">1,179 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION\CATH LAB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION\CATHERIZATION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDIAL INFRACTION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE MYOCARDISAL INFARCTION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ON CHRONIC SDH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ONSET CHF\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE OR CHRONIC SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS</td>
<td class="gt_row gt_center">683 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS; ETHANOL ABUSE</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS;ARDS</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS;GI BLEED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS;R/O HEPATITIS\ERCP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS;RENAL FAILURE</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITIS/SDA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PANCREATITITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PARAPLEGIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PARATITIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PNEUMONITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PULMONARY EDEMA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PULMONARY EDEMA/MI\CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PULMONARY EDEMA\CATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL </td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILRUE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">48,771 (0.6%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE ; BRADYCARDIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE-ACIDOSIS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE-ALTERED MENTAL STATUS-HYPOCALCEMIA-LUNG CANCER</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE-BACTEREMIA</td>
<td class="gt_row gt_center">1,885 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE-CHF EXACERBATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE-PELVIC MASS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE-UTI-?FASCITIS/HEMATOMA OF THIGH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE, CELLULITIS</td>
<td class="gt_row gt_center">275 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE, CIRRHOSIS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE, SEPSIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE, UREMIC SYNDROME</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,HEMATURIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,HYPOXIA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,HYPOXIA,CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,SEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE,UROSEPSIS,HYPOTENSION,HYPOXIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE; A FIB</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE; HYPERKALEMIA</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE; HYPOGLYCEMIA</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE; HYPOKALEMIA</td>
<td class="gt_row gt_center">1,566 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;(AML) ACUTE MYELOGENOUS LEUKEMIA</td>
<td class="gt_row gt_center">430 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;ACUTE PYELONEPHRITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;ANEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;ANEMIA;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;ARDS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;BRADYCARDIA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CHEST PAIN</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CHOLECYSTITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">916 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CONGESTIVE HEART FAILURE;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;CONGESTIVE HEART FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;DEHYDRATION</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">1,584 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HEART FAILURE;MITRAL REGURGITATION</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HEPATIC CANCER</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HYPERKALEMIA</td>
<td class="gt_row gt_center">825 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HYPERKALEMIA;ELEVATED INR</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HYPERNATREMIA;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HYPERTENSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;HYPOTENSION</td>
<td class="gt_row gt_center">197 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;JAUNDICE</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;LLL PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;LOW PLATELET COUNT\RENAL BIOPSY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;LYMPHOMA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;METASTATIC OVARIAN CANCER</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">790 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;NAUSIA;VOMOTTING;DIARRHEA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;NEUTROPENIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;NEUTROPENIA;CELLULITIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;PANCREATITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;PERICARDIAL EFFUSION;CHOLE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;PNEUMONIA;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;PNEUMONIA;THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;PULMONARY EDEMA;TELEMETRY</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;R/O MI;HYPERKALEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;RHABDO;ISCHEMIC BOWEL</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;SEPSIS</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">235 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;SEPTIC ARTHRITIS</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;TACHYCARDIA</td>
<td class="gt_row gt_center">875 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">2,094 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">2,228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;URINARY TRACT INFECTION;? C-DIFF COLITIS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;VOMITING;DIARRHEA;TELEMETRY</td>
<td class="gt_row gt_center">791 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE;WEAKNESS</td>
<td class="gt_row gt_center">714 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE:? LINE INFECTION</td>
<td class="gt_row gt_center">462 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE/ANEMIA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE/CHOLE/R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">1,530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL FAILURE/LIVER FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RENAL INSUFFICIENCY;HYPOXIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE REPIRATORY FAILURE,ACUTERENAL FAILURE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS SYNDROME,MESENTERIC THROMBOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS SYNDROME;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS SYNDROME;PNEUMONITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS SYNDROME;RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY DISTRESS,FEVER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY FAILURE;SEPSIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY FAILURE;UROSEPSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPIRATORY FAILURE/AMR</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE RESPITORY DISTRESS;LUNG CANCER</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SHORTNESS OF BREATH;CONFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SHORTNESS OF BREATH;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ST ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE ST SEGMENT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE STROKE</td>
<td class="gt_row gt_center">323 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE STROKE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDORAL HEMATOMA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HE,ATOMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">4,502 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;ENLARGED RIGHT VENTRICLE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;FACIAL FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;S/P FALL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;SEIZURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;SUBARACHNOID HEMORRHAGE;SKULL FX</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;TELEMETRY</td>
<td class="gt_row gt_center">1,940 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE SUBDURAL HEMATOMA;TELEMTRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE VASCULAR OCCLUSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE VIRAL HEPATITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE,MI\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ACUTE/CHRONIC LIVER FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADDISON&#39;S</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADEMA/LIVER FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENAL CARCINOMA OF LIVER/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENAL CARCINOMA OF STOMACH/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENEXAL MASS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENO CANCER ETHMOID SINUS /SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENO CARCINOMA OF STOMACH/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA OF COLON/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA OF STOMACH; UMBILICAL HERNIA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA OF THE ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA RIGHT COLON/SDA</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA STOMACH/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA, ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA, RIGHT COLON/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOCARCINOMA, SIGMOID COLON/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOID CYSTTIC CARCINOMA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOMA CECUM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOMA RIGHT COLON/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADENOPATHY</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADNEXAL MASS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADNEXAL MASS/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL CA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL CRISIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL MASS LEFT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL MASS; VENTRAL HERNIA/SDA</td>
<td class="gt_row gt_center">370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL MASS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL NEOPLASM/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADRENAL TUMOR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADTHMA;COPD EXACERBATION</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADULT RESPIRAROTY DISTRESS SYNDROME;PANCREATITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADULT RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADULT RESPIRATORY DISTRESS SYNDROME;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADULT RESPIRATORY DISTRRESS SYNDROME</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ADVANCED HEART FAILURE</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AF</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AF/HYPOTENSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AF\AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AF\THORACOSCOPIC MAZE PROCEDURE LEFT, PULMONARY VEIN ISOLATION, RESECTION LEFT ATRIAL APPENDAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AF\THORACOSCOPIC MAZE PROCEDURE, BILATERAL</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB RVR</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB W. RVR;ANEMIA;PNEUMONIA</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB W/ RVR</td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB WITH RAPID VENTRICULAR RESPONSE</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB WITH RVR</td>
<td class="gt_row gt_center">322 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB WITH RVR;LIVER FAILURE;HF</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB-CONGESTIVE HEART FAILURE\CARDIAC  CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB, AORTIC STENOSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB,SYNCOPE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB/AFLUTTER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB/PNA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB/RVR;?CHOLANGITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB\ EP STUDY; ABLATION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB\ PHARMACOLOGICAL/NONPHARMACOLOGICAL MANAGEMENT; AFIB ABLATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFIB\CAD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFLUTTER</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFLUTTER-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">1,144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFLUTTER;NEW MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFLUTTER;PULMONARY EDEMA;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AFLUTTER\EP STUDY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AGITATION</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AGITATION AND GIB</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AGITATION;SUICIDAL IDEATION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AHF\CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AI AND MR\AORTIC AND MITRAL VALVE REPLACEMENT; AORTIC VALVE REPLACEMENT ? ASCENDING; RE-DO STENOTOMY/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AICD FIRE;V TACH</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AICD FIRING</td>
<td class="gt_row gt_center">2,974 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIR IN PLEURAL SPACE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY COMPRESSION;LUNG CANCER</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY EDEMA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY EDEMA;S/P RADIATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY FAILURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY MASS</td>
<td class="gt_row gt_center">258 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY MONITORING; RIGID BRONCHOSCOPY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">3,765 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION-STERNAL INFECTION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION, LUNG CANCER\ RIGID BRONCHOSCOPY W/ STENT REMOVAL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION;LUNG CA\BRONCHOSCOPY FLEXIBLE; AND RIGID</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION;LUNG CANCER</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION;RELAPSING POLYCHONDRITIS\BRONCHOSCOPY FLEXIBLE; AND RIGID; ? STENT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">583 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION/SDA\ BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION/SDA\ BRONCHOSCOPY WITH STENT </td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\ BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\ BRONCHOSCOPY RIGID STENT PLACEMENT/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\ BRONCHOSCOPY W/ STENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\ BRONCHOSCOPY WITH STENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\ RIGID BRONCHOSCOPY W/STENT PLACEMENT</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\ TRACH TUBE PLACEMENT;BRONCHOSCOPY FLEXIBLE; AND RIGID</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY FLEXIBLE AND RIGID </td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY FLEXIBLE AND RIGID; STENT PLACEMENT; EXTERNAL FIXATION</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY FLEXIBLE AND RIGID;STENT REMOVAL; ? CRYO THERAPY</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY RIGID W/ Y STENT PLACEMENT</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY RIGID W/MICRODEBRIDER;  MITOMYCIN C; ? BALLOON DILITATION; ? STENT PLACEMENT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\BRONCHOSCOPY W/STENT REMOVAL</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\FLEXIBLE BRONCHOSCOPY; RADIAL ENDOBRONCHIAL ULTRASOUND (EBUS); BRONCHIAL AVEOLAR LAVAGE/ BRUSH; POSSIBLE TRANSBRONCHIAL BIOPSY ( LEFT UPPER LOBE); FLUOROSCOPY </td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\RIGID BRONCHOSCOPY WITH STENT </td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\RIGID BRONCHOSCOPY WITH STENT REMOVAL</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY OBSTRUCTION\RIGID BRONCHOSCOPY WITH TUMOR DEBRIDEMENT </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIRWAY STENOSIS</td>
<td class="gt_row gt_center">491 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AIWARY OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AKA,ETOH WD</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AKA;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AKI;HYPERKALEMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AKTERED MENTAL STATUS</td>
<td class="gt_row gt_center">594 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCAHOL WITHDRAWAL</td>
<td class="gt_row gt_center">119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCHOL WITHDRAWAL</td>
<td class="gt_row gt_center">1,062 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCHOLHOL W/D</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCHOLIC CIRRHOSIS\EGD ** REMOTE EAST STONEMAN 3 **</td>
<td class="gt_row gt_center">1,341 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL INTOXICATION</td>
<td class="gt_row gt_center">834 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL INTOXICATION/UNRESPONSIVE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL KETOACIDOSIS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL</td>
<td class="gt_row gt_center">33,540 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL WITH AKA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL-UPPER GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL; ? UPPER GI BLEED</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL;HYPONATREMIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL;SEIZURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWAL/UTI</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWL</td>
<td class="gt_row gt_center">449 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWL;CARDIOMYOPATHY;VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL WITHDRAWL;SEIZURES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOL;HEPATITIS;LIVER FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOLIC ACIDOSIS</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOLIC CIRRHOSIS</td>
<td class="gt_row gt_center">43 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOLIC HEPATITIS</td>
<td class="gt_row gt_center">166 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOLIC HEPATITIS; ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOLIC KETOACIDOSIS</td>
<td class="gt_row gt_center">858 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALCOHOLIC LIVER FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLERGIC REACTION</td>
<td class="gt_row gt_center">6,712 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLERGIC REACTION;HYPOTHERMIA</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLERGIC REACTION/LABILE HTN</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLERGIC REACTON</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLERGIC RXN</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLERGIC/ANAPHYLACTIC REACTION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALLO TX</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALRERED MENTAL STATUS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALS;COMMON BILE DUCT STONE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTER MENTAL STATUS, HYPOGLYCEMIA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MANTAL STATUS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATU</td>
<td class="gt_row gt_center">1,260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUA</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">140,087 (1.8%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS </td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS CHANGE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS CHANGES;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS CHANGES;TELEMETRY</td>
<td class="gt_row gt_center">1,204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS CHANGES;URINARY TRACT INFECTION;PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS-HEAD BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS-HYPOGLYCEMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS-HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS-HYPOTHERMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS-NARCOTIC OD-HYPOTENSION-HYPERGLYCENIA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS,ACUTE MI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS,FEVER,HYPOTENSION</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS,SPINAL DETRUSOR HYPERREFLEXIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS,URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS; ACUTE LEUKEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS; ARF; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS; DYSPNEA</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS; FEVER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS; HYPERNATREMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;ACIDOSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">731 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;ACUTE RENAL FAILURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">335 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;ALCOHOL INTOXICATION&#39;INTUBATE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;ALCOHOLIC HALLUCINATIONS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;CARDIAC ARREST</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;CONGESTIVE HEART FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;DELIRIUM;TREMERS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;FEBRILE</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;FEVER</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;HEAD INJURY;HYPERCARBIA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;HYPERCARBIA</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;HYPERTENSION;BRADYCARDIA</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;HYPOTENSIVE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;LIVER FAILURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;MENINGITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;METASTATIC CANCER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;NAUSEA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;OBSTRUCTING STONE</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;PNEUMONIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;PNEUMONIA;DEHYDRATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;POST PROCEDURE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;R/O MENINGITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;SEIZURE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;SEROTONIN SYNDROME</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">1,479 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS/ GI BLEED</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTAL STATUS\INTUBATED</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTALSTATUS;HEROIN OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MENTQL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED MS, UROSEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED NENTAL STATUS</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTERED;RLL;PNEUMONIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTEREDMENTAL STATUS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALTEREED MENTAL STATUS</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ALVEOLAR HEMORRHAGE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMANITA INTOXICATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMC</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMC;FEVER</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMI;DYSPNEA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AML</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AML-SEPSIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AML,PNEUMONIA,HYPOTENSION,THROMBOCYTOPENIA,ANEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AML;S/P BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AML/FEVER/DEHYDRATION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMMONIUM NITRATE INGESTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULARY ADENOMA/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULARY MASS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULLARY ADENOMA RESECTION;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULLARY ADENOMA/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULLARY CA/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULLARY CANCER/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULLARY MASS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPULLARY MASS/SDA</td>
<td class="gt_row gt_center">556 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPUTATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPUTATION LEFT FOUR FINGERS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPUTATION OF 4TH FINGER LEFT HAND</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMPUTATION RIGHT HAND 2ND DIGIT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMS</td>
<td class="gt_row gt_center">238 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMS/UTI</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMYL NITRATE OVERDOSE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AMYLOIDOSIS\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAL &amp; CERVICAL CONDYLOMATA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAL CANCER</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAL CARCINOMA/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAL SQUAMOUS CELL CANCER/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAL STRICTURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAPHALACTIC SHOCK;CARDIAC ARREST;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAPHYLAIXIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAPHYLAKIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAPHYLAXIS</td>
<td class="gt_row gt_center">8,989 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAPHYLAXIS, RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANAPHYLAXIS;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANASARCA</td>
<td class="gt_row gt_center">1,555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANASARCA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANASARCA;SLEEP APNEA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANASARCA;TELEMETRY</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANASTOMATIC LEAK</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA</td>
<td class="gt_row gt_center">60,951 (0.8%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA BLEED;TELEMETRY</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA JAUNDICE HEART FAILURE</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA WITH POSITIVE STOOL</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA-RENAL FAILURE</td>
<td class="gt_row gt_center">1,144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA-THROMBOCYTOPENIA-COAGULOPATHY</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA, PNEUMONIA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA, SHORTNESS OF BREATH, NAUSEA</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,EKG CHANGES</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,GI BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,PEPTIC ULCER DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,SHORTNESS OF BREATH,RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">575 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA,THROMBOCYTOPENIA,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA; UNABLE TO AMBULATE</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;? GI BLEEDING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ACUTE RENAL FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ANTERIOR MEDIASTINAL MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ATRIAL FIBRILLATION;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;BLADDER CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;CELLULITIS CHEST WALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">113 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;DYSPNEA ON EXERTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ELEVATED TROP</td>
<td class="gt_row gt_center">207 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;ENDOSCOPY;POST-PROCEDURE RESPIRATORY INSUFFICIENY\ENDOSCOPY</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;FEVER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;GASTRIC ULCERS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;GI BLEED</td>
<td class="gt_row gt_center">1,880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;GI BLEED;RESP ARREST</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;HEMATURIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;HYPERCALCEMIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;HYPERKALEMIA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;HYPONATREMIA;CELLULITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;HYPOTENSION</td>
<td class="gt_row gt_center">4,706 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;HYPOXIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;KNOWN ULCERS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;MDS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;OBSTRUCTING COMMON BILE DUCT</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;PNEUMONIA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;RENAL FAILURE;ASCITES</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;RESPIRATORY FAILURE;PNEUMONIA;AAA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;RETROPERITONEAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;RULE OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;S/P MI</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;SVT</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;TELEMETRY</td>
<td class="gt_row gt_center">6,663 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;TELEMETRY;NEUTROPENIA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA;THROMBOCYTOPENIA;PROSTATE CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA/ GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA/ GI BLEED ?</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA/BLEEDING FROM SURG SITE</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA/THROMBOCYTOPNEIA/FEVER</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA/UPPER GI BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIA\CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEMIS,SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">462 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURSYM HEAD</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURSYM/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURSYMAL BLEED</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM</td>
<td class="gt_row gt_center">304 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM AORTA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM CRANIOTOMY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM LEFT SIDE/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM OF LOWER EXTREMITIES/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM,PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM; CEREBRAL/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM; INCREASING HEADACHES</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM;TELEMETRY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM/SDA</td>
<td class="gt_row gt_center">1,570 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM\ CEREBRAL EMBOLIZATION/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM\REDO STERNOTOMY; REPLACEMENT ASCENDING AORTA; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM\REPAIR THORACOABDOMINAL AORTA W/ PARTIAL RIGHT HEART BYPASS/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSM\REPLACMENT OF ASCENDING AORTA, BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEURYSYM/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEXITY;COLITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEYROSYM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEYRYSM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANEYRYSM\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIEDEMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA</td>
<td class="gt_row gt_center">1,117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA PECTORIS;HYPERTENSION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA PECTORIS\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA,CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA; CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;+ ETT\CARDIAC CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;+ STRESS TEST\CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;+ETT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;+ETT\ASPIRIN DESENSITIZATION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;+ETT\CATH</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;+STRESS TEST\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;CHEST PRESSURE;+ETT\CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;CONGESTIVE HEART FAILURE;MULTIPLE PULMONARY EMBOLI\CARDIAC CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;CORONARY ARTERY DISEASE;RIGHT CORONARY ARTERY STENOSIS\ANGIOPLASTY WITH RIGHT CORONARY ARTERY STENT PLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;CORONARY ARTERY DISEASE;S/P CABG\CATH</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;DYSPNEA</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;DYSPNEA ON EXERTION; POSITIVE STRESS TEST\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;DYSPNEA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;INFERIOR ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;LAD DESION\CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;NEAR SYNCOPE;VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;NEEDS URGENT BYPASS SURGERY\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;NEW EKG CHANGES\CARDIAC CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;NON-SUSTAINED VENTRICULAR TACHYCARDIA;ASCITES\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;PERIPHERAL VASCULAR DISEASE\ CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;RULE OUT CORONARY ARTERY DISEASE\RIGHT AND LEFT CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA;SHORTNESS OF BREATH\CATH/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\ANGIOPRAM/ANGIOPLASTY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\CATH</td>
<td class="gt_row gt_center">619 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\CATH WITH ? BRACHY THERAPY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\LEFT HEART CATH</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGINA\LEFT HEART CATHETERIZATION/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIO</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIO ADEMA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIO ADEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIO EDEMA</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIODEMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIOEDEMA</td>
<td class="gt_row gt_center">3,685 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIOEDEMA;ABD PAIN</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIOEDEMA;S/P FALL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANGIOEDEMA;TELEMETRY</td>
<td class="gt_row gt_center">470 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANION GAP 33 WITH VOMITING</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANION GAP ACIDOSIS, ETOH INTOXICATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANKLE FRACTURE</td>
<td class="gt_row gt_center">382 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANKLE FRACTURE;HYPOXIA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANKLE FX</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANOMALOUS PULMONARY VEIN;TOTAL ANOMALOUS PULMONARY VEIN REPAIR</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANOMOLOUS RCA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANOREXIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANOREXIA NERVOSA;BMI 14.7</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANOXIC BRAIN INJURY</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANOXIC ENCEPHALOPATHY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR CERVICAL COLLECTION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR COMMUNICATED ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR COMMUNICATING ANEURYSM/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR COMMUNICATING ARTERY ANEURSYM/SDA</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR COMMUNICATING ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR COMMUNICATOR ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR CORD SYNDROME</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR FLOOR OF MOUTH CA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR FLOOR OF THE MOUTH CANCER/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MEDIASTINAL MASS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MI</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MI;TELEMETRY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MI\CARDIAC CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MI\CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MI\LEFT HEART CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR SKULL BASE TUMOR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR ST ELEVATIONS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR STEMI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR WALL MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR WALL MYOCARDIAL INFARCTION;RULE OUT CORONARY ARTERY DISEASE\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTERIOR WEDGE COMPRESSION FRACTURE C7/SDA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTICHOLINERGENIC TOXICITY, OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTICHOLINERGIC SYNDROME</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTICHOLINERGIC TOXICITY</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTICOAGULATION</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTIDEPRESSANT OVERDOSE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANTIFREEZE INGESTION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANUERYSM/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANURIC RENAL FAILURE; GI BLEED</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANXIETY</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ANXIETY\BYPASS FEMORAL PEDAL ARTERY GRAFT; LEFT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AOETIC STANOSIS \AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AOORTIC STENOSIS\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORLTIC STENOSIS\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AOROTOENTERIC FISTULA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTA STENOSIS\AVR/ ASCENDING AORTA VS BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTA THORACIC ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTA VALVE DISORDER\REDO STENOTOMY; AVR ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC  MASS\ ATRIAL MYXOMA REMOVAL; EXCISION AORTIC MASS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC  STEOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC &amp; MITRAL INSUFFICENCY\AORTIC AND MITRAL VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC &amp; MITRAL STENOSIS\ AORTIC &amp; MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC &amp; MITRAL STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC AND MITRA STENOSIS AND TRICUSPIC INSUFFICIENCY\AORTIC, MITRAL AND TRICUSPIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC AND MITRAL STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC AND MITRAL VALVE REPLACEMENT\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURSYM\ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM</td>
<td class="gt_row gt_center">369 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM \ASCENDING AORTA * HEMI ARCH REPLACEMENT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM DISSECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM;BACK PAIN</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM;IV HYDRATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM;TRACEAL BICUSPID AOTRIC VALVE\CARDIAC CATH/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ AORTIC VALVE REPLACEMENT; RESECTION ANEURYSM THORACIC; (ASCENDING AORTA) VIS; AORTIC VALVE REPLACEMENT WITH HOMOGRAFT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ ASCENDING AORTIC ANEURYSM REPAIR</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ ASCENDING AORTIC ARCH; DESCENDING THORACIC AORTIC REPLACEMENT/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ BENTAL PROCEDURE VS VALVE SPARING AORTIC ROOT REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ REPLACEMENT ASCENDING AORTA &amp; PROXIMAL ARCH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\AORTIC VALVE / ASCENDING AORTA REPLACEMENT;AORTIC ARCH REPLACEMENT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\AORTIC VALVE REPLACEMENT;ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ASCENDING AORTA REPLACEMENT WITH DEEP HYPOTHERMIC CIRCULATORY ARREST AND HEMIARCH REPLACEMSNT ? AORTIC VALVE ? CABG </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\BENTALL PROCEDURE; MECHANICAL VALVE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\ENDOVASCULAR THORACIC ANEURYSM REPAIR  </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\REDO STERNOTOMY X3 ; ANEURYSM REPAIR</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\RESECTION AAA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\RESECTION ANEURYSM THORACIC/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANEURYSM\RESECTION AORTIC ASCENDING ANEURYSM /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ANUERYSM W/ EMOBILZATION/SDA</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ARCH ANEURYSM</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ASCENTING ANEURYSM\ RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DILATATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISECTION</td>
<td class="gt_row gt_center">350 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISECTION\ ENDOVASCULAR STENT REPAIR W/ OPEN REPLANTATION OF SUPERIOR INOMINATE ARTERY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISECTION\ REPAIR OF AN ASCENDING AORTIC DISECTION/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTIION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION</td>
<td class="gt_row gt_center">3,348 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION </td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION TYPE B</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION, TYPE B</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION;ANUERYSM</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION;STROKE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION;TELEMETRY</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION\AORTIC DISSECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSECTION\ASCENDING AORTA REPLACEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSERCTION</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC DISSESTION</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ENTERIC FISTULA</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC HEMATOMA</td>
<td class="gt_row gt_center">447 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INJURY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICENCY\AORTIC AND MITRAL VALVE REPLACEMENT, PERCUTANEOUS RVAD PLACEMENT </td>
<td class="gt_row gt_center">1,472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICENCY\AORTIC VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICENCY\AORTIC VALVE REPLACEMENT W/? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICENCY\MEDIASTINOSCOPY; BRONCHOSCOPY FLEXIBLE; CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY &amp; ENLARGEMENT\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY;ENDOCARDITIS\RIGHT AND LEFT HEART CATH;SUPRAVALVULAR AORTOGRAM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY;STATUS POST ENDOCARDITIS\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE / ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE / ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE / ASCENDING AORTA REPLACEMENT W/ CIRCULATORY ARREST/SDA</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE RE-DO/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\APICO AORTIC VALVE CONDUIT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\ASCENDING AORTA REPLACEMENT; ? AVR/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\AVR, ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\BENTAL PROCEDURE; REPLACING ASCENDING &amp; HEMI-ARCH AORTA; ? CABG W/DEEP HYPOTHERMIC ARREST/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\RE-DO STERNOTOMY, CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENCY\RE-DO STERNOTOMY; AORTIC VALVE REPLACEMENT   </td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFICIENY\AORTIC VALVE REPLACEMENT  BENTAL PROCEDURE  ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFIENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFIENCY\AORTIC VALVE REPLACEMENT; ? MAZE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFIENCY\AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFIENCY\BENTAL PROCEDURE </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFIENCY\CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INSUFFINCIENCY\BENTAL PROCEDURE VS AVR DECENDING AORTA /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC INTRAMURAL HEMATOMA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC LESION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC OBSTRUCTION\ DIVISION OF DOUBLE AORTIC ARCH/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC OCCLUSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC OCCLUSION/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC OCCULSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC PSEUDOANEURYSM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION &amp; MITRAL REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT W/ ?  CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION;A-FIB\L HEART CATH;ATHENOL ABLATION</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION;CORONARY ARTERY DISEASE;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION\AORTIC VALVE REPLACEMENT REDO;  BENTAL PROCEDURE;  CORONARY ARTERY BYPASS GRAFT WITH MVR </td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION\AORTIC VALVE REPLACEMENT, RE-DO</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REGURGITATION\AORTIC VALVE REPLACEMENT; BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC REPLACEMENT</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ROOT DISSECTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ROOT STENOSIS\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ROUTE DILATION \BENTALL PROCEDURE; REDO ? HOMAGRAFT/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC RUPTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STANOSIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STANOSIS\AVR ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STANOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENISIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENISIS\AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOIS/AORTIC VALVE REPLACEMENT; BENTAL PROCEDURE POSSIBLE MAZE\AORTIC VALVE REPLACEMENT? BENTAL PROCEDURE POSSIBLE MAZE/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSI\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS</td>
<td class="gt_row gt_center">1,554 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS \AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS \BENTAL VERSUS AVR ACCENDING AORTA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS &amp; AAA\AORTIC VALVE REPLACEMENT / ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS &amp; CAD\AVR; POSSIBLE CORONARY ARTERY BYPASS GRAFT  /SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS &amp; CAD\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS &amp; MITRAL REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS 3VD\CORONARY ARTERY BYPASS GRAFT;BENTALL PROCEDURE; ? HOMOGRAFT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS CHRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS MITRAL REGURGITATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS, CAD\ CORONARY ARTERY BYPASS GRAFT W/ AVR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS, CAD\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS,\CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS,AORTIC INSUFFICIENCY\LEFT AND RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; 3 VESSEL DIAGNOSIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; CAD\AORTIC VALVE REPLACEMENT; POSSIBLE CORONARY ARTERY BYPASS GRAFT &amp; MAZE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; CAD\CORONARY ARTERY BYPASS GRAFT; WITH AVR/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; MITRAL REGURGITATION; CAD\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT;CORONARY ARTERY BYPASS GRAFT; TRICUSPID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; MITRAL REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS; SYNCOPE\LEFT HEART CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;? MITRAL REGURGITATION\AORTIC VALVE REPLACEMENT; ? MVR/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;\ AORTIC AND MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;\AORTIC VALVE REPLACEMENT; ? CABG/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;ABNORMAL STRESS TEST\CATH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT; BENTAL PROCEDURE; ? ROOT REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;AORTIC INSUFFICIENCY\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;ATRIAL FIBRILLATION;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;ATRIAL FIBRILLATION\ATRIOVENTRICULAR RECIPROCATING TACHYCARDIA;MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;ATRIAL FLUTTER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CARDIAC ARREST</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CARDIOMYOPATHY\RIGHT AND LEFT HEART CATH;AORTIC VALVULOPLASTY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CHEST PAIN;DYSPNEA\CARDIAC CATH</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CHRONIC OBSTRUCTIVE PULMONARY DISEASE FLARE</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE;SHORTNESS OF BREATH;DYSPNEA ON EXERTION\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CONGESTIVE HEART FAILURE\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">197 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\AORTIC ROOT REPLACEMENT REPAIR;? ASCENDING AORTIC REPLACEMENT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT, ? CORONARY ARTERY BYPASS GRAFT  /SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH AVR/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;CORONARY ARTERY DISEASE\LEFT HEART CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;DYSPNEA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;DYSPNEA\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;HYPOTENSION;PULMONARY EDEMA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MITRAL INSUFFIENCY;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MITRAL REGURGITATION;CAROTID STENOSIS\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MITRAL STENOSIS\AORTIC VALVE REPLACEMENT; WITH MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MITRAL VALVE REGURGITATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MR;CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT;CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MR\ AORTIC AND MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MR\ AORTIC AND MITRAL VALVE; REPLACEMENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MR\ AORTIC AND MITRIAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MR\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT; TOTAL MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS;PRESYNCOPE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS/AORTIC VALVE REPLACEMENT;MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS/CAD\CORONARY ARTERY BYPASS GRAFT, RE-DO;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS/MITRAL REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT; ? TRICUSPID VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS/STENT/\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC &amp; ? MITRAL VALVE REPLACEMNT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC AND MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC CAROTID SUBCLAVIAN BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMEMT MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT W/MAZE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT,MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE; POSSIBLE RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT; REDO/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">91 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AORTIC,MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AVR ASCENDING AORTIC REPAIR/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ AVR, HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ BENTAL PROCEDURE ; ASCENDING AORTIC REPLACEMENT MINIMMALLY INVASIVE AVR/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ BENTAL PROCEDURE W/MECHANICAL VALVE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ BENTAL PROCEDURE WITH HOMOGRAFT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ LIMITED ACCESS HEART PORT AV REPAIR/REPLACMENT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ MINAMALLY INVASIVE AVR/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ REDO AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT WITH AVR </td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT WITH AVR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT;  AVR /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT; AVR /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT; REDO STENOTOMY AVR/SDA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\? CORONARY ARTERY BYPASS GRAFT:  WITH AVR REDO /SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\?CORONARY ARTERY BYPASS GRAFT; AVR </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT  ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT  BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT  CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT ? MAZE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT ? MAZE /SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">229 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT REDO, ? CORONARY ARTERY BYPASS GRAFT  </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT REDO; ? TVR</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT;  ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT; ATRIAL MYXOMA REMOVAL;  BENTAL PROCEDURE; ? OF A MAZE/SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT;? REPLACEMENT OF ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ? ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT  CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT VS BENTAL PROCEDURE </td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT W/ HEMI ARCH REPLACEMENT &amp; MAZE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT; REDO STERNOTOMY /SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT; REDO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE /? ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE /? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPAIR ? ASCENDING AORTA REPLACEMENT; ?BENTAL PROCEDURE; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">743 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  ? BENTAL PROCEDURE </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  ? MAZE ? RESECTION OF LEFT ARTERAL APPENDAGE ? MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  BENTAL PROCEDURE ? REPLACEMENT ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  BENTAL PROCEDURE vs ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  CORONARY ARTERY BYPASS GRAFT X 2/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT  WITH ? MAZE AND LIGATION OF LEFT ATRIAL APPENDAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">3,654 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT &amp; CORONARY ARTERY BYPASS GRAFT ? MVR/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT REDO ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT REDO, ? CORONARY ARTERY BYPASS GRAFT  /SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT REDO, ? MITRAL VALVE REPLACEMENT, ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT REDO; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT W/ ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT w/ SEPTAL MYOMECTOMY</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT W/? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT WITH ? BENTAL/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT WITH HOMOGRAFT /SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT WITH HOMOGRAFT/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, ? BENTAL PROCEDURE, ?CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, ? MITRAL VALVEREPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, RE-DO; MITRAL VALVE REPLACEMENT; QUESTION OF, ALSO PERICARDECTOMY/SDA</td>
<td class="gt_row gt_center">245 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, RE-DO/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT, STERNOTOMY </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;  STERNAL PLATING W/ TALON SYSTEM; BILATERAL PEC FLAP ADVANCEMENT/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ?   CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? ACENDING AORTA PROCEDURE   /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? ASCENDING AORTA REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? ASCENDING AORTIC ANEURYSM REPAIR/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? BENTAL PROCEDURE   /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? CABG/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT; ? MAZE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT; ? RESECTION AORTIC ASCENDING; ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? MAZE /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? MITRAL VALVE REPLACEMENT; ? MAZE /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? PATENT FORAMEN OVALE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? RESECTION AORTIC ASCENDING; ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? SEPTAL MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ?ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ?CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ?MVR/SDA</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ACENDING AORTA PROCEDURE /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ASCENDING AORTA REPAIR/REPLACEMENT/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; DE-DO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">206 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; MAZE PROCEDURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; MINI VS STENOTOMY /SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; MINMALLY INVASIVE HEART PORT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; POSSIBLE   CORONARY ARTERY BYPASS GRAFT; POSSIBLE ASCENDING AORTA REPLACEMENT; POSSIBLE DEEP HYPOTHERMIC CIRCOTORY ARREST/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; POSSIBLE CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; RE-DO STERNOTOMY; ?? CABG/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; RE-DO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; REPAIR</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; REPLACEMENT ASCENDING AORTIA; ?MITRIAL VALVE REPLACEMENT; ? BENTAL /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; RESECTION OF ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; TALON CLOSURE ** NO ASSESSMENT NEEDED **</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; TISSUE VALVE /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; W/ ATRIACURE MAZE</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; W/RE-DO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; WITH ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;CORONARY ARTERY BYPASS GRAFT; ?/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;CORONARY ARTERY BYPASS GRAFT; ?MVR/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT; ?/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT;TRICUSPID VALVE REPLACEMENT; ?/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;POSSIBLE MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;RADIOFREQUENCY MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;REPLACMENT ASCENDING AORTA /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">1,087 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE REPLACEMT / ? ASCENDING AORTA  /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE; ? ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">234 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE; ? ASCENDING AORTA REPLACEMENT;  ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE; ? ASCENDING AORTA REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVULOPLASTY</td>
<td class="gt_row gt_center">463 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVULOPLASTY </td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AORTIC VALVULOPLASTY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ASCENDING AORTA REPLACEMENT; ? AORTIC VALVE REPLACEMENT; ? BENTAL PROCEDURE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\ATRIAL VALVE REPLACEMENT TISSUE ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AV FISTULA;MITRAL VALVE REPLACEMENT; MAZE PROCEDURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR ? CABG</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR &amp; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR STANDARD KHABBAZ /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR TISSUE ? CORONARY ARTERY BYPASS GRAFT ? MAZE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR W/ ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR W/? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR W/? CORONARY ARTERY BYPASS GRAFT; ? LEFT ATRIAL APPENDAGE RESECTION </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR, ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR, ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR, ?CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? ASCENDING AORTA REPLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? CORONARY ARTERY BYPASS GRAFT WITH /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ? MVR; ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; ?CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR; MVR?; TVR?; CORNARY ARTERY BYPASS?</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR;? CORONARY ARTERY BYPASS GRAFT  /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\AVR?; MVR? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE </td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE ? MVR/SDA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE REDO </td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE W/ TOTAL ARCH UNDER DEEP HYPOTHERMIC CIRCULATION ARREST; CORONARY ARTERY BYPASS GRAFT    /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE, ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL PROCEDURE; REDO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTAL; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTALL PROCEDURE; REDO/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTALL PROCEDURE; VS;AORTIC VALVE REPLACEMENT; W/ ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CATH</td>
<td class="gt_row gt_center">925 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CATH/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CATY;AORTIC VALVULOPLASTY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ANGIOGRAM;CAROTID STENT PLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR </td>
<td class="gt_row gt_center">142 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR  ? ASCENDING AORTA; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR ? ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">1,004 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR REDO </td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR REDO /SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR, ? MITRAL VALVE REPLACEMENT, ? TRICUSPID VALVE REPAIR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR, ?BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR;  ? MITRAL VALVE REPLACEMENT; ? TVR REPAIR</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? MAZE /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH MVR; RE-DO STERNOTOMY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT, RE-DO;AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; A; AVR (BOVINE VALVE)</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; AVR</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; W/AVR; ? RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; W/AVR/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; WITH AVR;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; WITH AVR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT?  AVR REDO /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT?;  AVR /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\LEFT HEART CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\MACHANICAL ATRIAL VALVE REPLACEMENT; MYECTOMY, ?CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\MITRAL VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\MITRAL VALVE REPLACEMENT; RE-DO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RE-DO AVR; ? ASCENDING AORTA REPLACEMENT    /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RE-DO STERNOTOMY, AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RE-DO STERNOTOMY; AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RE-DO STERNOTOMY; TOTAL ARCH REPLACEMENT; MVR; AVR; REMOVAL OF STENT FROM RIGHT MAIN PULMONARY ARTERY; ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO AORTIC VALVE / ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO AVR; MVR; ? CORONARY ARTERY BYPASS GRAFT; ? LEFT ATRIAL APPENDAGE LIGATION; ? MAZE </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO STENOTOMY/AVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO STERNOTOMY ACCENDING AORTA REPLACEMENT ?BENTAL PROCEDURE ? AVR ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO STERNOTOMY W/ AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO STERNOTOMY, ? AVR, ? BENTAL PROCEDURE, ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO STERNOTOMY, AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\REDO STERNOTOMY; AVR; ? CABG</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RESTYLE PROCINE BENTAL PROCEDURE; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RIGHT AND LEFT CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\RIGHT HEART CATH;LEFT HEART CATH</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\T</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\Transcatheter Aortic Valve Implant (TAVI) with Pump Stand-by (CoreValve) </td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENOSIS\Transcatheter Aortic Valve Implant (TAVI) with Pump Stand-by (CoreValve)  </td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STENSIS\? CORONARY ARTERY BYPASS GRAFT WITH AVR REDO /SDA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC STEONSIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC TEAR</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC THROMBOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC THROMBUS</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ULCERATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC ULCERS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALUE ENDOCARDITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALV INSUFFICIENCY\AORTIC VALVE / ASCENDING AORTA REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE ABSCESS</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE ABSCESS;SEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE</td>
<td class="gt_row gt_center">219 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE;CHF</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE\AORTIC VALVE REPLACEMENT; HOMOGRAFT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE\AORTIC VALVULOPLASTY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE\CATH</td>
<td class="gt_row gt_center">254 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISEASE\LEFT AND RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC AND MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC AND MITRAL VALVE REPLACEMENT ?CABG/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE / ASCENDING AORTA REPLACEMENT?  BENTAL PROCEDURE ? HEMI ARCH/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT POSSIBLE CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT; ? ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE REPLACEMENT; ? REPLACEMENT ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AORTIC VALVE; ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\AVR ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\RE-DO STERNOTOMY; BENTAL PROCEDURE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\RE-DO STERNOTOMY; REPAIR OF ASCENDING AORTA ? ANEURYSMAL; ? REPLACEMENT OF ASCENDING AORTA; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\REDO AVR ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDER\RESECTION OF AORTIC MASS VS AORTIC VALVE REPLACMENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE DISORDERS\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE ENDOCARDITIS</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE ENDOCARDITIS;AORTIC INSUFFICIENCY\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSIFFICIENCY\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICENCY\AORTIC VALVE REPLACEMENT REDO, ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICENCY\BENTAL PROCEDURE, ? VALVE SPARING ROOT REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICENCY\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICENCY\REDO REDO AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">714 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY;DYSPNEA ON EXERTION\RIGHT AND LEFT CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC AND MITRAL VALVE REPLACEMENT ? MAZE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE / ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE / ASCENDING AORTA REPLACEMENT; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE /? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT ? ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT ? MVR ? TRICUSPIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT REDO  BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT W/ ASCENDING AORTA REPLACEMENT &amp; CIRCULATORY ARREST /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT, ? MINI STERNOTOMY /SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AORTIC VALVE REPLACEMENT; ? ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\AVR ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\BENTAL PROCEDURE W/ ASCENDING AORTA &amp; HEMI ARCH REPLACEMENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\BENTAL PROCEDURE W/ HEMIARCH REPLACEMENT/MAZE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\BENTAL PROCEDURE; ASCENDING AORTAHEMI-ARCH REPLACEMENT W/ DEEP CIRCULAR ARREST/MAZE; Mitral Valve Repair/Replace with Concomitant Maze Procedure /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFICIENCY\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFIENCY\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFIENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFIENCY\AVR STANDARD KHABBAZ /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFIENCY\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFFIENCY\MAZE; AVR; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE INSUFICIENCY\AORTIC VALVE REPLACEMENT ? MVR/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE MALFUNCTIONING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE REGURGATATION</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE REGURGITATION;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE REGURGITATION\AORTIC VALVE REPLACEMENT, RE-DO/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE REPLACEMENT;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC VALVE REPLACEMENT; MINIMILLAY INVASIVE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC VALVE REPLACEMENT; W/MAZE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VALVE VEGETATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VASCULAR TIME/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VAVLE DISORDER\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VAVLE DISORDER\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT; ? REPLACE ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VAVLE DISORDER\REDO AORTIC VALVE REPLACEMENT; ? MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIC VEGATATION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTICDISECTION</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTIS STENOSIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTO ILIAC ANEURYSM/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AORTO ILIAC DISEASE/SDA</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AOTRIC VALVE DISEASE</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AP</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APHASIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APICAL ISCHEMIA\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APLASTIC ANEMIA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APLASTIC ANEMIA, PNH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APLASTIC ANEMIA;CHEMO</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APLASTIC ANEMIA;FEVERS;NEUTROPENIC</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APLASTIC ANEMIA;PANCYTOPENIA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APML</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APNEA</td>
<td class="gt_row gt_center">7,740 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APNEA,MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APNEA;BRADYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APPARENT INTOXICATION; SI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APPENDICEAL/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">APPENDICITIS</td>
<td class="gt_row gt_center">1,459 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\ AORTIC AND MITRAL VALVE REPLACEMENT REDO</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\ TOTAL AORTIC ROOT VS VALVE SPARING AORTIC REPAIR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">960 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\AORTIC VALVE REPLACEMENT; ? RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\AORTIC VALVE REPLACEMENT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AR\BENTALL PROCEDURE; **HOMOGRAFT**/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARACHNOID CYST/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARACHNOIDITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARDS</td>
<td class="gt_row gt_center">353 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARDS COAGULAPATHY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARDS VS SEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARDS, UROSEPSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARDS;PNEUMONIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARDS;PVD;RENAL INSUFFICIENCY;DIABETES MELLITUS</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF AND RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF RETROPERITONEAL BLEED</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF, BACK PAIN</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF, HEPATITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF, UROSEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF,GIB</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF,HYPERKALEMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF,HYPOTENION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARF/ABD PAIN</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARM INJURY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARM PAIN-NSTEMI</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARM SWELLING;?CLOT</td>
<td class="gt_row gt_center">1,476 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AROMEGLEY;BURKITTS LYMPHOMA</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AROTIC ANUERYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AROTIC DISSECTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AROTIC STENOSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AROTIC STENOSIS\AORTIC VALVE / ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AROTIC VALVE INSUFFICIENCY\AVR; ? OF MVR &amp; CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARR</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARREST</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARRHYTHMIA</td>
<td class="gt_row gt_center">1,050 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARRHYTHMIA\ PACEMAKER LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARRYTHMIA</td>
<td class="gt_row gt_center">403 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERAL OCCLUSION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL BLEED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL CLOT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL CLOTS;BACTEREMIA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL INJURY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL INSUFFICENCY LLE</td>
<td class="gt_row gt_center">553 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL INSUFFICIENCY</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL INSUFFICIENCY RIGHT FOOT</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL OCCLUSION</td>
<td class="gt_row gt_center">365 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL OCCLUSIVE DISEASE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL THROMBOSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL THROMBOSIS;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIAL VENOUS MALFORMATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIOVENOUS FISTULA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIOVENOUS FISTULA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIOVENOUS MALFORMATION/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTERIOVEOUS MALFORMATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTHEROSCLEROSIS REST PAIN/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTHEROSCLEROSIS W/ULCER LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTHEROSCLEROSIS WITH ISCHEMIC REST PAIN</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTHYMIA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTIAL FIBRILLATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTIFICAL VALVE, ATRIAL FIBRULATION, ANTICOAGULATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ARTRIAL FIBRILLATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AS CAD\CATH-COMPLETE HEART CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AS CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AS,\  REDO STERNOTOMY AVR; ASCENDING AORTIC ARCH REPLACEMENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AS,MR\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AS\CP</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASA INGESTION</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASA OVERDOSE</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASA TOXICITY</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASA\REPAIR ATRIAL-SEPTAL DEFECT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDIBG AORTIC ANEURYSM\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING &amp; DESCENDING AORTA\ ASCENDING AORTIC ARCH W/CABG</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AND DECENDING AORTIC DISS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING ANEURYSM \ASCENDIONG AORTA/ HEMI-ARCH REPLACEMENT; W/ DEEP HYPERTHERMIC CIRCULATORY ARREST/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA ANEURYSM</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA DISECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\ASCENDING AORTA REPLACEMENT &amp; HEMI-ARCH ? AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\ASCENDING AORTA REPLACEMENT; AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\BENTAL PROCEDURE; POSSIBLE CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\RE-DO STERNOTOMY; REPLACEMENT ACCENDING AORTA; TOTAL ARCH PLACEMENT W/ RIGHT AXILLARY &amp; CANNULATION DEEP HYPOTHERMIC ARREST/SDA</td>
<td class="gt_row gt_center">470 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTA\REPLACEMENT ASCENDING AORTA &amp; HEMI ARCH; ? CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC  ANEURSYM\ ASCENDING AROTA W/ PROXIMAL ARCH/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURSYM\ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM, S/P AVR 1986\ASCENDING AORTIC ANEURYSM REPAIR</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\ ASCENDING AORTA REPLACEMENT; HEMI-ARCH REPLACEMENT/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\ RESECTION AORTIC ASCENDING ANEURYSM</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\ RESECTION AORTIC ASCENDING ANEURYSM; POSSIBLE CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\ RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\AORTIC VALVE REPLACEMENT; REPAIR ASCENDING AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\AORTIC VALVE REPLACEMENT; RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\ASCENDING AORTA REPLACEMENT </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTAL PROCEDURE REDO</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTAL PROCEDURE, W/STENT GRAFT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTAL PROCEDURE; ? AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTALL PROCEDURE; ? VALVE SPARING ROOT REPLACEMENT/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTALL PROCEDURE; RED0</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\REPLACEMENT ASCENDING AORTA &amp; HEMIARCH;? AVR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ANEURYSM\REPLACEMENT ASCENDING ARCH AORTA /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC ARCH THROMBUS\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC DISSECTION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING AORTIC MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING CHOLANGITIS</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING CHOLANGITIS &amp; PANCREATIC MASS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING CHOLANGITIS;SEPTIC SHOCK</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING PARALYSIS;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING SINUS VENUS\ REPAIR ANOMALY PULMONARY VEIN; ASCENDING AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING THORACIC ANEURYSM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING THORACIC AORTIC ANEURYSM\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENDING THORASIC ANEURYSM</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCENGING ANEURYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES</td>
<td class="gt_row gt_center">1,067 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES MALNUTRITION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES-LIVER CONGESTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES-SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES, HYPOGLYCEMIA</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES,ABDOMINAL PAIN</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES,CIRRHOSIS,RENAL FAILURE</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES; ABDOMINAL PAIN</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES; CIRRHOSIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES; HEPATITIS C</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;CHRONIC RENAL FAILURE;TRANSAMINITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;EDEMA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;HYPERKALEMIA</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;LIVER AND RENAL DISEASE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;LIVER FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;RULE OUT SPONTANEOUS BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITES;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">515 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITIES</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITIES, MITROVALVE REGURGITATION</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASCITIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\ REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\ REPAIR ATRIAL SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\ASD CLOSURE **REMOTE WEST** **CATH LAB ROOM 1**/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\ATRIAL SEPTAL DEFECT REPAIR,  PATENT FORAMEN OVALE CLOSURE MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL SEPTAL DEFECT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL SEPTAL DEFECT, MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL-SEPTAL DEFECT; LIMITED ACCESS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL-SEPTAL DEFECT; LIMITED ACCESS; ? TRICUSPID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL-SEPTAL DEFECT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL-SEPTAL DEFECT; MAZE PROCEDURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASD\REPAIR ATRIAL-SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPERGILLOSIS\BRONCHOSCOPY RIGID; FLEXIBLE </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION</td>
<td class="gt_row gt_center">230 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION EVENT/SEPSIS</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION FOREIGN BODY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">8,789 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA,SEPSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA; COLON CANCER</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA;ALTERED MENTAL STATUS;ARF AND MYOCARDIAL ISCHEMIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA;C5 CERVICAL FRACTURE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA;SEPSIS</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA;SEPSIS;LYMPHOMA</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION PNEUMONIA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION SEIZURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION-ATRIAL FIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION; DYSPHASIA</td>
<td class="gt_row gt_center">594 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION; FAILURE TO THRIVE</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION/PNEUMONITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRATION/RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRIN DESENSITIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASPIRIN OVERDOSE</td>
<td class="gt_row gt_center">374 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASSAULT</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASSAULT- STAB WOUND</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASSUALT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHA,SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHA/COPD EXACERBATION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHAM,COPD EXACERBATION</td>
<td class="gt_row gt_center">335 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHAMA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA</td>
<td class="gt_row gt_center">4,787 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA / COPD EXACERBATION</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA /COPD EXACERBATION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA &amp; COPD EXACERBATION</td>
<td class="gt_row gt_center">954 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA ATTACK</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA COPD EXACERBATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA EXACERBATION</td>
<td class="gt_row gt_center">3,349 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA EXACERBATION;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">2,177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA EXACERBATION;CHRONIC OBST PULM DISEASE;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA EXACERBATION;COPD EXACERBATION</td>
<td class="gt_row gt_center">223 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA EXACERBATION;TELEMETRY</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA FLARE</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA FLARE-FLU</td>
<td class="gt_row gt_center">364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA FLARE;PNEUMONIA</td>
<td class="gt_row gt_center">250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA W\COPD EXACERBATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION</td>
<td class="gt_row gt_center">1,914 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA-COPD EXACERBATION</td>
<td class="gt_row gt_center">3,012 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA, COPD EXACERBATION</td>
<td class="gt_row gt_center">167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA,COPD</td>
<td class="gt_row gt_center">1,120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA,COPD EXACERBATION</td>
<td class="gt_row gt_center">6,902 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA,INTUBATED</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA; COPD EXACERBATION</td>
<td class="gt_row gt_center">749 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA; PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA; S/P ANGINA; CHF</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA; WOLFRAM DISEASE</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">47,465 (0.6%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD </td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD EXACERBATIOM</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD EXACERBATION</td>
<td class="gt_row gt_center">84,351 (1.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD EXACERBATION;TELEMETRY</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD EXACERBATION\TRABECULECTOMY/PHACO LEFT EYE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD EXACEREBATION</td>
<td class="gt_row gt_center">1,738 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPD EXCERBATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;COPDEXACERBATION</td>
<td class="gt_row gt_center">8,532 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;EXACERBATION</td>
<td class="gt_row gt_center">659 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;FEVER OF UNKNOW ORIGIN</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;LARYNGOSPASM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA;TROP LEAK</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/ COPD EXACERBATION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/COPD EACERBATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/COPD EXACERBATION</td>
<td class="gt_row gt_center">31,213 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/COPD EXCERBATION</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/COPD FLARE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/COPD/EXACERBATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMA/COPF EXACERBATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASTHMAQ;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">235 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASYSTOLE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ASYSTOLIC ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATAXIA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATERIAL EMBOLIZATION</td>
<td class="gt_row gt_center">553 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATERIAL INSUFFICIENCY</td>
<td class="gt_row gt_center">441 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROEMBOLISM SYNDROME/SDA</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS BILATERAL LOWER EXTREMITY</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS BYPASS GRAFT RIGHT/SDA</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS OF EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS OF LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS W/ CLAUDICATION/SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS W/ GANGRENE</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS W/CLAUDICATION &amp; INFECTED ARTERIAL GRAFT, RIGHT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS WITH CLAUDICATION</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS WITH CLAUDICATION/SDA</td>
<td class="gt_row gt_center">341 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS WITH GANGRENE</td>
<td class="gt_row gt_center">219 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS WITH ULCER</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS WITH ULCER\RIGHT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS;CLAUDICATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS;SYNCOPE</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS;ULCER</td>
<td class="gt_row gt_center">348 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHEROSCLEROSIS/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHERSCLEROSIS OF EXTREMITIES W/ CLAUDICATION RIGHT/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHERSCLEROSIS OF EXTREMITIES W/ INTERMITTENT CLAUDICATION RIGHT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATHERSCLEROSIS W/ ULCER/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRAIL SEPTAL DEFECT\ REPAIR ATRAIL SEPTAL DEFECT LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL AFRBILLATION\THORACOSCOPIC MAZE PROCEDURE BILATERAL/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL AFRIBILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL AND VENTRICULAR LEAD MALFUNCTION\ATRIAL &amp; VENTRICULAR LEAD EXTRACTION; DDD PACEMAKER REPLACEMENT /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL APPENDAGE\BILATERAL MINI THORACOTOMY;PULMONARY VEIN ISOLATION VIA ATRICARE BIPOLAR DEVICE;RESECTION OF ATRIAL APPENAGE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL CIRCULATION\THORACOSCOPIC MAZE PROCEDURE LEFT; RESECT LEFT ATRIAL APPENDAGE; BILATERAL MINI THORACOTAMIE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL DEFECT\ REPAIR ATRIAL SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL DEFECT\REPAIR ATRIAL-SEPTAL DEFECT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL DEFECT\REPAIR PATENT FORAMEN OVALE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIB/FLUTTER/VT/CAD\EP STUDY AND ABLATION/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRIALLTION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILATION</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILATION\PHARMACOLOGICAL / NON PHARM MGMT AFIB ABLATION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILATION\THORACOSCOPIC MAZE PROCEDURE </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLAION\AFIB ABLATION; PHARMACOLOGICAL/NONPHARMACOLOGICAL MANAGEMENT OF AFIB</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATIOM</td>
<td class="gt_row gt_center">468 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">2,024 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION W/ RVR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RATE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION,PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION; RIGHT UPPER LOBE NODULES\MINI MAZE SIMULTANEOUSLY WITH RIGHT UPPER LOBE BIOPSY;THORACOSCOPY VIDEO ASSISTED WEDGE RESECTION/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION; RVR</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;(+) TRAPONIN</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;ANGINA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;AORTIC STENOSIS;TELEMETRY\IV HEPARIN</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;BRADYCARDIA;AORTIC STENOSIS</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CARDIOVERSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CHEST PAIN;AORTIC VALVE DISEASE\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">615 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CONGESTIVE HEART FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;CORONARY ARTERY DISEASE; CHEST PAIN</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;DECREASED EJECTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;DYSPNEA</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;ESRD</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;MITRAL VALVE PROLAPSE AND REGURGITATION\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;PROLONGED QI</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;RAPID VENTRICULAR RESPONSE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">272 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;RVR</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">865 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;HYPOTENSION</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">650 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;RVR</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;RVR;TELEMETRY</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;TELEMETRY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;TELEMETRY;WITHDRAWAL</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;VT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION;WOUND INFECTION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION/PERI CARDIAL STRIPPING;PLUS MINSUS MAZE/SDA\MEDIAN STERNOTOMY; PERI CARDIAL STRIPPING PLUS/MINUS MAZE </td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\ AFIB ABLATION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\AFIB ABLATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\AFIB ABLATION; PHARMACOLOGICAL/NONPHARMACOLOGICAL MANAGEMENT OF AFIB</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\AORTIC VALVE REPLACEMENT ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\ATRIAL FIBRILLATION ABLATION</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\ATRIAL FIBRILLATION ABLATION(PULMONARY VEIN ISOLATION)</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\BILATERAL MINI-THORACOTOMY; PULMONARY VEIN ISOLATION W/RESECTION OF LEFT ATRIAL APPENDAGE &amp; LEFT UPPER LUNG BIOPSY/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION </td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION -MEDTRONIC ABLATION SYSTEM </td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION BILATERAL/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\CARDIOVERSION</td>
<td class="gt_row gt_center">487 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\CARDIOVERSION;TRANSESOPHAGEAL ECHOCARDIOGRAM</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\CORONARY ARTERY BYPASS GRAFT; THORACOSCOPIC MAZE PROCEDURE </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\FULL MAZE PROCEDURE </td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\HEPARIN THERAPY 9/21 - CV/TEE 9/22</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\MINI-MAZE PROCEDURE, PULMONARY VEIN ABLATION,  BILATERAL/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\MINIMALLY INVASIVE MAZE W/ LEFT ATRIAL APPENDAGE LIGATION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PACEMAKER IMPLANTATION/ATRIAL FLUTTER ABLATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PHARMACOLOGICAL / NON PHARM MGMT AFIB ABLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">416 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PHARMACOLOGICAL / NON PHARM MGMT AFIB ABLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PHARMACOLOGICAL / NON PHARM MGMT AFIB ABLATION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PHARMACOLOGICAL / NON PHARM MGMT AFIB ABLATION /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PULMONA VEIN ISOLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PVI **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\PVI Generator **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC BIVENTRICULAR LEAD PLACEMENT; LV LEAD PLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MAZE PROCEDURE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MAZE PROCEDURE BILATERAL</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MAZE PROCEDURE BILATERAL/SDA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MAZE PROCEDURE LEFT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MAZE PROCEDURE, BILATERAL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MAZE PROCEDURE, BILATERAL/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\THORACOSCOPIC MINI MAZE PROCEDURE /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\TRANSESOPHAGEAL ECHOCARDIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBRILLATION\TRANSESOPHAGEAL ECHOCARDIOGRAM;CARDIOVERSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBUATION\PERICARDIECTOMY; POSSIBLE MAZE  /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FIBULATION\REDO STERNOTOMY WITH FULL MAZE</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER</td>
<td class="gt_row gt_center">283 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER; CHF; CAD; RENAL INSUFFIENCY; DIABETES\ATRIAL FLUTTER ABLATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER;HEART FAILURE\BIVENTRICULAR ICD IMPLANT;AFLUTTER ABLATION;PACEMAKER REMOVAL</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER;TELEMTRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER/S/P PULMONARY VEIN ISOLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ATRAIL FLUTTER ABLATION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ATRIAL FLUTTER ABLATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ATRIAL FLUTTER ABLATION + ICD TEST</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ATRIAL FLUTTER ABLATION +/- PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ATRIAL FLUTTER ABLATION;TRANSESOPHAGEAL ECHOCARDIOGRAM</td>
<td class="gt_row gt_center">452 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ATRIAL VENTRICULAR JUNCTION ABLATION;BIVENTRICULAR IMPLANTABLE CARDIAC DEFIBRILLATOR INPLANT/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\CARIAC CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\ELECTROPHYSIOLOGY STUDY; ATRIAL FLUTTER ABLATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\EPS AND ATRIAL FLUTTER ABLATION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\FLUTTER ABLATION/PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FLUTTER\TEE; ATRIAL FLUTTER ABLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FRIBILLATION\AORTIC VALVE REPLACEMENT W/ BIVENTRICULAR MAZE PROCEDURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL FRIBILLATION\BILATERAL THORACOSCOPIC MINI MAZE PROCEDURE WITH LEFT ATRIAL APPENDAGE RESECTION </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL MASS,RIGHT\ EXCISION ATRIAL MASS,RIGHT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL MYXOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL MYXOMA\REPAIR ATRIAL MYXOMA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT \ATRIAL SEPTAL DEFECT FOR PATENT FORMEN OVAL CLOSURE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT; MR\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH; HEARTPORT; REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT;PATENT FORAMEN OVALE\MINIMALLY INVASIVE PATENT FORAMEN OVALE </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ MINIMALLY INVASIVE ATRIAL/SEPTAL DEFECT REPAIR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ MINIMALLY INVASIVE REPAIR ATRIAL SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ REPAIR ATRIAL SEPTAL DEFECT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ REPAIR ATRIAL SEPTAL DEFECT; REDO W/RIGHT ATRIAL MASS EXCISION/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ REPAIR ATRIAL SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">471 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ REPAIR LIMITED ACCESS ATRIAL SEPTAL DEFECT</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\ASD CLOSURE **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\MINIMALLY INVASIVE ATRIAL SEPTAL DEFECT CLOSURE/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\MINIMALLY INVASIVE ATRIAL SEPTUM DEFECT CLOSURE </td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\MINIMALY INVASIVE REPAIR ATRIAL SEPTAL DEFECT, ? STERNOTOMY /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\MINIMMALY INVASIVE ATRIAL SEPTAL DEFECT CLOSURE /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\MITRAL VALVE REPLACEMENT;REPAIR ATRIAL-SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\PATENT FORAMEN OVALE CLOSURE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT </td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS MINIMALL INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT; TRICUSPID VALVE REPLACEMENT; RECONSTRUCTION OF ANOMATOUS PULMONARY VEIN/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT;MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL-SEPTAL DEFECT; ?MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTAL DEFECT\REPAIR ATRIAL-SEPTAL DEFECT; LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTIC DEFECT\REPAIR ATRIAL SEPTAL DEFECT; MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL SEPTIC DEFECT\REPAIR ATRIAL SEPTAL DEFECT;MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL STENOSIS\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA;\CARDIOVERSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA/ MECHANICAL VALVE\ATRIAL TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA\ATRIAL TACHYCARDIA ABLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA\CARDIOVERSION</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA\EP STUDY; ATRIAL TACHYCARDIA ABLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">332 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA\LEFT ANTERIOR TACHYCARDIA ABLATION; TEE **REMOTE WEST**</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TACHYCARDIA\LEFT ATRIAL TACHYCARDIA ABLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL TUMUR\IVC RIGHT ATRIAL THROMBECTOMY/ TUMOR RESECTION;  OPEN RIGHT RADICAL NEPHRECTOMY;  MOBILIZATION LIVER EXTRACTION TABLE THROMBUS ? CABLE RECONSTRUCTION </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL VENTRICULAR NODAL RE-ENTRY TACHYCARDIA\ATRIAL VENTRICULAR NODAL RE-ENTRY TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATRIAL/SEPTAL DEFECT\ PATENT FORAMEN OVALE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATTEMPTED HANGING</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATV ACCIDENT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATYPICAL CHEST PAIN</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ATYPICAL CHEST PAIN\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AUTONOMIC DYSFUNCTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AUTUMN56</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV BLOCK</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV BLOCK; CARDIAC CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV FISTUALA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV FISTULA INFECTION</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV FISTULA;ANGIOPLASTY</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV FISTULA;HEMODYNAMIC INSTABILITY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV FISTULA/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV GRAFT INFECTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV GRAFT REVISION</td>
<td class="gt_row gt_center">3,290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV GRAFT THROMBECTOMY</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AV NODAL REENTRY TACHYCARDIA; HYPOT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVGS INFECTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVM ? BLEED</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVM;BLOOD LOSS;ANEMIA;UMBILICAL HERNIA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVM/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR</td>
<td class="gt_row gt_center">109 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR;ASCENDING AORTA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR;CABG</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR;MVR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\ AORTIC VALVE REPLACEMENT HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\AORTIC VALVE REPLACEMENT, RE-DO/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\AORTIC VALVE REPLACEMENT; *3RD CASE*/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AVR\LEFT HEART CATHETERIZATION/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">AXILLARY EXPLORATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">B BLOCKER TOXICITY; CHF; R/O MI RENAL IMPAIRMENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">B CELL LYMPHOMA;VRE</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">B-BLOCKER;BENZO OD</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">B-CELL LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">B/L DVTS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BABEIOSIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BABESIOSIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACERTIAL PERITONITIS</td>
<td class="gt_row gt_center">436 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK INFECTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK INJURY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN</td>
<td class="gt_row gt_center">2,770 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN R/O CORD COMPRESSION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN-ACUTE PAIN</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN-DISSECTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN-SACRAL FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN-WEAKNESS</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN, DELIRIUM</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN, FEVER</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN,CANNOT AMBULATE</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN;TACHYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN;URINARY RETENTION;LEG WEAKNESS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK PAIN/S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK WOUND</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACK/FLANK PAIN</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACOFLEN OD</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA</td>
<td class="gt_row gt_center">10,708 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA,DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA,STAPH INFECTION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA; ? ENDOCARDITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA; ALTERED MENTAL STATUS; C DIFF</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA; BACK PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA; KIDNEY STONES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA;ABDOMINAL ABCESS</td>
<td class="gt_row gt_center">742 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA;BILIARY COLIC</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA;FEVER;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA;LOWER BACK PAIN</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTEREMIA;SEPSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIAL ENDOCARDITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIAL ENDOCARDITIS;LEFT ARM EMBOLUS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIAL ENDOCARDITIS;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIAL MENINGITIS</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIAL,MENINGITIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERIEMA</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERMIA</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTERMIA;R/O ENDOCARDITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BACTREMIA</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRET ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRET&#39;S ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETS&#39; ESOPHAGUS AND HIGH GRADE DYSPLASIA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETT&#39;S ESOPHAGUS HIGH GRADE DYSPLASIA/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETT&#39;S ESOPHAGUS, HIGH GRADE DYSPHAGIA/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETT&#39;S ESOPHAGUS, HIGH GRADE DYSPLASIA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETT&#39;S ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETT&#39;S W/ HIGH GRADE DYSPLSIA/SDA</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETTS ESOPHAGUS ADENOCARCINOMA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BARRETTS ESOPHAGUS\ENDOSCOPY WITH RADIO FREQUENCY ABLATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL ANEURYSM</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL CCELL CARCINOMA OF TEMPLE AND EAR/SDA</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL CELL CANCER RIGHT CHEEK/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL CELL CARCINOMA OF PENILE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL GANGLIA BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL GANGLIA HEMORRHAGE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL GANGLIA INFARCT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL GANGLIA INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL SKULL MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASAL STEM STROKE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASE OF TONGUE TUMOR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR ANEURYSM</td>
<td class="gt_row gt_center">223 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR ANEURYSM/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR ARTERY STENOSIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR SKULL FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR STROKE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR THROMBOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILAR TIP ANEURYSM/SDA</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILE TRANSPOSITION;BRACHIAL RADIAL INTERPOSITION GRAFT;CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">609 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BASILLAR OCCLUSION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BATEREMIA;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BATTERY DEPLETION; HEART FAILURE\IMPLANTABLE CARDIOVERTER DEFIBRILLATOR EXPLANT; PACEMAKER IMPLANT; DIURISIS POST PROCEDURE/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BATTERY DEPLETION;LEAD MALFUNCTION\ICD LEAD EXTRACTION AND GENERATOR CHANGE/SDA</td>
<td class="gt_row gt_center">184 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BEHYDRATION</td>
<td class="gt_row gt_center">756 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENADRYL OVERDOSE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN COLON TUMOR/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN LIVER MASS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN NEOPLASM RIB,STERNUM,&amp; CLAVICLE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN NEOPLASM, HEART\PULMONARY VALVE REPAIR, ? REPLACEMENT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN PNEUMATOSIS</td>
<td class="gt_row gt_center">470 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN PROSTATIC HYPERPLASIA/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENIGN PROSTATIC HYPERTROPHY/SDA</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENTAL PROCEDURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENTEL PROCEDURE</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENZO OD</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENZO WITHDRAWAL</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENZODIAZEPINE OVERDOSE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BENZODIAZEPINE WITHDRAWL</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BETA BLOCKER OD</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BI PASS GRAFT OCCLUSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BI-LATERAL SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BICUSPID AORTIC VALVE DISRODER\AORTIC VALVE REPLACEMENT ? BENTAL PROCEDURE </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BICYCLIST STRUCK</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BICYCLIST STRUCK,SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BIKE ACCIDENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BIKER STRUCK</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BIL.PLEURAL EFFUSION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILARY OBSTRUCTION/PANCREATITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILARY STONES W/ RECURRENT CHOLECYSTITIS/SDA\BILIARY STONE REMOVAL **REMOTE WEST-INR** </td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILARY STONES/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILAT FEMUR FRACTURES</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILAT SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL ADNEXAL MASS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL ANKLE FRACTURE</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL ANKLE FX; LACERATED PERINEUM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL ANKLE FX; NEW AFLUTTER</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL BREAST CA/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL BREAST CANCER/SDA</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL BREAST MASSES;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL CAROTID STENOSIS\RIGHT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL CEREBELLAR STROKE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL DVT</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL DVT;LIKELY PE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL EXTREMITY ISCHEMIA/SDA</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL FEMORAL  FX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL FEMORAL FRACTURES</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL FEMORAL SUDOANEURYSMS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL FLANK PAIN</td>
<td class="gt_row gt_center">930 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL FOOT GANGRENE</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL GANGRENE; DIABETES</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL HIP FRACTURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL HIP FRACTURES</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL HYGROMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL INFECTED HEEL ULCERS</td>
<td class="gt_row gt_center">388 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL ISCHEMIC ULCERATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL KIDNEY CANCER/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL KNEE OSTEOARTHRITIS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL LEG FRACTURES</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL LOWER EXTEMITY FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL LOWER EXTREMITY EDEMA</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL LOWER EXTREMITY GANGRENE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL LUNG INFILTRATES</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL NON HEALING ULCERS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL OVARIAN CYST</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PE</td>
<td class="gt_row gt_center">167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PLEURAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PLEURAL EFFUSIONS;PNEUMONIA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PNEUMONIA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PNEUMONIA;PLEURAL EFFUSION;TONGUE MASS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PNEUMONIA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PNEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PULMONARY EMBOLI</td>
<td class="gt_row gt_center">440 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL PULMONARY NODULES/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL SAH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL SUBDURAL HEMATOMA;HEADACHE</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL SUBDURAL HEMATOMAS</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL ULCER LOWER EXTREMITY</td>
<td class="gt_row gt_center">4,928 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL UPPER ARM CELLULITIS;ABDOMINAL DISTENSION;ELEVATED HR</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL URETERAL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL VOCAL CORD PARALYSIS/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILATERAL VOCAL FOLDS LESIONS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT CANCER;SPHINCTEROTOMY</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT INJURY</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT INJURY/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT OBSTRUCTIOM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT OBSTRUCTION</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT OBSTRUCTION\ERCP </td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT STONE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT STRICTURE;S/P LIVER TRANSPLANT/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT STRICTURE/SDA</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE DUCT TUMOR/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE LEAK</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE LEAK FROM BILIARY DRAIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE LEAK S/P LIVING DONOR HEPATECTOMY/SDA</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE LEAK;ACUTE RENAL FAILURE;PNEUMONIA;HYPERTENSION\ERCP</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE LEAK;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE LEAK\ERCP</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILE OBSTRUCTION;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILFRONTAL TLANUM SPHENOIDEL MENEGIOMA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY ASCITES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY BRONCHIAL FISTULA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY CIRRHOSIS; ASCITES</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY CIRRHOSIS;RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC; CHRONIC PANCREATITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;ATRIAL FIBRILLATION\ERCP</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC;OBSTRUCTIVE JAUNDICE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC;POST SPHINCTEROTOMY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY COLIC\PERCUTANEUOS BILIARY DRAINAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY DILITATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY DUCT DILATION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY LEAK/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY OBSTRUCTION</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY OBSTRUCTION, PNEMONIA, FEVER</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY OBSTRUCTION, S/P LIVER TRANSPLANT/SDA\PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAM **WEST REMOTE-CC3 ANGIO SUITE**</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY OBSTRUCTION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY OBSTRUCTION\ERCP </td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY SEPSIS</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY STENT OBSTRUCTION</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY STRICTURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY STRICTURE/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILIARY TUMOR/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILLIARY OBSTRUCTION</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILLIARY SEPSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BILRUBINEMIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BIPOLAR PHEUMONIA</td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BISCUPID VALVE;DILATED AORTIC ROOT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BIVENTRICULAR HEART FAILURE</td>
<td class="gt_row gt_center">720 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER AND KIDNEY CA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER BLEED;ANEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CA</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CA/SDA</td>
<td class="gt_row gt_center">493 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CANCER</td>
<td class="gt_row gt_center">262 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CANCER; ATROPHIC RIGHT KIDNEY/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CANCER; PROSTATE CANCER/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CANCER;FEVER;NEUTROPENIA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CANCER;SEPSIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER CANCER/SDA</td>
<td class="gt_row gt_center">472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER MASS/SDA</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER OUTLET OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER PERFORATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER RUPTURE</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER RUPTURE,FRACTURES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER RUPTURE;SEPSIS</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER TUMOR</td>
<td class="gt_row gt_center">538 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLADDER TUMOR/SDA</td>
<td class="gt_row gt_center">211 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLAST CELL CRISIS;HYPERKALEMIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLAST CRISIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEED</td>
<td class="gt_row gt_center">241 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING ANEURYSM</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING AT TRACH SITE</td>
<td class="gt_row gt_center">539 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING AV FISTULA</td>
<td class="gt_row gt_center">158 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING BRAIN MASS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING BRAIN METS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING CHEST WOUND</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING DISORDER</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING FISTUA</td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING FROM DIALYSIS CATHETER</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING FROM NEPHRECTONY SITE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING FROM TRACH</td>
<td class="gt_row gt_center">606 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING GROIN ABSCESS</td>
<td class="gt_row gt_center">1,944 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING GUMS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING HEPATOMA</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING LIVER MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING LIVER METASTATIC</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING LOW HCT</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING MASS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING TRACHEOSTOMY</td>
<td class="gt_row gt_center">777 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING,INTERNAL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLEEDING,S/P TOTAL HIP REPLACEMENT</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLLEDING;D&amp;C</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLOCKED PORT-A-CATH</td>
<td class="gt_row gt_center">762 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLOMYSCIN RESPIRATORY TOXICITY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLOOD CLOTS, ATRIUM BODY\RESECTION OF INTRACARDIAC RETROHEPATIC ABDOMINAL TUMOR</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT ABDOMINAL TRAUMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT CHEST TRAUMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT HEAD TRAUMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TAUMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TRAUMA</td>
<td class="gt_row gt_center">3,247 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TRAUMA,LIVER LACERATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TRAUMA;HAND FRACTURE;LACERATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TRAUMA;PELVIC FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TRAUMA;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BLUNT TRAUMA;TELEMETRY</td>
<td class="gt_row gt_center">95 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BO</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOERHAAVE SYNDROME</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BONE-PAIN;METASTATIC CANCER</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BONY PAIN</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOOP SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOORHAAVE&#39;S</td>
<td class="gt_row gt_center">592 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOVINE MITRAL VALVE\CATH/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL DIVERSION FOR TAKEDOWN COLOSTOMY/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL ISCHEMIA</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBSRUCTION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">13,886 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBSTRUCTION; PANCREATITIS/SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBSTRUCTION;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBSTRUCTION;TELEMETRY</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL OBTRUCTION</td>
<td class="gt_row gt_center">376 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL PERFORATION</td>
<td class="gt_row gt_center">449 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL PERFORATION;SEPSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL PNEUMATOSIS</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL RESECTION DEAD BOWEL</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BOWEL RESECTION;CDIFFCOLITIS;LIVE TRANSPLANT LIST</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BP-FALLS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BPH W/ URINARY OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRACHEAL OCCULISON</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRACHIAL ARTERY INJURY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADE CARDIAC ARREST</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADICARDIA;RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADY ARRYTHMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADY CARDIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYARRHYTHMIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCADIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA</td>
<td class="gt_row gt_center">13,119 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA DIGOXIN TOXICITY</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA SHOCK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA WITH MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA-DYSPNEA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA-NAUSEA-VOMITINH</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA-RENAL FAILURE-HYPERKALEMIA</td>
<td class="gt_row gt_center">511 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA-SYNCOPE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA,CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA,SYNCOPE,SEIZURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA; RIGHT UPPER LOBE NODULE/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;ALTERED MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;CARDIAC ARREST</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;CHEST PAIN</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;DIZZINESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;EATING DISORDER</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;HYPOTENSION</td>
<td class="gt_row gt_center">840 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;HYPOTENSION;SEPSIS</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;HYPOTENSIVE;PACER REQUIRED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;JUNCTIONAL RHYTHM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;LOW BLOOD PRESSURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;RENAL FAILURE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;RENAL FAILURE;HYPERKALEMIA</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;RENAL FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;SYNCOPE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;SYNCOPE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;UNSTABLE ANGINA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;UTI</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRADYCARDIA;WEAKNESS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN  MASS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN ABSCESS</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN ANEURYSM</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN ANEURYSM /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN ANEURYSM/SDA</td>
<td class="gt_row gt_center">865 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN ANTERIOR VENOUS MALFORMATION/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN ARTERIAL CLOT</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN AVM</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN BLEED</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN CANCER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN CANCER - TERMINAL - INTUBATED</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN CONTUSION</td>
<td class="gt_row gt_center">1,820 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN CYST</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN EDEMA</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN HEMMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN HERNIATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN LESION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN LESION/SDA</td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN LESIONS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS</td>
<td class="gt_row gt_center">2,888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS /SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS LEFT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS OF THE MIDLINE SHIFT</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS WITH 12 MM SHIFT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS WITH SEIZURE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS-HYDROCEPHALUS</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS, BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS, LEFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS; LUNG MASS; RIGHT HIP FRACTURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS; SEIZURES</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS;CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS;S/P FALL</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS;SEIZURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS/SDA</td>
<td class="gt_row gt_center">895 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS/SDH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS/SEIZURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MASS/SZ</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN MENINGIOMA/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTASES</td>
<td class="gt_row gt_center">127 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTASES/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTASIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTASIS/LESION/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTASIS/SDA</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTESIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METASTESIS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METS</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METS-STATUS EPILEPTICUS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METS,(RENAL CELL CA)</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METS;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN METS/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN STEM CVA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN STEM MASS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN STEM STROKE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TIMOR/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR</td>
<td class="gt_row gt_center">771 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR MALIGNANT/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR RIGHT SIDE/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR RIGHT/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR WITH EDEMA/SHIFT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR, MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR, RIGHT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR,ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR,INTRA CEREBRAL HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR; INCREASED EDEMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR;HYPERNATREMIA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">3,167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAIN;CHEST AND LIVER MASS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRAINSTEM STROKE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRANCHIAL STENOSIS</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRBPR</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRBPR, DIARRHEA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRBPR/BLOOD LOSS ANEMIA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST  CANCER;HYPOXIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CA METASTATIC TO STERNUM/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CA,METS TO SPINE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CA;NEUTROPENIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CA/SDA</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER LEFT/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER RIGHT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER WITH BRAIN METASTASIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER WITH WETS TO BRAIN</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER, RIGHT/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER; FTT</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;BRAIN METS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;BRAIN METS;SEIZURE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;DEHYDRATION</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;DYSPNEA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;FEVER;HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;HYPOXIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;PNEUMONIA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;PNEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;RECONSTRUCTION,BREAST</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;RENAL FAILURE;HYDRONEPHROSIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;SUPRIOR VENA CAVA THROMBUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER;TRACHEAL STENOSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER/AIRWAY OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER/FEVER, BACK PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST CANCER/SDA</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BREAST MASS, HYPOXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIAN TUMOR/SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD BANITING/HEMIPTHSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM</td>
<td class="gt_row gt_center">1,852 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM; HCT 20; BRIEF HYPOTENSION</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM;LOWER GI BLEED</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRIGHT RED BLOOD PER RECTUM;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">3,104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL ASTHMA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL FISTULA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL LAVAGE/SPINAL DETRUSOR HYPERREFLEXIA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL LESION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL STENOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL STENOSIS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL STENOSIS\ BRONCHOSCOPY RIGID WITH T-TUBE PLACEMENT/SDA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIAL TUMOR</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIATISIS;BRONCHOSCOPY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHIECTASIS</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHITIS</td>
<td class="gt_row gt_center">590 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHITIS,UTI,CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHO PLEURAL FISTULA/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHOPLEURAL FISTULA</td>
<td class="gt_row gt_center">199 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHOPULMONARY FISTUAL</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHOSCOPY RIGID;LARYNGEAL EDEMA\BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHOSCOPY;RE-INTUBATION FOR LOW TIDAL VOLUME</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCHOSPASM</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRONCIAL CARCINOID, RIGHT MIDDLE LOBE\BRONCHOSCOPY RIGID; ENDOBRONCHIAL U/S; ? ARAGON PLASMA COAGULATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BRUGADA SYNDROME;SYNCOPE;TELEMETRY;DEHYDRATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BUDDCHIRROSIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BULEMIA,HYPOKALEMIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BULLOUS LUNG DISEASE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BURKITTS LYMPHOMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BURN;DEHYDRATION;UNRESPONSIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">BUTTOCK HEMATOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C 3-4-5, SPINAL CORD COMPRESSION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C SECTION,PRIMARY</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C SECTION,REPEAT</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C SPINE FRACTURE</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C SPINE FRACTURE,FRONTAL SINUS FRACTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C SPINE FRACTURE;SYNCOPE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C SPINE FX</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-2 FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-DIFF COLITIS</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-DIFF INFECTION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE BURST FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE FRACTURE</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE FRACTURE-S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE FRACTURE,FEMORAL FRACTURE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE FRACTURE;S/P FALL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE FRACTURES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE FX/ PARALYSIS S/P FALL</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE INJURY</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C-SPINE INJURY;S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C. DIF</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C. DIFF COLITIS;HYPOTENSION</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT; W/ MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1 FRACTURE</td>
<td class="gt_row gt_center">239 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1 FRACTURE/ANKLE FRACTURE/S/P MVC</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1 FX</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1-2 INSTABILITY/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1-C2 FRACTURE</td>
<td class="gt_row gt_center">89 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1-C2 INSTABILITY 2 DEGREE&#39;S TO ODONTOID FRACTURE ( REMOTE )</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C1-C3 TUMOR/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE</td>
<td class="gt_row gt_center">291 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE-S/P FALL</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE-S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE, S/P FALL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE,ODONTOID FRACTURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE,S/P MVA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE; RIGHT HIP FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FRACTURE;FACIAL FRACTURES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FX</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2 FXS;RIB FXS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C2-FX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C3 C4 ABSCESS;S/P DISCECTOMY</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C3 FRACTURE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C3 LATERAL MASS/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C3-4 DISC HERNIATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C4 COMPRESSION FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C4 FRACTURE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C4-5 SPINAL STENOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C4-C5 SUBLUXATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C4,C5 FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5 BURST FRACTURE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5 FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5 FRACTURE;S/P FALL</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5-6 FRACTURE</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5-C6 FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5-C6 FRACTURE,S/P MVA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C5/C6 NECK ABSCESS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C6 FRACTURE</td>
<td class="gt_row gt_center">312 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C6 SPINOUS FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C6-7 TUMOR/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C7 FRACTURE</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C7 FRACTURE-S/P FALL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C7 FRACTURE;HEAD INJURY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C7 SPINAL FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">C7,T1 FRACTURE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA ANTRUM OF STOMACH/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA BLADDER/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA IN SITE OF RECTUM/SDA</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA OF ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA OF LARYNX/SDA</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA OF LEFT BUCKLE FOSSA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA OF RIGHT ORAL CAVITY/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA OF TONGUE/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA RIGHT SKULL BASE;OSTEOMYELITIS RIGHT MANDIBLE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CA STOMACH/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAB</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CABG</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CACHEXIA,HYPOXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD ? TMR\CORONARY ARTERY BYPASS GRAFT; ? TRANS MYOCARDIAL; REVASCULARIZATION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD &amp; AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT, RE-DO;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD &amp; AS\CORONARY ARTERY BYPASS GRAFT; W/ AVR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD &amp; ATRIAL MYXOMA\CORONARY ARTERY BYPASS GRAFT;MYXOMA EXCISION /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD &amp; MR\CORONARY ARTERY BYPASS GRAFT WITH MVR REDO VIA STERNOTOMY/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD AND MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD AND MITRAL STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD AVR/SDA\CORONARY ARTERY BYPASS GRAFT; REDO;AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD FOR BALLOON</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD FOR CABG</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD FOR CABG/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR  ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT; W/ AVR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, AS\CORONARY ARTERY BYPASS GRAFT; W/ AVR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, AS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, CAROTID STENOSIS LEFT\CORONARY ARTERY BYPASS GRAFT  ENDARTERECTOMY CAROTID LEFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, MR\CORONARY ARTERY BYPASS GRAFT; W/ MVR/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, MR\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD, RENAL FAILURE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,AORTIC VALVE DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,AS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,CHF,S/P V-FIB ARREST,S/P CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,CRF\CORONARY ARTERY BYPASS GRAFT; WITH MVR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,FOR CABG\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,MR\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,R/O MI</td>
<td class="gt_row gt_center">1,118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD,S/P FALL,SYNCOPAL EPISODE</td>
<td class="gt_row gt_center">1,144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD;</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD;CHF</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD&#39;\CORONARY ARTERY BYPASS GRAFT WITH ? AVR /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD&#39;\CORONARY ARTERY BYPASS GRAFT; ? WITH MVR /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD&#39;\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/ MITRAL VALVE REGURGITATION\CORONARY ARTERY BYPASS GRAFT; ? W/ MVR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/+ETT\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/AS</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/AS\CORONARY ARTERY BYPASS GRAFT; WITH AVR/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/AS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/CABG/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/CATH\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT; W/AVR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT; W/MVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/SDA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD/UA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD\BENTALL PROCEDURE; PROXIMAL ARCH/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAD\CORONARY ARTERY BYPASS GRAFT WITH MVR;MAZE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CADAVER KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CADES\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CADIAC ARREST</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CADLNON-Q-WAVE MYOCARDIAL INFARCTION\LEFT MAIN STENT PLACEMENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CADS/P CABG\CX ANGIOPLASTY AND STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CALCIUM CHANEL BLOCKER,BETA BLOCKER OVERDOSE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CALCIUM CHANNEL BLOCKER OVERDOSE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CALVARIAL LESION/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER LARYNX/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER LEFT LOWER LOBE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER OF KIDNEY/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER OF LEFT COLON/SDA</td>
<td class="gt_row gt_center">336 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER OF ORAL PHARYNX/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER OF THE RIGHT ORAL TONGUE/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER OF THYROID/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER,WEAKNESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CANCER/RENAL FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAO; CHEST PAIN</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAPSULAR HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINO SARCOMA RIGHT THIGH/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOID CRISIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOID LUNG TUMOR LEFT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOID OF RIGHT MAIN STEM/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOID TUMOR/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOID TUMOR\BRONCHOSCOPY RIGID; W/ TUMOR REMOVAL </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOMA COLON/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOMA NECK/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOMA OF ANTERIOR MEDIASTINUM INVADING CHEST WALL/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOMATOSIS;ASCITES</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCINOMATOUS MENINGITIS SVC SYNDROME</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARCOMA ILIUM LEFT HIP/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARD ARREST</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC  ARREST</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST</td>
<td class="gt_row gt_center">5,619 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST </td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST, IPH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;COLON CA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;GI BLEED</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;SEPTIC SHOCK</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;TELEMETRY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST\CARDIAC CATH</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST\CATHETERIZATION</td>
<td class="gt_row gt_center">336 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARREST\VT ABLATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ARRHYTMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ATRIUM NEOPLASM\LEFT ATRIAL MYXOMA RESECTION WITH POSSIBLE MVR  </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CARREST</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CATH</td>
<td class="gt_row gt_center">291 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CATH S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CATH, S/P MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CATH;ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC CATHERIZATION;UNSTABLE ANGINA;TELEMETRY</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC DISEASE;CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC DZ.</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ISCHEMIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ISCHEMIA; POSITIVE STRESS TEST \LEFT HEART CATHERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ISCHEMIA;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ISCHEMIA;HYPOTENSION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC ISCHEMIA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC MASS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC SCHEMIA;ABNORMAL ELETROCARDIOGRAM\LEFT HEART CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC STENOSIS\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC TAMPIONADE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC TAMPONADE</td>
<td class="gt_row gt_center">893 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC TAMPONADE/ PNEUMOTHORAX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIAC TAMPONADE\PERICARDIAL TAP</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK</td>
<td class="gt_row gt_center">3,031 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK;CARDIAC ARREST</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK;CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK/MI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC SHOCK\CATH</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOGENIC,S/P MI, SHOCK, VF ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMELOPATHY;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">413 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY</td>
<td class="gt_row gt_center">930 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY, ATRIAL FIBRILLATION\LEFT AND RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY; HEART BLOCK\BIVENTRICULAR PACEMAKER IMPLANTATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;ABNORMAL STRESS TEST\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;ATRIAL FIBRILLATION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;CONGESTIVE HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;CORONARY ARTERY DISEASE;PNUEMONIA;ABDOMINAL AORTIC ANEURYSM\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;CORONARY ARTERY DISEASE\RIGHT AND LEFT CATH</td>
<td class="gt_row gt_center">372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;END STAGE RENAL DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">6,137 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;MI\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;MITRAL REGURGITATION\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;NON SUSTAINED VENTRICULAR TACHYCARDIA\DUAL CHAMBER IMPLANTABLE CARDIOVERTER DEFINRILLATOR IMPLANT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;RENAL FAILURE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;RUQ PAIN</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;SEVERE MITRAL REGURGITATION;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;SYNCOPE\IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PLACEMENT</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY;VENTRICULAR FIBRILLATION ARREST</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\BIVENTRICULAR LEFT VENTRICLE LEAD PLACEMENT VIA LEFT THORACOTOMY; SINGLE LUNG VENTILATION NO LINES LEFT ARM  /SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\CARDIAC CATH</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\CATH</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\EP STUDY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\ETHYANOL SEPTAL ABLATION STAND BY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANT</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\LEAD EXTRACTION;BIVENTRICULAR ICD IMPLANT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\MITRAL VALVE REPLACEMENT;REPAIR ATRIAL-SEPTAL DEFECT; ? LVAD</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATHY\RIGHT HEART CATH</td>
<td class="gt_row gt_center">1,397 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOMYOPATY/PULMONARY EDEMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARDIOPULMONARY ARREST</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARIDIA ARREST</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARINAL MASS/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROL&#39;S SYNDROME/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROLID STENOSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ANGIOGRAM\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY ANEURYSM, RIGHT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY DISEASE;ATRIAL FIBRILLATION;STATUS POST STROKE\CAROTID INTERVENTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY DISEASE\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY DISEASE\CAROTID ANGIOGRAM;POSSIBLE LEFT CAROTID STENT PLACEMENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY DISEASE\CAROTID STENTING/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY DISEASE\RIGHT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS;S/P ANGIOPLASTY,STENT\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTIC ANGIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTID ANGIOGRAM  AND STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTID ANGIOGRAM AND STENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTID ARTERY ANGIOGRAM WITH STENT PLACEMENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTID STENT</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTID STENT PLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID ARTERY STENOSIS\CAROTIS STENT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID BRUIT AND STENOSIS/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID DISEASE, LEFT/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID DISSECTION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID INJURIES</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID PSEUDOANEURYSM</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENISIS\CAROTID STENT</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENISIS\RELOOK CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSI/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS</td>
<td class="gt_row gt_center">334 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS \CAROTID ANGIOGRAM AND STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS LEFT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS LEFT/SDA</td>
<td class="gt_row gt_center">103 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS RIGHT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS RIGHT/SDA</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS, LEFT/SDA</td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS, RIGHT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS, RIGHT/SDA</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS,L/SDA</td>
<td class="gt_row gt_center">139 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS,R/SDA</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;CORONARY ARTERY DISEASE\CAROTID ANGIOGRAM;CATH</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;ELEVATED CREATININE\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;INTRACRANIAL STENT PLACEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;IV HEPARIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;RENAL INSUFFICIENCY\RIGHT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;S/P CVA\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS;SYNCOPAL EPISODES\LEFT INTERNAL CAROTID ARTERY ANGIOGRAM;STENT PLACEMENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS&#39;/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS/SDA</td>
<td class="gt_row gt_center">1,111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\ CAROTID ANGIOGRAM W/ STENT PLACEMENT AND INTERCRANIAL STENT PLACEMENT ; RIGHT/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\ CAROTID ANGIOGRAM WITH STENT; LEFT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\BYPASS AXILLO BIFEMORAL GRAFT; RIGHT; CAROTID CAROTID BYPASS GRAFT</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CARITID ANGIO</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIO</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIO AND STENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">535 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGRAM ? STENT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGRAM AND STENT</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGRAM/STENT PLACEMENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGRAM\INTERVENTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGRAPHY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOGTAM AND STENT</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID ANGIOPLASTY/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID STENT</td>
<td class="gt_row gt_center">457 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID STENT PLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\CAROTID STENT PLACEMENT/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\LEFT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\LEFT CAROTID ANGIOGRAM VIA RIGHT GROIN ACCESS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\LEFT CAROTID ANGIOGRAM;ANGIOPLASTY</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\LEFT CAROTID ANGIOPLASTY\INTERVENTION</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\R CARITID ANGIOGRAM AND STENT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSIS\RIGHT CAROTID ANGIOGRAM WITH INTERVENTION/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID STENOSUS/ELEVATED CREATNINE,L/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTID,STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTIS ARTERY STENOSIS\CAROTIS ANGIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAROTIS STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CARTID STENOSIS;SEVERE AORTIC STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CATATONIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CATH</td>
<td class="gt_row gt_center">1,207 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CATH LAB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CATHETER INFECTION</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAUDA EQUINA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAUDATE TUMOR/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAV\CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAV\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAVERNOUS ANGIOMA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAVERNOUS MALFORMATION RIGHT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAVERNOUS SINUS THROMBOSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CAVITARY MASS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CBC DILITAION;HYPOTENSION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CBD STONE</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CCB OVERDOSE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CCY</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CDIFF</td>
<td class="gt_row gt_center">546 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CDIFF COLITIS,ASCITES</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CECAL VOLVULOUS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CECAL VOLVULUS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CECUM PERFORATION</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CECUM POLYP/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CECUM/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELEXA OVERDOSE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELIAC DISEASE;GASTROENTERITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLUILITIS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULIIS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULIITIS-SEPSIS</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS</td>
<td class="gt_row gt_center">34,052 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS LEFT LOWER EXTREMITY;SD</td>
<td class="gt_row gt_center">332 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS LEFT WRIST AND ANKLE</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS NECK</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS OF RIGHT BREAST</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS OF RT BREAST-S/P MASTECTOMY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS OF UPPER EXTREMITY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS RIGHT ARM AND ELBOW</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS RIGHT LEG</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS RT FOOT-PVD-OSTEOMYELITIS-DM</td>
<td class="gt_row gt_center">400 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS SEPSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS TRACH DEPENDENT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS, GANGRENE, LEFT LEG</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS, HIP PAIN</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS, NECK/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS,A-FIB</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS,INABILITY TO URINATE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS,MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS,NECROTIZING FASCIITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS,RIGHT LEG</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS,SEPSIS</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS; ? SEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS; MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;AND SEPSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">1,566 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;DIABETES</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;DIALYSIS</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;DYSPNEA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;HYPOTENSION</td>
<td class="gt_row gt_center">497 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;L FOOT ULCER</td>
<td class="gt_row gt_center">545 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;LEFT LOWER EXTREMITY ULCER</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;OSTEOLYELITIS</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;POSSIBLE LEUKEMIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;R/O DKA;AXILLARY ABSCESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;SEPSIS</td>
<td class="gt_row gt_center">131 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;TELEMETRY</td>
<td class="gt_row gt_center">591 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;ULCER,LEFT FOOT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS;URINARY RETENTION;PNEUMONIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS/ABSCESS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULITIS/SEPSIS</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULTIIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELLULTITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CELO-VESSICLE FISTULA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTER AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTERAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">723 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL AIRWAY OBSTRUCTION;LUNG CANCER\BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL CORD SYNDROME</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL NERVOUS SYSTEM LESIONS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL NERVOUS SYSTEM LYMPHOMA</td>
<td class="gt_row gt_center">2,494 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL SCALP MELANOMA/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRAL VENOUS OCCLUSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CENTRALAIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERBRAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERBRAL EDEMA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLA BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLA HEMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLA TUMOR</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR BLEED</td>
<td class="gt_row gt_center">305 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR CVA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR HEMATOMA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR HEMORRHAGE</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR ICH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR INFACTS</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR INFARCT</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR INFARCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR LESION, LEFT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR LESIONS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR MASS</td>
<td class="gt_row gt_center">748 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR MASS VERSUS STROKE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR STROKE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR TUMOR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLAR TUMOR/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLER HEMORRHAGE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLER STOKE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLOPONTINE ANGLE TUMOR/SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLUM MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELLUM MASS;ATAXIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBELUM STROKE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURSYM/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYM/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM</td>
<td class="gt_row gt_center">334 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM /SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM LEFT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM;ANGIOGRAM</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM;FIBROMUSCULAR DYSPLASIA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">2,024 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANEURYSM\ CEREBRAL ANGIOGRAM; COILING/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANGIO;CAROTID STENT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANGIOGRAM</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ANUERYSM/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL ARTERIOVENOUS MALFORMATION/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL AVM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL AVM/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL BLEED</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL CONTUSION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL CONTUSION; S/P FALL</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL CYST/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL EDEMA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL HEMORRAHAGE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL HEMORRHAGE</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL INFARCT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL INFARCTION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL MASS</td>
<td class="gt_row gt_center">416 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL MASS AND BLEED</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL MENINGIOMA/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL METASTASES;BRAIN TUMOR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL PALSY; RECURRENT ASPIRATION PNEUMONIA/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL SPINAL FLUID OTORRHEA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT VS SEIZURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT VS TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT;HYPERCARBIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT;RESPIRATORY FAILURE;RAPIDN A-FIB</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULAR ACCIDENT;TELEMETRY</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRAL VASCULITIS;ILIO-VESICULAR FISTULA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRALVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRIAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRIAL ARTERIOVENOUS MALFORMATION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBRO VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROBASVULAR ACCIDENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULA ACCIDENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">1,677 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT-RT HEMIPARESIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;CAROTID DISSECTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;CHF</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;FEV</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;HEAD BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;PNEUMONIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;S/P TPA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;SEIZURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;SUBDURAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ACCIDENT;TELEMETRY</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREBROVASCULAR ANOMALY/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CEREMROVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERREBRAL HEMMORHAGE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL &amp; LUMBAR SPINAL STENOSIS/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL 1-2 FRACTURE; ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL CA/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL CORD COMPRESSION</td>
<td class="gt_row gt_center">193 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL CORD INJURY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL DISC HERNIATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL DISC HERNIATION/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL DISC NEURO COMPRESSION/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL DISHERNIATION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL EPIDURAL ABCESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL EPIDURAL ABSCESS/SDA</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL EPIDURAL HEMATOMA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL FRACTURE</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL FRACTURE, TRAUMATIC ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL FRACTURE/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL HEMATOMA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL INSTABILITY;FAILED HARDWARE</td>
<td class="gt_row gt_center">3,396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL LYMPHADENOPATHY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL MYELOPATHAY/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL MYELOPATHY</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL MYELOPATHY/SDA</td>
<td class="gt_row gt_center">282 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL MYLEOPATHY/SDA</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL MYOLOPATHY/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL NECK FUSION S/P</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL OSTEOMYELITIS AND NON UNION/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL RADICULOPATHY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINAL CORD COMPRESSION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINAL FX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINAL STENOSIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINAL STENOSIS/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINAL TUMOR/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINE DISLOCATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINE FRACTURE</td>
<td class="gt_row gt_center">289 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINE FX</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINE INJURY</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPINE INSTABILITY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOSIS C1-C7/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOSIS W/MYELOPATHY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOSIS WITH MYELOPATHY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">709 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOTIC MYELOPATHY; CERVICAL STENOSIS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL SPONDYLOTIC MYELOPATHY/SDA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL STENOSIS WITH MYELOPATHY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL STENOSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEURITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL STENOSIS;FAILED FUSION</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL STENOSIS/SDA</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL TRACHEAL STENOSIS</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL TRACHEOBRONCHOMALASIA/SDA</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CERVICAL TRACTION</td>
<td class="gt_row gt_center">3,104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CFS LEAK/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">1,563 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS, HYPOTENSION,BRADYCARDIA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS,HYPERTENSIVE URGENCY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS,INTUBATED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS,SEIZURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS;GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS;LOW PLATELETS;LEUKEMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS;METHICILLIN RESISTANT STAPH AUREUS;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS;RHABDOMYOLYSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS;SEIZURES</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE IN MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE MENTAL STATUS</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGE MS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHANGES IN MENTAL STATUS;S/P FALLS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOAL ASPIRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT DEFORMITY LEFT FOOT/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT DEFORMITY RIGHT FOOT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT LEFT FOOT/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT MARIE TOOTH DISEASE;CHRONIC SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT MARIE TOOTH;ARDS;ATN;OSTEOGENESIS IMPERFECTA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT RIGHT ANKLE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHARCOT, LEFT FOOT ULCER/SDA</td>
<td class="gt_row gt_center">492 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHAST PAIN\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEMICAL PNEUMONITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEMO</td>
<td class="gt_row gt_center">720 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEMO  DESENTITIZATION</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEMOTHERAPY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHESST PAIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST  PAIN;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST ABSCESS</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST APIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST APIN;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST DISCOMFORT</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST MASS/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST MASS\ATRIAL MYXOMA REMOVAL, SEPTAL MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST OAIN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAI N</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN</td>
<td class="gt_row gt_center">85,379 (1.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN </td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN 3 VESSEL DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN DYSPNEA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN R/O ISCHEMIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN R/O MI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN WITH LEFT ARM NUMBNESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN WITH NSTEMI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-LEUKEMIA</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-PNEUMONIA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-R/O MI</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-R/O MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN-STEMI\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN, A-FIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN, ALCOHOL WITHDRAWAL</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN, AORITIC ULCERATION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN, DYSPNEA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN, HYPOGLYCEMIA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN, R/O MI</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,ARM NUMBNESS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,CAD\ANGIOPLASTY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,ETOH INTOXICATION</td>
<td class="gt_row gt_center">1,062 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,FOR CABG\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,GALLSTONE,PANCREATITIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,GIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,HYPERTENSION</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,HYPOTENSION</td>
<td class="gt_row gt_center">262 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,R/O MI</td>
<td class="gt_row gt_center">233 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,RULE OUT MI</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,S/P CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN,STE MI</td>
<td class="gt_row gt_center">528 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; ABNORMAL STRESS TEST\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; ACUTE MI\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CAD\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CARDIAC ISCHEMIA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CATH </td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CHF EXACERBATION</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CORONARY ARTERY DISEASE\CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CORONARY ARTERY DISEASE\CORONARIES ANGIOGRAPHY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; CORONARY DISEASE; HYPERTENSION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; FEVER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; NON ST ELEVATION MI</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; NON-Q WAVE MI</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; PEROCARDIAL EFFUSION</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; PULMONARY EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; R/O MI</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; R/O MI; COPD FLARE</td>
<td class="gt_row gt_center">1,617 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; R/O PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; RULE OUT CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; SOB</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; SOB\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; USA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN; WOUND INFECTION</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;?TIA</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;\CATH</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+ ETT;ANGINA\CATH </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+ ETT\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+ STRESS TEST\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+ETT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+ETT\CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+ETT\CATH</td>
<td class="gt_row gt_center">231 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+MI\CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+MYOVIEW\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;+STRESS TEST\CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ABNORMAL ECHO;ADNORMAL EKG\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ABNORMAL ETT\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ABNORMAL STRESS TEST\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ABNORMAL STRESS TEST\CARDIAC CATHETERIZATION </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ACUTE CORONARY SYNDROME\CATH</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ANGINA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ANGINA PECTORIS\CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ANGINA\CATH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ANOMOLOUS CORONARY ARTERIES</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;AORTIC STENOSIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;AORTIC STENOSIS;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;AORTIC STENOSIS;CORONARY ARTERY DISEASE\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;AORTIC STENOSIS;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ATRIAL FIBRILLATION\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;BOWEL OBSTRUCTION;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">930 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CARDIAC ARREST\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">416 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CARDIAC ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CARDIOMYOPATHY; RULE OUT MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CARDIOMYOPATHY\CARDIAC CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CATH LAB</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CHRONIC RENAL FAILURE;AORTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CONGESTIVE HEART FAILURE;DYSPNEA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CONGESTIVE HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE; MITRAL REGURGITATION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE;+ETT\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE;RENAL INSUFFICIENCY\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">791 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">137 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE\CATH/STENT PLACEMENT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE\LEFT HEART CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;CORONARY ISCHEMIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DIABETIC KETOACIDOSIS;SUICIDAL IDEATION;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPENIA\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA ON EXERTION;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA ON EXERTION\CARDIAC CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA;CARDIAC ISCHEMIA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA;R/O MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA\CARDIAC CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;DYSPNEA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;EKG CHANGES</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;EKG CHANGES\CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ELEVATED TROPONIN</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ELEVATED TROPONIN\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ETT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HEART FAILURE</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HEART FAILURE\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HYPERTENSION;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HYPERTENSION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HYPERTENSIVE EMERGENCY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;HYPOTENSION</td>
<td class="gt_row gt_center">2,868 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;INFERIOR ISCHEMIA;MITRAL REGURGITATION\CARDIAC CATH;POSSIBLE ANGIOPLASTY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;LATERAL ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;MITRAL REGURGITATION;ELEVATED CREATININE\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;MYOCARDIAL ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON Q MI\CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON Q-WAVE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON ST ELEVATION MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON-Q WAVE MI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON-Q-WAVE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON-Q-WAVE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;ELEVATED TROPONIN\CARDIAC CATH</td>
<td class="gt_row gt_center">376 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;PNA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;POSITIVE STRESS TEST</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;POSITIVE STRESS TEST\CARDIAC CATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;POSITIVE STRESS TEST\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;POST INFARCT ANGINA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;PRIOR MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;PULMONARY EDEMA;ATNAL TACHYCARDIA</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RAPID ATRIAL FIBRILLATION\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RENAL FAILURE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RENAL INSUFFICIENCY;ELEVATED CREATININE\CARDIAC CATH</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RENAL INSUFFICIENCY\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE OUT CORONARY ARTERY DISEASE;ASPIRIN ALLERGY\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE OUT CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE OUT CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE OUT CORONARY ARTERY DISEASE\LEFT HEART CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE OUT CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">97 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;GI BLEED</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;HYPOTENSION</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;S/P SEIZURE\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;S/P VENTRICULAR FIBRILLATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SEPSIS</td>
<td class="gt_row gt_center">408 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SHORTNESS OF BREATH;ABNORMAL STRESS TEST\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SHORTNESS OF BREATH\CATH</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SOB</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;STATUS POST CARDIAC ARREST\CATH</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SURGICAL REVASCULARIZATION\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;SYNCOPE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">50,145 (0.7%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY,HYPOPHOSPHATEMIA</td>
<td class="gt_row gt_center">606 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY; GI BLEED</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;? PARTIAL SBO</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;CATHERIZATION,CARDIAC</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;GI BLEED</td>
<td class="gt_row gt_center">1,377 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;HYPOXIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;MELENA</td>
<td class="gt_row gt_center">1,377 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;PNEUMONIA</td>
<td class="gt_row gt_center">430 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;POSSIBLE PERICARDITIS;FEVER</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;SHORTNESS OF BREATH;ACUTE MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;TACHYCARDIA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TELEMETRY;THROAT PAIN</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;TIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;UNSTABLE ANGINA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;UNSTABLE ANGINA;TELEMETRY;+ETT\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;UNSTABLE ANGINA\CATH</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN;VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/ ABNORMAL STRESS TEST</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/ CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/ CATH</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/ CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/ SHOTNESS OF BREATH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/AORTIC STENOSIS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/CABG</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/CATH</td>
<td class="gt_row gt_center">218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/DYSPNEA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/HYPOTENSION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/MI</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/NQWMI</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/NSTEMI</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/POSITIVE EXERCISE TOLERANCE TEST\CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/S/P CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/SDA</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/SEPSIS</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN/UNSTABLE ANGINA</td>
<td class="gt_row gt_center">791 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\ANGIOPLASTY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\ANGIOPLASTY WITH BRACHY THERAPY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\ASPIRIN DESENSITIZATION;CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">563 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\CARDIAC CATHETREIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\CATH</td>
<td class="gt_row gt_center">4,159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\L HEART CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\LEFT HEART CATH</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">143 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIN\T</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PAIT;+ETT\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST PVD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST SARCOMA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST STAB WOUND</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST STAB WOUNDS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST TIGHTNESS\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST TRAUMA</td>
<td class="gt_row gt_center">146 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST WALL ABSCESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST WALL HEMATOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST WALL LESION</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHEST WALL PAIN</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF</td>
<td class="gt_row gt_center">722 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF &amp; ANKLE INFECTION</td>
<td class="gt_row gt_center">2,160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF CELLULITIS</td>
<td class="gt_row gt_center">332 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF EXACERBATION</td>
<td class="gt_row gt_center">8,827 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF EXACERBATION,R/O MI</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF EXACERBATION;END STAGE RENAL DISEASE</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF FLARE</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF VS PNA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF VS;MULTIFOCAL PNA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, A-FIB</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, AF, CARDIOMYOPATHY\LEAD EXTRACTION; BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, AFIB</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, HYPOGLYCEMIA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, LEFT VENTRICULAR LEAD CAUSING DIAPHRAGMATIC STIMULATION S/P ICD IMPLANT\LEFT VENTRICULAR LEAD REVISION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, PNEUMONIA</td>
<td class="gt_row gt_center">1,125 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF, R/O MI, ARF</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,+ETT\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,ARF</td>
<td class="gt_row gt_center">413 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,ARF,STROKE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,CAD,HYPERTENSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,CAD;COPD</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,CARDIOMYOPATHY</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,COPD,HYPERTENSION</td>
<td class="gt_row gt_center">3,136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,FEVER</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,HYPOTENSION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,MI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,MR\LEFT AND RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,PLEURAL EFFUSION,CLOTTED GRAFT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,R/O MI</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,R/O MII</td>
<td class="gt_row gt_center">355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF,RENAL INSUFFIENCY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;AORTIC STENOSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;AVR REPLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH MVR/SDA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;LEFT MAIN DISEASE;3 VESSEL DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;MITRAL REGURGITATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;OVARIAN CANCER;TELEMETRY;WEAKNESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;PLUERAL EFFUSION</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;S/P CABG;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;SEIZURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF;SEVERE AORTIC STENOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/A-FIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/COPD</td>
<td class="gt_row gt_center">1,164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/GIB/RLL PNEUMONIA</td>
<td class="gt_row gt_center">1,870 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/HYPONATREMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/PNA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF/SOB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\ AORTIC VALVE &amp; MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\BENTALL PROCEDURE; PROXIMAL ARCH/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\CORONARY ARTERY BYPASS GRAFT; EPICARDIAL LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\PNEUMONIA\ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHF\STATUS POST MITRAL VALVE REGURGITATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHI,TRAUMA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHI;FACIAL LACERATION;RIGHT ARM DEGLOVING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHIARI 1 MALFORMATION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHIARI I MALFORMATION/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHIARI MALFORMATION BILATERAL/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHIARI MALFORMATION SYRINGOMYELIA/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHIARI MALFORMATION/SDA</td>
<td class="gt_row gt_center">134 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHIARIN I MALFORMATION/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOALNGITIS;R/O ESOPHAGEAL RUPTURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOELITHIASIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOKING</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOKING EPISODE</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOKING/RESPIRATORY ARREST</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLAGIOCARCINOMA/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGEAL CARCINOMA/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIA CARCINOMA OF BILE DUCT/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO CA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO CANCER</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO CARCINOMA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO CARCINOMA /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO CARCINOMA/SDA</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO CNACER</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIO MASS</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOCARCINOMA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOCARCINOMA,DEHYDRATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOCARCINOMA;UPPER GASTROINTESTINA BLEED</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOCARCINOMA/SDA</td>
<td class="gt_row gt_center">406 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOCARCINOMA\ PTC/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOCARCINOMA\BILIARY DRAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGIOLIOLITIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS</td>
<td class="gt_row gt_center">6,119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS ABSCESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS,UPPER GI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS; BILE DUCT OBSTRUCTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;CHOLECYSTITIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;DISTAL COMMON BILE DUCT STONE IMPACTION</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;ELEVATED WHITE BLOOD COUNT;FEVER,ETIOLOGY UKNOWN</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;FAILED ERCP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;MOBITZ TWO</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;PANCREATITIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;RAPID ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;RENAL FAILURE;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;SEPSIS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;SEPTIC SHOCK</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;STATUS POST LIVER TRANSPLANT</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;STENT PLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS;TELEMETRY</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS\ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS\ERCP</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITIS\ERCP </td>
<td class="gt_row gt_center">302 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANGITISEPSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLANIOCARCINOMA - PAIN CONTROL</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECITHIASIS</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSITIS</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSITITS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS</td>
<td class="gt_row gt_center">6,505 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS; CHEST PAIN</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS; GALLSTONES/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS;ATRIAL FIBRILLATION WITH RVR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS;CHOLELITHIASIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS;SEPSIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS;TELEMETRY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYSTITIS/SDA</td>
<td class="gt_row gt_center">1,017 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLECYTITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCALITHIASIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHAL CYST;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;SPHINCTEROTOMY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLELITHIASIS/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLITHIADSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLITHIASIS</td>
<td class="gt_row gt_center">434 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLITHIASIS ; SUBQ EMPHYSEMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLITHIASIS; GASTRIC ADENOCARCINOMA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLITHIASIS/SDA</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCHOLITHIASIS\ERCP </td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCO CYST\ERCP **EAST REMOTE - G.I. ST4**</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDOCOLITHIASIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEDUODENAL FISTULA/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS</td>
<td class="gt_row gt_center">262 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS, CHOLECYSTITIS/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS; DILATED BILE DUCT</td>
<td class="gt_row gt_center">332 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS; INCISIONAL HERNIA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS;S/P ERCP;S/P SPHINCETEROTOMY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS;SIGNIFICANT PAIN UNRESPONSIVE TO PO MEDICATIONS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS/ERCP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLELITHIASIS/SDA</td>
<td class="gt_row gt_center">620 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLEYCYSTITIS</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLYCYSTITIS</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHOLYDOCHOLITHIASIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHORDAE RUPTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHR;AFIB WITH RVR</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHR/SDA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S DISEASE, NAUSEA, ANEMIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S DISEASE;THROMBOCTOPENIA;CVID</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S DISEASE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S DISEASE/VENTRAL HERNIA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S FLARE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S FLARE-ABDOMINAL ABSCESS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRON&#39;S FLARE;RENAL FAILURE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC AORTIC DISSECTION,R/O MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC AORTIC DISSECTION\RESECTION AORTIC ASCENDING ANEURYSM, CIRCULATORY ARREST</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC ASPIRATION, DYSPHAGIA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC ASPIRATION/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC BACK PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC BILATERAL PLEURAL EFFUSION/SDA</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC CHOLECYSTITIS</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC CHOLECYSTITIS/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC DISLOCATION RIGHT HIP/SDA</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC DISTAL COMMON BILE DUCT/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC DIVERTICULITIS/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC HEPATITIS C; CHIRRHOSIS OF LIVER, ESOPHAGEAL VARICES\ TIPS/SDA</td>
<td class="gt_row gt_center">581 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC IMMUNE DEMYELINATING POLYNEUROPATHY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC INTERSISTIAL CYSTISTIS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA,ASCITES,? SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA;PNEUMONIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA;SEIZURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC LYMPHOCYTIC LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MESENTERIC ISCHEMIA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MESENTERIC ISCHEMIA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MYELOGENOUS LEUKEMIA;FEVER;HYPERKALEMIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MYELOGENOUS LEUKEMIA;LOW WBC</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MYELOGENOUS LEUKEMIA;TRANSFUSION REACTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MYELOGENOUS LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MYELOGENOUS LEUKEMIA\INSERTION HICKMAN LINE; W/C-ARM DOUBLE AND 3L CVL</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC MYELOID LEUKEMIA;LEFT FOOT OSTEOMYELITIS</td>
<td class="gt_row gt_center">472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC NEURONAL DYSPLASIA BOWEL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">4,850 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE; BILAT PNEUMONIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE; RIGHT MAINSTREAM OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;ASTHMA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;BRONCHITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;CO2 NARCOSIS</td>
<td class="gt_row gt_center">8,532 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">778 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;CONGESTIVE HEART FAILURE;END STAGE RENAL DISEASE;DIABETES MELLITUS;PNEUMONIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;DEHYDRATION</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;HEMOPTYSIS</td>
<td class="gt_row gt_center">229 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;NSTEMI</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;PNEUMONIA</td>
<td class="gt_row gt_center">2,222 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;PNEUMONIA;METHICILLIN RESISTANT STAPH AUREUS;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;RENAL FAILURE;S/P STERNAL WOUND INFECTION</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;SEPSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULM DISEASE;TELEMETRY</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBST PULMONARY DISEASE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRCUTION PULMONARY DISEASE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE DISEASE EXACERBATION</td>
<td class="gt_row gt_center">1,617 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMOMARY DISEASE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">1,269 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION</td>
<td class="gt_row gt_center">18,298 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE FLARE</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE-EXACERBATION</td>
<td class="gt_row gt_center">10,314 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SYNCOPE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE;BLEBS IN LUNG</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE;CHOLANGITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE;HEMOPTYSIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE;PNEUMONIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVE PULMONARY DISEASE;TRACHEOBRONCHIALMALACIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUCTIVEPULMONARY DISEASE;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OBSTRUVTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC OSTEOMYELITIS</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PANCREATITIS</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PANCREATITIS W/ PSEUDOCYST/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PANCREATITIS/SDA</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PANCREATITIS\ ERCP</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PELVIC PAIN;EXTENSIVE LYSIS OF ADHESIONS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PELVIC PAIN/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PERICARDIAL\ REDO AORTIC ROOT/ARCH REPLACEMENT/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC PROSTATITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">6,784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE ;KIDNEY PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE-DIABETES MELLITUS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE;HYPERTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE;INFECTED AV GRAFT</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE;LIVER FAILURE</td>
<td class="gt_row gt_center">249 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE;NAUSEA;UNABLE TO TOLERATE PO&#39;S\REVISION;AV FISTULA; LEFT FOREARM</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE;OPEN EXPLORATORY LAP</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE;PANCREATITIS</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE/SDA</td>
<td class="gt_row gt_center">5,254 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE/SDA\TRANSPLANT KIDNEY RECIPIENT </td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE\ INSERTION PERMACATH W/C-ARM RIGHT INTERNAL JUGULAR/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL FAILURE\EXCHANGE RIGHT PERMACATH W/C-ARM /SDA</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RENAL INSUFFICIENCY;SYMPTOMATIC INTERNAL CAROTID ARTERY\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC RESPIRATORY FAILURE;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC STABLE ANGINA;HYPERTENSION;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC SUBDURAL BLEED</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC SUBDURAL HEMATOMA/SDA</td>
<td class="gt_row gt_center">170 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC TYLENOL INGESTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC ULCER LEFT FOOT/SDA</td>
<td class="gt_row gt_center">575 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC ULCERATIVE COLITIS/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC URINARY RETENTION/SDA</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONIC WOUND, RIGHT ABDOMINAL WALL</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHRONS DISEASE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHYLOTHORAX</td>
<td class="gt_row gt_center">608 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CHYLOUS ASCITES; PANCYTOPENIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CI BLEED</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIIRRHOSIS; RENAL FAILURE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS</td>
<td class="gt_row gt_center">1,549 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS BACTEREMIA;VANCOMYCIN RESISTANT ENTEROCOCCUS;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">406 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS FOR TIPSS\TIPSS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS GI BLEED</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS OF LIVER</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS OF LIVER;RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS W/ ASCITES\REDO TIPS /SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS WITH ASCITES\TIPS /SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS-ASCITES</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS-ASCITES-HEPATITIS C</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS-PORTAL VEIN THROMBOSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS-VARICEAL BLEED\TIPS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS, BLEEDING ULCER</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS, COMMON BILE DUCT STONE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS, HEP C</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS, LIVER LESION/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS,ESOPHAGEAL VARICES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS,FEVER</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;?SBP</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ASCITES</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ASCITES;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ASCITES;R/O CELLULITIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;CHRONIC PANCREATITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;DIABETIC KETOACIDOSIS;GALLSTANE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ENCEPHALOPATHY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ESOPHAGEAL VARICES</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;ETOH WITHDRAWAL;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;HEPATIC PLEURAL EFFUSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;HEPATITIS C</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;HEPATITIS;HEPATIC ENCEPHALOPATHY</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;HYPOTHERMIA;HYPOTENSION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;HYPOXIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;JAUNDICE</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;LIVER FAILURE</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;LIVER TRANSPLANT EVALUATION</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;LOWER EXTREMITY DYSPNEA;EDEMA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;MENTAL STATUS CHANGES;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;NEW ASCITES</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;PANCREATITIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;PORTAL HYPERTENSION;ESOPHAGEAL VARICES</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;R/O FOR TIPS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;SEPSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;TYLENOL TOXICITY</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;VARICEAL BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS;VOMITING</td>
<td class="gt_row gt_center">336 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS\REDO-TIPS  ** REMOTE WEST **/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CIRRHOSIS\TRANSJUGULAR INTRAHEPATIC PORTACAVAL SHUNT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CITALOPRAM OVERDOSE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CJR EXACERBATION &amp; HIP DISLOCATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION</td>
<td class="gt_row gt_center">722 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION /SDA</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION BILATERAL LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION LEFT </td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION LEFT LEG/SDA</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION RIGHT</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION RIGHT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION RIGHT/SDA</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION; PERIPHERAL VASCULAR DISEASE\RIGHT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION;ELEVATED CREATININE;RENAL FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION;IV HYDRATION</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION/SDA</td>
<td class="gt_row gt_center">1,455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\AA RUNOFFS</td>
<td class="gt_row gt_center">1,530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\BILATERAL ANGIOGRAM WITH RUN-OFFS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\BILATERAL LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\L LEG ANGIO ? SFA STENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\LEFT LOWER EXTREMITH ANGIO</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\LEFT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\LEFT LOWER EXTREMITY ANGIOGRAM WITH RUN-OFFS</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\LEFT LOWER EXTREMITY ANGIOPLASTY/STENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\R ILIAC ANGIO WITH SWAN GANZ</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATION\RIGHT LOWER EXTREMITY ANGIOGRAPHY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLAUDICATOIN\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLEANSER INGESTION-RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLIVAL MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLL;C-DIFF;FTT</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLL;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOGGED DOBOFF</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOGGED G-TUBE</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLONIDINE INGESTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLONUS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSE HEAD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSE LOOP OBSTRUCTON</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSED HEAD INJURY</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSED HEAD INJURY-S/P FALL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSED HEAD INJURY;LEFT FOOT FRACTURE</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSED LOOP OBSTRUCTION</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSED REDUCTION OF SHOULDER</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSTRIDIA NECROSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSTRIDIUM DIFFICILE</td>
<td class="gt_row gt_center">916 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSTRIDIUM DIFFICILE COLITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSTRIDUIUM DIFFICILE COLITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSTRIDUM DIFFICILE COLITIS;FEVER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOSURE OF OPENED WOUND/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOT</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTACATION/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED AV FISTULA</td>
<td class="gt_row gt_center">2,629 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED AV GRAFT</td>
<td class="gt_row gt_center">1,214 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED AV GRAFT LEFT/SDA</td>
<td class="gt_row gt_center">1,309 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED AVG</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED DIALYSIS ACCESS;OPEN WOUND,RIGHT ARM</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED DIALYSIS FISTULA;GASTROINTESTINAL BLEED;LIVER FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED DIALYSIS GRAFT</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED FISTULA;S/P EMBOLIZATION</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED GRAFT</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED ILEO FEMORAL GRAFT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED IV FISTULA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED LEFT AV FISTULA, CRF</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED LEFT AV GRAFT/CRF</td>
<td class="gt_row gt_center">1,476 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED LEFT FOREARM AV LOOP GRAFT\AV GRAFT; THROMBECTOMY, LEFT FOREARM LOOP GRAFT</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED LEFT UPPER ARM AV GRAFT/SDA</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED PERMA CATH;CRF;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED RIGHT UPPER EXTREMITY AV FISTULA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED SVC</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CLOTTED TIPS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CML,FEVER</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CMML,GOUT,DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CN 111 PALSY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CNS INFECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CNS MASS</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CO2 NARCOSIS</td>
<td class="gt_row gt_center">825 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CO2 RETENTION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COAGULATION MANAGEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COAGULOPATHIC</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COAGULOPATHY</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COARCTATION OF THE AORTA\ RESECTION AORTIC COARCTATION &amp; DUCTAL DIVERTICULUM; *LATEX ALLERGY*</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COCAINE INGESTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COCAINE INTOXICATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COCAINE OD</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COCAINE OVERDOSE</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CODE SEPISI</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CODE SPESIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CODE STEMI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CODE STROKE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COFFEE GROUND EMESIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COGIATED DELIRUM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COIL ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COILING</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLANGITIS</td>
<td class="gt_row gt_center">460 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLCHICIME OD</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD DISTAL FOOT</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD FOOT</td>
<td class="gt_row gt_center">211 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD ISCHEMIC LEG</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD LEFT FOOT</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD LEG</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD R FOOT, ? AORTIC DISSECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLD RIGHT LEG</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLECTOMY LEAK</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS</td>
<td class="gt_row gt_center">3,062 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS FLARE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS FLARE; RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS WITH ANEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS-GASTROENTERITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS;BILE LEAK</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS;CONSTIPATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS;DEHYDRATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS;INFECTION</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS;SEPSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS/PNA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLITIS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLLID CYST/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLLOID CYST RIGHT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLLOID CYST/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLO RECTAL CA;LIVER METS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLO-URETERAL FISTULA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLO-VAGINAL FISTULA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLO-VESICAL FISTULA S/P MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLOCUTANEOUS FISTULA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLOCUTANEOUS FISTULA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CA</td>
<td class="gt_row gt_center">271 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CA IDDM</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CA OF CECUM/SDA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CA/SDA</td>
<td class="gt_row gt_center">354 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER</td>
<td class="gt_row gt_center">193 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER W/ METASTASIS LIVER/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER;ARTERIAL CLOT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER;BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER;SEPTIC</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER/SDA</td>
<td class="gt_row gt_center">647 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CANCER\CHEMOTHERAPY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON CARCINOMA/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON MASS</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON NEOPLASM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON PERF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON POLYP</td>
<td class="gt_row gt_center">366 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON POLYP;BLEEDING/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON POLYP/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON POLYPS\COLONOSCOPY  **REMOTE EAST**</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON TUMOR BENIGN/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON TUMOR, BENIGN/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLON TUMOR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONGIC STRICTURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC DISTENTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC FISTULA/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC INERTIA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC INERTIA /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC MASS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC MASS/SDA</td>
<td class="gt_row gt_center">113 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC OBSTRUCTION</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC PERFORATION</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLONIC POLYPS/SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COLOSTOMY PROLAPSE; RECTAL STRICTURE/SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">2,240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMM ACQUIRED VS ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT DILATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT OBSTRUCTION;PNEUMONIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE;CHOLANGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE;ERCP;METHEMOGLOBIN ANEMIA\ERCP</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE;GASTRIC PERFORATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE\ERCP</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE\ERCP </td>
<td class="gt_row gt_center">115 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONE\ERCP //DUODENAL MASS W\OBSTRUCTIVE JAUNDICE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONES</td>
<td class="gt_row gt_center">178 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STONES;RESPIRATORY DISTRESS\ERCP  ** REMOTE EAST ** STONEMAN 1</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE DUCT STRICTURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMMON BILE STRICTURE/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPARTMENT SYNDROME</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLATE HEART BLOCK;SEPSIS;TRICUSPID VEGETETION\EPICARDIAL PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK</td>
<td class="gt_row gt_center">6,536 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK; ACS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK; SYNCOPE\PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK;CORONARY ARTERY DISEASE;RENAL DISEASE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK;EPIGASTRIC PAIN\CARDIAC CATH;PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK;LYME CARDITIS</td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK;MALFUNCTIONING PACEMAKER</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK;SYNCOPE</td>
<td class="gt_row gt_center">172 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK;TEMPORARY PACER WIRE\PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE HEART BLOCK\PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE LEFT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETE MAINSTEM OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLETED ABDOMINAL FISTULA/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLICATED DIVERTICULITIS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLICATED FINGER WOUND LEFT HAND/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLICATED LABOR</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLICATED RIGHT HAND WOUND/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLICATION FEMUR HARDWARE</td>
<td class="gt_row gt_center">315 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPLICATION OF DEVICE/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPOUND FRACTURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">420 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPRESS\ VERTEBROPLASTY; (WEST CC5)/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPRESSION FRACTURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPRESSION FRACTURE/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COMPRESSION FX</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONCUSSION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONFUDION, TEMPORAL MASS/STROKE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONFUSION</td>
<td class="gt_row gt_center">1,011 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONFUSION-HYPOGLYCEMIA</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONFUSION;LOW OXYGEN</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONFUSION;MYXEDEMA COMA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONFUSION;WEAKNESS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGENITAL HEART DEFECT\AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGENITAL HEART DESEASE\ DOUBLE CHAMBER RIGHT VENTRICULAR ; RESECTION W/VSD CLOSURE/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGENITAL HEART DISEASE\CORONARY ARTERY BYPASS GRAFT; RIGHT VENTRICULAR ANEURYSM; BI-ATRIAL MAZE PROCEDURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE</td>
<td class="gt_row gt_center">1,120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART DISEASE</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILUE, PNEUMONIA</td>
<td class="gt_row gt_center">2,060 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">255,789 (3.3%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE </td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE \ELECTROPHYSIOLOGY STUDY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE EXACERBATION</td>
<td class="gt_row gt_center">9,850 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE EXACERBATION-R/O MI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE EXACERBATION;ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE EXACERBATION;PNEUMONIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-ACUTE PULMONARY EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-AML</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-COPD</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-END STAGE RENAL DISEASE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-PNEUMONIA</td>
<td class="gt_row gt_center">624 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">651 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-RENAL FAILURE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-SEPSIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE-SYNCOPE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE, A-FIB</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,ACUTE RENAL FAILOURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,AFLUTTER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,AORTIC STENOSIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,COPD</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,COPD FLARE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,ENDOCARDITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,MITRAL CORD TEAR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,R/O MI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,RENAL FAILURE,ACIDOSIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,REPIRATORY FAILURE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,SEPSIS</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE,UNSTABLE ANGINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;</td>
<td class="gt_row gt_center">650 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; AORTIC STENOSIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; AORTIC STENOSIS\COREVALVE; AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; ATRIAL FIBRILLATION; S/P CVA\BIVENTRICULAR ICD IMPLANTATION/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; ATRIAL FLUTTER/FIBRILLATION; LEFT BUNDLE BRANCH BLOCK\ATRIAL FLUTTER ABLATION + BIVENTRICULAR ICD IMPLANTATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; CARDIOMYOPATHY\ICD IMPLANTATION +/- BIVENTRICULAR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; DM; CRF\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; EKG CHANGES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; HYPERCARBIC RESP FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; NEW LEFT BUNDLE BRANCH BLOCK</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; NON ST ELEVATION MYOCARDIAL INFARCTION\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; NSTEMI</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; R/O MI</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; RENAL FAILURE</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; SUDDEN CARDIAC DEATH RISK; CAD\ICD IMPLANTATION +/- BIVENTRICULAR</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; SYNCOPE AND LEG WOUND ULCER</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE; VENTRICULAR TACHYCARDIA\EP STUDY/LV MAPPING; BIVENTRICULAR ICD IMPLANTATION</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;? SEPSIS</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;?R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;(AML) ACUTE MYELOGENOUS LEUKEMIA;LUNG INFILTRATED</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;A FIB VS ATRIAL TACHUCARDIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;A-FIB</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ACUTE CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ACUTE CORONARY SYNDROME\CATH</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">703 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AFIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ANGINA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC REGURGITATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC STENOSIS</td>
<td class="gt_row gt_center">429 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC STENOSIS;COMPLETE HEART BLOCK\CARDIAC CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC STENOSIS;RENAL FAILURE;CIRRHOSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC STENOSIS\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIC STENOSIS\COREVALVE; AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTICSTENOSIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;AORTIS STENOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;APPENDICITIS</td>
<td class="gt_row gt_center">560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ARF</td>
<td class="gt_row gt_center">496 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ARF;HYPOTENSION</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ASTHMA EXACERBATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL CLOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL FIB</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL FIBRILATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL FIBRILLATION;+ TROPONIN\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL FIBRILLATION;HYPOXIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ATRIAL TACHYCARDIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;BRADYCARDIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CARDIOMYOPATHY\BIVENTRICULAR PACEMAKER PLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CARDIOMYOPATHY\CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CARDIOMYOPATHY\CATH</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CELLULITIS</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHEST PAIN</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">182 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHRONIC OBST PULM DISEASE;PNEUMONIA</td>
<td class="gt_row gt_center">1,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHRONIC OBST PULM DISEASE;TELEMETRY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHRONIC OBSTRUCTIVE PULMONARY DISEASE\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHRONIC RENAL FAILURE;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CHRONIC RENAL INSUFFICIENCY;ANEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;COMPLETE HEART BLOCK;ATRIAL FIBRILLATION\BIVENTRICULAR PACEMAKERIMPLANT/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;COPD</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;COPD EXACERBATION</td>
<td class="gt_row gt_center">2,060 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE;ELEVATE TROPONIN;PERIPHERAL VASCULAR DISEASE</td>
<td class="gt_row gt_center">388 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE;SEVERE PERIPHERAL VASCULAR DISEASE\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE\COMPLETE HEART CATHERIZATION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;CRF</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;DELTA MS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;DIALYSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;DIARRHEA</td>
<td class="gt_row gt_center">365 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;DIASTOLIC DYSFUNCTION\LEFT HEART CATH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;DYSPNEA\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ELEVATED CREATININE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ELEVATED INR</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;END-STAGE RENAL DISEASE;ALTERED MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;ENDOCARDITIS\TRANSESOPHAGEAL ECHOCARDIOGRAM</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;EXACERBATION</td>
<td class="gt_row gt_center">2,389 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;EXACERBATION;HYPOGLYEMIA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;GI BLEED;DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HEART BLOCK\BIVENTRICULAR PACEMAKER IMPLANT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HIP FAILURE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HIP FRACTURE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HYOTHYROIDISM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HYPERKALEMIA;ALTERED MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">3,136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HYPERTENSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HYPOTENSION</td>
<td class="gt_row gt_center">333 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HYPOTENSION;FEVER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;HYPOXIA</td>
<td class="gt_row gt_center">642 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;IDIOPATHIC DILATED CARDIOMYOPATHY</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;KIDNEY FAILURE;ATRIAL AND MITRAL VALVE DISEASE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;LEFT BUNDLE BRANCH BLOCK;CARDIOMYOPATHY\BIVENTRICULAR IMPLANTABLE CARDIAC DEFIBRILLATOR IMPLANT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MITRAL STENOSIS\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MORBID OBESITY</td>
<td class="gt_row gt_center">222 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MR\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NEW MI\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NON Q MI\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NON Q WAVE MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NON Q WAVE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NON S-T ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NON ST ELEVATION MI;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;NQWMI</td>
<td class="gt_row gt_center">695 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">3,250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA;HYPERTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA;HYPOXIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA;RULE OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">679 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PNEUMONIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;PULMONARY HYPERTENSION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;R/O MI</td>
<td class="gt_row gt_center">275 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RENAL FAILURE</td>
<td class="gt_row gt_center">473 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RENAL FAILURE;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">3,429 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">322 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RESPIRATORY FAILURE;HIP FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RESPIRATORY FAILURE;SEVERE AS</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RIB FRACTURES</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RULE OUT CORONARY ARTERY DISEASE;ATRIAL FIBRILLATION\CATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">383 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">236 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;S/P AVR</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;S/P CABG</td>
<td class="gt_row gt_center">227 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;S/P CARDIAC INTERVENTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;S/P RENAL TRANSPLANT;HYPERKALEMIA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;SEPSIS</td>
<td class="gt_row gt_center">170 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;SEVERE MIRTAL REGURGITATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;SEVERE MITRAL REGURGITATION;COPD\CATH</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">298 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;STEMI</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;SYNCOPE;TELEMETRY</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETERY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">7,560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY;CORONARY ARTERY DISEASE;DIABETES MELLITUS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY;STERNAL DEHISCENCE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY\BIVENTRICULAR LEAD PLACEMENT VIA LEFT THORACOTOMY /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY\EPICARDIAL LEFT VENTRICULAR LEAD PLACEMENT /SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY\THORASCOPIC VS LEFT THORACOTOMY, LEFT  VENTRICULAR EPICARDIAL LEAD PLACEMENT, AUTOMATIC INTERNAL CARDIAC DEFIBRILLATOR/PERMANENT PACEMEKER GENERATOR CHANGE </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) W/ DIRECT AORTIC APPROACH  </td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;TELEMETRY\Transcatheter Aortic Valve Implant (TAVI) with Pump Stand-by (CoreValve) </td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;URINARY TRACT INFECTION;PNEUMONIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">662 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE;VS;PNEUMONIA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/FOOT INFECTION</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/MITRAL REGURGITATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/PNEUMONIA</td>
<td class="gt_row gt_center">525 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/S/P MI AT RISK/DYSPNEA\BIVENTRICULAR INTRACARDIAC DEVICE IMPLANT</td>
<td class="gt_row gt_center">888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/SDA</td>
<td class="gt_row gt_center">258 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE/V TACH</td>
<td class="gt_row gt_center">666 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\ANGIOPLASTY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\BIVENTRICULAR ICD</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\BIVENTRICULAR ICD IMPLANTATION</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\BIVENTRICULAR ICD UPGRADE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PLACEMENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\BIVENTRICULAR LEAD PLACEMENT VIA LEFT THORACOTOMY /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\BIVENTRICULAR PACEMAKER UPGRADE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">2,453 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">1,158 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\CATH/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\EPICARDIAL LEAD PLACEMENT </td>
<td class="gt_row gt_center">364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\EPICARDIAL LEFT VENTRICULAR LEAD PLACEMNT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\INTERNAL CARDIOVERTER DEFIBRILLATOR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\LASER LEAD EXTRACTION; BIVENTRICULAR LEAD PLACEMENT VIA LEFT THORACOTOMY; SINGLE LUNG VENTILATION (LEAVE LEFT ARM FREE) /SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\MITRAL VALVE REPLACEMENT;POSSIBLE CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\MITRAL VALVULOPLASTY </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\R HEART CATH WITH SWAN PLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\RIGHT AND LEFT CARDIAC CATH</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\RIGHT HEART CATH</td>
<td class="gt_row gt_center">598 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\RIGHT HEART CATH;SWAN LINE</td>
<td class="gt_row gt_center">888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\SWAN PLACEMENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\THORACOSCOPIC LEFT VENTRICULAR LEAD PLACEMENT;? THORACOTOMY ? THORACOSCOPIC EPICARDIAL LEAD W/ OR WITHOUT ENDOVASCULAR LEAD/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) DIRECT ACCESS </td>
<td class="gt_row gt_center">119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) PERCUTANEOUS APPROACH  </td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) PERCUTANEOUS APPROACH   ** NO ASSESSMENT NEEDED **</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) PERCUTANEOUS APPROACH WITH SAPIEN </td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) PERCUTANEOUS APPROACH; TRANSFEMORAL APPROACH  </td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\TRANSCATHETER AORTIC VALVE IMPLANT (TAVI) TRANSFEMORAL APPROACH  </td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\Transcatheter Aortic Valve Implant (TAVI) with Pump Stand-by (CoreValve) </td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEART FAILURE\Transcatheter Aortic Valve Implant (TAVI)VIA DIRECT AORTIC ACCESS with Pump Stand-by (CoreValve) </td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGESTIVE HEARTH FAILURE</td>
<td class="gt_row gt_center">1,448 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONGETIVE HEART FAILURE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONJESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">863 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONN&#39;S SYNDROME/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONNECTIVE TISSUE TUMOR LEFT TEMPORAL REGION/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONSTIPATION</td>
<td class="gt_row gt_center">459 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONSTIPATION-ABDOMINAL MASS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONSTIPATION;HYPONATREMIA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONSTIPATION/DEHYDRATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONSTIPATION/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONSTRICTIVE PERICARDITIS\PERICARDIAL STRIPPING/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONTRICTIVE PERICARDITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONTRICTIVE PERICARDITIS\PERI CARDECTOMY/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONTRICTIVE PERICARDITIS\PERICARDIAL STRIPPING/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CONTROL OF TONSILAR BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COOAGULOPATHY;RIGHT HIP BLEEDING</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COOL RIGHT LOWER EXTREMITY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD AND PNEUMONIA</td>
<td class="gt_row gt_center">215 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD ASTHMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION</td>
<td class="gt_row gt_center">23,201 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION-ASPIRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION,PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION; PNEUMONIA</td>
<td class="gt_row gt_center">509 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION;HEMOPTOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION;RIB FRACTURE</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION;TELEMETRY</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">8,532 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXACERBATION/PNEUMONIA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD EXCERBATION</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE</td>
<td class="gt_row gt_center">28,863 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE-HYPOTENSION</td>
<td class="gt_row gt_center">3,136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE-RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">1,309 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE, CORD COMPRESSION</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE,PNEUMONIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE;RISING LACTATE</td>
<td class="gt_row gt_center">715 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD FLARE;SHORTNESS OF BREATH;RULE OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD W/HYPOXCEMIA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD, PNEUMONIA VS. BRONCHITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD, PNEUMONIA, ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD,PNEUMONIA,PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">335 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD/PNA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COPD/RENAL FAILURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORARTID STENOSIS /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORATID STENOSIS\CAROTIS ANGIOGRAM</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD COMPRESSION</td>
<td class="gt_row gt_center">674 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD COMPRESSION </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD COMPRESSION;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD COMPRESSION;PNEUMONIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD COMPRESSION;RENAL CELL CANCER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD CONTUSION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORD INJURY</td>
<td class="gt_row gt_center">91 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR </td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MITRAL VALVE REPAIR VS REPLACEMENT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE\ENDOSCOPIC CORNARY ARTERY BYPASS OFF PUMP LEFT CHEST/SDA</td>
<td class="gt_row gt_center">444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY ARTERY DISEASE\ENDOSCOPIC CORONARY BYPASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNARY DISEASE\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORNEAL ULCER</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COROANRY ARTERY STENOSIS\RIGHT CAROTID STENT PLACEMENT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERT DISEASE\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERTY BYPASS </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERTY DISEASE;LEFT MAIN DISEASE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERTY DISEASE\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY ARTHROSCLEROSIS\RE-DO STERNOTOMY, MYXOMA RESECTION </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY BYPASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">17,636 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE ;CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE \CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE-ARRYTHMIAS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE-RESPIRATORY ARREST</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE-UNSTABLE ANGINA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE,NON ST ELEVATION MI,SICK SINUS SYNDROME\LEFT ANTEN DESCENDING STENT </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE,PERFORATED LAD</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; ACUTE CORONARY SYNDROME\CORONARY STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; AF</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT  AORTIC AND MITRAL VALVE REPLACEMENT W/MAZE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; APRTIC STENOSIS\LEFT AND RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; CARDIOMYOPATHY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; CAROTID STENOSIS LEFT\CORONARY ARTERY BYPASS GRAFT  ENDARTERECTOMY CAROTID LEFT/SDA</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; CHEST PAIN\CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; CHEST PAIN\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; CONGESTIVE HEART FAILURE </td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; DYSPNEA; POSITIVE STRESS TESST FOR ISCHEMIA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; ISCHEMIC CARDIOMYOPATHY; S/P CORONARY ARTERY BYPASS GRAFT\CATH; ICD IMPLANTATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; MR\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; NEW ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; NON ST ELEVATION MYOCARDIAL INFARCTION\RUT STENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; PULMONARY HYPERTENSION; CHRONIC LIVER FAILURE; CHRONIC RENAL FAILURE\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; RECURRENT CHEST PAIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; ST ELEVATED MYOCARDIAL INFARCTION\CORONARY ANGIOGRAPHY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; THYROID NEOPLASM\CORONARY ARTERY BYPASS GRAFT; THYROIDECTOMY /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE; VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;? MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;?SARCOIDOSIS\CORONARY ARTERY BYPASS GRAFT;LYMPH NODE BIOPSY; (? LOCATION-P.M. WILL CB)/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+ ETT\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+ STRESS TEST\LEFT HEART CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+ETT\ANGIOPLASTY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+ETT\CAD;+ETT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+ETT\CARDIAC CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+ETT\CATH</td>
<td class="gt_row gt_center">304 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;+STRESS TEST\LEFT HEART CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;3 VESSEL DISEASE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ABNORMAL STRESS TEST\CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ACUTE ANTERIOR MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ACUTE CORONARY SYNDROME\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ACUTE CORONARY SYNDROME\RAMUS ARTERY STENT PLACEMENT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA;STATUS POST CORONARY ARTERY BYPASS GRAFT\LEFT HEART CATH;RENAL ANGIOGRAPHY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\ANGIOPLASTY</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\CATH</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\CORONARY STENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\LEFT ANTERIOR DESCENDING CORONARY ARTERY INTERVENTION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\LEFT HEART CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC INSUFFICIENCY</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC INSUFFICIENCY\CORONARY ARTERY BYPASS GRAFT WITH AVR  ? ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS;CONGESTIVE HEART FAILURE;PULMONARY EDEMA</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS;MITRAL VALVE DISEASE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS;MR\CORONARY ARTERY BYPASS GRAFT; WITH AVR; MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS;MR\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS\CATH</td>
<td class="gt_row gt_center">323 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT, RE-DO/SDA</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AORTIC VALVE INSUFFICIENCY</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AROTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AVR</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;AVR;CABG</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIAC ISCHEMIA;CHEST PAIN\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIAC ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIAC ISCHEMIA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIACTAMPONADE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIOGENIC SHOCK\LEFT ANTERIOR DESCENDING ARTERY; ANGIOPLASTY/STENT</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIOMYOPATHY\CATH</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CARDIOMYOPATHY\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CAROTID STENOSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CAROTID STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN SYNDROME\LEFT HEART CATHETERIZATION WITH ANGIOPLASTY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;+ETT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;+ETT\CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;ABNORMAL STRESS TEST\CARDIAC CATHETERIZATION/LEFT HEART CATHETRIZATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;ANGINA;SYNCOPE\CARDIAC CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;DYSPNEA\CATH</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;ELEVATED TROPONIN\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY\MULTIVESSEL STENTING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\ANGIOPLASTY AND STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\ASPIRIN DESENSITIZATION/3/31 CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">259 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\CATH WITH INTERVENTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\CORONARY ANGIOPLASTY (PTCA)</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\LEFT HEART CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHEST PAIN\RIGHT CORONARY ARTERY STENT PLACEMENT</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHF</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHF\BENTAL PROCEDURE  CORONARY ARTERY BYPASS GRAFT  AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CHRONIC OBSTRUCTIVE PULMONARY DISEASE;DIABETES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;CHEST PAIN</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;CHEST PAIN\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE;GASTROINTESTINAL BLEED;ANEMIA\CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE\ANGIOPLASTY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE\LEFT AND RIGHT HEART CATH</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CORONARY ARTERY BY PASS GRAFT/SDA\CORONARY ARTERY BY PASS GRAFT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;CP</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;DIABETES MELLITUS;HYPERTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;DM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;DYSPNEA;CHF</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;DYSPNEA;COPD</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;DYSPNEA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ELEVATED CREATININE\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ELEVATED TROPONIN</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;EXERCIONAL DYSPNEA\CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;EXERTIONAL ANGINA;+ETT\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;EXERTIONAL ANGINA;CHRONIC RENAL INSUFFICIENCY\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;EXERTIONAL ANGINA\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;EXERTIONAL ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;EXERTIONAL CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;FATIGUE\LEFT HEART CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;FOR AVR/CABG\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HEART FAILURE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HYPERLIPIDEMIA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HYPERTENSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HYPERTENSION;DIABETES\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HYPERTENSION;PERIPHERAL VASCULAR DISEASE\CATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;HYPERTENSION\CATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ICD DISCHARGE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ISCHEMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;ISCHEMIA\CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;LEAD INFECTION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;LEFT MAIN DISEASE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;LEFT MAIN DISEASE\CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;LEFT VENTRICULAR DYSFUNCTION\CATH</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MI</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL REGURGE</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL REGURGITATION</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL REGURGITATION\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL REGURGITATION\PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOGRAM\STENT PLACEMENT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL RESURGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL STENOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL VALVE DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR;AORTIC STENOSIS\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR\CORONARY ARTERY BYPASS GRAFT WITH MVR  TVR/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR\CORONARY ARTERY BYPASS GRAFT; ?MVR</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR\CORONARY ARTERY BYPASS GRAFT; WITH MVR/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MR\MITRAL VALVE REPLACEMENT; ; REDO;REPAIR ATRIAL-SEPTAL DEFECT; ?AVR/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MRSA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MULTIPLE SYSTEM FAILURE\ANGIOPLASTY</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MYOCARDIAL INFARCTION;RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MYOCARDIAL INFARCTION\CATH;STENT PLACEMENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;MYXOMA\CORONARY ARTERY BYPASS GRAFT;LEFT ATRIAL MYXOMA REMOVAL/SDA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NEW ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NON Q MI\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NON ST ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NON-Q-WAVE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CORONARY STENT PLACEMENT</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;POSITIVE STRESS TEST\CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PRESYNCOPE;END STAGE RENAL DISEASE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PROGRESSIVE CHEST PAIN\CATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PULMONARY EDEMA</td>
<td class="gt_row gt_center">61 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PULMONARY EDEMA,NON-ST-ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PULMONARY EDEMA\ANGIOPLASTY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PVD</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PVD\CARDIAC CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PVD\CATH AND L SFA INTERVENTION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PVD\CATH;AARUNOFFS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;PVD\R HEART CATH;PERIPHERAL ANGIO</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;R/O MI</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;RECURRENT CHEST PAIN;DYSPNEA;RENAL INSUFFICIENCY\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;RECURRENT PAIN\CATH WITH BRACHY S/B</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;RENAL ARTERY STENOSIS\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;RENAL FAILURE</td>
<td class="gt_row gt_center">131 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;S/P CABBAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;S/P CABG</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;S/P CATHERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;S/P CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;S/P NON Q MI</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;S/P RENAL TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SEVERE 3VESSELS DISEASE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SEVERE AORTIC STENOSIS</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SHORTNESS OF BREATH;CHEST PAIN\LEFT HEART CATH</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SHORTNESS OF BREATH;PULMONARY EDEMA\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SHORTNESS OF BREATH\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;SOB;TELEMETRY</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;STATUS POST MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;TELEMETRY</td>
<td class="gt_row gt_center">179 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;TELEMETRY\BALOON PUMP</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;TIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;TIA;CAROTID STENOSIS\CATH/STENT PLACEMENT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;UNSTABLE ANGINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;UNSTABLE ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;UNSTABLE ANGINA\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;UNSTABLE ANGINE;RENAL INSUFFICIENCY\LEFT HEART CATH</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;URINARY TRACT INFECTION;ELEVATED TROPONIN</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;VENTRICULAR ARREST\CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE;VENTRICULAR TACHYCARDIA\LEFT HEART CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/ CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/ V-TACH</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/CARDIAC CATH</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/SDA</td>
<td class="gt_row gt_center">737 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/SDA\AORTIC VALVE REPLACEMENT WITH STERNOTOMY</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/SDA\CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE/UNSTABLE ANGINA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ BENTAL HOMOGRAFT PROCEDURE;CORONARY ARTERY BYPASS GRAFT; RADIAL ARTERY; LEFT INTERNAL MAMMARY ARTERY/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ BENTAL PROCEDURE WITH HEMOGRAFT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ CORONARY ARTERY BYPASS GRAFT REDO/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ CORONARY ARTERY BYPASS GRAFT W/AVR; ASCENDING AORTA REPAIR/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ CORONARY ARTERY BYPASS GRAFT WITH AVR/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ CORONOARY ARTERY BYPASS GRAFT WITH MVR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ MINIMALLY INVASIVE CORONARY ARTERY BYPASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ OFF PUMP CORONARY ARTERY BYPASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ OFF PUMP CORONARY ARTERY BYPASS/SDA</td>
<td class="gt_row gt_center">1,247 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ OFF PUMP CORONARY ARTERY; BYPASS/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ TOTAL ARCH REPLACEMENT; BENTAL PROCEDURE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ANGIOPLASTY</td>
<td class="gt_row gt_center">490 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ANGIOPLASTY AND STENT</td>
<td class="gt_row gt_center">43 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ANGIOPLASTY WITH BRACHY THERAPY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ANGIOPLASTY;STENT PLACEMENT</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ANGIOPLASTY/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC AND MITRAL VALVE REPLACEMENT, ? CORONARY ARTERY BYPASS GRAFT  /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE / ASCENDING AORTA REPLACEMENT  CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE / ASCENDING AORTA REPLACEMENT;  CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE / ASCENDING AORTA REPLACEMENT;  MVR STANDARD HAGBERG R; CORONARY ARTERY BYPASS GRAFT; HEMI-ARCH/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">262 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT, R.F. MAZE PROCEDURE /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; ? CABG/SDA</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT; ? HOMO GRAFT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; ?MVR/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; TISSUE VALVE /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT; WITH MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ARDIAC CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ATRIAL MYXOMA REMOVAL;?AORTIC VALVE REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT; ? TRICUSPID VALVE REPLACEMENT;? REPLACEMENT ASCENDING AORTA /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AVR; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\AVR; ACENDING AORTA;?CORONARY ARTERY BYPASS  /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BENTAL HEMI ARCH REPLACEMENT; CORONARY ARTERY BYPASS GRAFT; ? STERNAL PLATING /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BENTAL PROCEDURE  CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BENTAL PROCEDURE; CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BENTALL PROCEDURE;CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BENTALL PROCEDURE;CORONARY ARTERY BYPASS GRAFT; ?MAZE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BiV ICD IMPLANT IN O.R. /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BRACHY THERAPY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\BYPASS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CABG</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARD CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">545 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATH WITH INTRAVASCULAR ULTRASOUND</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATH;PLANNED CORONARY ANGIOPLASTY;STENT PLACEMENT</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATHETER</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC CATHETERIZATION;BARE METAL STENT PLACEMENT LEFT ANTERIOR DESCENDING ARTERY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CARDIAC INTERVENTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CAROTID ANGIOGRAPHY</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CAROTID INTERVENTION;STENT PLACEMENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">6,547 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH WITH BRACHY S/B</td>
<td class="gt_row gt_center">590 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH WITH BRACHY STANDBY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH WITH INTERVENTION</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH; CABG</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH;ANGIOPLASTY</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH;RIGHT CORONARY ARTERY ANGIOPLASTY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH/STENT PLACEMENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CATH/SUBCLAVIAN INTERVATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\COROANRY ARTERY BYPASS GRAFT WITH MITRAL VALVE REGURGITATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">431 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">788 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT  ** NO ASSESSMENT NEEDED **</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT  ASCENDING AORTA HEMI ARCH REPLACEMENT/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT  ENDARTERECTORY FEMORAL RIGHT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT  MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT ? MAZE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT ? MVR /SDA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT ? PFO CLOSURE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">11,589 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT &amp; CONCOMINANT MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT &amp; MAZE PROCEDURE</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT AND RF MAZE /SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT ITH AVR /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT LV ANEURYSMECTOMY/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT MAZE; ? PATENT FORAMEN OVALE CLOSURE /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT REDO </td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT REDO /SDA</td>
<td class="gt_row gt_center">214 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT RIMA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/ ? MVR/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/ BILATERAL MAMMARY/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/ CRYOMAZE; ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/ VENTRICULAR ACCESS DEVICE/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/OPEN LUNG BIOPSY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/POSSIBLE ATRIAL SEPTAL DEFECT CLOSURE /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT w/RE-DO STERNOTOMY /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT W/VENTRICULAR ASSIST DEVICE BACKUP/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH ? AVR /SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH ? MVR /SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH ? MVR VS REPLACEMENT  /SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH ? PFO CLOSURE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AORTIC VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH ATRIAL VALVE REPLACEMENT  </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH ATRIAL VALVE REPLACEMENT; ? MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR </td>
<td class="gt_row gt_center">172 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR  ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR  BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR ? ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR ? MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR /SDA</td>
<td class="gt_row gt_center">1,291 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR RE-DO STERNOTOMY </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR REDO </td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR, ? MVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR, DEEP HYPOTHERMIC CIRCULATIORY ARREST/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR, MAZE </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR;  ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR;  MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? ASCENDING AORTA REPLACEMENT; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? ENDARTERECTOMY /SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? MVR REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; ? OF ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; LEFT ATRIAL APPENDAGE LIGATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR; RE-DO STERNOTOMY /SDA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH AVR;POSSIBLE MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MAZE </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MAZE; LEFT ATRIAL APPENDAGE LIGATION /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MITRAL VALVE REPAIR, ? MITRAL VALVE REPLACEMENT; </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR </td>
<td class="gt_row gt_center">97 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">1,688 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR &amp; TVR; ? AVR/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR AND TVR/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR LVAD</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR REDO; ? AVR/SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR REPAIR; ? REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR VERSUS REPLACEMENT/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR W/LEFT VENTRICULAR ASSISTED DEVICE BACK-UP/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR; ? left ventricular aneurysm repair</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR; ? MAZE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR; ? OF MAZE PROCEDURE /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH RADIAL ARTERY /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH RIMA &amp; LIMA; AVR/SDA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH; ? MVR /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITHRADIAL ARTERY; ? OFF PUMP CORONARY ARTERY BYPASS WITH RADIAL ARTERY LEFT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITHRADIAL ARTERY; RIGHT; VIDEOSCOPIC MAMMARY HARVEST/SDA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITHRADIAL ARTERY/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT x4 /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT,  ? AVR /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, ?  MVR /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, ? MVR /SDA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, MITRAL VALVE REPAIR, ? MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, RE-DO; MITRAL VALVE REPLACEMENT VIA LEFT THORACOTOMY</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, RE-DO; T.M.R./SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, RE-DO;MITRAL VALVE REPLACEMENT; ?AVR/SDA</td>
<td class="gt_row gt_center">350 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, RE-DO;THORACOTOMY; LEFT; ? OFF PUMP/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT, RE-DO/SDA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;  ? AORTIC VALVE / ?ASCENDING AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? AVR AND MVR/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? AVR/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? LEFT RADIAL ARTERY/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? MAZE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? MAZE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? MITRAL VALVE REPAIR VS REPLACEMENT; ? AVR; ? ASCENDING AORTA REPLACEMENT; ? MAZE /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? MITRAL VALVE REPLACEMENT; ? AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? MVR /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? MVR/SDA</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? OFF PUMP CABG/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? OFF PUMP CORONARY ARTERY BYPASS /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? OFF PUMP CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? OFF PUMP CORONARY ARTERY BYPASS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ? OFF PUMP/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ?? MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; ?TVR/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; HOMOGRAFT ROOT REPLACEMENT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; LEFT VENTRICULAR OUT-FLOW TRACT MASS RESECTION </td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; LVAD/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; MAZE /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; MAZE PROCEDURE; LEFT VENTRICULAR LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; OFF PUMP, USING LEFT RADIAL ARTERY/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; OFF PUMP; SINGLE VESSEL/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; OFF PUMP/SDA</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; PFO CLOSURE; ? AVR/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; PULMONARY VALVE REPLACEMENT AICD PLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; RADIAL ARTERY LEFT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; RADIAL ARTERY RIGHT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; REPAIR ATRIAL SEPTAL DEFECT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; RESECTION AORTIC ASCENDING ANEURYSM /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; RESECTION AORTIC ASCENDING ANEURYSM/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; STENT PLACEMENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/ ? MVR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/ LEFT VENTRICULAR ANEURYSM RESECTION</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/ LIMA/REMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/ RADIAL ARTERY; ? OFF PUMP CABG/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/AVR/SDA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/LIMA RIMA ? LRA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/MVR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/MVR/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; W/POSSIBLE LVAD/SDA</td>
<td class="gt_row gt_center">315 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH ? MVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH AVR; ? MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH AVR; ? OF MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH AVR;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH AVR/SDA</td>
<td class="gt_row gt_center">607 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH LEFT RADIAL ARTERY/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH MITRAL VALVE REPLACEMENT REDO WITH MAZE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH MVR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH MVR;MAZE/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH MVR/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH RADIAL ARTERY LEFT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT; X3/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;? ASCENDING AORTA/SDA</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;? AVR: REPLACEMENT ACENDING AORTA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT, RE-DO/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT; ? MAZE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT; ? MVR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT; ?MVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT; ASCENDING AORTA &amp; PROXIMAL ARCH/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT; REPAIR ASCENDING AORTA&#39;/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">262 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT; MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT;REDO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT: ? AVR /SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT? WITH MVR REDO /SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">9,140 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFTREDO /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFTWITH AVR </td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFTWITH AVR /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFTWITH AVR; ? REPLACING ACENDIND AORTA/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFTWITH MVR /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFTWITH RADIAL ARTERY /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY ARTERY STENTING</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY INTERVENTION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CORONARY STENT PLACEMENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\CYSTOSCOPY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\DIAGNOSTIC CATH</td>
<td class="gt_row gt_center">304 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ENDOSCOPIC CORONARY ARTERY BYPASS GRAFT ? STERNOTOMY/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\ENDOSCOPIC CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\HEART CATH</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\HIBRID MINIMALY INVASIVE CORONARY ARTERY BYPASS GRAFT AND CORONARY STENTING /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\INNOMINATE ARTERY BYPASS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\INTRAVASCULAR ULTRASOUND OF LEFT MAIN ARTERY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING ANGIOPLASTY</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING ANGIOPLASTY;STENT PLACEMENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING ARTERY ANGIOPLASTY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING ARTERY ANGIOPLASTY WITH STENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING INTERVENTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING PERCUTANEOUS CORONARY INTERVENTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT ANTERIOR DESCENDING STENT</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT CIRCUMFLEX AND LEFT MAIN CORONARY ARTERY INTERVENTION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT CIRCUMFLEX INTERVENTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT CIRCUMFLEX STENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT EART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT HEART CATH</td>
<td class="gt_row gt_center">422 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT HEART CATH WITH PERCUTAREOUS CORONARY INTERVENTION TO THE LEFT ANTERIOR DESCENDING ARTERY</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">235 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT INTERNAL MAMMARY ARTERY, LEFT ANTERIOR DESCENDING INTERVENTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT MAIN CORONARY ARTERY STENT PLACEMENT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\LEFT VENTRICULAR LEAD PLACEMENT VIA LEFT THORACOTOMY ** NO IV&#39;S OR A-LINES IN LEFT ARM ** ** ZIMETBAUM WILL NOT BE ASSISTING ** /SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MINIMALLY ENDOSCOPIC CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MINIMALLY INVASIVE ENDOSCOPIC CABG/SDA</td>
<td class="gt_row gt_center">444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT REDO W/TARGET VESSEL REVASCULARIZATION/SDA</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT;  RE-DO/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT; RE-DO STERNOTOMY </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT; REDO STERNOTOMY /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT; TRICUSPID REPAIR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT;CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\MYOMECTOMY, ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\OFF PUMP CORONARY ARTERY BYPASS </td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\OFF PUMP CORONARY ARTERY BYPASS /SDA</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\OFF PUMP CORONARY ARTERY BYPASS ENDOSCOPIC LEFT CHEST /SDA</td>
<td class="gt_row gt_center">278 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\OFF PUMP CORONARY ARTERY BYPASS; ? AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PATENT FORAMEN OVALE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PATENT FORAMENOVALE CLOSURE; CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PERCUTANEOUS CORONARY INTERVENTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PERCUTANEOUS CORONARY INTERVENTION OF DIAGNAL BRANCH;CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PERCUTANEOUS INTERVENTION TO RIGHT CORONARY ARTERY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PERICARDIAL WINDOW W/? OF PLEURAL EFFUSION </td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PLANNED INTERVENTION OF THE RCA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PLANNED INTERVENTION RCA AND LAD</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\PLANNED VEIN GRAFT INTERVENTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RCA STENT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RE-DO CORONARY ARTERY BYPASS GRAFT WITH AVR </td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RE-DO STERNOTOMY; AVT; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\REDO CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\REDO STERNOTOMY EPICARDIAL ALBATION FOR VENTRICAL TACHYCARDIA?CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\REDO STERNOTOMY/AVR(TISSUE)/CABG X1/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\REMOVAL CARDIAC MASS /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\REPAIR ANOMALOUS RIGHT CAROTID ARTERY; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">1,347 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT CAROTID ANGIOGRAPHY;POSSIBLE REVASCULARIZATION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT CORONARY ARTERY ANGIOPLASTY;POSSIBLE STENT PLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT CORONARY ARTERY ANGIOPLASTY;STENT PLACEMENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT CORONARY ARTERY STENT PLACEMENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT HEART CATH</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGHT VENTRICULAR OUTFLOW TRACK/PULMONIC ARTERY RECONSTRUCTION ? CORONARY ARTERY BYPASS GRAFT WITH AVR  ? TRISCUPID VALVE REPLACEMENT </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\RIGID BRONCHOSCOPY WITH Y-STENT PLACEMENT; CORONARY ARTERY BYPASS GRAFT  /SDA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STANT PLACEMENT</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STENT</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STENT AND ANGIOPLASTY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STENT PLACEMANT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STENT PLACEMENT</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STENT PLACEMENT OF LEFT ANTERIOR DESCENDING ARTERY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\STENT TO RIGHT LAD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\THORACOSCOPIC CORONARY ARTERY BYPASS GRAFT VIA MINI THORACOTOMY  /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISEASE\THORACOSCOPIC VENTRICULAR LEAD PLACEMENT LEFT; ? THORACOTOMY/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ARTERY DISESE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY DISEASE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY DISEASE\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY SRTERY DISEASE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CORONARY STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT REDO; ? CORONARY ARTERY BYPASS GRAFT WITH AVR REDO /SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COUGH</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COUGH, FEVER, GASTRIC OUTLET OBSTRUCTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COUGH;DYSPNEA</td>
<td class="gt_row gt_center">2,676 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">COUGH;FEVER</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CP</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CP,+ETT\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CP,CARDIOMYOPATHY;RULE OUT CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CP;FEVER</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CP.+ETT\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRANI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRANIAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRANIAL BONE DEFECT/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRANIAL DEFECT/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRANIOTOMY/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRASH INJURY FOREARM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRD\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRESCENDO ANGINA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRESCENDO ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CREST SYNDROME; NECROTIZING BRONCHIAL STUMP</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRF/SDA</td>
<td class="gt_row gt_center">4,257 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITCAL AS;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITCAL LEFT ICA STENOSIS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS</td>
<td class="gt_row gt_center">146 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS; HEART FAILURE</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS; PULM EDEMA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;CARDIOGENICSHOCK;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;DEPRESSED EF </td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;PULMONARY EDEMA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;S/P PNEUMONECTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS;TRANSPLANT EVALUATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS/HYPOTENSION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STENOSIS\CATH</td>
<td class="gt_row gt_center">265 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AORTIC STRESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AS , LEFT MAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL AS;COMPLETE HEART BLOCK\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL CAROTID STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL CAROTID STENOSIS\CAROTID ARTERY ANGIOGRAM</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITICAL RENAL ARTERY STENOSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRITITCAL AORTIC STENOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN;S DISEASE;SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S COLITIS</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S DISEASE</td>
<td class="gt_row gt_center">1,147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S DISEASE; ENTEROCUTANEOUS FISTULA</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S DISEASE;ABDOMINAL FISTULA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S DISEASE;PENTASA ALLERGY\PENTASA DESENSITIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S DISEASE/SDA</td>
<td class="gt_row gt_center">1,346 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S FLARE</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S FLARE;CONTAINED FERFORATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHN&#39;S; PERFORATION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHNS DISEASE;COLITIS;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHNS FLAIR</td>
<td class="gt_row gt_center">1,024 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CROHNS STRICTURE OF COLON/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRONIC MYELOGENOUS LEUKEMIA\FEVER</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRONIC OBSRUCTIVE PULMONARY DISEASE;LUNG ABCESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRUSH INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRUSH INJURY TO ABDOMEN</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRUSH TRAUMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRUSHING INJURY /RIGHT LEG</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CRYPTOGENIC CIRRHOSIS</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CSF LEAK</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CSF LEAKAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CSF OTORRHEA RIGHT EAR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CSF RHINORRHEA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CSPINE FRACTURES</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CSPINE INJURY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CUDA EQUINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CUSHING SYNDROME HYPERGLYCEMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CUTANIOUS FISTULA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA</td>
<td class="gt_row gt_center">606 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA VS.SEIZURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA, BRADYCARDIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA,INTRACRANIAL HEMORAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA; CHF PNEUMONIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA;HYPOTENSION</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CVA\ PATENT FORAMEN OVALE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CYCLIST STRUCK</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CYCLIST STRUCK, SEIZURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CYST IN BRAIN</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CYSTIC INTRA ABDOMINAL MASS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">CYSTO SUPRATOIC TUBE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">D.K.A. MALAISE, ELEVATED WBC</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">D.M. ACUTE RENAL FAILURE; RHABDOMYOLYSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DAH</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEBRIDEMENT HEEL ULCERS;? VEIN GRAFT RIGHT LEG</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECENDING THORACIC ANEURYSM\RESECTION ANEURYSM THORACIC; LEFT THORACOTOMY COMPLETION OF ELEPHANT TRUNK; DECENDING AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPENSATED CIRRHOSIS</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPENSATED CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPENSATED HEART FAILURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPENSATED LIVER DISEASE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPENSATED LIVER FAILURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPRESSED CIRRHOSIS;HYPONATREMIA</td>
<td class="gt_row gt_center">924 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECOMPRESSION LAMINECTOMY</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECONGESTINAL LIVER FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECREASE CALCIUM/MAGNISIUM/K+</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECREASE TEMPERATURE;HYPERBILIRUBINEMIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECREASED BLOOD FLOW TO THE LEFT LEG</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECREASED BLOOD PRESSURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECUBITIS ULCER</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECUBITUS ULCER</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DECUBITUS ULCERS</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP SPACE NECK INFECTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP TISSUE INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">1,512 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBOSIS;HEMOCULT POSITIVE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBOSIS;LEFT LEG WEAKNESS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBOSIS;POST OP INFECTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBOSIS;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBOSIS/ S/P AVR\ REDO HEMI STRENOTOMY ARCH TO DESCENDING STENT</td>
<td class="gt_row gt_center">592 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEEP VEIN THROMBUS;HYPERTENSION;CHRONIC OBST PULM DISEASE;</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEFIB FIRING</td>
<td class="gt_row gt_center">173 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEFIBRILLATOR FIRING</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEGENERATIVE JOINT DISEASE BILATERAL KNEES/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEGENERATIVE SCOLIOSIS &amp; SPINAL STENOSIS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEGLOVING INJURY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEGLOVING LEG INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHISCENCE OF WOUND</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHISCENT AVR</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHISENCE OF WOUND</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION</td>
<td class="gt_row gt_center">15,345 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION-NAUSEA-VOMITING</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION-PNEUMONIA-CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION-RULE OUT SEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION,DIARRHEA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION,FAILURE TO THRIVE</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION,HYPOTENSION</td>
<td class="gt_row gt_center">485 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION,LEUKOCYTOSIS,ABDOMINAL PAIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION,NAUSEA,ANEMIA,GI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION,SEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION; A FIB</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION; CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION; RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION; UTI</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;DIARRHEA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;DIARRHEA;LOWER EXTREMITY WEAKNESS;ANEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;DYSPHAGIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;EDEMA;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;ELEVATED INR</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;EXTERNAL HEMORRHOIDS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;FEVER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;HEAD AND NECK CANCER</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;HYPERNATREMIA</td>
<td class="gt_row gt_center">846 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;HYPERNATREMIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;HYPOKALEMIA;HYPONATREMIA;ARF;EKG CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;JAUNDICE</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;MALNUTRITION</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;METASTATIC COLON CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;NAUSEA W\VOMITING;VRE</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;NAUSEA;VOMITING;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;PAIN CONTROL</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;RENAL CELL CARCINOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;RENAL FAILURE;HYPO MASS</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;TACHYCARDIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;TELEMETRY</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;THROAT CANCER</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION;VOMITING W\DIARRHEA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION/ WEAKNESS</td>
<td class="gt_row gt_center">470 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION/CELLULITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION/INCREASE BS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEHYDRATION/UTI</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELERIUM</td>
<td class="gt_row gt_center">4,486 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELERIUM TREMENS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELERIUM TREMONS,ANKLE FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELERIUM TREMOR</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELERIUM, AFIB RVR</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELIRIUM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELIRIUM TREMENS</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELIRIUM TREMORS</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELIRIUM;TREMORS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELTA MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELTA MS</td>
<td class="gt_row gt_center">2,422 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELTA MS, PNEUMONIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DELTA MS/HYPERTENSION</td>
<td class="gt_row gt_center">1,790 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEMENTIA;CONGESTIVE HEART FAILURE;CHRONIC ATRIAL FIBRILLATION;C2 FRACTURE;HIP FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEMENTIA;FALLS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DENS FRACTURE</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEPAKOTE OD</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEPRESSED SKULL FRACTURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEPRESSION</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEPRESSION W/SUICIDIAL IDEATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DERMOID CYST</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING AORTIC ANEURYSM; COARCTATION OF DESCENDING AORTA\ DISTAL ARCH REPLACEMENT; DESCENDING THORACIC AORTIC REPLACEMENT; AORTA TO SUBCLAVIAN BYPASS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING AORTIC REPAIR</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING DISSECTING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING THORACIC ANEURYSM</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING THORACIC ANEURYSM\TAA ENDOSTENTING /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING THORACIC AORTA THROMBUS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING THORACIC AORTA\ AORTIC VALVE REPLACEMENT W/ ASCENDING AORTIC GRAFT BYPASS TO THORACIC DESCENDING AORTA/SDA</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESCENDING THORACIC AORTIC ANEURYSM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESENDING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESENSITIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESENSITIZATION TO CHEMO</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESENTITATION</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DESMOID TUMOR/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DETOX</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DEXTROMETHORPHAN OD</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DGN TOXICITY,V-TACH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DHOULDER DISLOCATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABECTIC KETOACIDOSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABEETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES KETOACIDOSIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS FOR PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS-PRE-OP PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;CHOLANGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;END STAGE RENAL DISEASE;ENDOCARDITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;FOOT ULCER;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;HIP FRACTURE;DECUBITIS ULCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;HYPERTENSION</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;HYPERTENSION;PVD; GANGRENOUS LEFT GREAT TOE; CELLULITIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;HYPOXIA;RT SIDED HEMIPARESIS;SEIZURES </td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;SEPTIC SHOCK</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES MELLITUS;UNSTABLE ANGINA;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES, HYPERGLYCEMIA, PNEUMONIA</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES;ACUTE PANCREATITIS;RENAL FAILURE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETES;KETOACIDOSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC FOOT</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC FOOT INFECTION</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC FOOT ULCER</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC FOOT ULCER;FEVER;TELEMETRY;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KEDOACIDOSIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KEOACIDOSIS;TELEMETRY</td>
<td class="gt_row gt_center">1,790 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETO ACIDOSIS</td>
<td class="gt_row gt_center">6,462 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETO ACIDOSIS,SEIZURES</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">598,215 (7.8%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS,R/O MI</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS,RENAL FAILURE</td>
<td class="gt_row gt_center">1,133 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;</td>
<td class="gt_row gt_center">11,129 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS; ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS; HTN EMERGENCY</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS; TTI/PYELONEPHRITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">145 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;ACUTE RENAL FAILURE;ACUTE PANCREATITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;BRAIN MASS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;CELLULITIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">169 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;CVA;FEVER,ETIOLOGY UNKNOWN</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;GROIN CELLULITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;HEMATEMESIS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;HYPERTENSION</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;HYPOTENSION</td>
<td class="gt_row gt_center">7,560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;HYPOTENSION;NSTEMI</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;HYPOTENTION</td>
<td class="gt_row gt_center">11,129 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;HYPOXIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;NEW ONSET DIABETES</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;NSTEMI</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;PANCREATITIS</td>
<td class="gt_row gt_center">433 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;PERICARDITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;PNEUMOMEDIASTINUM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;PNEUMONIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">6,177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;RENAL FAILURE;PYELO</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;RENAL FAILURE;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">569 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;SEPSIS</td>
<td class="gt_row gt_center">435 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;STEMI</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;TELEMETRY</td>
<td class="gt_row gt_center">32,910 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;UPPER GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;VOMITING</td>
<td class="gt_row gt_center">11,129 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS;WET GANGRENE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS.</td>
<td class="gt_row gt_center">624 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOACIDOSIS/TELEMETRY</td>
<td class="gt_row gt_center">6,137 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC KETOCIDOSIS</td>
<td class="gt_row gt_center">624 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC LEG ULCER;CELLULITIS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC RENAL FAILURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETIC ULCER, LEFT FOOT/SDA</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETICE KETOACIDOSIS;STATUS POST RENAL TRANSPLANT</td>
<td class="gt_row gt_center">2,160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIABETID KETOACIDOSIS</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAHRREA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIALATED AORTIC ROOT\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIALATED ASCENDING AORTA\AORTIC VALVE / ASCENDING AORTA REPLACEMENT; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIALIATED ASCENDING AORTA\ RESECTION AORTIC ASCENDING ANEURYSM; TRANSVERSE ARCH REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPGAHAMATIV HERNIA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAGM RUPTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAGMATIC DEFECT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAGMATIC HERNIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAGMATIC HERNIA/SDA</td>
<td class="gt_row gt_center">648 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAGMATIC INJURY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAMATIC HERNIA; S/P MVC</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAMATIC HERNIA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIAPHRAMATIC PARALYSIS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARETIC RESISTANT ASCITES W/ CIRRHOSIS\TIPS  ** REMOTE WEST ** INR STE/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA</td>
<td class="gt_row gt_center">3,898 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA AND BRBPR</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA-HYPOTENSION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA, DEHYDRATION</td>
<td class="gt_row gt_center">2,160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA,ABDOMINAL PAIN</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA,ANEMIA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA,DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA; DEHYDRATION</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;C-DIFF;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;DEHYDRATION</td>
<td class="gt_row gt_center">365 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;DEHYDRATION;CHEST PAIN</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;DEHYDRATION;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;ELEVATED LFTS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA;HYPOTENSION</td>
<td class="gt_row gt_center">888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIARRHEA/TACHYCARDIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIASTOLIC HEART FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIC</td>
<td class="gt_row gt_center">878 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DICA-HEMATEMESIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIFFUSED INFILTRATES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIG TOXICITY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIG TOXICITY,ARF,HPERKALEMIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIG. TOXICITY,BRADYCARDIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIGOXIN TOXICITY</td>
<td class="gt_row gt_center">444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIGOXIN TOXICITY; VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIGOXIN TOXICITY;HYPERTENSION</td>
<td class="gt_row gt_center">1,024 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILANTIN TOXICITY-MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED AORTA ROUTE\BENTALL PROCEDURE; VS AORTIC VALVE REPLACEMENT;ASCENDING AORTA REPAIR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED AORTIC ARC\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED AORTIC ROOT</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED ASCENDING AORTA\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED ASCENDING AORTA\BENTAL PROCEDURE; REDO STERNOTOMY;ASCENDING AORTA REPLACEMENT? AVR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED ASCENDING AORTA\BENTALL PROCEDURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED CARDIOMYOPATHY</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED CARDIOMYOPATHY;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">686 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED CARDIOMYOPATHY/VENTRICULAR TACHYCARDIA\BIVENTRICULAR INTRACARDIAC DEFIBRILLATOR IMPLANT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED CARDIOMYOPATHY\RIGHT SIDED HEART CATHETERIZATION; EP STUDY; ICD IMPLANT ; DFT **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILATED CBD</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DILAUDID</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIPLOPIA</td>
<td class="gt_row gt_center">888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISABLING CLAUDICATION RIGHT LEG/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISC DEGENERATION LUMBAR SPINE/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISC HERNIATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISC HERNIATION/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISC HERNIATION/SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISC PROTUSION L5-S1</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISCITIS</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISCITIS, OSTEOMYELITIS/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISEASES OF TRICUSPID VALVE\TRICUSPID VALVE REPLACEMENT  ? CORONARY ARTERY BYPASS GRAFT  EPICARDIAL PACE MAKER/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISECTING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISECTING THORACIC ANEURYSM</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISLODGED TRACH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISPLACED TRACH TUBE</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTED AORTA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING AAA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING ABDOMINAL AORTA ANEURYSM</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING ABDOMINAL AORTIC ANEURYSM</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING ANEURYSIM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING ANEURYSM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">714 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING ASCENDING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING THORACIC ANEURYSM</td>
<td class="gt_row gt_center">592 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTING THORACIC AORTA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTION</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTION AORTIC</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSECTION FOR BENTALL PROCEDURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSEMINATED INTRAVASCULAR COAGULATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISSEMINATED ZOSTER</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISTAL BILE DUCT TUMOR; PANCREATIC CA/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISTAL BILE DUCT TUMOR/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISTAL FEMUR FRACTURE</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DISTAL TIBIA FIBULA FRACTURE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIURETIC RESISTANCE ASCITIS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICUL;ITIS</td>
<td class="gt_row gt_center">1,400 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULAR BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULAR STRICTURE/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIES OF COLON</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS</td>
<td class="gt_row gt_center">10,448 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS WITH MICRO PERFORATION</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS;ACUTE RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS;FEVER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS;HYPOTENTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS;LOWER GI BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS;TELEMETRY</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS/SDA</td>
<td class="gt_row gt_center">615 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTICULITIS/UNSTABLE ANGINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIVERTING COLOSTOMY/SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIZZINESS</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DIZZINESS;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA</td>
<td class="gt_row gt_center">3,283 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA PNEUMONIA SEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA,  DEHYDRATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, ARF, CHOLECYSTITIS</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, CHEST PAIN R/O MI</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, CHEST PAIN, SI</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, DEHYDRATION, HEMATORIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, GI BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, PNEUMONIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, R/O MI</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, SEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA, UROSEPSIS</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA,SEIZURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA,SEPSIS</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA;UGIB</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA/ UGI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA/ABDOMINAL PAIN</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKA/HYPERNATREMIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DKS/GASTROPARESIS</td>
<td class="gt_row gt_center">615 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DM FOOT ULCER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DM;MR;PULMONARY EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DOE;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DOG BITE</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DOG BITES</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DOUBLE VESSEL DISEASE\CORONARY ARTERY BYPASS GRAFT; WITH AVR/SDA</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DOWNS SYNDROME,SINUS ARREST,DYSPHAGIA\PEG</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRA, SAH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRAIN LEAKAGE</td>
<td class="gt_row gt_center">450 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRAINAGE OF BURRHOLE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG ELUTING CORONARY ARTERY STENT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG OVERDOSE</td>
<td class="gt_row gt_center">291 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REACTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY  FOR ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIA FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATIN\PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\LEFT ATRIAL TACHYCARDIA ABLATION ? PVI **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\LEFT ATRIAL TACHYCARDIA ABLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\LEFT ATRIAL TACHYCARDIA ABLATION/ATRIAL FLUTTER ABLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST** **JET VENTILATION** **CARDIAC ANESTHESIA**/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST** **JET VENTILATION**/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  *REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION **REMOTE WEST** </td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION; ATRIAL TACHYCARDIA ABLATION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRUG REFRACTORY ATRIAL FIBRILLATION\REDO PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DRY GANGRENE</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DT&#39;S,ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DTS;ALCOHOL WITHDRAWAL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUEODENAL AMPULLARY MASS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL ADENOMA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL CANCER/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL FISTULA/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL FOREIGN BODY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL MASS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL OBSTRUCTION</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL PERFORATION</td>
<td class="gt_row gt_center">151 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL TUMOR/SDA</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL ULCER</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL ULCER PERFORATION/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENAL ULCER;S/P ERCP</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUODENITIS</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DURAL ARTERIAL VENOUS FISTULA/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DURAL AVM\ CEREBRAL ANGIOGRAM WITH COILING/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DUSKY SPELLS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DVT</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DVT, ANEMIA</td>
<td class="gt_row gt_center">312 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DVT, SZ. , RENAL FAILURE</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DVT,INTRACTABLE PAIN</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYPSNEA/EKG CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSARATHRIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSNEA</td>
<td class="gt_row gt_center">1,016 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPEA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPHAGIA</td>
<td class="gt_row gt_center">680 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPHAGIA-ESOPHAGEAL STRICTURE-HYPERTENSION-DIABETES</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPHAGIA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPHAGIA\ENDOSCOPY </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPHAGIA\EUS</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPHASIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA</td>
<td class="gt_row gt_center">79,891 (1.0%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON ECERTION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXCERTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION-CHROMIC RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION;CARDIAC ISCHEMIA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION;CHEST PAIN;CARDIOMYOPATHY\CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION;POSITIVE STRESS TEST\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION\CARDIAC CATH</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION\LEFT HEART CATHERIZATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA ON EXERTION\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA SUSPECTED PE.</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA-COPD EXACERBATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA-HYPONATREMIA-WEAKNESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA-RENAL FAILURE</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA, CAD\CATH </td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA, RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA,DECREASED O2</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA,FEVER</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA,HYPOTENSION</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA,HYPOXIA</td>
<td class="gt_row gt_center">258 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA,NAUSEA,VOMITING</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA; EDEMA LOWER EXTREMITY</td>
<td class="gt_row gt_center">500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA; HYPOXEMIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA; TAMPONADE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;ABOMINAL PAIN</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;ASCENDING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;BRADYCARDIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;CELLULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;CHEST PAIN;TELEMETRY;RAPID AFIB</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;CIRRHOSIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;COPD EXACERBATION</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;CORONARY ARTERY DISEASE;ANGINA\LEFT HEART CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;DEHYDRATION;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;DYSPHAGIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;EFFUSIION PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;EKG CHANGE;ELEVATED TROP</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;FLUID OVERLOAD</td>
<td class="gt_row gt_center">1,386 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;HEMOPTYSIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;HEMOPTYSIS;HIV</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;HYPOTENSION</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;HYPOXIA</td>
<td class="gt_row gt_center">705 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;LETHARGY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;LIVER CANCER</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;MAST CELL ACTIVATION</td>
<td class="gt_row gt_center">4,370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;MAST CELL DEGRANULATION</td>
<td class="gt_row gt_center">4,370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;NAUSEA W\VOMITING;TELEMETRY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;PNEUMONIA</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;PULMONARY EDEMA</td>
<td class="gt_row gt_center">410 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;R/O FLU</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;RULE OUT PULMONARY HYPERTENSION\RIGHT HEART CATH</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">318 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;S/P EGD</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;SARCOID FLARE;?PNEUMONIA</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;ST ELEVATION MYOCARDIAL INFARCTION\CARIDAC CATHETERIZATIONL</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;TACHYCARDIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;TELEMETRY</td>
<td class="gt_row gt_center">6,364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;TELEMTRY</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;TRACHIAL STENOSIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA;WEAKNESS;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNEA\RIGHT + LEFT HEART CATH </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSPNIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSRYTHMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSTONIA;S/P G-TUBE PLACEMENT</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSTONIA\REPLACEMENT GJ-TUBE ** REMOTE WEST INR SUITE **        </td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">DYSTONIC RXN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EARLY SEPSIS;PNEUMONIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EBV; MENINGITIS;PULMONARY EMBOLIS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ECOLI; SEPSIS</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ECTOPIC PREGNANCY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EDEMA</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EDEMA/ELEVATED TROPONIN</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EFFUSION;TELEMETRY</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EFFUSION/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EHRILICHIOSIS VS CHOLEDOCHOLITHIASIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EKG CHANGES</td>
<td class="gt_row gt_center">1,626 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EKG CHANGES;CHEST PAIN;PVD\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EKG CHANGES;PLEURAL EFFUSION\CARDIAC CATH</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EKG CHANGES;R/O ISCHEMIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELBOW FRACTURE</td>
<td class="gt_row gt_center">555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELECTROCUTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELECTROLYTE ABNORMALATIES</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELECTROLYTE ABNORMALITIES</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELECTROLYTE ABNORMALITIES;CANCER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELECTROLYTE IMBALANCE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED BILIRUBIN</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED BLOOD PRESSURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED CREATININE</td>
<td class="gt_row gt_center">4,238 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED CREATININE-DEHYDRATION</td>
<td class="gt_row gt_center">406 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED CREATNINE</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED FEVERS;LIVER MASSES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED GLUCOSE;TELEMETRY</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED INR</td>
<td class="gt_row gt_center">695 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED INR;COUMADIN TOXICITY;LOWER GI BLEED</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED INR;HYPERKALEMIA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LFT&#39;S</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LFT&#39;S/S/P TRANSPLANT</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LFTS</td>
<td class="gt_row gt_center">355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LFTS, PANCREATITIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LIVER FUNCTION TEST</td>
<td class="gt_row gt_center">460 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LIVER FUNCTION TESTS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LIVER FUNCTIONS;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED LIVER FUNCTIONS;S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED STEMI</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED TEMP;S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED TEMPERATURE/SEPTIC</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED TROPONIN</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED WBC</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED WBC,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED WEIGHT BEARING WITH CRUTCHES,HYPOTENSION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED WHITE BLOOD COUNT</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED WHITE COUNT</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATED WHITE COUNT; HALLUCINATIONS</td>
<td class="gt_row gt_center">889 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ELEVATER CREATININE;S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EMPHYEMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EMPHYSEMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EMPHYSEMA;ASPERGILLOSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EMPHYSEMATOUS PYELITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EMPYEMA</td>
<td class="gt_row gt_center">681 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EMPYEMA;GASTRIC ULCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALITIS</td>
<td class="gt_row gt_center">193 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOCELE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOCLE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY</td>
<td class="gt_row gt_center">7,077 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY;ASCITES</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY;HYPOXIC;TRANSPLANT EVAL</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY;LIVER FAILURE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY;SEPTIC SHOCK</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY;ST ELEVATION MI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPATHY;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHALOPHATHY</td>
<td class="gt_row gt_center">1,098 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHELITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHELOPATHY AND R/O MI</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENCEPHLOPATHIC;RIGHT PLEURAL EFFUSION;ASCITIES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE CARDIOMYOPATHY</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE KIDNEY DISEASE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE LIVER &amp; KIDNEY DISEASE</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE LIVER DISEASE</td>
<td class="gt_row gt_center">3,120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE LIVER DISEASE;ABDOMINAL PAIN;SUPRAVENTRICULAR TACHYCARDIA;FEVER</td>
<td class="gt_row gt_center">485 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE LIVER DISEASE;END STAGE KIDNEY DISEASE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE LIVER DISEASE;LIVER TRANSPLANT</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE LIVER FAILURE</td>
<td class="gt_row gt_center">107 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DIESEASE\DIALYSIS CATHETER PLACEMENT</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEAS;PANCREATITIS;LUPUS</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE</td>
<td class="gt_row gt_center">6,445 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE-FEVER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE-URTICARIA-FEVER</td>
<td class="gt_row gt_center">3,290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE; FLUID OVERLOAD AND CHF</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE; RASH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE;DELIRIUM;DIABETES MELLITUS</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE;FAILED AV GRAFT;SEPSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE;HYPOGLYCEMIA;HYPERTENSION</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE;STRIAL FIBRILLATION;HYPOTENSION;HEMATURIA;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">705 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL DISEASE/FOR TRANSPLANT</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STAGE RENAL FAILURE</td>
<td class="gt_row gt_center">217 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STEGE LIVER DISEASE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END STEMI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END-STAGE LIVE DISEASE</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END-STAGE LIVER DISEASE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">END-STAGE LIVER DISEASE; STATUS POST TRANSPLANT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOBRONCHIAL LUNG CANCER</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOBRONCHIAL TUMOR</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDIATITIS OF MITRAL VALVE\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS</td>
<td class="gt_row gt_center">2,897 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS; BACTEREMIA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS; S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;AORTIC VALVE DISEASE\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;CHEST PAIN;MITRAL VALVE MASS\CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;INFECTED PACEMAKER LEAD</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;MITRAL REGURGITATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;MRSA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;NON Q-WAVE;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;OSTEOMYELITIS;DISCITIS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS;RECURRENT FEVER</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS:LIVER MASS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS/SEPSIS</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS\AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS\REDO AVR; REDO ASCENDING AORTA; HEMIARCH CIRCULATORY ARREST/? BENTAL WITH HOMOGRAFT /SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS\TRANSESOPHAGEAL ECHOCARDIOGRAM</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOCARDITIS\TRICUSPID VALVE REPLACEMENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIAL CA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIAL CANCER</td>
<td class="gt_row gt_center">920 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIAL CANCER/SDA</td>
<td class="gt_row gt_center">89 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIAL HYPERPLASIA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIAL HYPOPLASIA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIAL NEOPLASM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRIL CA/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOMETRITIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">95 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;BILE LEAK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;BILIARY OBSTRUCTION;RESPIRATORY OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;SPHINCTEROTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY\ERCP </td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOSCOPY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOVASCULAR ANEURYSM\ENDOVASCULAR THORACIC ANEURYSM REPAIR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDOVASCULAR AORTIC ANEURYSM</td>
<td class="gt_row gt_center">169 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDSTAGE LIVER/KIDNEY DISEASE/TRANSPLANT</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENDSTAGE RENAL DISEASE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENLARGED AORTIC ROOT\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENLARGED PLEURAL EFFUSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENLARGED PNEUMOTHORAX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENLARGED PROSTATE/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTERIC FISTULA;DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTERO CUTANEOUS FISTULA/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTEROCUTAEOUS FISTULA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTEROCUTANEOUS FISTULA</td>
<td class="gt_row gt_center">744 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTEROCUTANEOUS FISTULA, VENTRAL HERNIA/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTEROCUTANEUS FISTULA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ENTEROCYTANEOUS FISTULA AND CHRON&#39;S DISEASE</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDERMOID/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDIRAL ABSCESS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL ABCESS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL ABSCESS</td>
<td class="gt_row gt_center">1,184 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL ABSCESS;ASCITES;SEPSIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL ABSCESS;TELEMETRY</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL AND SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL BLEED</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL FLUID COLLECTION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL HAMATOMA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL HEMATOMA</td>
<td class="gt_row gt_center">466 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL HEMATOMA; CSPINE FRACTURES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL HEMATOMA;S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL HEMATOMA;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">182 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURAL NECK HEMATOMA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIDURALHEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGASTRIC ABDOMINAL PAIN\ERCP </td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGASTRIC DISCOMFORT/ RULE OUT MYOCARDIAL INFACTION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGASTRIC PAIN</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGASTRIC PAIN,R/O MI</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGASTRIC PAIN\ERCP</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGLOTITIS</td>
<td class="gt_row gt_center">598 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGLOTITITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGLOTTIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGLOTTITIS</td>
<td class="gt_row gt_center">575 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGLOTTITIS;FEVER</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPIGLOTTITIS;PERITONSILAR CELLULITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPILEPSY</td>
<td class="gt_row gt_center">597 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPILEPSY AND EPILEPIC SYNDROMES/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPILEPSY/SDA</td>
<td class="gt_row gt_center">273 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAKIS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAXIS</td>
<td class="gt_row gt_center">667 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAXIS; ELEVATED INR; ANEMIA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAXIS;ANEMIA</td>
<td class="gt_row gt_center">576 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAXIS;NASOPHARNGYEAL CANCER</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAXIS;R/O GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EPISTAXIS;THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ERCP FAILED TO CANNULATE;PTC</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ERECTILE DYSFUCTION/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EROSION; INFRECTION OF ICD LEAD\ICD LEAD EXTRACTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ERYTHROLEUKEMIA\CHEMO</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESLD;ANEMIA;RENAL FAILURE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPAGEAL CANCER/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPH CA; FB IN ESOPH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAG CANCER/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGE CA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL ADENOCARCINOMA AT GE JUNCTION/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL ADENOMA CARCINOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CA AND DOWN&#39;S SYNDROME/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CA/SDA</td>
<td class="gt_row gt_center">2,044 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CA/SDA\ESOPHAGOGASTRECTOMY LAPAROSCOPIC </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER</td>
<td class="gt_row gt_center">1,003 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER &amp; TRACHEOESOPHAGEO FISTULA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER;CROHNS DISEASE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER;DEHYDRATION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER;PAIN CONTROL</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER/SDA</td>
<td class="gt_row gt_center">2,053 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CANCER\EGD</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CARCINOMA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL CENCER/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL DIVERTICULUM</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL DIVERTICULUM/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL DYSPLAGIA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL DYSPLASIA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL EXCLUSION S/P REPAIR OF TRANSESOPHAGEAL FISTULA/SDA</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL FOOD IMPACTION</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL FOREIGN BODY</td>
<td class="gt_row gt_center">606 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL GASTRIC VARICEAL BLEED</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL LEAK</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL MASS, NECK PAIN</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL MASS\EUS</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL OBSTRUCTION</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL PERFORATION</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL PERFORMATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL REFLUX ASPIRATION\LAPAROTOMY; C-NISSEN FUNDOPLICATION; J-TUBE PLACEMENT; COLOSTOMY TAKEDOWN</td>
<td class="gt_row gt_center">250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL REFLUX/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL RESECTION</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL RUPTURE</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL RUPTURE-FEVER</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL STRICTURE</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL STRICTURE/SDA</td>
<td class="gt_row gt_center">250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL TEAR</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL TUMOR</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL TUMOR;UPPER GI BLEED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL VARICES</td>
<td class="gt_row gt_center">400 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL VARICIES</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEAL VARILES BLEEDING</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGEL CANCER/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGIAL CA/SDA</td>
<td class="gt_row gt_center">190 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGIO CA/SDA</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGITIS,FEVER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGLE CANCER/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGUS CANCER/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHAGUS FOOD BOLUS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHEGEAL CA WITH BRAIN METS</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHOGEAL CA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHOGEAL CANCER;DYPSNEA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESOPHOGEAL CANCER/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESPHAGEAL FOOD IMPACTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESRD</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESRD-FEVER</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESRD/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ESSENTIAL TREMOR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETHLYENE GLYCOL INGESTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETHYLENE GLYCOL INTOXICATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH (CONCERN OF TOXIC ETOH)</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH ABUSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH AND DRUG WITHDRAWAL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH ASPIRATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIROHOSIS/SDA</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS</td>
<td class="gt_row gt_center">608 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS, ENDOCARDITIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS; VARICEAL BLEED</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;PANCREATITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;PANCREATITIS\ERCP</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;TELEMETRY</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;TIPS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS;UPPER GI BLEED</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS/SDA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH CIRRHOSIS\ TIPS/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH HEPATITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH IMTOXICATION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INDUCED CIRRHOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTOX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTOXICATION</td>
<td class="gt_row gt_center">30,553 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTOXICATION;DIVERTICULITIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTOXICATION;INTUBATED</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTOXICATION/INGESTION</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTOXICATION/RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH INTUBATED</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH LIVER DISEASE</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH LIVER FAILURE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH LIVER FAILURE;RENAL FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH OVERDOSE, SUICIDE ATTEMPT</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH OVERDOSE; BENZO OD</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH TOXICITY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH W D;COMPRESSION FX</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WD</td>
<td class="gt_row gt_center">355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">97,459 (1.3%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL / ABDOMINAL PAIN</td>
<td class="gt_row gt_center">7,392 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL SEIZURES</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL-? GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL-SUBTOTAL LOW PLATLETS LT ABNORMALITY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL, ACUTE PANCREATITIS, PANCREATIC PSEUDOCYST, FEVER, COPD</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL, ARF, RHABDOMYOLYSIS</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL,ABD PAIN</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL,ALCOHOLIC HEPATITIS,LACTIC ACIDOSIS</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL,DTS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;ASSUALT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;CHEST PAIN</td>
<td class="gt_row gt_center">1,062 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;CIRRHOSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;DEPRESSION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;EKG CHANGES</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;HYPOMAGNESIUM</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;HYPOXIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;LIKELY SEIZURES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;PNEUMONIA</td>
<td class="gt_row gt_center">236 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;RT FLANK PAIN</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;SEIZURE</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;SEIZURE;HYPOTHERMIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;SEIZURES</td>
<td class="gt_row gt_center">250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;SHOULDER PAIN</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;SUICIDAL IDEATION</td>
<td class="gt_row gt_center">190 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;TELEMETRY</td>
<td class="gt_row gt_center">7,392 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL;UNRESPONSIVE</td>
<td class="gt_row gt_center">7,392 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL/ PANCREATITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWAL/DETOX</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWEL</td>
<td class="gt_row gt_center">286 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWEL;LIVER FAILURE;RENAL FAILURE;ENCEPHALOPATHY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWL</td>
<td class="gt_row gt_center">9,480 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWL;HEMATEMESIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWL;SEIZURES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH WITHDRAWLS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH-PANCREATITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH-UNRESPONSIVE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH/COCAINE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETOH/COCAINE INTOXICATION</td>
<td class="gt_row gt_center">190 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ETT\CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EVACUATION OF HEMATOMA</td>
<td class="gt_row gt_center">1,400 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EVACUATION OF SUBDURAL HEMATOMA;EMERGENT CRANIOTOMY</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EVOLVING ANTERIOR M.I.</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EVOLVING MI\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXCESS ETOH INTAKE;VOMITING</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXCESS SKIN FROM BILATERAL ARMS</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXCESS SKIN OF ABDOMINAL WALL/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXCESSIVE WIGHT LOSS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL ANGIA;CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL ANGINA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL ANGINA;PERIPHERAL VASCULAR DISEASE\CARDIAC CATH/BILATERAL PERIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL ANGINA;RULE OUT CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL ANGINA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL ANGINA\CATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL CHEST PAIN;MYOCARDIAL ISCHEMIA\LEFT HEART CATHERTERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL CHEST PAIN;RULE OUT CORONARY ARTERY DISEASE\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL CHEST PAIN\LEFT HEART CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL DYSPNEA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL DYSPNEA; BIVENTRICULAR HEART FAILURE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL DYSPNEA;ANGINA\LEFT CARDIAC CATH</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXERTIONAL DYSPNEA\CARDIAC CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXP LAP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPANDED HEMATOMA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPANDING HEMATOMA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPANDING LUNG LESION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATION UNDER ANESTHESIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAP</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAP/SIGMOID COLECTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAPAROTOMY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAPAROTOMY FOR SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAPAROTOMY;LYSIS OF ASHESION;BOWEL RESECTION</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAPORATOMY</td>
<td class="gt_row gt_center">429 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORATORY LAPORATOMY/? BOWEL PROLAPSE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPLORTARY LAP/? PERFORATED BOWEL</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPOSED TRANSPLANT</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXPOSURE</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTERNAL FIXATION LEFT TIBIAL FRACTURE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTERNAL WOUND INFECTION</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTERTIONAL DYSPNEA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTREME PREMATURITY</td>
<td class="gt_row gt_center">158 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTREME PREMATURITY/? SEPSIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTREME PREMATURITY/?SEPSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EXTRNAL DRAINAGE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">EYE PAIN</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">F HUMERUS &amp; AF</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL AND HAND BURNS</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL CELLULITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTOR/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURE</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURE;ORBITAL FRACTURE</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURE;TRACH;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURE/PELVIC FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURES</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURES,S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURES;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURES;RADIUS FRACTURE</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FRACTURES/WRIST FRACTURES/INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FX</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL FX;MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL INFECTION</td>
<td class="gt_row gt_center">257 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL LACERATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL MASS RIGHT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL NUMBNESS</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL SWELLING</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL TRAUMA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL TRAUMA,INTRACEREBRAL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL TRAUMA;S/P FALL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACIAL TRAUMA;S/P PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FACTOR VIII INHIBITOR</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAHH;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED BACK SYNDROME</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED BYPASS GRAFT LEFT LEG</td>
<td class="gt_row gt_center">3,396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED DIALYSIS ACCESS;CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">1,323 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED DIALYSIS CATH.</td>
<td class="gt_row gt_center">2,868 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED FUSION RIGHT HIP/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED GRAFT LEFT/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED GRAFT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED INTRATHECAL PUMP REMOVE /REPLACE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED LEAD PLACMENT\ BIVENTRICULAR LEAD PLACEMENT VIA LEFT THORACOTOMY/SDA</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED LEFT HIP HEMI-ARTHROPLASTY/SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED LEFT TOTAL HIP REPLACEMENT/NON UNION INTERTROCHANTERIC FRACTURE/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED LEFT TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED LEFT TOTAL KNEE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED LEFT TOTAL KNEE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED RIGHT TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED RIGHT TOTAL HIP/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED RIGHT TOTAL KNEE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED TOTAL HIP LEFT/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED TOTAL HIP RIGHT/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILED TRANSPLANT</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILING GRAFT</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILING GRAFT;ACUTE PAIN</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILING GRAFT/SDA</td>
<td class="gt_row gt_center">167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE OF FIXATION/SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THIRVE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE</td>
<td class="gt_row gt_center">4,537 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE-ANEMA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE,R/O MI</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE,WEAKNESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;DEHYDRATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;EKG CHANGES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;HYPOTENSION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;INTUBATED</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;LIVER FAILURE\NG TUBE PLACEMENT</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;PEG PLACEMENT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;RENAL CELL CARCINOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;TELEMETRY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;VOMITING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO THRIVE;WEAKNESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO WEAN</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO WEAN OFF VENT</td>
<td class="gt_row gt_center">175 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAILURE TO WEAN;RESP FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL FROM A HORSE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL HEADBLEED.HIPFRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL WITH SDH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL, ANKLE FX</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL, SPINA; DETRUSOR HYPERREFLEXIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL,INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL,SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL; ? OD</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL; HYPOXIC</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;CONFUSION</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;FACIAL FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;FEMUR FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;HEAD INJURY</td>
<td class="gt_row gt_center">385 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;HYPONATREMIS;HYPERKALEMIA</td>
<td class="gt_row gt_center">365 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;HYPOXIA;DEHYDRATION;N/V/D</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;MULTITRAUMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;NEUTROPENIA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;RIB FRACTURES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;RIB FX;UTI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL/HEAD INJURY</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALL/PELVIC FRACTURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALLS</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALLS,BACK PAIN WEAKNESS</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FALX MENINGIOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAMILY HX OF BREAST CA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FAOLED GRAFT RIGHT LEG</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FASCIAL DEHISCENCE</td>
<td class="gt_row gt_center">1,472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FASCIITIS,RT LEG</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FATIGUE;DEHYDRATION;LUNG MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FATIGUE;MALAISE;POSTIVE TROPONIN</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FB ESOPHAGUS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FB IN ESOPHAGUS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FB IN TACHEA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBER</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBRILE NEUTROPENIA</td>
<td class="gt_row gt_center">1,260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBRILE NEUTROPENIA-? SEPSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBRILE SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBRILE SYNDROME;DIALYSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBRILE;HYPOTENSIVE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEBRILE/NEUTROPENIA</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEER;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL ARTERY ANEURYSM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL ARTERY THROMBOSIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL FRACTURE</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL GROIN DVT</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL HERNIA;SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL NECK FRACTURE</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMORAL THROMBOSIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE</td>
<td class="gt_row gt_center">1,134 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE-COLLAPSED LUNG</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE;ELBOW FRACTURE</td>
<td class="gt_row gt_center">1,593 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE;INTUBATED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE;RAF</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE;S/P FALL</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE;TACHYCARDIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURE;VASCULAR INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRACTURES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FRX</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FX</td>
<td class="gt_row gt_center">574 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR FX; SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMUR-TIBIAL AND C2 FRACTURE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEMURE FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FERORATED BOWEL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FETAL ABNORMALITY @ 15 WEEKS\D&amp;C</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER</td>
<td class="gt_row gt_center">154,750 (2.0%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER </td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER (WITH CENTRAL LINE)</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER AND NEUTROPENIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER OF AN UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER OF UNKNOWN ORIGEN;JAUNDICE</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER OF UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">1,278 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER OF UNKNOWN ORIGIN;DEHYDRATION</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER TACHY CARDIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER TRACH</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">484 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER UNKNOWN ORIGIN-SEPSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-CELLULITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-CHEST PAIN</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-EKG CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-FAILURE TO THRIVE</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-FLU</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-FOOT WOUND</td>
<td class="gt_row gt_center">492 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-HYPERTENSION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-HYPOTENSION</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-LINE SEPSIS</td>
<td class="gt_row gt_center">477 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-MANTLE CELL LYMPHOMA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-NEUTROPENIA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-R/O TB</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-RULE OUT SEPSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER-SEPSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, A-FIB</td>
<td class="gt_row gt_center">270 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, ABDOMINAL PAIN</td>
<td class="gt_row gt_center">3,686 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, AMS, RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, HEADACHE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, JAUNDICE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, LIKELY LINE SEPSIS</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, MALAISE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, NEUTROPENIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, RECTAL BLEED, OVARIAN CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER, SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ABD PAIN</td>
<td class="gt_row gt_center">742 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ABDOMIAL PAIN</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ABDOMINAL PAIN</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,DEHYDRATION,FAILURE TO THRIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,DIARRHEA,DEHYDRATION</td>
<td class="gt_row gt_center">8,532 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,DIARRHEA,HYPOTENSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,DYSPNEA</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ETIOLOGY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ETIOLOGY UNKNOWN</td>
<td class="gt_row gt_center">2,241 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ETIOLOGY UNKNOWN;INABILITY TO EAT</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ETIOLOGY UNKNOWN;SEPSIS</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,HEADACHE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,HEMOPTYSIS</td>
<td class="gt_row gt_center">384 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,HIV,HEMATURIA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,HYPOTENSION</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,LETHARGY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ORIGIN UNKNOWN</td>
<td class="gt_row gt_center">5,284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ORIGIN UNKNOWN;DYSRHYTHMIA;TELEMETRY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,ORIGIN UNKNOWN;HYPOTENSION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,PNEUMONIA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,R/O MENINGITIS</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,S/P CHEMO</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,SHAKING CHILLS OF UNKNOWN ETIOLOGY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,SVT</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,UNKNOWN ETIOLOGY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER,VOMITING</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; ASCITES; SOB</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; DEHYDRATION; EVAL FOR C-DIFF</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; MS FLARE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; N/V</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; NEUTROPENIA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; PANCREATITIS; ETHANOL WITHDRAWAL</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; R/O MENINGITIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER; TACHYCARDIA; JP DRAIN OUT</td>
<td class="gt_row gt_center">1,176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;? CVA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;? ENDOCARDITIS</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">175 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ABSCESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ACUTE LYMPHATIC LEUKEMIA</td>
<td class="gt_row gt_center">520 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ACUTE RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">3,136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ALTERED MENTAL STATUS;R/O MENINGITIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ANEMIA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;BACK PAIN;NAUSEA</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;BACK PAIN;SEPTICEMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;BILIARY BLOCKAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;BILIARY SLUDGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;CELLULITIS</td>
<td class="gt_row gt_center">4,706 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">1,995 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;CONFUSION</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;COUGH</td>
<td class="gt_row gt_center">259 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;DEHYDRATION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;DEHYDRATION;NECK MASS</td>
<td class="gt_row gt_center">1,192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">6,137 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;DIARRHEA</td>
<td class="gt_row gt_center">327 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;DIARRHEA;DEHYDRATION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;ELEVATED LIVER FUNCTION TEST</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;EPILEPSY</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;FLANK PAIN</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HEADACHE</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HEPATITIS;HYPOTENSION\HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HICKMAN LINE INFECTION</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPERKALEMIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPERTENSION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPERTENSIVE</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPOTENSION</td>
<td class="gt_row gt_center">5,783 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPOTENSION;TACCHYCARDIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPOTENSIVE URGENCY;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPOTENTION;TELEMETRY</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;HYPOXIA</td>
<td class="gt_row gt_center">337 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;IJ ANF LUE DVT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;JAUNDICE</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;LEFT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;LINE INFECTION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;LINE SEPSIS</td>
<td class="gt_row gt_center">534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;LOW BLOOD PRESSURE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;LOW PLATELETS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;MENINGITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">61 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;MYELOMA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;NAUSEA;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;NEUTOPENIA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;NEUTROPENIA</td>
<td class="gt_row gt_center">399 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;NEUTROPENIA;SAH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;NEUTROPENIC</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;NRUTROPENIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;PANCYTOPENIA</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;PANCYTOPENIA;CHRONIC LYMPHOCYTIC LEUKEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;PARALYSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;PNEUMONIA</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;R/O ENDOCARDITIS</td>
<td class="gt_row gt_center">960 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;R/O LINE INFECTION;RENAL FAILURE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;R/O LINE SEPSIS</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;RASH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;S/P BIOPSY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;S/P FALL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;SEIZURE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;SEPSIS</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;SEPSIS;HYPOXIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;SHORTNESS OF BREATH;? PNEUMONIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;TACHYCARDIA</td>
<td class="gt_row gt_center">173 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;TACHYCARDIA;DEHYDRATION</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;TELEMETRY</td>
<td class="gt_row gt_center">1,357 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;THROMBOCYTOPENIA;QUESTION OF TTP</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">1,584 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;VOMITING</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;WEAKNESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER;WOUND DRAINAGE</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/BACK PAIN</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/HYPER K/ AFIB RVR</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/HYPOTENSION</td>
<td class="gt_row gt_center">3,104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/NEUTROPENIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/R/O BACTEREMIA</td>
<td class="gt_row gt_center">3,290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/SEPSIS</td>
<td class="gt_row gt_center">191 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVER/SYNCOPE</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERE</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS</td>
<td class="gt_row gt_center">7,086 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS AND LEUKOCYTOSIS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS, A-FIB, RVR</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;CONFUSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;DECREASED PLATELET COUNT;HEADACHE;HIV</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;FOOT ABSCESS</td>
<td class="gt_row gt_center">1,503 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;HYPOTENSION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;HYPOXIA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;SEIZURES</td>
<td class="gt_row gt_center">470 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;STERNAL WOUND DRAINAGE</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FEVERS;TACHYCARDIA;</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBRO-THORAX/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBROID BLEED</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBROID UTERUS/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBROIDS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBROIDS &amp; MENORRHAGIA/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBROIDS/SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIBROTHORAX/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FIDELIS LEAD FRACTURE\IMPLANTABLE CARDIOVERER DEFIBRILLATOR FIDELIS LEAD EXTRACTION/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FINGER AMPUTATION</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FINGER AMPUTATIONS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FINGER CELLULITIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FISTULA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FISTULA /SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FISTULA BLEED</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FISTULA INFECTION</td>
<td class="gt_row gt_center">555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLACID PARALYSIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLAIL CHEST</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLANK PAIN</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLANK PAIN;CHEST PAIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLANK PAIN;HYPOTENSION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLARE OF ULCERATIVE CHOLITIS;STATUS POST VATS PROCEDURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLASH PULMONARY EDEMA</td>
<td class="gt_row gt_center">2,013 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLASH PULMONARY EDEMA;RENAL FAILURE</td>
<td class="gt_row gt_center">245 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLASH PULMONARY EDEMA\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLATBACK SYNDROME AND SCOLIOSIS/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLORID DT&#39;S</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLU,SYRINK</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLUCONAZOLE DESENSITIZATION</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLUID COLLECTION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLUID OVERLOAD</td>
<td class="gt_row gt_center">4,278 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLUID OVERLOAD;?INFECTION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLUID OVERLOAD;RENAL FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FLUID OVERLOAD;S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOCAL NODULAR HYPERPLASIA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOLLOCULAR LYMPHOMA\CHEMOTHERAPY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOLLOW-UP COMMON BILE DUCT INJURY/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOLLOW-UP EYE EXAM</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOD IMPACTION</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOD OBSTRUCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT GRAPH</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT INFECTION</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT INFECTION;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT INJURY</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT ISCHEMIA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT NUMBNESS;CLAUDICATION\RIGHT LEG ANGIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT PAIN</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT ULCER</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOT ULCERS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOOUND DOWN</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FORAMEN OVALE DEFECT\PATENT FORAMEN OVALE MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN  BODY IN STOMACH</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY ESOPHAGUS</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY IN ESOPHAGUS</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY IN ESPHAGUS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY IN STOMACH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY IN THROAT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOREIGN BODY INGESTION</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOUND DOWN</td>
<td class="gt_row gt_center">142 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOUND DOWN, S/P FALL</td>
<td class="gt_row gt_center">3,290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOUND DOWN,SUB DURAL HEMATOMA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOUND DOWN;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOUND DOWN;SCALP LACS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOUNIER GANFRENE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOURNIER GANGGRENE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOURNIER GANGRENE</td>
<td class="gt_row gt_center">825 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOURNIER GANGRENE/SDA</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOURNIER&#39;S GANGRENE</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FOURNIER&#39;S GANGRENE;ANEURYSM</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURE,C2 &amp; C5</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURED AICD LEAD\ICD IMPLANT IN O.R. </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURED ICD LEAD;SUBARACHNOID HEMORRHAGE\LEAD REPLACEMENT;LEAD EXTRACTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURED ICD LEAD\ICD LEAD EXTRACTION; LEAD IMPLANTATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURED PLEVIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURED RIBS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURED RIGHT HIP;S/P INTEROCHANTERIC\ ORIF INTERTROCHANTERIC FRACTURE RIGHT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURES</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURES THORACIC AND LUMBAR/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRACTURES;THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FREE ABDOMINAL AIR</td>
<td class="gt_row gt_center">1,738 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FREE AIR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FREE AIR ABDOMEN</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FREE AIR IN ABDOMEN</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FREQUENT FALLS-HYPOTENSION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL BRAIN LESION/SDA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL BRAIN MENINGIOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL BRAIN TUMOR</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL HEMATOMA;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL ICH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL LOBE SEIZURE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL MASS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL MENIGIOMA/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FRONTAL TUMOR/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FTT</td>
<td class="gt_row gt_center">546 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FTT;ABDOMINAL DISTENSION</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FULIMANT LIVER FAILURE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FULMINANT C-DIFF;LIVER FAILURE;CIRRHOSIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FULMINANT HEPATIC FAILURE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FULMINANT HEPATITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FUNGAL MENINGITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FUNGAL PNEUMONIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FUNGAL RESPIRATORY INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FUNGEMIA</td>
<td class="gt_row gt_center">1,146 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FUNGEMIA;BREAST CANCER;STATUS POST KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FX ANKLE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FX HIP,R</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FX HUMERUS;RENAL CELL CA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FX TO RT HIP &amp; SHOULDER-R/O MI</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">FZ2NMS\CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G I BLEED</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G TUBE OUT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G-J TUBE DISLODGED</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G-J TUBE PULLED</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G-TUBE FELL OUT</td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G-TUBE LEAK</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G.E JUNCTION CANCER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">G.I. BLEED</td>
<td class="gt_row gt_center">273 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAIT ABNORMALITY</td>
<td class="gt_row gt_center">994 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAIT CHANGES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAIT DISTURBANCE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAIT INSTABILITY;FALL;DEHYDRATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALL BLADDER CANCER/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALL STONE;EXPLORATORY LAPAROSTOMY;CHOLECYSTECTOMY;WEDGE LIVER BIOPSY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALL STONES/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER CANCER; FEVER</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER CANCER/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER FISTULA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER MASS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLBLADDER SEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE PANCREATITIS</td>
<td class="gt_row gt_center">776 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE PANCREATITIS-CHOLANGITIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE PANCREATITIS;CHOLECYSTITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE PANCREATITIS;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE,PANCREATITIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE; PANCREATITIS/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE;FAILED ERCP</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE;HYPOTENSION;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE;PANCREATITIS</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONE/PACREATIC CYST/SDA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES</td>
<td class="gt_row gt_center">347 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES-PANCREATITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES, NEED FOR ACCESS</td>
<td class="gt_row gt_center">960 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES;COLON CA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES;PANCREATITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES;SDA;METHICILLIN RESISTANT STAPH AUREUS/SDA</td>
<td class="gt_row gt_center">776 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES;SEIZURES MONITORING</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES/PANCRATITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALLSTONES/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GALSTONE PANCREATITIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAMMA BENZENE HEXACHLORIDE WITHDRAWAL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAMMA-BUTYROLACTONE WITHDRAWAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GAMMABUTEROL LACTONE WITHDRAWAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGENE RIGHT LEG</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGREEN LEFT FOOT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE</td>
<td class="gt_row gt_center">3,678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE BILATERAL FEET</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE BILATERAL FEET;IV ANTIBIOTICS</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE BILATERAL LOWER EXTREMITIES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE FOOT;CELLULITIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE L 4TH TOE ; S/P TRANSPLANT FOR IV ANTIBIOTICS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE L FOOT</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE L LEG</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE LEFT BIG TOE AND SECOND TOE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE LEFT FOOT</td>
<td class="gt_row gt_center">103 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE LEFT LEG</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE LEFT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE LEFT TOES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE OF FOOT</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE OF SCROTUM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE OF THE TOE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE R LEG</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE RIGHT FIRST TOE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE RIGHT FOOT</td>
<td class="gt_row gt_center">695 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE RIGHT LOWER EXTREMITY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE RIGHT SECOND TOE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE TOES, BILATERAL FEET</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE, RIGHT FOOT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE, RIGHT LOWER EXTREMITY</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE,BILATERAL FEET</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE,LT LOWER EXTREMITY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE,RIGHT FOOT</td>
<td class="gt_row gt_center">1,061 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE;CHEST PAIN</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE;TELEMETRY</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE/SDA</td>
<td class="gt_row gt_center">420 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE/SDA\RIGHT LOWER EXTREMITY ANGIOGRAM;PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY TO VEIN GRAFT</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENE\ANAGRADE LOWER EXTREMITH ANGIOGRAM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENOUS CHOLECYSTITIS</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GANGRENOUS RIGHT LEG</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GARBLED SPEECH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GARDNERS SYNDROME</td>
<td class="gt_row gt_center">1,500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASROINTESTINAL BLEED;ACUTE RENAL FAILURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASSTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTORINTESTINAL BLEED</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC ADENOCARCINOMA/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC AND ESOPHAGEAL VARICES</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC BLEED</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CA/SDA</td>
<td class="gt_row gt_center">167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CANCER</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CANCER;PANCREATITIS</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CANCER;PNEUMONIA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CANCER/SDA</td>
<td class="gt_row gt_center">393 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC CARDIA/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC FOREIGN BODY;VOLVULUS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC FUNDAL VARICES STAGE 4/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC MASS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC MASS/SDA</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC OBSTRUCTION</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC OUTLET</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC OUTLET OBSTRUCTION</td>
<td class="gt_row gt_center">554 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC PERFORATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC STUMP CANCER/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC TUMOR/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC ULCER;BLEED</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC VARICIES</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIC VOLVULUS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRINOMA/SDA</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRIOINTESTINAL BLEED</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRO CUTANEOUS FISTULA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRO ESOPHAGEAL REFLEX/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRO ESOPHAGEL REFLUX DISEASE/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRO INTESTINAL BLEED</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRO INTESTINAL BLEEDING</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTRO INTESTINAL MALIGNANCY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROADENOCARCINOMA/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROENTERITIS</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROENTERITIS,CHEST PAIN</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROENTERITIS/OI</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROESOPHAGEAL JUNCTION, ESOPHAGEAL MASS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROESOPHAGEAL REFLUX DISEASE/SDA</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINSTESTINAL BLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESINAL BLEED</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESITINAL BLEED</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">66,697 (0.9%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-ADVANCED LIVER FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-ANEMIA</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-LOW HAMATOCRIT</td>
<td class="gt_row gt_center">370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">552 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-RLL PNEUMONIA-R/O MI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED-SUBDURAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED, CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED, S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED,SPONTANEOUS BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED; R/O MI</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED; SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;;TELEMETRY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ACUTE MI</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ACUTE RENAL FAILURE;RESPPIRATORY ARREST</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ANEMIA</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ASCITES;FEVER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;CHEST PAIN;TELEMETRY;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">5,740 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">1,064 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;CIRRHOSIS</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;COMMON VARIABLE IMMUNODEFICIENCY</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;COPD EXACERBATION</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;DEHYDRATION;PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;DIABETIC KETOACIDOSIS;S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;DUODENAL LIPOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;DUODENAL ULCER;DOWN SYNDOME;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ESOPHAGEAL VARICIES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HEPATITIS C</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HEPETITIS C</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HYPERKALEMIA</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HYPERTENSION;RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HYPOTENSION</td>
<td class="gt_row gt_center">749 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HYPOTENSIVE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;HYPOXIA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;ISCHEMIC BOWEL</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;NON-ST ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;PANCREATIC CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;PNEUMONIA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;PNEUMONIA;RENAL FAILURE</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;R/O COLON CANCER\COLONOSCOPY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;RENAL FAILURE</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;RENAL FAILURE CAD</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">306 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;ST DEPRESSION</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;S/P COLONOSCOPY;HEMODYNAMIC INSTABILITY POST PROCEDURE;</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;SEPSIS</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">7,135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;TELMETRY</td>
<td class="gt_row gt_center">190 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;TRACHEAL OBSTRUCTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;VALVE DISEASE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED;VARICES</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED/JAUNDICE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEED/THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEEDING</td>
<td class="gt_row gt_center">406 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEEDING POST DILITATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL BLEEDING;EVOLVING MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL INFECTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL PERCUTANEOUS FISTULA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTINAL PERFORATION</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTESTIONAL BLEED</td>
<td class="gt_row gt_center">468 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROINTETINAL BLEED</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS</td>
<td class="gt_row gt_center">48,022 (0.6%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS WITH LONG STANDING G-TUBE/SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS, HYPERTENTIVE URGENCY</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS,HYPERTENSION</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS;ACUTE ON CHRONIC RF</td>
<td class="gt_row gt_center">968 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS;DIABETES MELLITUS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS\J-TUBE PLACEMENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPARESIS\PLACEMENT OF G-TUBE **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPASESIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GASTROPHARESIS/SDA</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GATROINTESTIONAL BLEEDING</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GBM;APHASIA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GBS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GERD; ASPIRATION PNEUMONIA/SDA</td>
<td class="gt_row gt_center">536 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GERD/SDA</td>
<td class="gt_row gt_center">83 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED</td>
<td class="gt_row gt_center">14,096 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED </td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED SCHLEROSING CHOLANGITIS</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED-PULMONARY EDEMAN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED-UNSTABLE ANGINA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED, ASPERATION, SEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED, HYPOTENSION,ANEMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED, POSITIVE TROPONIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED, R/O MI</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED, RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,ABDOMINAL PAIN</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,ARRYTHMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,BREAST CANCER</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,CHEST PAIN,HYPOTENSION</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,DIZZY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,ESOPHAGEAL VARICIES</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,HYPOTENSION,FEVER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,MI</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED,R/O MI</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED; GASTRIC MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;ANEMIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;ASPIRATION PNEUMONIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;BILATERAL PULMONARY EMBOLI</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;CECUM MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;HIP FX</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;JAUNDICE</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;LIVER FAILURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;PULSELESS LE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;RENAL FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;SEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;TELEMETRY</td>
<td class="gt_row gt_center">454 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;UNRESPONSIVE;HYPOTENTION</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED/ CHEST PAIN</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED/MASS TO HEPATIC FLEXURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED/NSTEMI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED/PVD</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEED/SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEEDING</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI BLEEDING\COLONOSCOPY</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI EVALUATION</td>
<td class="gt_row gt_center">1,892 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI PERFORATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI PROBLEM\ERCP</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GI,BLEED</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GIB, RENAL FAILURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GIBLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GILLIAM BARRE SYNDROME</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLAGARINE INSULIN OVERDOSE</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLASS INGESTION;GI SCOPE</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLIOBLASTOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLIOBLASTOMA MULTIFORM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLIOBLASTOMA, S/P FALL</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLIOBLASTOMA,NAUSEA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLIOBLASTOMA;DYSPNEA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLIOBLASTOMA;MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLOBE RUPTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLOTTIC MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GLUCOSE CONTROL;INSULIN DRIP;BILATERAL HERNIAS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GOITER</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GOITER MULTINODULAR/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GOITER;CHRONIC AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GOITER/SDA</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GOODPASTURES</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GOUT;FEVER</td>
<td class="gt_row gt_center">684 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRADE 2 LIVER LACERATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRADE 4 LIVER LACERATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAFT INFECTION</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAFT STENOSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAM +SEPSIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAM NEGATIVE RODS;BACTEREMIA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAM NEGATIVE SEPSIS/LIVER MASS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAND MAL SEIZURES</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRANULATION IN TRACH</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GRAVES DISEASE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GROIN BLEED;CP;TELEMETRY</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GROIN CELLULITIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GROSS HEMATURIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GROSS HEMOPTYSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GSW</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GSW R NECK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUIANNE BARRE SYNDROME</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUILLAIN BARRE SYNDROME</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUILLAIN-BARRE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUILLAIN-BARRE SYNDROME</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUILLAN BARRE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUILLIAN BARRE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUILLIAN BARRE SYNDROME</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GULLIAN BARRE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND</td>
<td class="gt_row gt_center">421 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND ; PNEUMOTHORAX</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND BACK</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND HEAD</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND RIGHT HAND/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND TO ABDOMEN</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND TO CHEST AND ABDOMEN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND TO CHEST/HEMOTHORAX</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND TO FACE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUN SHOT WOUND TO HEAD</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUNSHOT TO CHEST</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUNSHOT WOUND</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUNSHOT WOUND TO FACE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUNSHOT WOUND;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GUNSHOT WOUNDS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">GVH OF LIVER</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">H/O DVT, LEG SWELLING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAIRY CELL LEUKEMIA</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAMATEMESIS;UPPER GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND AMPUTATION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND AMPUTATION;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND AND FINGERS INFECTION</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND EMBOLI;THROMBOS GRAFT</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND INJURY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND LACERATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND LACERATION;PARTIAL FINGER AMPUTATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HAND TRAUMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HANGING</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HANGING INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HARD PALATE HEMATOMA</td>
<td class="gt_row gt_center">1,144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HARDARE FAILURE/SDA</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HARDWARE FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HARDWARE FAILURE; SPINAL METASTASIS/SDA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HARDWARE FAILURE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HARDWARE INFECTION</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HART MASS\EXCISION OF MYXOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HCAP;RIGHT SIDED PLEURAL EFFUSION</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HCC S/P TACE PROCEDURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HCT DROP</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HD CATHETER LINE INFECTION</td>
<td class="gt_row gt_center">1,944 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD ACHE,R/O BLEED</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED</td>
<td class="gt_row gt_center">2,586 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED VS TUMOR</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED WITH SHIFT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED, S/P MVC</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED;OPEN SKULL FRACTURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED;PNEUMONIA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED;S/P FALL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED;S/P FALL;TELEMETRY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED;TELEMETRY</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED;URINARY TRACT INFECTION;PNEUMONIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD BLEED/SPLENIC LACERATION/KIDNEY LACERATION/MVC</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURIES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY</td>
<td class="gt_row gt_center">511 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY,C SPINE FX</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY;S/P BICYCLIST ACCIDENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY;S/P FALL</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY;SUBDURAL HEMORRHAGE;SUBARACHNOID HEMATOMA;PI BLEED</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD INJURY;TELEMETRY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD LACERATION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MAS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MASS</td>
<td class="gt_row gt_center">339 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MASS WITH SHIFT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MASS;PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MASS;S/P SEIZURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MASS;SEIZURES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD MASS;UTI</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD OF PANCREAS CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD TRAUM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD TRAUMA</td>
<td class="gt_row gt_center">883 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD TRAUMA; PED STRUCK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD TRAUMA;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAD TRAUMA;SCALP LACERATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE</td>
<td class="gt_row gt_center">7,310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE-SEIZURES-R/O SHEEHAN SYNDROME</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE,FEVER</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE,R/O SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE,SINUSITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE; ANEURYSMS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE; ATAXIA; R/O MENINGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;ANEURYSM</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;BLURRED VISION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;FEVER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;FEVER;?MENINGITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;FEVER;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;R/O TB</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHE;TELEMETRY</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADACHES\ CEREBRAL EMBOLIZATION/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEADCAHE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAMATOMA, CERVICAL FRACTURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART BLOCK</td>
<td class="gt_row gt_center">1,022 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART BLOCK,NON STE MI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART BLOCK; UTI</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART BLOCK;SYNCOPE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART BLOCK;TELEMETRY</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART BLOCKAGE</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART DISEASE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE</td>
<td class="gt_row gt_center">3,285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE,CHOLECYSTITIS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE; NONSUSTAINED VT; S/P MITRAL VALVE REPLACEMENT\ICD LEAD REVISION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE; NSVT\EP STUDY +/-ICD IMPLANTATION</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;CARDIAC ARREST\INTRA-AORTIC BALLOON PUMP PLACEMENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;FEVER;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;KIDNEY RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;MITRAL REGURGITATION;TRICUSPID REGURGITATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">425 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;RENAL FAILURE;CHEST PAIN</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;SUPRAVENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE;VT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE/A-FIB</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE\BIVENTRICULAR PACEMAKER IMPLANT/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE\LEFT VENTRICULAR LEAD PLACEMENT VIA LEFT THORACOTOMY /SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART FAILURE\PACEMAKER IMPLANT/ABLATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART MASS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEART RATE CONTROL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEAT FATIGUE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HELP SYNDROME</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMANGIOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATEMASIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATEMESIS</td>
<td class="gt_row gt_center">1,720 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATEMESIS;PANCREATIC CANCER</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATEMSIS</td>
<td class="gt_row gt_center">490 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATOCHEZIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATOCHROMATOSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATOCRIT DROP</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATOMA</td>
<td class="gt_row gt_center">2,236 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATOMA OF CHEST</td>
<td class="gt_row gt_center">350 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATOMA-ANEMIA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA</td>
<td class="gt_row gt_center">2,072 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA,HYPOTENSION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA;ANEMIA;ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA;BLADDER BLEED</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA;DYSPNEA;HYPOXIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA;RENAL MASS</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMATURIA\CYSTOSCOPY;URETHERAL DILATION </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMETEMESIS;GASTROINTESTINAL BLEEDING</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMIPLEGIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMMO-HAGIC STROKE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMMORHAGIC SHOCK</td>
<td class="gt_row gt_center">515 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMMORRHAGIC ENCEPHALOMYELITIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMO PERITONEUM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOCHROMATOSIS;LIVER FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOLYTIC ANEMIA</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOLYTIC UREMIC SYNDROME</td>
<td class="gt_row gt_center">196 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPERITENEUM</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPERITONEUM</td>
<td class="gt_row gt_center">508 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPHILIA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPNEUMOTHORAX</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTESIS;LUNG CANCER;HUMAN IMMUNODEFIENCY VIRUS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTESIS;RESPIRATORY FAILURE;LEUKEMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTOSIS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS</td>
<td class="gt_row gt_center">8,926 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS VS.HEMATEMISIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS,HYPERTENSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS,LUNG CA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS; INTRACTIBLE DIARRHEA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS; PROBABLE ASPERGILLONA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;ESOPHAGEAL PERFORATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;HTN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;MET RENAL CELL CA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;PNEUMONIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;PULMONARY CONGESTION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;RENAL CELL CANCER</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPTYSIS\BRONCHOSCOPY RIGID; W. ARGON PLASMA COAGULATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPYTISIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOPYTSIS</td>
<td class="gt_row gt_center">1,965 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORHAGE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRAGIC STROKE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGE STROKE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGE;CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC BRAIN METASTISIS</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC CONTUSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC CVA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC CVA;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC PANCREATITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC SHOCK</td>
<td class="gt_row gt_center">101 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMORRHAGIC STROKE</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX</td>
<td class="gt_row gt_center">1,402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX, ANEMIA</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX;EMPYEMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX;FEVER;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX;HIP FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX/HIGH INR S/P FALL</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMOTHORAX/RIB FX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEMPOTYSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEP C CIRRHOSIS</td>
<td class="gt_row gt_center">460 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEP C, CIRRHOSIS, ARF</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPARIN INDUCED THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPARIN INFUSIN, S/P IVC FILTER PLACEMENT</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATACELLULAR CARCINOMA/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ABSCESS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ARTERY STENOSIS</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">4,538 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC CELLULAR CARCINOMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC CIRRHOSIS\SALT STUDY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC CYST</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC CYST/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC DECOMPENSATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEEPHALOPATHY</td>
<td class="gt_row gt_center">1,764 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEOPHALOPATHY</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEP</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPAHTY</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY</td>
<td class="gt_row gt_center">6,925 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY WITH HYPERBILIRUBENEMIA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY-NSTEMI</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY,LEG WEAKNESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY;LIVER TRANSPLANT</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY;S/P TRANSPLANT</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCEPHALOPATHY/ANEMIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC ENCHEPHALOPATHY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC FAILURE</td>
<td class="gt_row gt_center">628 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC FAILURE;ACUTE ABDOMEN;?SEPTIC</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC FAILURE;RENAL FAILURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC HYDROTHORAX</td>
<td class="gt_row gt_center">329 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC INSUFFICIENCY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC INSUFFIENCY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC LACERATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC LIVER FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC MASSES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATIC VEIN VENA CAVAL STENOSIS/SDA</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATICOCELLULAR CARCINOMA/SDA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS</td>
<td class="gt_row gt_center">1,466 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS B</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS B, HEPITOMA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C-LIVER FAILURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C, CIRRHOSIS/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C,LIVER FAILURE,ASCITES</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C;CIRRHOSIS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C;CIRRHOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">303 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS C;HEPATO-RENAL FAILURE;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS-C;LIVER FAILURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS-C;PRE-OP LIVER</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS, ACIDOSIS, ETOH WITHDRAWAL, ELEVATED ACETAMINOPHEN LEVEL</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS,JAUNDICE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS;ASCITES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">261 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS;CIRRHOSIS /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS;LIVER FAILURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS;SEIZURE D/O</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITIS;TYLENOL TOXICITY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATITS C;CIRRHOSIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATO CELLULAR CAECINOMA</td>
<td class="gt_row gt_center">623 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATO CELLULAR CARCINOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATO RENAL FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATO RENAL SYNDROME</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATO-BILI SYNDROME</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATO;BILIARY RESSECTION;VRE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOBILIARY CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOBILIARY FAILURE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLUAR CARCINOMA/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CA/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CANCER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CARCINOMA (155.0)\CHEMOEMBOLIZATION (AGENT-ADRIAMYCIN)</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CARCINOMA 155.0\RADIOFREQUENCY ABLATION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CARCINOMA/SDA</td>
<td class="gt_row gt_center">277 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOCELLULAR CARCINOMA\CHEMO EMBOLIZATION/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOMA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOMA;IV ANTIBIOTICS;PAIN CONTROL\CHEMO EMBOLIZATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOMA;SEPSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOMA/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOMNA LIVER</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATOPULMONARY SYNDROME</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATORENAL CIRRHOSIS</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATORENAL FAILURE</td>
<td class="gt_row gt_center">419 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATORENAL SYNDROME</td>
<td class="gt_row gt_center">576 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATORENAL SYNDROME HEMETEMSIS</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATORENAL SYNDROME; CIRRHOSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPATORENAL SYNDROME;ENCEPHALOPATHY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEPITO CELLULA CARCINOMA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERION OD</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIA</td>
<td class="gt_row gt_center">399 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIA LOCALIZED ADIPOSITY/SDA</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIA STRANGULATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIA,HEMATURIA,S/P LIVER TX</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIA;SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIATED DISC</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIATED DISC/SDA</td>
<td class="gt_row gt_center">472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERNIATED DISK</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEROIN OD</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEROIN OVERDOSE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEROIN OVERDOSE-ARDS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HEROIN OVERDOSE-TACHYCARDIA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HERPES ZOSTER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HETEROTOPIC BONE LEFT HIP/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HF;PNA</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIATAL HERNIA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIATAL HERNIA/SDA</td>
<td class="gt_row gt_center">137 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH BLOOD PRESSURE;ABDOMINAL AORTIC ANEURYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH BLOOD SUGAR;GASTROENTERITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH GRADE DYSPLASIA OF ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH GRADE DYSPLASIA/BARRETT&#39;S ESOPHAGUS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH GRADE DYSPLASIA/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH INR</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH INR;ANASARCA;TELEMETRY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH LFTS;R/O TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH RISK PREG, INDUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH WBC;TELEMETRY</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIGH-ANION GAP HYPERGLYCEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP DYSPLASIA WITH A POSSIBLE LABIAL TEAR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE</td>
<td class="gt_row gt_center">7,189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE-HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE-SYNCOPE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE,CELLULITIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE,R/O MI</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE,RIGHT SIDE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE; COPD OB-HYPO SYNDROME</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;ANEMIA</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;EKG CHANGES</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;ELEVATED TRAPEIN</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;PNEUMONIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;RENAL INSUFFIENCY</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;SUBDURAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;TELEMETRY</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;TROPONIN LEAK</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE;WRIST FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FRACTURE/ESRD</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP FX</td>
<td class="gt_row gt_center">238 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP PAIN</td>
<td class="gt_row gt_center">1,204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIP/WRIST FRACTURE;HEAD LACERATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISTOPLASMOSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISTORY OF BREAST CA/SDA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISTORY OF ENDOCARDITIS/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HISTORY SMALL BOWEL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIV</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIV,ESOPHAGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIV; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">1,309 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIV;DEHYDRATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HIV;JAUNDICE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HL;R/O SEPSIS; MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HNNK;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HODGKIN&#39;S DISEASE\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HODGKINS DISEASE; FEVER</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HODGKINS DISEASE;FEVER</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HODGKINS DISEASE\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HODGKINS, FEVER</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HONK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HPERTENSIVE URGENCY</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HPOGLYCEMIA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HTN CRISIS</td>
<td class="gt_row gt_center">18,360 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HTN EMERGENCY</td>
<td class="gt_row gt_center">305 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HTN URGENCY</td>
<td class="gt_row gt_center">15,888 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HTN URGENCY;GASTROPARESIS</td>
<td class="gt_row gt_center">752 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HTN URGENCY/ARF</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HTN; INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HTN;ANGINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HUMAN IMMUNODEFIENCY VIRUS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HUMAN IMMUNODEFIENCY VIRUS;MULTIPLE BRAIN LESIONS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HUMERAL FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HUMERUS FRACTURE</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HUMERUS FRACTURE;RENAL FAILURE;LIVER DISEASE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HUPERTROPHIC CARDIOMYOPATHY\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HX AORTIC STENOSIS;\ THORASCOPY;TRACHEAL STOMA DILATION; APICAL AORTIC CONDUIT;FEMORAL FEMORAL BYPASS/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HX ENDOCARDITIS;AORTIC VALVE;PLANNED VALVE REPLACEMENT</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HX OF BILE LEAK\ ERCP</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HX OF POLYPS\COLONOSCOPY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDRATION; PAIN MANAGEMENT; INFECTION</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDRATION;DROP IN HEMACRIT</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDRO HEPHROSIS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALIC/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALIS/METASTATIC MELANOMA/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALOUS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALUS</td>
<td class="gt_row gt_center">496 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALUS;HYPONATREMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALUS/SDA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROCEPHALUS/VP MALFUNTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDRONEPHROSIS</td>
<td class="gt_row gt_center">115 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDRONEPHROSIS &amp; URETERAL STENT OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDRONEPHROSIS\ROUTINE PERCUTANEOUS NEPHROSTOMY TUBE CHANGE; PERFORM RENAL BIOPSY RIGHT KIDNEY **REMOTE WEST** </td>
<td class="gt_row gt_center">930 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROTHORAX</td>
<td class="gt_row gt_center">298 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYDROTHORAX;LIVER FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYMOPTYSIS</td>
<td class="gt_row gt_center">306 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYOXIA</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPAGLYCEMIA, FOOT ULCER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPEERKALEMIA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBANEMIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBEN</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBENEMIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBENMIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBIMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBINA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBINANEMIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBINEMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBINEMIA</td>
<td class="gt_row gt_center">341 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUBINEMIA;PHOTOTHERAPY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERBILIRUEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCABRIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCALCEMIA</td>
<td class="gt_row gt_center">463 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCALCEMIA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCALCEMIA;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCALCEMIA: LUNG CANCER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCALCEMIA\IV FLUIDS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCALEMIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCAPNEA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">1,035 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCAPNEIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCAPNIA</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCARBIA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCARBIA;PNEUMONIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCARBIC RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCARBIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">1,872 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCARBIC RESPIRATORY FAILURE-PULSELESS ELECTRICAL</td>
<td class="gt_row gt_center">570 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERCARBIC RESPIRATORY FAILURE,MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPEREGLYCEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPEREMESIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA</td>
<td class="gt_row gt_center">25,937 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA AND UPPER GI BLEED</td>
<td class="gt_row gt_center">968 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA-DIABETES</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA-DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">7,560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA-LEFT SIDED WEAKNESS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA-PNEUMONIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA-PNEUMONIA-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA-SEIZURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA,DEHYDRATION;HYPOTENSION;PANCREATIC MASS</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA,RENAL FAILURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA,SEIZURES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;CONGESTIVE HEART FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;DYSPNEA</td>
<td class="gt_row gt_center">372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;FATIGUE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;FOOT ULCERS;HYPONATREMIA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;HEADACHE;? SEIZURE</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;HYPERNATREMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;HYPONATREMIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;HYPOTENSION;ACIDOSIS;</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;NECROTIC TOE</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;PNEUMONIA;RENAL FAILURE</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;SEIZURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;TELEMETRY</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;URTICARIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA;VOMITING</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIA/DKA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIC COMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIC HYPEROSMOLAR SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIC NONKETOTIC SYNDROME</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERGLYCEMIC/HYPEROSMOLAR</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERK</td>
<td class="gt_row gt_center">567 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMA;ARF;BRADYCARDIA</td>
<td class="gt_row gt_center">812 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA</td>
<td class="gt_row gt_center">23,167 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA AND CP</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA-ACUTE RENAL FAILURE-RECTAL BLEEDING</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA-GI BLEED</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA-PANCREATITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA-RENAL FAILURE-ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">395 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA, ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA, ANEMIA, NAUSEA, ARF</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA, HEART BLOCK</td>
<td class="gt_row gt_center">1,620 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA,? DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA,GANGRENE</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA,HYPERGLYCEMIA,UNRESPONSIVE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA,PNEUMONIA</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA,RENAL FAILURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA; ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">274 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;BRADYCARDIA</td>
<td class="gt_row gt_center">1,539 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;CARDIAC ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;FISTULA OBSTRUCTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;HYPOTENSION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;METASTATIC CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;MYOCARDIAL INFARCT;CHRONIC OBST PULM DISEASE;RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;PULMONARY EDMA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;RENAL FAILURE</td>
<td class="gt_row gt_center">218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;TELEMETRU</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA;TELEMETRY</td>
<td class="gt_row gt_center">443 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA/BRADYCARDIA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERKALEMIA/PACREATISIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERMAGNESEMIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA</td>
<td class="gt_row gt_center">1,621 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA-ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA-HYPERGLYCEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA, UROSEPSIS</td>
<td class="gt_row gt_center">1,176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA,FEVERS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA,HYPOTHERMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA,MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA; UTI; ALTERED MS</td>
<td class="gt_row gt_center">530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA;HEMORRHAGIC STROKE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">1,176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA;TACHYCARDIA</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA;TELEMETRY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERNATREMIA;UROSEPSIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPEROSMOLAR NON-KETOTIC HYPERGLYCEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPEROSMOLAR SYNDROME</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPEROSMOTOR NONKETOIC COMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERPARATHYRODISM/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERPARATHYROIDISM</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERPARATHYROIDISM;RIGHT THYROID MALIGNANT NEOPLASM/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERPARATHYROIDISM/SDA</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERSTIMULATION SYNDROME</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENBSIVE EMERGENCY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION</td>
<td class="gt_row gt_center">198,828 (2.6%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION EMERGENCY</td>
<td class="gt_row gt_center">18,372 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION URGENCY</td>
<td class="gt_row gt_center">520 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION, ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION, CHEST PAIN\CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION, DIABETES MELLITUS, CRITICAL AORTIC STENOSIS\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">1,022 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION,CELLULITIS,CHF</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION,CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION,HYPERLIPIDEMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;ANGINA;ABNORMAL STRESS TEST\CORONARY AND RENAL ANGIOGRAM</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;CORONARY ARTERY DISEASE;PERIPHERAL VASCULAR DISEASE;CHRONIC RENAL INSUFFICIENCY\CARDIAC CATH/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;ENCEPHALOPATHY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">752 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;JAUNDICE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;NAUSEA W\VOMITING</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;RENAL ARTERY ARTHEROSCLEROSIS\AORTIC FENESTRATION &amp; ANGIOGRAM W/BILATERAL RENAL STENT</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;RULE OUT CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;S/P BRONCH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;SEPSIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION;VOMITING</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION/HEADACHE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION/PERINEPHRIC HEMATOMA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION/VOMITING/HYPERGLYCEMIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSION\ TIPS</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE</td>
<td class="gt_row gt_center">735 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE CRISIS</td>
<td class="gt_row gt_center">36,846 (0.5%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE CRISIS, ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">615 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE CRISIS;?ENCEPHALOPATHY</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE EMERGENCY</td>
<td class="gt_row gt_center">83,992 (1.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE EMERGENCY;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">1,540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE EMERGENCY;DEMAND ISCHEMIA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE EMERGENCY;TELEMETRY</td>
<td class="gt_row gt_center">1,233 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE HEMORRHAGE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE ICH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URENCY</td>
<td class="gt_row gt_center">5,740 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY</td>
<td class="gt_row gt_center">161,529 (2.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY-HYPOGLYCEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY,NAUSEA,VOMITING</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY;ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY;CHEST PAIN</td>
<td class="gt_row gt_center">555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY;GASTROPARESIS</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY;TELEMETRY</td>
<td class="gt_row gt_center">3,760 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE URGENCY&#39;</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTENSIVE;BLEEDING</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTHERMIA</td>
<td class="gt_row gt_center">488 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTRNSIVE EMERGENCY.SEIZURE</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC CARDIO MYOPATHY\CATH WITH ETHANOL SEPTAL ABLATION/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC CARDIOMYOPATHY</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC CARDIOMYOPATHY\ETHANOL SEPTAL ABLATION/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY\ETHANOL ABLATION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY\ETHANOL SEPTAL ABLATION /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY\ETHANOL SEPTAL ABLATION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY\ETHENOL SEPTAL ABLATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY\RIGHT AND LEFT HEART CATH ETHANOL SEPTAL ABLATION/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPERTROPIC CADIOMYOPATHY\ETHANOL SEPTAL ABLATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOCAPNEA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOENSIA;SEPSIS</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLCEMIA;FEVER;HYPERKALEMIA</td>
<td class="gt_row gt_center">3,290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA</td>
<td class="gt_row gt_center">19,962 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA AND HYPECARBIA</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA-HYPOTHERMIA</td>
<td class="gt_row gt_center">1,694 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA-RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA, </td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA, HYPONATREMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA,GI BLEED</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;ALTERED MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;CHRONIC RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;DELTA MS;TELEMETRY</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;HYPOKALEMIA;PNEUMONIA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;HYPOTENSION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;HYPOTENSION;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;HYPOXIA</td>
<td class="gt_row gt_center">365 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;SEIZURE</td>
<td class="gt_row gt_center">2,534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;SEIZURES</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;TELEMETRY</td>
<td class="gt_row gt_center">134 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA/HYPOKALEMIA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA/HYPOTHERMIA/?BACTEREMIA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIA/MSDS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMIC SEIZURE</td>
<td class="gt_row gt_center">1,709 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOGLYCEMMIA</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA</td>
<td class="gt_row gt_center">774 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA SHOCK;PELVIC FRACTURE;COMATOSE;STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA-URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA;DIARRHEA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA;ETOH WITHDRAWAL AEIZURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA;TELEMETRY</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIA/HEPATITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIC PERIODIC PARALYSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOKALEMIMA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOMAGNESEMIA</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA</td>
<td class="gt_row gt_center">15,637 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA WITH SEIZURE-ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA-ASCITES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA-HYPOKALEMIA-DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA-R/O MYOCARDIAL INFARCTION-RHABDOMYOLYSIS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA, EMESIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA, LOW BICARB, DVT</td>
<td class="gt_row gt_center">222 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA,CONFUSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA,HYPOKALEMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA,HYPOTHROMBONEMIA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA,PNEUMONIA,DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA,SEIZURE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">234 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;BRAIN MASS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;COPD FLARE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;DEHYDRATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;ESOPHAGEAL CA;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;GENERAL WEAKNESS</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPERKALEMIA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPERKALEMIA;MELANOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPERKALEMIA;WEAKNESS;BREAST CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPERTENSION;BREAST CANCER;DIABETES MELLITUS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPOKALEMIA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPOTENSION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPOTHERMIA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;HYPOXIC DILANTIN TOXICITY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;INFECTION;PNEUMONIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;LE EDEMA</td>
<td class="gt_row gt_center">856 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;MALAISE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;MALNUTRITION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;PNA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;R/O SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;RENAL FAILURE</td>
<td class="gt_row gt_center">364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;SEIZURE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;STATUS POST SEIZURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;TELEMETRY</td>
<td class="gt_row gt_center">282 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIC;NEUTROPENIC</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPONATREMIS;ASCITES</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOPHARYNGEAL TUMOR</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENNSION;ATN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSIOM</td>
<td class="gt_row gt_center">615 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION</td>
<td class="gt_row gt_center">109,224 (1.4%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION ABDOMINAL PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION AND ARF</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION AND DEHYDRATION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION AND RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION FEVER</td>
<td class="gt_row gt_center">1,584 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION R/O CAD,S/P LAPAROSCOPIC CHOLECYSTECTOMY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION WITH HEMODIALYSIS</td>
<td class="gt_row gt_center">1,128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-ANEMIA</td>
<td class="gt_row gt_center">666 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-BLEEDING CATH SITE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-BRADYCARDIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-END STAGE RENAL CANCER</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-FEVER</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">1,144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-HEPATIC FAILURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-HEPATORENAL FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-HYPERGLYCEMIA</td>
<td class="gt_row gt_center">1,386 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION-TACHYCARDIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION, PNEUMONIA, URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION, RENAL FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION, S/P FALL URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">304 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,ANEMIA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,BRADYCARDIA</td>
<td class="gt_row gt_center">243 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,DIARRHEA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,FALL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,FEVER,DECUBITUS ULCER</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,GI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,LINE SEPSIS,RENAL FAILURE</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,LUNG CANCER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,PULMONARY EDEMA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,RASH,FEVER,SEIZURE</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,SEPSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,SHOCK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION,UREMIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; AMS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; BRADYCARDIA</td>
<td class="gt_row gt_center">656 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; GI BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; HYPOGLYCEMIA</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; HYPOXIA</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; JAUNDICE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; SEPSIS VERSUS GI BLEED</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; UNSTABLE ANGINA</td>
<td class="gt_row gt_center">2,160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION; URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;AAA REPAIR</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ACITIES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">5,054 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">1,409 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ANEMIA</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ANEMIA;HYPONATREMIA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;BILIARY PATHOLOGY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;BRADYCARDIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;BRADYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;BUTTOCK INFECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;CHEST PAIN</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;CONFUSION</td>
<td class="gt_row gt_center">370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;DEYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;DIARRHEA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;DIARRHEA;TELEMETRY</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;DISSEMINATED ZOSTER</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ESLD</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;ETOH WITHDRAWEL</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FALL;ELEVATED TROP</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FEMUR FX</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FEVER</td>
<td class="gt_row gt_center">5,908 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FEVER,ETIOLOGY UNKNOWN</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FEVER,ORIGINS UNKNOWN;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;FEVER;R/O SEPSIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;GASTROINTESTINAL BLEED;ACUTE RENAL FAILURE;SEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;GI BLEED;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;HEMOPTYSIS</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;HYPERGLYCEMIA;HYPERKALEMIA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;HYPERKALEMIA ? ADDISON</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;HYPOGLYCEMIA;SEIZURE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;HYPOTHERMIA</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;HYPOTHERMIA;HYPOXIA;MENTAL STATUS CHANGES;BRADYCARDIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;INFECTION</td>
<td class="gt_row gt_center">4,928 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;INSULIN DEPENDENT DIABETES MELLITUS;ESRD</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;L1 FRACTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;LEFT PERINEPHRO HEMATO</td>
<td class="gt_row gt_center">1,472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;METHICILLIN RESISTANT STAPH AUREUS;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;N/V/D; ADRENAL INSUFFICENCY</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;NEUTROPENIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;NEW CARDIOMYOPATHY;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;PANCREATITIS;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;POST DIALYSIS</td>
<td class="gt_row gt_center">1,944 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;PRE-SYNCOPE</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;R/O REJECTION;ELEVATED LFTS</td>
<td class="gt_row gt_center">385 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;R/O SEPSIS</td>
<td class="gt_row gt_center">876 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RAPID AFIB;GI BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RENAL FAILURE</td>
<td class="gt_row gt_center">530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RENAL FAILURE;CIRHOSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RESPIRATORY DECOMPRESSION;S/P LIVER BIOPSY</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RULE OUT SEPSIS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SEPSIS</td>
<td class="gt_row gt_center">392 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SEPSIS;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SHORTNESS OF BREATH;ACUTE RENAL FAILURE;HCT DROP</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SINUS TACHYCARDIA</td>
<td class="gt_row gt_center">1,944 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SIRS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;SUBSTANCE ABUSE;PANCREATITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;TACHYCARDIA</td>
<td class="gt_row gt_center">306 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;TELEMETRY</td>
<td class="gt_row gt_center">4,496 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;THROMOCYTOPENIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;UNRESPONSIVE</td>
<td class="gt_row gt_center">3,468 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">422 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;UROSEPSIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;UTI</td>
<td class="gt_row gt_center">616 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;WEAKNESS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION;WEAKNESS\HYPOTENSION;WEAKNESS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION.GASTRIC ILEAL BYPASS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION.GLOGGED DIALYSIS</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION/ ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">1,128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION/MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION/PNEUMONIA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSION/UNCLEAER ETIOLOGY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSIVE</td>
<td class="gt_row gt_center">305 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSIVE EPISODE</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENSIVE;SEPSIS</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTENTION;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA</td>
<td class="gt_row gt_center">2,667 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA-HYPOTENSION</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA-PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA-S/P FALL-TRANSITIONAL CELL CA W/METS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA, INTOXICATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA,BRADYCARDIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA;?SEPSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA;HYPOTENSION;TELEMETRY</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA;RHABDO</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA;TELEMETRY</td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA/ABDOMINAL PAIN</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIA/SEIZURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHERMIC;HYPOTENSIVE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOTHYRIOD,HYPOGLYCEMIC,HYPOGLYCEMIC</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOVENTILATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOVOLEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOVOLEMIA-HEMOTHORAX</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOVOLEMIC SHOCK</td>
<td class="gt_row gt_center">1,944 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXEMIA</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXEMIA;HYPOTENSION;CONGESTIVE HEART FAILURE;HYPERKALEMIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA</td>
<td class="gt_row gt_center">43,298 (0.6%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA AND CONSOLIDATION OF THE LEFT LOWER LOBE</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA OF UNKNOWN ETIOLOGY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA-INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA-MULTIPLE SCLEROSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA-PANCYTOPENIA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA, ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">552 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA, LEFT UPPER QUATDRANT TUMOR</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA, MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA, NEW LUNG MASS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA, RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA, SEIZURES</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,ACUTE CORONARY SYNDROME,HYPOTENSION,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,HYPOTENSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,PNEUMONITIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,SHOCK</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA,TACHYCARDIA</td>
<td class="gt_row gt_center">1,036 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA; A-FIB</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA; ABD. PAIN</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA; CHF</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA; PNEUMONIA; PULMONARY EDEMA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA; TRACHEALMALACEA\BRONCHOSCOPY RIGID;STENT REMOVAL</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;? PULMONARY HYPERTENSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;A-FIB</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;ACUTE RENAL FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;ASPIRATION PNEUMONIA;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;BENZO OVERDOSE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;CELLULITIS</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;DIARRHEA</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;DYSPHAGIA</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;FALL</td>
<td class="gt_row gt_center">235 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;FEVER</td>
<td class="gt_row gt_center">558 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;HY[PTENSION</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;HYPOTENSION</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;MORBID OBESITY</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;NSTEMI;PNEUMONIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;PLEURAL EFFUSIONS</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;PNEUMONIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;PULMONARY EMNBOLUS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;R/O PNA</td>
<td class="gt_row gt_center">1,384 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;R/O PNEUMONIA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;SHORTNESS OF BREATH;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;TELEMETRY</td>
<td class="gt_row gt_center">7,463 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA;TELEMETRY;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA/HYPERCAPNIA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIA/HYPOTENSION/NAUSEA/VOMITING</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIC PULMONARY HYPERTENSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">HYPOXIC;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IC CONTUSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICA ANEURYSM</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICA ANEURYSM/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICB</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD BATTERY  FAILURE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD FIRING</td>
<td class="gt_row gt_center">467 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD FIRING,RF,DM</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD FIRING;SOB</td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD INFECTION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAD COMPLICATION\ICE LEAD EXTRACTION W/ICD REIMPLANTATION /SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAD FRACTURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAD FRACTURE\LEAD REVISION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAD INFECTION</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAD MALFUNCTION; AFLUTTER; VT\ICD GENERATOR CHANGE/ LEAD REVISION</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAD RECALL\ICD LEAD EXTRACTION W/UPGRADE BiV ICD ? EPICARDIAL LEAD PLACEMENT </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD LEAN INFECTION;VEGITATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD MALFUNCTION; CHF; RECURRENT VT; SVT\ICD GENERATOR CHANGE/AV NODAL ABLATION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD POCKET INFECTION AND LEAD REVISION\LEAD REVISION </td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD SHOCK FOR VT/VF</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD SHOCK X2;VENTRICULAR TACHYCARDIA;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICD SITE INFECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH</td>
<td class="gt_row gt_center">1,810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH AND FACIAL FRACTURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH VS STROKE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH WITH HERNIATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH, PNEUMONIA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH, RIB FX&#39;S, PELVIS FX&#39;S</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH,RIB FRACTURE;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH,RIB FX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH;ACUTE RENAL FAILURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH;TELEMETRY</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH/C2 FX</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH/SAH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICH/STROKE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICP</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ICSHEMIC BOWEL</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDDM</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC CARDIOMYOPATHY;VENTRICULAR TACHYCARDIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS; VENTRICULAR FIBRILLATION\RIGHT VENTRICULAR LEAD EXTRACTION AND REPLACEMENT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS\ATRIAL FIBRILLATION ABLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS\ETHANOL ABLATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC PULMONARY FIBROSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC PULMONARY HEMOSIDDEROSIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC PULMONARY HEMOSIDEEROSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC SCOLIOSIS/SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC THROMBOCYTOPENIC PURPURA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IDIOPATHIC THROMBOCYTOPENIC PURPURA;LOW PLATELETS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IHC</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEO PSOAS ABSCESS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEO-ABDOMINAL COLECTOMY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEOSTOMY CLOSE/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEOSTOMY W/ COMPLICATION/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEUS</td>
<td class="gt_row gt_center">1,661 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEUS ASCITES</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEUS,ABDOMINAL PAIN</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILEUS;GASTROENTERITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILI</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC &amp; RENAL ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC ANEURYSM</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC ANEURYSM /SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC DISEASE BILATERAL</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC STENTING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC THROMBOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ILIAC VEIN THROMBOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IM ROD PLACEEMENT TO LEFT FEMUR</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IMI</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IMI\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IMMUNOCOMPROMISED HOST</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IMPENDING MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IMPLANTABLE CARDIAC DEFIBRILLATOR LEAD MALFUNCTION\IMPLANTABLE CARDIAC DEFIBRILLATOR LEAD PLACEMENT\REVISION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IMTRACEREBRAL HEMORRHAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IN ACTIVE LABOR</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INABILITY  TO AMBULATE-HYPONATREMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INABILITY TO WALK;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCARCERATED HERNIA</td>
<td class="gt_row gt_center">3,444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCARCERATED MENTAL HERNIA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCARCERATED PARASTOMAL HERNIA</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCARCERATED VENTRAL HERNIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCESSANT VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISION DRAINAGE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISIONAL DEFECT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISIONAL HERNIA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISIONAL HERNIA; EXCESSIVE SKIN/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISIONAL HERNIA; PERIPANCREATIC PSEUDO CYST/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISIONAL HERNIA/SDA</td>
<td class="gt_row gt_center">3,378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISON DEHISCENCE</td>
<td class="gt_row gt_center">372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCISONAL DEFECT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCOMPLETE T9 FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASED ANGINA;CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASED CREATINE;S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">581 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASED FLUID AT GRAFT SITE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASED INR;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASED INTRAOCULAR PRESSURES</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASED LFT&#39;S; S/P LIVER TX</td>
<td class="gt_row gt_center">595 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING ANGINA;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING LEG WEAKNESS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING SHORTNESS OF BREATH;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING SHORTNESS OF BREATH\RIGHT HEART CATHETERIZATION; ? LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INCREASING SOB R/T INTERSTITIAL LUNG DISEASE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INDUCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AAA GRAFT</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ABDOMINAL WALL;HERNIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AICD</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AORTA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AORTIC ENDO GRAFT</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AORTO BIFEM GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ARTERIAL GRAFT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AXILLO FEMORAL GRAFT/SDA</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED AXILLO-FEM, BYPASS GRAFT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED BACK WOUND</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED BKA; RIGHT/SDA</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED DEVICE\REMOVAL OF IMPLANTED CARDIOVERTER DEFIBRILLATOR</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED DIALYSIS CATHETER</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FEET</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FEMORAL CATHETER</td>
<td class="gt_row gt_center">1,323 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FEMORAL TO POPLITEAL BYPASS GRAFT, LEFT/SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FOOT</td>
<td class="gt_row gt_center">456 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FOOT REQUIRING IV ANTIBIOTICS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FOOT ULCER,RIGHT;IV ANTIBITOICS;VEIN MAPPING;DIALIYZE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED FOOT;IV ANTIBIOTIC</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED GRAFT</td>
<td class="gt_row gt_center">958 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ICD POCKET</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ICD WIRE;BACTEREMIA</td>
<td class="gt_row gt_center">184 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED INTERNAL CARDIOVERTER DEFIBRILLATOR\ICD GENERATOR CHANGE; LEAD EXTRACTION/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED KIDNEY STONE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED KIDNEY STONE;PYELONEPHRITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED L BKA STUMP</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEAD\LEAD EXTRACTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEAD\RIGHT SIDED PACEMAKER LEAD EXTRACTION; REIMPLANTATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT FOOT</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT FOOT; CELLULITIS; DIABETES</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT FOOT;CELLULITIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT FOOT;DIABETES</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT FOOT;DIABETES MELLITUS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT LEG</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT LEG ULCER</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT LEG ULCER/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT LEG ULCERS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT LEG WOUND</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT THIGH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEFT TOE ULCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEG</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEG WOUND POST CORONARY ARTERY BYPASS SURGERY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED LEG;SEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED OBSTRUCTED KIDNEY STONE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ORTHOPEDIC HARDWARE</td>
<td class="gt_row gt_center">1,133 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PACEMAKER POCKET\LEAD EXTRACTION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PACEMAKER\LEAD EXTRACTION</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PACER SITE/SEPSIS</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PANCREATIC PSEUDO-CYST</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PANCREATIC PSEUDOCYST</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PELVIC MASS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PIC LINE/FEVER</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PROSTHESIS LEFT FEMUR/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED PSEUDOCYST</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED R LEG;IV ANTIBIOTICS</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT ANKLE</td>
<td class="gt_row gt_center">825 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT FOOT</td>
<td class="gt_row gt_center">270 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT FOOT;IV ANTIBIOTIC</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT FOOT&#39;</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT HAND;EXPOSED HARDWARE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT HEEL;ULCER;DM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT HIP</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT HIP/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED RIGHT THIGH GRAFT</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED SEROMA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED SHUNT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED STENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED STONE,ACUTE RENAL FAILURE,SEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED THIGH WOUND</td>
<td class="gt_row gt_center">832 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED THYROGLOSSAL DUCT CYST</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ULCER</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ULCER;CELLULITIS;DIABETES</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED ULCER;DIABETES;PVD</td>
<td class="gt_row gt_center">348 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED VP SHUNT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTED WOUND,RIGHT THIGH</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTIN</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION</td>
<td class="gt_row gt_center">3,544 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION AND EPISTAXIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION LEFT AXILLO FEMORAL GRAFT</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION OF THE SPINAL STIMULATOR;CELLULITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION RIGHT KNEE</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION S/P HERNIA REPAIR</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION,UNSPECIIED ETIOLOGY;SHORTNESS OF BREATH;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTION;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFECTIOUS PROCESS</td>
<td class="gt_row gt_center">930 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR LATERAL MI\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR LATERAL MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MI;TELEMETRY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MI\CARDIAC CATH</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARDIAL INFARCTION;ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARDIAL INFARCTION\CARDIAC CATHETER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR MYOCARIDL INFARCTION/CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFERIOR STEMI</td>
<td class="gt_row gt_center">713 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFLAMED GALLBLADDER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFLAMMATORY BOWEL DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFLAMMED PANCREATITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFLUENZA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFLUENZA LIKE ILLNESS</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INFLUENZA;PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGEGSTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTED GLASS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTION OF</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTION OF COCAINE </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTION OF FOREIGN BODY</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTION OVERDOSE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGESTION;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGUINAL &amp; UMBILICAL HERNIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGUINAL HERNIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INGUINAL HERNIA REPAIR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INHALATION INJURY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INJURIES FROM BIKE VS. AUTOMOBILE COLLISION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INNOMINATE OCCLUSION\AORTO/ INNOMINATE/ CAROTID SUBCLAVIAN BYPASS  </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INOMINATE STENOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INRESPONSIVE-LIVER FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSTEMI\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSTRUMENTATION FAILURE/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSULIN DENSENTIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSULIN DEPENDENT DIABETES</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSULIN OVERDOSE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSULIN OVERDOSE;TELEMETRY</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INSULINOMA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTAMURAL AORTA THROMBUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTER CRANIAL HEMMORHAGE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTER CRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTER PARANCHMAL HEMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTER-CRANIAL MASS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERANAL CORTID ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCEREBRAL HEMORRHAGE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCEREBRAL HEMORRHAGE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL BLEED</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL CAROTID STENOSIS/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL HEMMORHAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL HEMORRAGE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">809 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERCRANIAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERIOR MI/CATH</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERIOR MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERIOR MYOCARDIAL INFARCTION;CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERIOR/POSTERIOR MI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERMEDIATE CARE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERMITANT CLAUDICATION/SDA</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERMITTENT CHEST PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERMITTENT HEART BLOCK;ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERMITTENT HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERNAL CAVERNOUS CAROTID ANEURYSM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTEROCUTANEOUS FISTULA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERPARENCHYMAL BLEED</td>
<td class="gt_row gt_center">190 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERPARENCYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERSTITIAL  PULMONARY FIBROSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERSTITIAL LUNG</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERSTITIAL LUNG DISEASE</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERSTITIAL LUNG DISEASE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERSTITIAL PNEUMONITIS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERSTITIAL PULMONARY FIBROSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERTROCH FX</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTERVENTRICULAR HEMORRHAGE</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL DISORDER/SDA</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL FISTULA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL LYMPHADENOPATHY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL MELAPTSIA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL OBSTRUCTION;TELEMETRY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL PERFORATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL STRICTURE</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTESTINAL VESICAL FISTULA/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTOXICATION</td>
<td class="gt_row gt_center">2,585 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTOXICATION;AGITATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTOXICATION/ETOH/BENZO</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA ABDOMINAL ABCESS; PERIRECTAL ABCESS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA ABDOMINAL ABSCESS</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA ABDOMINAL BLEEDING-AAA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA ABDOMINAL HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA CEREBRAL LESION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA CRANIAL BLEED</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA CRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA PARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-ABD ABSCESS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-ABDOMINAL ABSCESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-ABDOMINAL ABSCESS;FEVER</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-ABDOMINAL HEMORRHAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-ABDOMINAL MASS/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-CEREBRAL HEMMORHAGE/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-CRANIAL BLEED</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRA-VENTRICULAR BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAABDOMINAL ABSCESS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAABDOMINAL BLEED</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAABDOMINAL BLEEDING</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAABDOMINAL SEPSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRABDOMINAL HEMORRHAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACARANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACARDIAC THROMBUS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACEREBRAL BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACEREBRAL BLEED;KNEE FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACEREBRAL HEMORRHAGE</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACEREBRAL HEMORRHAGE; SAH; SDH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACEREBRAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACEREBRAL HEMORRHAGE/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRAINIAL BLEED</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">1,333 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL BLEED,SEIZURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL BLEED;ETOH ABUSE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL BLEEDING MASS;TELEMETRY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL CONTUSION;TELEMETRY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL FLUID</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEAD BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMMORHAGE</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMMORHHAGE</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRAGE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRAHGE;HEAD BLEED;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">13,033 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE WITH MASS EFFECT</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE WITH SHIFT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE-HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE-S/P FALL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE-SEIZURE-MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE, SYNCOPE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE,MENINGITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE,S/P ASSAULT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE; FEMUR FX; S/P ATV CRASH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;AFIB;ELEVATED INR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;ANEURYSM</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;BRADYCARDIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;BRAIN METS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;C1 FRACTURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;FACIAL FRACTURES</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;FALL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;FINGER DISLOCATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;LEUKEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;MASS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;OPEN FX</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;RESPIRTORY FAILURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;RUPTURED ANEURYSM</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;SEIZURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;SEIZURE;TACHYCARDIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;SKULL FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;SPELINEC LACERATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;SZ</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">456 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE/HEMOTHORAX/SPINAL FX/S/P FALL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL HEMORRHAGE/TRAUMA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL LESION</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL MASS</td>
<td class="gt_row gt_center">527 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL SWELLING</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACRANIAL TUMOR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE EPILEPSY/SDA</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE FRONTAL LOBE SEIZURES</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE HEMORRHAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE NAUSEA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE NAUSEA,VOMITING</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE PAIN</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE VOMITING;ALLERGIC REACTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACTABLE VOMITTING;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRACUTANEOUS FISTULA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAHEPATIC BILIARY DILATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAHEPATIC HEMATOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAMURAL HEMATOMA ASCENDING AORTA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRANCRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAORAL MASS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARANCHYMAL BLEED</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARANCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">448 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHGMAL HEMORRAGE</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHMAL HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYAL HEMORRHAGE</td>
<td class="gt_row gt_center">170 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL BLEED</td>
<td class="gt_row gt_center">270 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL BRAIN HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL BRAIN MASS/BLEED</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEAD BLEED, ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMORRAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">2,061 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMORRHAGE;GI BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMORRHAGE;S/P MOTOR VEHICLE ACCIDENT;?BRAIN MASS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMORRHAGE;SUBDURAL HEMATOMA;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMAL HEORRHAGE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCHYMEL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARENCYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPAREOLGEAL HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARIETAL HEMORRHAGE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARITAL HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPARYNCHMAL BLEED</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPERENCHYMAL BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPERITONEAL BLEED</td>
<td class="gt_row gt_center">841 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPERITONEAL HEMORRHAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPRAECHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPRANCHYMAL BLEED</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAPRANCHYMECAL BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRATHECAL MASS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAVENTRICULAR  HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAVENTRICULAR BLEED</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAVENTRICULAR BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAVENTRICULAR HEMORRHAGE</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRAVETEBRAL SUBARACHNOID BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRCRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRCRANIUM BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRDUCTAL PANCREATIC MUCINOUS TUMOR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTREPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTRPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTUBATION</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTUSSUCEPTION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INTUSSUSCEPTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INVADING LUNG CA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INVASIVE MELANOMA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INVASIVE SQUAMOUS CELL CARCINOMA OF SUB GLOTTIS/SDA</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INVERTED STOMA/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">INYTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IP BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IPH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IPH; SAH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IPH;BRAIN METS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IPH;CLAVICLE FX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IPMT/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IRREGULAR HEART RATE</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IRREGULAR HEART RHYTHM</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IRREGULAR RHYTHM</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCEHMIC COLITIS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA BILATERAL LEGS</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA BOTH LEGS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA BOWEL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA LEFT TOE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA RIGHT LOWER EXTREMITY</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA;HYPOTENSION</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIA\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ARM;TELEMETRY</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC BOWEL</td>
<td class="gt_row gt_center">1,054 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC BOWEL; HERNIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC BOWEL\MESENTERIC ANGIOGRAM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC CARDIOMYOPATHY</td>
<td class="gt_row gt_center">287 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC CARDIOMYOPATHY;RECURRENT CHEST PAIN\CATH</td>
<td class="gt_row gt_center">686 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC CARDIOMYOPATHY\CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC CARDIOMYOPATHY\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC CHANGES\CARD CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC CHOLITIS &amp; GALLBLADDER POLYP/SDA</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC COLILTIS;WRIST FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC COLITIS</td>
<td class="gt_row gt_center">362 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC COLITIS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ENTERITIS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC FOOT</td>
<td class="gt_row gt_center">1,356 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC FOOT RIGHT</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC FOOT;ABDOMINAL PAIN;TELEMETRY</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC FOOT;ELEVETED CREATININE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC HEART DISEASE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC INDEX FINGER</td>
<td class="gt_row gt_center">576 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC L FOOT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC L LEG</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEFT FOOT</td>
<td class="gt_row gt_center">599 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEFT FOOT-DIABETES MELLITUS</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEFT FOOT;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEFT FOOT;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEFT FOOT/SDA</td>
<td class="gt_row gt_center">158 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEFT LEG</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEG</td>
<td class="gt_row gt_center">370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEG/IV ANTIBIOTICS</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEG/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEGS</td>
<td class="gt_row gt_center">335 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LEGS DVTS</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LLE</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LT ARM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC LT LEG/SDA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC R LEG</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC REST PAIN FOR IV ANTIBIOTICS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC REST PAIN/ULCER BILATERAL</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC RIGHT FOOT</td>
<td class="gt_row gt_center">371 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC RIGHT FOOT;RENAL INSUFFIENCY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC RIGHT LEG</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC RIGHT LEG/SDA</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC RIGHT LOWER LEG</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC RT FOOT</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC STROKE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC TOES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCER LEFT ANKLE W/EXPOSED ACHILLES TENDON/SDA</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCER LEFT FOOT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCER R GREAT TOE;DIABETES</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCER RIGHT FOOT</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCER RIGHT TOE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCER/SDA</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCERATION LEFT FOOT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIC ULCERS INFECTED BOTH LEFT AND RIGHT LEGS</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISCHEMIS BOWEL</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISOPROPYL ALCOHOL OVERDOSE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ISOPROYL ETOH INGESTIOM</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ITRAPERITONEAL BLEED</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IV HEPARIN\ PATENT FORAMEN OVALE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IVC OBSTRUCTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IVC THROMBOS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IVC THROMBOSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">IVH</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">J TUBE DISPLACEMENT-CHRONIC VENT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">J-TUBE FAILURE</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE</td>
<td class="gt_row gt_center">454 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE, GASTRIC CANCER; PERCUTANROUS TRANSHEPATIC CHOLANGIOGRAPHY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE,KLATSKIN TUMOR</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE;COMMON BILE DUCT STONE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE;INCREASED BILIRUBIN</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE;PANCREATIC CA;FEVER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE;POST PROCEDURE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE;S/P ERCP</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAUNDICE;S/P ERCP;UNRESOLVED BILIARY OBSTRUCTION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAW ABSCESS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAW PAIN</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAW PAIN;DYSPNEA ON EXERSION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JAW SPASM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JNAJOJ77/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JNATHJW5</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JNATHJW8</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JOINT EFFUSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JOINT INFECTION</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JUNCTIONAL BRADCARDIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JUNCTIONAL RHYTHM REQUIRING PACEMAKER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JUNCTIONAL RHYTHM-GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">JUXTA-RENAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KEARNS SAYER SYNDROME</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KETOACIDOSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KICKED BY HORSE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY ABSCESS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY CANCER;NEW BRAIN METS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY CANCER;R/O CORD COMPRESSION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY FAILURE</td>
<td class="gt_row gt_center">795 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY FAILURE FOR KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">170 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY FAILURE; ENCEPHALOPATHY</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY INJURY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY LACERATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY LESION LEFT SIDE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY LESION;S/P KIDNEY;BLOOD IN URINE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY LESION/SDA</td>
<td class="gt_row gt_center">1,150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY RUPTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY STONE</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY STONE;TELEMETRY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY STONES</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY STONES;S/P URINARY CATHERIZATION</td>
<td class="gt_row gt_center">924 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY STONES/SDA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY THROMBOEMBOLISM</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">1,265 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY TUMOR/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY TX</td>
<td class="gt_row gt_center">1,218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY;LIVER INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KIDNEY/PANCREAS TX</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KLATSKIN TUMOR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KNEE AMPUTATION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KNEE DISLOCATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KNEE INFECTION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KNEE PAIN</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KYPHOSCOLIOSIS/SDA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KYPHOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KYPHOSIS, S/P FRACTURE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">KYPHOSIS/SDA</td>
<td class="gt_row gt_center">575 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L 1 FRACTURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L ANEURYSM,S/P ANGIOGRAM</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L ARM INFECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L BASAL GANGLIA BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L FOOT ULCER</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L HIP FX</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L HIP FX; HYPERGLYCEMIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L INTERCRANIAL BLEED</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L INTRACRANIAL HEMORRAHAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L LUNG COLLAPSE</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L MAIN DISEASE; FOR CABG</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L MCA ANEURYSM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L PARIETAL MASS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L SIDED PNEUMONIA; ESRD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L SIDED PNEUMOTHORAX</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L SIDED WEAKNESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L THIGH FLUID COLLECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L THIGH HEMATOMA;FACTOR V111 INHIBITOR</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L TOE ULCER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L. HIP FRACTURE; RF; ANEMIA</td>
<td class="gt_row gt_center">344 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L. HP FRACTURE AOTIC STENOSIS, SHINGLES</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L. NECK ADENOPATHY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L. SIDED EFFUSION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L.HIP FRACTURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L.L.E.ARTERIAL OCCLUSION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L.LOWER EXTREMITY ARTERIAL OCCLUSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L1 BURST FRACTURE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L1 DISC PROTRUSION;CORD COMPRESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L1 FRACTURE,RT RADIUS FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L1 FRACTURE/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L1 FX</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L1BURST FRACTURE</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 BURST FRACTURE</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 BURST FRACTURE; LUMBAR STENOSIS/SDA</td>
<td class="gt_row gt_center">61 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 COMPRESSION FRACTURE;HYPOTENSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 COMPRESSION FRACTURE/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 FRACTURE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 MASS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L2 METASTOSIS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L3 BURST FRACTURE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L3-L4 NONUNION AND STENOSIS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L3-L4 SPONDYLOLISTHESIS LEFT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L3-L4 STENOSIS/LESION/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L3-L5 SPINAL STENOSIS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L4-L5 LUMBAR STENOSIS/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L4-S1 SPONDYLOLISTHESIS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L5 FRACTURE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">L5 METASTATIC TUMOR/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LACERATED CERVIX</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LACERATED SPLEEN;STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LACERATIONS ARMS,THROAT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LACTIC ACIDOSIS</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LACTID ACIDOSIS</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LAMINECTOMY</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE &amp; SMALL BOWEL OBSTRUCTIONS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE ABDOMINAL FISTULA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE ABDOMINAL MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE ABDOMINAL MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE B CELL LYMPHOMA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE BIFRONTAL SKULL LESION/ MENINGIOMA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE COLONIC POLYP/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE FRONTAL MASS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE GASTOINTESTINAL BLEED</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE HIATAL HERNIA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE LEFT ATRIAL MASS\ ATRIAL MYXOMA REMOVAL/SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE LIVER HEMATOMA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE MEDISTINAL TUMOR</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE NECK MASS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE PERICARDIAL EFFUSION,MEDIASTINAL MASS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE PERICARDIAL EFFUSION\POSSIBLE TAP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE PFO\ PATENT FORAMEN OVALE/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGE VILLOUS ADENOMA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARGOTRACEAL STENOSIS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNEAL STENOSIS;NECK ARM PAIN</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL &amp; SUBGLOTTIC STENOSIS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL CANCER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL EDEMA</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL FRACTURE;S/P TRACH REMOVAL</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL INFECTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL MASS</td>
<td class="gt_row gt_center">151 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGEAL STENOSIS/SDA</td>
<td class="gt_row gt_center">372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGO-TRACHEAL STENOSIS/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNGOTRACHIAL STENOSIS/SDA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LARYNX CA/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LATE EFFECT RADIATION; CERVICAL SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LE EDEMA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LE EDEMA, R/O MI</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LE WEAKNESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAD FAILURE\LEAD &amp; DEVICE EXTRACTION LEFT SIDED SYSTEM ? PACEMAKER REIMPLANT ON RIGHT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAD MALFUNCTION\ICD LEAD EXTRACTION/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAD MALFUNCTION\LEAD EXTRACTION; LEFT VENTRICULAR LEAD IMPLANT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAD MALFUNCTION\LEAD EXTRACTION/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAD MALFUNCTION\MEDTRONIC BiV/ICD LEAD AND DEVICE EXTRACTION /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAKING ANEURYSM</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAKING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAKING THORACIC ANEURYSM</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAKING TRIPLE A</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEAKING TRIPLE A;PSEUDOANEURYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT  FOOT CELLULITIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ACETABULAR FRACTURE</td>
<td class="gt_row gt_center">408 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ADNEXAL MASS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ADRENAL MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ADRENAL NEOPLASM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE ARTHRITIS; LEFT SUB TALAR ARTHRITIS</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE BIMALLEOLAR FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE FRACTURE;INFECTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE FRACTURE/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE FX/SDA</td>
<td class="gt_row gt_center">2,160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE INFECTION</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE INTERMEDIATE GRADE SARCOMA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE PAINFUL HARDWARE</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANKLE ULCER</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ANTERIOR DESCENDING ARTERY PERFERATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ARM INJURY;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ARM SPASMS</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ATRIAL MYXOMA\ ATRIAL MYXOMA REMOVAL/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ATRIAL MYXOMA\LEFT ATRIAL MYXOMA RESECTION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ATRIAL THROMBUS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ATRIAL THROMBUS; ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ATRIAL TUMOR</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT BKA ISCHEMIA</td>
<td class="gt_row gt_center">553 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT BRAIN MASS/SDA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT BREAST CA/SDA</td>
<td class="gt_row gt_center">253 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT BREAST CANCER/SDA</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT BUNDLE BRANCH BLOCK/BRADYCARDIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CALF AND HEEL INFECTION</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID ANEURYSM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID ANEURYSM/SDA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID ARTERY DISEASE\LEFT CAROTID ANGIOGRAM;POSSIBLE STENT PLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID ARTERY STENOSIS\LEFT CAROTID ARTERY ANGIOGRAM</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID BODY TUMOR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID BODY TUMOR/SDA\ CAROTID ANGIOGRAM; ? WITH EMBOLIZATON</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID OCCULUSION\LEFT CAROTID TO CAROTID BYPASS; LEFT CAROTID TO SUBCLAVIAN GRAFT LEFT; LEFT FEMORAL AXILLARY BYPASS; DEPLOYMENT OF ENDOSTENT GRAFT  /SDA</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID OPTHALMIC ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID PSEUDOANEURYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID STENOSIS</td>
<td class="gt_row gt_center">163 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID STENOSIS/SDA</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID STENOSIS\CAROTID STENOSIS</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID STENOSIS\LEFT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CAROTID STENOSIS\LEFT CAROTID ANGIOGRAM;POSSIBLE STENT PLACEMENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CEBELLAR ISCHEMIC STROKE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CELEBRAL STENOSIS/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CEREBELLUM MASS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CEREBELLUM TUMOR/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CEREBRAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CEREBRAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CEREBRAL VASCULAR ACCIDENT</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CFA CLOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CHEST HEMATOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CHEST SPINDLE CELL TUMOR/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CHEST WALL TUMOR/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CHEST WALL WOUND</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT COLON CANCER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT COMMON CAROTID ARTERY ANEURYSM\ AORTO TO LEFT COMMON CAROTID BYPASS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT COMPRESSION FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT CVA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT DIAPHRAGM INJURY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT DISTAL RADIAL FRACTURE, RIGHT TIBIAL PLATEAU FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT DISTAL TIBIA FRACTURE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT EFFUSION;PNEUMONIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ELBOW FX/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT EMPHYSEMIC PYELONEPHRITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT EXTREMITY EDEMA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FACIAL TUMOR/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMORAL FRACTURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMORAL PSEUDOANEURYSM</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMORAL SUBTROCHANTERIC FX, NON-UNION/SDA</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMUR FRACTURE</td>
<td class="gt_row gt_center">1,095 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMUR FRACTURE;LOW HCT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMUR LESION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMUR MALUNION/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FEMUR NON UNION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FINGER CELLULITIS, INFECTION</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT CELLULITIS</td>
<td class="gt_row gt_center">469 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT FX/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT GANGRENE</td>
<td class="gt_row gt_center">97 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT GANGRENE;IV ANTIBIOTICS</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT GANGRENE\LEFT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT INFECTION</td>
<td class="gt_row gt_center">1,103 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT ISCHEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT NON HEALING ULCER</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT OPEN WOUMD/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT OSTEOMYELITIS/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT PAIN</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOOT ULCER</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FOREARM INJURY/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL ACYSTIC MASS</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL BLEED</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL BRAIN MASS/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL HEMORRHAGE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL LESION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL LOBE HEMATOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL LOBE MASS;ATAXIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL MASS;BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL MASS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL MENINGIOMA/SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL MENINGOMA/SDA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL SUBDURAL</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT FRONTAL TUMOR/SDA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT GROIN MASS;HEMATOMA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HAND 1ST DIGIT DEQUERVAIN&#39;S SYNDROME &amp; TENOSYNOVITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HAND 3RD DIGIT;INFECTION;;IV ANTIBIOTICS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HAND CRUSH INJURY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HAND WEAKNESS;METASTATIC RENAL CANCER</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HAND WOUND/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HEEL ULCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HEMI COLECTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HEMISPHERE STROKE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HEMOTHORAX</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP ABSCESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP AVASCULAR NECROSIS/SDA</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP DISLOCATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP FRACTURE</td>
<td class="gt_row gt_center">1,398 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP FRACTURE;LUNG CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP FRACTURE/R/O MI</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP FRACTURE/SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP HARDWARE FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP INFECTION</td>
<td class="gt_row gt_center">1,007 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP OA/SDA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP OSTEOARTHRISTIS/SDA</td>
<td class="gt_row gt_center">872 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP OSTEOARTHRITIS/SDA</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP OSTEONECROSIS/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP PAIN</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP PAIN, PATIENT UNABLE TO WALK</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HIP PERI PROSTHETIC FRACTURE/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HUMERUS FRACTURE</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HUMERUS FRACTURE;HIP FRACTURE;HYPOXIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT HUMERUS FRACTURE/SDA</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ICA STENOSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT IJ CLOT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INCISIONAL HERNIA/SDA</td>
<td class="gt_row gt_center">1,400 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTERAL CAROTID ANEURYSM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTERNAL CAROTID ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTERNAL CAROTID ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTERNAL JUGULAR VEIN THROMBOSIS;LEFT ARM EDEMA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTRA-ATRIAL MASS\LEFT INTRATRIAL MASS RESECTION/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTRAPARENCHYMAL HEMORRAHGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ISCHEMIC FOOT/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KIDNEY CA/SDA</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KIDNEY CANCER/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KIDNEY STONE/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE DJD/SDA</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE FAILED TOTAL KNEE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE FRACTURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE OA/SDA</td>
<td class="gt_row gt_center">347 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE OSTEOARTHRITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE OSTEOARTHRITIS /SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE OSTEOARTHRITIS/SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE OSTEOARTHRITIS\KNEE REPLACEMENT TOTAL LEFT</td>
<td class="gt_row gt_center">670 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE OSTEOARTROSIS UNSPECIFICED RATHER GENERALIZED OR LOCALIZED INVOLVING LOWER LEG/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE PAIN;WEAKNESS</td>
<td class="gt_row gt_center">448 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT KNEE SUPERFICAL CELLULITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG AMPUTATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG CELLULIIS;SEPSIS</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG CELLULITIS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG CELLULITIS\COLONOSCOPY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG COMPARTMENT SYNDROME</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG HEMATOMA-CELLULITIS</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG INFECTION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG INFECTION;S/P CABG;EKG CHANGES</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG ISCHEMIA /SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG ISCHEMIA; CHF</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG NUMBNESS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG ULCER</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG ULCER;PERIPHERAL VASCULAR DISEASE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LEG WEAKNESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITES;INFECTED RIGHT FOOT WOUND</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY CELLULITIS-S/P MOTOR VEHICLE CRASH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY DISCOMFORT;PERIPHERAL VASCULAR DISEASE;HYPERTENSION\LEFT LOWER EXTREMITY ANGIOGRAM WITH RUN-OFFS</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY GANGRENE</td>
<td class="gt_row gt_center">257 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY GANGRENE/SDA</td>
<td class="gt_row gt_center">196 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY INJURY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY ISCHEMIA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY OCCLUSION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY POPITEAL ANEURYSM</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY PVD\LEFT LOWER EXTREMITY ANGIOGRAM PROCEDURE  **REMOTE WEST**</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER EXTREMITY ULCER/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER LOBE CA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER LOBE COLLAPSE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER LOBE LUNG CA/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER LOBE NODULE</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LOWER LOBE NODULE/SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG CA]/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG CA/SDA</td>
<td class="gt_row gt_center">161 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG CANCER/SDA</td>
<td class="gt_row gt_center">337 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG CARCINOMA/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG EFFUSION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG MASS/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG NODULE, MEDIASTINALADENOPATHY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG NODULE/SDA</td>
<td class="gt_row gt_center">1,045 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT LUNG TUMOR/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN AIRWAY OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN ARTERY DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN CARDIAC DISEASE;CORONARY ARTERY DISEASE;ANGINA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN CORONARY DISEASE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN DISEASE</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN DISEASE; CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN DISEASE;3 VESSEL DISEASE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN DISEASE;CAD</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN DISEASE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN OCCULUSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAIN STEM OBSTRUCTION</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAINSTEM LUNG OBSTRUCTION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAINSTEM OBSTRUCTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MAINSTREAM BRONCHIAL MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MCA ANEURYSM-SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MCA ANEURYSM/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MIDDLE CAROTID ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MIDDLE CEREBRAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT MIDDLE CEREBRAL ARTERY STROKE;R/O MI</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT NASOPHARYNGEAL MASS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT NECK MASS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT NON-HEALING FOOT ULCER</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT NON-UNION FEMUR FRACTURE/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT OCCIPITAL LESION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT OCCIPITAL STROKE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT OCCIPITAL TUMOR/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PANCOAST TUMOR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PARALYSIS</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PARIETAL LOBE LESION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PAROTID MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PATELLA FRACUTRE/SDA</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PATIETAL MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PCA STROKE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PERIRENAL MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">531 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PLEURAL EFFUSION;STATUS POST LIVER TRANSPLANT</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PLEURAL EFFUSION/SDA</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PLEURO EFFUSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PNEUMOTHORAX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT POPLITEAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT POSTERIOR PARIETAL LOBE LESION/SDA</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PROXIMAL FEMUR; CHONDRO SACOMA/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT PROXIMAL TIBIAL FRACTURE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RADIUS FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RECURRENT PARIETAL TUMOR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RECURRENT SQUAMOUS CELL CARCINOMA LEFT EYEBROW &amp; FRONTAL SCALP/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL CA/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL MASS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL MASS/SDA</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL STONE</td>
<td class="gt_row gt_center">151 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL STONE/SDA</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL TUMOR;LEFT RENAL ARTERY STENOSIS</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RENAL TUMOR/SDA</td>
<td class="gt_row gt_center">514 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RETRO PERITONEAL MALIGNANT NEOPLASM </td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RETROPERITONEAL ABSCESS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RETROPERITONEAL MASS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RETROPERITONEAL SARCOMA/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT RIB FRACTURES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SHOULDER AC DISTRUPTION\LEFT SHOULDER AC RECONSTRUCTION AUTOHAMSTRING ? ALLOGRAFT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SHOULDER HARDWARE REMOVAL/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SHOULDER ROTATOR CUFF TEAR/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED CVA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED HEMATOMA;STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED HEMIPARESIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED HEMIPLEGIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED WEAKNESS</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED WEAKNESS-PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED WEAKNESS;2/2 BRAIN MASS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SIDED WEAKNESS;BRADYCARDIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SPHENOID MENENGIOMA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT STAGHORN CALCULUS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT STUMP INFECTION</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SUBCLAVIAN DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SUBCLAVIAN DISEASE\SUBCLAVIAN INTERVENTION </td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SUBMANDIBULAR STONE, CHRONIC SIALODENITIS/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SUBOCCIPITAL TUMOR/SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT SUPRACLINOID ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TALUS FRACTURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TEMPORAL BRAIN MASS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TEMPORAL CAVENOMA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TEMPORAL HEMATOMA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TEMPORAL LESION/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TEMPORAL LOBE LESION-S/P SEIZURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TEMPORAL MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TENTORIAL LESION &amp; MENINGIOMA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT THALAMIC BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT THALMIC BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT THIGH WOUND INFECTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TIBIA AND FIBULA FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TIBIA MASS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TIBIAL FIB FRACTURE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TIBIAL FRACTURE</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TIBIAL PLATEAU FRACTURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TOTAL KNEE LOOSENING TIBIAL PLATE/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT TRUE VOCAL CORD PARALYSIS/SDA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE CA/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE CARCINOMA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE LUNG CA/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE LUNG CANCER/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE LUNG NODULE/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE MASS;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE MASS/SDA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE NODULE/SDA</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LOBE NODULES&#39;/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER LUNG NODULE/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT UPPER POLE RENAL LESION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT URETER TUMOR/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT URETERAL CANCER/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT URETERAL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT URETERAL STONE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT VENTRICULAR ANEURYSM;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT VENTRICULAR DYSFUNCTION;CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION;IMPLANTABLE CARDIVOERTER DEFIBRILLATOR IMPLANT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT VENTRICULAR LEAD MALFUNCTION\LEFT VENTRICULAR LEAD REVISION/SDA</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT VOCAL CORD PARALYSIS\LARYNGOSCOPY DIRECT;GEL FOAM INJECTION LEFT VOCAL CORD</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT WOUND INFECTION</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT ZYGOMA AND LEFORTH FX</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT-SIDED BRAIN BLEED;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEFT-SIDED WEAKNESS;TELEMETRY</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG CELLILITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG CELLULITIS;SPINAL MUSCULAR ATROPHY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG EDEMA,CELLULITIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG GANGRENE;HYPOTENSION;CHF;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG INFECTION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG ISCHEMIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG LACERATION;ELEVATAD INR;HYPOTENSION;RENAL FAILURE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG PAIN</td>
<td class="gt_row gt_center">21,612 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">LEG PAIN FROM LYTIC LESIONS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG PAIN,ABSCESS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG PAIN;ELEVATED CREATININE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG REPAIR S/P MVA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG SWELLING</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG ULCER,END STAGE RENAL DISEASE,DIABETES</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG ULCER/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG WEAKNESS</td>
<td class="gt_row gt_center">1,094 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG WEAKNESS AND SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG WEAKNESS;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEG WOUND</td>
<td class="gt_row gt_center">832 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEIOMYO SARCOMA RIGHT LEG/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LERYAGEAL CA/CAROTID INJURY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LESION FRONTAL LOBE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LESION OF THE KIDNEY/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LETHARGRY</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LETHARGY</td>
<td class="gt_row gt_center">423 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA</td>
<td class="gt_row gt_center">2,726 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA VS LYMPHOMA;ANEMIA</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA; PNEUMONIA</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA;FEVER;NEUTROPENIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA;SEPSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA;SEPSIS;PNEUMONIA</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA/PNEUMONIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA\BMT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKEMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKO ENCEPHALOPATHY</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKOCYTOSIS</td>
<td class="gt_row gt_center">145 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKOCYTOSIS,BANDEMIA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LEUKOCYTOSIS;FEVER;END STAGE RENAL DISESE</td>
<td class="gt_row gt_center">385 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LF SIDE RIB FRACTURE; S/P FALL.</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LFT SUBDURAL HEMATOMA; S/P PED STRUCK BY A CAR.</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LGE,BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LGI BLEED</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LGIB</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LHC;CATHPLACEMENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LI TOXICITY</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LICA ANEURYSM/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIKELY THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LINE INFECTION</td>
<td class="gt_row gt_center">3,287 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LINE INFECTION;TELEMETRY</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LINE INFECTION;YPOTENSION;ACQUIRED IMMUNE DEFICIENCY SYNDROME</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LINE SEPSIS</td>
<td class="gt_row gt_center">946 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LINE SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">2,868 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIP MELANOMA/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LITHIUM OVERDOSE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LITHIUM TOXICITY</td>
<td class="gt_row gt_center">163 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LITHIUM TOXICITY,SCHIZOPHRENIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LITHIUM/TCA OD</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVE AND KIDNEY FAILURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER &amp; RENAL FAILURE-CHOLANGITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER ABSCESS</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER ABSCESSES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER AND KIDNEY FAILURE</td>
<td class="gt_row gt_center">134 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER AND LUNG FISTULA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER AND RENAL FAILURE</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER BLEED &amp; HEMATOMA, HEMOPERITON</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER CANCER;?ESOPHAGEAL VARICIES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER CANCER;MELENA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER CANCER;SEVERE MUCUSITIS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER CIRRHOSIS</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER CONTUSION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER CONTUSION;S/P ASSAULT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER DISEASE</td>
<td class="gt_row gt_center">1,155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER DISEASE; GI BLEED</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER DONOR/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE</td>
<td class="gt_row gt_center">13,751 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE AND SIRS</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE HYPOGLYCEMIA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE TRANSPLANT</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE-CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE-PRE-OP LIVER TX</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE-RENAL FAILURE</td>
<td class="gt_row gt_center">460 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE-TYLENOL OVERDOSE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE, ABDOMINAL PAIN</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE, HEPATITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE,HEPATITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE,TYLENOL OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE; ETOH ABUSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE; VARICEAL BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;?PNEUMONIA;ENCEPHALOPATHY</td>
<td class="gt_row gt_center">658 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;ACUTE RENAL FAILURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;ASCITES</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;BACTERIAL  PERITONITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;CELLULITIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;CIRRHOSIS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;ENCEPHALOPATHY</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;HEPATIC ENCEPHALOPATHY</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;HEPATITIS C</td>
<td class="gt_row gt_center">101 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;JAUNDICE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;LIVER TRANSPLANT</td>
<td class="gt_row gt_center">1,856 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;RENAL FAILURE</td>
<td class="gt_row gt_center">372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;RENAL INSUFICIENCY;HEPATORENAL SYNDROME</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;S/P TIPS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;STATUS POST TYLENOL OVERDOSE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;TRANSPLANT PRE-OP</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;TYLENOL OVERDOSE</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER FAILURE;VICODIN OVERDOSE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER HEMATOMA</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER HEMOANGIOMA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER HEMORRHAGE</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER INSUFFICIENCY</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LAC</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATIN S/P MVA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION</td>
<td class="gt_row gt_center">370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION,S/P MVA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION;PNEUMOTHORAX</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION;RENAL FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION;S/P MOTOR VEHICLE ACCIDEMT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION;SAH</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACERATION/RIB FRACTURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LACTERATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION;CHOLANGIOCARCINOMA/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION\RADIO FREQUENCY ABLATION LIVER **REMOTE WEST**</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION\RADIO FREQUENCY ABLATION OF LIVER **REMOTE WEST**</td>
<td class="gt_row gt_center">1,780 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION\RADIOFREQUENCY ABLATION LIVER LESION ** REMOTE WEST **</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESION\RADIOFREQUENCY ABLATION OF LIVER LESION ** REMOTE WEST **</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER LESSION/SDA\RADIOFREQUENCY ABLATION LIVER</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER MASS</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER MASS, S/P RIGHT COLECTOMY/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER MASS;BACK PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER MASS;PVT;HEAD BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER MASS/SDA</td>
<td class="gt_row gt_center">721 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRANFER</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRANSPLANT</td>
<td class="gt_row gt_center">762 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRANSPLANT EVAL</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">417 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRANSPLANT WORK UP</td>
<td class="gt_row gt_center">267 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRANSPLANT;PRE OP</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TRASPLANT CANDITATE\ PERCUSTANEOUS TRANSPATIC CHOLANGIOGRAM OF LIVER</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVER TX</td>
<td class="gt_row gt_center">446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVING ADULT LIVER DONOR/SDA</td>
<td class="gt_row gt_center">262 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVING LIVER DONOR/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVING RELATED LIVER DONOR/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LIVING UNRELATED LIVER DONOR/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LL MASS</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LLE DVT</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LLIVER FAILURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LLL PNEUMONIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LLL PNEUMONIA/PLEURAL EFFUSIOM</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LM DISEASE\BALOON PUMP</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOBAR PNEUMONIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOEWR GI BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOLWER GI BLEED</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LONGITUDINAL DEFICIENT RADIUS LEFT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LONGITUDINAL EFFICIENT RADIUS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOOSE HIP,LEFT SIDE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOOSE STOOL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW BACK PAIN</td>
<td class="gt_row gt_center">796 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW BLOOD PRESSURE</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW HCT</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW HCT;HYPOXIA;FEVER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW HEMATOCRIT</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW HEMATOCRIT;HYPOTENSION</td>
<td class="gt_row gt_center">4,706 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW O2 SATURATION;ACUTE MYELOID LEUKEMIA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW PLATE COUNT</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW PLATELETS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW PLATLETS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOW URINE OUTPUT</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER BACK PAIN</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER BI  BLEED</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER BI BLEED</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTEMITY ISHEMIA</td>
<td class="gt_row gt_center">726 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMETY EDEMA</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMETY EDEMA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY  PARALYSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY ARTERIAL INSUFFICIENCY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY ARTHROSLOROSIS/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY CELLULITIS;HYPERKALEMIA;RENAL FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY CRUSH INJURIES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY EDEMA</td>
<td class="gt_row gt_center">1,505 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY EDEMA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY FRACTURES</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY ISCHEMIA</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY REST PAIN</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER EXTREMITY WEAKNESS</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTOINTESTINAL BLEED</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTRIINTESTINAL BLEED</td>
<td class="gt_row gt_center">8,532 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTRINTESTINAL BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTRO INTESTINAL BLEED</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTRO INTESTINAL BLEED;S/P ERCP\ERCP</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTEDTINAL BLEED</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESINAL BLEED</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTIAL BLEED</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">17,004 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEED;A FIB</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEED;ANEMIA</td>
<td class="gt_row gt_center">659 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEED;LUNG CANCER</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEED;SUPRATHERAPEUTIC INR</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEED;TUMOR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GASTROINTESTINAL BLEEDING</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GATROINTESTINAL BLEED</td>
<td class="gt_row gt_center">891 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI  BLEED</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED</td>
<td class="gt_row gt_center">57,207 (0.7%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED; L FIBULAR FX</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED;CHRONIC OBST PULM DISEASE;HUMAN IMMUNODEFIENCY VIRUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED;DIABETES MELLITUS;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED;SYNCOPE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED;TELEMETRY</td>
<td class="gt_row gt_center">1,645 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEED\RIGHT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEEDING</td>
<td class="gt_row gt_center">355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEEED</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI BLEEN</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GI;TELEMETRY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GIB</td>
<td class="gt_row gt_center">269 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GIB;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GO BLEED</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GSTROINTEDTINAL BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER GSTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER HEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER INTESTINAL BLEED</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER LEG ISCHEMIA; ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER LIP CANCER/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LOWER LOBE NODULE, LEFT LUNG/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LRG PAIN</td>
<td class="gt_row gt_center">440 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT ARM WEAKNESS;R/P CVA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT ATRIAL THROMBOSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT BASALAR BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT FEMORAL SHAFT FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT FEMUR FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT FEMUR FRACTURE;PULMONARY EDEMA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT FINGER AMPUTATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT FOOT GANGRENE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT GROIN ABSCESS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT HALLUX GANGRENE</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT HAND FX-BLUNT HEAD INJURY-S/P MVA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT HIP FRACTURE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT HIP FX, DIALYSIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT HIP PAIN</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT LEG ISCHEMIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT LOWER LOBE PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT MAIN DISEASE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT SCROTAL ABCESS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT SIDED STROKE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LT SUB DURAL HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUDWIG ANGINA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUDWIG&#39;S ANGINA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUDWIGS ANGINA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUEKEMIA;LYMPHOMA;NSTEMI</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUKEMIA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUL LUNG NODULE\CYBERKNIFE PROCEDURE - 4 TREATMENTS TO LEFT LUNG</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMAR SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR DEGENERATION/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR DISC DEGENERATION/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR DISC HERNIATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR DISC HERNIATION L3/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR DISC HERNIATION/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR FRACTURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR HERNIATED DISC/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR RADICULOPATHY/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SCOLIOSIS;SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPINAL INSTABILITY/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPINAL STENOSIS; SCOLIOSIS/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPINAL STENOSIS/SDA</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPINE COMPRESSION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPONDYLOLISTHESIS/SDA</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPONDYLOSIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR STENOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR STENOSIS/SDA</td>
<td class="gt_row gt_center">1,463 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBAR STENOSIS\FUSION LAMINECTOMY LUMBAR L3-L5</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMBER SPINE FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUMPHOMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG  CANCER-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">230 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG ABCESS;PAINLESS JAUNDICE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG ABSCESS;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG AND BRAIN MASS</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG ANGIOMA;BILATERAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA</td>
<td class="gt_row gt_center">229 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA LEFT/SDA</td>
<td class="gt_row gt_center">202 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA WITH AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA, LEFT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA,AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA; HYPOXEMIA</td>
<td class="gt_row gt_center">1,968 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA/SDA</td>
<td class="gt_row gt_center">3,333 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CA\ BRONCHOSCOPY WITH LASER/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER</td>
<td class="gt_row gt_center">850 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER RIGHT UPPER/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER W/ SPINAL INVASION/SDA</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER WITH CENTRAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">230 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER-SPINAL CORD COMPRESSION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER,</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER,AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER,HYPERKALEMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER,NAUSEA,VOMITING</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER; CENTRAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER; S/P FALL</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;CENTRAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;COPD;PNEUMONIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;DYSPNEA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;HEMOPTYSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;HEMOPTYSIS;BREAST CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;HYPONATREMIA;SYNCOPE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;METS;BRONCOSCOPY</td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;PNEUMONIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">166 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;SUPERIOR VENA CAVA SYNDROME</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;SVC SYNDROME</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;TRACEAL FISTULA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;TRACHEAL ESOPHAGEAL FISTULA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER;WEAKNESS</td>
<td class="gt_row gt_center">306 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER/AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER/L.SIDED OBSTRUCTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER/SDA</td>
<td class="gt_row gt_center">1,941 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANCER\INSERTION INDWELLING PORT **WEST REMOTE-CC2 INR SUITE**/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CANFER;CHRONIC OBST PULM DISEASE;PNEUMONIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CARCINOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG CARCINOMA, RIGHT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG COLLAPSE</td>
<td class="gt_row gt_center">500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG DISEASE/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG HERNIA;DOE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG LESION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG LESION\ RADIO FREQUENCY TUMOR ABLATION LEFT LUNG</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS LEFT/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS RIGHT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS-SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS, DIVERTICULAR ABSCESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS;CHORD COMPRESSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS;HEMOPTYSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS;TACHYPNEA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG MASS/SDA</td>
<td class="gt_row gt_center">547 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODLE/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODULE LEFT/SDA</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODULE RIGHT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODULE; EPITHELIUM/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODULE/SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODULE\THORACOSCOPY VIDEO ASSISTED LUNG BIOPSY RIGHT; STERNOTOMY; PERICARDIAL STRIPPING /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG NODULES/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG TUMOR</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG TUMOR LEFT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG TUMOR RIGHT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUNG TUMOR/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUPUS ERYTHMATOSIS</td>
<td class="gt_row gt_center">511 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUPUS FLARE, HYPERGLYCEMIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LUPUS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYME CARDITIS,CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYME RIDICULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPH ADEMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHADENOPATHY;FEVER</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHADENOPATHY;NECK MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHASTITHELIAL CARCINOMA/SDA</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHEPIT HELIOMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA</td>
<td class="gt_row gt_center">6,076 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA,FEVER, NEUTROPENIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;CHEMO</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;CHEMOTHERAPY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;DEHYDRATION;PAIN CONTROL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;FEBRILE NEUTROPENIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;FEVER</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;HIP FRACTURE</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;HYPOXIA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA;SPLENOMEGALY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA/ PLURAL EFFUSION</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA/COUGH/R/O PULMONARY INFECTION</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA/SPINAL CORD COMPRESSION</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA\CHEMO</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA\CHEMOTHERAPY</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA\CHEMOTHERAPY ( ICE)</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYMPHOMA\CHEMOTHERAPY/ICE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYNPHOMA;TUBERCULOSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYPHANOPATHY/FAILURE TO THRIVE/ABNORMAL LIVER FUNCTION TEST</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">LYSIS ADHESIONS/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">M.I.</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">M/I; PULMONARY EDEMA</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MACRODACTYLY RIGHT 1ST DIGITI/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MAGLIGNANT NEOPLASM OF ESOPHAGUS /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MAJOR DEPRESSION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALAISE</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALAISE S/P SLEEVE GASTRECTOMY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALARIA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALFUCTION ICD</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALFUNCTIONING ILEAL POUCH/SDA</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT ACITES/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT CENTRAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT EFFUSION;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT HYPERTENSION</td>
<td class="gt_row gt_center">35,512 (0.5%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT HYPERTENSION S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT MELANOMA FACE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT MELANOMA OF SKIN AND SCALP AND NECK /SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT MELANOMA; SEIZURES</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT MELANOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT MESOTHELIOMA;RETROPERTONEAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASIA OF LEFT EYE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM COLON/SDA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM ESOPHAGUS UNSPECIFIED/SDA</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM HARD PALATE/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM OF COLON</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM OF OROPHARNYX/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM OF OVARY TO DIAPHRAGM &amp; LIVER</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM OF THE RECTUM/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT NEOPLASM, RIGHT HAND/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT PERICARDIAL EFFUSION\PERICARDIAL DRAINAGE AND WINDOW</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT PLEURAL EFFUSION/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT RETROPERITONEAL TUMOR, RIGHT RENAL MASS VASCULAR TUMOR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALIGNANT VERTIBRAL NEOPLASM/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALLERY-WEISS TEAR</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALLORY-WEISS TEAR</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALNUTRISION;RENAL FAILURE</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MALNUTRITION\EGD</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANDIBLE ABSCESS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANDIBLE FRACTURE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANDIBLE FX;HIP FX; WRIST FX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANDIBULAR ABSCESS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANDIBULAR FRACTURE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANDIBULAR MASS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MANIA, ANEMIA, LE EDEMA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MAOI OVERDOSE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MARFAN&#39;S AORTA\ DAVID PROCEDURE; REPLACEMENT OF ASCENDING AORTA &amp; ARCH/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MARFAN&#39;S SYNDROME\BENTALL PROCEDURE; TOTAL VALVE SPARING ROOT REPLACEMENT VS; HOMOGRAFT  ROOT REPLACEMENT; REPLACEMENT OF ARCH, PROXIMAL ROOT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASS BRAIN</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASS LESION IN BRAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASS,UNSPECIFIED LOCATION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASSIVE ASCITES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASSIVE DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASSIVE HEMOPTYSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASSIVE PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASSIVE WEIGHT LOSS/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MAST CELL CRISIS</td>
<td class="gt_row gt_center">4,370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MAST CELL DEGRANULATION</td>
<td class="gt_row gt_center">8,740 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MAST CELL REACTION;CHEST PAIN</td>
<td class="gt_row gt_center">4,370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASTOCYTOSIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASTOCYTOSIS FLARE</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASTOCYTOSIS,GI BLEED</td>
<td class="gt_row gt_center">4,370 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MASTOIDITIS. R. FACIAL MASS</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA ANEURYSM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA SROKE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA STOKE S/P THROMBOLYSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA STROKE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA STROKE;COMP SYNDROME;RHABDOMYOLISIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCA;STROKE</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCC</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCC WITH LEFT. LOWER EXTREMITY INJURY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MCC;PULMCONTUSION;SPLENIC INJURY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MED</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIA STINAL MASS/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIAL PARIETAL TUMOR/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIAL STINAL TUMOR/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL ADENOPATHY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL ADENOPATHY WITH EXTRINSIC COMPRESSION OF TRACHEA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL ADENOPATHY\FLEXIBLE BRONCHOSCOPY; LINEAR ENDOBRONCHIAL ULTRASOUND (EBUS); FLUOROSCOPY; TRANSBRONCHIAL BIOPSY; TRANSBRONCHIAL NEEDLE ASPIRATION; BRONCHIAL ALVEOLAR LAVARGE </td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL HEMATOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL INFECTION</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL LYMPHADENOPATHY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL LYMPHADENOPATHY; HYPOXIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL MASS</td>
<td class="gt_row gt_center">620 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL MASS;RESPIRATORY ARREST</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL MASS/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL SARCOMA/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL THYMIC CANCER/SDA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINAL TUMOR/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINITIS</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDIASTINUM TUMOR;LYMPHOMA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDICATION REACTION,ISCHEMIC FOOT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEDISTINAL ADENOPATHY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MEGACOLON</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANA/HTN/MIGRAINE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA ? ABSCESS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA METASTASES/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA OF MID BACK/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA ORAL CAVITY/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA WITH BRAIN METS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA-INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA, LEFT FACIAL REGION/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA; AIRWAY OBTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA;DEHYDRATION;?OBSTRUCTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA;FEVER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA;WEAKNESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA. LEFT WRIST/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA/SDA</td>
<td class="gt_row gt_center">146 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA\CHEMO(INTERLEUKIN-2)</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOMA\CHEMOTHERAPY (HD-IL2)</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELANOTIC STOOL</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELENA</td>
<td class="gt_row gt_center">696 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MELENA;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENGIOMA OF BRAIN/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENGIOMA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENIGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGIOMA</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGIOMA LEFT FRONTAL/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGIOMA, RIGHT SIDE/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGIOMA/SDA</td>
<td class="gt_row gt_center">397 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS</td>
<td class="gt_row gt_center">4,723 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS RHABDOMYOLYSIS</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS, STATUS POST CARDIAC ARREST</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS; ? TB</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS; INTRACRANIAL ABCESS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS;DRUG ALLERGY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGITIS/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGOENCEPHALITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINGOMA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENINIGIOMA/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENORRAGIA/UTERINE PROLAPSE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">3,183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGE WITH FEVER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">7,982 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES-DECREASED SATS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES-HYPOXIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES, FEVER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES, KETOACIDOSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES, RHABDO, ARF</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES,CHF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;?BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;?NORO VIRUS</td>
<td class="gt_row gt_center">348 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;ACIDOSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;BRAIN TUMOR</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;HYPONATREMIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;HYPOTENSION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;LIVER CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;LOWER GI BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;PERFORATED VISCUS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;R/O SEPSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES;TELEMETRY</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STATUS CHANGES/ FEVER</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MENTAL STUATUS CHANGE RULE-OUT EPIDURAL ABCESS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENPERIC ISCHEMIA</td>
<td class="gt_row gt_center">555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC ARTERY ISCHEMIA/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC ARTERY OCCLUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC BLEEDING</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC ISCHEMIA</td>
<td class="gt_row gt_center">897 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC ISCHEMIA/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC ISCHEMIC</td>
<td class="gt_row gt_center">555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC TUMOR/COMMON BLE DUCT STONES/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESENTERIC VASCULAR INJURY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESH INFECTION, UMBILICAL WOUND/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESINTERIC ISCHEMIA</td>
<td class="gt_row gt_center">107 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESOTHELIOMA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESOTHELIOMA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MESTERIC ISCHEMIA;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MET ALKALOSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MET BREAST CA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MET CA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MET CHOLANGIOCARCINOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MET LESION</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MET RENAL CELL CA-TRACHEL OBSTRUCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METABOLIC ABNORMALTIES</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METABOLIC ACIDOSIS</td>
<td class="gt_row gt_center">1,354 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METAL STATUS CHANGES;UNRESPONSIVE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTASIS BREAST CANCER</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTASIS OCCULAR MELANOMA TO LIVER/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTASTIC BREAST CANCER TO LIVER/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC  RENAL CELL CARCINOMA\CHEMO</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC ADENOCARCINOMA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC ADENOCARCINOMA COLON TO LIVER/SDA</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC ADENOCARCINOMA OF LIVER; PAPILLARY RENAL CELL CARCINOMA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC ADENOCARCINOMA, COLON TO LIVER/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC ADENOIDCYSTIC CANCER</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BONE CANCER/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BRAIN CANCER</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BRAIN LESION/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BRAIN LESIONS</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BRAIN TUMOR</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER TO BRAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER TO LIVER/SDA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER;CENTRAL AIR OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER;LEG SWELLING;FEVER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER;MALIGNANT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER;SHORTNESS OF BREATH\PLEURODESIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC BREAST CANCER\CHEMO</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CA TO SPINE; T SPINE FX</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CA. OF UNKNOWN PRIMARY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CA/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CANCER</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CANCER TO SPINE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CANCER;BACK PAIN</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CANCER;HYPOXIA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CANCER;UNKOWN PRIMARY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC CARCINOID\CHEMOEMBOLIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CA TO LIVER/SDA</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CA/SDA</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER TO LIVER /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER TO LIVER/SDA</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER TO LIVER/STERNUM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER;NAUSEA;VOMITIN;HEADACHES</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER/SDA</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC COLON CANCER\INTERNALIZATION OF BILIARY DRAIN</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC DISEASE TO MENINGES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LESION LEFT FEMUR/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LESION ON SPINE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LIVER LESION/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LUNG CA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LUNG CA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LUNG CANCER</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LUNG CANCER LEFT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LUNG CANCER, DIARRHEA, NEUTRUPENIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LUNG CANCER;PNEUMONIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC LYMPHOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA /SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA LEFT NECK/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA TO NECK/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA; RIGHT SUBMANDIBULAR MASS;PHARYNGEAL LESION/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA;BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA;BRAIN METASTASIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA;DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA;PAIN CONTROL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA\CHEMO (HIGH DOSE INTERLEUKIN-2)</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA\CHEMO(HIGH DOSE INTERLEUKIN-2)</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA\CHEMOTHERAPY (HD-IL2)</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MELANOMA\INTERLEUKIN (HD-IL2)</td>
<td class="gt_row gt_center">169 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC MYXOFIBROSARCOMA, TO LEFT LUNG &amp; PLEURA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC OVARIAN CANCER;TELEMETRY</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC PANCREATIC CA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC PANCREATIC CANCER</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC PANCREATIC CANCER TO LIVER/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC PRIMARY UNKNOWN</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RECTAL CA,R/O SPINAL CORD COMPRESSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RECTAL CANCER TO LIVER/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RECTAL CANCER; BILE DUCT OBSTRUCTION\PLACEMENT OF METALLIC STENT TO BILE DUCT **REMOTE WEST -- INR SUITE**/SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CA-SPINAL MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CARCINOMA&#39;</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CANCER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CANCER RIGHT FEMUR/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA\CHEMOTHERAPY (HD-IL2)</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA\CHEMOTHERAPY INTERLEUKIN (HD-IL2)</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA\INTERLEUKIN (HD-IL2)</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA\INTERLEUKIN CHEMOTHERAPY (HD-IL2)</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA\INTERLEUKIN HD-IL2</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC RENAL CELL CARCINOMA\INTERLEUKIN HIGH DOSE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC SARCOMA;SUPERIOR VENAL CAV SYNDROME</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC SQUAMOS CELL RIGHT NECK/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC SQUAMOUS CELL CANCER</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC THRYOID CA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIC THYROID CANCER</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTATIS CANCER</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTIC MELANOMA;ANEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METASTSTIC SARCOMA/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METATASTIC BRAIN TUMOR</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METATASTIC CARCINOID TUMOR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METATASTIC LEFT NECK MELANOMA; THYROID CA/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METHADONE OVERDOSE</td>
<td class="gt_row gt_center">143 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METHEMOGLOBINEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METHEMOGLOBINEMIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METHICILLIN RESISTANT STAPH AUREUS;FEVER;HYPOTENSION;TELEMETRY</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METHICILLIN RESISTANT STAPH AUREUS;SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METHYLGLOBLUIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METISTATIC LEIOMYOSARCOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METRAL STENOSIS\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METS BRAIN CA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METS CA,PLEURAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">METS TO BRAIN/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MG CRISIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI</td>
<td class="gt_row gt_center">2,631 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI CHF</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI ST ELEVATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI-UTI-PNEUMONIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI, CHF</td>
<td class="gt_row gt_center">415 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI,CHF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI,CHF,CRI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI,RESPIRATORY DISTRESS LOW CRIT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI,RIGHT IJ CLOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI; PNEUMONIA; CHF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI/CARDIAC ARREST\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI/CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI/CHF</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI/DKA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI/PE</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI/S/P TRANSPLANT\CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI\CATH</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MI\L HEART CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIDDLE CEREBRAL ARTERY ANEURYSM</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIDDLE CEREBRAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIDGUT VOLVULUS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIDLINE HERNIA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIGRAINE HEADACHE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MILD ABDOMINAL PAIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MINIMALLY INVASIVE OVAL</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MIRRIZI SYNDROME/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MISFIRING AICD</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITAL VALVE AND AORTIC STENOSIS\ AORTIC AND MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITAL VALVE DISORDER\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITAL VALVE INSUFFICENCY\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITAL VALVE PROLAPSE\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRA\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL &amp; AORTIC STENOSIS\ AORTIC VALVE REPLACEMENT; CABG W/MITRAL VALVE REPLACEMENT &amp; MAZE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL AND AORTIC VALVES INSUFFICIENCY\CATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\MITRAL VALVE REPLACEMENT ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\MITRAL VALVE REPLACEMENT / TVR ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\MITRAL VALVE REPLACEMENT VERSUS REPAIR </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL DISORDER\MITRAL VALVE REPLACEMENT; ? TRICUSPID VALVE REPLACEMENT; ? PATENT FORAMEN OVALE; ? AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICENCY\MITRAL VALVE REPLACEMENT, COMCOMITANT MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICENCY\MVR, ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\CORONARY ARTERY BYPASS GRAFT WITH MVR </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPAIR VS REPLACEMENT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPAIR; ? EPLACEMENT; MINIMALLY INVASIVE; ? STERNOTOMY  </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPAIR; ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPAIR; ? REPLACEMENT VIA STERNOTOMY OR MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPLACEMENT / MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPLACEMENT; ? REDO AORTIC VALVE REPLACEMENT VIA REDO STENOTOMY VS RIGHT THORACOTOMY </td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\MITRAL VALVE REPLACEMENT; ? REPAIR; HEART PORT MINIMALLY INVASIVE; PERCUTANEOUS FEMORAL CANNULATION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\RE STERNOTOMY VS RIGHT THORACOTOMY; MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL INSUFFICIENCY\SEPTAL MYOMECTOMY ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGUGITATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURG</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURG;RHEUMATIC HEART DISEASE\RIGHT HEART CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGE;TRICUSPID REGURGE</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGETATION\MITRAL VALVE REPLACEMENT; HEART PORT MINMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATIO\ REDO MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION</td>
<td class="gt_row gt_center">1,891 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION &amp; CAD\CORONARY ARTERY BYPASS GRAFT WITH MVR; ? MAZE PROCEDURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION &amp; RENAL INSUFFICIENY\MITRAL VALVE REPLACEMENT  W/ ? MAZE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION;AORTIC INSUFFICIENCY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION;CHF</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION;RECENT IMI;+ETT\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION;SHORTNESS OF BREATH\CARDIAC CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION;TRICUSPID REGURGITATION;AORTIC INSUFFICIENCY\SWAN GANZ CATHETER PLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\ AORTIC &amp; MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\ MITRAL VALVE REPLACEMENT HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\ MITRAL VALVE REPLACEMENT REDO VIA RIGHT THORACOTOMY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\ MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\ MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\ MITRAL VALVE REPLACEMENT; POSSIBLE CORONARY ARTERY BYPASS GRAFT; POSSIBLE RESECTION SUB AORTIC MUSCLE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\AORTIC AND MITRAL VALVE REPLACEMENT; PULMONIC VALVE REPLACEMENT; VENTRICULAR SEPTAL DEFECT CLOSURE; RE-DO X 2/SDA</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\AORTIC VALVE REPLACEMENT  ? MITRAL VALVE REPLACEMENT  ASCENDING AORTA  ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\AORTIC VALVE REPLACEMENT;  TRICUSTID VALVE REPLACEMENT; ? OF A MAZE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\BENTALL PROCEDURE; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CARDIAC CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">350 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CARDIAC CATHETERIZATION MITRAL VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CATH</td>
<td class="gt_row gt_center">119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CATH/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT WITH MVR </td>
<td class="gt_row gt_center">211 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\CORONARY ARTERY BYPASS GRAFT WITH MVR W/MAZE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MINI MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MINIMALLY INVASIVE MITRAL VALVE REPAIR VS REPLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MINIMALLY INVASIVE MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MINIMALLY INVASIVE REPAIR VS MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPAIR VS REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPAIR VS REPLACEMENT;CONMANINT MAZE/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPAIR; ? REPLACEMENT/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">249 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT  CORONARY ARTERY BYPASS GRAFT REDO </td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">416 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT &amp; TVR ? CORONARY ARTERY BYPASS GRAFT;REDO STERNOTOMY</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE </td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT REDO AND VRA THORACOTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT VS REPAIR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT, HEART PORT MINIMALLY INVASIVE VS STERNOTOMY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE w/ MAZE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; ? AORTIC VALVE REPLACEMENT MAZE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; ? MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; MAZE PROCEDURE; LLA LIGATION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; MAZE; LEFT ATRIAL APPENDAGE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; W/MAZE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT; W/RIGHT THORACTOMY MAZE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT;DAVID PROCEDURE /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT: ? TRICUSPID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT/CONCOMITANT MAZE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT/REPAIR </td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT/REPAIR HEART PORT MINIMALLY INVASIVE VS STERNOTOMY/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MVR; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\MVR/AVR AND MAZE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\REDO STENOTOMY/MITRAL VALVE REPAIR; ? TRICUSPID REPAIR; ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">695 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\REPAIR ANOMALOUS PULMONARY VEIN; ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\REPAIR ATRIAL SEPTAL DEFECT  MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\RIGHT AND LEFT CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURGITATION\SEPTAL MYOMECTOMY ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL REGURITATION\ MVR; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS \MITRAL VALVE REPAIR VERSUS PLACEMENT ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS FOR CABG</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS;ATRIAL FIBRILLATION\CATHETERIZATION;INITIATION OF ANTIARRHYTHMIC MEDICATION DOFETILIDE/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS;INTERSTIAL LUNG DISEASE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS;MITRAL REGURGITATION;AORTIC STENOSIS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS;PULMONARY HYPERTENSION</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\ AORTIC &amp; MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\ MITRAL VALVE REPLACEMENT ?  AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\ MITRAL VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\? CORONARY ARTERY BYPASS GRAFT; MVR </td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\ANGIOPLASTY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT  ** NO ASSESSMENT NEEDED **</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\AORTIC VALVE REPLACEMENT, RE-DO;MITRAL VALVE REPLACEMENT; REDO/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\AORTIC VALVE REPLACEMENT?; MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\CATH</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\CORONARY ARTERY BYPASS GRAFT WITH MVR; ? TVR</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\FULL MAZE/ MITRAL VALVE REPLACEMENT/ TRICUSPID VALVE REPLACEMENT; CORONARY ARTERY BYPASS GRAFT   </td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\HEPARIN</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MINIMALLY INVASIVE MICRO VALVE REPLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MINIMALLY INVASIVE VS STERNOTOMY MVR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR ? REPLACEMENT /SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR VERSUS REPLACEMENT; CLOSURE OF ATRIAL SEPTAL DEFECT WITH RESECTION SEPTAL ANEURYSM; ? CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR VS REPLACEMENT /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR VS REPLACEMENT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR, ? REPLACEMENT </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR; TRICUSPID VALVE REPAIR; REDO STERNOTOMY; MAZE   </td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\Mitral Valve Repair/Replace with Concomitant Maze Procedure /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPAIR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT  BENTAL PROCEDURE </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT ? MAZE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">1,876 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT REDO;  ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT REDO; ? TVR   /SDA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT REDO; TVR; ? EPICARDINAL LEAD PLACEMENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT VS REPAIR/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT WITH ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT;  ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT; ? AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT; ? REPAIR; ? MAZE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT; TRICUSPIC VALVE REPLACEMENT; MAZE </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT; TRICUSPID VALVE REPLACEMENT </td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT; W/MAZE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT;? OF AVR;METINANINA LYMP NODE BIOPSY /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT;CORONARY ARTERY BYPASS GRAFT; ?</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT/ MAZE; ? CORONARY ARTERY BYPASS GRAFT WITH </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT/ TRI-CUSPID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE RPAIR VS REPLACEMENT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVE VS REPLACEMENT </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MITRAL VALVULOPLASTY</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\MVR; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\REDO MITRAL VALVE REPLACEMENT &amp; ? AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\REDO MVR ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\REDO/ REDO MITRAL VAVLE REPLACEMENT; ?CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\REPAIR VS REPLACEMENT MITRAL VALVE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL STENOSIS\TRANSESOPHAGEAL ECHOCARDIOGRAM;MITRAL VALVULOPLASTY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALSE INSUFFICIENCY\MITRAL VALVE REPAIR VS REPLACEMENT /SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALUE REPLACEMENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE ABNORMALITY\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DEFICIENCY\MITRAL VALVE REPLACEMENT; TRICUSPIC VALVE REPLACEMENT; ATRIAL SEPTAL DEFECT REPAIR </td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DIFFIENCY\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISEASE</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISEASE\ AORTIC AND MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISEASE\ RE-DO;MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISEASE\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISEASE\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE; ? PATENT FORAMEN OVALE CLOSURE /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER \MITRAL VALVE REPLACEMENT; TRICUSPID VALVE REPLACEMENT; REDO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER \MVR;? TVR;? CORONARY ARTERY BYPASS GRAFT WITH MVR/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER, CORONARY ARTERY DISEASE\CORONARY ARTERY BYPASS GRAFT WITH MVR </td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\? CORONARY ARTERY BYPASS GRAFT;  MVR /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\AORTIC AND MITRAL VALVE REPLACEMENT;   THORACOSCOPIC MAZE PROCEDURE;  BRONCHOSCOPY FLEXIBLE DIAGNOSTIC /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\AORTIC AND MITRAL VALVE REPLACEMENT; ASCENDING AORTA REPLACEMENT; ? TRICUSPID VALVE REPAIR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\CORONARY ARTERY BYPASS GRAFT WITH MVR REDO &amp; REDO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPAIR VERSUS REPLACEMENT; CORONARY ARTERY BYPASS GRAFT; MAZE/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPAIR VS REPLACEMENT ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPAIR VS REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPAIR, ? MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT ; TVR ;AVR</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT REDO; PERI CARDIAL STRIPPING </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT W/ CONCOMITANT MAZE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT WITH TVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT, ? AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT, ? TRICUSPID VALVE REPLACEMENT</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT, HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; ? AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; MAZE </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; TRICUSPIC VALVE REPLACEMENT; MAZE PROCEDURE /SDA</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; TRICUSPID VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; TRISCUPID VALVE REPLACEMENT; LEFT ATRIAL APPENDAGE LIGATION; ? CORONARY ARTERY BYPASS GRAFT; ? MAZE; ? LEFT EPICARDIAL LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; TVR; POSSIBLE LEAD PLACEMENT VIA RIGHT THORACOTOMY VS STERNOTOMY  </td>
<td class="gt_row gt_center">368 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MITRAL VALVE REPLACEMENT; TVR/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MVR  ? CABG ? MAZE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MVR  REPAIR VS REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT; MAZE   /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MVR ? ASCENDING AORTA REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\MVR/ MAZE ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\RE-DO STERNOTOMY MITRAL VALVE REPLACEMENT; TRICUSPID VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE DISORDER\THORACOSCOPIC MAZE PROCEDURE LEFT; MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE ENDOCARDITIS</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE ENDOCARDITIS\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INFECTION;COPD;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFCENCY\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY, CAD\CORONARY ARTERY BYPASS GRAFT WITH MVR, PATENT FORAMEN OVALE, ? AVR </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MITRAL VALVE REPAIR</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MITRAL VALVE REPLACEMENT REDO REDO THORACOTOMY RIGHT</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MITRAL VALVE REPLACEMENT; TRICUSPID VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT, ? MAZE </td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MITRAL VALVE REPLACEMENT;?TRICOUSTID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\MVR, MAZE PROCEDURE, ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICENCY\PERCARDIAL STRIPPING W/ MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY/MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\CORONARY ARTERY BYPASS GRAFT WITH MVR POSSIBLE AVR AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPAIR VS REPLACEMENT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPAIR; ? REPLACEMENT  /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\Mitral Valve Repair/Replace with Concomitant Maze Procedure /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT ? TRICUSPID VALVE REPLACEMENT  </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT MAZE;  ? TRICUSPID VALVE REPLACEMENT </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT REDO; ? AORTIC VALVE REPLACEMENT </td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT W/MAZE; ? CORONARY ARTERY BYPASS GRAFT; RESECTION LEFT ATRIAL APPENDAGE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT; ? TRICUSPID VALVE REPLACMENT; ? MAZE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT; ?MAZE: ? TRICUSPID VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT; MAZE; ?TVR AND AVR </td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT/?CABG/? TRICUSPID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MVR ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENCY\MVR STANDARD - KHABBAZ K  /SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENT\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFICIENTCY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIECIENY\CORONARY ARTERY BYPASS GRAFT WITH MVR  AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIENCY\MINIMALLY INVASIVE MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIENCY\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIENCY\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIENCY\MITRAL VALVE REPLACEMENT W/ MAZE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIENCY\MITRAL VALVE REPLACEMENT W/ MAZE /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE INSUFFIENCY\MVR/ ? CORONARY ARTERY BYPASS; ? MAZE/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE LEAFLET\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE MASS</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE PROLAPSE;NEW ONSET ATRIAL FIBRILLATION\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE PROLAPSE\ MINIMALLY INVASIVE MVR ? OPEN MVR/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE PROLAPSE\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH; HEARTPORT/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE PROLAPSE\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGORDITATION\MITRAL VALVE REPLACEMENT; ?CABG/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURETATI0N\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGETATION\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGETATION\MITRAL VALVE REPLACEMENT; WITH MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITAION\MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION; HYPOXIC PULMONARY HYPERTENSION\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION;VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\ MITRAL VALVE REPLACEMENT HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\ MITRAL VALVE REPLACEMENT REDO; ?AORTIC VALVE REPLACEMENT; TRICUSPID VALVE REPAIR OR REPLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\MITRAL VALVE REPLACEMENT MECHANICAL/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\MITRAL VALVE REPLACEMENT; ? TVR</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURGITATION\REPAIR MITRAL VALVE /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURITATION\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REGURITION\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH; HEART PORT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE RELAPSE\MITRAL VALVE REPAIR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REPLACEMENT;ACCENDING AORTA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE REPLACEMENT\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE RUPTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE STENOSIS; SHORTNESS OF BREATH\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE STENOSIS\MITRAL VALVE REPLACEMENT WITH CONCMITANT MAZE; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE STENOSIS\MITRAL VALVULOPLASTY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VALVE THICKENING</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VASLVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VSLVE DISORDER\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRAL VSLVE DISORDER\MITRAL VALVE REPLACEMENT/MYOMECTOMY/? MAZE/? LEFT ATRIAL APPENDAGE /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRIAL DISORDER\MITRAL VALVE REPLACEMENT; ? SEPTAL MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRO VALVE DISECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITRO VALVE RELAPSE</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MITTAL VALVE INSUFFICIENCY\MITRAL VALVE REPLACEMENT </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MONO</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY AND GALLSTONES/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY, CHOLELITHIASIS/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY, GALLSTONES/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY; CHOLECYSTITIS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY;INCISIONAL HERNIA;GALLSTONES/SDA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY/GALLSTONES/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESITY/SDA</td>
<td class="gt_row gt_center">1,577 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESTIY /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORBID OBESTIY/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MORPHINE OVERDOSE;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR  VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR CYCLE ACCIDENT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR CYCLE COLLISION</td>
<td class="gt_row gt_center">560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICAL CRASH,OPEN ANKLE FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">465 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT WITH UNSPECIFIED INJURIES</td>
<td class="gt_row gt_center">1,170 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT WITH UNSPECIFIED INJURIES;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT WITH UNSPECIFIED INJURIES;LIVER LACERATION;FEMUR FX</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT;BILATERAL PNEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT;PELVIC FRACTURE;RIB FRACTURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT;RIB FRACTURES;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT&#39;</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT\INJURIES</td>
<td class="gt_row gt_center">386 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT\INJURIES;HEAD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE ACCIDENT\INJURIES;TELEMETRY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE COLLISION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE COLLISION;HYPOXIA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE COLLISION;LIVER HEMATOMA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE COLLISION;RIGHT ANKLE FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE COLLISON;? SEIZURES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE CRASH</td>
<td class="gt_row gt_center">101 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTOR VEHICLE CRASH;HYPOTENSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE ACCIDENT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE ACCIDENT ,MBC</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE ACCIDENT SPLENIC LACERATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE ACCIDENT;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE CRASH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE CRASH;LEG FRACTURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MOTORCYCLE CRASH;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR; CAD\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;\MITRAL VALVE REPLACEMENT REDO, WITH MAZE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;AF\MITRAL VALVE REPLACEMENT; MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;AORTIC STENOSIS &amp; INSUFFICIENCY\ AORTIC AND MITRAL VALVE REPLACEMENT; ? BENTAL PROCEDURE/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;AORTIC STENOSIS;AFIB\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT; MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;AORTIC STENOSIS\AORTIC VALVE REPLACEMENT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;AR\ AORTIC &amp; MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;CORONARY ARTERY DISEASE;\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT;TRICUSPID VALVE REPLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR;CORONARY ARTERY DISEASE;AORTIC STENOSIS\AORTIC AND MITRAL VALVE REPLACEMENT,  CORONARY ARTERY BYPASS GRAFT, ASCENDING AORTA REPAIRT /SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR/CHF\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ ? MITRAL VALVE REPLACEMENT; HOMOGRAFT ROOT REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ AORTIC AND MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ BENTAL PROCEDURE REDO; MITRAL VALVE REPLACEMENT W/ TVR/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MINIMALLY INVASIVE WITH HEART PORT; AND ENDOSCOPIC/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MITRAL VALVE PLACEMENT HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MITRAL VALVE REPLACEMENT ; HEART PORT MINIMALLY ; INVASIVE/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MITRAL VALVE REPLACEMENT HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MITRAL VALVE REPLACEMENT REDO WITH TVR ; VIA RIGHT THORACOTOMY/SDA</td>
<td class="gt_row gt_center">306 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MITRAL VALVE REPLACEMENT REDO; ? MAZE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\ REDO MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\AORTIC VALVE REPLACEMENT; ?  CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\AORTIC VALVE REPLACEMENT; ?MVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\AORTIC VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\CORONARY ARTERY BYPASS GRAFT WITH MVR /SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\CORONARY ARTERY BYPASS GRAFT; WITH MVR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\CORONARY ARTERY BYPASS GRAFT;MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\EXCISION OF STERNUM /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE ANNULOPLASTY; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPAIR REPLACEMENT/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH,HEART PORT;CORONARY ARTERY DISEASE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH; HEART PORT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT REDO, ? MYOMECTOMY/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT, ? CORONARY ARTERY BYPASS GRAFT  </td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT, L-VAD BACK-UP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT,HEART PORT MINIMALLY INVASIVE; ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT;  VIA RIGHT THORACOTOMY/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; ? AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT </td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; ?AORTIC VALVE REPLACEMENT; ?CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; ?CABG/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; ASCENDING AORTA TO SUPRACILIAC AORTA BYPASS /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALY INVASIVE/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; HEART PORT, MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; RE-DO/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; REDO</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; REDO WITH MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; REDO; ? CABG/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; REDO/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; VIA STERNOTOMY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT; WITH MAZE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MR\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">442 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MRV\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS CHANGE, DEHYDRATION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS CHANGE,SHOCK</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS CHANGES</td>
<td class="gt_row gt_center">1,760 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS CHANGES AND HYPOTENSION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS CHANGES,HX LUNG CANCER</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS CHANGES;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MS FLARE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MSC;OD;CLOSED HEAD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MTIRAL REGURGITATION\MINIMALLY INVASIVE MITRAL VALVE REPAIR/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MUCOCELE/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MUCUS PLUGGING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULITPLE RIB FRACTURES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULITPLE STAB WOUNDS/PENETRATING TRAUMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULT TRAUMA,S/P MVA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI DRUG OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI LOBAR PNEUMONIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI LOBE PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI MYELOMA;PAIN</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI ORGAN FAILURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI RIB FRACTURE-HYPOXIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI SYSTEM FAILURE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI SYSTEM ORGAN FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI TRAUMA</td>
<td class="gt_row gt_center">173 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI VESSEL CORONARY ARTERY DISEASE;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI-TRAUMA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTI-TRAUMA-S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIFOCAL ATRIAL TACHYCARDIA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIFOCAL HEPATOCELLULAR CA/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIFOCAL MOTOR NEUROPATHY</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIFOCAL PNA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIFOCAL PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIFOCAL PNEUMONIA,COPD,HYPERGLYCEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTILOBAR PNA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTILOBULAR PNEUMONIA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE ARRYTHMIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE DRUG OD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE DRUG OVERDOSE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FACIAL FRACTURES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FALLS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FRACTURE,S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FRACTURE;S/P PED. STRUCK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FRACTURE;S/P PEDESTRIAN V. CAR</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FRACTURES</td>
<td class="gt_row gt_center">103 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FRACTURES,FRONTAL CONTUSIONS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE FRACTURES;S/P PEDESTRIAN STRUCK BY MOTOR VEHICLE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE GUN SHOT WOUNDS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE GUNSHOT WOUNDS</td>
<td class="gt_row gt_center">43 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE ICD CHARGES</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE INGESTIONS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE INJURIES</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA</td>
<td class="gt_row gt_center">361 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;FEVER;NEUTROPENIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;HEPATITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;R/O INFECTION VS BRONCHITIS OBLITERANS WITH ORGANIZED PNEUMONIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;SHORTNESS OF BREATH;MEDIASTINAL MASS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;SPINAL METASTASIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;STATUS POST BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA;TRANSPLANT</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">173 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMA\BONE MARROW TRANSPLANT </td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE MYELOMAS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE PES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE PULMONARY EMBOLI</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE PULMONARY MBOLI</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE RIB FX</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE RIB FXS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE SCLEROSIS</td>
<td class="gt_row gt_center">883 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE SCLEROSIS FLARE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE SCLEROSIS;DEEP VEIN THROMBOSIS;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE SCLEROSIS;UROSEPSIS;SEIZURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE SCLEROSIS/FACIAL PAIN/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE STAB WOUNDS</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE STROKE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMA</td>
<td class="gt_row gt_center">341 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMA, SDH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMA,PLANE CRASH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMA; S/P MOTORCYLE ACCIDENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMA;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMA;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE TRAUMAS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTIPLE VESSEL CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTISYSTEM ORGAN FAILURE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTISYSTEM TRAUMA</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTITRAUMA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MULTITRAUMA;RIB FRACTURES</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MUSCLE WEAKNESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MUTIPLE RIB FRACTURE;RIGHT CLAVICLE FRACTURE;HEMOTHORAX;PNEUMOTHORAX</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MV ENDOCARDITIS\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MV PROLAPSE\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MV\MITRAL VALVE REPLACEMENT; ?MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVA</td>
<td class="gt_row gt_center">461 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVA,HEAD BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVA; HEAD BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVA;CLOSED HEAD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVA;PNEUMOTHORAX</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVA;TRAUMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC L1 FRACTURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC TRAUMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC, FEMUR FX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC, LIVER LAC X 2</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC,PNEUMOTHORAX,RT WRIST FRACTURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVC;PELVIC FRACTURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVD\ MITIRAL VALVE REPAIR VS REPLACEMENT   ? CORONARY ARTERY BYPASS GRAFT    </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVP\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVP\MITRAL VALVE REPLACEMENT; HEART PORT MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVP\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR CABG\MVR CABG</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR, TVR</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR\AORTIC VALVE REPLACEMENT, RE-DO/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR\CORONARY ARTERY BYPASS GRAFT WITH MVR ;TVR</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR\MITRAL VALVE REPAIR? REPLACEMENT ?TVR </td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR\MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR\MITRAL VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MVR\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHEMIA GRAVIS &amp; THYMIC MASS/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA CRISIS</td>
<td class="gt_row gt_center">221 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA EXACERBATION</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA FLARE</td>
<td class="gt_row gt_center">474 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA GRAVID</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA GRAVIS</td>
<td class="gt_row gt_center">926 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA GRAVIS CRISIS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA GRAVIS;TELEMETRY</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIA GRAVIS/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIC CRISIS</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHENIC GRAVIS</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYASTHESNIA GRAVIA;VENTRAL HERNIA</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYCOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYCOPLASMA;PNEUMONIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYCOTIC ANEURYSM</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELITIS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASIA;BONE MARROW TRANSPLANT/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASIA;FEVER</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASTIC SYNDROME</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASTIC SYNDROME;FEVER;LOW BLOOD COUNT</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASTIC SYNDROME\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASTIC SYNDROME\BONE MARROW TRANSPLANT </td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLASTIC SYNDROME\CHEMOTHERAPY</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELODYSPLATIC SYNDROME;ACUTE MYELOGENOUS LEUKEMIA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELOFIBROSIS\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYELOMA;SEVERE ANEMIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYESTEMIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYESTHENIA GRAVIS EXACERBATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYESTHENIA GRAVIS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYESTHENIC CRISIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFACTION/CHF/RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCT;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCT;HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCT;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCT;SEPSIS;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCT;TELEMETRY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">8,072 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION S/P CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION-ATRIAL FLUTTER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION-RENAL FAILURE-ANEMIA</td>
<td class="gt_row gt_center">588 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION-SEPSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION,ACUTE RENAL DISEASE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION,PULMONARY EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION; CARDIOGENIC SHOCK\CATH</td>
<td class="gt_row gt_center">385 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION; CHEST PAIN\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION; CONGESTIVE HEART FAILURE\BIVENTRICULAR PACEMAKER</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION; CONGESTIVE HEART FAILURE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;+ETT\CATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;ACUTE CORONARY SYNDROME\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;ANGINA\CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;ATRIAL FLUTTER\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CHRONIC RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">490 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE\CORONARY STENT PLACEMENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;DIZZINESS\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;DYSPNEA\CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;GI BLEED</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;HEART ATTACK;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;HYPOXIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;LEFT HIP FRACTURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;LOWER VALVE THROMBUS\CATH</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;MYOCARDITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;PNEUMONIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;PULMONARY EDEMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;PULMONARY EDEMA\CATH</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;RENAL FAILURE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;S/P ARREST</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;S/P CARDIAC ARREST\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;SEVERE AORTIC STENOSIS;ALCOHOL ABUSE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;STROKE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;UNSTABLE ANGINA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;UNSTABLE ANGINA\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;V-FIB ARREST</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION;VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION/CARDIAC CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION/CATH</td>
<td class="gt_row gt_center">582 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION/CHEST PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION/FAILURE TO THRIVE</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION/PNEUMONIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\ CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\ANGIOPLASTY</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">537 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\CARDICA CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">2,061 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\CATHETERIZATION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\LEFT HEART CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFRACTION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFRARTION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL INFRCTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDIAL ISCHEMIA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYOCARDITIS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYXEDEMA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYXOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYXOMA\ ATRIAL MYXOMA REMOVAL/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYXOMA\EXCISION LEFT ATRIAL MASS/MYXOMA /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">MYXOMA\REMOVAL LEFT ATRIAL MASS, MYXOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N STEMI</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N;V</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N. STEMI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N/V</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N/V, HYPERGLYCEMIA,NEW ONSET A-FIB</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N/V/D</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N/V/D ; PNEUMONIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">N/V/D, HYPOTENSION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NARCOTIC OVERDOSE</td>
<td class="gt_row gt_center">953 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NARROW ENDOCRINE TUMOR OF PANCREAS/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NARROWING OF AIRWAY</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NASAL NASOPHARYNGEAL BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NASAL POLYPS LEFT;PULMONARY EDEMA\SINUS SURGERY ENDOSCOPIC CT GUIDED WITH SEPTOPLASTY; LEFT NASAL POLYPECTOMY</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NASOPHARNGEAL CA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NASOPHARYNGEAL CARCINOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NASOPHARYNGEAL MASS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSA VOMITING</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSA,VOMITING</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA</td>
<td class="gt_row gt_center">3,185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA AND VOMITING</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA VOMITING WEAKNESS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W/VOMITING</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITING</td>
<td class="gt_row gt_center">3,712 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITING;DIARRHEA;FEVER,ETIOLOGY UNKNOWN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITING;ELEVATED LFTS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITING;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITING;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">388 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITING;MYALGIAS</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA W\VOMITTING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA WITH JAUNDICE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA-HEADACHE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA-VOMITING</td>
<td class="gt_row gt_center">31,231 (0.4%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA-VOMITING-HYPERGLYCEMIA-INCREASED WBC</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA, DYSPNEA</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA, VOMITING/CHOLONGITIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA, VOMITTING</td>
<td class="gt_row gt_center">376 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA,UNABLE TO TAKE PO</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA,VOMITING</td>
<td class="gt_row gt_center">15,615 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA,VOMITING,ABD PAIN,?UTI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA,VOMITING,CHOLECYSTITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA,VOMITING,DEHYDRATION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA,VOMITING,DIARRHEA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA; VOMITING; ABD PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA; VOMITING; RENAL FAILURE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA; VOMITTING</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;HEADACHE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING</td>
<td class="gt_row gt_center">9,627 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING; IMBALANCE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING;ALCOHOL WITHDRAWAL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING;DEHYDRATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING;DIARRHEA</td>
<td class="gt_row gt_center">757 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING;JAUNDICE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITING;S/P ABSCESS DRAINAGE</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA;VOMITTING; HYPOTENSION</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA/VOMITING</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA/VOMITING,GASTROPARESIS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NAUSEA/VOMITING,S/P TRANSPLANT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NBB</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEAR DROWNING</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEAR SYNCOPE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEAR SYNCOPE;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEAR SYNCOPE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEC PANCREATITIS</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK ABSCESS</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK CELLULITIS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK EDEMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK FX;HAND WOUND</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK HEMATOMA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK INFECTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK INJURY;?CHEST INJURY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK LACERATION</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK MASS</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK MASS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PAIN</td>
<td class="gt_row gt_center">3,458 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PAIN; ?CORD COMPRESSION ON MR</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PAIN;? EPIDURAL ABSCESS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PAIN;METS TO C-SPINE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PAIN;POSSIBLE INFECTION</td>
<td class="gt_row gt_center">3,396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PAIN/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK PHLEGMON</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK SWELLING</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECK TUMOR</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECRATIZING PANCREATITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC BOWEL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC CALVARIAL BONE FLAP AND CHRONIC SCALP WOUND/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC LEFT GREAT TOE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC MASTITIS OF THE RIGHT BREAST</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC PANCREATITIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC PENIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC TOE</td>
<td class="gt_row gt_center">91 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC TOE LEFT FOOT</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC TOE;PVD</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIC TOES AND ULCERS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTISING PANCREATITIS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTISING PNEUMONIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING CHOLECYSTITIS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCEITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCIATIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCIETIS OF THE ABDOMEN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCIITIS</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCIITIS LEFT LEG</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCILITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCITIS</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCITIS LEFT LEG</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCITITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING FASCITITIS;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING PANCREATITIS</td>
<td class="gt_row gt_center">965 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING PANCREATITIS;ALCOHOL DELIRIUM TREMENS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTIZING SOFT TISSUE OF LEFT LEG</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECROTZING FASCIITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NECTROTIZING FASCIITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEED GI SCOPE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEEDS CASPOFUNGIN DESENSITIVITY</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEEDS FLUCONAZOLE DESENSITIVITY</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEOPLASM OF HEART\ATRIAL MYXOMA REMOVAL ? TRICUSIP VALVE REPAIR; ? MITRAL VALVE RAPAIR;? PULMONARY EMBOLECTOMY  /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEOPLASM OF LEFT RETRO PERITONEAL /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER LYMPHATIC AND HEMATOPOIETIC TISSUES\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEOPLASM SOFT TISSUE HEAD/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEPHROLITHIASIS</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEPHROLITHIASIS, RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEPHROLITHIASIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEPHROLITHIASIS;PYELONEPHRITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NESOTHELIOMA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUMONIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEURO SYPHILIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROCYSTERCYCOSIS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROCYSTICERCOSIS W/CYST/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROENDOCRINE TUMOR OF LIVER AND PANCREAS/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROGENIC BLADDER/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROGENIC SHOCK TRAUMA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROLEPTIC MALIGNANT SYNDROME</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROLOGIC SYMPTOMS; ABMORMAL MRI</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROPATHY</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROSAICOIODOSIS</td>
<td class="gt_row gt_center">280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUROSYPHILLIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA</td>
<td class="gt_row gt_center">965 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA,CHEST PAIN</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA; HYPOMATREMIA; METASTIC BREAST CANCER</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;ANEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;DIARRHEA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;ESOPHEGEAL CANCER</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;HYPOTENSION</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;SEIZURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;SEPSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIA;THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIC FEVER</td>
<td class="gt_row gt_center">1,150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIC FEVER;? PNEUMONIA</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIC FEVER;HYPOTENSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIC FEVERS</td>
<td class="gt_row gt_center">356 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEUTROPENIC;WEAKNESS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW A-FIB,CHF</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW AFIB;FLUTTER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW AFIB/PNA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW BRAIN MASS</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW BRAIN MASS AND LUNG LESION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW BRAIN MASS, CONFUSION, SEIZURES</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW CHF</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW CVA</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW CVA; ESRD</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW DEPRESSED EJECTION FRACTION; CONGESTIVE HEART FAILURE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW DIAGNOSIS LEUKEMIA</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW DILATED CARDIOMYOPATHY\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW DVT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW FISTULA</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW LEFT BUNDLE BRANCH BLOCK;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW LEUKEMIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW MASS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET AFIB;;LEG PAIN;HYPOXIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET AFIB;SOB</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET ANGINA;POSSIBLE AORTIC STENOSIS\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET ANGINA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET CGEST PAIN\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET CHF</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET CHF;BRADYCARDIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET DIABETES</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET JAUNDICE, ENCEPHALOPATHY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET OF EXERTIONAL CHEST PAIN;CARDIAC ISCHEMIA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET SEIZURE;BRAIN LESION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET SEIZURES</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW ONSET SEIZURES;BRAIN METS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEW RENAL FAILURE;HYPERKALEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NEWBORN</td>
<td class="gt_row gt_center">35,624 (0.5%)</td></tr>
    <tr><td class="gt_row gt_left">NEWLY DIAGNOSED BRAIN MASS;LACKS CAPACITY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NICKED BILE DUCT;CHEST PAIN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NO ST ELEVATION MI,PANCREATITIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NODULAR HISTIOCYTIC LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NOM HODGKIN&#39;S LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING LEFT LEG ULCER</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING LEFT LOWER EXTREMITY ULCER</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING LEG ULCER</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING RIGHT FOOT ULCER</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER</td>
<td class="gt_row gt_center">291 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER LEFT FOOT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER LEFT LEG</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER LEFT LEG EXTREMITIES</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER LEFT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">368 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER OF RIGHT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER RIGHT LEG</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER RIGHT LOWER EXTREMIOTY</td>
<td class="gt_row gt_center">576 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER RIGHT LOWER EXTREMITY/SDA</td>
<td class="gt_row gt_center">1,224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER, RIGHT FOOT</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER, RIGHT LEG/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER;ANGIOPLASTY;TENT PLACEMENT</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCER/SDA</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING ULCERS</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING WOUND RIGHT AXILLARY/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HEALING WOUND/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HODGKIN&#39;S LYMPHOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HODGKIN&#39;S LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HODGKIN&#39;S LYMPHOMA\CHEMOTHERAPY</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HODGKINS LYMPHOMA</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HODGKINS LYMPHOMA-SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON HODGKINS LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ISCHEMIC CARDIOMYOPATHY; CONGESTIVE HEART FAILURE\RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ISCHEMIC CARDIOMYOPATHY\IMPLANTABLE CARDIOVERTER DEFIBRILLATOR UPGRADE TO BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ISCHEMIC CARDIOMYPATHY;STATUS POST VENTRICULAR FIBRILLATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ISCHEMIC IDIOPATHIC CARDIOMYOPATHY</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON KETOTIC DIABETIC HYPERGLYCEMIA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON MELANOMA NEOPLASM OF THE FACE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI</td>
<td class="gt_row gt_center">83 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;+ETT\CATH</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;COPD;GI BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;PULMONART EDEMA\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI;VTACH\CATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MI\CATH</td>
<td class="gt_row gt_center">673 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q MU;UROSEPSIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MI</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MI;HYPOTENSION\CATH</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MI\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MI\CATH</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFACTION\CARDIAC CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFARCTION;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q WAVE MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q-WAVE MI,S/P CABG</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON Q-WAVE MI;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON QWAVE MI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON S-T ELEVATION MI;CONGESTIVE HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON S-T ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON SMALL CELL CANCER;HYPOXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON SMALL CELL CARCINOMA/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON SMALL CELL LUNG CANCER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON SMALL CELL LUNG CANCER;ESOPHAGEAL STRUCTURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATED MI; SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATED MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">83 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATED MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MI</td>
<td class="gt_row gt_center">999 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MI, CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MI;FEMUR FRACTURE;ANEMIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MI\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">134 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION; RECURRENT ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION;ACUTE CORONARY SYNDROME;CHEST PAIN\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION;CHRONIC RENAL INSUFFICIENCY\CATH</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE\INTRA AORTIC BALLON PUMP</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION/CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST ELEVATION MYOICARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST MI</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST MI\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST SEGMENT MI</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON ST SEGMENT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON STE MI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON STE MI,URINARY TRACT INFECTION,INTRAPARYNCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON STE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON STEMI MI</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON STEN ELECTRICAL MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON SUSTAINED VENTRICULAR TACHYCARDIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON UNION FRACTURE, LEFT FEMUR/SDA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON VIABLE LEG</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON- HEALING LEFT LOWER EXTREMITY ULCER</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING LEFT LEG ULCER</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING RIGHT FOOT ULCER;DIABETES MELLITUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING RIGHT FOOT ULCER\PERIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING ULCER</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING ULCER LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING ULCER RIGHT FIRST TOE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HEALING ULCER/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HODGKIN LYMPHOMA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HODGKIN&#39;S LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HODGKIN&#39;S LYMPHOMIA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HODGKINS LYMPHOMA;FEBRILE;NEUTROPENIA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HODGKINS LYMPHOMA\BONE MARROW TRANSPLANT</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-HODGKINS&#39;S DISEASE</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-INSULIN DEPENDANT DIABETES MELLITUS;COAGULOPATHY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q WAVE MI</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q WAVE MI;CONGESTIVE HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q WAVE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q-WAVE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">307 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q-WAVE MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q-WAVE MYOCARDIAL INFARCTION\LEFT HEART CATH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q-WAVE MYOCARDIAL INFARCTION\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-Q-WAVE MYOCARDIAL INFARTION\CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYCOARDIAL INFRACTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">3,932 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;ATRIAL FIBRILLATION;HYPOTENSION\CARDIAC CATH</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">652 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE;PNA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;COPD EXACERBATION</td>
<td class="gt_row gt_center">184 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;GI BLEED ;PNEUMONIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;PERIPHERAL VASCULAR DISEASE;ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;PEUMONIA\CATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;PNEUMONIA\CARDIAC CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;STROKE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;TELEMETRY\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">704 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST-ELEVATION MYOCARDIAL INFARCTION; CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST-ELEVATION MYOCARDIAL INFARCTION; CONGESTIVE HEART FAILURE </td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-ST-ELEVATION MYOCARDIAL INFARCTION;SYNCOPE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-STEM MI/INFLUENZA/PNA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-STRESS ELEVATED MI</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-SURGICAL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-UNION LEFT HIP FRACTURE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON-UNION, LEFT FEMUR FRACTURE\REPAIR NON-UNION LEFT HIP  **C-ARM**</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NON0Q0WAVE MYOCARDIAL INFARCTION;HYPOTENSION\CARDIAC CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NONHEALING ULCER LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NONHEALING ULCERS R LEG,SEVERE ISCHEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NONHODGKINS LYMPHOMA/FEVER</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NONQ WAVE MI</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NONRUPTED CEREBRAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NONUNION T12-L1/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NORMAL PREGNANCY</td>
<td class="gt_row gt_center">182 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NORMAL PRESSURE HYDROCEPHALUS</td>
<td class="gt_row gt_center">444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NORMAL PRESSURE HYDROCEPHALUS/SDA</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NOSE BLEED</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NOT RESPONSIVE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NQW MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NQWMI,CRI,AS,CHF\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEM;? ENDOCARDITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI</td>
<td class="gt_row gt_center">277 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI AND SAH</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI-PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI;ACUTE SPINE FRACTURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI;HIP FRACTURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI/CHF EXACERBATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI/DKA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMI/HYPOTENSION</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NSTEMYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NUERO SARCOIDOSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NUMBNESS IN LIP</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NUMBNESS/WEAKNESS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">NUTRITIONAL DEFICIT,WEIGHT LOSS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OA BILATERAL KNEE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OA LEFT HIP/SDA</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OA LEFT KNEE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OA LEFT KNEE/SDA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OA RIGHT HIP/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OA RIGHT KNEE/SDA</td>
<td class="gt_row gt_center">351 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBESE;DIABETES MELLITUS;CORONARY ARTERY DISEASE;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTED CBD</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTED COLON</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTED KIDNEY STONE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTED RENAL STONE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTED RIGHT MIDDLE LOBE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTING RECTAL CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTING RENAL STONE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTING RENAL STONE;URINARY TRACT INFECTION;PYELONEPHRITIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTION</td>
<td class="gt_row gt_center">331 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTION,NAUSA, VOMITING</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIUE JAUNDICE\ ERCP; STONEHAM ONE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE AIRWAY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY\ETHANOL SEPTAL ABLATION/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE JAUNDICE</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE JAUNDICE;CHOLANGIOCARCINOMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE JAUNDICE;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE JAUNDICE\ERCP</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE JAUNDICE\ERCP </td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE PNEUMONIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE SLEEP APNEA /SDA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBSTRUCTIVE SLEEP APNEA; SOFT PALATE LESION; NASAL &amp; TONSILLAR HYPERTROPHY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OBTUNDED</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCAINE CHEST PAIN;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">5,740 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCIPITAL FRACTURE;SUBARACHNOID HEMATOMA;SYNCOPE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCIPITAL MASS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCIPITAL TUMOR/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED AV GRAFT</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED CELIAC ARTERY/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED FEM FEM GRAFT</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED FEMORAL GRAFT</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED GRAFT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED RIGHT CORONARY ARTERY LESION\RIGHT CORONARY ARTERY INTERVENTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED RIGHT FEMORAL VEIN\ANGIOPLASTY; RIGHT FEMORAL/SDA</td>
<td class="gt_row gt_center">1,500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED RIGHT LEG</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUDED T TUBE</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OCCLUSIVE DISEASE RIGHT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OD HEPATIC FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OD,ALTERED MS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OD/DKA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OD/HYPOVOLEMIA</td>
<td class="gt_row gt_center">462 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OD/UNRESPONSIVE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ODONTOID FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ODYNOPHAGIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OGILVE&#39;S SYNDROME</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OGILVIE&#39;S SYNDROME</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OGILVIE&#39;S SYNDROME, R.O PNEUMONIA</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OLIGODENDROGLIOMA RIGHT /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ONGOING ANGINA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OOZING BELOW KNEE AMPUTATION</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN ABDOMEN</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN ABDOMINAL WOUND/SDA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN CHEST WOUK\DEBRIDEMENT STERNUM WITH FLAP/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN DISTAL ULNAR FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN FRACTURE, NULTIPLE SPINE FRACTURES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN FRACTURE,LEFT LEG</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN LEFT KNEE FX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN LEFT TIB FIB FRACTURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN LEFT TIBIA FIB FX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN RADIAL FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN SKULL FRACTURE-FACIAL SMASH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN TIB/FIB FRACTURE</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND ABDOMINAL WALL/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND BILATERAL LEGS/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND CHEST</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND CHEST WALL/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND CHEST/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND LEFT FOOT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND LEFT HAND/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND OF CHEST/SDA</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND OF RIGHT LEG/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND OF THE SACRUM/SDA</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND ON SKULL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND RIGHT FOOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND RIGHT HEEL/SDA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND RIGHT LEG</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND SCALP</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND SCALP/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND TO CHEST/SDA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND, CHEST/SDA</td>
<td class="gt_row gt_center">1,176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND, RIGHT FACE/SDA</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND,RIGHT FOOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPEN WOUND;S/P MOH&#39;S SURGERY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPIATE INTOXICATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPIATE OVERDOSE</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPIATE TOXICITY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPIATE WITHDRAWEL</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPIOD OVERDOSE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OPOID WITHDRAWAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORAL ABSCESS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORAL BLEEDING</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORAL SWELLING</td>
<td class="gt_row gt_center">184 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORAL TOUNGUE CANCER RIGHT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORBITAL FLOOR FRACTURE LEFT/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORBITAL FRACTURES/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORBITAL MENINGIOMA, LEFT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORGAN DONOR</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORGAN DONOR </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORGAN DONOR ACCOUNT</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORGANOPHOSPHATE OVERDOSE</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ORIF LEFT ELBOW;EXP LAPAROTOMY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OROPHARYNGEAL BLEEDING</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OROPHARYNGEAL MASS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OROPHARYNX BURN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEMOYELITIS</td>
<td class="gt_row gt_center">1,280 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEMYLITIS RIGHT FOOT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEO SARCOMA LEFT DISTAL FEMUR/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS BILATERAL KNEES/SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS LEFT HIP/SDA</td>
<td class="gt_row gt_center">483 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS LEFT KNEE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS LEFT KNEE\LEFT KNEE ARTHROPLASTY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS LEFTKNEE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS RIGHT KNEE/SDA</td>
<td class="gt_row gt_center">382 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS, BILATERAL KNEES/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS, LEFT SHOULDER/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITIS, RIGHT KNEE/SDA</td>
<td class="gt_row gt_center">133 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOARTHRITS, BILATERAL KNEES/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOLYSIS  LEFT ACETABULUM &amp; FEMUR/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS</td>
<td class="gt_row gt_center">717 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS C5,C6</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS LEFT FOOT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS LEFT HIP/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS RIGHT FOOT</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS T12-L1</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS W/EPIDERAL EMPYEMA PARA/SDA</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS, RIGHT LEG</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS; LEFT UPPER LOBE LUNG CANCER/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS;ANKLE FRACTURE</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS;ANTIBIOTIC THERAPY;DIALYSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS/SDA</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYELITIS\BILATERAL LEG ANGIOGRAM</td>
<td class="gt_row gt_center">208 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYLELITIS SPINE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYLITIS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYLITIS 2ND LEFT DIGIT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYLITIS AND CELLULITIS OF LEFT FOOT</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYLITIS LEFT KNEE/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYLITIS;SEPSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOMYOLITIS LEFT SECOND TOE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEONECROSIS LEFT MAXILLA/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEORADIONECROSIS OF MANDIBLE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEOSARCOMA RIGHT PROXIMAL FEMUR/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTEROARTHRITIS OF LEFT WRIST/SDA</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTIUM SECONDUM TYPE ATRIAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OSTOMY/SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OTHER MACHANIC COMP OF OTHER INTERNAL ORTHOPEDIC DEVICE IMPLANTS AND GRAFTS/SDA</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CA; ASCITES</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CA/SDA</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER;ACUTE RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER;BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER;NAUSEA;VOMITTING;RULE OUT OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER;NEUTROPENIC;HYPOTENSION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER;SOB;ASCITES</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER/SDA</td>
<td class="gt_row gt_center">191 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER\CHEMO/CYCLE OF CARBOPLATIN AND PACLITAXEL</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN CANCER\CHEMOTHERAPY</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN HYPER STIMULATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN HYPERSTIMULATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN MASS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN MASS;? SBO</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVARIAN MASS;PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVER DOSE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVER DOSE,HYPOXIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVER DOSE(TYLENOL AND KLONOPIN)</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVER DOSE/SUICIDAL IDEATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE</td>
<td class="gt_row gt_center">13,037 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE OF BUSPAR &amp; ORPHENADRINE CITRATE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE ON DEPAKOTE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE ON ECSTASY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE-RIGHT PARIETAL MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE, SEPSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE,ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE,TRICYCLIC ANTIDEPRESSANT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE; ASPIRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;APNEA;TELEMETRY</td>
<td class="gt_row gt_center">258 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;ARDS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;CHANGE IN MENTAL STATUS;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;HYPOTENSION</td>
<td class="gt_row gt_center">149 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;R/O MENINGITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;S/P FALL</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;SUICIDAL IDEATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE;TELEMETRY</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE/ SUICIDIAL IDEATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERDOSE/HYPOXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OVERMEDICATED</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">OXYCONTIN OVERDOSE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER ASSESSMENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER ESTRACTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER FAILURE; TEMPORARY PACING WIRE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER INFECTION\PACEMAKER &amp; LEAD EXTRACTION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER INSTALLATION\ LEFT VENTRICULAR LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER PLACEMENT\ LEFT VENTRICULAR LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACEMAKER REVISION</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACER EROSION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACER LEAD INFECTION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACER MALFUNCTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PACREATITIS/SEPSIS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAIN</td>
<td class="gt_row gt_center">381 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAIN CONTROL</td>
<td class="gt_row gt_center">642 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAIN CONTROL,S/P VIDEO ASSISTED THORACOSCOPY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINFUL HARDWARE LEFT KNEE/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINFUL HARDWARE RIGHT FOOT/SDA</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINFUL RIGHT TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINFUL RIGHT TOTAL HIP/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINLESS JAUNDICE</td>
<td class="gt_row gt_center">115 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINLESS JAUNDICE ; BILIARY OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAINLESS JAUNDICE AND WEIGHT LOSS</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PALATE CANCER/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PALPATATIONS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PALPITATIONS</td>
<td class="gt_row gt_center">1,530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PALPITATIONS, SOB, ATRIAL MYXOMA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PALPITATIONS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAN COLITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAN,ARF</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAN;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCEREATITIS\ERCP</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCOAST TUMOR/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCOLITIS</td>
<td class="gt_row gt_center">194 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCRATITIS</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREACYSTIC MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREAS CANCER/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREAS FAILURE</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREAS KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">924 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREAS TX</td>
<td class="gt_row gt_center">270 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC  CYST/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC ABCESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC ABSCESS</td>
<td class="gt_row gt_center">421 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CA/SDA</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CA\ASSESS BILIARY STRICTURES **REMOTE WEST**</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER;BILE DUCT OBSTRUCTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER;EDEMA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER;FEBRILE NEUTROPENIA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER;GASTRIC OUTLET OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER;RAPID ATRIA; FIBRILLATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER;RESPIRATORY FAILURE\WHIPPLE PROCEDURE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER/SDA</td>
<td class="gt_row gt_center">553 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CANCER\CHEMO EMBOLIZATION LIVER/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC COLONIC FISTULA</td>
<td class="gt_row gt_center">444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CYST</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CYST PLANNED WHIPPLE PROCEDURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CYST/SDA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CYST\ERCP </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC CYST\EUS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC DUCT CANCER/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC DUODENAL ANEURYSM</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC FAILURE</td>
<td class="gt_row gt_center">369 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC FISTULA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC FISTULA;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">450 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC HEAD CANCER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC MASS</td>
<td class="gt_row gt_center">331 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC MASS /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC MASS;CHOLECYSTITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC MASS/SDA</td>
<td class="gt_row gt_center">1,402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC MASS\EUS</td>
<td class="gt_row gt_center">1,503 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC NECROSIS</td>
<td class="gt_row gt_center">154 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC PSEDUDAL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC PSEUDOCYST</td>
<td class="gt_row gt_center">877 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC PSEUDOCYST/SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC PSUEDO CYST</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC TAIL MASS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC TAIL MASS/SDA</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC TRANSPLANT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC TUMOR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC TUMOR, ? LIVER METS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATIC TUMOR/SDA</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS</td>
<td class="gt_row gt_center">24,711 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS &amp; BILIARY STRICTURE/SDA</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS-ARDS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS-DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS-GALL STONES</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS-GALLSTONES</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS, BLEED</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS, ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS, HIV</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS,DIABETIC KETO ACIDOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS,GALL STONES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS; SPLENOMEGALY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ACUTE RENAL FAILURE;DIABETIC KETO ACIDOSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ALCOHOL</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;CHOLANGITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;CONGESTIVE HEART FAILURE;A FIB RVR</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;CONGESTIVE HEART FAILURE;PNEUMONIA;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;DTS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;ETOH WITHDRAWL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;FEVER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;GALLSTONE</td>
<td class="gt_row gt_center">172 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;PSEUDOCYST</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;SICK SINUS SYNDROME</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS;TELEMETRY</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS/SDA</td>
<td class="gt_row gt_center">354 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITIS\ERCP</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCREATITS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCYTOPENIA</td>
<td class="gt_row gt_center">1,479 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCYTOPENIA;FEBRILE NEUTROPENIA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCYTOPENIA;PANCREATITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANCYTOPENIA;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">920 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANNUS HEMATOMA</td>
<td class="gt_row gt_center">470 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANNUS ULCERS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANOLITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PANREATITIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAPILLARY RUPTURE</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAESOPHAGEAL HERNIA/SDA</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAESOPHAGEAL HERNIA\LAPARSCOPIC REPAIR PARAESOPHAGEAL HERNIA W/ FUNDOPLICATION; ? OPEN/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAFUSION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAGANGLIONOMA OF ABDOMEN/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARALYSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARANEOPLASTIC NEUROPATHY;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAPHARYNGEAL ABSCESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAPHARYNGEAL MASS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAPHARYNGEAL SPACE INFECTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARAPLEGIA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARASPINAL ABSCESS</td>
<td class="gt_row gt_center">209 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARASTOMAL HERNIA</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARASTOMAL HERNIA LEFT ABDOMEN/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARASTOMAL HERNIA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARATHYROID CANCER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARATONSILLAR ABSCESS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARATRACHEAL MASS/SDA</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARCREATIC TRANSPLANT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARIETAL BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARIETAL MASS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARKINSON DISEASE; ACUTE RELAPSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARKINSON&#39;S DISEASE/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARKINSON&#39;S/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROTID CANCER; HYPERGLYCEMIA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROTID TUMOR/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROTIDITIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROTITIS,PAROTID ABSCESS,NEW DM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROTITIS;MRSA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROXYMAL ATRIAL FIBRILLATION\ATRIOVENTRICULAR JUNCTION ABLATION/ATRIOVENTRICULAR NODE ABLATION</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROXYSMAL ATRIAL AFRIBILLATION\MITRAL VALVE REPLACEMENT (FULL MAZE) /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROXYSMAL ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION **REMOTE WEST** /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PAROXYSMAL VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION  ICD LEAD EXTRACTION/REIMPLANT /SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARSPINAL TUMOR/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARTIAL SBO</td>
<td class="gt_row gt_center">2,440 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARTIAL SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARTIAL SMALL BOWEL OBSTRUCTION;RECTAL CANCER</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PARTIAL THUMB AMPUTATION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATENT FORAMAN OVALE\ PATENT FORAMEN OVALE MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATENT FORAMEN OVALE</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATENT FORAMEN OVALE\PATENT FORAMEN OVALE CLOSURE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATENT FORAMEN OVALE\PATENT FORAMEN OVALE MINIMALLY INVASIVE </td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATHOLOGIC FRACTURE OF MANDIBLE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATHOLOGICAL FRACTURE, L1/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATHOLOGICAL FRACTURES TO SPINE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATIENT FORAMEN OVALE\ PATENT FORAMEN OVALE MINIMALLY INVASIVE/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PATIENT FORAMEN OVALE\ PATIENT FORAMEN OVALE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PCA ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PCN DESENTIZATION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PCOM</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PCOM ANEURYSM/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PCP PNEUMONIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PDA/PREMATURITY</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PDA\ RE-DO RIGHT VENTRICULAR; FLOW RECONSTRUCTION/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PE</td>
<td class="gt_row gt_center">167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PE;AORTIC DISSECTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PE/DVT</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PE/PNA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEA ARREST</td>
<td class="gt_row gt_center">131 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEA ARREST;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEANUT ALLERGIC REACTION;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PED STRUCK</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PED STRUCK; MULTI SYSTEM TRAUMA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PED. STRUCK L2 COMPRESSION FRACTURE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDAL EDEMA,HYPOKALEMIA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESRTRIAN STRUCK, LEG FRACTURES</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRAIN STRUCK</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAL STRUCK</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">977 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK BU MOTORCYCLE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK BY CAR</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK,HEAD INJURY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK,SUBARACHNOID HEMORRHAGE,ANKLE FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK;MULTIPLE TRAUMA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STRUCK;SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN STUCK</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN VS AUTO</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDESTRIAN VS. MOTOR VEHICLE;SUBARACHNOID HEMORRHAGE;C7 JOINT FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDISTRIAN STRUCK</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDISTRIAN STRUCK;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDISTRIAN STRUCK;TELEMETRY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEDISTRIAN STUCK;INFERIOR RAMUS PELVIC FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEERFORATION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC ABSCESS</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC ABSCESS WITH PERFORATED VISCUS;FISTULA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC ADHESIONS AND BREAST CANCER/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC BLEED</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE</td>
<td class="gt_row gt_center">612 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE-S/P PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE,MULTIPLE TRAUMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE; ICH</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE;BLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE;HUMERUS FRACTURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE;HYPOXIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE;S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURE;TELEMETRY</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FRACTURES</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC FX</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC HEMATOMA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC INFECTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC INFLAMMATORY DISEASE;SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC INJURY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC MASS</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC MASS, OVARIAN CA/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC MASS;URINARY RETENTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC MASS/BREAST CANCER/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC MASS/SDA</td>
<td class="gt_row gt_center">643 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC ORGAN PROLAPSE /SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC ORGAN PROLAPSE; STRESS URINARY INCONTINENCE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC ORGAN PROLAPSE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC PAIN</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC PAIN-? OVARIAN TORSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC PAIN/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC PROLAPSE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIC TUMOR/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIS AND BILATERAL WRIST FRACTURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIS FRACTURE</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PELVIS FRACTURE;FACIAL FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEMPHIGUSKIN CONDITION</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PENCARDIAL EFFUSION;HYPOXIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PENETRATING TRAUMA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PENILE CANCER/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PENILE LACERATION-CELLULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEPTIC ULCER DISEASE/VENTRAL HERNIA/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PEPTIC ULCER;HIATIAL HERNIA/SDA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PER OP LIVER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERCARDITIS\ PERICARDECTOMY/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERF APPENDIX</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFED BOWEL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFED DUODENUM</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFERATED CECUM/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFERATION S/P ERCP</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED ANUS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED APPENDIX</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED BILE DUCT</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED BOWEL</td>
<td class="gt_row gt_center">567 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED BOWEL </td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED CHRON&#39;S COLITIS</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED COLON</td>
<td class="gt_row gt_center">1,055 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED DIVERTICULA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED DIVERTICULITIS</td>
<td class="gt_row gt_center">549 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED DIVERTICULITIS/SDA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED DIVERTICULUM</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED DUODENUM</td>
<td class="gt_row gt_center">523 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED DUODEUM</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED ESOPHAGUS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED ESPHAGUS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED GALLBLADDER/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED GASTRIC ULCER</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED GASTRIC ULCER; HYPOTENSION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED RIGHT CORONARY ARTERY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED VISCERA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED VISCOUS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATED VISCUS</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATION S/P ERCP</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATION S/P ERCP;GALLSTONES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERFORATION; S/P ERCP</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERI RECTAL ABSCESS</td>
<td class="gt_row gt_center">558 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERI-RECTAL ABSCESS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIAPPENDICEAL ABSCESS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICADIAL EFFUSION\PERICARDECTOMY/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL ABSCESS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL AND PLEURAL EFFUSION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL CONSTRICTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL DISEASE\PERICARDIAL STRIPPING/SDA</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL DRAIN</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUAION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">5,729 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION WITH TAMONADE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION WITH TAMPONADE\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION, TOMPONADE</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION,SEPSIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION; CHEST PAIN</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION; DYSPNEA; METASTATIC BREAST CA\PERICARDIAL TAP</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;ATRIAL FIBRILLATION\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;CARDIAC ARREST</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;CHOLECYSTITIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;DYSPNEA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;DYSPNEA\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;NON SMALL CELL CARCINOMA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;PERICARDIAL TAMPONADE\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;PLUERAL EFFUSIONS</td>
<td class="gt_row gt_center">576 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;RIGHT HIP FRACTURE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;S/P FALL</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;TAMPONADE</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;TELEMETRY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION;UPPER GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION/ PNEUMONIA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION/NSTEMI</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION\BALLOOM PERICARDIOTOMY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION\CATH</td>
<td class="gt_row gt_center">302 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION\PERICARDIAL CENTESIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION\PERICARDIAL TAP</td>
<td class="gt_row gt_center">143 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION\PERICARDIAL TAP/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL EFFUSION\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL FUSION/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL HEMATOMA</td>
<td class="gt_row gt_center">714 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL MASS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL RUB</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL TAMPONADE</td>
<td class="gt_row gt_center">554 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL TAMPONADE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDIAL TAMPONADE\PERICARDIAL TAP</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS-HYPOTENSION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS\CHEST TAP</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS\PERICARDECTOMY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITIS\PERICARDECTOMY/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICARDITITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICOLOSTOMY HERNIA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERICRDIAL EFFUSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIDONTAL ABSCESS;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERINATAL DEPRESSION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERINEAL ABSCESS </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERINEPHRIC BLEEDING</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIORBITAL CELLULITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIORBITAL STREP CELLULITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL EDEMA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL INSUFFICIENCY;RIGHT FOOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DIEASE;HYPERTENSION;CORONARY ARTERY DISEASE\RIGHT LEG ANGIOGRAM</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE</td>
<td class="gt_row gt_center">4,310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE, CAROTID STENOSIS, TIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE; REST PAIN\RIGHT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE; RIGHT SUPERFICIAL FEMORAL ARTERY DISEASE\RIGHT PERIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;CELLULITIS LEFT HEEL</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;CORONARY ARTERY DISEASE\PERIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;CORONARY ARTERY DISEASE\RIGHT LOWER EXTREMITY ANGIOGRAM;CORONARY CATH</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;FEMUR FRACTURE;ORBITAL FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;HYPERTENSION;CLAUDICATION;CORONARY ARTERY DISEASE\LEFT LEG ANGIOGRAM</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;HYPERTENSION\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;ISCHEMIA;HYPERTENSION\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;ISCHEMIC LEFT FOOT</td>
<td class="gt_row gt_center">3,396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;RENAL INSUFFICIENCY\LEG ANGIOGRAM;AA RUNOFF</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;RIGHT ILIAC STENOSIS\ANGIOGRAM WITH RUN-OFFS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE;SHORTNESS OF BREATH;CHEST HEAVINESS;ISCHEMIA;HYPERTENSION;DIABETES\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE/SDA</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\AA RUNOFFS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\BILATERAL LEG ANGIOGRAM</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\BILATERAL LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\LEEMAN,DAVID</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\LEFT LEG ANGIOGRAM</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\PERIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DISEASE\RIGHT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPHERAL VASCULAR DUSEASE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIPJERAL VASCULAR DISEASE</td>
<td class="gt_row gt_center">791 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIRECTAL ABCESS WITH GANGRENE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIRECTAL ABSCESS</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERIRENAL BLEED HEMATOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONEAL BLEED</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONEAL MASS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONEAL SEPSIS</td>
<td class="gt_row gt_center">658 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONITIS</td>
<td class="gt_row gt_center">1,299 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONITIS, S/P SIGMOID RESECTION/SDA</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONSILAR CELLULITIS</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONSILLAR ABSCESS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONSILLAR ABSESS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERITONSILLAR PHELEGMON</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTANT NAUSEA AND VOMITING</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTANT NAUSEA-VOMITING-ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTANT TACHYCARDIA;?HYPOTHYROID</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTENT AFRIBULATION\ MINI MAZE PROCEDURE W/ BILATERAL THORACOTOMIES/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTENT ANGINA\CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTENT HYPOTENSION</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTENT PNEUMONIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSISTENT V-FIB ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PERSONAL HX OF BREAST CA/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PES PLANOVALGULS DEFORMITY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PETECHIAE;HYPOTENSION</td>
<td class="gt_row gt_center">1,500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PETITONITIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PETROUS MEINGIOMA /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PFO\ MINIMALLY INVASIVE PFO CLOSURE/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PFO\ PFO</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PFO\AORTIC VALVE REPLACEMENT; PFU; MAZE PROCEDURE; ? MVR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PFO\PATENT FORAMEN OVALE CLOSURE </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PFO\PATENT FORAMEN OVALE;MINIMALLY INVASIVE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PFO\REPAIR ATRIAL-SEPTAL DEFECT; PFO</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHARYNGEAL ABSCESS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHARYNGEAL SWELLING</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHARYNGITIS</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHENOBARBITAL OVERDOSE</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHENOBARBITAL TOXICITY</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHEO CHROMACYTOMA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHEOCHROMOCYTIOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PHLEGMASIA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PIC LINE PLACEMENT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PICA ANEURYSM</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PICC LINE INFECTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PINEAL REGION EPIDIMOID/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PINEAL REGION TUMOR/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY ABSCESS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY ADENOMA; HYPONATREMIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY ADENOMA/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY MASS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY MASS/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY TUMOR</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PITUITARY TUMOR/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLASMA CELL LEUKEMIA;FEVER</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL CUT FISTULA PE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION</td>
<td class="gt_row gt_center">7,235 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION AND RIGHT NODE NODULE /SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION RIGHT/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION-CHEST PAIN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION, RIGHT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION,R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION; AIRWAY TUMOR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;ELEV INR</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;ELEVATED BILIRUBIN</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;EMPYEMA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;HYPOTENSION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;HYPOXIA</td>
<td class="gt_row gt_center">352 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;LEFT LOWER LOBE MASS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;MEDIASTINAL MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;METASTATIC RCC</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;NONSUSTAINED VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;PERINEAL INFECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;PNEUMONIA</td>
<td class="gt_row gt_center">460 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;QUESTION OF EMPYEMA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;RENAL FAILURE</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;RESPIRATORY FAIL</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;SEPSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION/SDA</td>
<td class="gt_row gt_center">511 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSION\PLEUR-X CATHETER PLACEMENT; RIGHT</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSIONS</td>
<td class="gt_row gt_center">298 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL EFFUSIONS;LYMPHOCYTIC EFFUSSION\PLEUROSCOPY/PLEURODESIS WITH TALK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL FLUID</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURAL HEMATOMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURISY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURITIC CHEST PAIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURITIC RIGHT FLANK PAIN</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLEURO EFFUSION/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLURAL EFFUSION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PLURAL EFFUSION;ACUTE RENAL FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PMEUMONIA</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PMEUMONIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PMEUMONIA/SEPSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PMNEUMONIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA AND HEAD BLEED</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA SEIZURE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA, ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA, CHF</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA, RECTAL BLEEDING</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA, RENAL FAILURE, SEPSIS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA, UTI, ANASARCA</td>
<td class="gt_row gt_center">372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA,CHF</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA,LOW HCT, HYPOGLYCEMIA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA,SEPSIS</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA,UTI</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA; FEVER</td>
<td class="gt_row gt_center">5,740 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA;TELEMETRY</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA:TELEMETRY</td>
<td class="gt_row gt_center">450 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA/AFIB</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA/ILI</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA/RF</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA/SEPSIS</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNA/THYROID STORM</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNAUMONIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEMONIA</td>
<td class="gt_row gt_center">5,080 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEMONIA/ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEMOTHORAX</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEMOTHORAX CHRONIC AIR LEAK</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMATOSIS OF BOWEL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMNOIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMO</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMO FIBROSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOCEPHALUS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOCOCCIAL SEPSIS OF HAND AND FEET</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOCYSTIS PNEUMONIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOHYDROTHORAX</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOMEDIASTINUM</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOMEDIASTINUM;RHABDO;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOMIA</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONI</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA</td>
<td class="gt_row gt_center">359,999 (4.7%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA E/EMPYEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA HODGKINS DISEASE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA R/O MI</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA VERSUS PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">1,112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA VS. INFLUENZA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-? MULTIPLE MELANOMA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-ABDOMINAL PAIN</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-ACUTE RENAL FAILURE-MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">4,928 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-AFLUTTER-HYPERTENSION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-ANEMIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-ASTHMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-BOOP</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-COPD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-COPD-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-FEVER-POST-OP</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-GAIT</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-HYPERGLYCENIA</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-HYPOGLYCEMIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-HYPOTENSION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-HYPOXIA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-LT HIP FRACTURE-EMPHYSEMA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-NSTEMI</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-R/O FLU</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-R/O MYOCARDIAL INFARCTIOM</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-R/O TB</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-RENAL FAILURE</td>
<td class="gt_row gt_center">818 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-SEPSIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-UNSSTABLE ANGINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA-URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">230 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, COPD EXACERBATION</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, D.T&#39;S</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, HIV</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, HYPERKALEMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, HYPOTENSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, HYPOXIA, FEVER</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, R/O MI</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA, SEPSIS</td>
<td class="gt_row gt_center">679 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,ARRYTHMIA,R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,BLADDER CARCINOMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,CHEST PAIN,RENAL FAILURE</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,CHF</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,COPD</td>
<td class="gt_row gt_center">1,617 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,DEHYDRATION,ANEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,FEVER</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,FEVER,S/P TRANSPLANT</td>
<td class="gt_row gt_center">623 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HEMATASIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HEPATITIS C</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HOSPITAL VS COMMUNITY ACQUIRED</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HYPONATREMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HYPOTENSION</td>
<td class="gt_row gt_center">1,979 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HYPOTHERMIA</td>
<td class="gt_row gt_center">864 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,HYPOXIA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,MULTIFOCAL</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,NEW ONSET ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,R/O MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,RIGHT MIDDLE LOBE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,RT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,SEPSIS</td>
<td class="gt_row gt_center">749 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,SEPSIS,HYPOTENSION</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,SICKLE CELL DIZZENESS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,TACHYCARDIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA,URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; ACUTE RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; AMS; THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; CELLULITIS</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; CELLULITIS; ? SEIZURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; CELLULITIS; DVT</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; CHF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; COPD</td>
<td class="gt_row gt_center">1,617 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; HEART FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; HIV</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; POST RESPIRATORY ARREST</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; R/O MI</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; RENAL FAILURE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; SEIZURE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; SEPSIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; SEPSIS; POSSIBLE CHF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA; UTI</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;? CHF</td>
<td class="gt_row gt_center">2,078 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;?PULMONARY EMOBULIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;(AML) ACUTE MYELOGENOUS LEUKEMIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;A-FIB</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ABDOMINAL DISTENTION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">871 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ALS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ALTERED MENTAL STATUS; AFIB;RVR</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ANEMIA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ARDS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ATRIAL FIBRILLATION;TELEMETRY</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ATRIAL FIBRILLATION;TELEMETRY;RESP FAILURE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ATRIAL FIBRILLATION;TELEMETRY;RVR</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ATRIAL FLUTTER</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;BACK PAIN</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;BRONCHIECTASIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;C-DIFF</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CARDIOGENIC SHOCK</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CELLULITIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CELLULITS</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CEREBELLUM LESION</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHANGE IN MENTAL STATUS;TELEMETRY;</td>
<td class="gt_row gt_center">215 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHEST PAIN</td>
<td class="gt_row gt_center">519 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHOLECYSTITIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHRONIC OBST PULM DISEASE;HYPERTENSION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CHRONIC OBST PULM DISEASE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">732 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;CONGESTIVE HEART FAILURE;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;COPD EXACERBATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;COPD EXACERVATIOON</td>
<td class="gt_row gt_center">245 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;COUGH</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;DEEP VEIN THROMBOSIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;DEEP VEIN THROMBOSIS;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;DEHYDRATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;DELIRIUM;HYPERCALCEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">1,272 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;DYSPHAGIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;EFFUSION</td>
<td class="gt_row gt_center">149 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;EFFUSION;DELIRUM;SUICIDAL IDEATION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ELEVATED TROPONIN</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;EMPYEMA</td>
<td class="gt_row gt_center">447 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;FEVER;TACHYCARDIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;FLUID OVERLOAD</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;GI BLEED</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HEART FAILURE</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HEART MURMUR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HEMOPTYSIS</td>
<td class="gt_row gt_center">437 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HIP DISLOCATION</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HUMAN IMMUNODEFIENCY VIRUS;RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HYPERTENSION;DEPRESSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HYPOTENSION</td>
<td class="gt_row gt_center">669 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HYPOTHERMIA</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;HYPOXIA</td>
<td class="gt_row gt_center">687 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;INFLUENZA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ISCHEMIC LEG</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;LEFT EMPYEMA\ THORACOSCOPY VIDEO ASSISTED; DECORTICATION LEFT</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;LINE INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;LIVER FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;LIVER FAILURE;RENAL FAILURE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;LUNG CA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;MENTAL STATUS CHANGE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">963 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;MRSA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;NECROTIC RIGHT FOOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;NSTEMI;SEPSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;OVERDOSE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PACE MAKER REPLACEMENT</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PANCREATIC MASS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PHARYNGEAL EDEMA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">518 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;POLYSUBSTANCE ABUSE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PROBABLE PCP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;R/O TB</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RAF</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RAPID AF;HYPOXIA</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RAPID AFIB</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RENAL FAILURE</td>
<td class="gt_row gt_center">637 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">521 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RESPIRATORY FAILURE;TRACHEAL BRONCHIAL MALACIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RHABDOMYLOSIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RULE OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;RULE-OUT INFLUENZA</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;S/P LIVER TRANSPLANT;DEHYDRATION</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;S/P RENAL TRANSPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SEIZURE;FALL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SEPSIS</td>
<td class="gt_row gt_center">1,148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">1,476 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SEPTIC ARTHRITIS;ACUTE LEUKEMIA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SEVERE AORTIC STENOSIS</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;SHOULDER PAIN</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;TACHYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">8,181 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;TELEMETRY;METHICILLIN RESISTANT STAPH AUREUS;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;TRACHEOMALACIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;TRANSAMINITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;TROPONIN LEAK</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">797 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;URINARY TRACT INFECTION;AKI</td>
<td class="gt_row gt_center">530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;URINARY TRACT INFECTION;DEHYDRATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;URINARY TRACT INFECTION;HYPOTENSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;URINARY TRACT INFECTION;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;URINARY TRACT INFECTION;SACRAL DECUB</td>
<td class="gt_row gt_center">472 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;UROSEPSIS</td>
<td class="gt_row gt_center">1,112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;VANCOMYCIN RESISTANT ENTEROCOCCUS;RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">623 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;VOLUME OVERLOAD</td>
<td class="gt_row gt_center">960 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA;ZOSTER RASH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA&#39;</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA&#39;PLEURAL EFFUSIONS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/ COPD</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/ SEPSIS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/ANEMIA</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/ASTHMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/CONGESTIVE HEART FAILURE/NSTEMI</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/COPD</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/DEHYDRATION</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/HYPOGLCEMIA/SYNCOPE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/HYPOTENSION</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/R/O FLU</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/SEPSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/SEPSIS/RAPID AFIB</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIA/URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONIN, R/O MI</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMONNIA;? LUNG ABSCESS;ADULT RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOPERITONEM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOPERITONEUM</td>
<td class="gt_row gt_center">410 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOPERTONEUM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOSEPSIS</td>
<td class="gt_row gt_center">690 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX</td>
<td class="gt_row gt_center">1,478 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX-FRACTURED RIBS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX-S/P TRACTOR ACCIDENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX,INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX; HYDROTHORAX</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX; PULMONARY CONTUSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;ACETABULAR FRACTURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;FACIAL FX</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;FEVER;PNEUMONIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;FRACTURES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;HEMOTHORAX;MCC</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;HIATAL HERNIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;HYPOTENSION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;MYASTHENIA GRAVIS</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;PEA ARREST</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX;SYCOPE;C SPINE FRACTURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX/CLAVICLE &amp; PELVIC FRACTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTHORAX/RIB FRACTURES</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUMOTOSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNEUOSEPSIS;HEART FAILURE</td>
<td class="gt_row gt_center">520 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PNUEMOCOCCAL PNEUMONIA; ARDS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POCKET INFECTION\PARTIAL LEAD EXTRACTION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLTRAUMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY SUBSTANCE ABUSE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY SUBSTANCE ABUSE,DT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY SUBSTANCE INTOXICA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY SUBSTANCE OD</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY SUBSTANCE OVERDOSE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY TRAUMA</td>
<td class="gt_row gt_center">125 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLY-TRAUMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYCHONDRITIS WITH AIRWAY MANISFESTATION\ STERNATOMY CARDIOPULMONARY; BYPASS; ANTERIOR TRACHEAL SPLITTING; TY STENT PLACEMENT; LAPAROTOMY/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYCHONDRITIS;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYCYSTIC KIDNEY DISEASE/SDA</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYCYTHEMIA</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYMORPHIC V TACH\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYMORPHIC VENTRICULAR TACHYCARDIA\CARDIAC CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYNEUROPATHY;FEVER</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYP ADENOMATOUS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBSTANCE AABUSE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBSTANCE ABOUSE;SEIZURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBSTANCE INGESTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBSTANCE OD</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBSTANCE OVERDOSE</td>
<td class="gt_row gt_center">179 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBSTNACE ABUSE;FOUND DOWN</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYSUBTANCE OVERDOSE</td>
<td class="gt_row gt_center">660 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYTAUMA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYTRAUMA</td>
<td class="gt_row gt_center">879 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYTRAUMA S/P FALL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYTRAUMA S/P MVC</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYTRAUMA-FACIAL TRAUMA</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POLYTRAUMA-SUBDURAL HEMORRHAGE-FACIAL FRACTURES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PONS HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PONTINE BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PONTINE HEMORRAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PONTINE HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PONTINE STROKE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POPLITEAL ANEURYSM LEFT/SDA</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POPLITEAL ANEURYSM, RIGHT/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POPLITEAL ARTERY ANEURY SM</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POPLITEAL INJURY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POPLITEAL TRANSECTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORCELAIN GALLBLADDER/SDA</td>
<td class="gt_row gt_center">410 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORT INFECTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTA CATH OBSTRUCTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL HTN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL HYPERTENSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL HYPERTENSION W/ ASCITES/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL HYPERTENSION;VARICEAL BLEED</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL HYPERTENSION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL VEIN CLOT</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL VEIN OCCLUSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL VEIN THROMBOSIS</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL VEIN THROMBOSIS/S/P LIVER TX</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PORTAL VEIN THROMBUS</td>
<td class="gt_row gt_center">172 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSITIVE BLOOD CULTURE</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSITIVE BLOOD CULTURE;BACTEREMIA</td>
<td class="gt_row gt_center">400 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSITIVE BLOOD CULTURES</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSITIVE ETT\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSITIVE EXERCISE TOLERANCE TEST\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSITIVE STRESS TEST</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE CEREBROVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">1,133 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE CROHN&#39;S FLARE</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE GASTRINTESTINAL BLEED</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE ISCHEMIA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE OVARIAN CA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE PNEUMONIA,ASCITES,HYPONATREMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE STROKE</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE SVC SYNDROME</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSSIBLE UPPER GI BLEED</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST ANGIOGRAM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST ARREST</td>
<td class="gt_row gt_center">1,015 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST ARREST ? SEPSIS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST ARREST;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST BIOPSY BLOOD</td>
<td class="gt_row gt_center">749 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST CARDIAC ARREST</td>
<td class="gt_row gt_center">178 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST ERCP</td>
<td class="gt_row gt_center">245 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST INFARCT ANGINA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST INFARCT CARDIOMYOPATHY\IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST MENOPAUSAL BLEEDING/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST MENOPAUSAL BLEEDING\HYSTEROSCOPY </td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST MI;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OBSTRUCTIVE PNEUMONIA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OBSTRUCTIVE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP BLEEDING</td>
<td class="gt_row gt_center">282 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP BOWEL RESECTION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP INFECTION</td>
<td class="gt_row gt_center">345 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP INTRA ABDOMINAL ABSCESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP KNEE INFECTION</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP STERNAL WOUND</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OP WOUND INFECTION;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OPERATIVE BLEEDING</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST OPERATIVE ILEUS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PARTUM CARDIOMYOPATHY</td>
<td class="gt_row gt_center">413 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PARTUM FEVER</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PROCEDURE BLEED;GASTROINTESTINAL BLEED;S/P ERCP</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PROCEDURE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PROCEDURE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;? SEPSIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PROCEDURE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;RESPIRATORY ARREST</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST PROCEDURE PAIN AND FEVER</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST SPHINCTERECTOMY BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST ST ELEVATION MI</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST SURGICAL INFECTION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST TRANSPLANTATION STRICTURE\BRONCHOSCOPY RIGID; WITH LASER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST TRAUMATIC ARTHRITIS INFECTION LEFT KNEE/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST TRAUMATIC STRESS DISCORDER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST- ARREST</td>
<td class="gt_row gt_center">1,530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST-ARREST</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST-CARDIAC ARREST</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST-ERCP</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST-OP BLEEDING</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST-OPERATIVE BLEEDING</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST-POLYPECTOMY BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POST/OP FEVER</td>
<td class="gt_row gt_center">642 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR COMMUNICATING ANEURYSM/SDA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR COMMUNICATING ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR DECOMPRESSION T9-L4</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR FOSSA BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR FOSSA HEMORRHAGE</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR FOSSA MASS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR FOSSA MASS LESION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR FOSSA MENIGIOMA LEFT/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR INFERIOR CEREBELLAR ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR MEDIASTINAL MASS/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR NASAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTERIOR NOSE BLEED</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTITIVE STRESS TEST\CARDIAC CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTOP BLEED</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTOPERATIVE BILE LEAK</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTOPERATIVE INFECTION/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POSTPARTUM CARDIOMYOPATHY;TELEMETRY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">POUCHITIS</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE OP AVR;MVR\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE OP LIVER</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE OP LIVER TRANSPLANT</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE OP LIVER TX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE OP PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE SYNCOPE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE TERM CONTRACTIONS;31 WEEKS</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-HYDRATION;CORONARY ARTERY DISEASE;PVD\CATH AND LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-MATURITY</td>
<td class="gt_row gt_center">179 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP COLECTOMY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP FOR MVR ON 1/21/02</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP KIDNEY</td>
<td class="gt_row gt_center">389 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP LIVER</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP LIVER TRANSPLANT</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP LIVER TX</td>
<td class="gt_row gt_center">149 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-OP PANCREAS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-SEPSIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-SYNCOPE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE-SYNCOPE;TELEMETRY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRE/OP PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREMATURE</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREMATURITY</td>
<td class="gt_row gt_center">3,055 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREMATURITY;POOR RESPIRATORY EFFORT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREMATURITY/S/P SURGERY</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREMTURITY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRENEPHRIC HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREOP HEPARIN/ AORTIC VALVE REPLACEMENT\AORTIC VALVE REPLACEMENT, RE-DO</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREOP HYDRATION</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREOP KIDNEY</td>
<td class="gt_row gt_center">219 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREOP PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRES SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRESTHETIC VALVE ENDOCARDITIS;1ST &amp;2ND AV BLOCK</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRESYCOPE;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRESYNCOPE</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRESYNCOPE;PALPITATIONS;CORONARY ARTERY DISEASE;HYPERTENSION\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PREVERTEBRAL ABSCESS</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY BILIARY CIRRHOSIS;END STAGE LIVER DISEASE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY PULMONARY HYPERTENSION\SWAN-GANZ CATHERER PLACEMENT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEORSING CHOLANGITIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEROSING CHOLANGITIS</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEROSING CHOLANGITIS CIRRHOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEROSING CHOLANGITIS;POSSIBLE STRICTURE\ERCP</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEROSING CHOLANGITIS/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEROSING CHOLANGITS;LIVING UNRELATED LIVER TRANSPLANT/SDA</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PRIMARY SCLEROSIS CHOLANGITIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROBABLE ACUTE LEUKEMIA;PNEUMONIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROBABLE DELERIUM TREMONS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROBABLE PNA</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROCTITIS</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROFOUND DEHYDRATION</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE ANGINA;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE ANGINA;STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE EXERTIONAL DYSPNEA;CORONARY ARTERY DISEASE\CARDIAC CATH/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE HEART FAILURE;ANGINA;MITRAL REGURGITATION\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE PARAPLEGIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE RESPIRATORY DISEASE</td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROGRESSIVE WEAKNESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROLAPSE UTERUS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROLONGED HYPOGLYCEMIA;END STAGE RENAL DISEASE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROLONGED PREMATURE RUPT OF MEMB</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE ABSCESS</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE CA/SDA</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE CANCER</td>
<td class="gt_row gt_center">321 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE CANCER; ? CORD COMPRESSION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE CANCER;DVT</td>
<td class="gt_row gt_center">312 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE CANCER;PNEUMONIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE CANCER/SDA</td>
<td class="gt_row gt_center">199 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATE NODULE;S/P AORTIC VALVE REPLACEMENT\COLONOSCOPY;PROSTATE BIOPSY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTATITIS;FEVER</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTETIC VALVE ENDOCARDITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROSTHETIC VALVE ENDOCARDITIS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PROTRUDING STERNAL WIRE\STERNAL WIRE REMOVAL/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDO ANEURYSM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDO ANEURYSM/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDO ANEURYSM\REDO AORTIC ARCH RECONSTRUCTION/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDO AORTIC ANEURYSM\ REPAIR OF PSEUDO ANEURYSM/SDA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOANEURYSM</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOANEURYSM OF THE DESCENDING THORACIC AORTA\BENTALL PROCEDURE; TRANS AORTIC ANEURYSM STENT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOANEURYSM OR PULMONARY ARTERY</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOANEURYSM RUPTURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOARTHROSIS CERVICAL SPINE/SDA</td>
<td class="gt_row gt_center">448 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOARTHROSIS, C5-C6/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOCYST</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOCYST PANCREATIC</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOCYST;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSEUDOOBSTRUCTION</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSOAS ASSCESS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSORIATIC ARTHRITIS\ORENCIA INFUSION</td>
<td class="gt_row gt_center">714 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSYCHOGENIC LARYNGOSPASM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSYCHOGENIC POLYDISPIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PSYCHOSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PTC FOR CHOLESTASIS</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PTX; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">340 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULM EDEMA</td>
<td class="gt_row gt_center">222 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULM FIBROSIS FLARE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMOARY EDEMA;ANEMIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMOMNARY EMBOLUS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONAARY EDEMA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY ALBEOLAR PROPEINOSIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY ALVEOLAR PROTEINOSIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY ALVEOLAR PROTEINOSIS\ LUNG LAVAGE BILATERAL HOLES</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY ARTERY STENOSIS\ PULMONARY ARTERY RESECTION AND REPAIR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY AVEOLAR PROTEINOSIS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY CONTUSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA</td>
<td class="gt_row gt_center">10,008 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA-R/O MI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA, MI</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA, MITRAL VALVE REGURGITATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA,AORTIC STENOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA,ARF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA,CARDIAC ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA,DM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA; ANEMIA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA; S/P MI/CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;ANEMIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;ANEMIA; NON ST ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;CARDIOGENIC SHOCK\RIGHT HEART CATH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;CHEST PAIN;TELEMETRY</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;HYPERTENSION</td>
<td class="gt_row gt_center">18,360 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;MYOCARDIAL INFARCTION\CATH;POSSIBLE ANGIOPLASTY\STENTPLACEMENT</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;PERIPHERAL VASCULAR DISEASE\CATH</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA;SVT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA\CARDIAC CATH</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMA\CATH</td>
<td class="gt_row gt_center">273 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EDEMIA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EFFUSION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EFFUSION;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLI</td>
<td class="gt_row gt_center">477 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLI; COPD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLI;HYPOXIA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLI\R HEART CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">6,082 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS-DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS-HEMATEMESIS</td>
<td class="gt_row gt_center">1,540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS; PERICARD; PLEURAL EFFUSIONS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS; RIGHT VENTRICULAR THROMBUS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS; SEPSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;ENDOCARDITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;HYPOXIA;NEW CA DX</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;PNEUMONIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;POSSIBLE CARCINOMA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;SUPER VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;TELEMETRY</td>
<td class="gt_row gt_center">2,658 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLIS;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">4,213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLISM,PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLISM;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLISM;TELEMETRY</td>
<td class="gt_row gt_center">43 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLISM\THROMBECTOMY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLUS-GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLUS-S/P IVC FILTER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLUS;JAUNDICE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLUS;PNEUMONIA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBOLUS;RENAL FAILURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY EMBULUS</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY FIBROSIS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY FIBROSIS PNEUMONIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY FIBROSIS; PNEUMONIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY FIBROSIS;HAMMOND RICH SYNDROME</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY FIBROSIS;OBSTRUCTIVE JAUNDICE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY FIBROSIS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HEMMORHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HEMORRHAGE</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HTN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HTN\CATH</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION</td>
<td class="gt_row gt_center">821 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION;MITRAL STENOSIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION;PULMONARY VENO-OCCLUSIVE DISEASE\RIGHT HEART CATH/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION;SYNCOPE</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION;SYSTEMIC SCLEROSIS;ENDSTAGE CHF;ELEVATED INR\RIGHT HEART CATH/SDA</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION\CENTRAL LINE PLACEMENT/REMODULIN INFUSION</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION\INITIATION OF FLOLAN</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY HYPERTENSION\RIGHT HEART CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY INFILTRATE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY INFILTRATES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY INFUSION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY NODULE, LEFT /SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY NODULE/SDA</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY NODULES</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY POLYCRONDRITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY SEPTIC EMBOLI</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY VALVE DISORDER\REDO PULMONARY VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY VASCULITIS</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONARY VEIN INJURY\THORACOSCOPIC MAZE PROCEDURE LEFT;MINI MAZE;BILATERAL MINI THORACOTOMY;PULMONARY VEIN ISOLATION;RESECTION OF LEFT ATRIAL APPENDAGE/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULMONAY EMBOLISM</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULOMARY EMBOLIS;TELEMETRY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULOMONARY EMBOLIS;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULOMONARY FIBROSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULONARY NODULE, RIGHT /SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS ARREST</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS ELECTRICAL ACTIVITY ARREST</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS EXTREMITY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS FOOT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS FOOT;TELEMETRY</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS LEFT FOOT</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS LEFT LEG</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSELESS R. LOWER EXTREMETY</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PULSLESS FOOT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PUMONARY NODULES/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PURULENT STERNAL INCISION WOUND</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PV THROMBOSIS; RAF; PNA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD;END STAGE RENAL DISEASE;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\AA R UNOFFS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\AAA RUNOFFS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\AORTIC RUN-OFFS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\ARTERIOGRAM</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\LEFT LEG ANGIO</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\LEFT LEG ANGIOGRAM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\PARIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\PREIPHERAL ANGIOGRAM</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PVD\RIGHT LEG ANGIO</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS</td>
<td class="gt_row gt_center">323 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS &amp; ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">408 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS;PULMONARY EMBOLIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS;RIGHT KIDNEY OBSTRUCTION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS;SEPSIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYELONEPHRITIS/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYLEONEPHRITIS;CO2 RETENTION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYLONEPHRITIS</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">PYRAMETHAMINE DESENSITIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION OF OSTEOMYLITIS</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION OF OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION OF SAH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION OF SEIZURES;HYPONATREMIA;PNEUMONIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION OF SEPSIS</td>
<td class="gt_row gt_center">267 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION OF STROKE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTION SEPSIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QUESTIONABLE PRE-SEPSIS;LINE INFECTION;FEVER</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">QWAVE MI;TELEMETRY</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R FEMUR &amp; LIVER LACERATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R FEMUR FRACTURE; RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R HIP FRACTURE</td>
<td class="gt_row gt_center">1,859 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R HIP FX</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R KIDNEY BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R PLEURAL EFFUSION</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R PTX</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R-SIDED WEAKNESS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R. FACIAL SWELLING/ R. MANDIBULAR REPAIR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R. LOWER LOBE PNEUMONIA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R. THUMB AMPUTATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R. VENTRICULAR MI</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R.LEG ABCESS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R.U.Q. PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/I MI</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O AAA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O AORTIC DISSECTION</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O AORTIC VALVE THROBOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O APNEA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O ARDS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O ASPIRATION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O BACTEREMIA</td>
<td class="gt_row gt_center">2,731 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O BILIARY OBSTRUCTION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O BILIARY OBSTRUCTION;HEPATITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O BILIARY PERFERATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O BOWL ISCHEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CAD; CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CAD;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CANCER OF SPINE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CAROTID DISECTION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CEREBRITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CEREBROVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CHOLECYSTITIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O COMMON BILE DUCT STONE\ERCP</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O COMPARTMENT SYNDROME</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CORD COMPRESSION&#39;</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CORONARY ARTERY DISEASE;HEART CATHERIZATION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CVA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CVA;CHEST PAIN</td>
<td class="gt_row gt_center">555 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O CVA;SYNCOPE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O DEHYDRATION</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O DISSECTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O EMPHYSEMATOUS GASTRITIS;COLITIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O ENDOCARDITIS</td>
<td class="gt_row gt_center">3,735 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O EPIDURAL ABSCESS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O EPIGLOTTITIS</td>
<td class="gt_row gt_center">243 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O FLU; AML</td>
<td class="gt_row gt_center">1,384 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O GANGRENOUS CHOLECYSTITIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">450 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O HEAD BLEED; S/P KIDNEY TX</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O HEAT STROKE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O HEMORRHAGIC STROKE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O HERSCH.</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O HYDROCEPHALUS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O ISCHEMIC BOWEL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O LEG INFECTION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O LYMPHOMA;CHRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O M.I.-COPD EXACERBATION-RESP DISTRESS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MEDIASTINITIS</td>
<td class="gt_row gt_center">211 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MENINGITIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MENINGITIS-FEVER</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MENINGITITIS</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MENINGOENCEPHALITIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MESENTERIC ISCHEMIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MESENTERICISCHEMIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O METASTASIS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI</td>
<td class="gt_row gt_center">977 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI FOR CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI N/V</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI PNEUMONIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI, BRBPR</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI, FEVER</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI, L. HIP FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI, UNSTABLE ANGINA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI,NEW ACUTE RENAL FAILURE,ANEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI; BRONCHITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI; CHF</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MI/CATH</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYASTHENIA GRAVIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYCOARDIAL INFARCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">467 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-ACUTE CORONARY SYNDROME</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-CHEST PAIN</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-CHF EXACERBATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">107 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-FAILURE TO THRIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-FAILURE TO THRIVE-ABD PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-FEVER</td>
<td class="gt_row gt_center">609 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-SOB-HYPERKALEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDIAL INFARCTION-SYNCOPE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O MYOCARDITIS</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O NECROTISING FASCITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O OBSTRUCTION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O OBSTRUCTION-ABDOMINAL PAIN</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PANCREATITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PANCREATITIS-SPONTANEOUS BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PE</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PERFORATED ILEUM</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PERICARDITIS;UROSEPSIS</td>
<td class="gt_row gt_center">360 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PNEUMONIA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PULMONARY EMBOLIS;FEMUR FX</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O PULMONARY EMBOLUS-CHEST PAIN</td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SAH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEIZURE VS STROKE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEIZURE;DEYDRATIONS</td>
<td class="gt_row gt_center">762 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPSIS</td>
<td class="gt_row gt_center">1,227 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPSIS /ERCP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPSIS ANAPLASTIC  ASTROYTOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPSIS-DKA-IMMUNO SUPRESSED KIDNEY TX</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPSIS, S/P LAP CHOLE.</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SEPTIC SHOCK</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SMA THROMBOSIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">246 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SMV THROMBOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O ST SEGMENT MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O STROKE</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SUB ARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O TAMPONADE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O TB</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O TB-ADENOCARCINOMA-UNKNOWN PAIN-FEVER-R/O INFECTION</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O TIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O VERTEBRAL ARTERY DISSECTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">R/O VIRAL HEPATITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RA MASS W\CLOT</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RACH DISLODGED</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RADIUS AND ULNA FRACTURES;OSTEOPENIA;POST OPERATIVE BLEEDING</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID  AFIB;UTI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID A- FIB/PNEUMONIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID A-FIB</td>
<td class="gt_row gt_center">783 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID A-FIB,SDH, PELVIC FRACTURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AF CHF</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB UTI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB-URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB; CHF</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB; FLUTTER</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB;FEVER;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID AFIB;PLEURAL EFFUSION;TELEMETRY</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIB</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;AORTIC ANEURYSM;ANEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;CORONARY ARTERY DISEASE;LATERAL ST DEPRESSION\CATH</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;MITRAL REGURGITATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;NON ST ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;PULMONARY EDEMA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;RULE-OUT MYOCARDIAL INFARCTION;PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIAL FIBRILLATION;STATUS POST LIVER TRANSPLANT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID ATRIALFIBRILLATION;HYPOTENSION;ELEVATED INR</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID HEART RATE,RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAPID VENTRICULAR RATE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RASH</td>
<td class="gt_row gt_center">366 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RASH; ? SYPHILLIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RASH;FEVER;RAPID ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RASH/UTI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RASP FAILURE BMT</td>
<td class="gt_row gt_center">924 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RAYNAUDS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RCC WITH METS TO CEREBELLUM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RE-DO CABBAGE\CORONARY ARTERY BYPASS GRAFT, RE-DO</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REACTIVE AIRWAY DISEASE</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL ABSCESS</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL AND ANAL STENOSIS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL BLEED</td>
<td class="gt_row gt_center">125 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL BLEEDING</td>
<td class="gt_row gt_center">607 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL BLEEDING;COAGULOPATHY</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL BLEEDING;HIGH INR</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CA/GIB</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CA/SDA</td>
<td class="gt_row gt_center">658 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CANCER</td>
<td class="gt_row gt_center">61 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CANCER;ASCENDING CHOLANGITIS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CANCER/SDA</td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CARCINOMA, DISTAL/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL CARCINOMA/SDA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL FISTULA;DEHYDRATION</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL MALIGNANT NEOPLASM/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL MASS/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL NEURONAL DISTONA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL PROLAPSE</td>
<td class="gt_row gt_center">313 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL PROLAPSE/SDA</td>
<td class="gt_row gt_center">181 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL PROLASPE</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL SHEATH HEMATOMA</td>
<td class="gt_row gt_center">850 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTAL, VAGINAL FISTULA/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTUS HEMATOMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTUS SHEATH HEMATOMA</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECTUS SHEATH HEMATOMA;COAGULOPATHY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENCE LARYNGEAL CA</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ANGINA PECTORIS, STATUS POST ANGIOPLSTY OF RM GRAFT\LEFT HAEART CATHETERIZATION</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ANGINA;CORONARY ARTERY DISEASE\CARDIAC CATH</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ANGINA\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ASPIRATION; MENTAL RETARDATION/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ASPIRATION; PNEUMONIA/SDA\G TUBE CONVERSION TO GJ TUBE ** REMOTE WEST-INR **</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ATRIAL FIBRILLATION\PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ATRIAL TACHYCARDIA\LEFT ATRIAL TACHYCARDIAC ABLATION/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ATRIAL TACHYCARDIA\PULMONARY VEIN ISOLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT BILATERAL PLEURAL FUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT BILIARY CANCER</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT BRAIN TUMOR</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT BREAST CANCER;RIGHT AXILLA CHEST /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CANCER ABDOMINAL SUTURE LINE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CAROTID STENOSIS;RIGHT ANGIOGRAM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CAROTID STENOSIS\ CAROTID ANGIOGRAM/SDA</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CERVICAL CANCER;PAIN</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CHEST PAIN;CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CHEST PAIN;DYSPNEA ON EXERTION;CORONARY ARTERY DISEASE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT COLON CANCER/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT CONJESTIVE HEART FAILURE;ATRAIL FIBRILLATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT DYSPNEA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ENDOCARDITIS, ENLARGED AORTIC ROOT\ BENTAL PROCEDURE HOMOGRAFT REDO/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ENDOMETRIAL SARCOMA/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT ESOPHAGEAL CANCER/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT GASTRIC CANCER/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT HEMOPTYSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT HIATAL HERNIA/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT HODGKINS LYMPHOMA;DYSPNEA</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT INCISIONAL HERNIAS X2/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT INTERNAL CARDIOVERTER DEFIBRILLATOR SHOCKS;HEART FAILURE MANAGEMENT</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT INTRA-ABDOMINAL SARCOMA/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT LEFT CAROTID STENOSIS,PRE HYDRATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT LEFT TUBERCULUM CELLA MENIGIOMA/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT LEUKEMIA</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT LT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT LUNG CANCER/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT MEDIASTINAL CARCINOID TUMOR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT MENINGIOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT PITUITARY TUMOR/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT PLEURAL EFFUSION\PLEUROSCOPY/CHEST TUBE PLACEMENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT PLEURAL EFFUSIONS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT PMB, ENDOMETRIAL HYPOPLASIA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT PNEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT RECTAL CA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT REFLUX &amp; HIATAL HERNIA/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT RIGHT FRONTAL TUMOR/SDA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT RIGHT RETROPERITONEAL SARCOMA/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT SPINE METASTASIS/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT SQUAMOUS CELL CA ORAL CAVITY/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT SYMPTOMATIC BRADYCARDIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT VAGINAL CA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">314 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT VENTRICULAR TACHYCARDIA;STATUS POST IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FIRING\VENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RECURRENT VT\EP STUDY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REDO STERNOTOMY-MVR</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REFRACTORY ARITERITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REFRACTORY ASCITES</td>
<td class="gt_row gt_center">303 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REFRACTORY GI BLEED</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REGURGITAION\MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REIMPLANTATION OF LEFT INDEX AND MIDDLE FINGER</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REIMPLANTATION OF LEFT THUMB</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REIMPLANTATION OF THUMB</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RELAPSING POLYCHONDRIPIS;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RELAPSING POLYCHONDRITIS;AIRWAY OBSTRUCTION\ BRONCHOSCOPY WITH STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RELL CELL METASTASIS/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REMOVAL SOFT TISSUE MASS POSTERIOR TO ODONTOID PROCESS/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ABSCESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS;CLAUDICATION\RIGHT KIDNEY; LEFT LEG ANGIOGRAM</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS;S/P ANGIOPLASTY;S/P RENAL ARTERY STENOSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS/ARF</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS\REANL ANGIOGRAM;RENAL STENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS\RENAL ANGIOGRAM</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS\RENAL ANGIOPLASTY/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS\RENAL ARTERIOGRAN</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS\RENAL ARTERY STENT</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY STENOSIS\RIGHT KIDNEY STENT</td>
<td class="gt_row gt_center">245 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL ARTERY THROMBOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL BLEED</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL BLEEDING</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CA</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CA/SDA</td>
<td class="gt_row gt_center">329 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CALCULI/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CALCULUS</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CALL CANCER/CHEMO</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CANCER LEFT SIDE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CANCER;BACK PAIN</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CANCER;PERICARDIAL FLUID</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CANCER;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CANCER/ATRIAL FLUTTER</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CANCER/SDA</td>
<td class="gt_row gt_center">3,956 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CA</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CA; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CANCER</td>
<td class="gt_row gt_center">197 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CANCER; FAILURE TO THRIVE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CANCER;FEVER</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CANCER;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CANCER/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CANER; RESP DISTRESS</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA 189.0\INTERLEOKIN 2</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA;BACK PAIN</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA;CAUDA EQUINA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA;CHEMO</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA;FEVER,HYPOKALEMIA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA/SDA</td>
<td class="gt_row gt_center">182 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA\BRONCHOSCOPY WITH PDT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA\CHEMO</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA\CHEMOTHERAPY (INTERLEUKIN (HD-IL)</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA\CHEMOTHERAPY (INTERLEUKIN2 HD-IL2)</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA\CHEMOTHERAPY(INTERLEUKIN-2)</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL CARCINOMA\INTERLEUKIN-2</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL MET&#39;S\ CEREBRAL EMBOLICATION/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL CELL METASTASES/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL COLIC</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILIURE-SYNCOPE-HYPERKALEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE</td>
<td class="gt_row gt_center">20,251 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE-CONFUSION</td>
<td class="gt_row gt_center">534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE-HYPONATREMIA-SEIZURE</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE-KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE-SEPSIS</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE, GASTROCUTANEOUS FISTULA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE, HYPERKALEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE, MS CHANGE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE,FOR KIDNEY TX</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE,HYPOKALEMIA,DEHYDRATION</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE,MI</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE,RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">729 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE; ABD PAIN</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE; ALCOHOLIC HEPATITIS</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE; ASPIRATION PNEUMONIA; BILATERAL DVT&#39;S; THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE; PANC</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE; VASCULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;ACIDOSIS;HYPERKALEMIA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;ANASARCA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;ANEMIA</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;ANGINA\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;CHEST PAIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;CIRRHOSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;COLITIS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;CONGESTIVE HEART FAILURE;EKG CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;CORONARY ARTERY DISEASE;SEPSIS</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;DIABETES MELLITUS;FEVER UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;HEMATURIA;PROSTATE CA</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;HEPATIC FAILURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;HEPATITIS;COAGULOPATHY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;HYPERKALEMIA</td>
<td class="gt_row gt_center">182 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;HYPOTENSION</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;KIDEY TRANSPLANT</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;LUNG CA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;LUNG CANCER;MELENA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;NEPHROLITHIASIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;PANCREATITIS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;PERICADIAL EFFUSION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;PNEUMONIA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;PYELONEPHRITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;RESP FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;RESPIRATORY FAILURE;DIABETES MELLITUS</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;SEIZURES</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;SEPSIS</td>
<td class="gt_row gt_center">142 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;STATUS POST KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">490 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;TRANSAMINITIS</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE;V FIB ARREST</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE/ KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE/KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FAILURE/SEIZURES</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL FLOW/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL HEMATOMA;MVC</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL HEMATURIA</td>
<td class="gt_row gt_center">3,396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL HEMORRHAGE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL INFARCTION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL INSUFFICIENCY</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL INSUFFICIENCY;HYPERTENSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL LACERATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL MASS LEFT/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL MASS RIGHT; GALLSTONES/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL MASS, CAVA THROMBUS/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL MASS, RIGHT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL MASS/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL PELVIC CA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL STENOSIS\RENAL AND ILIAC ANGIOGRAM W/STENT PLACEMENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL STONE</td>
<td class="gt_row gt_center">3,104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL STONE OBSTRUCTION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL STONES\ESWL; RIGHT</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL TRANSPLANT</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENAL TUMOR/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RENO STAGE- LIVER DISEASE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REPAIR OF ASCENDING AORTIC ANEURYSM</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REPAIR OF PERFORATED ESOPHAGUS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REPEAT CABG</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REPIRATORY FAILURE</td>
<td class="gt_row gt_center">679 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REPLACE DIALYSIS LINE</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">REPSIRATORY DISTRESS\BRONCHOSCOPY FLEXIBLE </td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESIDUAL PITUITARY TUMOR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESOLVED UPPER GI BLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESOLVING ABDOMINAL COLLECTION/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP DESTRESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP DISTRESS</td>
<td class="gt_row gt_center">592 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP DITRESS</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP FAILURE</td>
<td class="gt_row gt_center">1,124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP FAILURE-HYPOTENSION-PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP FAILURE-RENAL FAILURE-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP. DISTRESS/PNEUMONIA</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP. FAILURE</td>
<td class="gt_row gt_center">536 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP. FAILURE; MULTIPLE SCLEROSIS</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESP. FAILURE;TRACHEAL STENOSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY  DISTRESS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY ACIDOSIS</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY ALKALOSIS</td>
<td class="gt_row gt_center">606 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY ARREST</td>
<td class="gt_row gt_center">4,101 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY ARREST;S/P ERCP</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY ARREST;TELEMETRY</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY COMPROMISE</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DIFFICULTY</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISEASE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">44,109 (0.6%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS AND FEVER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS-ALS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS-LUNG CANCER</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS-PNEUMONIA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS,UROSEPSIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS; PNEUMONIA</td>
<td class="gt_row gt_center">726 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS; RENAL FAILURE; CARDIOMYOPATHY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;? BOWEL ISCHEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;BREAST MASS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;DIARRHEA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;FEVER</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;HYPOTENSION</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;PNEUMONIA</td>
<td class="gt_row gt_center">2,002 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;PNEUMONIA;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;PNEUMONIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">1,128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;S/P LITHOTRIPSY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;SEPSIS</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;TELEMETRY</td>
<td class="gt_row gt_center">193 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;TRACH BLOCKAGE</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;VOLUME OVERLO</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY DISTRESS;WILLIAMS SYNDROME</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILIUR</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">67,186 (0.9%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE-ALS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE-ANEMIA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE-ASTHMA FLARE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE-HYPONATREMIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE-HYPOXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE-TRACHEA MALASIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE, SEPSIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,ASPIRATION PNA</td>
<td class="gt_row gt_center">980 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,GI BLEED</td>
<td class="gt_row gt_center">1,118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,S/P FALL HIP FRACTURE, SHOULDER FRAXTURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,TRACHEAL STENOSIS,EMPYEMA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,UROSEPSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE,VOLUME OVERLOAD</td>
<td class="gt_row gt_center">345 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE; HYPOTENSION</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE; LYMPHADENOPATHY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE; MITRAL REGURGITATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE; TRACHEOBRONCHOMALACIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;AORTIC STENOSIS;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;ARDS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;ASPIRATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;ASPIRATION;S/P INTUBATION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;CARDIAC ARREST</td>
<td class="gt_row gt_center">345 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;CENTRAL AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;CHRONIC OBSTRUCTIVE PULMONARY DISEASE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;CHRONIC OBSTRUCTIVE PULMONARY EMPHYSEMA</td>
<td class="gt_row gt_center">1,023 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;COMPLETE HEART BLOCK;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">676 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;CONGESTIVE HEART FAILURE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;COPD EXACERBATION;PNEUMONIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;DEHYDRATION;ACHONDROPLASIA;HYPERTENSION;SPINAL STENOSIS</td>
<td class="gt_row gt_center">609 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;DIABETES;PERIPHERAL VASCULAR DISEASE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;DIALYSIS LINE OCCLUSION</td>
<td class="gt_row gt_center">345 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;ESOPHAGEAL TEAR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;HEADACHE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;HYPERTENSION</td>
<td class="gt_row gt_center">752 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;KIDNEY FAILURE;METHICILLIN RESISTANT STAPH AUREUS;VRE</td>
<td class="gt_row gt_center">445 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;LEAKING J TUBE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;LEFT LOWER LOBE COLLAPSE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;LIVER FAILURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;LUNG CANCER</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;NQWMI</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;PANCREATITIS</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;PELVIC FRACTURE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;PNEUMOCOCCAL PNEUMONIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;PNEUMONIA</td>
<td class="gt_row gt_center">379 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;PNEUMONIA;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;R/O TB</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;RENAL FAILURE</td>
<td class="gt_row gt_center">444 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;SEPSIS</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;SEPTIC SHOCK</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;SUBGLOTTIC STENOSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">389 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;TM</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;TRACHEAL MALACIA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;TRACHEAL MALASIA;S/P BRONCHOSCOPY</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;TRACHEAL OBSTRUCTION</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE;TRACHEAL STENOSIS</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE/ ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">666 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE/EFFUSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE/G TUBE MALFUNCTION</td>
<td class="gt_row gt_center">153 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY FAILURE/TRACHEAL INJURY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY INSUFFICENCY/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY INSUFFICIENCY</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY INSUFFICIENCY; COPD</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY INSUFFICIENCY/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY INSUFFIENCY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRATORY SYSTEM DISEASE</td>
<td class="gt_row gt_center">756 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPIRTORY FAILURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPITORY DISTRESS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPITORY FAILURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPITORY FAILURE;ACUTE KIDNEY INJURY</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPITORY FAILURE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPORTORY FAILURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPPIRATORY OBSTRUCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPRTORY DISTRESS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESPSIRATORY FAILURE</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESTENOSIS;ASA ALLERGY;ASPIRIN DESENSITIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESTRISTED LUNG DISEASE/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RESUCITATED CARDIAC ARREST</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETAINED PRODUCTS OF CONCEPTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETRO ORBITAL ABCESS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETRO PERITONEAL BLEED</td>
<td class="gt_row gt_center">328 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETRO-PERITONEAL BLEED;SACRAL FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL &amp; LEFT LEG PSEUDOANEURYSM/SDA</td>
<td class="gt_row gt_center">660 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL ABSCESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL AND URINARY BLEEDS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL BLADDER RUPTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL BLEED</td>
<td class="gt_row gt_center">1,236 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL HEMATOMA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL HEMORRHAGE</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL MASS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPERITONEAL MASS/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPHARYNGEAL PHLEGMON\TELEMETRY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROPHARYNGEAL SWELLING</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RETROSTERNAL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RF</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO COMPARTMENT SYNDROME</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO MYOLYSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO; AFIB</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO;LIVER FAILURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO;RENAL FAILURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDO;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMMYOLYSIS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYALASIS;TELEMETRY</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYELOSIS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYOLISIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYOLOSIS;ETOH INTOXICATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYOLOSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYOLSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYOLYSIS</td>
<td class="gt_row gt_center">391 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABDOMYOLYSIS,COMPARTMENT SYNDROME</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHABOMYOLSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHADOMYOLYSIS;SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHC</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHEUMATIC HEART DISEASE;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHEUMATIC HEART DISEASE\ AORTIC AND MITRAL VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RHEUMATIC HEART DISEASE\MITRAL VALVE REPLACEMENT REDO  TRICUSPID VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE AND LUNG PUNCTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE, HEMOTHORAX</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE; ALCOHOL INTOXICATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE; STERNAL FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE;PNEUMOTHORAX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE;PULMONARY CONTUSION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE;S/P PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURE;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURES</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURES-SPLEEN LACERATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURES, PNEUMOTHORAX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURES;PNEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURES;T SPINE FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FRACTURES/VOMITING/</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FX, S/P FALL</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB FX; HIP FX</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB; FX/ ETOH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIB;SCAPULAR FXS;HEMO-PNEUMOTHORAX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT  CORONARY INTERVENTION\RIGHT CORONARY ARTERY DISSECTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT  SUBCLAVIAN ANEURYSM/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ACETABULAR FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ACETABULUM FRACTURE/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ACOUSTIC NEUROMA/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ACQUIRED BREAST DEFORMITY/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ADRENAL MASS/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ADRENAL NEOPLASM/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT AKA STUMP INFECTION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT AND LEFT HEART CATH\CARDIAC CATH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE ARTHOPATHY/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE CELLULITIS; R/O SUBACUTE BACTERIAL ENDOCARDITIS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE EQUINUS/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE FRACTURE</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE FRACTURE-NECROSIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE FRACTURE/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE INFECTION</td>
<td class="gt_row gt_center">398 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE JOINT PAIN/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANKLE WOUND</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ANTERIOR CEREBRAL ARTERY STROKE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ARM  WEAKNESS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ARM CELLULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ARM FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ARM LACERATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ARM SWELLING</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ARM WOUND</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ASPERGILOMA/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ATRIAL CLOT;PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ATRIAL THROMBUS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT AX BIFEM</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BASAL GANGLIA BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BLOODY PLEURAL EFFUSION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BRAIN GLIOBLASTOMA MULTIFORME/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BRAIN MASS/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BRAIN STEM LESION/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BREAST CA/HX OF DCIF LEFT BREAST/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BREAST CA/SDA</td>
<td class="gt_row gt_center">77 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BREAST CANCER/SDA</td>
<td class="gt_row gt_center">374 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BRONCHIAL MASS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BRONCHUS INTERMEDIAS CARCINOID/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT BUTTOCK/THIGH DEFECT/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID BODY TUMOR/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS;CHRONIC RENAL INSUFFCIENCY\RIGHT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS;CORONARY ARTERY DISEASE\RIGHT INTERNAL CAROTID ARTERY ANGIOGRAM;STENT PLACEMENT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS/SDA</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS\RIGHT CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">134 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS\RIGHT CAROTID ANGIOGRAM;ANGIOPLASTY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CAROTID STENOSIS\RIGHT CAROTID ANGIOGRAM;POSSIBLE STENT PLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CEREBELLA LESION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CEREBELLAR HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CEREBELLAR LESION/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CEREBULLUM HEMORRHAGE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CHEST HEMATOMA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CHEST WALL MASS/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CHOLESTEROL CYST/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLLASPE LUNG</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLON CA/SDA</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLON CANCER/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLON MASS;ASCITES</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLON MASS/SDA</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLON POLYP/SDA</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLON TUMOR/SDA</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COLONIC MASS/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COMMON CAROTID ARTERY DISECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT COMMON CAROTID ARTERY W/ INTRAHEPATIC THROMBUS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT CRANIAL FLUID COLLECTION</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ELBOW PAIN/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT EMPYEMA</td>
<td class="gt_row gt_center">163 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FACIAL DROOP</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FAILED TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FEMERAL FRACTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FEMORAL ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FEMORAL NECK FRACTURE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FEMORAL TIBIAL STENOSIS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FEMUR FRACTURE</td>
<td class="gt_row gt_center">43 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FEMUR FX;ACUTE ANEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FIB &amp; TIB FRACTURE</td>
<td class="gt_row gt_center">256 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FLANK ( VENTRAL ) HERNIA/SDA</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FLANK PAIN</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FLOOR OF MOUTH CANCER/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOOT CELLULITIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT BUNION AND HAMMER TOE/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT CELLULITIS</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT CELLULITIS;TELEMETRY</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT CHARCOT/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT CHRONIC ULCER/SDA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT EQUINUS, CHARCOT/SDA</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT FRACTURE</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT GANGRENE</td>
<td class="gt_row gt_center">880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ISCHEMIA</td>
<td class="gt_row gt_center">307 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT OSTEOMYELITIS</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT PAIN</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ULCER</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ULCER W\CELLULITIS</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ULCER-CELLULITIS-DIABETES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ULCER;CELLULITIS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ULCER;CELLULITIS;INFECTION,UKNOWN</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FOOT ULCER/SDA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL BRAIN TUMOR N/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL CAVENOMA/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL COLLOID CYST/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL GLIOBASTOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL LESION/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL LOBE STROKE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL LOBE TUMOR;LOW PLATELETS</td>
<td class="gt_row gt_center">171 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL MASS/SDA</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL MENINGIOMA;SEIZURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL MENINGIOMA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL PARIETAL INTERCRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL PARIETAL STROKE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL SINUS FRACTURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT FRONTAL TUMOR/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT GROIN SARCOMA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT GROIN SARCOMA/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HAND 3RD DIGIT PROXIMAL INTERPHALANGEAL ARTHRITIS AND DEFORMITY; RIGHT HAND 3RD DIGIT STIFFNES/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HAND ISCHEMIA/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEART CATH;HYPERTHROPIC CARDIOMYOPATHY;RENAL INSUFFICIENCY\RIGHT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEART FAILURE</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEART FAILURE;PULMONARY HYPERTENSION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEEL GANGRENE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEEL INFECTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEEL INFECTION;</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEEL OSTEOMYELITIS;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEEL ULCER/SDA</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEMORRHAGIC CVA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEMOTHORAX</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HEPATIC DUCT STRICTURE/SDA</td>
<td class="gt_row gt_center">406 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HILAR MASS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIND FOOT ARTHRITIS/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP ANKYLOSIS/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FRACTURE</td>
<td class="gt_row gt_center">903 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FRACTURE S/P FALL</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FRACTURE;HYPONATREMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FRACTURE;LOWER EXTREMITY CELLULITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FRACTURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FRACTURE/SDA</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP FX</td>
<td class="gt_row gt_center">366 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP HARDWARE DISLOCATION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP HEMATOMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP NECROSIS/SDA</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP NON HEALING WOUND/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP OA/SDA</td>
<td class="gt_row gt_center">2,209 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP OSTEOARTHRITIS/SDA</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP OSTEOMYELITS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP PAIN</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP PAIN/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIP WOUND</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HIPOA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HUMEROUS FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT HYLAR MASS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ICA STENOSIS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ICA STENOSIS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ILIAC ARTERY ANEURYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INFECTED TOTAL HIP /SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INGUINAL &amp; UMBILICAL HERNIA</td>
<td class="gt_row gt_center">840 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INGUINAL HERNIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INGUINAL HERNIA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INGUNAL HERNIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INTERNAL ARTERY STENOSIS;CHEST PAIN;LOWER EXTREMITY CLAUDICATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INTERNAL CAPSULE HEMORRHAGE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INTERNAL CAROTID ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INTERNAL JUGULAR THROMBUS</td>
<td class="gt_row gt_center">455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INTRACRANIAL HEMORRHAGE;C2 FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT INTRACRANIAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KIDNEY CA/SDA</td>
<td class="gt_row gt_center">336 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KIDNEY MASS/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KIDNEY STONE</td>
<td class="gt_row gt_center">241 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KIDNEY TUMOR/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KNEE AO/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KNEE FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KNEE INFECTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KNEE OA/SDA</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KNEE OPEN WOUND INFECTION</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT KNEE OSTEOARTHRITIS/SDA</td>
<td class="gt_row gt_center">826 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG ARTERIAL CLOT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG ARTERIAL INSUFFENCY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG ARTERIAL THROMBOSIS</td>
<td class="gt_row gt_center">861 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG CELLULITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG CLAUDICATION</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG HEMATOMA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG ISCHEMIA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG ISCHEMIA/SDA</td>
<td class="gt_row gt_center">315 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG PAIN</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG REST PAIN/SDA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG RUPTURE QUADRICEPS TENDON/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG SARCOMA/SDA</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG WEAKNESS</td>
<td class="gt_row gt_center">6,460 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LEG WEAKNESS;DEMENTIA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER ETREMITES GANGRENE</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER EXTREMITY FAILED FIXATION/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER EXTREMITY ISCHEMIA</td>
<td class="gt_row gt_center">755 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LEG ISCHEMIA;RIGHT LEG INFRACTION;RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE CANCER;PNEUMONIA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE CANCER/SDA</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE CAVITARY NODULE;MULTIPLE SMALL PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE COLLAPSE;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE LUNG CA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE LUNG MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE MASS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE NODULE/SDA</td>
<td class="gt_row gt_center">173 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER LOBE;LARGE VOCAL CORD MASSES</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LOWER QUADRANT PAIN/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG  CA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG ABSCESS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG CA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG CA/SDA</td>
<td class="gt_row gt_center">522 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG CANCER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG CANCER;WEAKNESS</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG CANCER/SDA</td>
<td class="gt_row gt_center">251 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG LESION\RADIO FREQUENCY ABLATION RIGHT LUNG W/BIOPSY/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG MASS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG MASS;HEMOPTYSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG MASS/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG NODULE/SDA</td>
<td class="gt_row gt_center">119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT LUNG TUMOR/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MANDIBULAR CELLULITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MCA STROKE</td>
<td class="gt_row gt_center">484 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MCA STROKE;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE CERBERAL ANEURYM/SDA</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE CEREBRAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE CEREBRAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE CEREBRAL ARTERY STROKE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE LOBE CA/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE LOBE COLLAPSED;SEPSIS/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE LOBE MASS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE LOBE NODULE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE LOBE OBSTRUCTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT MIDDLE LUNG CANCER/SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT NASAL CARCINOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT NECK ABSCESS</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT NECK MASS</td>
<td class="gt_row gt_center">67 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT NECK NODE/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ORAL TONGUE CANCER/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ORBITAL FRACTURE;S/P FALL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARACOSTASL TUMOR/SDA</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARIETAL BLEED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARIETAL BRAIN MASS</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARIETAL BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">103 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARIETAL HEMORRHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARIETAL METASTATIC LESION/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PARIETAL SUBARACHNOID BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PAROTID MASS/SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PAROTID TUMOR/SDA</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PATELLA FRACTURE/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PATELLA FX-LEFT FEMORAL NECK FX</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PELELLAR FRACTURE;LEFT TIBILAR FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PERIATAL TUMOR/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PHARYNGEAL LESION</td>
<td class="gt_row gt_center">528 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PLEURAL EFFUSION</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PLEURAL EFFUSION CIRRHOSIS PHT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PLEURAL EFFUSION;LOWER EXTREMITY EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PLEURAL EFFUSION;MULTIPLE PULMONARY EMBOLI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PLEURAL EFFUSION/SDA</td>
<td class="gt_row gt_center">584 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PNEUMOTHORAX</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT POPLITEAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT POPLITEAL ARTERY STENOSIS/SDA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT POST CIRCULATING ARTERY STROKE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PROXIMAL HUMERUS FRACTURE/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PROXIMAL TIBIA SARCOMA/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT PULMONARY NODULES/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RECURRENT PLEURAL EFFUSION/SDA</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL CA/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL CALCULI;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL CELL CANCER W/VENA CAVA THROMBUS/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL CELL CANCER/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL MASS</td>
<td class="gt_row gt_center">73 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL MASS/SDA</td>
<td class="gt_row gt_center">281 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL STENOSIS;CORONARY ARTERY DISEASE;RENAL INSUFFICIENCY\RIGHT RENAL ARTERY ANGIOGRAM;STENT PLACEMENT;CORONARY ANGIOGRAPHY</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL STONE DISEASE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RENAL STONE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RIB FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT RIB MASS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT ROTATOR CUFF TEAR;POORBLOOD GASES;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SCV CLOT;RIGHT BC VEIN CLOT;TELEMETRY</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SHOULDER ADHESIVE CAPSULITIS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SHOULDER DISLOCATION;ULNAR NERVE INVOLVEMENT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SHOULDER FRACTURE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDE FRONTAL BRAIN LESION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDE GLIOMA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDE HEART FAILURE; TRICUSPID REGURGITATION\ICD LEAD EXTRACTION</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED CEREBRAL MENINGIOMA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED EVACUATION OF SUBDRUAL HEMATOMA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED FACAIL WEAKNESS, DYSPHAGIA, DIPLOPIA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED HEART FAILURE;CONGENITAL HEART DISEASE</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED INTERCRANIAL MASS/ICH</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED MENINGIOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED PNEUMONIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED TEMPORAL GLIOMA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED TRIGEMINAL NEURALGIA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED WEAKNESS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SIDED WEAKNESS;ANEMIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT STUMP GANGRENE;N/V</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SUBCLAVIAN ARTERY PSEUDOANEURYSM</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TEMPLE LESION/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TEMPORAL ICH;ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TEMPORAL MASS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TEMPORAL MASS;SEIZURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TEMPORAL MENIGIOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TEMPORAL/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT THALMIC HEMORRHAGE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT THIGH EXTENSIVE HETEROTOPIC OSSIFICATION/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT THORACTOMY MVR</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TIBIA FRACTURE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TIBIAL NON-UNION; RIGHT LEG TIBIAL DEFECT/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TOE INFECTION</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TOE ISCHEMIA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT TUMOR FRONTAL/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPJ STRICTURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER EXTREMITY DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER EXTREMITY HEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE CA/SDA</td>
<td class="gt_row gt_center">352 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE CANCER/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE LUNG CA/SDA</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE LUNG CANCER/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE LUNG MASS;COPD</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE LUNG NODULE/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE MASS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE MASS/SDA</td>
<td class="gt_row gt_center">121 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE MASSES/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE NODULE/SDA</td>
<td class="gt_row gt_center">656 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER LOBE PNEUMONIA</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER NODULE/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER POLE MASS/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER QUADRANT PAIN</td>
<td class="gt_row gt_center">607 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER QUADRANT PAIN;GASTROESOPHAGEAL REFLUX DISEASE;CHOLECYSTITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT UPPER QUADRANT PAIN;OLD AORTIC DISSECTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT URETERAL CA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT URETERAL CALCULI\URETEROSCOPY WITH LASER LITHOTRIPSY RIGHT</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT URETERAL CALCULUS</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT URETERAL STONE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT URETERAL STRICTURE/SDA</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT VENTRICULAR ANEURYSM\RESECTION RIGHT VENTRICULAR ANEURYSM /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT VENTRICULAR INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT VENTRICULAR LEAD MALFUNCTION;INAPPROPRIATE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FRING\RIGHT VENTRICULAR IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR LEAD EXTRACTION/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT VENTRICULAR MASS\RIGHT VENTRICULAR MASS EXCISION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT VENTRICULAR TUMOR</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT VISION LOSS</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT WING MENINGIOMA/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT WRIST FRACTURE;S/P FALL</td>
<td class="gt_row gt_center">1,503 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT WRISTS FRACTURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT-SIDED PARALYSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT-SIDED WEAKNESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHT,LEFT EX-FIX HOWEDIC</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGHTBRONCHUS MASS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIGID BRONCHOSCOPY\RIGID BRONCHOSCOPY</td>
<td class="gt_row gt_center">531 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RIP FRACTURES</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RITUXIMAB DESENSITIZATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RLE CELLULITIS</td>
<td class="gt_row gt_center">960 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RLE CELLULITIS, LIVER FAILURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RLE ISCHEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RLE THROMBOSIS</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RO/MI</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ROLLOVER MVC</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ROMI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ROOT ABSCESS</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ROP;SEIZURES</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ROTATOR CUFF TEAR;RIGHT SHOULDER</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RP BLEED</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RP BLEED;HYPOTENSION</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RP BLEED/ HEMATOMA</td>
<td class="gt_row gt_center">126 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RP HEMATOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RPA;SUPRAGLOTITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RRA STENOSIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RRETROPERTONAL HEMATOMA,FEVER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RSV PNUEMONIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT BASAL GANGLIA BLEEDING</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT CAROTID STENOSIS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT CEREBELLAR BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT CEREBELLAR INFARCTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT EYE INFLAMMATION,VISION LOSS,HEPATITIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FLANK STABBING</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FOOT CELLULITIS,DIABETIC KETO ACIDOSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FOOT ISCHEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FOOT OSTEOMYELITIS-DM-HYPONATREMIA</td>
<td class="gt_row gt_center">230 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FOOT ULCER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FOREARM LACERATION-ULNAR NERVE INJURY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT FRONTAL CONTUSION</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT HIP FRACTURE,R/O MI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT LEG ARTERIAL OCCLUSION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT LEG ISCHEMIA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT LEG SWELLING</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT LOWER EXTREMITY CELLULITIS;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT LOWER EXTREMITY STENT FAILURE</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT LOWER LOBE PNEUMONIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT MCA STROKE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT PLEURAL EFFUSION,R/O CA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT SIDED SUB ARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT SUBDURAL BLEED</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT THIGH HEMATOMA,R/O MI</td>
<td class="gt_row gt_center">483 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT TIBIA,FIBULA FRACTURES</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT TMA-DM-CELLULITIS-RENAL FAILURE</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT UPPER EXTREMITY CRUSH INJURY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT UPPER EXTREMITY SWELLING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RT UPPER QUADRANT ABSCESS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUE INFECTION</td>
<td class="gt_row gt_center">462 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUE PAIN;SWELLING</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE IN MI, CHEST PAIN</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE IN MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OTU CORONARY ARTERY DISEASE; SEVERE MITRAL REGURGITATION\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT AORTIC ROOT ABSCESS</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT BOWEL PERFORATION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CEREBROVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CEREBROVASCULAR ACCIDENT;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CORONARY ARTERY DISEASE; CHEST PAIN\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CORONARY ARTERY DISEASE;ABNORMAL STRESS TEST\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CORONARY ARTERY DISEASE;CARDIAC ISCHEMIA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CORONARY ARTERY DISEASE;DEPRESSED LEFT VENTRICULAR FUNCTION\CARDIAC CATH RIGHT AND LEFT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT CORONARY ARTERY DISEASE\LEFT HEART CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT GUILLAIN BARRE SYNDROME;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT INSULINOMA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT LINE SEPSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT LYMPHOMA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT MEAINGITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT MYCARDIAL INFRACTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT MYOCARDIAL INFARCTION PNEUMONIA </td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT MYOCARDIAL INFARCTION;CHEST PAIN;HYPERTENSION;TELEMETRY</td>
<td class="gt_row gt_center">375 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT TIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE OUT TUBERCULOSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">1,144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;R/O PE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;S/P PACER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">5,218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY; CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY; CP</td>
<td class="gt_row gt_center">6,455 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;?CVA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;CVA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;FREQUENT FALLS</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;HYPERTENSION</td>
<td class="gt_row gt_center">314 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;HYPOTENSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;HYPOXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;PNEUMONIA</td>
<td class="gt_row gt_center">437 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;PVD</td>
<td class="gt_row gt_center">530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;RIGHT PNEUMOTHORAX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;RIGHT-HAND ISCHEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;S/P FALL</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;THORACIC AORTA INTRAMURAL HEMATOMA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFRACTION</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFRACTION;TELEMETRY</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RULE-OUT MYOCARDIAL INFRACTION;VOMITING;RAPID AFIB</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURE AORTIC ANEURYSM</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURE ESOPHAGUS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED AAA</td>
<td class="gt_row gt_center">442 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED ABDOMINAL AORTIC ANEURYSM</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED ADRENAL </td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED ANEURYSM</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED ANGIOMIOLIPOMA, RIGHT/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED AORTA</td>
<td class="gt_row gt_center">237 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED AORTIC ANEURYSM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED AORTIC PLAQUE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED ASCENDING AORTIC GRAFT</td>
<td class="gt_row gt_center">207 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED BLEB/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED DIAPHRAGM</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED DIAPHRAM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED DIAPHRAM;FRACTURED FEMUR</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED DIVERTICULITIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED DIVERTICULUM</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED DUODENAL ULCER</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED FISTULA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED GRAFT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED MEMBRANES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUPTURED SPLEEN</td>
<td class="gt_row gt_center">226 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RUQ PAIN</td>
<td class="gt_row gt_center">326 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">RV THROMBIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S T ELEVATED ION MI</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S T ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S-T ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S-T ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S-T ELEVATIONS;MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/O CABG WITH CHF</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/O COLECTOMY</td>
<td class="gt_row gt_center">483 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/O MOTOR VEHICLE ACCIDEMT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/O MVA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/OP MVA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P  CHOLECYSTECTOMY/BILE LEAK</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P  FALL</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P  MOTORCYCLE ACCIDENT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ,VC;R RIB FRACTURE;L FIB -TIB FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P 20FT FALL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P 25 FT FALL</td>
<td class="gt_row gt_center">462 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P 30 FOOT FALL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P 45 FOOT FALL</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P AAA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P AAA REPAIR</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ABDOMAL SURGER</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P AIRPLANE CRASH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ANTERIOR MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P AORTIC DISSECTION</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P AORTO FEMORAL BYPASS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P APPENDECTOMY</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P APPENDECTOMY;NAUSEA;VOMTING</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P APPY LARGE LEG PE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ARREST</td>
<td class="gt_row gt_center">1,390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ARREST AT REHAB</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ARREST;CERVICAL FX</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ARREST;COPD FLARE</td>
<td class="gt_row gt_center">1,617 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASD REPAIR;S/P MVR\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASSAULT</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASSAULT-LEFT ORBITAL FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASSAULT-SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASSAULT, ICH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASSULT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ASYSTOLIC ARREST</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ATV ACCIDENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P AV GRAFT</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BICYCLE ACCIDENT</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BICYCLE/CAR CRASH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BIKE ACCIDENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BIKE ACCIDENT WITH MULTIPLE FX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BIKE CRASH-MANDIBULAR FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BILATERAL CRANIOTOMY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BILATERAL HERNIA REPAIR</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BKA;GANGRENE LEFT FOOT/SDA</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BLAST INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BLUNT TRAUMA TO HEAD</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BOATING ACCIDENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BOWEL PERFORATION/SDA</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P BRONCHOSCOPY</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P C SECTION,D.I.C.</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P C2FRACTURE TYPE 2;OPEN REDUCTION INTERNAL FIXATION</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CABG</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CABG; CHF</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CABG\STERNAL PLATING /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CABG\STERNAL WIRE REMOVAL/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CADAVER RENAL TRANSPLANT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">2,719 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC ARREST;CATH LAB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC ARREST;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC ARREST;UPPER GI BLEED</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC ARREST/CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC ARREST\CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC CATH</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CARDIAC CATH PLACEMENT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CATH</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CATH;?CABG\CATH</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CATH;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CATH;FOR SURGICAL REVASCULARIZATION\CATH</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CATH\CATH</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CEREBRAL ANGIOGRAM;CAROTID STENOSIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CEREBRAL CONTUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CHEST CONTUSION/CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CHOCKING,PERFORATED BOWEL</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CHOLECYSTECTOMY;? BILE LEAK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P COLECTOMY/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P COLON RESECTION; ?ISCHEMIA</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CRANI</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CRANIOTOMY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CVA,FAILURE TO THRIVE</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CVA;CAROTID STENOSIS\CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P CVA;FEVER OF UNKNOWN ORIGEN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P D&amp;C;ABDOMINAL HYSTERECTOMY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P DEBRIDEMENT OF NECK FASCIA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P DILATION &amp; CURTTAGE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P DIRT BIKE CCIDENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P EPILEPTICUS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ERCP </td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ERCP W/ SPHINCTOROTOMY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ERCP WITH ? PERF</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ERCP;BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ESPIRATORY ARREST</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P EXP. LAP;SPLEENECTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P EXPLORATORY LAPAROTOMY</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FAL</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL</td>
<td class="gt_row gt_center">14,691 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL 10 FEET;RIB FRACTURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL C1 FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL TEMP. FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL TRAUMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL WITH AORTIC INJURY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL WITH C2 FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL WITH CERVICAL FRACTURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-C5 FRACTURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-CHEST HEMATOMA-POSSIBLE TRAUMA TO KIDNEY</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-CONTUSION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-HEAD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-HEMOTHORAX-SPINE FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-INTRACRANIAL CONTUSION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-MULTIPLE INJURIES</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-NECK LACERATION-SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-PNEUMOTHORAX RIB FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-RIGHT HIP PAIN</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-SEIZURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL-SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL, L EYE INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL, S/P R/O MI</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL, SPINAL CORD INJURY</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL, SUBDURAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,FRONTAL CONTUSIONS,R RIB/WRIST FX</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,HAND INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,HIP FRACTURE</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,ICH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,L2 BURST FX</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,LT FRONTAL HEAD BLEED,SUB ARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,RT FEMUR FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,SDH,SAH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL,TRAUMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL; ANEMIA</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL; HEAD INJURY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL; SPINE FX</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL; SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;BLEEDING;HYPOTENSION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;C2 FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;CERVICAL SPIN FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;DEHYDRATION;ALTERED MENTAL CHANGES</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;DROWNING</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;END STAGE RENAL DISEASE;FRACTURE,LEFT SIDE RIB</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;FACIAL FRACTURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;HEAD BLEED</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;HEAD LACERATION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;HIP FRACTURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;HIP PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;ICH</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;L4 BURST FRACTURE;RIB FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;LEFT EPIDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;MULTIPLE FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;PAIN CONTROL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;PTX;RIB FRACTURE;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;RIB FRACTURE;PNEUMOTHORAX</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;RIB FRACTURES</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SKULL FRACTURE;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SPLENIC LACERATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;STAB WOUND;POLYTRAUMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SUBARACHNOID HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SYNCOPE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;SYNCOPE;R/O ISCHEMIC EVENT</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;TELEMETRY</td>
<td class="gt_row gt_center">1,093 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;THORACIC FRACTURE;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL;WRIST FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL/MULTIPLE FRACTURES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FALL/R/O SPINAL CORD INJURY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FEMORAL ENDARARECTOMY</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P FETAL DEMISE,BLEEDING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P G-TUBE PLACEMENT</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GASTRIC BY PASS;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GASTRIC BYPASS,CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GASTRIC BYPASS;?GASTRIC PERFORATION</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GUN SHOT WOUND</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GUN SHOT WOUND TO HEAD</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GUN SHOT WOUND TO NECK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GUN SHOT WOUND-COCAINE OVERDOSE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GUNSHOT WOUND</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P GUNSHOT WOUND TO ABD;PARALYSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HANGING</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HANGING-CARDIAC ARREST</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HEAD BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HEAD INJURY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HEAD TRAUMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HEMI CRANIECTOMY/SDA</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HERNIA REPAIR</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HIP FX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HIP REPLACEMENT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P HIT BY CAR;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ILEOSTOMY; DIABETES INSIPIDIS; SCHIZO-AFFECTIVE DISORDER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P IMI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P IMI\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P INFARCT\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P INFERIOR MI\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P INJURY CRUSHING</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P JET SKI ACCIDENT</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P JUMP</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P JUMP FROM MOVING VEHICLE </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY PANCREAS TRANSPLANT;DEHYDRATION</td>
<td class="gt_row gt_center">1,224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">298 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT-ELEVATED CREATININE</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT, ELEVATED CREOTINE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT,FEVER</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT; URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;?REJECTION</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;BACTEREMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;BIOPSY BLEED;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;FEVER</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;FEVERS</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;INCREASED CREATINE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;INCREASED CREATININE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;PANCREATITIS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;SEPSIS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TRANSPLANT;URINARY RETINTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TX</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TX-PULMONARY EDEMA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TX,ARF,RESP DISTRESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY TX,PRE OP PANCREAS TX</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY-PANCREAS TX-R/O PNEUMONIA</td>
<td class="gt_row gt_center">385 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY;ACUTE RESPIRATORY FAILURE; ? MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY/PANCREAS TX-LEFT LEG CELLULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P KIDNEY/TRANSPLANT RENAL FAILURE</td>
<td class="gt_row gt_center">516 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P L.ELBOW FRACTUR, PNEUMONIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LAP CHOLE WITH LEAK</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER &amp; KIDNEY TX-HYPERKALEMIA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER ABSCESS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSFER;FEVER</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT</td>
<td class="gt_row gt_center">913 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT QUESTION REJECTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT; R/O RIB FRACTURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;? REJECTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">623 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;ELEVATED LIVER FUNCTION TEST\PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAM  **REMOTE WEST INR SUITE CC3**/SDA</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;GI BLEED</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;HEPATIC ARTERY THROMBOSIS</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;R/O CMV</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;R/O REJECTION;S/P MI</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;REJECTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT;SEIZURE</td>
<td class="gt_row gt_center">1,780 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TRANSPLANT\TUBE CHOLANGIOGRAM ? BALLOON DILATATION **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX ASCTES CONFUSION</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX N;V;D</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX-GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX-NAUSEA-VOMITING</td>
<td class="gt_row gt_center">285 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX, FEVER</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX,NAUSEA,VOMITING</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX; FEVER; MALAISE</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX;ELEVATED LFTS</td>
<td class="gt_row gt_center">595 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER TX;NAUSEA;VOMITING;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVER/NAUSEA/VOMITING/DIARRHEA</td>
<td class="gt_row gt_center">385 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P LIVERTX,ELEVATED LFT&#39;S</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MCC</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MCC;OPEN TIB/FIB FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MCC;PNEUMOTHORAX;OPEN TIBIA FIBULA FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MEGA COLON/SDA</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI</td>
<td class="gt_row gt_center">722 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI; UNSTABLE ANGINA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI;CHEST PAIN;AORTIC STENOSIS\? CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI;ISCHEMIC LEFT LEG</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI;POST INFARCT ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI\CATH</td>
<td class="gt_row gt_center">631 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI\LEFT HEART CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR  VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR CYCLE CRASH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR ROLLOR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VECHICLE ACCIDENT</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICAL ACCIDENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICHLE CRASH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICKE ACCIDENT</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCCIDENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDEMT</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">3,194 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT ROLLOVER;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT WITH INJURIES;RIGHT FEMUR HEAD FRACTURE;DISLOCATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-BILAT FEMUR FRACTURES</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-BLUNT TRAUMA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-CERVICAL SPINE FX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-CHEST TRAUMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-DISSECTING ANEURYSM</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-EDH-SUBARAHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-FACIAL TRAUMA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-FEMUR FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-HEAD TRAUMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-OPEN TIBIA/FIBIA FX</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-SPLENIC LACERATION&#39;</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT-STABBING</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT; SUBARACHNOID HEMORRHAGE; C2 FRACTURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;ARREST</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;BRACHIAL ARTERY INJURY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;C2 FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;DIAPHRAGMATIC RUPTURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;EPIDURAL HEMATOMA;LEFT FEMUR FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;FACIAL FRACTURES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;FEMUR FX</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;HEMOTHORAX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;LEFT PNEUMOTHORAX;LEFT HIP FX;LEFT ANKLE FX</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;MULTISYSTEM TRAUMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;PELVIC FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;RIGHT ARM FX</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;SPLENIC LAC;SKULL FRACTURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;SPLENIC LACERATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDENT;TELEMTRY</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE ACCIDNENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE CRASH</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE CRASH WITH SUBRACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEHICLE CRASH/FLAIL CHEST</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTOR VEWHICLE ACCIDENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTORCYCLE ACCIDENT</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTORCYCLE ACCIDENT WITH MULTIPLE INJURIES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTORCYCLE ACCIDENT;?RUPTURED AIRWAY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTORCYCLE ACCIDENT;BLUNT TRAUMA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MOTORCYCLE CRASH</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MPOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MULTIPLE STAB WOUNDS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA</td>
<td class="gt_row gt_center">1,027 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA WITH INJURIES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA-C5-6 FX-RT1ST LT CLAVICLE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA-MESENTERIC HEMATOMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA, FACIAL FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA, HEAD BLEED</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA,SPLENIC LACERATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA; FACIAL TRAUMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA; LX IPH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA; SPINAL CORD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA;MULTIPLE FRACTURES</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA;PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVA;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC R SUBARACHNOID BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC, LIVER LACERATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC, SAH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC,HEAD INJURY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC,TRAUMA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;C-1 FRACTURE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;COMPAT SYNDROME;TIB FRACTURE</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;HEAD INJURY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;LIVER LACERATION;RIGHT ANKLE FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;SKULL FX;PELVIS FX</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MVC;SYNCOPE</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MYOCARDIAL INFARCTION;CHEST PAIN;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NAIL THROUGH EYE INTO BRAIN</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NECK EXPLORATION</td>
<td class="gt_row gt_center">97 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NECROTIZING FASCITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NON Q MI;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NON Q MI\CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NON Q W MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NON Q WAVE MI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NON Q WAVE MI;ALTERED MENTAL STATUS\CATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NON Q WAVE MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NQMI\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NQW MI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NQW\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P NQWMI\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P ORIF TIBIA FX</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PACEMAKER;PLEURAL EFFUSION;SP PNEUMOTHORAX\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PANCREATIC TX-RIGHT ABDOMINAL PAIN</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEA ARREST</td>
<td class="gt_row gt_center">215 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRAIN STRUCK</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">422 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK BY CAR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK BY TRAIN</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK-INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK-SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK-TIBIA PLATEAY</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PEDESTRIAN STRUCK;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PELVIC FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PLEUROSCOPY WITH PLEURIDESIS;CHEST TUBE PLACEMENT;PLEURX CATHETER PLACEMENT;PNEUMOTHORAX</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P POSTERIOR LAMINECTOMY</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PULSELESS ARREST</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P PULSELESS ELECTRICAL ACTIVITY; R/O MI</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P R. LOBECTOMY,FEVER OF UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RECENT MI AND AS/MR</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P REINPLANT RIGHT INDEX FINGER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P REJECTION KIDNEY TRANSPLANT</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RENAL STENT PLACEMENT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RENAL TRANSPLANT;HYPERTENSIVE URGENCY</td>
<td class="gt_row gt_center">880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RESECTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RESECTION AND GRAFTING OF ASCENDING AORTA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RESPIRATORY ARREST</td>
<td class="gt_row gt_center">498 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RESPIRATORY/CARDIAC ARREST</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RIGHT COLECTOMY; BOWEL RESECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RIGHT CRANIOTOMY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RIGHT GROIN EXPLORATION;? ANGIO</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RIGHT SIDE CRANIOTOMY</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P RIGID BRONCH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SEIZURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SEIZURE ATTACH,ETOH ABUSE</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SEPSIS</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SHUNT</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SKIING ACCIDENT</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SMALL BOWEL OBSTRUCTION;SEPSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SMALL BOWEL RESECTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SPHINCTEROTOMY</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SPLEENECTOMY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SPLENECTOMY;POLYCYTHEMIA VERA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STAB WOUND</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STAB WOUND TO CHEST</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STAB WOUND TO EYE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STAB WOUNDS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STABBIMG</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STABBING</td>
<td class="gt_row gt_center">149 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STRANGULATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STROKE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P STRUCK BY CAR</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P SVT;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P THROMBECTOMY</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TIA/ CAROTID STENOSIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TOTAL COLECTOMY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRACHEA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRACHEAL STENT;FAILURE TO WEAN</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRANSPLANT</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRAUMA</td>
<td class="gt_row gt_center">217 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRAUMA-PNEUMOTHORAX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRAUMA,BASILAR SKULL FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRAUMA;CHRONIC ALCOHOLISM;DT</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TRAUMA;NEUROLOGIC INJURY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TREE LIMB FELL ON PATIENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P TWELVE FOOT FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P V - FIB ARREST/ CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P V FIB ARREST</td>
<td class="gt_row gt_center">199 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P V TACH ARREST</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P V-FIB ARREST</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P VENTRICULAR FIBRILLATION ARREST;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P VF ARREST</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P VF ARREST </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P VF ARREST;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">288 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P VFIB ARREST</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P VTACH</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/P WITHDRAWAL SEIZURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/PFALL</td>
<td class="gt_row gt_center">140 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S/PO FALL</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">S\P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SABARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SACRAL DECUBITUS,SHORTNESS OF BREATH,HYPOTENSION</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SACRAL FRACTURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SACRAL METASTASIS/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SADDLE EMBOLUA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SADDLE PE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SADDLE PULMONARY EDEMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SADDLE PULMONARY EMBOLUS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAFE BED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAGITAL SINUS THROMBOSIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH</td>
<td class="gt_row gt_center">534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH S/P ASSAULT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH S/P FALL</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH,SDH,S/P FALL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH,TIB/FIB FX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH; HYPOTENSION</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;ANKLE FX</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;FEMUR FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;PEDISTRIAN STRUCK</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;SDH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH;VETEBRAL DISSECTION;TROP LEAK</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH&#39;</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH/HYPERTENSION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH/S/P FALL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAH/SDH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SALICYLATE OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SALICYLATE TOXICITY</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SALT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SAMILIAL POLYPOSIS COLI/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SARCOMA LEFT FEMUR/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SARCOMA LEFT PELVIS &amp; GROIN/SDA</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SARCOMA SCALP/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SARCOMA/SDA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SATUS POST TACH ARREST</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SBO</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SBP VS INCARCERATED HERNIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCALP LACERATION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCALP LESIONS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCALP WOUND, EXPOSED HARDWARE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCAPULA FRACTURE;HUMERUS FRACTURE;PULMONARY CONTUSION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCHATZKI&#39;S RING</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCHLEROSING CHOLANGITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCI</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCIATIC NEUROPATHY</td>
<td class="gt_row gt_center">310 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCLEROSING CHOLANGITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCLOLIOSIS, STENOSIS/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCOLIOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCOLIOSIS /SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCOLIOSIS,STENOSIS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCOLIOSIS;RESPIRAORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCOLIOSIS/SDA</td>
<td class="gt_row gt_center">840 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCROTAL ABSCESS</td>
<td class="gt_row gt_center">879 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCROTAL CELLULITIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCROTAL EDEMA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCROTAL INFECTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SCROTAL PYOCELE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH + S/P CARDIAC ARREST</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH AND FEMUR FX</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH BILATERAL</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH, S/P FALL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH; HEMATOMAS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH;PNEUMONCEPHAMUS,BLUNT HEAD INJURY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH;SAH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH/HEART BLOCK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH/SAH</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDH/SAH/ETOH WITHDRAWL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SDHS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEAZURES;CVA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECOND DEGREE AV BLOCK</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECOND DEGREE BLOCK;? STROKE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECOND DEGREE ESOPHAGEAL CANCER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECOND DEGREE HEART BLOCK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECONDARY MALIGNANT NEOPKASM BONE AND BONE MARROWP PERSONAL HX MALIGNANT NEOPLASM KIDNEY/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECONDARY MALIGNANT NEOPLASM BONE AND BONE MARROW LEFT FEMUR/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SECONDARY MALIGNANT NEOPLASM OF BONE AND BONE MARROW/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEGMENT ELEVATION MYOCARDIAL INFACTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEISURE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE</td>
<td class="gt_row gt_center">21,736 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE DISORDER</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE DISORDER;PNEUMONIA;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">1,885 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE DISORDER/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE VS STROKE</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE WITH ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE-HYDROCEPHALUS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE-MRSA IN SPUTUM</td>
<td class="gt_row gt_center">1,885 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE-R/O CEREBROVASCULAR ACCIDENT</td>
<td class="gt_row gt_center">320 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE-TRAUMA-C-SPINEFRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE, BRAIN METS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE, DT&#39;S</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE, MET TO BRAIN</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE,ASPIRATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE,FEEVER</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE,FEVER</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE,NAUSEA,VOMITING</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE,RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE,RHABDOMYOLSIS,FEVER</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE; BRAIN METASTASES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE; HYPONATREMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;? CVA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;ALCOHOL WITHDRAWAL;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;BRAIN &amp; LUNG MASSES</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;BRAIN METS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;DIABETIC KETOACIDOSIS;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;FEVER</td>
<td class="gt_row gt_center">345 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;GLIOBLASTOMA MULTIFORME</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;HEAD BLEED;28 WEEKS ANTEPARTUM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;HEAD MASS</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;HEPATIC ENCEPHALOPATHY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;HYPOGLYCEMIA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;HYPONATREMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;LEFT PARIETAL LESION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;POSSIBLE STROKE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;SEPSIS</td>
<td class="gt_row gt_center">1,885 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;STATUS EPILEPTICUS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;STROKE;TELEMETRY;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;TELEMETRY</td>
<td class="gt_row gt_center">446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;UNRESPONSIVE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE/ CHEST PAIN</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE/DIABETIC KETOACIDOSIS/ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">364 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURE/TACHYCARDIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES</td>
<td class="gt_row gt_center">6,284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES AND SKULLTUMOR</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES HEAD MASS</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES,HYPOGLYCEMIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES,MULTIPLE SCLEROSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;BRAIN MASS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;EPILEPSY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;FEVER</td>
<td class="gt_row gt_center">510 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">4,928 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;OVARIAN CARCINOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;OVERDOSE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;RAPID HEART RATE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;TELEMETRY</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES;TOTAL HIP REPLACEMENT</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES/HEMOPTITIS</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEIZURES/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SELLA MASS</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SENCONDAR LESION TO SPINE/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SENCONDARY MALIGNANT NEOPLASM OF BONE AND BONE MARROW/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SENSORY MOTOR NEUROPATHY</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPATIC ENCEPHALAPATHY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPIS</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPISI/RESPIRATORY ARREST</td>
<td class="gt_row gt_center">679 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSI</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS</td>
<td class="gt_row gt_center">267,218 (3.5%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS LIKELY LINE INFECTION</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS S/P BILL KNEE REPL</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS VS CARDIOGENIC SHOCK</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS WITH DIC</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-CHOLANGITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-FEVER</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-HYPERGLYCEMIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-MYOCARDIAL INFARCTION-HEAD BLEED</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-PNEUMONIA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS-S/P ARREST</td>
<td class="gt_row gt_center">414 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, GI BLEED, ESOPHAGEAL CA</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, HYPOSTENSION</td>
<td class="gt_row gt_center">1,309 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, MET CA ESOPHAGEAL</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, PE, RENAL FAILURE</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, PNEUMONIA</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS, R/O MI</td>
<td class="gt_row gt_center">637 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,ADULT RESPIRATORY DISTRESS SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,CHF</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,COLONIC OBSTRUCTION</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,FEVER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,HYPERGLYCEMIA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,HYPERKALEMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,HYPERSTENSION, RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,INFECTED LEG ULCERS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,PNEUMONIA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,PNEUMONIA,SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,RENAL FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,STROKE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS,URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; BLADDER CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; PERITONITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; PULMONARY EDEMA; DIABETES MELLLITUS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; RENAL FAILURE</td>
<td class="gt_row gt_center">101 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; S/P RENAL TX</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; UTI</td>
<td class="gt_row gt_center">3,458 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS; UTI; PYELONEPHRITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;?SBP</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ACUTE PANCREATITIS;RENAL FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ACUTE RESPIRATORY DISTRESS SYMDROME</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ATRIAL FLUTTER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CARDIAC ISCHEMIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CELLULITIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CELLULITIS;TELEMETRY</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CHOLANGITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CHOLEDOCHOLITHIASIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;DIARRHEA;NAUSEA;VOMITING;RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;DISSEMINATED INTRAVASCULAR CLOTTING</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ENDOCARDITIS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;EPIDURAL ABCESS</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;FAILURE TO WEAN</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;FEVER</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;FEVER;NEUTROPENIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;HEMOLYSIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;HEPATIC ABSCESS;TELEMETRY</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;HYPOTENSION</td>
<td class="gt_row gt_center">279 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;HYPOTENSION;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;HYPOTENSION;HYPOXIC;OVARIAN CA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;HYPOXIA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ICD LEAD INFECTION</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;ILEUS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;INFECTED RENAL STONE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;JYPOTENSION</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;LEFT FOOT ULCER</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;LIVER FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;LIVER FAILURE;SHORT GUT SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;MEDIASTINITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">585 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;METHICILLIN RESISTANT STAPH AUREUS;VANCOMYCIN RESISTANT ENTEROCOCCUS</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;MITRAL VALVE INFECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">660 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;PACEMAKER SITE INFECTION\EPICARDIAL PACEMAKER PLACEMENT</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;PILONIDAL ABSCESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;PNEUMONIA</td>
<td class="gt_row gt_center">417 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">207 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;PNEUMONIA;URINE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;PYELONEPHRITIS;HYPOGLYCEMIA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RECTAL MASS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RENAL FAILURE</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RESPIRATORY DISTRES</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RESPIRATORY FAILURE;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RESPIRATORY FAILURE;TELEMETRY</td>
<td class="gt_row gt_center">5,088 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;RESPITORY FAILURE</td>
<td class="gt_row gt_center">2,676 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;S/P CHOLY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;S/P CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;S/P V-FIB ARREST</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;SIGMOID VOLVULUS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;SINUS TRACT DRAINAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">10,782 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;TELEMETRY;FEVER,UNKNOWN ORIGIN</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;TELEMETRY;METHICILLIN RESISTANT STAPH AUREUS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;TELEMTRY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;THROMBOCYTOPENIA;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;UGIB</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;UNRESPONSIVE</td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;UNRESPONSIVE;CHRONIC LYMPHOCYTIC LEUKEMIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;URINARY TRACT INFECTION;PNEUMONIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;VOMITING;DIARRHEA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;WEAKNESS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS;WOUND INFECTION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS.</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/ AFIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/ CHEST PAIN</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">1,390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/CELLULITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/ERCP</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/FEVER</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPSIS/HYPOTENSION</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTAL DEFECT\ATRIAL SEPTAL DEFECT CLOSURE ? CORONARY ARTERY BYPASS GRAFT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTAL DEFECT\PATENT FORAMEN OVALE MINIMALLY INVASIVE /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTAL DEFECT\REPAIR ATRIAL SEPTAL DEFECT LIMITED ACCESS /SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTAL DEFECT\REPAIR ATRIAL-SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTAL ETHANOL ABLATION\R+L HEART CATH;SEPTAL ETHANOL ABLATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC</td>
<td class="gt_row gt_center">263 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC ARTHRITIS</td>
<td class="gt_row gt_center">2,812 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC BURSITIS;RESPIRATORY DISTRESS;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC EMBOLI</td>
<td class="gt_row gt_center">237 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC ENDOCARDITIS</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC HIP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC KNEE</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC KNEE;PNEUMONIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC LEFT TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC LT HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC MENINGITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC PULMONARY EMBOLI</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC RIGHT HIP</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC RIGHT KNEE;CHRONIC OBST PULM DISEASE;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK</td>
<td class="gt_row gt_center">1,771 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK &amp; PNEUMONIA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK W\NEUTROPENIA;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK,RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK; LIVER ABCESS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK;CELLULITIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK;CHOLANGITIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK;PNEUMONIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOCK;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC SHOULDER</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC THROMBOPHLEBITIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC TOTAL HIP REPLACEMENT/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTIC; SEIZURES</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTICEMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEPTICK SHOCK</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEROQUEL OVERDOSE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEROTONIN SYNDROME</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SESIS,EMPYEMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVER ANEMIA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVER AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT; PATENT FORAMEN CLOSURE; AORTIC ROOT REPLACEMENT /SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVER HEAD INJURY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE ACUTE PANCREATITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE ANEMIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;? ISCHEMIA\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;CHEST PAIN;ATRIAL FIBRILLATION\RIGHT AND LEFT HEART CATHERTERIZATION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;CONGESTIVE HEART FAILURE;SEVERE BILATERAL LEG PAIN\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;CONGESTIVE HEART FAILURE\CARDIAC CATH WITH AORTIC VALVULOPLASTY</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;CONGESTIVE HEART FAILURE\CATH/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;S/P CABG\CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS;TRICUSPID REGURGITATION;STATUS POST MECHANICAL MITRAL VALVE REPLACEMENT\CARH</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS\ AORTIC VALVE LIMITED ACCESS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS\CATH</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS\PACEMAKER</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC STENOSIS\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AORTIC VALUE STENOSIS\LEFT HEART CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AS\ BENTAL PROCEDURE W/ ? HOMOGRAFT/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AS\AORTIC VALVE REPLACEMENT</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE AS\AORTIC VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE BACK PAIN/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE CAD\TRICUSPID VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE CARDIOMYOPATHY;MITRAL VALVE DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE DRUG RASH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE DYSMENORRHEA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE GALLSTONE PANCRETITIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE GASTROENTERITIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE GERD/SDA</td>
<td class="gt_row gt_center">662 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HEADACHE;R/O MENINGITIS;R/O SAH;</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTENSION,PAIN CONTROL,PRESSURE CONTROL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTROPHIC CARDIOMYOPATHY\LEFT HEART CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTROPHIC CARDIOMYOPATHY\RIGHT AND LEFT HEART CATH </td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTROPHIC CARDIOMYOPATHY\SEPTAL ETHANOL ABLATION</td>
<td class="gt_row gt_center">471 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTROPHIC CARDIOMYOPATHY\SEPTAL ETHANOL ABLETION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTROPHIC CARDIOMYOPATHY\SEPTEL ETHANOL ABLATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPERTROPHIS CARDIO MYOPATHY\SEPTAL ETHANOL ABLATION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPOMAG &amp; HYPOKALEMIA</td>
<td class="gt_row gt_center">889 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE HYPOTENSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE ISCHEMIA</td>
<td class="gt_row gt_center">145 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE ISCHEMIA/SDA</td>
<td class="gt_row gt_center">119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE ISCHEMIC LEG</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL REGURGITATION</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL REGURGITATION;CORONARY ARTERY DISEASE\CATH/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL REGURGITATION\CARDIAC CATH/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL REGURGITATION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL REGURGITATION\MITRAL VALVE REPLACEMENT MINIMALLY INVASIVE APPROACH/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL REGURGITOTION:MITRAL VALVE REPLACEMENT\MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MITRAL VALVE REGURGITATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR RENAL FAILURE\ MITRAL VALVE REPLACEMENT REDO; TVR RIGHT CHEST BEATING HEART/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR/MITRAL VALVE REPLACEMENT;MAZE PROCEDURE\MITRAL VALVE REPLACEMENT; MAZE PROCEDURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR\MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR\MITRAL VALVE REPLACEMENT; ? CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR\MITRAL VALVE REPLACEMENT; RE-DO STERNOTOMY/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR\MITRAL VALVE REPLACEMENT; W/ ? LVAD BACKUP ? RVAD BACKUP/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR\MITRAL VALVE REPLACEMENT;REPAIR ATRIAL-SEPTAL DEFECT; VENTRICULAR SEPTAL DEFECT; TRICUSPID VALVE REPAIR; ? REPLACEMENT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MR\MITRAL VALVE REPLACEMENT;TRICUSPID VALVE REPLACEMENT; MAZE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE MULTIVESSEL CAD</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY\SEPTAL ETHANOL ABLATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE PANCREATITIS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE PANCREATITIS; INFECTED PSEUDOCYST/SDA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE PES;PLANOVALGUS RIGHT FOOT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE PULMONARY HYPERTENSION; HYPOXIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE PVD/SDA</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE RIGHT SUPERFICIAL FEMORAL ARTERY STENOSIS\RIGHT LOWER EXTREMITY ANGIOGRAM</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE SEPSIS</td>
<td class="gt_row gt_center">179 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE SPINAL STENOSIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEVERE TRICUSPID REGURGITATION\ TRICUSPID VALVE REPLACEMENT/SDA</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEZIURE</td>
<td class="gt_row gt_center">696 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEZIURES</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SEZIZURES</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHEATHS NEED TO BE PULLED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHINGLES</td>
<td class="gt_row gt_center">389 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHINGLES;CONSTIPATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK</td>
<td class="gt_row gt_center">2,257 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK HYPOLEMIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK,ACUTE RENAL FAILURE,CARDIAC ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK,GI BLEED</td>
<td class="gt_row gt_center">439 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK; RHABDOMYOLSIS; RF/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK;HYPOTENSION;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK;HYPOVOLEMIA;BILATERAL ANKLE LACERATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOCK;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORT GUT ILEOSTOMY/SDA</td>
<td class="gt_row gt_center">552 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORT GUT SYNDROME/SDA</td>
<td class="gt_row gt_center">1,534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORT GUT SYNDROME\ SHARP RECANELIZATION,  SVG OCCLUSION, UPPER CHEST/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORT GUT SYNDROME\ TUNNELLED CATHETER</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORT GUT SYNDROME\ VENOUS RECANULATION/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORT OF BREATH; AORTIC STENOSIS\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF  BREATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREADTH; HYPERTENSION; AFIBRILLATION\MITRAL VALVE REPLACEMENT REDO /SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">109,111 (1.4%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH </td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH WITH EXERTION\CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH WITH STRIDOR</td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-ASCITES</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-FLU</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-FOREIGN BODY ASPIRATION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-HYPOGLYCEMIA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-HYPOTENSION</td>
<td class="gt_row gt_center">268 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-NEUTROPENIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH-R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH, HYPOTENSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH,CHEST PAIN</td>
<td class="gt_row gt_center">413 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH,HYPOXIA</td>
<td class="gt_row gt_center">258 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH,LUNG CANCER</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH,PLEURAL EFFUSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH,R/O MI</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH,RENAL FAILURE</td>
<td class="gt_row gt_center">3,396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH; CONTUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH; HEPATIC HYDROTHORAX</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH; LUNG CANCER</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;?R/O TB</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;ANEMIA;TELEMETRY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;AORTIC STENOSIS\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;AORTIC STENOSIS\LEFT HEART CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;AORTIC STENSIS;ANEMIA</td>
<td class="gt_row gt_center">366 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;AORTIC VALVE DISEASE/CABG</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;CELLULITIS</td>
<td class="gt_row gt_center">183 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;CHEST MASS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;CHEST PAIN</td>
<td class="gt_row gt_center">404 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;CHRONIC OBST PULM DISEASE;CHF EXACERBATION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;CONGESTIVE HEART FAILURE;ATRIAL FIBRILLATION\RIGHT AND LEFT HEART CATH</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;CORONARY ARTERY DISEASE;MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;DIZZINESS</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;DYSPNEA ON EXERTION</td>
<td class="gt_row gt_center">270 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;END STAGE RENAL DISEASE</td>
<td class="gt_row gt_center">3,040 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;FAILURE TO THRIVE</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;HEMOPTYSIS</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;HYPERKALEMIA;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;HYPOXIA</td>
<td class="gt_row gt_center">1,618 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;HYPOXIA;TELEMETRY</td>
<td class="gt_row gt_center">1,120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;INCREASED CREATININE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;ISCHEMIA\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;LYMPHOMA</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;MITRAL VALVE DISEASE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;MULTIFOCAL PNA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;NAUSEA W\VOMITING</td>
<td class="gt_row gt_center">1,968 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;NEW ASCITES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;PALPITATIONS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;PLUERAL EFFUSION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;PNEUMONIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;PULMONARY EDEMA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;RENAL FAILURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;RESPIRATORY ARREST</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;RULE-OUT MYOCARDIAL INFRACTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;S/P TRACHEOPLASTY</td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;SEVERE ANEMIA;NECK MASS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;STATUS POST STENT PLACEMENT</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;TACHYPNEA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;TELEMETRY</td>
<td class="gt_row gt_center">1,372 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;TRACHEAL STENT</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH;WEAKNESS</td>
<td class="gt_row gt_center">104 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH/FEVER</td>
<td class="gt_row gt_center">236 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH/MULT MYELOMA</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH/R/O PULMONARY EMBOLISM</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH\ TRACHEALPLASTY/BRONCHEOPLASTY VIA RIGHT THORACOTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH\CATH</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OF BREATH\CATH ? RENAL ANGIOGRAM</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHORTNESS OFR BREATH</td>
<td class="gt_row gt_center">4,641 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOTRNESS OF BREATH/PLERAL EFFISION\PLEUROSCOPY/PLEURODESIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOULDER DISLOCATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHOULDER PAIN</td>
<td class="gt_row gt_center">409 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHUNT FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHUNT INFECTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SHUNT MALFUNCTION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SICK SINUS SYNDROME\PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SICK SINUS SYNDROME\PACEMAKER INSERTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SICKLE CELL ANEMIA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SICKLE CELL CRISIS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIEZURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIG VOLVULUS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID CA/SDA</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID CANCER</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID COLON CA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID COLON CA/SDA</td>
<td class="gt_row gt_center">98 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID COLON CANCER/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID COLON STRICTURE/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID DIVERTICULITIS, COLOVESTICAL FISTULA/SDA</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID DIVERTICULITIS; PARASTOMA HERNIA/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID DIVERTICULITIS/SDA</td>
<td class="gt_row gt_center">179 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID MASS;RECTAL BLEEDING</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID MASS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID PERFORATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID VOLVULUS</td>
<td class="gt_row gt_center">237 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGMOID VULVULOS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SIGOID TUMOR/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SINUS BRADY;RIGHT BUNDLE BRANCH BLOCK;ATRIAL FLUTTER\ELECTROPHYSIOLOGIC STUDY;POSSIBLE ABLATION;POSSIBLE PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SINUS PAUSE</td>
<td class="gt_row gt_center">296 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SINUSITIS;CELLULITIS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL /BRAIN LESIONS/SDA</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL BASE MENINGIOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL BASED LESION/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL BASED TUMOR/SDA</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE; HEAD BLEED</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE; IPH</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE;HEAD INJURY;SAH</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE;ICH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE;SDH;SAH;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FRACTURE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FX</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FX; INTRACRANIAL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FX;SUBARACHNOID HEMORRHAGE;ACUTE SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL FX/HEAD BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL INFECTION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SKULL METASTASIS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLEEP APNEA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLEEP APNEA;AIRWAY DISEASE;HYPERTENSION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLEEP APNEA;OVER DOSE;ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLEEVE DEHISCENCE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLENIC LACERATION;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLURRED SPEACH;R/O STROKE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SLURRED SPEECH</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMA CLOT</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL CARCINOIDS/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL FISTULA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL ISCHEMIA-CLOTTED DIALYSIS ACCESS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL LEAK;BLADDER CANCER</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL MASS/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">13,278 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION                                                                                                                                                                                 </td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION AND ABSCESS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION, CHRON&#39;S DISEASE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;ACUTE CHOLEYCYSITIS</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;FISTULA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;GALLBLADDER CANCER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;HYPOXIA</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;LARGE BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;SEPSIS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION;TELEMETRY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL OBTRUCTION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWEL TUMOR/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL BOWELL OBSTRUCTION/UTI</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL CELL CANCER</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL CELL LUNG CANCER</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL CELL LUNG CANCER;PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL CELL LUNG CANCER;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL FRONTAL BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL INTESTINAL STRICTURE/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMALL SUBDURAL</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMOKE INHALATION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMOKE INHALATION INJURY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SMS OBSTRUCTION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB</td>
<td class="gt_row gt_center">520 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB ? PE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB, FEVER</td>
<td class="gt_row gt_center">164 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB, PLEURAL EFFUSION,</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB,BILATERALPUL, SVC TUMOR</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB,R/O CHF</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB,RAPID AFIB;CONSTIPATION</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;+ETT\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;AORTIC INSUFFICIENCY\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;BILATERAL PE&#39;S</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;HYPOTENSION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;NEW PLEURAL EFFUSION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;PERICARDIAL INFARCTION</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOB;TELEMETRY</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOFT TISSUE LOSS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOFT TISSUE MASS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SOMULENCE/CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SORE THROAT</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SORE THROAT;HOARSENESS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SORE THROAT;IMMUNOSUPRESSION</td>
<td class="gt_row gt_center">1,192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SP CABG\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SP DEPRESSED SCULL FX</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SP FALL</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SP MVC</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SP MVC;TENSION PTX</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPEECH CHANGES;TELEMETRY</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPESIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPHINCTER MALFUNCTION/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPIANAL METASTASES</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINA BIFIDA-TRACHEAL OBSTRUCTION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINA BIFIDA;LEG ULCERS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL ABSCESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL ABSCESS;PNEUMONIA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL ARTERIOVENOUS MALFORMATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD BLEED&#39;</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD COMPRESSION</td>
<td class="gt_row gt_center">167 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD INFARCTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD INJURY</td>
<td class="gt_row gt_center">146 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD INJURY;NSTEMI</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD INJURY;TELEMETRY</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD TRANSECTION</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL CORD TUMOR</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL DETRUSOR HYERREFLEXIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL DETRUSOR HYPERREFLEXIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL DURAL FISTULA/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL EPIDURAL ABCESS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL FRACTURE</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL FRACTURE-PELVIC FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL FRACTURE,S/P FALL</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL INFECTION</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL INJURY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL INSTABILITY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL LESION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL LESION/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL MASS</td>
<td class="gt_row gt_center">282 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL MENINGIOMA/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL METASTASIS/SDA</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL METS;NAUSEA;VOMITING</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL NEOPLASM/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL OSTEOMYELITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL SEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL SHOCK</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL STENOSIS</td>
<td class="gt_row gt_center">250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL STENOSIS L3-S1/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL STENOSIS L4-L5/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL STENOSIS, CAUDA EQUINA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL STENOSIS/SDA</td>
<td class="gt_row gt_center">720 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL SURGERY SITE INFECTION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL TUMOR</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINAL TUMOR/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINDAL CORD TUMOR</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE FRACTURE</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE FRACTURE; PELVIS FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE FRACTURE;FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE FRACTURE;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE FRACTURES; CP; SAH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE INFECTION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPINE INJURY;TELEMETRY</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLEEN LACERATION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLEEN;LACERATION;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLEENIC LACERATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC ABSCESS</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC ACUATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC AND RENAL LACERATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC HE,ATOMA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC HEMATOMA</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC HEMORRHAGE</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC INFARCT;OBSTRUCTIVE JAUNDICE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC INJURY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LAC</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LAC;FALL;WRIST FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATION</td>
<td class="gt_row gt_center">1,221 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATION-S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATION,HIP FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATION;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATION;SEIZURE;TONGUE LACERATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATION;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC LACERATIONS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC MARGINAL ZONE LYMPHOMA\CHEMOTHERAPY</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC RUPTURE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENIC RUPTURE;TELEMETRY</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENICLYMPHOMA/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENOMEGALIA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENOMEGALY/HYPERTENSION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENOMEGALY/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPLENONEGALY/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPON BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONDYLOLISTHESIS/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONDYLOLITHESIS/SDA</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONDYLOLOTHIASIS/SDA</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONDYLOSIS/SDA</td>
<td class="gt_row gt_center">133 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANEOUS BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">2,951 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANEOUS BACTERIAL PERITONITIS,SEPSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANEOUS BACTERIAL PERTONITIS</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANEOUS HEMOPERITONEUM</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANEOUS RETROPERITONEAL BLEED</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANEOUS SAH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SPONTANOUS BACTERIAL PERITONITIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CA FLOOR OF MOUTH/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CA, RIGHT LATERAL TONGUE/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CANCER</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CANCER OF HYPO PHARYNX/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CANCER OF THE HEAD AND NECK</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARCINOMA ORAL TONGUE/SDA</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARCINOMA RIGHT SIDE OF NECK/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARCINOMA SCALP/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARCINOMA, ORAL CAVITY/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARCINOMA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARCINOMA/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL CARNINOMA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL ESOPHAGEAL CANCER/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SQUAMOUS CELL LUNG CANCER</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SRTOKE;TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SRTROKE/TIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST CHANGES</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEEVATION MI</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELELEVATION MI</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MI</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">19,200 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION;HYPOTENSION</td>
<td class="gt_row gt_center">408 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION;S/P VF ARREST</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION;S/P VT ARREST</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION;STATUS POST CARDIAC ARREST\CARDIAC CATH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION\CARDIAC CARTH</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">118 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATED MYOCRDIAL INFARCT\CARDIAC CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI</td>
<td class="gt_row gt_center">557 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI; RESPIRATORY FAILURE\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI;S/P ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI;TELEMETRY</td>
<td class="gt_row gt_center">1,105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI;V-FIB ARREST\CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI\CARDIAC CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MI\CATH</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">277 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION;CORONARY ARTERY DISEASE\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\CORONARY ANGIOGRAM </td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\CORONARY ANGIOGRAPHY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\CORONARY INTERVENTION</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION MYOCARDIAL INFRACTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION;MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION\CATH</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATION\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVATIONS</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELEVETAED MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST ELLEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; HYPERTENSION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;VENTRICULAR SEPTAL DEFECT;RIGHT TO LEFT SHUNT\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST SEGMENT MYOCARDIQAQL INFARCTION\CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST WAVE MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ANTERIOR\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">91 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">536 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION\LEFT HEART CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION MYOCARIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVATION;MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ST-SEGMENT ELEVETION MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND CHEST</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND LEFT CHEST</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND TO CHEST</td>
<td class="gt_row gt_center">47 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND TO FACE AND CHEST</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND TO NECK</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUND;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUNDS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAB WOUNDS-CORD INJURY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STABBING</td>
<td class="gt_row gt_center">89 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STABBING VICTIM</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STABBING;SKULL FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STABLE LEFT FRONT IPH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAGE III LUNG CA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAGE III RECTAL CANCER;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAGE IV SUBGLOTTIC CANCER</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STAPH BACTERMIA</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STARVATION KETOSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS ASTHMATICUS</td>
<td class="gt_row gt_center">1,152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPELEPTICUS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPI</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPILECTICUS;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPILEPITICUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPILEPTIC</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPILEPTICUS</td>
<td class="gt_row gt_center">2,660 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPILEPTICUS;SVT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS EPILEPTIOUS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST ASSAULT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST BENTALL MAZE; PERICARDIAL TAMPONADE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST C SECTION;ACUTE RENAL FAILURE;HYPOTENSION;ACUTE PANCREATITIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST C5-T2 FUSION;STATUS POST FALL WITH FRACTURE</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST CABBAGE\STERNAL WIRE REMOVAL W/HEART TEAM/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST CABG\SAPHENOUS VEING GRAFT - RIGHT CORONARY ARTERY PSUEDOANEURYSM/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST CARDI ARREST</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST CARDIAC ARREST</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST CARDIAC ARREST;UNABLE TO WEAN</td>
<td class="gt_row gt_center">474 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST CARDIAC ARREST\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST COLECTOMY;ANASTOMOSIS LEAK</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST COLECTOMY;RENAL FAILURE;SEPSIS</td>
<td class="gt_row gt_center">560 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST ESIPHAGOGASTRODUODENOSCOPY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST FALL</td>
<td class="gt_row gt_center">93 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST FALL;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST FALL;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST HANGING</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST KIDNEY TRANSPLANT; MULTIPLE SCLEROSIS CHANGES</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST KIDNEY TRANSPLANT;?REJECTION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST KIDNEY TRANSPLANT;ELEVATED CREATININE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST KIDNEY-PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST LEFT ILIAC ARTERY SURGERY; ? PANCREATIC MASS</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST LEFT NEPHRECTOMY;PANCREATIC LEAK</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST LIVER TRANSPLANT;RENAL FAILURE</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MITRAL VALVE REPLACEMENT;FEVER;ELEVATED WHITE BLOOD COUNT</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MITRAL VALVE REPLACEMENT;PROBABLE COLON CANCER\COLONOSCOPY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES</td>
<td class="gt_row gt_center">869 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES;DROWNING</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES;HEAD TRAUMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES;MULTI TRAUM</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES;MULTIPLE FRACTURES</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES;TELEMETRY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT WITH INJURIES;TRAUMA;HEAD LACERATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT; EXPLORATORY LAPAROTOMY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTOR VEHICLE ACCIDENT;MULTIPLE TRAUMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MOTORVEHICLE ACCIDENT</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MYOCARDIAL INFARCTION;+ ETT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MYOCARDIAL INFARCTION;CONGESTIVE HEART FAILURE\CARDIAC CATH;CORONARY ARTERY DISEASES STENT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">124 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST PULSELESS ELECTRICAL ACTIVITY ARREST</td>
<td class="gt_row gt_center">200 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST VALVE REPLACEMENT\DEBRIDEMENT STERNUM /SDA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST VENTRICULAR FIBRILLATION ARREST</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST VENTRICULAR FIBRILLATION ARREST;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST VENTRICULAR FIBRILLATION ARREST\CARDIAC CATH</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS POST VENTRICULAR FIBRILLATION ARREST\LET HEART CATHETERIZATION;IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANT /SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STATUS-POST PANCREAS TRANSPLANT;FEVER</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STE MI</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STE MI\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STE MYOCARDIAL INFARCTIN</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">162 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STE MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEM I\CARDIAC CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI</td>
<td class="gt_row gt_center">11,427 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI-GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI;</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI;CARDIAC CATH</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI;CATH\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI;GASTROINTETINAL BLEED</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI;HEAD BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI;TELEMETRY</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI/CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI\CARDIAC CATH</td>
<td class="gt_row gt_center">148 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMI\CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEMYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">495 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENOSIS OF LARYNX /SDA</td>
<td class="gt_row gt_center">980 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENOSIS OF LARYNX/SDA</td>
<td class="gt_row gt_center">980 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENOSIS/SDA</td>
<td class="gt_row gt_center">106 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENOSIS\ AORTIC &amp; MITRAL VALVE REPLACEMENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENOSIS\BILATERAL CAROTID ANGIOGRAM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STENT NON FUNCTION\BRONCHOSCOPY RIGID; STENT REMOVAL</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL DEHISCENCE</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL DEHISSENCE</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL DRAINAGE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL DRAINAGE;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL FRACTURE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL FRACTURE,RIB FRACTURE,LACERATIONS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL FRACTURE;EPIDERMAL HEMATOMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL FX</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL FX RIB FX PTX, HIP FIX</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL HEMATOMA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL LESION\STERNAL BIOPSY </td>
<td class="gt_row gt_center">252 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL MASS</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND  EVALUATION</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND DEHISCENCE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND INFECTION</td>
<td class="gt_row gt_center">5,115 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND INFECTION;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND INFECTION;FEVER</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND INFECTION/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND INFECTION\ STERNAL WOUND EXPLORATION/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND INFECTION\STERNAL DEBRIDEMENT/SDA</td>
<td class="gt_row gt_center">300 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNAL WOUND/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STERNOTOMY WOUND INFECTION</td>
<td class="gt_row gt_center">1,176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEVEN JOHNSON SYNDROME</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEVENS JOHNSON SYNDROME</td>
<td class="gt_row gt_center">1,221 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STEVENS-JOHNSON SYNDROME</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STOKE;TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STOMACH CA/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STOMACH INFECTION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STOMACH MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STOMACH POLYP\ENDOSCOPY </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRANGULATED HERNIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRANGULATION/ ? ENDOCARDITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRESS INCONTINECE &amp; CYSTOCELE/SDA</td>
<td class="gt_row gt_center">312 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRESS URINARY INCONTINENCE/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIDOE;AIRWAY COMPROMISE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIDOR</td>
<td class="gt_row gt_center">1,389 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIDOR;NEUTROPENIA;FEVER</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIDOR;S/P THYROIDECTOMY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIDOR;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIDOR/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRIKE;TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE</td>
<td class="gt_row gt_center">1,950 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE /TIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE WITH HEAD BLEED</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE-R/O VASCULITIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE-TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">927 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE-TRANSIENT ISCHEMMIC ATTACK</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,CEREBRAL EDEMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,DEHYDRATION,ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,ENDOCARDITIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,HEAD BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,MI</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,RIGHT MCA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,TIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE,TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">717 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE; TIA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;HEAD BLEED WITH SHIFT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;HEAD MASS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;HEPATIC ENCEPHALOPATHY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;RHABDO,URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY</td>
<td class="gt_row gt_center">2,017 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY; ICH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY; TIA</td>
<td class="gt_row gt_center">139 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY; TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TELEMETRY</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TELEMETRY;SEIZURES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TELEMETRY;TELEMETRY</td>
<td class="gt_row gt_center">197 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">11,365 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TRANSIENT ISCHEMIC ATTACK;SHINGLES</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TRANSIENT ISCHEMIC ATTACK;TELEMETRY</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TELEMETRY;TRANSINET ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TIA</td>
<td class="gt_row gt_center">367 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">224 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE;TRANSIENT ISCHEMIC ATTACK (TIA)</td>
<td class="gt_row gt_center">83 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE.TIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE/ TIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROKE/TIA</td>
<td class="gt_row gt_center">2,763 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STROMAL CELL TUMOR/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRUCK BY A CAR</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRUCK BY TRAIN</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">STRUKE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB ARACHNOID</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB ARACHNOID BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB ARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">152 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB ARACHNOID HEMORRHAGE,INTER CRANIAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB ARACHNOID HEMORRHAGE,S/P FALL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB DURAL HEMATOMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB DURAL HEMATOMA,FALL,C6 FRACTURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB DURAL HEMATOMA,S/P FALL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB GALEAL COLLECTION</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB GLOTTIC MASS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUB STERNAL GOITER; RIGHT UPPER LOBE MASS/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBACUTE APPENDICITIS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBACUTE MYOCARDIAL INFARCTION\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBACUTE STROKE</td>
<td class="gt_row gt_center">387 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBACUTE SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBAORTIC MEMBRANE\ RESECTION SUBAORTIC MEMBRANE/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNIOD HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID BLEED</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID BLEED; S/P MVC</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID BLEEDING</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEM., WITH FACIAL FXS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMARRHAGE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMARRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">260 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;CLAVICLE FRACTURE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;CSPINE FRACTURES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;FACIAL FRACTURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;MAXILLARY SINUS FRACTURE</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;S/P FALL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;SUBDURAL HEMORRHAGE;T12 FX;ABDOMINAL HEMATOMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;TELEMETRY</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMATOMA;TRAUMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMMORHAGE</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMMORHAGE/SDA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMMORRHAGE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRAHAGE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">7,486 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE-HEAD INJURY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE-INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE-SUBDURAL HEMORRHAGE-FEVER-UROSEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE,ANEURYSM</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;ACUTE SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">185 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;ACUTE SUBDURAL HEMATOMA;INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;ANEURYSM</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;BASILAR TIP ANEURYSM</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;C2 FRACTURE</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;CEBREBRAL CONTUSION;S/P FALL</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;FALL</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;INTRAPARENCHYMAL BLEED</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;LIVER LACERATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;SDH;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;SKULL FX</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;STROKE;TELEMETRY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HEMORRHAGE/SDA</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID HENORRHAGE;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHNOID;SPINE FRACTURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHOID HEMORRAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACHROID HEMORRHAGE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARACNOID HEMORRHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARCHANOID HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARCHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARCHNOID HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">198 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBARRACHNOID HEMMORAGE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBBARACHNOID HEMORRHAGE/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBCARINAL MASS</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBCLAVIAN STEAL PHENOMENMA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBCLAVIAN STENOSIS, RIGHT/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBCLAVIAN THROMBOSIS;CHANGE OF PICC LINE FOUND LARGE DVT VS LYSIS OF DOT</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBCLAVIAN VEIN COMPRESSION SYNDROME</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBCORTICAL STROKE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDERAL HEMATOMA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL</td>
<td class="gt_row gt_center">182 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL &amp; SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL BLEED</td>
<td class="gt_row gt_center">349 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL BLEEDING</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL COLLETION/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HAMATOMA</td>
<td class="gt_row gt_center">35 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMAOTOMA/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMAROMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">7,414 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA </td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA S/P FALL</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA-COMA</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA-S/P FALL</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA,CRF,L WRIST FX</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA,SEIZURE,C3 FRACTURE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA,SKULL FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;EAR LACERATION;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;FALL</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;GI BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;HEAD INJURIES</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;HIP HEMATOMA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;HYPERTENSION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;HYPERTENSIVE URGENCY</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;MIDBRAIN BLEED</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;MRSA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;RIB FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;SAH;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;SEIZURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA;TELEMETRY</td>
<td class="gt_row gt_center">142 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA/CONTUSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA/S/P FALL</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMATOMA/SDA</td>
<td class="gt_row gt_center">618 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMMORAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMMORAGE, AORTIC DISSECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMMORRHAGE</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMOATOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRAGE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">2,387 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE-DENS FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE-S/P ASSAULT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE-S/P FALL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE,ANKLE FRACTURE</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE; BILATERAL PE; TRAUMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;C-SPINE FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;CLAVICLE FRACTURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;GLUTEAL HEMATOMA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;HIP FRACTURE</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;INTRAPARENCHYMAL HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;IPH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;JAW FRACTURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;LEFT HIP FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;SKULL FRACTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">142 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;SUBARACHNOID HEMATOMA;FALL</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;SUBARACHNOID HEMATOMA;FRACTURES</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;TELEMETRY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;TRAUMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMORRHAGE;UTI;FRACTURES</td>
<td class="gt_row gt_center">82 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL HEMOTOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL SUBARACHNOID</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL SUBARACHNOID HEMMORRHAGE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL VS. SUBARACHNOID HEMATOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBDURAL, PELVIC FRACTURE</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBENDOCARDIAL MI</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBFILAMENT HEPATIC FAILURE</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBGLOTIC STENOSIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBGLOTTIC STENOSIS</td>
<td class="gt_row gt_center">811 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBGLOTTIC STENOSIS;ESOPHAGEAL MASS\LARYNGOSCOPY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBGLOTTIC STENOSIS/SDA</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBGLOTTIC STENOSIS\LARYNGOSCOPY; MICRO WITH C02 LASER BILATERAL; PLACEMENT OF T-TUBE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBGLOTTIC TRACHEAL STENOSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBLINGUAL INFECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBMANDIBULAR ABCESS</td>
<td class="gt_row gt_center">408 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBMANDIBULAR ABSCESS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBMANDIBULAR GLAND INFECTION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBPHRENIC ABDCESS S/P COLECTIMY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBSTERNAL CHEST PAIN</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBTHERAPEUTIC INR</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBTHERAPEUTIC INR;EPISTAXIS;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBTHERAPUTIC INR</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBURAL HEMATOMA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBURAL HEMATOMA;TELEMETRY</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUBURAL HEMORRHAGE</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUDURAL HEMATOMA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDAL IDEATION</td>
<td class="gt_row gt_center">7,498 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDAL IDEATION;ALCOHOL INTOXICATION</td>
<td class="gt_row gt_center">231 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDAL IDEATION;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDAL IDEATION;FOREIGN BODY INGESTION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDAL IDEATION;PSYCH EVAL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDAL IDEATION;RAZOR INGESTION</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUICIDE ATTEMPT;GLASS IN GI TRACT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPAGLOTLITIS</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPER RENAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERFICIAL FEMORAL ARTERY STENOSIS</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERGLOTTITIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR MESENTERIC ARTERY STENOSIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR MESENTERIC EMBOLUS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR MESENTERIC VEIN THROMBOSIS</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR VENA CAVA STENOSIS\SUPERIOR VENA CAVA STENT PLACEMENT</td>
<td class="gt_row gt_center">504 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR VENA CAVA SYNDROME</td>
<td class="gt_row gt_center">751 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR VENA CAVA SYNDROME\MEDIAN STERNOTOMY SUPERIOR VENA CAVA RECONSTRUCTION WITH PUMP STANDBY/SDA</td>
<td class="gt_row gt_center">355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERIOR VENA CAVA SYNDROME\VENOGRAM;THROMBOLISIS/SDA</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPERVENTRICULAR TACHYCARDIA;NON-HODGKINS LYMPHOMAWEAKNESS</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRA GLOTTITIS</td>
<td class="gt_row gt_center">295 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRACELLAR LESION/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAGLOTTIC AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">980 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAGLOTTIC EDEMA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAGLOTTIC HEMATOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAGLOTTIC MASS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAGLOTTITIS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRATHERAPEUTIC INR</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRATHERAPEUTIC INR; HYPOTENSION</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">394 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA;HYPOTENSION</td>
<td class="gt_row gt_center">888 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA\CATH</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA\ELECTROPHYSIOLOGY STUDY</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA\ELECTROPHYSIOLOGY STUDY;POSSIBLE ABLATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA\SUPRAVENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUPRAVENTRICULAR TACHYCARDIA\VT ABLATION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUSPECTED EPIGLOTIS ABSCESS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SUSPECTED OSTEOMYELITIS</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVA CLOT;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVC</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVC CLOT;RIGHT ATRIAL CLOT</td>
<td class="gt_row gt_center">355 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVC SYNDROME</td>
<td class="gt_row gt_center">966 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVC SYNDROME \ UPPER STERNAL SPLIT; LEFT SUBCLAVIAN TUBE; RIGHT ATRIAL BYPASS/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVC SYNDROME\ RECANALIZATION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVC SYNDROME\ VENOUS RECANALIZATION/SDA</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVT</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVT;HYPOTENSION</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVT;PNEUMONIA;TELEMETRY</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SVT\EP STUDY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SWALLOWED FOREIGN BODY;TELEMETRY</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SWALLOWED PLASTIC SPOON</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SWALLOWED TOOTHBRUSH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SWOLLEN KNEE;TELEMETRY</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPROMATIC FIBROIDS/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC 3RD DEGREE HEART BLOCK</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC AAA</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC ABDOMINAL AORTIC ANEURYSM</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC BRADYCARDIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC CAROTID STENOSIS</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC CAROTID STENOSIS LEFT/SDA</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC CAROTID STENOSIS RIGHT</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC CHOLELITHIASIS</td>
<td class="gt_row gt_center">155 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC FIBROID UTERUS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC FIBROID UTERUS/SDA</td>
<td class="gt_row gt_center">63 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC FIBROIDS UTERUS/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC PERIRENAL ANEURYSM</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC R CAROTID STENOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMPTOMATIC VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMTOMATIC ANEURYSM AORTIC ABDOMINAL</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMTOMATIC CAROTID STENOSIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMTOMATIC FIBROID UTERUS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYMTOMATIC FIBROIDS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPAL EPISODE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPAL EPISODES</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE</td>
<td class="gt_row gt_center">6,149 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-BLUNT HEAD TRAUMA-INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-HYPERGLYCEMIA-EKG CHANGES</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-HYPERKALEMIA</td>
<td class="gt_row gt_center">500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-HYPONATREMIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-HYPOXIA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-RENAL FAILURE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE-VTACH</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE, EPIDURAL</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE,RECTAL PROLAPSE,HIP PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE,SAIT</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE; AORTIC STENOSIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE; HEART BLOCK\ELECTROPHYSIOLOGY STUDY +/- PACEMAKER IMPLANTATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;AICD FIRED</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;AORTIC STENOSIS\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;ATRIAL FIBRILLATION\PACEMAKER IMPLANT/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;BRADYCARDIA</td>
<td class="gt_row gt_center">335 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;CARDIAC ISCHEMIA\CARDIAC CATH</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;CHEST PAIN</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;DENS FRACTURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;EDEMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;PACEMAKER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;SUBARACHNOID HEMATOMA;TRAUMA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY</td>
<td class="gt_row gt_center">8,698 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;ANEMIA;ETOH INTOXICATION</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;HIP FRACTURE</td>
<td class="gt_row gt_center">196 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;LEFT HIP FRACTURE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;S/P FALL</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;SUBDURAL HEMATOMA; BASILAR SKULL FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;TELEMETRY</td>
<td class="gt_row gt_center">204 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;TELEMETRY;THIGH LACERATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE;WEAKNESS</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE/BRADYCARDIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE/BRADYCARDIA/SEIZURES\PACEMAKER IMPLANT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE/HEAD INJURY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE/MI</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE\CATH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE\EP STUDY;PACEMAKER INSERTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE\LEFT HEART CATH</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPE\LEFT HEART CATHERTERIZTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPY</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPY C2 FRACTURE</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNCOPY\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYNOVIAL SARCOMA, RIGHT WRIST/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYPHILIS</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYRINGOMYELIA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYSTEMIC INFLAMMATORY RESP SYNDROME</td>
<td class="gt_row gt_center">150 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYSTOLIC DYSFUNCTION\CATH</td>
<td class="gt_row gt_center">267 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYSTOLIC HEART FAILURE;ATRIAL FIBRILLATION\BIVENTRICULAR PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SYSTOLIC HEART FAILURE;ISCHEMIC CARDIOMYOPATHY\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SZ; COFFEE GROUND EMESIS; SYNCOPE</td>
<td class="gt_row gt_center">228 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">SZ/HYPOTENSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T 11 INTRADURAL TUMOR</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T CELL LYMPHOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T SPINE FRACTURE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T-8 FRACTURE/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T-CELL LYMPHOMA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T-SPINE ABCESS; KYPHOSIS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T-SPINE HARDWARE EXPOSED</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T-SPINE INFECTION</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T-SPINE MASS</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T1 FRACTURE</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T10 COMPOUND FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T10 LYTIC LESION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T10 MASS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T10 SPINAL MASS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T11 FRACTURE-AORTIC DISECTION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T11 METASTASTIS/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T12 AND C1 FRACTURES</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T12 BURST FRACTURE</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T12 FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T12 FRACTURE AND CORD COMPRESSION</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T12 SPINAL CORD COMPRESSION/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T4 COMPRESSION FX/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T5 FRACTURE</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T5 RENAL CELL METASTASIS/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T6 COMPRESSION FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T6 FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T6 METASTISIS/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T7 FRACTURE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T7 FX</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T7-8 DISC HERNIATION WITH MYELOPATHY/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T8 FRACTURE AND HEMOTHORAX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T8 FRACTURE WITH CORD COMPRESSION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T8 LESION/SDA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T8 SPINAL CORD COMPRESSION AND CELLULITIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T8-T9 FRACTURE-UPPER BACK PAIN</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T9 FRACTURE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">T9-T10 VERTEBRAL OSTEOMYELITIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACCHYCARDIA/BRADYCARDIA;ATRIAL FLUTTER\A-FLUTTER ABLATION;BV PACER</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHY-BRADY SYNDROME;ATRIAL FLUTTER\ELECTROPHYSIOLOGIC STUDY/ABLATION/?PACEMAKER IMPLANT</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHY-BRADY SYNDROME\DUAL CHAMBER PACEMAKER IMPLANT/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHY-BRADYCARDIA</td>
<td class="gt_row gt_center">276 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHY, DEHYDRATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYARRYTHMIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYBRADY SYNDROME\DUAL CHAMBER PACEMAKER IMPLANT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA</td>
<td class="gt_row gt_center">19,373 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA-INR 22</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA,ETOH WITHDRAWAL SYNCOPE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA; ELEVATED TROP; PNA; CH</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;? COCAINE USE</td>
<td class="gt_row gt_center">585 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;ALCOHOL WITHDRAWAL</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;HYPERGLYCEMIA;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;HYPOTENSION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;HYPOTENSION;PNEUMONIA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;HYPOXIA;FEVER</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">343 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYCARDIA/HYPOTENSION</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYDYSRHYTHMIA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYPNEA</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYPNEA,? ASPIRATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TACHYPNEA;TELEMETRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE</td>
<td class="gt_row gt_center">2,321 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE S/P PACEMAKER PLACEMENT</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE;PLEURAL EFFUSION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE\PERICADIOCENTESIS</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE\PERICARDIAL TAP</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE\PERICARDIOCENTESIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONADE\PERICARDIOCENTESIS/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONDAE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TAMPONEDE </td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TARUMA;STATUS POST FALL</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TBA\ BRONCHOSCOPY W/ STENT/SDA</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TBM</td>
<td class="gt_row gt_center">374 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TCA OVERDOSE</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TCA TOXICITY-TACYCARDIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TE FISTULA,ASPIRATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TEGRETOL OVERDOSE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TEMPORAL BLEED</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TEMPORAL BONE FX</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TEMPORAL HEMORRHAGE</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TEMPORPARIETAL BRAIN MASS</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TERTIARY SYPHILIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TESTICULAR CA; RETROPERITONEAL LYMPHADENOPATHY/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TESTICULAR CANCER/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TESTICULAR PAIN</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TETRALOGY OF FALLOT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TETRALOGY OF FALLOT\ PFO CLOSURE;CORONARY ARTERY BYPASS GRAFT; PULMONARY OUTFLOW RECONSTRUCTION; PULMONARY VALVE REPAIR</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TETRALOGY OF FALLOT\ PULMONARY VALVE REPAIR; VENTRICULAR OUTFLOW RECONSTRUCTION, RIGHT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THALAMIC BLEED</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THALAMIC BLEED;TELEMETRY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THALAMIC HEMORRHAGE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THALAMUS HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THALMUS BLEED</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THEOCHROMOCYTOMA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THIGH ABSCESS;PORTAL HYPERTENSION</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THIGH HEAMTOMA</td>
<td class="gt_row gt_center">1,022 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THIGH HEMATOMA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THIGH HEMATOMA; TRANSFUSION REACTION</td>
<td class="gt_row gt_center">282 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THIRD DEGREE AV BLOCK</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THIRD DEGREE HEART BLOCK</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THOMACIC ANEURYSM\THORACOABDOMINAL ENDARTERECTOMY/ RIGHT PARTIAL BYPASS; LUBAR DRAIN  </td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ABDOMINAL ANEURYSM</td>
<td class="gt_row gt_center">31 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ABDOMINAL ANEURYSM\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AND SPINAL ABSCESS</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM</td>
<td class="gt_row gt_center">266 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM WITH MENTION OF RUPTURE\OPEN DESCENDING THORACIC AORTIC ANEURYSM REPAIR /SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM WITH OUT MENTION RUPTURE\AORTIC VALVE / ASCENDING AORTA REPLACEMENT; ? BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM WITHOUT MENTION OF RUPTURE\REPAIR DECENDING AORTIC THORACIC ANEURYSM; ILIAC STENTING LEFT/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM WITHOUT RUPTURE\AORTIC VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM WITHOUT RUPTURE\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM WITHOUT RUPTURE\DESCENDING LEFT THORACIC AORTIC REPLACEMENT VIA LEFT THORACOTOMY /SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM-PNEUMONIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">1,367 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM/SDA\REDO STERNOTOMY; REPAIR AORTIC ARCH ANEURYSM  </td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\ASCENDING AND HEMI-ARCH REPLACEMENT W/ FULL MAZE   </td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\ASCENDING/HEMI-ARCH AORTA REPLACEMENT /SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\BENTALL PROCEDURE/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\DISTAL ARCH; DECENDING THORACIC VIA LEFT AORTIC REPLACEMENT; CIRC ARREST VIA LEFT THORACTOMY/SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\ENDOVASCULAR THORACIC ANEURYSM REPAIR  /SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\REPAIR SINUS ANEURYSM/VALVE SPARING ROOT VS BENTAL VS PATCH REPAIR ROOT/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\REPLACEMENT OF ASCENDING AORTA/ MAZE; LIGATION OF LEFT ATRIAL APPENDAGE ** SPECIAL EQUIPTMENT **/SDA</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\RESECTION ANEURYSM THORACIC /SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\THORACO-ABDOMINAL ANEURSYM REPAIR W/PARTIAL RIGHT HEART BYPASS &amp; LUMBAR DRAIN  /SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEURYSM\THORACO-ABDOMINAL ANEURYSM REPAIR/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANEUYSM WITHOUT MENTION RUPTURE\BENTAL PROCEDURE(METRONIC FREESTYLE)/ ACENDING AORTA; HEMI ARCH REPLACEMENT  W/ DEEP HYPERTHERMIC ARREST/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ANUERYSM/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURSYM/SDA</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM</td>
<td class="gt_row gt_center">210 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM DISSECTION\ 2ND RE-DO TOTAL AORTIC ARCH REPLACEMENT, MEDUSA GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM WITHOUT RUPTURE\BENTAL PROCEDURE; VENTRAL SEPTAL DEFECT REPAIR; REPAIR PARTIAL ANOMALOUS PULMONARY VENOUS RETURN/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM; AORTIC VALVE REPLACEMENT REDO\AORTIC VALVE REPLACEMENT REDO </td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM;DISSECTION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">590 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\ RE-DO STERNOTOMY; ?? STENT/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\ RESECTION ANEURYSM THORACIC; LEFT CHEST/SDA</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\BENTAL PROCEDURE /SDA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\BENTAL PROCEDURE WITH ? AORTIC ARCH REPLACEMENT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\BENTAL PROCEDURE; CORONARY ARTERY BYPASS GRAFT, REPLACEMENT OF HEMI-ARCH /SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\ENDOVASCULAR THORACIC ANEURYSM REPAIR /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\REPLACEMENT ASCENDING AORTA W/ HEMI-ARCH VS BENTAL PROCEDURE/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\RESECTION ANEURYSM THORACIC/SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANEURYSM\RESECTION; THORACO-ABDOMINAL AN EURYSM, VIA LEFT CHEST/SDA</td>
<td class="gt_row gt_center">220 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ANUERYSM\BENTAL/VALVE SPARING ROUTE REPLACEMENT, ASCEDNING AORTA &amp; ARCH W/ ELEPHANT TRUNK  /SDA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC DISSECTION;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC DISSECTION/SDA</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AORTIC ULCERATION</td>
<td class="gt_row gt_center">237 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC AROTIC ANEURYSM</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC ASCENDING AORTIC ANEURYSM\RESECTION; AORTIC ASCENDING ANEURYSM, REPLACEMENT PROXIMAL ARCH/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC CORD COMPRESSION/SDA</td>
<td class="gt_row gt_center">29 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC DISSECTION</td>
<td class="gt_row gt_center">89 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC FRACTURE-PARAPLEGIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC FX/SDA</td>
<td class="gt_row gt_center">129 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC LESION/SDA</td>
<td class="gt_row gt_center">616 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC MASS</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC MASS/SDA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC MENINGIOMA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC METASTATIC TUMOR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC MYELOPATHY/SDA</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC MYEOLOPATHY/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC PHLEGMON</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC SPINE FRACTURE;DISLOCATION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC SPINE INJURY;TRAUMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACIC TUMOR/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACID ANEURYSM WITHOUT MENTION OF RUPTURE\RESECTION ANEURYSM THORACIC /SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACO AAA/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACO ABDOMINAL ANEURYSM\ THORACO ABDOMINAL ANEURYSM REPAIR</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACO-ABD ANEURYSM</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACO-ABDOMINAL ANEURYSM \ THORACO-ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACO-ABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">65 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACO-ABDOMINAL AORTIC ANEURYSM/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACOABDOMINAL ANEURSYM/SDA</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACOABDOMINAL ANEURYSM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACOABDOMINAL ANEURYSM WITHOUT MENTION OF RUPTURE\ENDOVASCULAR THORACIC ANEURYSM REPAIR /SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACOABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">196 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORACOABDOMINAL ANEURYSM\ THORACO ABDOMINAL ANEURYSM REPAIR/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THORASIC SPINE TUMOR</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THOROABDOMINAL ANEURYSM/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THREATENED LEFT LOWER EXTREMITY</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THREE VESSEL CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THREE VESSEL CORONARY DISEASE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THREE VESSEL DISEASE/CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THREE VESSELL DISEASE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROACIC ANEURYSM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROAT HEMATOMA</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROAT INFECTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROAT MASS;BLEEDING</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROAT PAIN</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROAT SWELLING</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROBOVYTOPENIA</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBECTOMY W/C ARM UPPER AV GRAFT</td>
<td class="gt_row gt_center">825 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBIC THROMBOCYTOPENIA EXACERBATION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA</td>
<td class="gt_row gt_center">2,265 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA,HYPOXIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA; ANEMIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA; BIPOLAR;DEPRESSED;LEUKOCYTOSIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA;ANEMIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA;GASTROINTESTINAL BLEED;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA;MALARIA;TELEMETRY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA;NEUTROPENIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA;SYNCOPE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA/ANEMIA/?SEPSIS</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIA\EPISTAXIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOCYTOPENIC PURPURA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOEMBOLISM</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOSED AORTIC DISSECTION</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOSED STENT;ACUTE MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOSIS OF THE AV FISTULA</td>
<td class="gt_row gt_center">110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOSIS;RIGHT AV LOOP GRAFT</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOTIC THROMBOCYTOPENIA PURPURA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOTIC THROMBOCYTOPENIC PUPURA</td>
<td class="gt_row gt_center">97 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOTIC THROMBOCYTOPENIC PUPURA;? STROKE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOTIC THROMBOCYTOPENIC PURPURA</td>
<td class="gt_row gt_center">43 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBOYTIC THROMBOCYTOPENIC PURPURA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THROMBUS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THUMB AMPUTATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYMIC CA/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYMOMA/SDA</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYMUS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYRIOD GOITER/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID  MASS/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID CA/SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID CANCER/SDA</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID GOITER/SDA</td>
<td class="gt_row gt_center">263 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID MASS IMPINGING AIRWAY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID NEOPLASM UNCERTAIN TYPE/SDA</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID NEOPLASM UNCERTSIN TYPE/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID NODULE/SDA</td>
<td class="gt_row gt_center">159 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID STORM</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID TUMOR</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROID TUMOR MALIGNANT/SDA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">THYROTOXICOSIS</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIA</td>
<td class="gt_row gt_center">241 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIA VS SEIZURES</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIA;A-FIB</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIA;CEREBRAL STENOSIS;TELEMTRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIA;SPLENIC LACERATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIA;STROKE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIB FIB FRACTURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIB FX;LIVER LACERATION;S/P MOTOR VEHICLE ACCIDENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIB;FIB</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIB;FIB;FEMUR FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIB/FIB FRACTURE-LEFT ELBOW FRACTURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIB/FIB FRX</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIBIA FRACTURE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIBIAL FX, PELVIC FX.</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIBIAL PLATEAU FRACTURE</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIBIAL PLATEAU FRACTURES</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIGHT RIGHT CAROTID, SYMPTOMATIC WITH VISUAL CHANGES</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIPS EVALUATION;ANEMIA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIPS\ TIPS REDO/SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TIZANIDINE OVERDOSE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOE GANGRENE;R/O MI</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOE INFECTION</td>
<td class="gt_row gt_center">192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONGUE AND FLOOR OF MOUTH SQUAMOUS CELL CA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONGUE CA/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONGUE CANCER/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONGUE LACERATION</td>
<td class="gt_row gt_center">686 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONGUE SWELLING</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONGUE SWELLING ALLERGIC REACTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONSIL CANCER/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONSIL HYPERTROPHY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONSILLAR CANCER</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONSILLAR HYPERTROPHY W/ SLEEP APNEA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONSILLAR HYPERTROPHY;HEMOPTYSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TONSILLECTOMY BLEED</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOOTH ABSCESS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TORN MENISCUS LEFT KNEE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TORN MENISCUS;SEVERE ASTHMA ATTACK\ARTHROSCOPY KNEE; RIGHT</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TORSADE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TORSADES</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOUNGE SWELLING</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC ALCOHOL INGESTION</td>
<td class="gt_row gt_center">609 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC INGESTION</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC MEGACOLOM/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC MEGACOLON</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC MEGACOLON;TELEMETRY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC SHOCK</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXIC SHOCK;SEPSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TOXICITY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACEAL BRONCHIAL MALACIA/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACH BLEEDING</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACH COMPLICATION</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACH OCCLUSION</td>
<td class="gt_row gt_center">195 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACH OUT</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACH PLACEMENT</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACH REPLACEMENT</td>
<td class="gt_row gt_center">168 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHAEL MASS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHAEL STENOSIS</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEA MALACIA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BLEEDING</td>
<td class="gt_row gt_center">225 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHEAL MALACIA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIAL MALACIA, RIGHT SIDE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIAL MALACIA/SDA</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIAL MALACIA\ BRONCHOSCOPY W/&quot;Y&quot; STENT PLACEMENT</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIAL MALACIA\BRONCHOSCOPY RIGID; W/ STENT REMOVAL, BILATERAL/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIAL MALASIA</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIAL MALASIA\ RIGID BRONCHOSCOPY W/STENT REMOVAL</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIALMALACIA/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHIO MALASCIA/SDA</td>
<td class="gt_row gt_center">600 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCHOMALASIA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL BRONCOMALASIA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL CANCER</td>
<td class="gt_row gt_center">41 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL ESOPHAGEAL FISTULA</td>
<td class="gt_row gt_center">799 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL ESOPHAGEAL FISTULA/SDA</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL ESOPHAGEAL FISTULA\STENT PLACEMENT ESOPHAGUS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL FISTULA</td>
<td class="gt_row gt_center">500 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL INJURY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL LACERATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL LEAK, RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">308 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL LEAK;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALACEA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALACIA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALACIA-RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">980 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALACIA;SPONTANEOUS PNEUMOTHORAX</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALACIA/SDA</td>
<td class="gt_row gt_center">122 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALASIA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALASIA;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MALASIA;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL MASS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL OBSTRUCTION</td>
<td class="gt_row gt_center">421 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL OBSTRUCTION;ACUTE NAD CRONIC RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL OBSTRUCTION;CVA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL OCCLUSION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS</td>
<td class="gt_row gt_center">2,973 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS, SOB\BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">784 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS; END STAGE PARKINSON&#39;S DISEASE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS;BULBAR PALSY\BRONCHOSCOPY RIGID</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS;NON SMALL CELL LUNG CANCER</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS/AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS/AMYLOIDSIS\ SUSPENSION LARYNGOSCOPY/SDA</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS/SDA</td>
<td class="gt_row gt_center">1,041 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL STENOSIS\BRONCHOSCOPY FLEXIBLE AND RIGID; BALLOON DILATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL TEAR</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL TEAR-MEDIASTINAL EMPHYSEMA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL-BRONCHIO MALACEA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL-BRONCHO MALACEA/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL;BRONCHIAL MALACIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAL/BRONCHIAL ACHALSIA/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALBRONCHEAL MALACEA/SDA</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALBRONCHIALMALACIA/SDA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALBRONCHIOMALACIA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALBRONCHOMALACIA</td>
<td class="gt_row gt_center">94 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALBRONCHOMALACIA/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALBRONCIAL MALACEA/SDA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEALMALACEA\BRONCHOSCOPY RIGID;STENT REMOVAL/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEAOBRONCHEO MALACIA, RIGHT/SDA</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEBRONCHIALMALACIA/SDA</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEL STENOSIS</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO &amp; BRONCHO MALACIA/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO BRONCHIAL FISTULA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO BRONCHIAL MALACIA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO BRONCHO MALACIA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO BRONCHOMALACIA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO-BRONCHEAL MALACEA/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO-BRONCHEO MALACEA\BRONCHOSCOPY RIGID;STENT REMOVAL</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO-BRONCHIO MALACEA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEO-BRONCHO MALACEA/SDA</td>
<td class="gt_row gt_center">411 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBROCHOMALACIA&#39;/SDA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBROCHOMALACIA/SDA</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBROCHOMALACIA\BRONCHOSCOPY FLEXIBLE AND RIGID </td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHAL MALACIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHEAL MALACIA</td>
<td class="gt_row gt_center">341 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHEO MALACEA/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHEOMALACIA/SDA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIAL FISTULA</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIAL MALACEA/SDA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIAL MALACIA</td>
<td class="gt_row gt_center">1,192 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIAL MALASIA</td>
<td class="gt_row gt_center">332 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIALMALACEA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIALMALACHIA</td>
<td class="gt_row gt_center">136 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIO MALACIA/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIOMALACIA</td>
<td class="gt_row gt_center">1,052 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIOMALACIA/SDA</td>
<td class="gt_row gt_center">266 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHIOMALECIA</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHO MALACEA/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHO MALACIA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOMALACIA</td>
<td class="gt_row gt_center">540 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOMALACIA;DYSPNEA</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOMALACIA/SDA</td>
<td class="gt_row gt_center">1,072 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOMALACIA\BRONCHOSCOPY RIGID W/ STOMA REVISION T TUBE PLACEMENT</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOMALACIA\BRONCHOSCOPY RIGID, MICRODEBRIDEMENT, CRYO-THERAPY, TRACHEAL CANNULA CHANGE </td>
<td class="gt_row gt_center">570 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOMALASIA/SDA</td>
<td class="gt_row gt_center">332 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCHOPLASTY;EPIDURAL CATHETER</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCIOMALACEA/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCOMALASIA /SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBRONCOMALICIA/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOBROPCHIAL MALACIA/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOESOPHEAL FISTULA</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOMALACIA</td>
<td class="gt_row gt_center">458 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOMALACIA/SDA</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOMALACIA\ RIGID BRONCHOSCOPY WITH STENT REMOVAL; LASER RESECTION/SDA</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOMALASIA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOMALASIA;FAILED EXTUBATION</td>
<td class="gt_row gt_center">410 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOSTOMY</td>
<td class="gt_row gt_center">4,692 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOSTOMY BLEEDING</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOSTOMY EVALUATION</td>
<td class="gt_row gt_center">1,885 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHEOSTOMY PLACEMENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACHIOBRONCHOMALACIA/SDA</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRACIAL MALAICIA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANCHEAL BRONCHIAL MALACIA/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANCHEAL MALACIA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSAMINITIS;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSAMINITIS/FEVER</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSBRONCHIAL BIOPSY</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSFUSION REACTION</td>
<td class="gt_row gt_center">71 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSIENT HYPOTENSION;NEAR SYNCOPE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSIENT ISCHEMIC ATTACK</td>
<td class="gt_row gt_center">678 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSIENT ISCHEMIC ATTACK; CVA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSIENT ISCHEMIC ATTACK;ICA CLOT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSIENT ISCHEMIC ATTACK\CAROTID STENT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSPLANT</td>
<td class="gt_row gt_center">415 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSPLANT REJECTION</td>
<td class="gt_row gt_center">249 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSPLANT SITE BLEEDING</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRANSVERSE COLON CANCER/SDA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUM</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUM;S/P MOTOR VEHICLE ACCIDENT;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA</td>
<td class="gt_row gt_center">1,130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA ;INTRACRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA FALL</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA W\INJURIES</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA,BICYCLE VS CAR</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA,HEAD BLEED,HIP FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA,INTER CRANIAL HEMORRHAGE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA,S/P FALL</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA,S/P MOTOR VEHICAL ACCIDENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA,S/P MVA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA; HEAD INJURY; MULTI FRACTURES</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;CLOSED HEAD INJURY;ORBITAL FX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;CSPINE FRACTURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;EPIDURAL BLEED</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;FEMUR FX</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;HYPOXIA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;INTUBATION</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;IPH</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;LEFT SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;MANDIBULAR FX</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;MULTUPLE FRACTURES</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;PEDESTRIAN STRUCK</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;S/P ASSAULT</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;S/P FALL;CERVICAL FRACTURE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;SAH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA;SUBARACHNOID HEMATOMA;C 6-7 FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMA/ICH</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC AMP LEFT FOOT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC AORTIC DISSECTION</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC BRAIN HEMORRHAGE, LEFT /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC BRAIN INJURY</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC BRAIN INJURY/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC CORD INJURY </td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC HEAD BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC HEAD INJURY</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC HEAD INJURY/SDA</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC INTRACRANIAL BLEED</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC LEFT ARM AMPUTATION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC PANCREATITIS</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC RIGHT UPPER EXTREMITY INJURY/SDA</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SAH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SHOCK;PELVIC FRACTURE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SPONDYLOLISTHESIS/SDA</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SUBARACHNOID BLEED</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SUBARACHNOID HEMMORHAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SUBARACHNOID HEMORRHAGE</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SUBARACHNOID HEMORRHAGE-RT HIP FRACTURE</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAUMATIC SUBDURAL HEMORRHAGE</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRAZADONE OD</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TREACHEAL STENOSIS /SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TREMOR</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TREMOR,ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TREMOR;BRAIN TUMOR</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID DISORDER\REDO STERNOTOMY; PULMONARY VALVE REPLACEMENT; TRICUSPID VALVE REPAIR; LEAD REMOVAL/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID REGURDS\TRICUSPID VALVE REPLACEMENT; REDO STERNOTOMY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID REGURGITATION\ REDO TVR; MAZE PROCEDURE/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID REGURGITATION\ TRICUSPID REPAIR OF REPLACEMENT/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID REGURGITATION\REDO-REDO TRICUSPID VALVE REPAIR/REPLACEMENT</td>
<td class="gt_row gt_center">156 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID REGURGITATION\TRICUSPID VALVE REPLACEMENT, LEFT VALVE LEAD PLACEMENT/SDA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID REGURGITATION\TRICUSPID VALVE REPLACEMENT; REPAIR/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID VALVE DISORDER\REDO STERNOTOMY TVR </td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICUSPID VALVE DISORDERS\REDO STERNOTOMY; TRICUSPID VALVE REPLACEMENT /SDA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICYCLIC &amp;  BENZOS OVERDOSE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICYCLIC ANTIDEPRESSANT</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRICYCLIC ANTIDEPRESSANT OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMIANAL NEURALGIA/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINAL NEURALGA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINAL NEURALGIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINAL NEURALGIA /SDA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINAL NEURALGIA/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINAL NEUROLGIA/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINAL;NEURALGIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIGEMINIAL NEURALGIA/SDA</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIMAN FRACTURE AND DISLOCATION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIPLE A/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIPLE AAA</td>
<td class="gt_row gt_center">119 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIPLE AAA;RESECTION AORTIC ASCENDING ANEURSYM</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRIPLE AAA;TELEMETRY</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TROMVECTOMY</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRUMA SUB DURAL HEMATOMA</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TRUMA,RIGHT BLOBE RUPTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TSAH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TTP </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TTP VS  HUS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TUBAL LIGATION;EXPLORATORY LAP</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TUBERCULUM MENINGIOMA/SDA</td>
<td class="gt_row gt_center">57 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TUMOR OF THROAT &amp; VOICE BOX/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TUMOR RIGHT TUMOR/SDA</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TURBT</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TVR</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TVR\ REDO STERNOTOMY TRICUSPID VALVE;REPAIR &amp; REPLACEMENT</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYELNOL OD,HEPATITIS C</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL AND ASPIRIN OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL BENZO OVERDOSE</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL HEPATOTOXICITY</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL LIVER TOXICITY</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL O/D</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OD</td>
<td class="gt_row gt_center">330 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OD; WRIST LACERATION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OVERDOSE</td>
<td class="gt_row gt_center">763 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OVERDOSE-GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OVERDOSE-LIVER FAILURE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OVERDOSE;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL OVERDOSE;LIVER FAILURE</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL,OVERDOSE;LIVER FAILURE</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYLENOL;BARBITUATE INGESTION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYNELOL OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYNENOL OD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE 1 AORTIC DISSECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE 1 DISECTION</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE A AORTIC DISSECTION</td>
<td class="gt_row gt_center">201 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE A DISSECTION</td>
<td class="gt_row gt_center">145 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE B AORTIC DISSECTION</td>
<td class="gt_row gt_center">212 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE B AORTIC DISSECTION-ODONTOID FRACTURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE B AORTIC DISSECTION\ RESECTION THORACIC ANEUYSM VIA LEFT THORACOTOMY/SDA</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE B DISSECTION</td>
<td class="gt_row gt_center">79 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPE B THORAUA AORTIC DISSECTION</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">TYPHLITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">U/A</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UC FLARE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGI BLEED</td>
<td class="gt_row gt_center">923 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGIB</td>
<td class="gt_row gt_center">926 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGIB; NEW INFARCT</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGIB;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">216 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGIB;HEMATEMESIS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGIB;HYPERKALEMIA</td>
<td class="gt_row gt_center">378 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UGIB;PANCREATIC MASS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UIT;PNEUMONIA</td>
<td class="gt_row gt_center">726 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UIT;PYELONEPHRITIS</td>
<td class="gt_row gt_center">422 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UIT;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER</td>
<td class="gt_row gt_center">243 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER LEFT FOOT/SDA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER LEFT LEG</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER RIGHT LEG/SDA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER RIGHT LOWER EXTREMITY</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER SEVERITY; RENAL FAILURE</td>
<td class="gt_row gt_center">490 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCER;IV ANTIBIOTICS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATED LEFT MAIN CORONARY ARTERY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATION/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS</td>
<td class="gt_row gt_center">242 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS CHRONIC/SDA</td>
<td class="gt_row gt_center">157 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS, CHRONIC/SDA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS, POLYPS</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS,ABD PAIN</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS;PNEUMONIA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERATIVE COLITIS/SDA</td>
<td class="gt_row gt_center">117 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULCERS/CELLULITIS LEFT FOOT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULNAR FRACTURE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULNAR FRACTURE;SUBARACHNOID HEMATOMA;C5 FRACTURE</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ULNAR/RADIAL FX; C2 FX;S/P FALL</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UMBILICAL HERNIA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UMBILICAL HERNIA &amp; RIGHT INGUINAL HERNIA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UMBILICAL HERNIA;ASCITES LEAK</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UMBILICAL HERNIA/SDA</td>
<td class="gt_row gt_center">459 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNABLE TO AMBULATE</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNABLE TO STAND</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNABLE TO WALK</td>
<td class="gt_row gt_center">747 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNABLE TO WALK/WEAKNESS</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCINATE MASS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCONTROLLED DIABETES MELLITUS</td>
<td class="gt_row gt_center">51 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCONTROLLED DIABETES;PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">480 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCONTROLLED DIABETES/PANCREAS TRANSPLANT</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCONTROLLED EPISTAXIS</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCONTROLLED HYPERTENSION</td>
<td class="gt_row gt_center">218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNCONTROLLED HYPERTENSION-NAUSEA-VOMITING</td>
<td class="gt_row gt_center">15,523 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">UNEXPLAINED THROMBOSIS OF LEFT LEG; FEMORAL POPLITEAL GRAFT/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNKNOWN BRAIN TUMOR/SDA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNREPONSSIVE</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE</td>
<td class="gt_row gt_center">8,333 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE AND SEIZED</td>
<td class="gt_row gt_center">490 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE HYPERKALEMIA</td>
<td class="gt_row gt_center">6,446 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE-DRUG OVERDOSE</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE-OVERDOSE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE, R/O CVA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE,FOUND DOWN</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE; RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE; S/P OVERDOSE</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE;ASPIRATION</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE;FEVER</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE;MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE;OVERDOSE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE/? STROKE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE/FOUND DOWN/? PNEUMONIA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE/INTUBATED</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVE/RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVENESS</td>
<td class="gt_row gt_center">415 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVENESS, CVA VS. SEIZURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPONSIVENESS;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">81 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNRESPOSIVE - (FOUND DOWN)</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSATABLE ANGINA</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSPECIFIED BRAIN MASS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSPECIFIED INJUIRIES FROM TRAUMA</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSPECIFIED TRAUMA;TELEMETRY</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABEL ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGIN-CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA</td>
<td class="gt_row gt_center">8,383 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA-ACUTE PULMONARY EDEMA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA,CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA,R/O MI</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA; ELEVATED TROPONIN\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA; R/O MI</td>
<td class="gt_row gt_center">365 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;+ETT\CATH</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;3 VESSEL DISEASE;CONGESTIVE HEART FAILURE;CHRONIC OBSTRUCTIVE PULMONARY DISEASE\CATH</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;ABNORMAL ECHO\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;ACUTE MI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;AORTIC STENOSIS\CARDIAC CATH</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;ASTHMA;BRONCHITIS</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CHEST PAIN\CARDIAC CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CHEST PAIN\CATH</td>
<td class="gt_row gt_center">85 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CONGESTIVE HEART FAILURE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CORONARY ARTERY DISEASE</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CORONARY ARTERY DISEASE\ANGIOPLASTY WITH STENT</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;CORONARY ARTERY DISEASE\CATH</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;ELEVATED CREATININE\CATH</td>
<td class="gt_row gt_center">165 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;MITRAL REGURGITATION\CATH</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;MYOCARDIAL INFARCTION\CARDIAC CATH</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;MYOCARDIAL INFARCTION\UPDATE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;NON Q WAVE MI</td>
<td class="gt_row gt_center">810 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;NON Q WAVE MI\CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;PERIPHERAL VASCULAR DISEASE\CATH</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;S/P MI\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;TELEMETRY</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;TELEMETRY\CARDIAC CATHERIZATION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;TELEMETRY\CATH</td>
<td class="gt_row gt_center">432 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA;TELEMETRY\CATH;STENT PLACEMENT</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA/CATH</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA/R/O MI</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\ANGIOPLASTY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CARD CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CARDIAC CATH</td>
<td class="gt_row gt_center">218 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CARDIAC CATH;STAGED CIRCUMFLEX STENTING</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CATH</td>
<td class="gt_row gt_center">3,594 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CATH WITH BRACHY S/B</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CATHETER</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\COMPLETE HEART CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CORONARY ANGIOGRAM</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\CORONARY ARTERY BYPASS GRAFT</td>
<td class="gt_row gt_center">128 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\LEFT HEART CATH</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\LEFT HEART CATHERIZATION</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">2,056 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\LFT HEART CATH</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANGINA\RIGHT AND LEFT CATH</td>
<td class="gt_row gt_center">46 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTABLE ANINA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UNSTEADY GAIT/BRAIN METS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER &amp; LOWER EXTREMITY WEAKNESS</td>
<td class="gt_row gt_center">56 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER AIRWAY OBSTRUCTION</td>
<td class="gt_row gt_center">133 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER AIRWAY RESTRICTION, LEUKEMIA</td>
<td class="gt_row gt_center">132 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER AND LOWER GI BLEED</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER BI BLED/SDA</td>
<td class="gt_row gt_center">324 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER EXTREMITY DEEP VEIN THROMBUS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER EXTREMITY DVT; UNABLE TO REMOVE PIC</td>
<td class="gt_row gt_center">264 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER EXTREMITY THROMBOSIS</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER G.I. BLEED</td>
<td class="gt_row gt_center">396 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTRO INTESTINAL BLEED</td>
<td class="gt_row gt_center">1,160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTENSTINAL BLEED;HIP FRACTURE;ETOH WITHDRAWAL</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESINAL BLEED</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESSTINAL BLEED</td>
<td class="gt_row gt_center">11,129 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL </td>
<td class="gt_row gt_center">576 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">19,286 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;HYPOTENSION</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;NSTEMI</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;PNEUMONIA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;POSITIVE TROP;CHRONIC OBST PULM DISEASE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;SEPSIS</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEED/ FEVER</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEEDING</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GASTROINTESTINAL BLEEN</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GATROINTESTINAL BLEEDING</td>
<td class="gt_row gt_center">138 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED</td>
<td class="gt_row gt_center">93,710 (1.2%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED </td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED-SMALL BOWEL OBSTRUCTION</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED; HYPOTENSION</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED;DEHYDRATION;METASTATIC MELANOMA</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED;FEVER;COUGH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED;PANCREATITIS</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEED;TELEMETRY</td>
<td class="gt_row gt_center">2,016 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLEES</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLLED</td>
<td class="gt_row gt_center">84 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GI BLLEED</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER GIB</td>
<td class="gt_row gt_center">1,866 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER LOBE LESION/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER RESPIRATORY INFECTION;PYELONEPHRITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPER;GASTROINTESTINAL BLEED;ESOPHAGEAL BLEED</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UPPPER GI BLEED</td>
<td class="gt_row gt_center">402 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UREMIA</td>
<td class="gt_row gt_center">615 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UREMIA;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URESPONSIVE</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETER STONES</td>
<td class="gt_row gt_center">147 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETERAL CA/SDA</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETERAL STICTURE</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETERAL STONE</td>
<td class="gt_row gt_center">92 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETERAL STONES LEFT</td>
<td class="gt_row gt_center">74 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETERAL STRICTURE/SDA</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETERAL THROMBUS</td>
<td class="gt_row gt_center">2,002 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URETEROLITHIASIS</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URI PERICARDIAL EFFUSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URIMARY TRACT INFECTION;PYELONEPHRITIS</td>
<td class="gt_row gt_center">624 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY FREGUENCY/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY INCONTINENCE, RENAL CALCULUS, RENAL OBSTRUCTION/SDA</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY INCONTINENCE/SDA</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY OBSTRUCTION;? NEW MALIGNANCY</td>
<td class="gt_row gt_center">120 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY POUCH STONE;STENT PLACEMENT</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY RETENTION</td>
<td class="gt_row gt_center">112 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY RETENTION; URETHERAL STRICTURE/SDA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY SEPSIS</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACK INFECTION;SEPSIS</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTIOM;PYELONEPHRITIS</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION</td>
<td class="gt_row gt_center">13,675 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION S/P TRANSPLANT</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION-COLITIS</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION-PNEUMONIA-TRACH INFECTION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION-PYELONEPHRITIS</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION, SYNCOPE, DKA</td>
<td class="gt_row gt_center">1,176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION,ALTERED MENTAL STATUS,NON STE MI</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION,DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">575 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION,HEEL HEMATOMA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION,HYPOGLYCEMIA</td>
<td class="gt_row gt_center">534 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION,NAUSEA,VOMITING,DIARRHEA</td>
<td class="gt_row gt_center">111 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION,PYELONEPHRITIS</td>
<td class="gt_row gt_center">3,656 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION; CHF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION; CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION; PYELONEPHRITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;ACIDOSIS;RENAL FAILURE;?INFLUENZA</td>
<td class="gt_row gt_center">812 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">491 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;ACUTE RENAL FAILURE;ELEVATED INR</td>
<td class="gt_row gt_center">272 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;AKI</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">458 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;AMA;PERIDURAL ABSCESS</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;ANTI COAGULATION</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;BACK PAIN;ATRIAL FIBRILLATION</td>
<td class="gt_row gt_center">32 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;BRADYCARDIA;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">530 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;CELLULITIS;HYPERGLYCEMIA</td>
<td class="gt_row gt_center">2,250 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;DEEP VEIN THROMBOSIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;DEHYDRATION</td>
<td class="gt_row gt_center">222 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;DEHYDRATION;HYPERGLYCEMIA;TELEMTRY</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;DEHYDRATION;TROPONIN LEAK</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;DEMENTIA;SUICIDAL IDEATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;FEMUR FX;S/P FALL</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;FEVER</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;FEVER;SEPSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;GASTROINTESTINAL BLEED</td>
<td class="gt_row gt_center">86 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HEMATEMASIS</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HIATAL HERNIA</td>
<td class="gt_row gt_center">232 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYOPERGLYCEMIA;FOOT ULCER</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYPERKALEMIA</td>
<td class="gt_row gt_center">177 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYPERNATREMIA</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYPOTENSION</td>
<td class="gt_row gt_center">277 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYPOTENSION;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">984 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYPOTENSION;TELEMETRY</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;HYPOXIA</td>
<td class="gt_row gt_center">325 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;LABILE BLOOD SUGAR;SEPSI</td>
<td class="gt_row gt_center">80 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;NARCOTOSIS</td>
<td class="gt_row gt_center">5,644 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;NEPHROLITHIASIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PNEUMONIA</td>
<td class="gt_row gt_center">130 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONE</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONEOHRITIS</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONEP</td>
<td class="gt_row gt_center">468 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONEPHRITIS</td>
<td class="gt_row gt_center">21,581 (0.3%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONEPHRITIS;ACUTE RENAL FAILURE;RIGHT HIP PAIN</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONEPHRITIS;FEVERS</td>
<td class="gt_row gt_center">19 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYELONEPHRITIS;TELEMETRY</td>
<td class="gt_row gt_center">144 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;PYLONEPHRITIS</td>
<td class="gt_row gt_center">62 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;R/O MRSA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;RENAL FAILURE</td>
<td class="gt_row gt_center">55 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;RESPIRATORY FAILURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;SEIZURE</td>
<td class="gt_row gt_center">466 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;SEPSIS</td>
<td class="gt_row gt_center">2,412 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;SHORTNESS OF BREATH</td>
<td class="gt_row gt_center">4,706 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;TELEMETRY</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION;WEAKNESS</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION/ MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION/DIARRHEA</td>
<td class="gt_row gt_center">189 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION/PYELONEPHRITIS</td>
<td class="gt_row gt_center">322 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URINARY TRACT INFECTION/PYELONPHRITIS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">URO-SEPSIS</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS</td>
<td class="gt_row gt_center">15,116 (0.2%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS-ANEMIA-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">99 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS-CHANGE IN MENTAL STATUS</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS-HYPOTENSION</td>
<td class="gt_row gt_center">390 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS, ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS,DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS,FEVER</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS,PNEUMONIA,COLITIS</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS,PNEUMONIA,R/O MI</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS,R/O MI</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS; CAD</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS; MENTAL STATUS CHANGES</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS; OBSTRUCTING STONE</td>
<td class="gt_row gt_center">231 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;HYPERKALMIA</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;HYPOTHERMIA</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;NEPHROLITHIASIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;NSTEMI</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;PANCREATITIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;PNEUMOTHORAX</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;PYELONEPHRITIS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;TELEMETRY</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;TROP LEAK</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSEPSIS;WOUND INFECTION</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UROSPEPSIS</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">USA +ETT FOR CATHERIZATION\CATHERIZATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">USA,SEVERE MR\CATH</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">USA/SDA</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTERINE BLEED</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTERINE MALIGNANCY/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTERINE RUPTURE\D&amp;C</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTERINE TUMOR/BILATERAL HYDRONEPHROSIS</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI AND AMS</td>
<td class="gt_row gt_center">654 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI, ALTERED MENTAL STATE</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI, BLADDER CANCER</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI,CHF</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI,CHRONIC RENAL FAILURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI,FREQUENT FALLS</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI,LOW BLOOD PRESSURE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI; PYELONEPHRITIS</td>
<td class="gt_row gt_center">87 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI;ABDOMINAL PAIN</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI;ALTERED MENTAL STATUS</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI;PYELONEPHRITIS</td>
<td class="gt_row gt_center">381 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI;PYLONEPHRITIS</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI;S/P RENAL TRANSPLANT</td>
<td class="gt_row gt_center">284 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI;VOMITING</td>
<td class="gt_row gt_center">78 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI.PYLONEPHRITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/ PYELONEPHRITIS</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/ETOH WITHDRAWL/R HIP FX</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/HYPERNATREMIA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/PYELONEHRITIS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/PYELONEPHRITIS</td>
<td class="gt_row gt_center">6,729 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/PYELONESPHRITIS</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTI/URINARY RETENTION</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UTL/PYLELONEPHRITIS</td>
<td class="gt_row gt_center">292 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UVEITIS</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">UVULAR EDEMA</td>
<td class="gt_row gt_center">1 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V  TACH</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V -TACH ARREST</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V FIB ARREST</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V FIB ARREST;PNEUMONIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V TACH</td>
<td class="gt_row gt_center">553 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V TACH/AICD FIRE</td>
<td class="gt_row gt_center">342 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V TACH/CARDIOMYOPATHY</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-F ARREST</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-FIB ARREST</td>
<td class="gt_row gt_center">187 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-FIB ARREST,METASTATIC CANCER</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-FIB ARREST/ S/P CATH</td>
<td class="gt_row gt_center">123 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-FIB ARREST\CATH</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH</td>
<td class="gt_row gt_center">173 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH ARREST</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH ARREST;SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH, HEART FAILURE</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH,FEVER</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH; ARREST</td>
<td class="gt_row gt_center">38 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH/CARDIOVERSION</td>
<td class="gt_row gt_center">552 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACH\EP STUDY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V-TACK;ASPIRATION PNEUMONIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">V2 TYPICAL TRIGEMINAL NEURALGIA/SDA</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VAGINAL BLEED</td>
<td class="gt_row gt_center">39 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VAGINAL BLEEDING</td>
<td class="gt_row gt_center">279 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VAGINAL BLEEDING; ANEMIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VAGINAL BLEEDING;TELEMETRY</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VAGINAL VAULT PROLAPSE/SDA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VAGINOENTERIC FISTULA</td>
<td class="gt_row gt_center">405 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VALPROATE OVERDOSE</td>
<td class="gt_row gt_center">37 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VALSALVA ANEURYSM</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VANCO DESENTSITIZATION</td>
<td class="gt_row gt_center">135 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARCEAL BLEED</td>
<td class="gt_row gt_center">290 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEED</td>
<td class="gt_row gt_center">1,536 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEED CIRRHOSIS</td>
<td class="gt_row gt_center">1,341 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEED,S/P TIPS</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEED;CIRRHOSIS</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEED;HEMATEMESIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEAL BLEEDING</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICEL BLEED;TELEMETRY</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICELLA PNEUMONIA</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICELLA ZOSTER ENCEPHALITIS</td>
<td class="gt_row gt_center">66 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARICOSE VEINS,L/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VARIOES BLEEDING</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VASCULAR BLOCKAGE;R/O MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VASCULAR INSUFFICIENCY;RIGHT LEFT GRAFT FAILURE</td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VASCULAR OCCLUSION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VASCULITIS</td>
<td class="gt_row gt_center">316 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VASOSPASM</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VEIN GRAFT STENOSIS</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VEIN THROMBUS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENA CAVAL TUMOR</td>
<td class="gt_row gt_center">28 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENOUS CLAUDICATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENOUS SINUS THROMBOSIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENOUS STASIS ULCER</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENOUS THROMBOSIS</td>
<td class="gt_row gt_center">33 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA</td>
<td class="gt_row gt_center">278 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA / ABDOMINAL PANNUS/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA &amp; CHOLECYSTITIS/SDA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA, ABDOMINAL PANNUS</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA; ENTEROCUTANEOUS FISTULA/SDA</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA; SKIN LAXITY ABDOMEN &amp; BREASTS/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA;SIGNFICANT PAIN UNRESPONSIVE TO PO MEDICATION;SURGERY MORE EXTENSIVE THAN PLANNED</td>
<td class="gt_row gt_center">96 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL HERNIA/SDA</td>
<td class="gt_row gt_center">2,215 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL SEPTAL DEFECT\MITRAL VALVE REPLACEMENT; VENTRAL SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRAL, BILATERAL INGUINAL HERNIAS/SDA</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR ARREST</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR BIGEMINY</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR BLEED</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR FIBRILLATION</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR FIBRILLATION \CATH</td>
<td class="gt_row gt_center">40 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR FIBRILLATION ARREST</td>
<td class="gt_row gt_center">59 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR FIBRILLATION ARREST\CATH</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR FIBRILLATION\ICD</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR HEMORRHAGE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR MASS</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR SEPTAL D EFFECT</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR SEPTAL DEFECT\ CLOSURE OF VENTRICULAR SEPTAL DEFECT/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACCHYCARDIA</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYARRHYTHMIA STORM</td>
<td class="gt_row gt_center">213 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">2,265 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA </td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA STORM</td>
<td class="gt_row gt_center">90 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA, HEART FAILURE\VENTRICULAR TACHYCARDIA ABLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA, STATUS POST MYOCARDIAL INFARCTION \ELECTROPHYSIOLOGY STUDY; VENTRICULAR TACHYCARDIA ABLATION /SDA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA; SYNCOPE\VENTRICULAR TACHYCARDIA ABLATION ? TANDEM HEART</td>
<td class="gt_row gt_center">141 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;ACID FIRING</td>
<td class="gt_row gt_center">184 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;CARDIOMYOPATHY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;CONGESTIVE HEART FAILURE\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;ICD SHOCKS\VENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;ISCHEMIA\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">13 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;SEPSIS;HYPERTENSION</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;SHORTNESS OF BREATH; ABNORMAL STRESS TEST\CARDIAC CATHETERIZATION</td>
<td class="gt_row gt_center">21 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;SYNCOPE</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA;TELEMETRY</td>
<td class="gt_row gt_center">176 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA/CHEST PAIN</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA/VENTRICULAT TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\ EPS; VENTRICULAR TACHYCARDIA ABLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\CATH</td>
<td class="gt_row gt_center">174 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\EP STUDY + ABLATION</td>
<td class="gt_row gt_center">11 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\EP STUDY/ABLATION</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\POSSIBLE SUPRAVENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">23 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\SYMPATHETIC NERVE RESECTION</td>
<td class="gt_row gt_center">255 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\TEE; VENTRICULAR TACHYCARDIA ABLATION; ? PVI **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">60 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION</td>
<td class="gt_row gt_center">239 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION  **REMOTE WEST**</td>
<td class="gt_row gt_center">64 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION  **REMOTE WEST**/SDA</td>
<td class="gt_row gt_center">244 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION **REMOTE WEST** </td>
<td class="gt_row gt_center">42 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\VENTRICULAR TACHYCARDIA ABLATION/SDA</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIA\VT ABLATION</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACHYCARDIC</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TACKYCARDIA</td>
<td class="gt_row gt_center">102 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULAR TCHYCARDIA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTRICULOMEGALY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VENTURAL HERIA</td>
<td class="gt_row gt_center">76 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VER AETNA PER NEHEN 020807 PTB\CHEMO HIGH DOSE INTERLEUKIN-2)</td>
<td class="gt_row gt_center">34 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERAPAMIL OVERDOSE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERNTICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">686 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">3 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL ARTERY DISSECTION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL ARTERY OCCLUSION</td>
<td class="gt_row gt_center">25 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL ARTERY STENOSIS</td>
<td class="gt_row gt_center">53 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL ARTEY DISSECTION</td>
<td class="gt_row gt_center">2 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL BASALAR INSUFFICENCY/SDA</td>
<td class="gt_row gt_center">26 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL BASILAR STENOSIS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL DISSECTION;STROKE;TELEMETRY</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTEBRAL FRACTURE</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTIGO</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VERTRICULAR TACHYCARDIA</td>
<td class="gt_row gt_center">50 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VESICLE VAGINAL FISTULA/SDA</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VETRICULAR FIBRILLATION\LEFT HEART CATH</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VF ARREST</td>
<td class="gt_row gt_center">49 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VF ARREST </td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VF ARREST\CATH</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VFIB</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VFIB ARREST</td>
<td class="gt_row gt_center">247 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VFIB ARREST;TELEMETRY</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VFIB-CARDIAC ARREST</td>
<td class="gt_row gt_center">88 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VIRAL GASTROENTERITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VIRAL MENINGITIS</td>
<td class="gt_row gt_center">30 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VIRAL MENINGITIS;BRADYCARDIA</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VISCERAL ARTERY ANEURYSM/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VISION LOSS</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VISUAL CHANGES</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOCAL CORD DISFUNCTION</td>
<td class="gt_row gt_center">100 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOCAL CORD EDEMA</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOCAL CORD LESION</td>
<td class="gt_row gt_center">273 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOCAL CORD TUMOR</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOCAL FOLD PARALYSIS</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOCAL PARALYSIS\LARYNGOSCOPY MICRO SUSPENSION; W/CO2 LASER</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOLUME DEPLETION </td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOLUME OVERLOAD</td>
<td class="gt_row gt_center">5,846 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOLUME OVERLOAD HYPERKALEMIA</td>
<td class="gt_row gt_center">248 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOLVULUS</td>
<td class="gt_row gt_center">380 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING</td>
<td class="gt_row gt_center">3,641 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING AND DIARRHEA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING PYELO</td>
<td class="gt_row gt_center">623 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING-DIARRHEA-TACHYCARDIA</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING, PNEUMONIA</td>
<td class="gt_row gt_center">840 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING; HYPERGLYCEMIA; HEADACHE</td>
<td class="gt_row gt_center">105 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING; UNABLE TO TOLERATE PO</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;ALCOHOL WITHDRAWAL</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;CONGESTIVE HEART FAILURE;COUGH</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;DEHYDRATION</td>
<td class="gt_row gt_center">75 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;DIARRHEA;HYPOTENSION</td>
<td class="gt_row gt_center">68 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;FEVER UNKNOWN ORIGEN;HIV</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;R/O PNEUMONIA</td>
<td class="gt_row gt_center">1,880 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;RESPIRATORY DISTRESS</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITING;RULE OUT MYOCARDIAL INFARCTION;DIABETIC KETOACIDOSIS</td>
<td class="gt_row gt_center">114 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITTING</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VOMITTING, DEHYDRATION, DIARRHEA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VP SHUNT MALFUNCTION</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VR\ MVR REDO</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT</td>
<td class="gt_row gt_center">435 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT  WITH ACID FIRING</td>
<td class="gt_row gt_center">17 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT ABLATION</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT ARREST</td>
<td class="gt_row gt_center">349 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT WITH AICD FITTING</td>
<td class="gt_row gt_center">27 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT;SYNCOPE</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VT/VF</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTAC</td>
<td class="gt_row gt_center">544 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTACH</td>
<td class="gt_row gt_center">1,110 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTACH;CONGESTIVE HEART FAILURE;ACUTE RENAL FAILURE;COLITIS</td>
<td class="gt_row gt_center">20 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTACH;FATIGUE</td>
<td class="gt_row gt_center">58 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTACH;TELEMETRY</td>
<td class="gt_row gt_center">231 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTACH\EP STUDY</td>
<td class="gt_row gt_center">6 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VTAH;SOB</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VULVA CANCER/SDA</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VULVAR CANCER;CELLULITIS</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VULVUS</td>
<td class="gt_row gt_center">5 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">VY36PH\CORONARY ARTERY BYPASS GRAFT/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WARFARIN TOXICITY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS</td>
<td class="gt_row gt_center">9,133 (0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS-BRADYCARDIA-ACUTE RENAL FAILURE</td>
<td class="gt_row gt_center">54 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS-RENAL FAILURE</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS, BACK PAIN</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS, DIARRHEA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS,FAILURE TO THRIVE</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;ANEMIA;TELEMETRY</td>
<td class="gt_row gt_center">160 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;C-DIFF DIARRHEA</td>
<td class="gt_row gt_center">12 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;CERVICAL STENOSIS</td>
<td class="gt_row gt_center">116 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;DEHYDRATION</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;FEVER</td>
<td class="gt_row gt_center">8 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;HYPOTENSION</td>
<td class="gt_row gt_center">24 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;HYPOTENTION</td>
<td class="gt_row gt_center">44 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;LETHARGY</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;R/O GUILLAIN BARRE</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;R/O MENINGITIS;</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;RULE-OUT MYOCARDIAL INFARCTION</td>
<td class="gt_row gt_center">10 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;RULE-OUT MYOCARDIAL INFARCTION;TELEMETRY</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;TELEMETRY</td>
<td class="gt_row gt_center">205 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS;TELEMTRY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS/BRAIN BIOPSY</td>
<td class="gt_row gt_center">69 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEAKNESS/UROSEPSIS</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEBSTER TRIPLE A</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEIGHT LOSS</td>
<td class="gt_row gt_center">72 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WEIGHT LOSS;DIARRHEA</td>
<td class="gt_row gt_center">272 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WET GANGRENE</td>
<td class="gt_row gt_center">315 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WIDE COMPLEX TACHYCARDIA</td>
<td class="gt_row gt_center">154 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WIDE COMPLEX TACYCARDIA</td>
<td class="gt_row gt_center">70 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WITHDRAWAL</td>
<td class="gt_row gt_center">464 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WITHDRAWL</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOLFF PARKINSON WHITE SYNDROME</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOLLFE-PARKINSON-WHITE SYNDROME;SUPRAVENTRICULAR TACHYCARDIA\EP STUDY WITH ABLATION</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSEING RENAL FAILURE</td>
<td class="gt_row gt_center">48 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSENING ANGINA;CORONARY ARTERY DISEASE\LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSENING DYSPNEA ON EXERTION;AORTIC STENOSIS\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">15 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSENING LOWER BACK /LEG PAIN</td>
<td class="gt_row gt_center">52 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSENING RENAL FAILURE;ACIDOSIS</td>
<td class="gt_row gt_center">1,988 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSENING SHORTNESS OF BREAT;CONGESTIVE HEART FAILURE\RIGHT AND LEFT HEART CATHETERIZATION</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WORSENING SUBDURAL HEMATOMA</td>
<td class="gt_row gt_center">14 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND DEHISCENCE</td>
<td class="gt_row gt_center">359 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND DEHISCENCE INFECTION</td>
<td class="gt_row gt_center">16 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND DRAINAGE</td>
<td class="gt_row gt_center">180 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND HEMATOMA</td>
<td class="gt_row gt_center">18 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND INFECTION</td>
<td class="gt_row gt_center">5,591 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND INFECTION OF LEFT TIBIA/SDA</td>
<td class="gt_row gt_center">9 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND INFECTION R/O SEPSIS</td>
<td class="gt_row gt_center">240 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND INFECTION;HYPOTENSION</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND INFECTION;TELEMETRY</td>
<td class="gt_row gt_center">36 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND INFECTION&#39;OSTEOMYELITIS</td>
<td class="gt_row gt_center">108 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND TO RLE</td>
<td class="gt_row gt_center">22 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">WOUND ULCER</td>
<td class="gt_row gt_center">186 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ZENKER&#39;S DIVERTICULUM/SDA</td>
<td class="gt_row gt_center">45 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ZONE 2 NECK INJURY</td>
<td class="gt_row gt_center">7 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ZOSTER VS. MENINGITIS</td>
<td class="gt_row gt_center">188 (&lt;0.1%)</td></tr>
    <tr><td class="gt_row gt_left">ZYGOMATIC FRACTURE LEFT</td>
<td class="gt_row gt_center">4 (&lt;0.1%)</td></tr>
  </tbody>
  
  <tfoot class="gt_footnotes">
    <tr>
      <td class="gt_footnote" colspan="2"><sup class="gt_footnote_marks">1</sup> n (%)</td>
    </tr>
  </tfoot>
</table>
</div>
<p>#Creating case and control cohorts.</p>
<div class="sourceCode" id="cb59"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb59-1"><a href="#cb59-1" aria-hidden="true" tabindex="-1"></a><span class="co">#Control cohort</span></span>
<span id="cb59-2"><a href="#cb59-2" aria-hidden="true" tabindex="-1"></a><span class="co">#Creating a new dataset which contains control (aka where HF is not listed as a ICD diagnosis code)</span></span>
<span id="cb59-3"><a href="#cb59-3" aria-hidden="true" tabindex="-1"></a>MIMICIII_control <span class="ot">&lt;-</span> MIMICIII[(MIMICIII<span class="sc">$</span>ICD9_CODE <span class="sc">!=</span> <span class="st">&quot;42840&quot;</span>) <span class="sc">&amp;</span> (MIMICIII<span class="sc">$</span>ICD9_CODE <span class="sc">!=</span> <span class="st">&quot;42841&quot;</span>) <span class="sc">&amp;</span> (MIMICIII<span class="sc">$</span>ICD9_CODE <span class="sc">!=</span> <span class="st">&quot;42842&quot;</span>), ]</span>
<span id="cb59-4"><a href="#cb59-4" aria-hidden="true" tabindex="-1"></a><span class="fu">class</span>(MIMICIII<span class="sc">$</span>ICD9_CODE)</span></code></pre></div>
<pre><code>## [1] &quot;character&quot;</code></pre>
<div class="sourceCode" id="cb61"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb61-1"><a href="#cb61-1" aria-hidden="true" tabindex="-1"></a><span class="fu">unique</span>(MIMICIII<span class="sc">$</span>ICD9_CODE)</span></code></pre></div>
<pre><code>##    [1] &quot;01193&quot; &quot;4254&quot;  &quot;42731&quot; &quot;2639&quot;  &quot;2762&quot;  &quot;5070&quot;  &quot;5119&quot;  &quot;2113&quot;  &quot;5191&quot; 
##   [10] &quot;49121&quot; &quot;51881&quot; &quot;486&quot;   &quot;2761&quot;  &quot;2449&quot;  &quot;311&quot;   &quot;5185&quot;  &quot;496&quot;   &quot;45340&quot;
##   [19] &quot;5533&quot;  &quot;51884&quot; &quot;5849&quot;  &quot;34830&quot; &quot;2760&quot;  &quot;4160&quot;  &quot;3594&quot;  &quot;5780&quot;  &quot;53010&quot;
##   [28] &quot;4871&quot;  &quot;2766&quot;  &quot;V0254&quot; &quot;45829&quot; &quot;53190&quot; &quot;51919&quot; &quot;E9320&quot; &quot;41401&quot; &quot;2724&quot; 
##   [37] &quot;4019&quot;  &quot;80506&quot; &quot;42823&quot; &quot;2930&quot;  &quot;4538&quot;  &quot;E882&quot;  &quot;4280&quot;  &quot;4011&quot;  &quot;V4502&quot;
##   [46] &quot;V1254&quot; &quot;8020&quot;  &quot;78820&quot; &quot;V4581&quot; &quot;2252&quot;  &quot;7140&quot;  &quot;7102&quot;  &quot;4430&quot;  &quot;53081&quot;
##   [55] &quot;V4364&quot; &quot;V4365&quot; &quot;41519&quot; &quot;5779&quot;  &quot;V4582&quot; &quot;V5861&quot; &quot;V1046&quot; &quot;V4501&quot; &quot;4378&quot; 
##   [64] &quot;74781&quot; &quot;3485&quot;  &quot;9092&quot;  &quot;34590&quot; &quot;73819&quot; &quot;27800&quot; &quot;30001&quot; &quot;42843&quot; &quot;41071&quot;
##   [73] &quot;5990&quot;  &quot;4275&quot;  &quot;4148&quot;  &quot;44020&quot; &quot;25000&quot; &quot;5997&quot;  &quot;E8796&quot; &quot;00845&quot; &quot;42830&quot;
##   [82] &quot;40391&quot; &quot;2875&quot;  &quot;2800&quot;  &quot;5789&quot;  &quot;1120&quot;  &quot;4401&quot;  &quot;V1005&quot; &quot;40301&quot; &quot;5855&quot; 
##   [91] &quot;2767&quot;  &quot;2859&quot;  &quot;5856&quot;  &quot;2765&quot;  &quot;4111&quot;  &quot;3659&quot;  &quot;3051&quot;  &quot;42090&quot; &quot;042&quot;  
##  [100] &quot;42732&quot; &quot;53551&quot; &quot;11284&quot; &quot;73027&quot; &quot;30401&quot; &quot;07032&quot; &quot;4233&quot;  &quot;28529&quot; &quot;3970&quot; 
##  [109] &quot;2749&quot;  &quot;07054&quot; &quot;412&quot;   &quot;49390&quot; &quot;30000&quot; &quot;86803&quot; &quot;07051&quot; &quot;07030&quot; &quot;30490&quot;
##  [118] &quot;78057&quot; &quot;1983&quot;  &quot;6826&quot;  &quot;1977&quot;  &quot;1970&quot;  &quot;5939&quot;  &quot;28522&quot; &quot;4251&quot;  &quot;4589&quot; 
##  [127] &quot;28521&quot; &quot;6961&quot;  &quot;70719&quot; &quot;42822&quot; &quot;45981&quot; &quot;V4511&quot; &quot;V4986&quot; &quot;V1582&quot; &quot;56210&quot;
##  [136] &quot;3669&quot;  &quot;5781&quot;  &quot;1536&quot;  &quot;27652&quot; &quot;5551&quot;  &quot;V1251&quot; &quot;79092&quot; &quot;99811&quot; &quot;5559&quot; 
##  [145] &quot;1363&quot;  &quot;2189&quot;  &quot;46450&quot; &quot;51189&quot; &quot;47824&quot; &quot;6950&quot;  &quot;46430&quot; &quot;0415&quot;  &quot;7907&quot; 
##  [154] &quot;5180&quot;  &quot;42789&quot; &quot;5770&quot;  &quot;9974&quot;  &quot;57400&quot; &quot;57410&quot; &quot;5859&quot;  &quot;41400&quot; &quot;0389&quot; 
##  [163] &quot;99591&quot; &quot;57440&quot; &quot;9998&quot;  &quot;2554&quot;  &quot;68110&quot; &quot;48283&quot; &quot;4464&quot;  &quot;2869&quot;  &quot;99592&quot;
##  [172] &quot;24900&quot; &quot;70703&quot; &quot;70721&quot; &quot;4476&quot;  &quot;78791&quot; &quot;73300&quot; &quot;4439&quot;  &quot;V5867&quot; &quot;E9308&quot;
##  [181] &quot;25080&quot; &quot;V420&quot;  &quot;4241&quot;  &quot;9971&quot;  &quot;4271&quot;  &quot;7318&quot;  &quot;73017&quot; &quot;25060&quot; &quot;3572&quot; 
##  [190] &quot;25040&quot; &quot;58381&quot; &quot;25050&quot; &quot;36201&quot; &quot;41031&quot; &quot;78551&quot; &quot;20280&quot; &quot;99672&quot; &quot;99812&quot;
##  [199] &quot;2851&quot;  &quot;V08&quot;   &quot;V1051&quot; &quot;V1011&quot; &quot;E8790&quot; &quot;44021&quot; &quot;V1581&quot; &quot;7824&quot;  &quot;03842&quot;
##  [208] &quot;5845&quot;  &quot;20158&quot; &quot;71828&quot; &quot;78552&quot; &quot;51882&quot; &quot;6822&quot;  &quot;34982&quot; &quot;7823&quot;  &quot;2874&quot; 
##  [217] &quot;5722&quot;  &quot;5712&quot;  &quot;30501&quot; &quot;5723&quot;  &quot;5761&quot;  &quot;5768&quot;  &quot;78039&quot; &quot;9690&quot;  &quot;72888&quot;
##  [226] &quot;30560&quot; &quot;9899&quot;  &quot;E9503&quot; &quot;30928&quot; &quot;72981&quot; &quot;78559&quot; &quot;570&quot;   &quot;5163&quot;  &quot;53011&quot;
##  [235] &quot;53560&quot; &quot;7904&quot;  &quot;4168&quot;  &quot;40390&quot; &quot;32723&quot; &quot;79029&quot; &quot;2662&quot;  &quot;30500&quot; &quot;51883&quot;
##  [244] &quot;7485&quot;  &quot;27803&quot; &quot;32742&quot; &quot;30502&quot; &quot;78659&quot; &quot;07070&quot; &quot;3342&quot;  &quot;2720&quot;  &quot;7242&quot; 
##  [253] &quot;73679&quot; &quot;34989&quot; &quot;03849&quot; &quot;431&quot;   &quot;3314&quot;  &quot;9962&quot;  &quot;2536&quot;  &quot;9950&quot;  &quot;4582&quot; 
##  [262] &quot;E9420&quot; &quot;42831&quot; &quot;57450&quot; &quot;5771&quot;  &quot;04104&quot; &quot;0414&quot;  &quot;3320&quot;  &quot;78830&quot; &quot;5762&quot; 
##  [271] &quot;43491&quot; &quot;99739&quot; &quot;9972&quot;  &quot;45383&quot; &quot;78729&quot; &quot;25002&quot; &quot;3159&quot;  &quot;V463&quot;  &quot;E8798&quot;
##  [280] &quot;53140&quot; &quot;53501&quot; &quot;82022&quot; &quot;E8889&quot; &quot;9975&quot;  &quot;7885&quot;  &quot;80600&quot; &quot;81200&quot; &quot;7230&quot; 
##  [289] &quot;87342&quot; &quot;34489&quot; &quot;56881&quot; &quot;42833&quot; &quot;27801&quot; &quot;79311&quot; &quot;41402&quot; &quot;2948&quot;  &quot;49392&quot;
##  [298] &quot;319&quot;   &quot;4238&quot;  &quot;1963&quot;  &quot;1972&quot;  &quot;1960&quot;  &quot;1748&quot;  &quot;V860&quot;  &quot;4572&quot;  &quot;78609&quot;
##  [307] &quot;V153&quot;  &quot;V5412&quot; &quot;E9331&quot; &quot;5570&quot;  &quot;5400&quot;  &quot;V552&quot;  &quot;5601&quot;  &quot;V553&quot;  &quot;2830&quot; 
##  [316] &quot;2518&quot;  &quot;41011&quot; &quot;40401&quot; &quot;5854&quot;  &quot;37701&quot; &quot;4372&quot;  &quot;4258&quot;  &quot;2768&quot;  &quot;30521&quot;
##  [325] &quot;9694&quot;  &quot;29689&quot; &quot;9654&quot;  &quot;30520&quot; &quot;27541&quot; &quot;2753&quot;  &quot;E9500&quot; &quot;V4579&quot; &quot;4240&quot; 
##  [334] &quot;60000&quot; &quot;55320&quot; &quot;7210&quot;  &quot;6000&quot;  &quot;2989&quot;  &quot;E9379&quot; &quot;33829&quot; &quot;7921&quot;  &quot;4941&quot; 
##  [343] &quot;4270&quot;  &quot;7994&quot;  &quot;5609&quot;  &quot;2704&quot;  &quot;28850&quot; &quot;56400&quot; &quot;55090&quot; &quot;5303&quot;  &quot;30563&quot;
##  [352] &quot;30503&quot; &quot;V462&quot;  &quot;78701&quot; &quot;78907&quot; &quot;78060&quot; &quot;28860&quot; &quot;53550&quot; &quot;72283&quot; &quot;2809&quot; 
##  [361] &quot;51889&quot; &quot;8600&quot;  &quot;80702&quot; &quot;8056&quot;  &quot;8054&quot;  &quot;8082&quot;  &quot;86403&quot; &quot;92400&quot; &quot;E8147&quot;
##  [370] &quot;V8801&quot; &quot;V4571&quot; &quot;4321&quot;  &quot;430&quot;   &quot;34591&quot; &quot;V1082&quot; &quot;49320&quot; &quot;7821&quot;  &quot;V4987&quot;
##  [379] &quot;28804&quot; &quot;1749&quot;  &quot;78061&quot; &quot;V442&quot;  &quot;V707&quot;  &quot;78702&quot; &quot;2853&quot;  &quot;V4572&quot; &quot;V5869&quot;
##  [388] &quot;0270&quot;  &quot;3207&quot;  &quot;7895&quot;  &quot;99674&quot; &quot;5566&quot;  &quot;V5865&quot; &quot;73390&quot; &quot;0380&quot;  &quot;3202&quot; 
##  [397] &quot;99663&quot; &quot;99813&quot; &quot;340&quot;   &quot;48241&quot; &quot;47874&quot; &quot;6930&quot;  &quot;4260&quot;  &quot;20410&quot; &quot;72989&quot;
##  [406] &quot;E8859&quot; &quot;8404&quot;  &quot;7213&quot;  &quot;185&quot;   &quot;70714&quot; &quot;70706&quot; &quot;43820&quot; &quot;V090&quot;  &quot;5724&quot; 
##  [415] &quot;7291&quot;  &quot;04109&quot; &quot;73730&quot; &quot;V1052&quot; &quot;V4573&quot; &quot;40493&quot; &quot;V451&quot;  &quot;71590&quot; &quot;4263&quot; 
##  [424] &quot;99662&quot; &quot;36230&quot; &quot;53511&quot; &quot;4239&quot;  &quot;2763&quot;  &quot;4210&quot;  &quot;E9342&quot; &quot;27542&quot; &quot;04111&quot;
##  [433] &quot;0539&quot;  &quot;5307&quot;  &quot;36589&quot; &quot;36250&quot; &quot;53150&quot; &quot;5672&quot;  &quot;3310&quot;  &quot;29410&quot; &quot;261&quot;  
##  [442] &quot;7872&quot;  &quot;V444&quot;  &quot;03819&quot; &quot;1519&quot;  &quot;5370&quot;  &quot;2867&quot;  &quot;78062&quot; &quot;27669&quot; &quot;4592&quot; 
##  [451] &quot;42832&quot; &quot;4139&quot;  &quot;V441&quot;  &quot;V440&quot;  &quot;99664&quot; &quot;51909&quot; &quot;78829&quot; &quot;49321&quot; &quot;485&quot;  
##  [460] &quot;56989&quot; &quot;41189&quot; &quot;9658&quot;  &quot;4821&quot;  &quot;E8508&quot; &quot;5118&quot;  &quot;2920&quot;  &quot;30441&quot; &quot;30411&quot;
##  [469] &quot;1735&quot;  &quot;7243&quot;  &quot;04119&quot; &quot;53450&quot; &quot;5679&quot;  &quot;56889&quot; &quot;V4586&quot; &quot;5109&quot;  &quot;33182&quot;
##  [478] &quot;30391&quot; &quot;2910&quot;  &quot;45184&quot; &quot;V600&quot;  &quot;29181&quot; &quot;30301&quot; &quot;99859&quot; &quot;3203&quot;  &quot;V1085&quot;
##  [487] &quot;1911&quot;  &quot;7837&quot;  &quot;59970&quot; &quot;E9443&quot; &quot;78009&quot; &quot;56983&quot; &quot;56722&quot; &quot;86504&quot; &quot;80502&quot;
##  [496] &quot;80709&quot; &quot;8088&quot;  &quot;86229&quot; &quot;86405&quot; &quot;591&quot;   &quot;99654&quot; &quot;E8120&quot; &quot;86121&quot; &quot;5715&quot; 
##  [505] &quot;45620&quot; &quot;27650&quot; &quot;725&quot;   &quot;1562&quot;  &quot;1962&quot;  &quot;57511&quot; &quot;V1043&quot; &quot;4414&quot;  &quot;55321&quot;
##  [514] &quot;19889&quot; &quot;3481&quot;  &quot;78550&quot; &quot;V1009&quot; &quot;59010&quot; &quot;27651&quot; &quot;2410&quot;  &quot;5283&quot;  &quot;78831&quot;
##  [523] &quot;2810&quot;  &quot;E9478&quot; &quot;V425&quot;  &quot;V103&quot;  &quot;1891&quot;  &quot;53082&quot; &quot;53012&quot; &quot;1179&quot;  &quot;1628&quot; 
##  [532] &quot;1985&quot;  &quot;51181&quot; &quot;V1087&quot; &quot;2440&quot;  &quot;V667&quot;  &quot;55200&quot; &quot;25200&quot; &quot;2811&quot;  &quot;5852&quot; 
##  [541] &quot;2883&quot;  &quot;0382&quot;  &quot;38300&quot; &quot;3829&quot;  &quot;28731&quot; &quot;04186&quot; &quot;4599&quot;  &quot;53540&quot; &quot;4389&quot; 
##  [550] &quot;78722&quot; &quot;5602&quot;  &quot;9982&quot;  &quot;99673&quot; &quot;56081&quot; &quot;56212&quot; &quot;5750&quot;  &quot;2939&quot;  &quot;1952&quot; 
##  [559] &quot;19882&quot; &quot;1981&quot;  &quot;1976&quot;  &quot;1975&quot;  &quot;E8794&quot; &quot;E8497&quot; &quot;4558&quot;  &quot;4420&quot;  &quot;7850&quot; 
##  [568] &quot;78959&quot; &quot;4561&quot;  &quot;79001&quot; &quot;30392&quot; &quot;4169&quot;  &quot;2911&quot;  &quot;53789&quot; &quot;2112&quot;  &quot;4802&quot; 
##  [577] &quot;7011&quot;  &quot;2375&quot;  &quot;2848&quot;  &quot;72889&quot; &quot;1919&quot;  &quot;1890&quot;  &quot;2731&quot;  &quot;2469&quot;  &quot;V180&quot; 
##  [586] &quot;V1749&quot; &quot;V163&quot;  &quot;2764&quot;  &quot;28800&quot; &quot;79902&quot; &quot;41072&quot; &quot;V173&quot;  &quot;3181&quot;  &quot;34510&quot;
##  [595] &quot;3576&quot;  &quot;V1204&quot; &quot;E9361&quot; &quot;E9363&quot; &quot;78720&quot; &quot;53085&quot; &quot;34500&quot; &quot;V0980&quot; &quot;3129&quot; 
##  [604] &quot;3569&quot;  &quot;34501&quot; &quot;3483&quot;  &quot;2752&quot;  &quot;7955&quot;  &quot;4940&quot;  &quot;4400&quot;  &quot;5531&quot;  &quot;5738&quot; 
##  [613] &quot;V1272&quot; &quot;29680&quot; &quot;71536&quot; &quot;4556&quot;  &quot;V4589&quot; &quot;V4577&quot; &quot;80325&quot; &quot;3484&quot;  &quot;E8809&quot;
##  [622] &quot;51851&quot; &quot;34931&quot; &quot;29281&quot; &quot;E8788&quot; &quot;E9384&quot; &quot;E9358&quot; &quot;V454&quot;  &quot;5778&quot;  &quot;V8535&quot;
##  [631] &quot;30981&quot; &quot;3694&quot;  &quot;V148&quot;  &quot;V1541&quot; &quot;V146&quot;  &quot;V1508&quot; &quot;V1504&quot; &quot;V140&quot;  &quot;V1505&quot;
##  [640] &quot;V145&quot;  &quot;7070&quot;  &quot;V550&quot;  &quot;V1042&quot; &quot;V433&quot;  &quot;03811&quot; &quot;V461&quot;  &quot;V422&quot;  &quot;99831&quot;
##  [649] &quot;99883&quot; &quot;53641&quot; &quot;5950&quot;  &quot;2794&quot;  &quot;70901&quot; &quot;42820&quot; &quot;V1302&quot; &quot;33520&quot; &quot;34400&quot;
##  [658] &quot;53390&quot; &quot;3574&quot;  &quot;V1201&quot; &quot;E8709&quot; &quot;34839&quot; &quot;481&quot;   &quot;70704&quot; &quot;70707&quot; &quot;3559&quot; 
##  [667] &quot;04185&quot; &quot;30590&quot; &quot;72885&quot; &quot;V0991&quot; &quot;8208&quot;  &quot;9964&quot;  &quot;8220&quot;  &quot;V4975&quot; &quot;E8784&quot;
##  [676] &quot;5184&quot;  &quot;34200&quot; &quot;29590&quot; &quot;56211&quot; &quot;5695&quot;  &quot;25082&quot; &quot;73007&quot; &quot;6827&quot;  &quot;70715&quot;
##  [685] &quot;E9424&quot; &quot;E9310&quot; &quot;25062&quot; &quot;29620&quot; &quot;5853&quot;  &quot;3099&quot;  &quot;42741&quot; &quot;V1002&quot; &quot;25012&quot;
##  [694] &quot;5711&quot;  &quot;25013&quot; &quot;25001&quot; &quot;44022&quot; &quot;53530&quot; &quot;71947&quot; &quot;6953&quot;  &quot;920&quot;   &quot;6823&quot; 
##  [703] &quot;41041&quot; &quot;95208&quot; &quot;80126&quot; &quot;3361&quot;  &quot;7197&quot;  &quot;E8490&quot; &quot;80122&quot; &quot;7802&quot;  &quot;72402&quot;
##  [712] &quot;43310&quot; &quot;3962&quot;  &quot;24220&quot; &quot;9986&quot;  &quot;V641&quot;  &quot;E8705&quot; &quot;4471&quot;  &quot;2740&quot;  &quot;4660&quot; 
##  [721] &quot;4829&quot;  &quot;3363&quot;  &quot;72740&quot; &quot;72141&quot; &quot;0413&quot;  &quot;28981&quot; &quot;3241&quot;  &quot;73008&quot; &quot;7211&quot; 
##  [730] &quot;V6284&quot; &quot;72271&quot; &quot;9341&quot;  &quot;5194&quot;  &quot;E915&quot;  &quot;4373&quot;  &quot;33394&quot; &quot;E9378&quot; &quot;07044&quot;
##  [739] &quot;07022&quot; &quot;45621&quot; &quot;2841&quot;  &quot;30553&quot; &quot;7847&quot;  &quot;7245&quot;  &quot;80705&quot; &quot;V1551&quot; &quot;33811&quot;
##  [748] &quot;43330&quot; &quot;99661&quot; &quot;5121&quot;  &quot;E8782&quot; &quot;45182&quot; &quot;71691&quot; &quot;44629&quot; &quot;8670&quot;  &quot;E9305&quot;
##  [757] &quot;E8781&quot; &quot;E9289&quot; &quot;58089&quot; &quot;71690&quot; &quot;44422&quot; &quot;56089&quot; &quot;34831&quot; &quot;44421&quot; &quot;42821&quot;
##  [766] &quot;29690&quot; &quot;5716&quot;  &quot;4552&quot;  &quot;2866&quot;  &quot;99594&quot; &quot;4131&quot;  &quot;4299&quot;  &quot;78059&quot; &quot;5128&quot; 
##  [775] &quot;515&quot;   &quot;5730&quot;  &quot;4928&quot;  &quot;V0382&quot; &quot;4578&quot;  &quot;71591&quot; &quot;33819&quot; &quot;79431&quot; &quot;72400&quot;
##  [784] &quot;78841&quot; &quot;53100&quot; &quot;1560&quot;  &quot;99590&quot; &quot;1978&quot;  &quot;57420&quot; &quot;8500&quot;  &quot;29651&quot; &quot;3480&quot; 
##  [793] &quot;29633&quot; &quot;9630&quot;  &quot;9661&quot;  &quot;E9504&quot; &quot;V610&quot;  &quot;E8786&quot; &quot;43853&quot; &quot;42840&quot; &quot;99762&quot;
##  [802] &quot;5733&quot;  &quot;28989&quot; &quot;44031&quot; &quot;V4973&quot; &quot;7295&quot;  &quot;44024&quot; &quot;20190&quot; &quot;V1089&quot; &quot;7283&quot; 
##  [811] &quot;29630&quot; &quot;29520&quot; &quot;6869&quot;  &quot;3003&quot;  &quot;3332&quot;  &quot;E9352&quot; &quot;3383&quot;  &quot;5110&quot;  &quot;E8668&quot;
##  [820] &quot;V1584&quot; &quot;73311&quot; &quot;1625&quot;  &quot;29900&quot; &quot;7580&quot;  &quot;9973&quot;  &quot;7294&quot;  &quot;25043&quot; &quot;25053&quot;
##  [829] &quot;25063&quot; &quot;58881&quot; &quot;58389&quot; &quot;39890&quot; &quot;501&quot;   &quot;6010&quot;  &quot;1889&quot;  &quot;78650&quot; &quot;V5866&quot;
##  [838] &quot;3540&quot;  &quot;82531&quot; &quot;82529&quot; &quot;8911&quot;  &quot;E8161&quot; &quot;42781&quot; &quot;1123&quot;  &quot;4570&quot;  &quot;72982&quot;
##  [847] &quot;2512&quot;  &quot;2700&quot;  &quot;V1044&quot; &quot;1173&quot;  &quot;4846&quot;  &quot;53200&quot; &quot;585&quot;   &quot;25030&quot; &quot;25070&quot;
##  [856] &quot;25061&quot; &quot;72293&quot; &quot;48230&quot; &quot;82009&quot; &quot;41511&quot; &quot;9125&quot;  &quot;5641&quot;  &quot;E9064&quot; &quot;56969&quot;
##  [865] &quot;70709&quot; &quot;78003&quot; &quot;2738&quot;  &quot;70711&quot; &quot;43882&quot; &quot;85221&quot; &quot;43411&quot; &quot;56721&quot; &quot;7843&quot; 
##  [874] &quot;99702&quot; &quot;4830&quot;  &quot;7810&quot;  &quot;78901&quot; &quot;7963&quot;  &quot;7101&quot;  &quot;49120&quot; &quot;53783&quot; &quot;41061&quot;
##  [883] &quot;78001&quot; &quot;3453&quot;  &quot;99731&quot; &quot;25051&quot; &quot;5920&quot;  &quot;1122&quot;  &quot;11289&quot; &quot;0417&quot;  &quot;2270&quot; 
##  [892] &quot;1623&quot;  &quot;1961&quot;  &quot;73319&quot; &quot;24200&quot; &quot;1514&quot;  &quot;7910&quot;  &quot;71941&quot; &quot;78065&quot; &quot;37230&quot;
##  [901] &quot;2710&quot;  &quot;3942&quot;  &quot;39891&quot; &quot;2713&quot;  &quot;3898&quot;  &quot;60001&quot; &quot;78052&quot; &quot;V1588&quot; &quot;V5417&quot;
##  [910] &quot;85220&quot; &quot;20300&quot; &quot;9212&quot;  &quot;9248&quot;  &quot;78093&quot; &quot;41412&quot; &quot;V5831&quot; &quot;4142&quot;  &quot;35800&quot;
##  [919] &quot;2181&quot;  &quot;6171&quot;  &quot;6146&quot;  &quot;70723&quot; &quot;1103&quot;  &quot;60886&quot; &quot;70725&quot; &quot;43811&quot; &quot;4568&quot; 
##  [928] &quot;V138&quot;  &quot;V1209&quot; &quot;7876&quot;  &quot;E9496&quot; &quot;E8499&quot; &quot;29572&quot; &quot;9160&quot;  &quot;2819&quot;  &quot;3708&quot; 
##  [937] &quot;37941&quot; &quot;7905&quot;  &quot;2967&quot;  &quot;586&quot;   &quot;49322&quot; &quot;57490&quot; &quot;7804&quot;  &quot;1733&quot;  &quot;55092&quot;
##  [946] &quot;2559&quot;  &quot;47831&quot; &quot;04184&quot; &quot;5848&quot;  &quot;7863&quot;  &quot;E9426&quot; &quot;28984&quot; &quot;59972&quot; &quot;8850&quot; 
##  [955] &quot;E9194&quot; &quot;40310&quot; &quot;V8741&quot; &quot;4786&quot;  &quot;5130&quot;  &quot;7100&quot;  &quot;78630&quot; &quot;58281&quot; &quot;V1255&quot;
##  [964] &quot;34690&quot; &quot;E912&quot;  &quot;V4983&quot; &quot;V4512&quot; &quot;4242&quot;  &quot;3543&quot;  &quot;4162&quot;  &quot;99679&quot; &quot;E9479&quot;
##  [973] &quot;E9444&quot; &quot;1125&quot;  &quot;3568&quot;  &quot;0388&quot;  &quot;99659&quot; &quot;42842&quot; &quot;6820&quot;  &quot;25041&quot; &quot;45821&quot;
##  [982] &quot;E8791&quot; &quot;28959&quot; &quot;E8799&quot; &quot;99931&quot; &quot;25003&quot; &quot;3501&quot;  &quot;V1079&quot; &quot;7866&quot;  &quot;2912&quot; 
##  [991] &quot;30300&quot; &quot;5728&quot;  &quot;1550&quot;  &quot;4590&quot;  &quot;49122&quot; &quot;53019&quot; &quot;2880&quot;  &quot;7856&quot;  &quot;99889&quot;
## [1000] &quot;34290&quot; &quot;1991&quot;  &quot;2394&quot;  &quot;7892&quot;  &quot;36234&quot; &quot;7209&quot;  &quot;78652&quot; &quot;7813&quot;  &quot;85301&quot;
## [1009] &quot;63320&quot; &quot;6391&quot;  &quot;6396&quot;  &quot;6398&quot;  &quot;5680&quot;  &quot;2165&quot;  &quot;V230&quot;  &quot;7806&quot;  &quot;E8844&quot;
## [1018] &quot;44284&quot; &quot;9663&quot;  &quot;96502&quot; &quot;9708&quot;  &quot;7931&quot;  &quot;7135&quot;  &quot;5960&quot;  &quot;3004&quot;  &quot;E8540&quot;
## [1027] &quot;56213&quot; &quot;56982&quot; &quot;99603&quot; &quot;44101&quot; &quot;5193&quot;  &quot;2721&quot;  &quot;71106&quot; &quot;34292&quot; &quot;78451&quot;
## [1036] &quot;V113&quot;  &quot;7464&quot;  &quot;95892&quot; &quot;0701&quot;  &quot;E9174&quot; &quot;4919&quot;  &quot;29570&quot; &quot;9693&quot;  &quot;34281&quot;
## [1045] &quot;59971&quot; &quot;7812&quot;  &quot;V642&quot;  &quot;7906&quot;  &quot;34291&quot; &quot;38600&quot; &quot;2411&quot;  &quot;4387&quot;  &quot;43300&quot;
## [1054] &quot;99643&quot; &quot;72709&quot; &quot;71865&quot; &quot;33828&quot; &quot;71105&quot; &quot;56981&quot; &quot;99647&quot; &quot;2409&quot;  &quot;99666&quot;
## [1063] &quot;V1041&quot; &quot;28489&quot; &quot;1984&quot;  &quot;73313&quot; &quot;28803&quot; &quot;52801&quot; &quot;40291&quot; &quot;56409&quot; &quot;29562&quot;
## [1072] &quot;4359&quot;  &quot;53531&quot; &quot;5710&quot;  &quot;9999&quot;  &quot;72210&quot; &quot;514&quot;   &quot;4739&quot;  &quot;E9354&quot; &quot;V1000&quot;
## [1081] &quot;V453&quot;  &quot;135&quot;   &quot;6989&quot;  &quot;51901&quot; &quot;34570&quot; &quot;V1259&quot; &quot;5989&quot;  &quot;43889&quot; &quot;2387&quot; 
## [1090] &quot;2384&quot;  &quot;4553&quot;  &quot;4580&quot;  &quot;23875&quot; &quot;29040&quot; &quot;28249&quot; &quot;43883&quot; &quot;43813&quot; &quot;3580&quot; 
## [1099] &quot;20212&quot; &quot;20213&quot; &quot;V4611&quot; &quot;25541&quot; &quot;4588&quot;  &quot;193&quot;   &quot;41021&quot; &quot;6954&quot;  &quot;78900&quot;
## [1108] &quot;56985&quot; &quot;99939&quot; &quot;9992&quot;  &quot;5790&quot;  &quot;3518&quot;  &quot;41091&quot; &quot;3899&quot;  &quot;7873&quot;  &quot;7818&quot; 
## [1117] &quot;36846&quot; &quot;04149&quot; &quot;3079&quot;  &quot;7991&quot;  &quot;8730&quot;  &quot;75312&quot; &quot;42651&quot; &quot;40311&quot; &quot;74763&quot;
## [1126] &quot;72142&quot; &quot;317&quot;   &quot;07999&quot; &quot;57401&quot; &quot;7820&quot;  &quot;56729&quot; &quot;V1083&quot; &quot;6929&quot;  &quot;9331&quot; 
## [1135] &quot;45384&quot; &quot;5647&quot;  &quot;45381&quot; &quot;1512&quot;  &quot;0090&quot;  &quot;56723&quot; &quot;4820&quot;  &quot;2858&quot;  &quot;2689&quot; 
## [1144] &quot;V160&quot;  &quot;V1007&quot; &quot;V1271&quot; &quot;5302&quot;  &quot;99593&quot; &quot;99932&quot; &quot;3545&quot;  &quot;04112&quot; &quot;3542&quot; 
## [1153] &quot;3550&quot;  &quot;5718&quot;  &quot;7244&quot;  &quot;22804&quot; &quot;4870&quot;  &quot;E9313&quot; &quot;7384&quot;  &quot;2532&quot;  &quot;7200&quot; 
## [1162] &quot;80116&quot; &quot;8024&quot;  &quot;E916&quot;  &quot;70400&quot; &quot;2890&quot;  &quot;V8530&quot; &quot;E8708&quot; &quot;V0261&quot; &quot;4847&quot; 
## [1171] &quot;V4282&quot; &quot;27900&quot; &quot;V4281&quot; &quot;78097&quot; &quot;E9394&quot; &quot;V1004&quot; &quot;E8785&quot; &quot;78099&quot; &quot;V0259&quot;
## [1180] &quot;0416&quot;  &quot;2448&quot;  &quot;23331&quot; &quot;07811&quot; &quot;45341&quot; &quot;37854&quot; &quot;V5489&quot; &quot;V4962&quot; &quot;E9351&quot;
## [1189] &quot;E9452&quot; &quot;99678&quot; &quot;73314&quot; &quot;99649&quot; &quot;73309&quot; &quot;5178&quot;  &quot;E8495&quot; &quot;0310&quot;  &quot;0312&quot; 
## [1198] &quot;4539&quot;  &quot;5932&quot;  &quot;99681&quot; &quot;29411&quot; &quot;V430&quot;  &quot;E8498&quot; &quot;E8780&quot; &quot;V643&quot;  &quot;4371&quot; 
## [1207] &quot;34202&quot; &quot;7845&quot;  &quot;57431&quot; &quot;42971&quot; &quot;03810&quot; &quot;5809&quot;  &quot;44023&quot; &quot;E9422&quot; &quot;70722&quot;
## [1216] &quot;72252&quot; &quot;28419&quot; &quot;5961&quot;  &quot;3313&quot;  &quot;V452&quot;  &quot;4822&quot;  &quot;V182&quot;  &quot;7455&quot;  &quot;23873&quot;
## [1225] &quot;V443&quot;  &quot;36900&quot; &quot;75563&quot; &quot;70710&quot; &quot;81240&quot; &quot;1129&quot;  &quot;V4361&quot; &quot;E887&quot;  &quot;73025&quot;
## [1234] &quot;V5415&quot; &quot;7854&quot;  &quot;04189&quot; &quot;81221&quot; &quot;E9288&quot; &quot;81201&quot; &quot;1610&quot;  &quot;V4976&quot; &quot;64224&quot;
## [1243] &quot;4010&quot;  &quot;E8532&quot; &quot;3589&quot;  &quot;73741&quot; &quot;V1301&quot; &quot;5888&quot;  &quot;V6549&quot; &quot;2390&quot;  &quot;5690&quot; 
## [1252] &quot;4149&quot;  &quot;5699&quot;  &quot;71107&quot; &quot;29980&quot; &quot;29560&quot; &quot;70713&quot; &quot;70712&quot; &quot;E9395&quot; &quot;55300&quot;
## [1261] &quot;25022&quot; &quot;25042&quot; &quot;4465&quot;  &quot;V1003&quot; &quot;56962&quot; &quot;1541&quot;  &quot;E8792&quot; &quot;80321&quot; &quot;34889&quot;
## [1270] &quot;V6441&quot; &quot;37900&quot; &quot;V8536&quot; &quot;81341&quot; &quot;81402&quot; &quot;7249&quot;  &quot;42091&quot; &quot;71945&quot; &quot;9951&quot; 
## [1279] &quot;9210&quot;  &quot;5793&quot;  &quot;20283&quot; &quot;29650&quot; &quot;E9317&quot; &quot;44103&quot; &quot;3441&quot;  &quot;30390&quot; &quot;V427&quot; 
## [1288] &quot;57470&quot; &quot;V5331&quot; &quot;37991&quot; &quot;1552&quot;  &quot;99779&quot; &quot;3449&quot;  &quot;30400&quot; &quot;5111&quot;  &quot;71104&quot;
## [1297] &quot;53110&quot; &quot;30561&quot; &quot;71598&quot; &quot;V5332&quot; &quot;1629&quot;  &quot;53541&quot; &quot;79901&quot; &quot;E9429&quot; &quot;25052&quot;
## [1306] &quot;3510&quot;  &quot;2419&quot;  &quot;8028&quot;  &quot;80232&quot; &quot;87344&quot; &quot;E8849&quot; &quot;87341&quot; &quot;9961&quot;  &quot;68601&quot;
## [1315] &quot;90253&quot; &quot;E8716&quot; &quot;99642&quot; &quot;27739&quot; &quot;4379&quot;  &quot;7078&quot;  &quot;3489&quot;  &quot;5183&quot;  &quot;4370&quot; 
## [1324] &quot;5225&quot;  &quot;33900&quot; &quot;99645&quot; &quot;73342&quot; &quot;4412&quot;  &quot;V183&quot;  &quot;5379&quot;  &quot;2812&quot;  &quot;1973&quot; 
## [1333] &quot;0419&quot;  &quot;59654&quot; &quot;99604&quot; &quot;3331&quot;  &quot;0088&quot;  &quot;605&quot;   &quot;24280&quot; &quot;V4972&quot; &quot;E9309&quot;
## [1342] &quot;5579&quot;  &quot;4422&quot;  &quot;7948&quot;  &quot;7944&quot;  &quot;2769&quot;  &quot;V1072&quot; &quot;1518&quot;  &quot;9348&quot;  &quot;99671&quot;
## [1351] &quot;3439&quot;  &quot;27401&quot; &quot;40491&quot; &quot;5521&quot;  &quot;566&quot;   &quot;E9300&quot; &quot;4550&quot;  &quot;7919&quot;  &quot;9340&quot; 
## [1360] &quot;78194&quot; &quot;V549&quot;  &quot;E8783&quot; &quot;9349&quot;  &quot;78459&quot; &quot;E9364&quot; &quot;V1351&quot; &quot;V0950&quot; &quot;V551&quot; 
## [1369] &quot;51902&quot; &quot;53642&quot; &quot;73016&quot; &quot;80700&quot; &quot;85182&quot; &quot;7220&quot;  &quot;0383&quot;  &quot;48284&quot; &quot;5569&quot; 
## [1378] &quot;34580&quot; &quot;V4459&quot; &quot;V1006&quot; &quot;80110&quot; &quot;E8298&quot; &quot;85180&quot; &quot;82392&quot; &quot;8058&quot;  &quot;8840&quot; 
## [1387] &quot;29532&quot; &quot;87343&quot; &quot;0979&quot;  &quot;30571&quot; &quot;09152&quot; &quot;57149&quot; &quot;99709&quot; &quot;80501&quot; &quot;30541&quot;
## [1396] &quot;3071&quot;  &quot;30183&quot; &quot;31400&quot; &quot;7881&quot;  &quot;56489&quot; &quot;3093&quot;  &quot;30423&quot; &quot;30393&quot; &quot;E9359&quot;
## [1405] &quot;7817&quot;  &quot;71596&quot; &quot;5368&quot;  &quot;4110&quot;  &quot;V1659&quot; &quot;6918&quot;  &quot;V6442&quot; &quot;07033&quot; &quot;2396&quot; 
## [1414] &quot;1912&quot;  &quot;9351&quot;  &quot;2550&quot;  &quot;4232&quot;  &quot;42612&quot; &quot;V5883&quot; &quot;80121&quot; &quot;80112&quot; &quot;45342&quot;
## [1423] &quot;96509&quot; &quot;3488&quot;  &quot;E8502&quot; &quot;34540&quot; &quot;78899&quot; &quot;4720&quot;  &quot;78261&quot; &quot;94108&quot; &quot;94800&quot;
## [1432] &quot;1759&quot;  &quot;25072&quot; &quot;36816&quot; &quot;3968&quot;  &quot;24290&quot; &quot;1538&quot;  &quot;99676&quot; &quot;04100&quot; &quot;7840&quot; 
## [1441] &quot;1578&quot;  &quot;53240&quot; &quot;2558&quot;  &quot;44102&quot; &quot;99749&quot; &quot;4408&quot;  &quot;6960&quot;  &quot;1729&quot;  &quot;4352&quot; 
## [1450] &quot;5272&quot;  &quot;0785&quot;  &quot;36320&quot; &quot;2441&quot;  &quot;42611&quot; &quot;5921&quot;  &quot;7851&quot;  &quot;53290&quot; &quot;31401&quot;
## [1459] &quot;8026&quot;  &quot;2864&quot;  &quot;E8888&quot; &quot;36500&quot; &quot;36565&quot; &quot;56949&quot; &quot;5829&quot;  &quot;2825&quot;  &quot;5839&quot; 
## [1468] &quot;74689&quot; &quot;6191&quot;  &quot;44032&quot; &quot;8602&quot;  &quot;80701&quot; &quot;4413&quot;  &quot;72190&quot; &quot;56039&quot; &quot;42490&quot;
## [1477] &quot;73028&quot; &quot;47829&quot; &quot;70705&quot; &quot;2860&quot;  &quot;71946&quot; &quot;45389&quot; &quot;99881&quot; &quot;34680&quot; &quot;4659&quot; 
## [1486] &quot;24991&quot; &quot;7212&quot;  &quot;78079&quot; &quot;42989&quot; &quot;27787&quot; &quot;35989&quot; &quot;7589&quot;  &quot;78904&quot; &quot;28861&quot;
## [1495] &quot;58889&quot; &quot;V174&quot;  &quot;1974&quot;  &quot;4264&quot;  &quot;V1252&quot; &quot;82021&quot; &quot;452&quot;   &quot;45387&quot; &quot;45385&quot;
## [1504] &quot;25081&quot; &quot;V020&quot;  &quot;5363&quot;  &quot;3599&quot;  &quot;7292&quot;  &quot;73019&quot; &quot;6111&quot;  &quot;60784&quot; &quot;73605&quot;
## [1513] &quot;4294&quot;  &quot;8832&quot;  &quot;9035&quot;  &quot;5819&quot;  &quot;E8880&quot; &quot;9556&quot;  &quot;2630&quot;  &quot;7862&quot;  &quot;41001&quot;
## [1522] &quot;53649&quot; &quot;41092&quot; &quot;5571&quot;  &quot;07020&quot; &quot;99799&quot; &quot;5081&quot;  &quot;3963&quot;  &quot;86500&quot; &quot;8505&quot; 
## [1531] &quot;87201&quot; &quot;V011&quot;  &quot;78321&quot; &quot;53089&quot; &quot;78839&quot; &quot;4269&quot;  &quot;2339&quot;  &quot;V556&quot;  &quot;7098&quot; 
## [1540] &quot;36960&quot; &quot;475&quot;   &quot;67454&quot; &quot;37749&quot; &quot;3688&quot;  &quot;30029&quot; &quot;2127&quot;  &quot;1589&quot;  &quot;78951&quot;
## [1549] &quot;96561&quot; &quot;E8581&quot; &quot;5168&quot;  &quot;4785&quot;  &quot;56941&quot; &quot;03844&quot; &quot;1522&quot;  &quot;3315&quot;  &quot;71855&quot;
## [1558] &quot;47879&quot; &quot;E9315&quot; &quot;99667&quot; &quot;30470&quot; &quot;V152&quot;  &quot;V151&quot;  &quot;80606&quot; &quot;86804&quot; &quot;41042&quot;
## [1567] &quot;5964&quot;  &quot;2771&quot;  &quot;33818&quot; &quot;80707&quot; &quot;9587&quot;  &quot;6262&quot;  &quot;23871&quot; &quot;5754&quot;  &quot;03843&quot;
## [1576] &quot;E9393&quot; &quot;0527&quot;  &quot;0521&quot;  &quot;0778&quot;  &quot;3570&quot;  &quot;E9346&quot; &quot;3379&quot;  &quot;V5411&quot; &quot;28866&quot;
## [1585] &quot;56942&quot; &quot;70724&quot; &quot;9093&quot;  &quot;5968&quot;  &quot;99631&quot; &quot;V446&quot;  &quot;03812&quot; &quot;1119&quot;  &quot;42099&quot;
## [1594] &quot;4230&quot;  &quot;75162&quot; &quot;44481&quot; &quot;8744&quot;  &quot;7508&quot;  &quot;72751&quot; &quot;5720&quot;  &quot;2839&quot;  &quot;7142&quot; 
## [1603] &quot;9724&quot;  &quot;9623&quot;  &quot;E8583&quot; &quot;E8580&quot; &quot;81342&quot; &quot;8052&quot;  &quot;80503&quot; &quot;57512&quot; &quot;5600&quot; 
## [1612] &quot;73382&quot; &quot;E927&quot;  &quot;9054&quot;  &quot;E9299&quot; &quot;2126&quot;  &quot;41051&quot; &quot;72992&quot; &quot;6959&quot;  &quot;2534&quot; 
## [1621] &quot;32721&quot; &quot;2971&quot;  &quot;V694&quot;  &quot;53170&quot; &quot;29420&quot; &quot;1918&quot;  &quot;7336&quot;  &quot;1830&quot;  &quot;5678&quot; 
## [1630] &quot;2148&quot;  &quot;1725&quot;  &quot;2392&quot;  &quot;28260&quot; &quot;28262&quot; &quot;5173&quot;  &quot;7822&quot;  &quot;99832&quot; &quot;E8789&quot;
## [1639] &quot;2116&quot;  &quot;30420&quot; &quot;4809&quot;  &quot;4281&quot;  &quot;2166&quot;  &quot;92411&quot; &quot;E8261&quot; &quot;V1253&quot; &quot;E0064&quot;
## [1648] &quot;1121&quot;  &quot;4472&quot;  &quot;59382&quot; &quot;5934&quot;  &quot;42610&quot; &quot;49300&quot; &quot;72973&quot; &quot;56738&quot; &quot;3330&quot; 
## [1657] &quot;07989&quot; &quot;4466&quot;  &quot;2873&quot;  &quot;3238&quot;  &quot;05319&quot; &quot;36210&quot; &quot;3558&quot;  &quot;99677&quot; &quot;04102&quot;
## [1666] &quot;E8150&quot; &quot;3089&quot;  &quot;25208&quot; &quot;5880&quot;  &quot;4549&quot;  &quot;V4574&quot; &quot;5401&quot;  &quot;59582&quot; &quot;5080&quot; 
## [1675] &quot;69282&quot; &quot;45183&quot; &quot;6945&quot;  &quot;86503&quot; &quot;E8160&quot; &quot;44322&quot; &quot;59969&quot; &quot;34280&quot; &quot;60091&quot;
## [1684] &quot;5935&quot;  &quot;59389&quot; &quot;3229&quot;  &quot;37852&quot; &quot;4329&quot;  &quot;048&quot;   &quot;78603&quot; &quot;2651&quot;  &quot;07983&quot;
## [1693] &quot;37810&quot; &quot;41090&quot; &quot;71516&quot; &quot;25021&quot; &quot;2638&quot;  &quot;V5811&quot; &quot;3009&quot;  &quot;V1081&quot; &quot;30570&quot;
## [1702] &quot;30540&quot; &quot;57510&quot; &quot;96500&quot; &quot;71535&quot; &quot;27730&quot; &quot;71101&quot; &quot;E8121&quot; &quot;73719&quot; &quot;57451&quot;
## [1711] &quot;5568&quot;  &quot;41404&quot; &quot;490&quot;   &quot;3432&quot;  &quot;6821&quot;  &quot;75683&quot; &quot;0218&quot;  &quot;70701&quot; &quot;70720&quot;
## [1720] &quot;1700&quot;  &quot;1609&quot;  &quot;5122&quot;  &quot;7313&quot;  &quot;99602&quot; &quot;78639&quot; &quot;70700&quot; &quot;7310&quot;  &quot;72291&quot;
## [1729] &quot;0549&quot;  &quot;71481&quot; &quot;37515&quot; &quot;7861&quot;  &quot;36616&quot; &quot;V4363&quot; &quot;78002&quot; &quot;V4283&quot; &quot;3210&quot; 
## [1738] &quot;1175&quot;  &quot;6279&quot;  &quot;43401&quot; &quot;37887&quot; &quot;4843&quot;  &quot;0338&quot;  &quot;9980&quot;  &quot;1570&quot;  &quot;80605&quot;
## [1747] &quot;80136&quot; &quot;80704&quot; &quot;82321&quot; &quot;81501&quot; &quot;81601&quot; &quot;9190&quot;  &quot;59080&quot; &quot;V4984&quot; &quot;55220&quot;
## [1756] &quot;79989&quot; &quot;25092&quot; &quot;1987&quot;  &quot;2330&quot;  &quot;67404&quot; &quot;E9387&quot; &quot;0391&quot;  &quot;52100&quot; &quot;V4576&quot;
## [1765] &quot;25202&quot; &quot;5651&quot;  &quot;73710&quot; &quot;42761&quot; &quot;85201&quot; &quot;5799&quot;  &quot;5959&quot;  &quot;71943&quot; &quot;61610&quot;
## [1774] &quot;587&quot;   &quot;E0070&quot; &quot;25010&quot; &quot;1548&quot;  &quot;1966&quot;  &quot;7141&quot;  &quot;81209&quot; &quot;81109&quot; &quot;8700&quot; 
## [1783] &quot;8820&quot;  &quot;9213&quot;  &quot;36274&quot; &quot;1510&quot;  &quot;5100&quot;  &quot;1509&quot;  &quot;1508&quot;  &quot;5589&quot;  &quot;42769&quot;
## [1792] &quot;82525&quot; &quot;70702&quot; &quot;9720&quot;  &quot;E8538&quot; &quot;99601&quot; &quot;4262&quot;  &quot;E8748&quot; &quot;79021&quot; &quot;9068&quot; 
## [1801] &quot;E9298&quot; &quot;25201&quot; &quot;9070&quot;  &quot;E9290&quot; &quot;23874&quot; &quot;79022&quot; &quot;1530&quot;  &quot;03840&quot; &quot;86112&quot;
## [1810] &quot;8074&quot;  &quot;86132&quot; &quot;90142&quot; &quot;8605&quot;  &quot;9584&quot;  &quot;73026&quot; &quot;4404&quot;  &quot;0362&quot;  &quot;V4575&quot;
## [1819] &quot;1892&quot;  &quot;5721&quot;  &quot;55221&quot; &quot;2535&quot;  &quot;V8539&quot; &quot;2156&quot;  &quot;2781&quot;  &quot;62210&quot; &quot;4881&quot; 
## [1828] &quot;220&quot;   &quot;3239&quot;  &quot;2888&quot;  &quot;0542&quot;  &quot;3334&quot;  &quot;4409&quot;  &quot;2631&quot;  &quot;85181&quot; &quot;E8801&quot;
## [1837] &quot;71695&quot; &quot;34460&quot; &quot;05479&quot; &quot;0490&quot;  &quot;20288&quot; &quot;6181&quot;  &quot;1531&quot;  &quot;07071&quot; &quot;V8522&quot;
## [1846] &quot;5798&quot;  &quot;6201&quot;  &quot;73349&quot; &quot;9983&quot;  &quot;42613&quot; &quot;6824&quot;  &quot;20010&quot; &quot;85224&quot; &quot;E9682&quot;
## [1855] &quot;27788&quot; &quot;4779&quot;  &quot;2900&quot;  &quot;71615&quot; &quot;7530&quot;  &quot;E9330&quot; &quot;2357&quot;  &quot;2397&quot;  &quot;5300&quot; 
## [1864] &quot;75612&quot; &quot;69010&quot; &quot;9766&quot;  &quot;E9804&quot; &quot;73006&quot; &quot;44589&quot; &quot;29640&quot; &quot;E9398&quot; &quot;7423&quot; 
## [1873] &quot;E911&quot;  &quot;30302&quot; &quot;5290&quot;  &quot;4353&quot;  &quot;45989&quot; &quot;04183&quot; &quot;80507&quot; &quot;56961&quot; &quot;20510&quot;
## [1882] &quot;3519&quot;  &quot;53021&quot; &quot;38611&quot; &quot;V4561&quot; &quot;1534&quot;  &quot;E9307&quot; &quot;0859&quot;  &quot;67311&quot; &quot;66811&quot;
## [1891] &quot;64131&quot; &quot;66612&quot; &quot;67432&quot; &quot;86401&quot; &quot;65971&quot; &quot;V270&quot;  &quot;85305&quot; &quot;55229&quot; &quot;2180&quot; 
## [1900] &quot;V644&quot;  &quot;44771&quot; &quot;2511&quot;  &quot;E9323&quot; &quot;73739&quot; &quot;85306&quot; &quot;80708&quot; &quot;5552&quot;  &quot;E9304&quot;
## [1909] &quot;E9319&quot; &quot;2832&quot;  &quot;73015&quot; &quot;2115&quot;  &quot;3575&quot;  &quot;33384&quot; &quot;27400&quot; &quot;4801&quot;  &quot;6012&quot; 
## [1918] &quot;7105&quot;  &quot;42979&quot; &quot;E8187&quot; &quot;37239&quot; &quot;78760&quot; &quot;72401&quot; &quot;E8700&quot; &quot;30924&quot; &quot;1913&quot; 
## [1927] &quot;9993&quot;  &quot;3209&quot;  &quot;85162&quot; &quot;85102&quot; &quot;7816&quot;  &quot;3689&quot;  &quot;E9430&quot; &quot;7099&quot;  &quot;4778&quot; 
## [1936] &quot;85226&quot; &quot;85206&quot; &quot;E888&quot;  &quot;85202&quot; &quot;30562&quot; &quot;56481&quot; &quot;99769&quot; &quot;9072&quot;  &quot;E969&quot; 
## [1945] &quot;V555&quot;  &quot;30550&quot; &quot;3017&quot;  &quot;4255&quot;  &quot;0085&quot;  &quot;38010&quot; &quot;2452&quot;  &quot;4295&quot;  &quot;58289&quot;
## [1954] &quot;28240&quot; &quot;V142&quot;  &quot;41405&quot; &quot;80111&quot; &quot;37272&quot; &quot;E8810&quot; &quot;80703&quot; &quot;81003&quot; &quot;81103&quot;
## [1963] &quot;8910&quot;  &quot;44489&quot; &quot;72887&quot; &quot;20191&quot; &quot;7231&quot;  &quot;V851&quot;  &quot;1539&quot;  &quot;75319&quot; &quot;7299&quot; 
## [1972] &quot;20070&quot; &quot;2520&quot;  &quot;4423&quot;  &quot;5821&quot;  &quot;3941&quot;  &quot;1888&quot;  &quot;1504&quot;  &quot;99669&quot; &quot;64893&quot;
## [1981] &quot;64783&quot; &quot;65953&quot; &quot;64233&quot; &quot;V854&quot;  &quot;1921&quot;  &quot;85225&quot; &quot;83901&quot; &quot;20500&quot; &quot;2894&quot; 
## [1990] &quot;74101&quot; &quot;9181&quot;  &quot;7248&quot;  &quot;85200&quot; &quot;80841&quot; &quot;4290&quot;  &quot;E9303&quot; &quot;4296&quot;  &quot;59651&quot;
## [1999] &quot;5226&quot;  &quot;V1542&quot; &quot;30443&quot; &quot;2273&quot;  &quot;E8881&quot; &quot;9802&quot;  &quot;E8603&quot; &quot;49302&quot; &quot;34550&quot;
## [2008] &quot;9050&quot;  &quot;E9293&quot; &quot;99682&quot; &quot;20210&quot; &quot;7083&quot;  &quot;6019&quot;  &quot;27549&quot; &quot;71236&quot; &quot;E9421&quot;
## [2017] &quot;48289&quot; &quot;9698&quot;  &quot;25011&quot; &quot;42682&quot; &quot;78909&quot; &quot;4419&quot;  &quot;E9438&quot; &quot;59960&quot; &quot;7831&quot; 
## [2026] &quot;20078&quot; &quot;34461&quot; &quot;V536&quot;  &quot;2722&quot;  &quot;E8543&quot; &quot;4738&quot;  &quot;82101&quot; &quot;20302&quot; &quot;80505&quot;
## [2035] &quot;5244&quot;  &quot;52340&quot; &quot;1982&quot;  &quot;E9173&quot; &quot;45351&quot; &quot;4719&quot;  &quot;07052&quot; &quot;V8541&quot; &quot;35579&quot;
## [2044] &quot;2733&quot;  &quot;53340&quot; &quot;8242&quot;  &quot;88100&quot; &quot;2898&quot;  &quot;65221&quot; &quot;64421&quot; &quot;64861&quot; &quot;64821&quot;
## [2053] &quot;64831&quot; &quot;70219&quot; &quot;4540&quot;  &quot;2182&quot;  &quot;6202&quot;  &quot;V1202&quot; &quot;67324&quot; &quot;64274&quot; &quot;71430&quot;
## [2062] &quot;7080&quot;  &quot;37943&quot; &quot;81502&quot; &quot;1572&quot;  &quot;1971&quot;  &quot;4610&quot;  &quot;78442&quot; &quot;5296&quot;  &quot;5291&quot; 
## [2071] &quot;217&quot;   &quot;5772&quot;  &quot;1763&quot;  &quot;53400&quot; &quot;36231&quot; &quot;36901&quot; &quot;37741&quot; &quot;32351&quot; &quot;2707&quot; 
## [2080] &quot;80100&quot; &quot;8470&quot;  &quot;99686&quot; &quot;59381&quot; &quot;71595&quot; &quot;5988&quot;  &quot;5811&quot;  &quot;2870&quot;  &quot;5550&quot; 
## [2089] &quot;42511&quot; &quot;1533&quot;  &quot;0093&quot;  &quot;0780&quot;  &quot;7902&quot;  &quot;2356&quot;  &quot;2454&quot;  &quot;53784&quot; &quot;45375&quot;
## [2098] &quot;6110&quot;  &quot;27509&quot; &quot;4267&quot;  &quot;34201&quot; &quot;53270&quot; &quot;4416&quot;  &quot;51852&quot; &quot;86345&quot; &quot;5693&quot; 
## [2107] &quot;1532&quot;  &quot;7048&quot;  &quot;25020&quot; &quot;4808&quot;  &quot;20400&quot; &quot;5120&quot;  &quot;43311&quot; &quot;3482&quot;  &quot;035&quot;  
## [2116] &quot;V4585&quot; &quot;30750&quot; &quot;7224&quot;  &quot;25083&quot; &quot;04110&quot; &quot;390&quot;   &quot;E9447&quot; &quot;6988&quot;  &quot;28982&quot;
## [2125] &quot;71504&quot; &quot;71884&quot; &quot;9597&quot;  &quot;3549&quot;  &quot;E918&quot;  &quot;80432&quot; &quot;9534&quot;  &quot;81101&quot; &quot;9514&quot; 
## [2134] &quot;9515&quot;  &quot;2381&quot;  &quot;4532&quot;  &quot;87363&quot; &quot;2388&quot;  &quot;60789&quot; &quot;72691&quot; &quot;E8762&quot; &quot;30593&quot;
## [2143] &quot;32082&quot; &quot;2899&quot;  &quot;V632&quot;  &quot;5739&quot;  &quot;24960&quot; &quot;5362&quot;  &quot;542&quot;   &quot;92410&quot; &quot;35981&quot;
## [2152] &quot;449&quot;   &quot;53020&quot; &quot;71109&quot; &quot;8449&quot;  &quot;9957&quot;  &quot;7842&quot;  &quot;37999&quot; &quot;71696&quot; &quot;51631&quot;
## [2161] &quot;44773&quot; &quot;95909&quot; &quot;7202&quot;  &quot;7503&quot;  &quot;V620&quot;  &quot;V6141&quot; &quot;4259&quot;  &quot;34481&quot; &quot;43331&quot;
## [2170] &quot;7234&quot;  &quot;30552&quot; &quot;V0981&quot; &quot;V8532&quot; &quot;V161&quot;  &quot;V4569&quot; &quot;6828&quot;  &quot;57461&quot; &quot;30002&quot;
## [2179] &quot;4231&quot;  &quot;8604&quot;  &quot;92232&quot; &quot;3369&quot;  &quot;78604&quot; &quot;2751&quot;  &quot;34620&quot; &quot;V5302&quot; &quot;04082&quot;
## [2188] &quot;08881&quot; &quot;0579&quot;  &quot;5650&quot;  &quot;0340&quot;  &quot;43490&quot; &quot;3592&quot;  &quot;53250&quot; &quot;1744&quot;  &quot;1881&quot; 
## [2197] &quot;2980&quot;  &quot;7830&quot;  &quot;41081&quot; &quot;86509&quot; &quot;90223&quot; &quot;87340&quot; &quot;2949&quot;  &quot;E9411&quot; &quot;5305&quot; 
## [2206] &quot;78071&quot; &quot;99644&quot; &quot;48282&quot; &quot;48242&quot; &quot;5172&quot;  &quot;V850&quot;  &quot;4536&quot;  &quot;45382&quot; &quot;28749&quot;
## [2215] &quot;82020&quot; &quot;99989&quot; &quot;78703&quot; &quot;80025&quot; &quot;86402&quot; &quot;80125&quot; &quot;8025&quot;  &quot;8260&quot;  &quot;V1552&quot;
## [2224] &quot;E9063&quot; &quot;72884&quot; &quot;33183&quot; &quot;57491&quot; &quot;3581&quot;  &quot;5373&quot;  &quot;2521&quot;  &quot;78094&quot; &quot;2592&quot; 
## [2233] &quot;20936&quot; &quot;20975&quot; &quot;86501&quot; &quot;E8192&quot; &quot;V5419&quot; &quot;3940&quot;  &quot;53440&quot; &quot;36281&quot; &quot;7935&quot; 
## [2242] &quot;43821&quot; &quot;E8843&quot; &quot;33821&quot; &quot;9989&quot;  &quot;4171&quot;  &quot;9984&quot;  &quot;78605&quot; &quot;20021&quot; &quot;V170&quot; 
## [2251] &quot;20020&quot; &quot;3529&quot;  &quot;E8501&quot; &quot;47830&quot; &quot;4460&quot;  &quot;72292&quot; &quot;78799&quot; &quot;1914&quot;  &quot;5528&quot; 
## [2260] &quot;1640&quot;  &quot;27949&quot; &quot;35801&quot; &quot;V1029&quot; &quot;E9348&quot; &quot;2191&quot;  &quot;6271&quot;  &quot;6170&quot;  &quot;2210&quot; 
## [2269] &quot;7993&quot;  &quot;56882&quot; &quot;7020&quot;  &quot;38870&quot; &quot;08882&quot; &quot;V1279&quot; &quot;20401&quot; &quot;2774&quot;  &quot;4266&quot; 
## [2278] &quot;3341&quot;  &quot;78606&quot; &quot;4920&quot;  &quot;4555&quot;  &quot;V5309&quot; &quot;4618&quot;  &quot;0796&quot;  &quot;5259&quot;  &quot;85011&quot;
## [2287] &quot;E8233&quot; &quot;87320&quot; &quot;83402&quot; &quot;37652&quot; &quot;3682&quot;  &quot;E9325&quot; &quot;V4960&quot; &quot;81344&quot; &quot;9726&quot; 
## [2296] &quot;30151&quot; &quot;29212&quot; &quot;40300&quot; &quot;5851&quot;  &quot;30481&quot; &quot;V652&quot;  &quot;71103&quot; &quot;3960&quot;  &quot;1537&quot; 
## [2305] &quot;59589&quot; &quot;V8533&quot; &quot;2739&quot;  &quot;5691&quot;  &quot;2555&quot;  &quot;5951&quot;  &quot;55010&quot; &quot;74685&quot; &quot;78906&quot;
## [2314] &quot;72972&quot; &quot;2538&quot;  &quot;40290&quot; &quot;48239&quot; &quot;7590&quot;  &quot;38861&quot; &quot;73399&quot; &quot;3384&quot;  &quot;30789&quot;
## [2323] &quot;V554&quot;  &quot;V189&quot;  &quot;E9530&quot; &quot;29634&quot; &quot;V489&quot;  &quot;4320&quot;  &quot;5969&quot;  &quot;55329&quot; &quot;41032&quot;
## [2332] &quot;71901&quot; &quot;V1241&quot; &quot;1622&quot;  &quot;29530&quot; &quot;56731&quot; &quot;6825&quot;  &quot;80311&quot; &quot;8240&quot;  &quot;61172&quot;
## [2341] &quot;V8389&quot; &quot;7990&quot;  &quot;4358&quot;  &quot;6802&quot;  &quot;41410&quot; &quot;70583&quot; &quot;45910&quot; &quot;53782&quot; &quot;56984&quot;
## [2350] &quot;7469&quot;  &quot;41082&quot; &quot;35781&quot; &quot;99656&quot; &quot;9243&quot;  &quot;1965&quot;  &quot;71906&quot; &quot;V1021&quot; &quot;V1084&quot;
## [2359] &quot;2773&quot;  &quot;44100&quot; &quot;41181&quot; &quot;7428&quot;  &quot;1231&quot;  &quot;99982&quot; &quot;37881&quot; &quot;2564&quot;  &quot;1543&quot; 
## [2368] &quot;25542&quot; &quot;05410&quot; &quot;4440&quot;  &quot;48249&quot; &quot;25090&quot; &quot;V626&quot;  &quot;2849&quot;  &quot;86602&quot; &quot;81354&quot;
## [2377] &quot;8751&quot;  &quot;81000&quot; &quot;81401&quot; &quot;E8122&quot; &quot;8793&quot;  &quot;9032&quot;  &quot;88122&quot; &quot;9571&quot;  &quot;7533&quot; 
## [2386] &quot;44030&quot; &quot;9100&quot;  &quot;56200&quot; &quot;1769&quot;  &quot;4417&quot;  &quot;40591&quot; &quot;E9413&quot; &quot;1521&quot;  &quot;27901&quot;
## [2395] &quot;28732&quot; &quot;7019&quot;  &quot;932&quot;   &quot;V1242&quot; &quot;3668&quot;  &quot;78838&quot; &quot;79439&quot; &quot;44283&quot; &quot;E8842&quot;
## [2404] &quot;E8199&quot; &quot;E8190&quot; &quot;6011&quot;  &quot;28863&quot; &quot;99641&quot; &quot;37313&quot; &quot;72705&quot; &quot;80604&quot; &quot;8072&quot; 
## [2413] &quot;44281&quot; &quot;3438&quot;  &quot;3337&quot;  &quot;71849&quot; &quot;47819&quot; &quot;7226&quot;  &quot;075&quot;   &quot;2254&quot;  &quot;1440&quot; 
## [2422] &quot;23879&quot; &quot;82130&quot; &quot;8221&quot;  &quot;82320&quot; &quot;E8811&quot; &quot;81100&quot; &quot;E8845&quot; &quot;938&quot;   &quot;9352&quot; 
## [2431] &quot;41411&quot; &quot;2572&quot;  &quot;0931&quot;  &quot;96501&quot; &quot;E9800&quot; &quot;84200&quot; &quot;64781&quot; &quot;64621&quot; &quot;65641&quot;
## [2440] &quot;64891&quot; &quot;65951&quot; &quot;V271&quot;  &quot;0319&quot;  &quot;30421&quot; &quot;V8542&quot; &quot;V1001&quot; &quot;5881&quot;  &quot;E8846&quot;
## [2449] &quot;7517&quot;  &quot;2758&quot;  &quot;72611&quot; &quot;6273&quot;  &quot;80423&quot; &quot;80843&quot; &quot;30471&quot; &quot;9011&quot;  &quot;8281&quot; 
## [2458] &quot;1501&quot;  &quot;4560&quot;  &quot;99675&quot; &quot;37200&quot; &quot;07819&quot; &quot;0412&quot;  &quot;28809&quot; &quot;8469&quot;  &quot;E9356&quot;
## [2467] &quot;V029&quot;  &quot;99609&quot; &quot;4770&quot;  &quot;1551&quot;  &quot;6238&quot;  &quot;4478&quot;  &quot;436&quot;   &quot;43320&quot; &quot;99685&quot;
## [2476] &quot;0499&quot;  &quot;27950&quot; &quot;69589&quot; &quot;52809&quot; &quot;33510&quot; &quot;3910&quot;  &quot;72700&quot; &quot;47825&quot; &quot;7280&quot; 
## [2485] &quot;7051&quot;  &quot;2862&quot;  &quot;9678&quot;  &quot;E9502&quot; &quot;E9390&quot; &quot;51911&quot; &quot;28951&quot; &quot;80315&quot; &quot;2734&quot; 
## [2494] &quot;V8538&quot; &quot;3698&quot;  &quot;4470&quot;  &quot;E9344&quot; &quot;V5339&quot; &quot;1101&quot;  &quot;2111&quot;  &quot;7454&quot;  &quot;74729&quot;
## [2503] &quot;22802&quot; &quot;53220&quot; &quot;7429&quot;  &quot;20240&quot; &quot;85100&quot; &quot;2913&quot;  &quot;2732&quot;  &quot;22809&quot; &quot;2376&quot; 
## [2512] &quot;99529&quot; &quot;85302&quot; &quot;E8136&quot; &quot;99668&quot; &quot;74721&quot; &quot;7062&quot;  &quot;7868&quot;  &quot;2861&quot;  &quot;4293&quot; 
## [2521] &quot;60889&quot; &quot;80022&quot; &quot;82302&quot; &quot;V4450&quot; &quot;3961&quot;  &quot;V168&quot;  &quot;3499&quot;  &quot;V4289&quot; &quot;2669&quot; 
## [2530] &quot;01190&quot; &quot;99652&quot; &quot;5539&quot;  &quot;7992&quot;  &quot;1588&quot;  &quot;42689&quot; &quot;7470&quot;  &quot;57471&quot; &quot;34404&quot;
## [2539] &quot;34403&quot; &quot;9099&quot;  &quot;E8493&quot; &quot;E8550&quot; &quot;42653&quot; &quot;9953&quot;  &quot;V1509&quot; &quot;E9389&quot; &quot;V716&quot; 
## [2548] &quot;5233&quot;  &quot;30523&quot; &quot;3643&quot;  &quot;9697&quot;  &quot;0041&quot;  &quot;36217&quot; &quot;E8542&quot; &quot;73341&quot; &quot;E9397&quot;
## [2557] &quot;4571&quot;  &quot;1630&quot;  &quot;2443&quot;  &quot;28411&quot; &quot;E9353&quot; &quot;56987&quot; &quot;5523&quot;  &quot;6140&quot;  &quot;78066&quot;
## [2566] &quot;05413&quot; &quot;05419&quot; &quot;82002&quot; &quot;73734&quot; &quot;60499&quot; &quot;43819&quot; &quot;1620&quot;  &quot;75983&quot; &quot;2382&quot; 
## [2575] &quot;7149&quot;  &quot;0949&quot;  &quot;V071&quot;  &quot;E9391&quot; &quot;86415&quot; &quot;86131&quot; &quot;8601&quot;  &quot;E966&quot;  &quot;9029&quot; 
## [2584] &quot;V4588&quot; &quot;5713&quot;  &quot;7596&quot;  &quot;1726&quot;  &quot;87374&quot; &quot;8745&quot;  &quot;E9554&quot; &quot;85194&quot; &quot;87359&quot;
## [2593] &quot;44389&quot; &quot;0092&quot;  &quot;6208&quot;  &quot;5280&quot;  &quot;1505&quot;  &quot;44772&quot; &quot;2154&quot;  &quot;500&quot;   &quot;53781&quot;
## [2602] &quot;V1047&quot; &quot;75481&quot; &quot;E9179&quot; &quot;27403&quot; &quot;95912&quot; &quot;6084&quot;  &quot;3368&quot;  &quot;3090&quot;  &quot;5304&quot; 
## [2611] &quot;V0179&quot; &quot;52800&quot; &quot;53510&quot; &quot;99791&quot; &quot;5563&quot;  &quot;7942&quot;  &quot;5735&quot;  &quot;7038&quot;  &quot;5942&quot; 
## [2620] &quot;5941&quot;  &quot;79094&quot; &quot;60883&quot; &quot;3699&quot;  &quot;6079&quot;  &quot;6089&quot;  &quot;79099&quot; &quot;67484&quot; &quot;2759&quot; 
## [2629] &quot;7109&quot;  &quot;79409&quot; &quot;7366&quot;  &quot;4531&quot;  &quot;80621&quot; &quot;8244&quot;  &quot;82301&quot; &quot;E8504&quot; &quot;20000&quot;
## [2638] &quot;80026&quot; &quot;8738&quot;  &quot;86601&quot; &quot;4178&quot;  &quot;3220&quot;  &quot;43380&quot; &quot;1579&quot;  &quot;138&quot;   &quot;37730&quot;
## [2647] &quot;3102&quot;  &quot;0091&quot;  &quot;V1053&quot; &quot;72886&quot; &quot;096&quot;   &quot;E8706&quot; &quot;2326&quot;  &quot;03841&quot; &quot;27903&quot;
## [2656] &quot;5846&quot;  &quot;936&quot;   &quot;7510&quot;  &quot;20002&quot; &quot;0543&quot;  &quot;V166&quot;  &quot;3336&quot;  &quot;3373&quot;  &quot;7961&quot; 
## [2665] &quot;33372&quot; &quot;2391&quot;  &quot;64803&quot; &quot;64833&quot; &quot;30431&quot; &quot;25093&quot; &quot;64663&quot; &quot;64903&quot; &quot;V618&quot; 
## [2674] &quot;75169&quot; &quot;75313&quot; &quot;37273&quot; &quot;41012&quot; &quot;05472&quot; &quot;9047&quot;  &quot;9053&quot;  &quot;1373&quot;  &quot;6806&quot; 
## [2683] &quot;44329&quot; &quot;1715&quot;  &quot;V141&quot;  &quot;78721&quot; &quot;V118&quot;  &quot;V624&quot;  &quot;20080&quot; &quot;53260&quot; &quot;9691&quot; 
## [2692] &quot;9800&quot;  &quot;75989&quot; &quot;59000&quot; &quot;27906&quot; &quot;53370&quot; &quot;38612&quot; &quot;2863&quot;  &quot;5374&quot;  &quot;7852&quot; 
## [2701] &quot;11599&quot; &quot;7864&quot;  &quot;3553&quot;  &quot;47875&quot; &quot;3593&quot;  &quot;541&quot;   &quot;75982&quot; &quot;V1641&quot; &quot;1820&quot; 
## [2710] &quot;V162&quot;  &quot;1307&quot;  &quot;3240&quot;  &quot;01803&quot; &quot;2822&quot;  &quot;23872&quot; &quot;01896&quot; &quot;99851&quot; &quot;V8543&quot;
## [2719] &quot;1370&quot;  &quot;46619&quot; &quot;2893&quot;  &quot;01194&quot; &quot;E9385&quot; &quot;37430&quot; &quot;7801&quot;  &quot;72273&quot; &quot;2728&quot; 
## [2728] &quot;4530&quot;  &quot;3180&quot;  &quot;30473&quot; &quot;73018&quot; &quot;36544&quot; &quot;36202&quot; &quot;36563&quot; &quot;36570&quot; &quot;V8531&quot;
## [2737] &quot;82300&quot; &quot;8248&quot;  &quot;53561&quot; &quot;V175&quot;  &quot;E8703&quot; &quot;71233&quot; &quot;42983&quot; &quot;36000&quot; &quot;86502&quot;
## [2746] &quot;79093&quot; &quot;38910&quot; &quot;69515&quot; &quot;78842&quot; &quot;V8537&quot; &quot;E9347&quot; &quot;79579&quot; &quot;45377&quot; &quot;8407&quot; 
## [2755] &quot;1969&quot;  &quot;59789&quot; &quot;71531&quot; &quot;7483&quot;  &quot;99801&quot; &quot;95200&quot; &quot;95205&quot; &quot;7218&quot;  &quot;28319&quot;
## [2764] &quot;2871&quot;  &quot;78600&quot; &quot;29010&quot; &quot;3371&quot;  &quot;0030&quot;  &quot;V023&quot;  &quot;42650&quot; &quot;1211&quot;  &quot;56782&quot;
## [2773] &quot;5562&quot;  &quot;60090&quot; &quot;9651&quot;  &quot;82123&quot; &quot;95901&quot; &quot;2879&quot;  &quot;75317&quot; &quot;25073&quot; &quot;8921&quot; 
## [2782] &quot;E9209&quot; &quot;V8534&quot; &quot;44381&quot; &quot;7079&quot;  &quot;4480&quot;  &quot;30410&quot; &quot;2352&quot;  &quot;6160&quot;  &quot;71120&quot;
## [2791] &quot;1361&quot;  &quot;30751&quot; &quot;4386&quot;  &quot;99657&quot; &quot;3536&quot;  &quot;25071&quot; &quot;7595&quot;  &quot;71589&quot; &quot;5755&quot; 
## [2800] &quot;33391&quot; &quot;20030&quot; &quot;92421&quot; &quot;45379&quot; &quot;2730&quot;  &quot;1124&quot;  &quot;4838&quot;  &quot;30461&quot; &quot;0530&quot; 
## [2809] &quot;7015&quot;  &quot;E959&quot;  &quot;V5413&quot; &quot;43301&quot; &quot;43321&quot; &quot;V5862&quot; &quot;01300&quot; &quot;78903&quot; &quot;78832&quot;
## [2818] &quot;20380&quot; &quot;2141&quot;  &quot;6253&quot;  &quot;5361&quot;  &quot;71949&quot; &quot;1479&quot;  &quot;6951&quot;  &quot;60783&quot; &quot;7462&quot; 
## [2827] &quot;5192&quot;  &quot;57430&quot; &quot;7833&quot;  &quot;20501&quot; &quot;6260&quot;  &quot;36847&quot; &quot;7103&quot;  &quot;7835&quot;  &quot;0479&quot; 
## [2836] &quot;44324&quot; &quot;75310&quot; &quot;3442&quot;  &quot;5371&quot;  &quot;04101&quot; &quot;33119&quot; &quot;7871&quot;  &quot;4257&quot;  &quot;41513&quot;
## [2845] &quot;6173&quot;  &quot;6175&quot;  &quot;6268&quot;  &quot;393&quot;   &quot;71930&quot; &quot;1420&quot;  &quot;36043&quot; &quot;V017&quot;  &quot;47411&quot;
## [2854] &quot;85222&quot; &quot;1624&quot;  &quot;29041&quot; &quot;9670&quot;  &quot;E9501&quot; &quot;E851&quot;  &quot;84500&quot; &quot;30015&quot; &quot;35782&quot;
## [2863] &quot;5224&quot;  &quot;41419&quot; &quot;8246&quot;  &quot;3201&quot;  &quot;5060&quot;  &quot;E8641&quot; &quot;7424&quot;  &quot;E8257&quot; &quot;87202&quot;
## [2872] &quot;9570&quot;  &quot;E0009&quot; &quot;86404&quot; &quot;80508&quot; &quot;9081&quot;  &quot;E8197&quot; &quot;78902&quot; &quot;29624&quot; &quot;4581&quot; 
## [2881] &quot;1739&quot;  &quot;8080&quot;  &quot;9729&quot;  &quot;7235&quot;  &quot;7093&quot;  &quot;44321&quot; &quot;3490&quot;  &quot;4548&quot;  &quot;5581&quot; 
## [2890] &quot;4441&quot;  &quot;67323&quot; &quot;64863&quot; &quot;63592&quot; &quot;64843&quot; &quot;64203&quot; &quot;5764&quot;  &quot;9828&quot;  &quot;E9809&quot;
## [2899] &quot;4272&quot;  &quot;4474&quot;  &quot;7018&quot;  &quot;6205&quot;  &quot;9722&quot;  &quot;85140&quot; &quot;43410&quot; &quot;82121&quot; &quot;3319&quot; 
## [2908] &quot;80320&quot; &quot;V0481&quot; &quot;4243&quot;  &quot;9753&quot;  &quot;V4971&quot; &quot;20200&quot; &quot;20281&quot; &quot;82382&quot; &quot;6141&quot; 
## [2917] &quot;41403&quot; &quot;9947&quot;  &quot;4351&quot;  &quot;2539&quot;  &quot;80706&quot; &quot;5582&quot;  &quot;2777&quot;  &quot;53210&quot; &quot;2929&quot; 
## [2926] &quot;66551&quot; &quot;66921&quot; &quot;3950&quot;  &quot;4411&quot;  &quot;V5041&quot; &quot;71942&quot; &quot;79319&quot; &quot;72610&quot; &quot;6164&quot; 
## [2935] &quot;61650&quot; &quot;41512&quot; &quot;6203&quot;  &quot;00581&quot; &quot;262&quot;   &quot;34511&quot; &quot;05313&quot; &quot;46431&quot; &quot;0529&quot; 
## [2944] &quot;45374&quot; &quot;45371&quot; &quot;78050&quot; &quot;V568&quot;  &quot;V143&quot;  &quot;28851&quot; &quot;27661&quot; &quot;V091&quot;  &quot;33523&quot;
## [2953] &quot;49381&quot; &quot;8930&quot;  &quot;81203&quot; &quot;83109&quot; &quot;9110&quot;  &quot;9120&quot;  &quot;2699&quot;  &quot;1707&quot;  &quot;2142&quot; 
## [2962] &quot;&quot;      &quot;V653&quot;  &quot;40501&quot; &quot;86101&quot; &quot;81302&quot; &quot;99527&quot; &quot;E8704&quot; &quot;0971&quot;  &quot;1716&quot; 
## [2971] &quot;42841&quot; &quot;35971&quot; &quot;7104&quot;  &quot;64823&quot; &quot;71966&quot; &quot;5078&quot;  &quot;V581&quot;  &quot;61882&quot; &quot;34600&quot;
## [2980] &quot;5409&quot;  &quot;1968&quot;  &quot;6072&quot;  &quot;56032&quot; &quot;34409&quot; &quot;55202&quot; &quot;3619&quot;  &quot;9701&quot;  &quot;71902&quot;
## [2989] &quot;0074&quot;  &quot;58181&quot; &quot;43830&quot; &quot;2808&quot;  &quot;7962&quot;  &quot;73681&quot; &quot;4380&quot;  &quot;1710&quot;  &quot;78930&quot;
## [2998] &quot;6119&quot;  &quot;79009&quot; &quot;462&quot;   &quot;80101&quot; &quot;6180&quot;  &quot;6256&quot;  &quot;36800&quot; &quot;0520&quot;  &quot;4200&quot; 
## [3007] &quot;90241&quot; &quot;7420&quot;  &quot;99809&quot; &quot;9878&quot;  &quot;E8698&quot; &quot;30021&quot; &quot;463&quot;   &quot;20301&quot; &quot;46451&quot;
## [3016] &quot;33729&quot; &quot;6040&quot;  &quot;1450&quot;  &quot;1986&quot;  &quot;4731&quot;  &quot;27789&quot; &quot;71198&quot; &quot;V1261&quot; &quot;E9401&quot;
## [3025] &quot;5181&quot;  &quot;1639&quot;  &quot;27503&quot; &quot;37853&quot; &quot;57460&quot; &quot;1369&quot;  &quot;29384&quot; &quot;E9803&quot; &quot;68100&quot;
## [3034] &quot;2755&quot;  &quot;71916&quot; &quot;2528&quot;  &quot;E9278&quot; &quot;2884&quot;  &quot;57142&quot; &quot;6970&quot;  &quot;37300&quot; &quot;1602&quot; 
## [3043] &quot;5264&quot;  &quot;4479&quot;  &quot;734&quot;   &quot;V8544&quot; &quot;90221&quot; &quot;8760&quot;  &quot;8792&quot;  &quot;25510&quot; &quot;56986&quot;
## [3052] &quot;53570&quot; &quot;7354&quot;  &quot;5538&quot;  &quot;45189&quot; &quot;V5427&quot; &quot;6983&quot;  &quot;8300&quot;  &quot;81305&quot; &quot;43831&quot;
## [3061] &quot;92401&quot; &quot;E9571&quot; &quot;9173&quot;  &quot;E9208&quot; &quot;78723&quot; &quot;1540&quot;  &quot;1642&quot;  &quot;V1088&quot; &quot;2537&quot; 
## [3070] &quot;99732&quot; &quot;27482&quot; &quot;43400&quot; &quot;3577&quot;  &quot;47832&quot; &quot;20260&quot; &quot;99833&quot; &quot;7937&quot;  &quot;V5416&quot;
## [3079] &quot;5238&quot;  &quot;V1091&quot; &quot;33379&quot; &quot;E9451&quot; &quot;79381&quot; &quot;470&quot;   &quot;2104&quot;  &quot;4780&quot;  &quot;4781&quot; 
## [3088] &quot;4510&quot;  &quot;82129&quot; &quot;9581&quot;  &quot;E8384&quot; &quot;85205&quot; &quot;30591&quot; &quot;3949&quot;  &quot;78199&quot; &quot;81220&quot;
## [3097] &quot;4519&quot;  &quot;53291&quot; &quot;28243&quot; &quot;33189&quot; &quot;2979&quot;  &quot;6829&quot;  &quot;73097&quot; &quot;30551&quot; &quot;9089&quot; 
## [3106] &quot;5258&quot;  &quot;5239&quot;  &quot;78449&quot; &quot;0318&quot;  &quot;E9383&quot; &quot;1764&quot;  &quot;E9318&quot; &quot;72669&quot; &quot;E9306&quot;
## [3115] &quot;55011&quot; &quot;72789&quot; &quot;2778&quot;  &quot;9130&quot;  &quot;3530&quot;  &quot;V8745&quot; &quot;33721&quot; &quot;33720&quot; &quot;34691&quot;
## [3124] &quot;4730&quot;  &quot;57481&quot; &quot;25031&quot; &quot;5758&quot;  &quot;81301&quot; &quot;2114&quot;  &quot;3234&quot;  &quot;33381&quot; &quot;7010&quot; 
## [3133] &quot;99665&quot; &quot;2541&quot;  &quot;25033&quot; &quot;3693&quot;  &quot;99683&quot; &quot;V421&quot;  &quot;1177&quot;  &quot;5260&quot;  &quot;71500&quot;
## [3142] &quot;73630&quot; &quot;V5482&quot; &quot;V8821&quot; &quot;43812&quot; &quot;1980&quot;  &quot;87261&quot; &quot;37630&quot; &quot;73743&quot; &quot;57441&quot;
## [3151] &quot;7296&quot;  &quot;V9089&quot; &quot;28730&quot; &quot;9221&quot;  &quot;5812&quot;  &quot;5275&quot;  &quot;5831&quot;  &quot;20023&quot; &quot;29282&quot;
## [3160] &quot;78863&quot; &quot;36813&quot; &quot;71509&quot; &quot;79389&quot; &quot;7945&quot;  &quot;75889&quot; &quot;V1090&quot; &quot;2750&quot;  &quot;23772&quot;
## [3169] &quot;59659&quot; &quot;37520&quot; &quot;3014&quot;  &quot;85242&quot; &quot;32719&quot; &quot;33812&quot; &quot;55091&quot; &quot;30430&quot; &quot;2698&quot; 
## [3178] &quot;2798&quot;  &quot;6272&quot;  &quot;71530&quot; &quot;68102&quot; &quot;75733&quot; &quot;28950&quot; &quot;30150&quot; &quot;99567&quot; &quot;51284&quot;
## [3187] &quot;71699&quot; &quot;6101&quot;  &quot;5670&quot;  &quot;4718&quot;  &quot;4710&quot;  &quot;4732&quot;  &quot;52460&quot; &quot;28802&quot; &quot;19881&quot;
## [3196] &quot;71534&quot; &quot;538&quot;   &quot;1542&quot;  &quot;1104&quot;  &quot;40403&quot; &quot;V171&quot;  &quot;83101&quot; &quot;72761&quot; &quot;94204&quot;
## [3205] &quot;E899&quot;  &quot;990&quot;   &quot;5963&quot;  &quot;2903&quot;  &quot;30403&quot; &quot;3101&quot;  &quot;4542&quot;  &quot;E9382&quot; &quot;53300&quot;
## [3214] &quot;9713&quot;  &quot;30989&quot; &quot;7513&quot;  &quot;V4963&quot; &quot;85402&quot; &quot;34541&quot; &quot;V1529&quot; &quot;V0262&quot; &quot;07053&quot;
## [3223] &quot;684&quot;   &quot;48232&quot; &quot;5164&quot;  &quot;78934&quot; &quot;6178&quot;  &quot;6264&quot;  &quot;7092&quot;  &quot;20220&quot; &quot;8860&quot; 
## [3232] &quot;81611&quot; &quot;99693&quot; &quot;7964&quot;  &quot;V5841&quot; &quot;V1203&quot; &quot;85246&quot; &quot;E8500&quot; &quot;E8541&quot; &quot;9696&quot; 
## [3241] &quot;4841&quot;  &quot;00869&quot; &quot;V562&quot;  &quot;29389&quot; &quot;86354&quot; &quot;90254&quot; &quot;88012&quot; &quot;86813&quot; &quot;V5481&quot;
## [3250] &quot;1580&quot;  &quot;47833&quot; &quot;5982&quot;  &quot;5289&quot;  &quot;2355&quot;  &quot;81403&quot; &quot;73004&quot; &quot;20192&quot; &quot;1765&quot; 
## [3259] &quot;11519&quot; &quot;1761&quot;  &quot;5933&quot;  &quot;79551&quot; &quot;99700&quot; &quot;71698&quot; &quot;V0253&quot; &quot;E9412&quot; &quot;20290&quot;
## [3268] &quot;7514&quot;  &quot;43884&quot; &quot;20005&quot; &quot;37601&quot; &quot;0463&quot;  &quot;8064&quot;  &quot;2513&quot;  &quot;27502&quot; &quot;7069&quot; 
## [3277] &quot;V5881&quot; &quot;60782&quot; &quot;88000&quot; &quot;8830&quot;  &quot;8900&quot;  &quot;8770&quot;  &quot;E963&quot;  &quot;E964&quot;  &quot;27411&quot;
## [3286] &quot;44289&quot; &quot;38630&quot; &quot;V5812&quot; &quot;2459&quot;  &quot;1945&quot;  &quot;8708&quot;  &quot;98989&quot; &quot;6274&quot;  &quot;V074&quot; 
## [3295] &quot;E8619&quot; &quot;56789&quot; &quot;43822&quot; &quot;4613&quot;  &quot;4376&quot;  &quot;37851&quot; &quot;4612&quot;  &quot;6038&quot;  &quot;55093&quot;
## [3304] &quot;80306&quot; &quot;3591&quot;  &quot;8710&quot;  &quot;8716&quot;  &quot;42652&quot; &quot;88101&quot; &quot;1611&quot;  &quot;83100&quot; &quot;5966&quot; 
## [3313] &quot;5564&quot;  &quot;V1649&quot; &quot;E0089&quot; &quot;73005&quot; &quot;38022&quot; &quot;V426&quot;  &quot;V1061&quot; &quot;80236&quot; &quot;8728&quot; 
## [3322] &quot;59689&quot; &quot;9752&quot;  &quot;68609&quot; &quot;502&quot;   &quot;5160&quot;  &quot;1520&quot;  &quot;75550&quot; &quot;9273&quot;  &quot;E9196&quot;
## [3331] &quot;70401&quot; &quot;V1507&quot; &quot;7089&quot;  &quot;8603&quot;  &quot;8796&quot;  &quot;9598&quot;  &quot;E8191&quot; &quot;E8181&quot; &quot;V169&quot; 
## [3340] &quot;86801&quot; &quot;85300&quot; &quot;8821&quot;  &quot;9040&quot;  &quot;9042&quot;  &quot;81511&quot; &quot;8912&quot;  &quot;8750&quot;  &quot;E970&quot; 
## [3349] &quot;8672&quot;  &quot;38869&quot; &quot;80326&quot; &quot;80220&quot; &quot;0478&quot;  &quot;6266&quot;  &quot;5285&quot;  &quot;8411&quot;  &quot;83501&quot;
## [3358] &quot;74761&quot; &quot;81308&quot; &quot;V3000&quot; &quot;76515&quot; &quot;7718&quot;  &quot;769&quot;   &quot;77210&quot; &quot;7732&quot;  &quot;7746&quot; 
## [3367] &quot;76383&quot; &quot;V053&quot;  &quot;78055&quot; &quot;94224&quot; &quot;E9248&quot; &quot;V3100&quot; &quot;76518&quot; &quot;7742&quot;  &quot;V290&quot; 
## [3376] &quot;V502&quot;  &quot;7673&quot;  &quot;36522&quot; &quot;V331&quot;  &quot;7793&quot;  &quot;76406&quot; &quot;7708&quot;  &quot;76516&quot; &quot;V3101&quot;
## [3385] &quot;V3001&quot; &quot;7765&quot;  &quot;7783&quot;  &quot;7706&quot;  &quot;3952&quot;  &quot;74749&quot; &quot;2143&quot;  &quot;28983&quot; &quot;23877&quot;
## [3394] &quot;9140&quot;  &quot;85186&quot; &quot;E9688&quot; &quot;86339&quot; &quot;81212&quot; &quot;E9579&quot; &quot;27953&quot; &quot;3798&quot;  &quot;1503&quot; 
## [3403] &quot;20198&quot; &quot;1272&quot;  &quot;78843&quot; &quot;5753&quot;  &quot;57411&quot; &quot;2972&quot;  &quot;24981&quot; &quot;05312&quot; &quot;20022&quot;
## [3412] &quot;V4587&quot; &quot;63411&quot; &quot;64824&quot; &quot;6214&quot;  &quot;44323&quot; &quot;3222&quot;  &quot;7012&quot;  &quot;33399&quot; &quot;7756&quot; 
## [3421] &quot;76405&quot; &quot;76495&quot; &quot;75251&quot; &quot;7761&quot;  &quot;V3401&quot; &quot;76502&quot; &quot;7707&quot;  &quot;76501&quot; &quot;7776&quot; 
## [3430] &quot;7623&quot;  &quot;7766&quot;  &quot;36221&quot; &quot;7798&quot;  &quot;76079&quot; &quot;76517&quot; &quot;V721&quot;  &quot;7731&quot;  &quot;77431&quot;
## [3439] &quot;80312&quot; &quot;80322&quot; &quot;9948&quot;  &quot;74762&quot; &quot;82111&quot; &quot;E8230&quot; &quot;E8231&quot; &quot;3249&quot;  &quot;V1309&quot;
## [3448] &quot;V872&quot;  &quot;6144&quot;  &quot;7587&quot;  &quot;2821&quot;  &quot;20047&quot; &quot;74769&quot; &quot;V8489&quot; &quot;8439&quot;  &quot;37432&quot;
## [3457] &quot;38915&quot; &quot;53490&quot; &quot;4619&quot;  &quot;72990&quot; &quot;2337&quot;  &quot;76409&quot; &quot;7790&quot;  &quot;77213&quot; &quot;7671&quot; 
## [3466] &quot;76389&quot; &quot;2334&quot;  &quot;7750&quot;  &quot;6851&quot;  &quot;7702&quot;  &quot;7260&quot;  &quot;5902&quot;  &quot;V4965&quot; &quot;9916&quot; 
## [3475] &quot;E9010&quot; &quot;8245&quot;  &quot;9046&quot;  &quot;9529&quot;  &quot;E8496&quot; &quot;4279&quot;  &quot;99701&quot; &quot;E8556&quot; &quot;36641&quot;
## [3484] &quot;9245&quot;  &quot;71580&quot; &quot;51289&quot; &quot;E8232&quot; &quot;0790&quot;  &quot;2370&quot;  &quot;56971&quot; &quot;325&quot;   &quot;3019&quot; 
## [3493] &quot;72672&quot; &quot;73315&quot; &quot;9563&quot;  &quot;3551&quot;  &quot;V2651&quot; &quot;1561&quot;  &quot;66561&quot; &quot;65571&quot; &quot;65661&quot;
## [3502] &quot;65921&quot; &quot;64892&quot; &quot;E8130&quot; &quot;9222&quot;  &quot;81400&quot; &quot;57421&quot; &quot;56031&quot; &quot;V110&quot;  &quot;76519&quot;
## [3511] &quot;7624&quot;  &quot;V1643&quot; &quot;74193&quot; &quot;7661&quot;  &quot;65613&quot; &quot;74511&quot; &quot;74710&quot; &quot;7564&quot;  &quot;29623&quot;
## [3520] &quot;70409&quot; &quot;75689&quot; &quot;5439&quot;  &quot;V0189&quot; &quot;71694&quot; &quot;8861&quot;  &quot;81603&quot; &quot;E9201&quot; &quot;2824&quot; 
## [3529] &quot;7593&quot;  &quot;73629&quot; &quot;9064&quot;  &quot;2865&quot;  &quot;71912&quot; &quot;24901&quot; &quot;64661&quot; &quot;64201&quot; &quot;65671&quot;
## [3538] &quot;65421&quot; &quot;V252&quot;  &quot;94214&quot; &quot;E989&quot;  &quot;34401&quot; &quot;7934&quot;  &quot;7068&quot;  &quot;46611&quot; &quot;E8764&quot;
## [3547] &quot;80609&quot; &quot;80624&quot; &quot;80629&quot; &quot;53241&quot; &quot;80466&quot; &quot;81250&quot; &quot;81343&quot; &quot;83908&quot; &quot;38830&quot;
## [3556] &quot;7775&quot;  &quot;7724&quot;  &quot;7617&quot;  &quot;82332&quot; &quot;90450&quot; &quot;83660&quot; &quot;90441&quot; &quot;2230&quot;  &quot;55120&quot;
## [3565] &quot;48240&quot; &quot;45386&quot; &quot;46400&quot; &quot;3561&quot;  &quot;52689&quot; &quot;E9198&quot; &quot;1568&quot;  &quot;1619&quot;  &quot;33385&quot;
## [3574] &quot;E9392&quot; &quot;7827&quot;  &quot;3410&quot;  &quot;0272&quot;  &quot;94421&quot; &quot;73301&quot; &quot;1535&quot;  &quot;30491&quot; &quot;41002&quot;
## [3583] &quot;61179&quot; &quot;E9399&quot; &quot;0940&quot;  &quot;59370&quot; &quot;28311&quot; &quot;99589&quot; &quot;86389&quot; &quot;86329&quot; &quot;76506&quot;
## [3592] &quot;7703&quot;  &quot;77212&quot; &quot;7797&quot;  &quot;76514&quot; &quot;7795&quot;  &quot;71846&quot; &quot;2250&quot;  &quot;9755&quot;  &quot;9754&quot; 
## [3601] &quot;E8586&quot; &quot;9711&quot;  &quot;83401&quot; &quot;81323&quot; &quot;88110&quot; &quot;44620&quot; &quot;6039&quot;  &quot;53441&quot; &quot;1449&quot; 
## [3610] &quot;1418&quot;  &quot;E8110&quot; &quot;23770&quot; &quot;74100&quot; &quot;1874&quot;  &quot;V198&quot;  &quot;1743&quot;  &quot;73712&quot; &quot;20282&quot;
## [3619] &quot;49391&quot; &quot;V435&quot;  &quot;9627&quot;  &quot;66131&quot; &quot;66531&quot; &quot;66541&quot; &quot;64881&quot; &quot;66632&quot; &quot;66411&quot;
## [3628] &quot;65961&quot; &quot;64822&quot; &quot;5759&quot;  &quot;3839&quot;  &quot;2726&quot;  &quot;34551&quot; &quot;34581&quot; &quot;30522&quot; &quot;72290&quot;
## [3637] &quot;V1652&quot; &quot;677&quot;   &quot;2718&quot;  &quot;72633&quot; &quot;V5423&quot; &quot;4533&quot;  &quot;20150&quot; &quot;V109&quot;  &quot;3340&quot; 
## [3646] &quot;7960&quot;  &quot;3674&quot;  &quot;73689&quot; &quot;27952&quot; &quot;05443&quot; &quot;45372&quot; &quot;1398&quot;  &quot;7560&quot;  &quot;76496&quot;
## [3655] &quot;6910&quot;  &quot;76497&quot; &quot;75261&quot; &quot;71887&quot; &quot;3804&quot;  &quot;2119&quot;  &quot;7028&quot;  &quot;4219&quot;  &quot;36001&quot;
## [3664] &quot;683&quot;   &quot;40490&quot; &quot;E9370&quot; &quot;2788&quot;  &quot;29592&quot; &quot;20920&quot; &quot;7726&quot;  &quot;95204&quot; &quot;34402&quot;
## [3673] &quot;E9170&quot; &quot;E8494&quot; &quot;8249&quot;  &quot;9051&quot;  &quot;13109&quot; &quot;75679&quot; &quot;9779&quot;  &quot;E9805&quot; &quot;1390&quot; 
## [3682] &quot;3182&quot;  &quot;32381&quot; &quot;34211&quot; &quot;34571&quot; &quot;34210&quot; &quot;326&quot;   &quot;20287&quot; &quot;78607&quot; &quot;43840&quot;
## [3691] &quot;7811&quot;  &quot;78724&quot; &quot;2251&quot;  &quot;7808&quot;  &quot;3911&quot;  &quot;20411&quot; &quot;E0010&quot; &quot;0498&quot;  &quot;1618&quot; 
## [3700] &quot;1251&quot;  &quot;5198&quot;  &quot;9220&quot;  &quot;81602&quot; &quot;V4985&quot; &quot;86802&quot; &quot;8250&quot;  &quot;88003&quot; &quot;8748&quot; 
## [3709] &quot;2155&quot;  &quot;5734&quot;  &quot;V1071&quot; &quot;78937&quot; &quot;66511&quot; &quot;66602&quot; &quot;66941&quot; &quot;1940&quot;  &quot;81383&quot;
## [3718] &quot;V537&quot;  &quot;7714&quot;  &quot;07031&quot; &quot;64111&quot; &quot;66911&quot; &quot;05379&quot; &quot;0400&quot;  &quot;78651&quot; &quot;33392&quot;
## [3727] &quot;5279&quot;  &quot;1732&quot;  &quot;37924&quot; &quot;73316&quot; &quot;85216&quot; &quot;85256&quot; &quot;7722&quot;  &quot;7633&quot;  &quot;83805&quot;
## [3736] &quot;80639&quot; &quot;3548&quot;  &quot;81311&quot; &quot;E8129&quot; &quot;81259&quot; &quot;88120&quot; &quot;88121&quot; &quot;9031&quot;  &quot;9562&quot; 
## [3745] &quot;9228&quot;  &quot;9238&quot;  &quot;1638&quot;  &quot;94532&quot; &quot;V5426&quot; &quot;04671&quot; &quot;42291&quot; &quot;9180&quot;  &quot;80023&quot;
## [3754] &quot;25023&quot; &quot;1490&quot;  &quot;38860&quot; &quot;87200&quot; &quot;20921&quot; &quot;20973&quot; &quot;41010&quot; &quot;9679&quot;  &quot;E8529&quot;
## [3763] &quot;E9888&quot; &quot;44502&quot; &quot;20480&quot; &quot;1108&quot;  &quot;99800&quot; &quot;80120&quot; &quot;81500&quot; &quot;9942&quot;  &quot;2706&quot; 
## [3772] &quot;9680&quot;  &quot;34431&quot; &quot;6924&quot;  &quot;96901&quot; &quot;30580&quot; &quot;E8551&quot; &quot;9778&quot;  &quot;9588&quot;  &quot;37993&quot;
## [3781] &quot;9809&quot;  &quot;E9509&quot; &quot;4253&quot;  &quot;64804&quot; &quot;56781&quot; &quot;75482&quot; &quot;7383&quot;  &quot;0039&quot;  &quot;9760&quot; 
## [3790] &quot;82131&quot; &quot;V4509&quot; &quot;32727&quot; &quot;74190&quot; &quot;8021&quot;  &quot;9055&quot;  &quot;1910&quot;  &quot;20402&quot; &quot;5282&quot; 
## [3799] &quot;2395&quot;  &quot;36970&quot; &quot;48801&quot; &quot;34881&quot; &quot;30781&quot; &quot;67153&quot; &quot;1950&quot;  &quot;V167&quot;  &quot;V4989&quot;
## [3808] &quot;1458&quot;  &quot;69512&quot; &quot;69550&quot; &quot;78933&quot; &quot;59011&quot; &quot;7289&quot;  &quot;9524&quot;  &quot;2373&quot;  &quot;6162&quot; 
## [3817] &quot;86103&quot; &quot;80620&quot; &quot;71986&quot; &quot;71895&quot; &quot;1209&quot;  &quot;1208&quot;  &quot;53500&quot; &quot;99561&quot; &quot;5996&quot; 
## [3826] &quot;5967&quot;  &quot;82330&quot; &quot;81503&quot; &quot;E8918&quot; &quot;28952&quot; &quot;3109&quot;  &quot;64303&quot; &quot;7946&quot;  &quot;5952&quot; 
## [3835] &quot;7458&quot;  &quot;1718&quot;  &quot;1511&quot;  &quot;V5863&quot; &quot;43852&quot; &quot;V561&quot;  &quot;64264&quot; &quot;64784&quot; &quot;64664&quot;
## [3844] &quot;64844&quot; &quot;86381&quot; &quot;86321&quot; &quot;E9068&quot; &quot;E8702&quot; &quot;2309&quot;  &quot;34670&quot; &quot;V1501&quot; &quot;1915&quot; 
## [3853] &quot;1728&quot;  &quot;99639&quot; &quot;71191&quot; &quot;2594&quot;  &quot;7534&quot;  &quot;1471&quot;  &quot;3431&quot;  &quot;29285&quot; &quot;71213&quot;
## [3862] &quot;72703&quot; &quot;4375&quot;  &quot;V5049&quot; &quot;V8409&quot; &quot;20412&quot; &quot;45352&quot; &quot;79959&quot; &quot;64271&quot; &quot;64862&quot;
## [3871] &quot;37950&quot; &quot;1613&quot;  &quot;9020&quot;  &quot;E9871&quot; &quot;05329&quot; &quot;60490&quot; &quot;1649&quot;  &quot;3897&quot;  &quot;35921&quot;
## [3880] &quot;5731&quot;  &quot;3380&quot;  &quot;3578&quot;  &quot;1643&quot;  &quot;V1069&quot; &quot;86239&quot; &quot;E956&quot;  &quot;75651&quot; &quot;33511&quot;
## [3889] &quot;6938&quot;  &quot;E9301&quot; &quot;V7281&quot; &quot;1105&quot;  &quot;8448&quot;  &quot;5642&quot;  &quot;7265&quot;  &quot;V1585&quot; &quot;2931&quot; 
## [3898] &quot;7542&quot;  &quot;3158&quot;  &quot;3068&quot;  &quot;V1062&quot; &quot;4918&quot;  &quot;99689&quot; &quot;4150&quot;  &quot;94504&quot; &quot;78469&quot;
## [3907] &quot;55012&quot; &quot;9920&quot;  &quot;E9000&quot; &quot;E0011&quot; &quot;9773&quot;  &quot;32382&quot; &quot;632&quot;   &quot;6392&quot;  &quot;20957&quot;
## [3916] &quot;36283&quot; &quot;62130&quot; &quot;33902&quot; &quot;78821&quot; &quot;E9425&quot; &quot;1574&quot;  &quot;30250&quot; &quot;V714&quot;  &quot;20312&quot;
## [3925] &quot;20008&quot; &quot;6981&quot;  &quot;38021&quot; &quot;38420&quot; &quot;E9689&quot; &quot;3419&quot;  &quot;3418&quot;  &quot;4733&quot;  &quot;1109&quot; 
## [3934] &quot;53311&quot; &quot;72939&quot; &quot;9172&quot;  &quot;4289&quot;  &quot;20018&quot; &quot;7461&quot;  &quot;45119&quot; &quot;80130&quot; &quot;7131&quot; 
## [3943] &quot;E8744&quot; &quot;45376&quot; &quot;5692&quot;  &quot;V8524&quot; &quot;71594&quot; &quot;E8162&quot; &quot;66624&quot; &quot;66914&quot; &quot;67014&quot;
## [3952] &quot;6150&quot;  &quot;64251&quot; &quot;67402&quot; &quot;65261&quot; &quot;66331&quot; &quot;65651&quot; &quot;65801&quot; &quot;V272&quot;  &quot;7041&quot; 
## [3961] &quot;04089&quot; &quot;75611&quot; &quot;2271&quot;  &quot;2117&quot;  &quot;32726&quot; &quot;72704&quot; &quot;2371&quot;  &quot;1571&quot;  &quot;V8545&quot;
## [3970] &quot;33390&quot; &quot;07951&quot; &quot;7908&quot;  &quot;7238&quot;  &quot;34440&quot; &quot;5298&quot;  &quot;73329&quot; &quot;6023&quot;  &quot;V1389&quot;
## [3979] &quot;44029&quot; &quot;6190&quot;  &quot;9580&quot;  &quot;0398&quot;  &quot;V8812&quot; &quot;3971&quot;  &quot;9198&quot;  &quot;V812&quot;  &quot;2692&quot; 
## [3988] &quot;73001&quot; &quot;6249&quot;  &quot;V560&quot;  &quot;68101&quot; &quot;V5864&quot; &quot;V5873&quot; &quot;2462&quot;  &quot;99933&quot; &quot;38014&quot;
## [3997] &quot;82120&quot; &quot;E8151&quot; &quot;4291&quot;  &quot;20930&quot; &quot;7217&quot;  &quot;5644&quot;  &quot;5640&quot;  &quot;1110&quot;  &quot;7891&quot; 
## [4006] &quot;44621&quot; &quot;72211&quot; &quot;4449&quot;  &quot;7859&quot;  &quot;74686&quot; &quot;75322&quot; &quot;2531&quot;  &quot;2218&quot;  &quot;72741&quot;
## [4015] &quot;937&quot;   &quot;9952&quot;  &quot;V434&quot;  &quot;5306&quot;  &quot;E9670&quot; &quot;9211&quot;  &quot;E9457&quot; &quot;7836&quot;  &quot;38401&quot;
## [4024] &quot;28412&quot; &quot;86810&quot; &quot;0540&quot;  &quot;71909&quot; &quot;V8401&quot; &quot;43810&quot; &quot;1734&quot;  &quot;90301&quot; &quot;V558&quot; 
## [4033] &quot;66111&quot; &quot;64782&quot; &quot;75610&quot; &quot;81241&quot; &quot;8418&quot;  &quot;72743&quot; &quot;27402&quot; &quot;2682&quot;  &quot;1612&quot; 
## [4042] &quot;1481&quot;  &quot;3076&quot;  &quot;4489&quot;  &quot;28862&quot; &quot;3824&quot;  &quot;4170&quot;  &quot;3300&quot;  &quot;6235&quot;  &quot;0839&quot; 
## [4051] &quot;V431&quot;  &quot;9471&quot;  &quot;E8768&quot; &quot;31289&quot; &quot;1330&quot;  &quot;1720&quot;  &quot;38589&quot; &quot;1648&quot;  &quot;83500&quot;
## [4060] &quot;94323&quot; &quot;94534&quot; &quot;99771&quot; &quot;71102&quot; &quot;V1642&quot; &quot;44409&quot; &quot;37140&quot; &quot;37420&quot; &quot;94127&quot;
## [4069] &quot;94425&quot; &quot;94423&quot; &quot;E9241&quot; &quot;72762&quot; &quot;7108&quot;  &quot;3082&quot;  &quot;57140&quot; &quot;4551&quot;  &quot;2325&quot; 
## [4078] &quot;20205&quot; &quot;1840&quot;  &quot;36840&quot; &quot;43381&quot; &quot;71593&quot; &quot;99684&quot; &quot;27700&quot; &quot;4220&quot;  &quot;37143&quot;
## [4087] &quot;1882&quot;  &quot;80226&quot; &quot;6018&quot;  &quot;9196&quot;  &quot;5369&quot;  &quot;4541&quot;  &quot;37775&quot; &quot;V1859&quot; &quot;1529&quot; 
## [4096] &quot;81509&quot; &quot;81600&quot; &quot;E9600&quot; &quot;80228&quot; &quot;7061&quot;  &quot;37240&quot; &quot;81321&quot; &quot;V2652&quot; &quot;78940&quot;
## [4105] &quot;2690&quot;  &quot;1808&quot;  &quot;83301&quot; &quot;81333&quot; &quot;80229&quot; &quot;267&quot;   &quot;6210&quot;  &quot;72403&quot; &quot;37990&quot;
## [4114] &quot;72871&quot; &quot;81351&quot; &quot;3709&quot;  &quot;4374&quot;  &quot;85405&quot; &quot;2793&quot;  &quot;01186&quot; &quot;92320&quot; &quot;9142&quot; 
## [4123] &quot;80426&quot; &quot;22801&quot; &quot;9858&quot;  &quot;2281&quot;  &quot;46411&quot; &quot;30011&quot; &quot;76527&quot; &quot;76526&quot; &quot;75329&quot;
## [4132] &quot;77082&quot; &quot;77981&quot; &quot;8870&quot;  &quot;81510&quot; &quot;9552&quot;  &quot;9553&quot;  &quot;71844&quot; &quot;77089&quot; &quot;80131&quot;
## [4141] &quot;76528&quot; &quot;8075&quot;  &quot;1958&quot;  &quot;37311&quot; &quot;9991&quot;  &quot;37733&quot; &quot;9893&quot;  &quot;E9506&quot; &quot;8873&quot; 
## [4150] &quot;75619&quot; &quot;74687&quot; &quot;E8600&quot; &quot;74602&quot; &quot;77081&quot; &quot;76525&quot; &quot;V3201&quot; &quot;77989&quot; &quot;E9178&quot;
## [4159] &quot;85185&quot; &quot;40200&quot; &quot;7689&quot;  &quot;74569&quot; &quot;80504&quot; &quot;V1250&quot; &quot;E9229&quot; &quot;80435&quot; &quot;48281&quot;
## [4168] &quot;E9357&quot; &quot;5206&quot;  &quot;71965&quot; &quot;V596&quot;  &quot;7452&quot;  &quot;7786&quot;  &quot;7701&quot;  &quot;260&quot;   &quot;3370&quot; 
## [4177] &quot;1737&quot;  &quot;8620&quot;  &quot;80625&quot; &quot;E8353&quot; &quot;8089&quot;  &quot;9249&quot;  &quot;E8250&quot; &quot;9596&quot;  &quot;V4578&quot;
## [4186] &quot;62211&quot; &quot;79500&quot; &quot;40492&quot; &quot;36019&quot; &quot;37632&quot; &quot;37005&quot; &quot;36400&quot; &quot;82521&quot; &quot;3555&quot; 
## [4195] &quot;7630&quot;  &quot;85240&quot; &quot;7767&quot;  &quot;73340&quot; &quot;44581&quot; &quot;4421&quot;  &quot;27951&quot; &quot;2889&quot;  &quot;76504&quot;
## [4204] &quot;64683&quot; &quot;7757&quot;  &quot;7634&quot;  &quot;9219&quot;  &quot;34120&quot; &quot;V111&quot;  &quot;V293&quot;  &quot;9881&quot;  &quot;E8655&quot;
## [4213] &quot;72272&quot; &quot;42760&quot; &quot;85173&quot; &quot;8027&quot;  &quot;8711&quot;  &quot;34981&quot; &quot;37739&quot; &quot;52109&quot; &quot;05471&quot;
## [4222] &quot;76513&quot; &quot;76493&quot; &quot;5561&quot;  &quot;56202&quot; &quot;1478&quot;  &quot;77083&quot; &quot;56201&quot; &quot;76408&quot; &quot;5981&quot; 
## [4231] &quot;9082&quot;  &quot;7612&quot;  &quot;7717&quot;  &quot;25091&quot; &quot;74912&quot; &quot;V289&quot;  &quot;80842&quot; &quot;7504&quot;  &quot;9839&quot; 
## [4240] &quot;E9507&quot; &quot;9010&quot;  &quot;82312&quot; &quot;7515&quot;  &quot;7463&quot;  &quot;75555&quot; &quot;64761&quot; &quot;64931&quot; &quot;1409&quot; 
## [4249] &quot;1730&quot;  &quot;94522&quot; &quot;E9249&quot; &quot;5560&quot;  &quot;92820&quot; &quot;E8002&quot; &quot;81243&quot; &quot;86330&quot; &quot;86350&quot;
## [4258] &quot;80172&quot; &quot;80162&quot; &quot;82535&quot; &quot;8029&quot;  &quot;9509&quot;  &quot;77181&quot; &quot;E9360&quot; &quot;7716&quot;  &quot;74601&quot;
## [4267] &quot;76524&quot; &quot;82100&quot; &quot;7686&quot;  &quot;7631&quot;  &quot;87351&quot; &quot;87353&quot; &quot;V3200&quot; &quot;0846&quot;  &quot;37800&quot;
## [4276] &quot;75981&quot; &quot;7421&quot;  &quot;8488&quot;  &quot;7755&quot;  &quot;77211&quot; &quot;64121&quot; &quot;66932&quot; &quot;64292&quot; &quot;65441&quot;
## [4285] &quot;64682&quot; &quot;85196&quot; &quot;7683&quot;  &quot;0912&quot;  &quot;01325&quot; &quot;77214&quot; &quot;75567&quot; &quot;76402&quot; &quot;76512&quot;
## [4294] &quot;80238&quot; &quot;80222&quot; &quot;V292&quot;  &quot;7758&quot;  &quot;7622&quot;  &quot;76492&quot; &quot;87412&quot; &quot;6258&quot;  &quot;63380&quot;
## [4303] &quot;7523&quot;  &quot;E8152&quot; &quot;7774&quot;  &quot;5756&quot;  &quot;4959&quot;  &quot;7473&quot;  &quot;74860&quot; &quot;76503&quot; &quot;76522&quot;
## [4312] &quot;99772&quot; &quot;4473&quot;  &quot;86113&quot; &quot;E9585&quot; &quot;63311&quot; &quot;76381&quot; &quot;76407&quot; &quot;7422&quot;  &quot;7728&quot; 
## [4321] &quot;37555&quot; &quot;71913&quot; &quot;71917&quot; &quot;7676&quot;  &quot;80021&quot; &quot;29644&quot; &quot;1922&quot;  &quot;V5849&quot; &quot;6984&quot; 
## [4330] &quot;75430&quot; &quot;7660&quot;  &quot;42290&quot; &quot;36275&quot; &quot;3335&quot;  &quot;1713&quot;  &quot;30530&quot; &quot;1464&quot;  &quot;86400&quot;
## [4339] &quot;8241&quot;  &quot;90289&quot; &quot;75263&quot; &quot;37431&quot; &quot;7511&quot;  &quot;71226&quot; &quot;20270&quot; &quot;74609&quot; &quot;7662&quot; 
## [4348] &quot;76382&quot; &quot;29631&quot; &quot;97081&quot; &quot;30592&quot; &quot;V741&quot;  &quot;90140&quot; &quot;95911&quot; &quot;7621&quot;  &quot;7754&quot; 
## [4357] &quot;9684&quot;  &quot;9685&quot;  &quot;13102&quot; &quot;E8528&quot; &quot;87364&quot; &quot;71537&quot; &quot;8471&quot;  &quot;11285&quot; &quot;80441&quot;
## [4366] &quot;80141&quot; &quot;80030&quot; &quot;81102&quot; &quot;3523&quot;  &quot;3522&quot;  &quot;24950&quot; &quot;01894&quot; &quot;0049&quot;  &quot;85141&quot;
## [4375] &quot;78064&quot; &quot;99564&quot; &quot;8922&quot;  &quot;86340&quot; &quot;9161&quot;  &quot;76075&quot; &quot;V301&quot;  &quot;01402&quot; &quot;82322&quot;
## [4384] &quot;1569&quot;  &quot;75501&quot; &quot;7539&quot;  &quot;30749&quot; &quot;8083&quot;  &quot;8782&quot;  &quot;1641&quot;  &quot;2897&quot;  &quot;V1589&quot;
## [4393] &quot;80106&quot; &quot;1603&quot;  &quot;73600&quot; &quot;8822&quot;  &quot;E9222&quot; &quot;6948&quot;  &quot;81002&quot; &quot;8621&quot;  &quot;30016&quot;
## [4402] &quot;8504&quot;  &quot;38015&quot; &quot;9162&quot;  &quot;38900&quot; &quot;47400&quot; &quot;2776&quot;  &quot;77982&quot; &quot;75321&quot; &quot;73381&quot;
## [4411] &quot;71903&quot; &quot;86600&quot; &quot;E8227&quot; &quot;86122&quot; &quot;87349&quot; &quot;3236&quot;  &quot;E8132&quot; &quot;E8841&quot; &quot;7771&quot; 
## [4420] &quot;9585&quot;  &quot;7792&quot;  &quot;76498&quot; &quot;6071&quot;  &quot;6259&quot;  &quot;7678&quot;  &quot;V298&quot;  &quot;3100&quot;  &quot;V4284&quot;
## [4429] &quot;1880&quot;  &quot;V058&quot;  &quot;81231&quot; &quot;4377&quot;  &quot;1309&quot;  &quot;82003&quot; &quot;7608&quot;  &quot;7788&quot;  &quot;E9338&quot;
## [4438] &quot;83104&quot; &quot;7700&quot;  &quot;74510&quot; &quot;95203&quot; &quot;80476&quot; &quot;V222&quot;  &quot;90003&quot; &quot;4475&quot;  &quot;80616&quot;
## [4447] &quot;74259&quot; &quot;75613&quot; &quot;7563&quot;  &quot;75470&quot; &quot;75489&quot; &quot;37940&quot; &quot;E8793&quot; &quot;47834&quot; &quot;E9175&quot;
## [4456] &quot;5994&quot;  &quot;78031&quot; &quot;E8282&quot; &quot;80301&quot; &quot;V1049&quot; &quot;80020&quot; &quot;52101&quot; &quot;3360&quot;  &quot;7780&quot; 
## [4465] &quot;9561&quot;  &quot;9530&quot;  &quot;243&quot;   &quot;37923&quot; &quot;36372&quot; &quot;7828&quot;  &quot;2599&quot;  &quot;2519&quot;  &quot;7670&quot; 
## [4474] &quot;V625&quot;  &quot;79400&quot; &quot;7615&quot;  &quot;80500&quot; &quot;3094&quot;  &quot;20780&quot; &quot;36203&quot; &quot;20502&quot; &quot;8851&quot; 
## [4483] &quot;3552&quot;  &quot;80601&quot; &quot;E9441&quot; &quot;8678&quot;  &quot;8676&quot;  &quot;76505&quot; &quot;7721&quot;  &quot;7611&quot;  &quot;7600&quot; 
## [4492] &quot;V448&quot;  &quot;03285&quot; &quot;32341&quot; &quot;36841&quot; &quot;E8133&quot; &quot;226&quot;   &quot;33382&quot; &quot;80223&quot; &quot;78834&quot;
## [4501] &quot;64244&quot; &quot;67434&quot; &quot;6159&quot;  &quot;E8126&quot; &quot;81382&quot; &quot;80076&quot; &quot;81251&quot; &quot;74742&quot; &quot;82110&quot;
## [4510] &quot;73609&quot; &quot;2121&quot;  &quot;2123&quot;  &quot;2515&quot;  &quot;9941&quot;  &quot;67403&quot; &quot;20208&quot; &quot;7535&quot;  &quot;7712&quot; 
## [4519] &quot;9592&quot;  &quot;75315&quot; &quot;74900&quot; &quot;75511&quot; &quot;75513&quot; &quot;7672&quot;  &quot;74489&quot; &quot;6944&quot;  &quot;7282&quot; 
## [4528] &quot;6952&quot;  &quot;80071&quot; &quot;81322&quot; &quot;7358&quot;  &quot;51853&quot; &quot;86232&quot; &quot;9086&quot;  &quot;3541&quot;  &quot;5187&quot; 
## [4537] &quot;80015&quot; &quot;04182&quot; &quot;9642&quot;  &quot;E8582&quot; &quot;0844&quot;  &quot;86222&quot; &quot;1724&quot;  &quot;78931&quot; &quot;86513&quot;
## [4546] &quot;7566&quot;  &quot;86412&quot; &quot;6142&quot;  &quot;03641&quot; &quot;7741&quot;  &quot;7764&quot;  &quot;7730&quot;  &quot;78939&quot; &quot;4784&quot; 
## [4555] &quot;73722&quot; &quot;7467&quot;  &quot;80115&quot; &quot;85142&quot; &quot;80422&quot; &quot;9149&quot;  &quot;80174&quot; &quot;80221&quot; &quot;85314&quot;
## [4564] &quot;80164&quot; &quot;9500&quot;  &quot;96971&quot; &quot;9733&quot;  &quot;E8503&quot; &quot;E8584&quot; &quot;71432&quot; &quot;E8624&quot; &quot;8749&quot; 
## [4573] &quot;9038&quot;  &quot;7920&quot;  &quot;1414&quot;  &quot;83902&quot; &quot;7778&quot;  &quot;9056&quot;  &quot;4958&quot;  &quot;2552&quot;  &quot;9664&quot; 
## [4582] &quot;44282&quot; &quot;72782&quot; &quot;E8241&quot; &quot;66634&quot; &quot;64864&quot; &quot;92231&quot; &quot;59373&quot; &quot;88102&quot; &quot;5199&quot; 
## [4591] &quot;61689&quot; &quot;43850&quot; &quot;75732&quot; &quot;75432&quot; &quot;80360&quot; &quot;2840&quot;  &quot;67204&quot; &quot;08240&quot; &quot;83809&quot;
## [4600] &quot;80102&quot; &quot;V0381&quot; &quot;V063&quot;  &quot;E8156&quot; &quot;80421&quot; &quot;81318&quot; &quot;90141&quot; &quot;37710&quot; &quot;38912&quot;
## [4609] &quot;37716&quot; &quot;32725&quot; &quot;7585&quot;  &quot;2727&quot;  &quot;94332&quot; &quot;94234&quot; &quot;45350&quot; &quot;64814&quot; &quot;V660&quot; 
## [4618] &quot;83920&quot; &quot;E8853&quot; &quot;7627&quot;  &quot;7930&quot;  &quot;E8131&quot; &quot;E8251&quot; &quot;E8211&quot; &quot;56401&quot; &quot;E9588&quot;
## [4627] &quot;74684&quot; &quot;71926&quot; &quot;7709&quot;  &quot;37203&quot; &quot;29043&quot; &quot;71230&quot; &quot;95891&quot; &quot;52310&quot; &quot;7809&quot; 
## [4636] &quot;20511&quot; &quot;41000&quot; &quot;E8216&quot; &quot;87365&quot; &quot;75502&quot; &quot;7450&quot;  &quot;3649&quot;  &quot;00863&quot; &quot;29574&quot;
## [4645] &quot;7610&quot;  &quot;3588&quot;  &quot;6248&quot;  &quot;63491&quot; &quot;85239&quot; &quot;9009&quot;  &quot;85219&quot; &quot;30480&quot; &quot;85125&quot;
## [4654] &quot;E9580&quot; &quot;E8196&quot; &quot;2940&quot;  &quot;7932&quot;  &quot;E848&quot;  &quot;8731&quot;  &quot;1800&quot;  &quot;7569&quot;  &quot;3951&quot; 
## [4663] &quot;73024&quot; &quot;6185&quot;  &quot;37611&quot; &quot;37612&quot; &quot;80061&quot; &quot;80151&quot; &quot;30493&quot; &quot;7030&quot;  &quot;64813&quot;
## [4672] &quot;55841&quot; &quot;4512&quot;  &quot;V5399&quot; &quot;7901&quot;  &quot;8631&quot;  &quot;E9650&quot; &quot;E9018&quot; &quot;9913&quot;  &quot;1100&quot; 
## [4681] &quot;6979&quot;  &quot;76494&quot; &quot;7520&quot;  &quot;92619&quot; &quot;80853&quot; &quot;7512&quot;  &quot;V040&quot;  &quot;V061&quot;  &quot;V066&quot; 
## [4690] &quot;75453&quot; &quot;72930&quot; &quot;2442&quot;  &quot;2799&quot;  &quot;74783&quot; &quot;34710&quot; &quot;29622&quot; &quot;7841&quot;  &quot;76510&quot;
## [4699] &quot;3393&quot;  &quot;29042&quot; &quot;E9991&quot; &quot;77183&quot; &quot;2358&quot;  &quot;11281&quot; &quot;5820&quot;  &quot;5830&quot;  &quot;9695&quot; 
## [4708] &quot;4789&quot;  &quot;9080&quot;  &quot;07041&quot; &quot;34282&quot; &quot;71940&quot; &quot;90089&quot; &quot;7570&quot;  &quot;90226&quot; &quot;86814&quot;
## [4717] &quot;86399&quot; &quot;86819&quot; &quot;6188&quot;  &quot;80224&quot; &quot;73729&quot; &quot;7385&quot;  &quot;3590&quot;  &quot;74362&quot; &quot;7132&quot; 
## [4726] &quot;85241&quot; &quot;37482&quot; &quot;7509&quot;  &quot;5583&quot;  &quot;E9225&quot; &quot;37689&quot; &quot;71155&quot; &quot;95214&quot; &quot;8920&quot; 
## [4735] &quot;V291&quot;  &quot;V195&quot;  &quot;75559&quot; &quot;52510&quot; &quot;78341&quot; &quot;80001&quot; &quot;35789&quot; &quot;7449&quot;  &quot;20530&quot;
## [4744] &quot;76523&quot; &quot;1883&quot;  &quot;53230&quot; &quot;2693&quot;  &quot;9510&quot;  &quot;6962&quot;  &quot;7784&quot;  &quot;6269&quot;  &quot;2380&quot; 
## [4753] &quot;76529&quot; &quot;1348&quot;  &quot;E8718&quot; &quot;96905&quot; &quot;67012&quot; &quot;64811&quot; &quot;66401&quot; &quot;V0251&quot; &quot;20050&quot;
## [4762] &quot;99653&quot; &quot;V0482&quot; &quot;8677&quot;  &quot;83979&quot; &quot;8780&quot;  &quot;9260&quot;  &quot;3349&quot;  &quot;5929&quot;  &quot;8360&quot; 
## [4771] &quot;8361&quot;  &quot;1528&quot;  &quot;V192&quot;  &quot;5800&quot;  &quot;36101&quot; &quot;73302&quot; &quot;37556&quot; &quot;74561&quot; &quot;74722&quot;
## [4780] &quot;30402&quot; &quot;7625&quot;  &quot;3430&quot;  &quot;24990&quot; &quot;81512&quot; &quot;7936&quot;  &quot;3732&quot;  &quot;64894&quot; &quot;70909&quot;
## [4789] &quot;90229&quot; &quot;8409&quot;  &quot;V698&quot;  &quot;20278&quot; &quot;V8381&quot; &quot;73022&quot; &quot;73023&quot; &quot;99580&quot; &quot;E9673&quot;
## [4798] &quot;8790&quot;  &quot;90222&quot; &quot;7636&quot;  &quot;2353&quot;  &quot;80626&quot; &quot;80420&quot; &quot;80430&quot; &quot;80410&quot; &quot;9539&quot; 
## [4807] &quot;81411&quot; &quot;83313&quot; &quot;83303&quot; &quot;9551&quot;  &quot;E0162&quot; &quot;E0000&quot; &quot;E8212&quot; &quot;59655&quot; &quot;81332&quot;
## [4816] &quot;83302&quot; &quot;81393&quot; &quot;80470&quot; &quot;85109&quot; &quot;7480&quot;  &quot;83300&quot; &quot;81313&quot; &quot;8795&quot;  &quot;87330&quot;
## [4825] &quot;76621&quot; &quot;11283&quot; &quot;46410&quot; &quot;37635&quot; &quot;81408&quot; &quot;20891&quot; &quot;31381&quot; &quot;36107&quot; &quot;75616&quot;
## [4834] &quot;1460&quot;  &quot;80316&quot; &quot;88002&quot; &quot;8794&quot;  &quot;86809&quot; &quot;81612&quot; &quot;88020&quot; &quot;74349&quot; &quot;2598&quot; 
## [4843] &quot;3595&quot;  &quot;71489&quot; &quot;80135&quot; &quot;99830&quot; &quot;0392&quot;  &quot;6151&quot;  &quot;80132&quot; &quot;E8260&quot; &quot;74741&quot;
## [4852] &quot;1300&quot;  &quot;87360&quot; &quot;29421&quot; &quot;77084&quot; &quot;74365&quot; &quot;11590&quot; &quot;9067&quot;  &quot;59371&quot; &quot;78096&quot;
## [4861] &quot;4559&quot;  &quot;59581&quot; &quot;1832&quot;  &quot;1608&quot;  &quot;9094&quot;  &quot;9949&quot;  &quot;2164&quot;  &quot;13101&quot; &quot;V1651&quot;
## [4870] &quot;71697&quot; &quot;700&quot;   &quot;25801&quot; &quot;V1811&quot; &quot;7262&quot;  &quot;3080&quot;  &quot;61802&quot; &quot;37452&quot; &quot;7586&quot; 
## [4879] &quot;V9081&quot; &quot;56944&quot; &quot;7583&quot;  &quot;52400&quot; &quot;74782&quot; &quot;71238&quot; &quot;86414&quot; &quot;7768&quot;  &quot;V1060&quot;
## [4888] &quot;5513&quot;  &quot;29383&quot; &quot;87322&quot; &quot;0491&quot;  &quot;05881&quot; &quot;7222&quot;  &quot;34700&quot; &quot;80425&quot; &quot;52469&quot;
## [4897] &quot;81307&quot; &quot;99802&quot; &quot;1848&quot;  &quot;74600&quot; &quot;75269&quot; &quot;85400&quot; &quot;E9220&quot; &quot;2540&quot;  &quot;2548&quot; 
## [4906] &quot;1320&quot;  &quot;1329&quot;  &quot;99741&quot; &quot;00861&quot; &quot;2652&quot;  &quot;37992&quot; &quot;8440&quot;  &quot;29012&quot; &quot;79415&quot;
## [4915] &quot;74343&quot; &quot;74902&quot; &quot;82342&quot; &quot;0048&quot;  &quot;76072&quot; &quot;0311&quot;  &quot;7599&quot;  &quot;75526&quot; &quot;80182&quot;
## [4924] &quot;1573&quot;  &quot;8509&quot;  &quot;86413&quot; &quot;74429&quot; &quot;7481&quot;  &quot;74363&quot; &quot;76404&quot; &quot;5309&quot;  &quot;85203&quot;
## [4933] &quot;36289&quot; &quot;7628&quot;  &quot;75560&quot; &quot;0860&quot;  &quot;38201&quot; &quot;7388&quot;  &quot;V5401&quot; &quot;8901&quot;  &quot;8797&quot; 
## [4942] &quot;7350&quot;  &quot;7271&quot;  &quot;8671&quot;  &quot;9618&quot;  &quot;9614&quot;  &quot;24291&quot; &quot;36040&quot; &quot;78837&quot; &quot;3321&quot; 
## [4951] &quot;0051&quot;  &quot;E0073&quot; &quot;79402&quot; &quot;75617&quot; &quot;7705&quot;  &quot;1448&quot;  &quot;86409&quot; &quot;80849&quot; &quot;V024&quot; 
## [4960] &quot;1712&quot;  &quot;74560&quot; &quot;E8548&quot; &quot;53201&quot; &quot;66942&quot; &quot;67482&quot; &quot;64842&quot; &quot;2779&quot;  &quot;36362&quot;
## [4969] &quot;71888&quot; &quot;72999&quot; &quot;71843&quot; &quot;7279&quot;  &quot;E9433&quot; &quot;9579&quot;  &quot;1714&quot;  &quot;20600&quot; &quot;79399&quot;
## [4978] &quot;6179&quot;  &quot;6270&quot;  &quot;20028&quot; &quot;V311&quot;  &quot;86342&quot; &quot;59984&quot; &quot;7888&quot;  &quot;76521&quot; &quot;29699&quot;
## [4987] &quot;63451&quot; &quot;67451&quot; &quot;29632&quot; &quot;82133&quot; &quot;V6443&quot; &quot;83905&quot; &quot;80012&quot; &quot;9518&quot;  &quot;92800&quot;
## [4996] &quot;92612&quot; &quot;95215&quot; &quot;23691&quot; &quot;73029&quot; &quot;3869&quot;  &quot;64254&quot; &quot;75739&quot; &quot;30573&quot; &quot;460&quot;  
## [5005] &quot;90210&quot; &quot;82139&quot; &quot;53084&quot; &quot;5643&quot;  &quot;E8740&quot; &quot;85309&quot; &quot;78601&quot; &quot;95209&quot; &quot;86320&quot;
## [5014] &quot;1410&quot;  &quot;64511&quot; &quot;00862&quot; &quot;75521&quot; &quot;76491&quot; &quot;85105&quot; &quot;9392&quot;  &quot;7635&quot;  &quot;9712&quot; 
## [5023] &quot;E8555&quot; &quot;1467&quot;  &quot;87402&quot; &quot;E9538&quot; &quot;77182&quot; &quot;92321&quot; &quot;85310&quot; &quot;20152&quot; &quot;37034&quot;
## [5032] &quot;9895&quot;  &quot;E9053&quot; &quot;V1502&quot; &quot;92303&quot; &quot;87352&quot; &quot;23771&quot; &quot;V0489&quot; &quot;85103&quot; &quot;8972&quot; 
## [5041] &quot;85231&quot; &quot;7325&quot;  &quot;74359&quot; &quot;80031&quot; &quot;0470&quot;  &quot;7969&quot;  &quot;51636&quot; &quot;E9283&quot; &quot;37871&quot;
## [5050] &quot;77189&quot; &quot;37501&quot; &quot;37000&quot; &quot;37489&quot; &quot;88019&quot; &quot;2872&quot;  &quot;92810&quot; &quot;9995&quot;  &quot;9735&quot; 
## [5059] &quot;6009&quot;  &quot;1431&quot;  &quot;7744&quot;  &quot;83103&quot; &quot;76403&quot; &quot;65451&quot; &quot;75529&quot; &quot;2510&quot;  &quot;E9345&quot;
## [5068] &quot;7704&quot;  &quot;7273&quot;  &quot;71911&quot; &quot;7613&quot;  &quot;48231&quot; &quot;72883&quot; &quot;86349&quot; &quot;E9654&quot; &quot;20917&quot;
## [5077] &quot;20972&quot; &quot;3885&quot;  &quot;76499&quot; &quot;9605&quot;  &quot;5088&quot;  &quot;2881&quot;  &quot;V1365&quot; &quot;7466&quot;  &quot;85146&quot;
## [5086] &quot;75531&quot; &quot;74910&quot; &quot;85404&quot; &quot;9578&quot;  &quot;5071&quot;  &quot;77430&quot; &quot;36189&quot; &quot;1905&quot;  &quot;47412&quot;
## [5095] &quot;75323&quot; &quot;E9386&quot; &quot;85229&quot; &quot;53141&quot; &quot;81613&quot; &quot;81519&quot; &quot;E9238&quot; &quot;31239&quot; &quot;2589&quot; 
## [5104] &quot;5769&quot;  &quot;86100&quot; &quot;30303&quot; &quot;41022&quot; &quot;85212&quot; &quot;E9550&quot; &quot;E9589&quot; &quot;V062&quot;  &quot;75614&quot;
## [5113] &quot;80165&quot; &quot;8704&quot;  &quot;E8854&quot; &quot;V861&quot;  &quot;0980&quot;  &quot;75479&quot; &quot;85144&quot; &quot;72781&quot; &quot;82380&quot;
## [5122] &quot;E8589&quot; &quot;E9001&quot; &quot;28652&quot; &quot;58189&quot; &quot;E9190&quot; &quot;2367&quot;  &quot;2729&quot;  &quot;62570&quot; &quot;74423&quot;
## [5131] &quot;7540&quot;  &quot;64241&quot; &quot;66622&quot; &quot;65101&quot; &quot;07810&quot; &quot;82390&quot; &quot;V1369&quot; &quot;1916&quot;  &quot;80032&quot;
## [5140] &quot;75881&quot; &quot;35922&quot; &quot;2362&quot;  &quot;V1506&quot; &quot;9559&quot;  &quot;9039&quot;  &quot;0880&quot;  &quot;72671&quot; &quot;72619&quot;
## [5149] &quot;6082&quot;  &quot;E9108&quot; &quot;7541&quot;  &quot;E9204&quot; &quot;9033&quot;  &quot;8629&quot;  &quot;6172&quot;  &quot;90220&quot; &quot;80473&quot;
## [5158] &quot;9043&quot;  &quot;9048&quot;  &quot;74740&quot; &quot;29600&quot; &quot;80416&quot; &quot;V135&quot;  &quot;90082&quot; &quot;0919&quot;  &quot;7720&quot; 
## [5167] &quot;85406&quot; &quot;7626&quot;  &quot;30460&quot; &quot;9013&quot;  &quot;9012&quot;  &quot;E9294&quot; &quot;75016&quot; &quot;75522&quot; &quot;75265&quot;
## [5176] &quot;1500&quot;  &quot;47822&quot; &quot;5269&quot;  &quot;81352&quot; &quot;1844&quot;  &quot;6198&quot;  &quot;2122&quot;  &quot;76719&quot; &quot;V202&quot; 
## [5185] &quot;77012&quot; &quot;3789&quot;  &quot;99688&quot; &quot;9582&quot;  &quot;73312&quot; &quot;37842&quot; &quot;42292&quot; &quot;9600&quot;  &quot;96909&quot;
## [5194] &quot;94128&quot; &quot;88023&quot; &quot;9278&quot;  &quot;83200&quot; &quot;4554&quot;  &quot;85175&quot; &quot;V708&quot;  &quot;7441&quot;  &quot;30181&quot;
## [5203] &quot;0360&quot;  &quot;76384&quot; &quot;7687&quot;  &quot;9523&quot;  &quot;E8200&quot; &quot;28733&quot; &quot;7582&quot;  &quot;2300&quot;  &quot;53640&quot;
## [5212] &quot;V172&quot;  &quot;31234&quot; &quot;74922&quot; &quot;38039&quot; &quot;E8830&quot; &quot;77589&quot; &quot;V181&quot;  &quot;71847&quot; &quot;7753&quot; 
## [5221] &quot;V5844&quot; &quot;9001&quot;  &quot;E8163&quot; &quot;3013&quot;  &quot;71222&quot; &quot;74732&quot; &quot;87373&quot; &quot;2581&quot;  &quot;E9192&quot;
## [5230] &quot;71954&quot; &quot;9059&quot;  &quot;42293&quot; &quot;118&quot;   &quot;73672&quot; &quot;2308&quot;  &quot;29654&quot; &quot;76070&quot; &quot;85189&quot;
## [5239] &quot;79509&quot; &quot;0794&quot;  &quot;V6111&quot; &quot;75671&quot; &quot;7538&quot;  &quot;7571&quot;  &quot;7014&quot;  &quot;85403&quot; &quot;72813&quot;
## [5248] &quot;72971&quot; &quot;20285&quot; &quot;3573&quot;  &quot;37942&quot; &quot;80631&quot; &quot;86343&quot; &quot;E9109&quot; &quot;8243&quot;  &quot;82523&quot;
## [5257] &quot;8798&quot;  &quot;34430&quot; &quot;2329&quot;  &quot;V4614&quot; &quot;E8609&quot; &quot;7762&quot;  &quot;77018&quot; &quot;V068&quot;  &quot;74683&quot;
## [5266] &quot;1869&quot;  &quot;E8717&quot; &quot;77016&quot; &quot;29540&quot; &quot;53251&quot; &quot;86419&quot; &quot;86331&quot; &quot;86812&quot; &quot;77581&quot;
## [5275] &quot;9095&quot;  &quot;82381&quot; &quot;29284&quot; &quot;29211&quot; &quot;55121&quot; &quot;27802&quot; &quot;01136&quot; &quot;82522&quot; &quot;0059&quot; 
## [5284] &quot;64841&quot; &quot;4848&quot;  &quot;3083&quot;  &quot;28801&quot; &quot;6183&quot;  &quot;E8123&quot; &quot;81001&quot; &quot;1723&quot;  &quot;86612&quot;
## [5293] &quot;81242&quot; &quot;84209&quot; &quot;87361&quot; &quot;87350&quot; &quot;86603&quot; &quot;76401&quot; &quot;9557&quot;  &quot;8630&quot;  &quot;95893&quot;
## [5302] &quot;37633&quot; &quot;37921&quot; &quot;86130&quot; &quot;V1059&quot; &quot;77087&quot; &quot;52406&quot; &quot;75569&quot; &quot;3492&quot;  &quot;8261&quot; 
## [5311] &quot;8973&quot;  &quot;81244&quot; &quot;80239&quot; &quot;29604&quot; &quot;V155&quot;  &quot;77088&quot; &quot;V188&quot;  &quot;V1851&quot; &quot;83900&quot;
## [5320] &quot;V608&quot;  &quot;V638&quot;  &quot;1452&quot;  &quot;37603&quot; &quot;8872&quot;  &quot;66524&quot; &quot;80603&quot; &quot;80024&quot; &quot;51900&quot;
## [5329] &quot;80623&quot; &quot;80608&quot; &quot;9330&quot;  &quot;83903&quot; &quot;83904&quot; &quot;8799&quot;  &quot;6218&quot;  &quot;79510&quot; &quot;2458&quot; 
## [5338] &quot;V51&quot;   &quot;7488&quot;  &quot;V1086&quot; &quot;2169&quot;  &quot;99640&quot; &quot;1893&quot;  &quot;80607&quot; &quot;80475&quot; &quot;80485&quot;
## [5347] &quot;E9177&quot; &quot;82001&quot; &quot;52330&quot; &quot;7759&quot;  &quot;74869&quot; &quot;6200&quot;  &quot;1106&quot;  &quot;8362&quot;  &quot;74441&quot;
## [5356] &quot;75019&quot; &quot;8713&quot;  &quot;E8228&quot; &quot;36812&quot; &quot;90453&quot; &quot;8702&quot;  &quot;87354&quot; &quot;87371&quot; &quot;30120&quot;
## [5365] &quot;6923&quot;  &quot;63401&quot; &quot;V7219&quot; &quot;V0252&quot; &quot;57480&quot; &quot;2530&quot;  &quot;90234&quot; &quot;90233&quot; &quot;E9205&quot;
## [5374] &quot;4292&quot;  &quot;66934&quot; &quot;81010&quot; &quot;E954&quot;  &quot;E8252&quot; &quot;1768&quot;  &quot;8960&quot;  &quot;78051&quot; &quot;20310&quot;
## [5383] &quot;3434&quot;  &quot;E8860&quot; &quot;80436&quot; &quot;9528&quot;  &quot;V078&quot;  &quot;7913&quot;  &quot;2829&quot;  &quot;64801&quot; &quot;67002&quot;
## [5392] &quot;6145&quot;  &quot;64261&quot; &quot;71693&quot; &quot;75460&quot; &quot;2354&quot;  &quot;9108&quot;  &quot;75160&quot; &quot;33522&quot; &quot;1917&quot; 
## [5401] &quot;92720&quot; &quot;92721&quot; &quot;24980&quot; &quot;20211&quot; &quot;20218&quot; &quot;3200&quot;  &quot;69581&quot; &quot;30009&quot; &quot;75539&quot;
## [5410] &quot;7789&quot;  &quot;92710&quot; &quot;81419&quot; &quot;81418&quot; &quot;9034&quot;  &quot;42742&quot; &quot;53521&quot; &quot;V1586&quot; &quot;36207&quot;
## [5419] &quot;86411&quot; &quot;8875&quot;  &quot;81219&quot; &quot;9558&quot;  &quot;E9651&quot; &quot;E8415&quot; &quot;81230&quot; &quot;81391&quot; &quot;52333&quot;
## [5428] &quot;92310&quot; &quot;E9102&quot; &quot;29524&quot; &quot;77439&quot; &quot;20590&quot; &quot;8081&quot;  &quot;30014&quot; &quot;E8348&quot; &quot;2331&quot; 
## [5437] &quot;2153&quot;  &quot;56030&quot; &quot;E8852&quot; &quot;73671&quot; &quot;4179&quot;  &quot;75839&quot; &quot;78340&quot; &quot;75510&quot; &quot;3007&quot; 
## [5446] &quot;V1819&quot; &quot;80324&quot; &quot;90002&quot; &quot;8742&quot;  &quot;8701&quot;  &quot;E8140&quot; &quot;37443&quot; &quot;2301&quot;  &quot;9090&quot; 
## [5455] &quot;E9292&quot; &quot;36233&quot; &quot;52550&quot; &quot;52512&quot; &quot;8055&quot;  &quot;86512&quot; &quot;E9889&quot; &quot;6254&quot;  &quot;96972&quot;
## [5464] &quot;75262&quot; &quot;5131&quot;  &quot;2828&quot;  &quot;E9445&quot; &quot;6805&quot;  &quot;20001&quot; &quot;E8182&quot; &quot;25639&quot; &quot;3308&quot; 
## [5473] &quot;E9380&quot; &quot;86352&quot; &quot;1468&quot;  &quot;86110&quot; &quot;90182&quot; &quot;7618&quot;  &quot;71907&quot; &quot;72690&quot; &quot;85135&quot;
## [5482] &quot;80075&quot; &quot;E0008&quot; &quot;53087&quot; &quot;53111&quot; &quot;E8171&quot; &quot;9061&quot;  &quot;1953&quot;  &quot;3571&quot;  &quot;0545&quot; 
## [5491] &quot;7475&quot;  &quot;67004&quot; &quot;49382&quot; &quot;7685&quot;  &quot;7536&quot;  &quot;E8217&quot; &quot;30122&quot; &quot;E9343&quot; &quot;75450&quot;
## [5500] &quot;V123&quot;  &quot;5847&quot;  &quot;3221&quot;  &quot;32361&quot; &quot;38619&quot; &quot;71235&quot; &quot;7335&quot;  &quot;1760&quot;  &quot;8442&quot; 
## [5509] &quot;E8146&quot; &quot;81514&quot; &quot;88013&quot; &quot;E8012&quot; &quot;38582&quot; &quot;E8769&quot; &quot;6868&quot;  &quot;7796&quot;  &quot;1513&quot; 
## [5518] &quot;9075&quot;  &quot;74861&quot; &quot;75249&quot; &quot;7529&quot;  &quot;73670&quot; &quot;76077&quot; &quot;V6149&quot; &quot;80336&quot; &quot;9599&quot; 
## [5527] &quot;99583&quot; &quot;E9677&quot; &quot;V6289&quot; &quot;80196&quot; &quot;80851&quot; &quot;81110&quot; &quot;E8238&quot; &quot;88001&quot; &quot;5719&quot; 
## [5536] &quot;01205&quot; &quot;80010&quot; &quot;80375&quot; &quot;80225&quot; &quot;74923&quot; &quot;64204&quot; &quot;6143&quot;  &quot;67414&quot; &quot;65444&quot;
## [5545] &quot;66944&quot; &quot;E9322&quot; &quot;E976&quot;  &quot;01330&quot; &quot;7592&quot;  &quot;71815&quot; &quot;24911&quot; &quot;76508&quot; &quot;75520&quot;
## [5554] &quot;20040&quot; &quot;20042&quot; &quot;5253&quot;  &quot;76711&quot; &quot;80124&quot; &quot;85184&quot; &quot;E9081&quot; &quot;83906&quot; &quot;9617&quot; 
## [5563] &quot;9619&quot;  &quot;36206&quot; &quot;07799&quot; &quot;37275&quot; &quot;9671&quot;  &quot;83650&quot; &quot;3959&quot;  &quot;82122&quot; &quot;7402&quot; 
## [5572] &quot;80171&quot; &quot;5273&quot;  &quot;52331&quot; &quot;1885&quot;  &quot;36403&quot; &quot;37214&quot; &quot;71180&quot; &quot;24281&quot; &quot;E8800&quot;
## [5581] &quot;E9193&quot; &quot;8970&quot;  &quot;86393&quot; &quot;86514&quot; &quot;80145&quot; &quot;20800&quot; &quot;3918&quot;  &quot;85145&quot; &quot;81331&quot;
## [5590] &quot;38023&quot; &quot;7602&quot;  &quot;74330&quot; &quot;9710&quot;  &quot;V4382&quot; &quot;85101&quot; &quot;73002&quot; &quot;73012&quot; &quot;81513&quot;
## [5599] &quot;V6109&quot; &quot;7791&quot;  &quot;9019&quot;  &quot;7321&quot;  &quot;V1012&quot; &quot;V6405&quot; &quot;29573&quot; &quot;81405&quot; &quot;81406&quot;
## [5608] &quot;81407&quot; &quot;V052&quot;  &quot;85215&quot; &quot;1140&quot;  &quot;20243&quot; &quot;V1741&quot; &quot;36512&quot; &quot;88112&quot; &quot;66534&quot;
## [5617] &quot;65404&quot; &quot;75500&quot; &quot;V5842&quot; &quot;2827&quot;  &quot;2360&quot;  &quot;78491&quot; &quot;45111&quot; &quot;7355&quot;  &quot;7711&quot; 
## [5626] &quot;7284&quot;  &quot;1809&quot;  &quot;V4961&quot; &quot;V604&quot;  &quot;1941&quot;  &quot;E9687&quot; &quot;1736&quot;  &quot;7773&quot;  &quot;53520&quot;
## [5635] &quot;70521&quot; &quot;9074&quot;  &quot;83942&quot; &quot;00847&quot; &quot;4748&quot;  &quot;23876&quot; &quot;52462&quot; &quot;73620&quot; &quot;83400&quot;
## [5644] &quot;69514&quot; &quot;69551&quot; &quot;7176&quot;  &quot;74442&quot; &quot;29580&quot; &quot;6118&quot;  &quot;2333&quot;  &quot;96569&quot; &quot;72664&quot;
## [5653] &quot;1400&quot;  &quot;71905&quot; &quot;E9408&quot; &quot;2298&quot;  &quot;20890&quot; &quot;9041&quot;  &quot;90081&quot; &quot;90251&quot; &quot;53989&quot;
## [5662] &quot;30022&quot; &quot;27911&quot; &quot;80142&quot; &quot;82310&quot; &quot;30583&quot; &quot;41020&quot; &quot;3526&quot;  &quot;9513&quot;  &quot;80009&quot;
## [5671] &quot;75557&quot; &quot;3556&quot;  &quot;36510&quot; &quot;179&quot;   &quot;7088&quot;  &quot;74512&quot; &quot;30723&quot; &quot;0700&quot;  &quot;9996&quot; 
## [5680] &quot;67154&quot; &quot;92311&quot; &quot;34882&quot; &quot;90287&quot; &quot;E8141&quot; &quot;80660&quot; &quot;1488&quot;  &quot;24210&quot; &quot;V6285&quot;
## [5689] &quot;V6142&quot; &quot;4350&quot;  &quot;8441&quot;  &quot;74103&quot; &quot;7380&quot;  &quot;64234&quot; &quot;E8180&quot; &quot;E8193&quot; &quot;1149&quot; 
## [5698] &quot;8247&quot;  &quot;30422&quot; &quot;7500&quot;  &quot;75026&quot; &quot;80006&quot; &quot;81381&quot; &quot;85131&quot; &quot;80109&quot; &quot;V449&quot; 
## [5707] &quot;7929&quot;  &quot;73088&quot; &quot;01504&quot; &quot;80114&quot; &quot;3612&quot;  &quot;37274&quot; &quot;20722&quot; &quot;59001&quot; &quot;86351&quot;
## [5716] &quot;90242&quot; &quot;2561&quot;  &quot;74789&quot; &quot;52410&quot; &quot;V503&quot;  &quot;84503&quot; &quot;8370&quot;  &quot;9390&quot;  &quot;80180&quot;
## [5725] &quot;80080&quot; &quot;E8839&quot; &quot;7887&quot;  &quot;V5422&quot; &quot;68111&quot; &quot;83411&quot; &quot;E0020&quot; &quot;38100&quot; &quot;80711&quot;
## [5734] &quot;E9679&quot; &quot;E9601&quot; &quot;28859&quot; &quot;E0299&quot; &quot;V016&quot;  &quot;53261&quot; &quot;V8521&quot; &quot;86384&quot; &quot;E8795&quot;
## [5743] &quot;E0061&quot; &quot;36815&quot; &quot;E0069&quot; &quot;9569&quot;  &quot;79929&quot; &quot;9832&quot;  &quot;64671&quot; &quot;64252&quot; &quot;65701&quot;
## [5752] &quot;V9103&quot; &quot;71597&quot; &quot;88029&quot; &quot;88111&quot; &quot;E9060&quot; &quot;52540&quot; &quot;V5410&quot; &quot;27501&quot; &quot;9170&quot; 
## [5761] &quot;84509&quot; &quot;E0190&quot; &quot;75433&quot; &quot;6182&quot;  &quot;9604&quot;  &quot;86611&quot; &quot;8251&quot;  &quot;85106&quot; &quot;6073&quot; 
## [5770] &quot;66604&quot; &quot;74681&quot; &quot;6850&quot;  &quot;75615&quot; &quot;7286&quot;  &quot;92300&quot; &quot;E8210&quot; &quot;29575&quot; &quot;85304&quot;
## [5779] &quot;3445&quot;  &quot;99670&quot; &quot;1160&quot;  &quot;E9460&quot; &quot;85150&quot; &quot;51634&quot; &quot;V8523&quot; &quot;79539&quot; &quot;00843&quot;
## [5788] &quot;8408&quot;  &quot;2823&quot;  &quot;E9291&quot; &quot;67333&quot; &quot;64403&quot; &quot;E9011&quot; &quot;E8587&quot; &quot;9252&quot;  &quot;78072&quot;
## [5797] &quot;E0039&quot; &quot;E0076&quot; &quot;9239&quot;  &quot;53013&quot; &quot;E8381&quot; &quot;71996&quot; &quot;80372&quot; &quot;E9132&quot; &quot;9879&quot; 
## [5806] &quot;E8588&quot; &quot;85316&quot; &quot;64101&quot; &quot;75314&quot; &quot;78704&quot; &quot;2468&quot;  &quot;52563&quot; &quot;90451&quot; &quot;E8318&quot;
## [5815] &quot;7505&quot;  &quot;71831&quot; &quot;3888&quot;  &quot;7949&quot;  &quot;0993&quot;  &quot;37700&quot; &quot;6169&quot;  &quot;05821&quot; &quot;07889&quot;
## [5824] &quot;92309&quot; &quot;30759&quot; &quot;33722&quot; &quot;20929&quot; &quot;75311&quot; &quot;E8169&quot; &quot;80150&quot; &quot;80234&quot; &quot;73013&quot;
## [5833] &quot;25032&quot; &quot;99582&quot; &quot;72742&quot; &quot;6184&quot;  &quot;82032&quot; &quot;8170&quot;  &quot;8502&quot;  &quot;78869&quot; &quot;71239&quot;
## [5842] &quot;E8710&quot; &quot;38905&quot; &quot;V4981&quot; &quot;36211&quot; &quot;53130&quot; &quot;9831&quot;  &quot;67401&quot; &quot;74682&quot; &quot;9610&quot; 
## [5851] &quot;E857&quot;  &quot;71821&quot; &quot;20979&quot; &quot;86800&quot; &quot;86394&quot; &quot;95207&quot; &quot;71958&quot; &quot;60011&quot; &quot;74401&quot;
## [5860] &quot;52342&quot; &quot;80034&quot; &quot;2125&quot;  &quot;E975&quot;  &quot;80152&quot; &quot;66574&quot; &quot;36252&quot; &quot;33822&quot; &quot;1906&quot; 
## [5869] &quot;3671&quot;  &quot;80036&quot; &quot;V8525&quot; &quot;E8041&quot; &quot;80175&quot; &quot;95206&quot; &quot;8712&quot;  &quot;1429&quot;  &quot;E9270&quot;
## [5878] &quot;6940&quot;  &quot;1951&quot;  &quot;94335&quot; &quot;80000&quot; &quot;94536&quot; &quot;9462&quot;  &quot;81409&quot; &quot;6931&quot;  &quot;86613&quot;
## [5887] &quot;E8178&quot; &quot;1515&quot;  &quot;31230&quot; &quot;78033&quot; &quot;35571&quot; &quot;80610&quot; &quot;80002&quot; &quot;37189&quot; &quot;80105&quot;
## [5896] &quot;9171&quot;  &quot;74320&quot; &quot;6390&quot;  &quot;5834&quot;  &quot;2978&quot;  &quot;55000&quot; &quot;5970&quot;  &quot;5991&quot;  &quot;3348&quot; 
## [5905] &quot;64793&quot; &quot;64673&quot; &quot;36003&quot; &quot;1738&quot;  &quot;6028&quot;  &quot;6289&quot;  &quot;E9324&quot; &quot;9083&quot;  &quot;E8554&quot;
## [5914] &quot;V602&quot;  &quot;72191&quot; &quot;72251&quot; &quot;8068&quot;  &quot;E8840&quot; &quot;3831&quot;  &quot;43391&quot; &quot;87411&quot; &quot;8761&quot; 
## [5923] &quot;2110&quot;  &quot;79923&quot; &quot;V4031&quot; &quot;6080&quot;  &quot;5949&quot;  &quot;8479&quot;  &quot;2130&quot;  &quot;2120&quot;  &quot;38921&quot;
## [5932] &quot;78343&quot; &quot;6209&quot;  &quot;36100&quot; &quot;E0161&quot; &quot;E0032&quot; &quot;36251&quot; &quot;01485&quot; &quot;37882&quot; &quot;78492&quot;
## [5941] &quot;69510&quot; &quot;9535&quot;  &quot;1455&quot;  &quot;64884&quot; &quot;64914&quot; &quot;8406&quot;  &quot;30285&quot; &quot;85204&quot; &quot;85211&quot;
## [5950] &quot;2553&quot;  &quot;86120&quot; &quot;1727&quot;  &quot;72409&quot; &quot;80176&quot; &quot;34939&quot; &quot;9473&quot;  &quot;9472&quot;  &quot;E9242&quot;
## [5959] &quot;5763&quot;  &quot;3729&quot;  &quot;0849&quot;  &quot;0840&quot;  &quot;4467&quot;  &quot;0578&quot;  &quot;V6542&quot; &quot;2702&quot;  &quot;47870&quot;
## [5968] &quot;82534&quot; &quot;E030&quot;  &quot;8191&quot;  &quot;8280&quot;  &quot;81210&quot; &quot;73733&quot; &quot;73711&quot; &quot;2167&quot;  &quot;9747&quot; 
## [5977] &quot;E0080&quot; &quot;63522&quot; &quot;63512&quot; &quot;65583&quot; &quot;E9463&quot; &quot;74920&quot; &quot;36232&quot; &quot;86510&quot; &quot;0279&quot; 
## [5986] &quot;99586&quot; &quot;36002&quot; &quot;36315&quot; &quot;V9010&quot; &quot;V1559&quot; &quot;37855&quot; &quot;28246&quot; &quot;64904&quot; &quot;2650&quot; 
## [5995] &quot;1498&quot;  &quot;E9335&quot; &quot;5234&quot;  &quot;7763&quot;  &quot;83661&quot; &quot;9114&quot;  &quot;79955&quot; &quot;7825&quot;  &quot;83503&quot;
## [6004] &quot;E8189&quot; &quot;9132&quot;  &quot;9102&quot;  &quot;78862&quot; &quot;20961&quot; &quot;32737&quot; &quot;40599&quot; &quot;8076&quot;  &quot;5752&quot; 
## [6013] &quot;V2541&quot; &quot;V2501&quot; &quot;5286&quot;  &quot;75461&quot; &quot;63552&quot; &quot;63572&quot; &quot;65963&quot; &quot;34693&quot; &quot;52181&quot;
## [6022] &quot;31531&quot; &quot;64623&quot; &quot;30472&quot; &quot;71835&quot; &quot;24201&quot; &quot;5278&quot;  &quot;71108&quot; &quot;E8170&quot; &quot;78932&quot;
## [6031] &quot;20951&quot; &quot;V6129&quot; &quot;2820&quot;  &quot;5235&quot;  &quot;1469&quot;  &quot;83209&quot; &quot;81303&quot; &quot;81412&quot; &quot;73089&quot;
## [6040] &quot;3061&quot;  &quot;3562&quot;  &quot;80227&quot; &quot;00804&quot; &quot;E9328&quot; &quot;78905&quot; &quot;78443&quot; &quot;E8669&quot; &quot;V5391&quot;
## [6049] &quot;E977&quot;  &quot;34441&quot; &quot;2137&quot;  &quot;80161&quot; &quot;1273&quot;  &quot;20033&quot; &quot;33709&quot; &quot;9060&quot;  &quot;9531&quot; 
## [6058] &quot;7324&quot;  &quot;78441&quot; &quot;2150&quot;  &quot;7933&quot;  &quot;52108&quot; &quot;81249&quot; &quot;9894&quot;  &quot;9683&quot;  &quot;96979&quot;
## [6067] &quot;38922&quot; &quot;82532&quot; &quot;82524&quot; &quot;7333&quot;  &quot;90001&quot; &quot;V5301&quot; &quot;2379&quot;  &quot;1228&quot;  &quot;1516&quot; 
## [6076] &quot;9164&quot;  &quot;2842&quot;  &quot;1717&quot;  &quot;38000&quot; &quot;7581&quot;  &quot;7575&quot;  &quot;8073&quot;  &quot;7785&quot;  &quot;5529&quot; 
## [6085] &quot;61804&quot; &quot;V6103&quot; &quot;7601&quot;  &quot;75440&quot; &quot;86355&quot; &quot;8787&quot;  &quot;8785&quot;  &quot;80710&quot; &quot;65423&quot;
## [6094] &quot;3749&quot;  &quot;7443&quot;  &quot;38832&quot; &quot;37909&quot; &quot;3491&quot;  &quot;1270&quot;  &quot;83961&quot; &quot;66582&quot; &quot;1920&quot; 
## [6103] &quot;7572&quot;  &quot;6926&quot;  &quot;E8654&quot; &quot;V072&quot;  &quot;9191&quot;  &quot;9911&quot;  &quot;2144&quot;  &quot;05889&quot; &quot;1884&quot; 
## [6112] &quot;92301&quot; &quot;80082&quot; &quot;E8405&quot; &quot;9063&quot;  &quot;83652&quot; &quot;E9019&quot; &quot;7799&quot;  &quot;06641&quot; &quot;06642&quot;
## [6121] &quot;3212&quot;  &quot;8690&quot;  &quot;0902&quot;  &quot;74711&quot; &quot;E9499&quot; &quot;9224&quot;  &quot;64231&quot; &quot;94840&quot; &quot;78864&quot;
## [6130] &quot;2149&quot;  &quot;6116&quot;  &quot;38908&quot; &quot;80412&quot; &quot;V672&quot;  &quot;V671&quot;  &quot;64944&quot; &quot;4611&quot;  &quot;6149&quot; 
## [6139] &quot;5940&quot;  &quot;55129&quot; &quot;V469&quot;  &quot;7537&quot;  &quot;37702&quot; &quot;4481&quot;  &quot;72612&quot; &quot;6809&quot;  &quot;9912&quot; 
## [6148] &quot;V239&quot;  &quot;30440&quot; &quot;80622&quot; &quot;E9620&quot; &quot;1599&quot;  &quot;38903&quot; &quot;0622&quot;  &quot;V403&quot;  &quot;9052&quot; 
## [6157] &quot;9308&quot;  &quot;80332&quot; &quot;5277&quot;  &quot;64933&quot; &quot;64293&quot; &quot;55100&quot; &quot;5832&quot;  &quot;72679&quot; &quot;8961&quot; 
## [6166] &quot;E9200&quot; &quot;5219&quot;  &quot;78461&quot; &quot;24230&quot; &quot;99971&quot; &quot;3091&quot;  &quot;73810&quot; &quot;8871&quot;  &quot;V6104&quot;
## [6175] &quot;95914&quot; &quot;5822&quot;  &quot;0329&quot;  &quot;3769&quot;  &quot;82019&quot; &quot;83202&quot; &quot;81392&quot; &quot;9301&quot;  &quot;8831&quot; 
## [6184] &quot;01880&quot; &quot;01215&quot; &quot;71784&quot; &quot;8371&quot;  &quot;75566&quot; &quot;8791&quot;  &quot;82132&quot; &quot;92811&quot; &quot;9065&quot; 
## [6193] &quot;9767&quot;  &quot;E9581&quot; &quot;80085&quot; &quot;E8341&quot; &quot;86610&quot; &quot;04105&quot; &quot;86511&quot; &quot;81504&quot; &quot;81252&quot;
## [6202] &quot;75010&quot; &quot;8786&quot;  &quot;64133&quot; &quot;9725&quot;  &quot;36105&quot; &quot;58081&quot; &quot;76416&quot; &quot;E8142&quot; &quot;9593&quot; 
## [6211] &quot;5804&quot;  &quot;3010&quot;  &quot;38610&quot; &quot;71616&quot; &quot;83651&quot; &quot;1598&quot;  &quot;0239&quot;  &quot;E8613&quot; &quot;72660&quot;
## [6220] &quot;80235&quot; &quot;83305&quot; &quot;80016&quot; &quot;1174&quot;  &quot;38200&quot; &quot;9631&quot;  &quot;7779&quot;  &quot;9890&quot;  &quot;77985&quot;
## [6229] &quot;79589&quot; &quot;E8552&quot; &quot;2132&quot;  &quot;80160&quot; &quot;62402&quot; &quot;2386&quot;  &quot;E8714&quot; &quot;9233&quot;  &quot;E986&quot; 
## [6238] &quot;E9559&quot; &quot;E8127&quot; &quot;E9340&quot; &quot;5760&quot;  &quot;85190&quot; &quot;E9850&quot; &quot;47820&quot; &quot;3029&quot;  &quot;V640&quot; 
## [6247] &quot;7484&quot;  &quot;7522&quot;  &quot;75219&quot; &quot;71856&quot; &quot;90442&quot; &quot;8472&quot;  &quot;3509&quot;  &quot;64313&quot; &quot;78891&quot;
## [6256] &quot;73320&quot; &quot;04103&quot; &quot;75320&quot; &quot;7981&quot;  &quot;47811&quot; &quot;7620&quot;  &quot;E8219&quot; &quot;9851&quot;  &quot;E8663&quot;
## [6265] &quot;2588&quot;  &quot;V5843&quot; &quot;63412&quot; &quot;E8062&quot; &quot;95202&quot; &quot;80602&quot; &quot;V0971&quot; &quot;71515&quot; &quot;7138&quot; 
## [6274] &quot;94100&quot; &quot;80662&quot; &quot;05829&quot; &quot;05314&quot; &quot;61171&quot; &quot;53171&quot; &quot;43881&quot; &quot;36523&quot; &quot;5518&quot; 
## [6283] &quot;V486&quot;  &quot;E0291&quot; &quot;E9455&quot; &quot;8940&quot;  &quot;00841&quot; &quot;29381&quot; &quot;94420&quot; &quot;73393&quot; &quot;17372&quot;
## [6292] &quot;1990&quot;  &quot;05311&quot; &quot;05371&quot; &quot;E9678&quot; &quot;99581&quot; &quot;E8585&quot; &quot;74361&quot; &quot;53191&quot; &quot;E9410&quot;
## [6301] &quot;3502&quot;  &quot;E8850&quot; &quot;30543&quot; &quot;2118&quot;  &quot;36441&quot; &quot;78262&quot; &quot;0071&quot;  &quot;E9453&quot; &quot;23989&quot;
## [6310] &quot;34212&quot; &quot;2891&quot;  &quot;99562&quot; &quot;6213&quot;  &quot;36253&quot; &quot;9721&quot;  &quot;72879&quot; &quot;7915&quot;  &quot;69513&quot;
## [6319] &quot;6982&quot;  &quot;6920&quot;  &quot;69289&quot; &quot;72270&quot; &quot;1703&quot;  &quot;71990&quot; &quot;79401&quot; &quot;20003&quot; &quot;6168&quot; 
## [6328] &quot;2818&quot;  &quot;8363&quot;  &quot;95899&quot; &quot;V6282&quot; &quot;99651&quot; &quot;0793&quot;  &quot;99563&quot; &quot;V1352&quot; &quot;8364&quot; 
## [6337] &quot;30483&quot; &quot;2984&quot;  &quot;37751&quot; &quot;8190&quot;  &quot;9744&quot;  &quot;V1050&quot; &quot;52511&quot; &quot;29289&quot; &quot;V4966&quot;
## [6346] &quot;E9314&quot; &quot;80123&quot; &quot;1401&quot;  &quot;5161&quot;  &quot;36205&quot; &quot;62989&quot; &quot;1419&quot;  &quot;78833&quot; &quot;6002&quot; 
## [6355] &quot;7236&quot;  &quot;49301&quot; &quot;87323&quot; &quot;90181&quot; &quot;38917&quot; &quot;29653&quot; &quot;7482&quot;  &quot;53410&quot; &quot;30752&quot;
## [6364] &quot;9152&quot;  &quot;9583&quot;  &quot;83907&quot; &quot;V6406&quot; &quot;80119&quot; &quot;20148&quot; &quot;53430&quot; &quot;63421&quot; &quot;86353&quot;
## [6373] &quot;67412&quot; &quot;83114&quot; &quot;78602&quot; &quot;E9051&quot; &quot;01304&quot; &quot;01164&quot; &quot;6261&quot;  &quot;71650&quot; &quot;27540&quot;
## [6382] &quot;8703&quot;  &quot;32362&quot; &quot;4957&quot;  &quot;E8311&quot; &quot;53101&quot; &quot;3152&quot;  &quot;29614&quot; &quot;36573&quot; &quot;73009&quot;
## [6391] &quot;53160&quot; &quot;9165&quot;  &quot;3343&quot;  &quot;72665&quot; &quot;E9505&quot; &quot;E8058&quot; &quot;5565&quot;  &quot;24221&quot; &quot;99585&quot;
## [6400] &quot;73020&quot; &quot;66001&quot; &quot;65251&quot; &quot;66822&quot; &quot;32724&quot; &quot;E8797&quot; &quot;7013&quot;  &quot;42981&quot; &quot;30742&quot;
## [6409] &quot;E9466&quot; &quot;07059&quot; &quot;92821&quot; &quot;80362&quot; &quot;83309&quot; &quot;83969&quot; &quot;4749&quot;  &quot;8053&quot;  &quot;71840&quot;
## [6418] &quot;51283&quot; &quot;7597&quot;  &quot;71687&quot; &quot;9112&quot;  &quot;61801&quot; &quot;30113&quot; &quot;36859&quot; &quot;64214&quot; &quot;V1022&quot;
## [6427] &quot;80070&quot; &quot;V6107&quot; &quot;E8742&quot; &quot;72706&quot; &quot;69012&quot; &quot;43885&quot; &quot;7760&quot;  &quot;01354&quot; &quot;73396&quot;
## [6436] &quot;71845&quot; &quot;75564&quot; &quot;E9570&quot; &quot;4910&quot;  &quot;70900&quot; &quot;42518&quot; &quot;38918&quot; &quot;0031&quot;  &quot;2163&quot; 
## [6445] &quot;85223&quot; &quot;4878&quot;  &quot;36646&quot; &quot;2571&quot;  &quot;78053&quot; &quot;47871&quot; &quot;6021&quot;  &quot;47821&quot; &quot;64263&quot;
## [6454] &quot;71842&quot; &quot;80859&quot; &quot;E8052&quot; &quot;7320&quot;  &quot;E8240&quot; &quot;2102&quot;  &quot;29502&quot; &quot;1731&quot;  &quot;20252&quot;
## [6463] &quot;V510&quot;  &quot;2533&quot;  &quot;20974&quot; &quot;27731&quot; &quot;41040&quot; &quot;3411&quot;  &quot;E9572&quot; &quot;42654&quot; &quot;3344&quot; 
## [6472] &quot;73732&quot; &quot;53341&quot; &quot;V6110&quot; &quot;8209&quot;  &quot;8065&quot;  &quot;8679&quot;  &quot;01890&quot; &quot;E9203&quot; &quot;E0031&quot;
## [6481] &quot;65414&quot; &quot;66554&quot; &quot;90225&quot; &quot;6031&quot;  &quot;8977&quot;  &quot;E8042&quot; &quot;95219&quot; &quot;78865&quot; &quot;20024&quot;
## [6490] &quot;37410&quot; &quot;20382&quot; &quot;38003&quot; &quot;29544&quot; &quot;V4451&quot; &quot;8400&quot;  &quot;E0030&quot; &quot;64294&quot; &quot;99984&quot;
## [6499] &quot;64934&quot; &quot;5511&quot;  &quot;81353&quot; &quot;81314&quot; &quot;78947&quot; &quot;85209&quot; &quot;01505&quot; &quot;72882&quot; &quot;64681&quot;
## [6508] &quot;80230&quot; &quot;80170&quot; &quot;60785&quot; &quot;28264&quot; &quot;79095&quot; &quot;7323&quot;  &quot;82539&quot; &quot;04590&quot; &quot;75289&quot;
## [6517] &quot;9122&quot;  &quot;81012&quot; &quot;29625&quot; &quot;72763&quot; &quot;05440&quot; &quot;25512&quot; &quot;37210&quot; &quot;5890&quot;  &quot;40400&quot;
## [6526] &quot;20203&quot; &quot;E8188&quot; &quot;23773&quot; &quot;94320&quot; &quot;E8735&quot; &quot;80400&quot; &quot;8171&quot;  &quot;72991&quot; &quot;8461&quot; 
## [6535] &quot;9994&quot;  &quot;0309&quot;  &quot;1461&quot;  &quot;08249&quot; &quot;71533&quot; &quot;3081&quot;  &quot;7359&quot;  &quot;80146&quot; &quot;E9659&quot;
## [6544] &quot;07049&quot; &quot;37922&quot; &quot;60820&quot; &quot;40201&quot; &quot;32089&quot; &quot;83921&quot; &quot;5265&quot;  &quot;74353&quot; &quot;59800&quot;
## [6553] &quot;82520&quot; &quot;7094&quot;  &quot;6861&quot;  &quot;2312&quot;  &quot;29681&quot; &quot;83311&quot; &quot;75431&quot; &quot;2253&quot;  &quot;2725&quot; 
## [6562] &quot;94203&quot; &quot;E9240&quot; &quot;36470&quot; &quot;20071&quot; &quot;E8242&quot; &quot;8691&quot;  &quot;7237&quot;  &quot;64852&quot; &quot;E856&quot; 
## [6571] &quot;11505&quot; &quot;7246&quot;  &quot;20903&quot; &quot;36204&quot; &quot;37530&quot; &quot;29382&quot; &quot;67202&quot; &quot;20963&quot; &quot;V703&quot; 
## [6580] &quot;V468&quot;  &quot;94209&quot; &quot;20011&quot; &quot;40411&quot; &quot;5909&quot;  &quot;5169&quot;  &quot;5200&quot;  &quot;E8138&quot; &quot;3814&quot; 
## [6589] &quot;20512&quot; &quot;45181&quot; &quot;33701&quot; &quot;20969&quot; &quot;36284&quot; &quot;71592&quot; &quot;20048&quot; &quot;E9583&quot; &quot;71970&quot;
## [6598] &quot;87321&quot; &quot;3069&quot;  &quot;0038&quot;  &quot;2302&quot;  &quot;27941&quot; &quot;20206&quot; &quot;V8811&quot; &quot;5186&quot;  &quot;V655&quot; 
## [6607] &quot;72632&quot; &quot;3301&quot;  &quot;V580&quot;  &quot;29564&quot; &quot;75029&quot; &quot;51633&quot; &quot;86344&quot; &quot;37312&quot; &quot;96903&quot;
## [6616] &quot;33920&quot; &quot;1439&quot;  &quot;1943&quot;  &quot;3524&quot;  &quot;80350&quot; &quot;0709&quot;  &quot;5995&quot;  &quot;53120&quot; &quot;3879&quot; 
## [6625] &quot;36012&quot; &quot;07953&quot; &quot;37500&quot; &quot;85210&quot; &quot;36844&quot; &quot;3108&quot;  &quot;74720&quot; &quot;94524&quot; &quot;E9801&quot;
## [6634] &quot;80341&quot; &quot;37850&quot; &quot;40211&quot; &quot;05412&quot; &quot;36520&quot; &quot;20943&quot; &quot;03289&quot; &quot;V583&quot;  &quot;986&quot;  
## [6643] &quot;E9821&quot; &quot;36213&quot; &quot;79380&quot; &quot;40210&quot; &quot;E9211&quot; &quot;53211&quot; &quot;E9671&quot; &quot;37956&quot; &quot;69018&quot;
## [6652] &quot;05320&quot; &quot;52579&quot; &quot;6221&quot;  &quot;28310&quot; &quot;86102&quot; &quot;29512&quot; &quot;6192&quot;  &quot;36106&quot; &quot;1453&quot; 
## [6661] &quot;7869&quot;  &quot;65821&quot; &quot;66021&quot; &quot;65411&quot; &quot;40511&quot; &quot;3062&quot;  &quot;V1869&quot; &quot;32720&quot; &quot;8902&quot; 
## [6670] &quot;80376&quot; &quot;80366&quot; &quot;38842&quot; &quot;78960&quot; &quot;V1364&quot; &quot;E8248&quot; &quot;38871&quot; &quot;5671&quot;  &quot;V065&quot; 
## [6679] &quot;71904&quot; &quot;32713&quot; &quot;33989&quot; &quot;E9274&quot; &quot;2306&quot;  &quot;5993&quot;  &quot;9393&quot;  &quot;E9138&quot; &quot;E9854&quot;
## [6688] &quot;29990&quot; &quot;71296&quot; &quot;99941&quot; &quot;94850&quot; &quot;94325&quot; &quot;94519&quot; &quot;36511&quot; &quot;5810&quot;  &quot;64103&quot;
## [6697] &quot;79953&quot; &quot;17322&quot; &quot;9229&quot;  &quot;80011&quot; &quot;85401&quot; &quot;92701&quot; &quot;64913&quot; &quot;64883&quot; &quot;64653&quot;
## [6706] &quot;64243&quot; &quot;94126&quot; &quot;94321&quot; &quot;87264&quot; &quot;9540&quot;  &quot;83813&quot; &quot;8783&quot;  &quot;V037&quot;  &quot;6255&quot; 
## [6715] &quot;17341&quot; &quot;42491&quot; &quot;37952&quot; &quot;36801&quot; &quot;E0139&quot; &quot;9635&quot;  &quot;3154&quot;  &quot;31539&quot; &quot;E8694&quot;
## [6724] &quot;V0389&quot; &quot;3739&quot;  &quot;3629&quot;  &quot;80060&quot; &quot;V9039&quot; &quot;E0071&quot; &quot;85232&quot; &quot;E8145&quot; &quot;71918&quot;
## [6733] &quot;E9250&quot; &quot;60010&quot; &quot;5082&quot;  &quot;E8908&quot; &quot;E8902&quot; &quot;62981&quot; &quot;29621&quot; &quot;79671&quot; &quot;3452&quot; 
## [6742] &quot;71666&quot; &quot;6965&quot;  &quot;E9674&quot; &quot;0970&quot;  &quot;01123&quot; &quot;9595&quot;  &quot;71950&quot; &quot;2982&quot;  &quot;38302&quot;
## [6751] &quot;38321&quot; &quot;38906&quot; &quot;30531&quot; &quot;E9295&quot; &quot;85183&quot; &quot;E0060&quot; &quot;80013&quot; &quot;80113&quot; &quot;E0062&quot;
## [6760] &quot;E8278&quot; &quot;17342&quot; &quot;17332&quot; &quot;17331&quot; &quot;E9262&quot; &quot;36910&quot; &quot;9517&quot;  &quot;61189&quot; &quot;5931&quot; 
## [6769] &quot;56960&quot; &quot;E0138&quot; &quot;E8343&quot; &quot;99687&quot; &quot;28241&quot; &quot;38872&quot; &quot;76511&quot; &quot;1702&quot;  &quot;V0990&quot;
## [6778] &quot;34701&quot; &quot;6232&quot;  &quot;V400&quot;  &quot;1308&quot;  &quot;6963&quot;  &quot;71680&quot; &quot;E8761&quot; &quot;1838&quot;  &quot;37289&quot;
## [6787] &quot;84512&quot; &quot;20925&quot; &quot;20971&quot; &quot;95919&quot; &quot;E0026&quot; &quot;V0739&quot; &quot;80144&quot; &quot;85121&quot; &quot;7916&quot; 
## [6796] &quot;86383&quot; &quot;60781&quot; &quot;5293&quot;  &quot;75530&quot; &quot;94232&quot; &quot;85245&quot; &quot;6278&quot;  &quot;71195&quot; &quot;71985&quot;
## [6805] &quot;78961&quot; &quot;66614&quot; &quot;55001&quot; &quot;29522&quot; &quot;3759&quot;  &quot;82331&quot; &quot;82030&quot; &quot;79552&quot; &quot;71237&quot;
## [6814] &quot;E9419&quot; &quot;80718&quot; &quot;81254&quot; &quot;52489&quot; &quot;V601&quot;  &quot;37182&quot; &quot;2882&quot;  &quot;87269&quot; &quot;8438&quot; 
## [6823] &quot;E9100&quot; &quot;E8314&quot; &quot;9309&quot;  &quot;E8258&quot; &quot;78054&quot; &quot;99569&quot; &quot;7386&quot;  &quot;9189&quot;  &quot;E9334&quot;
## [6832] &quot;1489&quot;  &quot;20060&quot; &quot;5646&quot;  &quot;6251&quot;  &quot;71848&quot; &quot;37820&quot; &quot;28244&quot; &quot;92420&quot; &quot;01405&quot;
## [6841] &quot;9104&quot;  &quot;3862&quot;  &quot;E8249&quot; &quot;81610&quot; &quot;27709&quot; &quot;27702&quot; &quot;4772&quot;  &quot;2140&quot;  &quot;94401&quot;
## [6850] &quot;8460&quot;  &quot;64943&quot; &quot;V045&quot;  &quot;69279&quot; &quot;30089&quot; &quot;37955&quot; &quot;V8709&quot; &quot;5262&quot;  &quot;34442&quot;
## [6859] &quot;20201&quot; &quot;37886&quot; &quot;44382&quot; &quot;1430&quot;  &quot;5824&quot;  &quot;33912&quot; &quot;20037&quot; &quot;36552&quot; &quot;72673&quot;
## [6868] &quot;V7651&quot; &quot;01085&quot; &quot;01895&quot; &quot;01805&quot; &quot;2101&quot;  &quot;4431&quot;  &quot;72230&quot; &quot;E8767&quot; &quot;30747&quot;
## [6877] &quot;36811&quot; &quot;81202&quot; &quot;V789&quot;  &quot;76076&quot; &quot;1898&quot;  &quot;73345&quot; &quot;99565&quot; &quot;71944&quot; &quot;7947&quot; 
## [6886] &quot;32372&quot; &quot;09181&quot; &quot;99680&quot; &quot;3969&quot;  &quot;27489&quot; &quot;1463&quot;  &quot;94426&quot; &quot;E9881&quot; &quot;71897&quot;
## [6895] &quot;E9470&quot; &quot;92801&quot; &quot;7912&quot;  &quot;30012&quot; &quot;71891&quot; &quot;20490&quot; &quot;V122&quot;  &quot;V1553&quot; &quot;7874&quot; 
## [6904] &quot;2813&quot;  &quot;316&quot;   &quot;E8851&quot; &quot;V1381&quot; &quot;78499&quot; &quot;E9329&quot; &quot;53401&quot; &quot;37024&quot; &quot;40413&quot;
## [6913] &quot;9116&quot;  &quot;39899&quot; &quot;63502&quot; &quot;63310&quot; &quot;V1020&quot; &quot;61800&quot; &quot;3060&quot;  &quot;36241&quot; &quot;E8637&quot;
## [6922] &quot;43814&quot; &quot;4144&quot;  &quot;6212&quot;  &quot;83801&quot; &quot;7459&quot;  &quot;81404&quot; &quot;9594&quot;  &quot;07998&quot; &quot;29189&quot;
## [6931] &quot;71216&quot; &quot;1118&quot;  &quot;1745&quot;</code></pre>
<div class="sourceCode" id="cb63"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb63-1"><a href="#cb63-1" aria-hidden="true" tabindex="-1"></a> <span class="co">#Control cohort has 7633150 obs (which + case of 6286 give the initial total of 7639436)</span></span>
<span id="cb63-2"><a href="#cb63-2" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb63-3"><a href="#cb63-3" aria-hidden="true" tabindex="-1"></a><span class="co">#Case cohort</span></span>
<span id="cb63-4"><a href="#cb63-4" aria-hidden="true" tabindex="-1"></a><span class="co">#Of note, this case cohort has the similar subject IDs as the case cohort that was pulled from Bigquery Google. </span></span>
<span id="cb63-5"><a href="#cb63-5" aria-hidden="true" tabindex="-1"></a>MIMICIII_case <span class="ot">&lt;-</span> <span class="fu">filter</span>(MIMICIII, ICD9_CODE <span class="sc">==</span> <span class="st">&quot;42840&quot;</span> <span class="sc">|</span> ICD9_CODE <span class="sc">==</span> <span class="st">&quot;42841&quot;</span> <span class="sc">|</span> ICD9_CODE <span class="sc">==</span> <span class="st">&quot;42842&quot;</span>) <span class="co">#Case cohort has 6286 obs</span></span></code></pre></div>
<p>#Apply open-source NLP tools to encode variables for your study</p>
<p>#Develop and apply logic to features that are indicative to HFrEF
definition from notes to predict case label</p>
<p>#Evaluate how well the predictive power of rule logic for phenotyping
HFrEF (extrinsic evaluation) and areas for improvement based on errors
in NLP and rules (intrinsic evaluation)</p>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
